"date_created","prevalence_estimate_name","source_name","publication_date","grade_of_estimate_scope","specific_geography","sampling_start_date","sampling_end_date","sample_frame_groups_of_interest","sample_frame_age","denominator_value","serum_positive_prevalence","serum_pos_prevalence_95pct_ci_lower","serum_pos_prevalence_95pct_ci_upper","sampling_method","isotype_reported","overall_risk_of_bias","source_type","first_author_full_name","lead_institution","url","data_quality_status","country_or_area","test_manufacturer","sensitivity","specificity","test_type","adm0_isocode","adm1_isocode"
"2020-04-28","200902_Lille_InstitutPasteur_BloodDonors_ELISA-N","A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations","2020-09-02","Local","France; Hauts-de-France; Clermont, Noyon, Lille","2020-03-20","2020-03-24","Blood donors","Multiple groups",200.0,0.0,"","","Sequential","IgA; IgE; IgD; IgM; IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Ludivine Grzelak","Institut Pasteur","https://stm.sciencemag.org/content/12/559/eabc3103","Verified","France","Author-designed","",0.95,"ELISA-N","FR","FR-HDF"
"2020-05-01","210419_Kobe_KobeMedicalCenterGeneralHospital_Outpatients_PopAdj","Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study","2021-04-19","Local","Japan; Hyogo Prefecture; Kobe","2020-03-31","2020-04-07","Residual sera","Multiple groups",1000.0,0.027,0.018,0.039,"Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Asaka Doi","Kobe City Medical Center General Hospital","https://dx.doi.org/10.1016/j.cegh.2021.100747","Verified","Japan","Kurabo Industries",0.764,1.0,"LFIA: Lateral flow immunoassay","JP","JP-28"
"2020-05-02","200422_Idaho_CrushTheCurveIdaho_Patients","CrushTheCurveIdaho finds small population with antibodies: 'We are far from herd immunity'","2020-04-22","Regional","United States of America; Idaho","","2020-04-22","Residual sera","Multiple groups",1946.0,0.018,"","","Convenience","IgG","High","News and Media","Ryan Morrison","Crush The Curve Idaho","https://idahonews.com/news/coronavirus/crushthecurveidaho-finds-small-population-with-antibodies-we-are-far-from-herd-immunity","Verified","United States of America","University of Washington",1.0,0.996,"Not reported","US","US-ID"
"2020-05-02","200424_Brevard_OMNI_GeneralPopulation","OMNI Healthcare's COVID-19 antibody testing data for Brevard shows low rates of immunity","2020-04-24","Local","United States of America; Florida","2020-04-17","2020-04-24","Household and community samples","Multiple groups",1000.0,0.01,"","","Self-referral","IgM; IgG","High","News and Media","Alessandro Sassoon","OMNI Healthcare","https://www.floridatoday.com/story/news/2020/04/24/omni-covid-19-immunity-testing-data-brevard-county-florida-antibody/3022571001/","Verified","United States of America","Not reported",1.0,1.0,"LFIA: Lateral flow immunoassay","US","US-FL"
"2020-05-02","200429_Singapore_NCID_GeneralPopulation","Coronavirus: Community transmission in  S'pore very low","2020-04-29","Local","Singapore","2020-02-15","2020-04-15","Household and community samples","Multiple groups",774.0,0.0,"","","Unclear","Not reported","Unclear","News and Media","Rei Kurohi","Singapore National Centre for Infectious Diseases","https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says","Verified","Singapore","Not reported","","","Not reported","SG",""
"2020-05-02","200429_Singapore_Singapore_NCID_HCW","Coronavirus: Community transmission in  S'pore very low","2020-04-29","Local","Singapore","2020-02-15","2020-04-15","Health care workers and caregivers","Multiple groups",1096.0,0.0,"","","Unclear","Not reported","Unclear","News and Media","Rei Kurohi","Singapore National Centre for Infectious Diseases","https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says","Verified","Singapore","Not reported","","","Not reported","SG",""
"2020-05-03","200423_BatonRouge_BatonRougeGeneralHospital_GenPop","Takeaways from coronavirus antibody tests: Infections might be more widespread than cases suggest","2020-04-28","Local","United States of America; Louisiana; Baton Rouge","","2020-04-21","Household and community samples","Multiple groups",432.0,0.044,"","","Unclear","Not reported","Unclear","News and Media","Blake Paterson","Baton Rouge General Hospital","https://www.theadvocate.com/baton_rouge/news/coronavirus/article_b499efa0-8983-11ea-a3f1-af936ecb1d2c.html","Verified","United States of America","Mayo Clinic","",0.986,"Not reported","US","US-LA"
"2020-05-03","200508_Seattle_UniversityofWashington_Adults","Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24–April 21, 2020","2020-05-08","Local","United States of America; Washington; Seattle","2020-03-01","2020-03-31","Residual sera","Adults (18-64 years)",221.0,0.004,"","","Convenience","Not reported","High","Institutional Report","Anne Schuchat","University of Washington","https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6918e2-H.pdf","Verified","United States of America","Not reported","","","Not reported","US","US-WA"
"2020-05-14","200503_SaltLakeCity_UniversityofUtah_HCW","Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees","2020-05-03","Local","United States of America; Utah; Salt Lake City","2020-04-13","2020-04-19","Health care workers and caregivers","Adults (18-64 years)",270.0,0.059,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Troy Madsen","University of Utah","https://www.ajemjournal.com/article/S0735-6757(20)30306-5/fulltext","Verified","United States of America","EUROIMMUN",0.954,0.983,"ELISA","US","US-UT"
"2020-05-14","200506_Atlanta_GeorgiaStateUniversity_GeneralPop_IgG","Antibodies to SARS/CoV-2 in arbitrarily-selected Atlanta residents","2020-05-06","Local","United States of America; Georgia; Atlanta","2020-04-17","2020-04-27","Household and community samples","Multiple groups",127.0,0.024,"","","Convenience","IgG","High","Preprint","Jun Zou","Georgia State University","https://www.medrxiv.org/content/10.1101/2020.05.01.20087478v1","Verified","United States of America","Author-designed","","","ELISA","US","US-GA"
"2020-05-14","200508_Bari_IstitutoTumoriGPaolo_HCW_IgG","COVID-19 SCREENING AND MONITORING OF ASYMPTOMATIC HEALTH WORKERS WITH A RAPID SEROLOGICAL TEST","2020-05-08","Local","Italy; Puglia; Bari","2020-03-26","2020-04-17","Health care workers and caregivers","Adults (18-64 years)",606.0,0.003,"","","Convenience","IgG","High","Preprint","Angelo Virgilio Paradiso","Istituto Tumori G. Paolo II","https://www.medrxiv.org/content/10.1101/2020.05.05.20086017v1","Verified","Italy","Snibe Diagnostic","","","Chemiluminescence Immunoassay","IT","IT-75"
"2020-05-18","200515_Winona_WinonaHealth_GeneralPopulation","New COVID-19;   antibody testing in Winona gives health officials a better picture of the;   spread","2020-05-15","Local","United States of America; Minnesota; Winona","2020-05-10","2020-05-15","Household and community samples","Multiple groups",1000.0,0.07,"","","Self-referral","IgG","High","News and Media","Mal Meyer","Winona Health","https://www.google.com/url?rct=j&sa=t&url=https://www.news8000.com/new-covid-19-antibody-testing-in-winona-gives-health-officials-a-better-picture-of-the-spread/&ct=ga&cd=CAEYDyoTMTE4NjM1MjEyMTUyMjIzNTE5ODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNE5fpVM7tRmIsEhSRedRkru-TpZOA","Verified","United States of America","NR","","","Not reported","US","US-MN"
"2020-05-19","200513_Indiana_IndianaUniversity_Wave1GenPop_PopAdj","Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020","2020-07-24","Regional","United States of America; Indiana","2020-04-25","2020-04-29","Household and community samples","Multiple groups",3518.0,0.011,0.008,0.015,"Stratified probability","IgG","Moderate","Institutional Report","Nir Menachemi","Indiana University Fairbanks School of Public Health","https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w","Verified","United States of America","Author derived",1.0,0.996,"Chemiluminescence Immunoassay","US","US-IN"
"2020-05-21","200518_LosAngelesCounty_StanfordUniversity_GenPopWeighted_TestAdj","Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020","2020-05-18","Local","United States of America; California","2020-04-10","2020-04-14","Household and community samples","Multiple groups",863.0,0.047,0.025,0.071,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Neeraj Sood","Stanford University School of Medicine","https://jamanetwork.com/journals/jama/fullarticle/2766367","Verified","United States of America","Premier Biotech",0.827,0.995,"LFIA: Lateral flow immunoassay","US","US-CA"
"2020-05-21","200520_England_RutherfordHealth_HCW_IgG","Serological prevalence of antibodies to SARS CoV-2 amongst cancer centre staff","2020-05-20","Local","United Kingdom of Great Britain and Northern Ireland; England; Reading, Newport, Liverpool, Bedlington","2020-04-14","2020-04-24","Health care workers and caregivers","Adults (18-64 years)",161.0,0.012,"","","Convenience","IgG","High","Preprint","Karol Sikora","Rutherford Health","https://www.medrxiv.org/content/10.1101/2020.05.16.20099408v1.full.pdf+html","Verified","The United Kingdom","Sugentech","","","Colloidal Gold Immunochromatography Assay (LFIA)","GB","GB-ENG"
"2020-05-21","210203_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_UnAdj","SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan","2021-02-03","Local","Italy; Lombardy; Milan","2020-02-24","2020-04-08","Blood donors","Adults (18-64 years)",789.0,0.051,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luca Valenti","Fondazione IRCCS Ca' Granda Ospedale Maggiore","https://dx.doi.org/10.2450/2021.0324-20","Verified","Italy","Prima Lab","","","LFIA: Lateral flow immunoassay","IT","IT-25"
"2020-05-25","201112_Netherlands_AmsterdamUMC_GenPop_Overall_1Test","Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands.","2020-11-12","National","Netherlands","2020-04-01","2020-04-15","Blood donors","Multiple groups",7361.0,0.034,"","","Sequential","IgG; IgA; IgM","Moderate","Journal Article (Peer-Reviewed)","Ed Slot","Amsterdam UMC","https://www.nature.com/articles/s41467-020-19481-7","Verified","Netherlands","Wantai Biological Pharmacy Enterprise",1.0,0.991,"ELISA","NL",""
"2020-05-26","200523_SouthCarolina_MUSCHealthLancaster_HCW","Antibody tests;   show just 2% exposure rate to COVID-19","2020-05-23","Local","United States of America; South Carolina; Lancaster","2020-03-16","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",230.0,0.022,"","","Unclear","Not reported","High","News and Media","Lisa Geraci","MUSC Health-Lancaster","https://www.google.com/url?rct=j&sa=t&url=https://www.thelancasternews.com/content/antibody-tests-show-just-2-exposure-rate-covid-19&ct=ga&cd=CAEYFSoSNjI0MTExNTA1MzQ0Mjc2MzA2Mho5MGRlYTk4OTk0ZTkxODU5OmNvbTplbjpVUw&usg=AFQjCNEYxEO1T-WE8tAinlY5KZVTRufQSA","Verified","United States of America","Abbott","","","Not reported","US","US-SC"
"2020-05-26","200525_Frankfurt_Goethe-UniversityFrankfurt_Employees","Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area","2020-05-25","Local","Germany; Hesse; Frankfurt","2020-04-06","2020-04-14","Essential non-healthcare workers","Adults (18-64 years)",998.0,0.004,0.002,0.01,"Convenience","IgG","High","Preprint","Verena Kraehling","Goethe-University Frankfurt","https://www.medrxiv.org/content/10.1101/2020.05.20.20107730v1","Verified","Germany","Author-designed","",0.992,"ELISA","DE","DE-HE"
"2020-05-30","200520_Iowa_IowaDepartmentofPublicHealth_IowaStateGeneralPopulation","Iowa begins to release serology test results, showing greater local spread of COVID-19","2020-05-20","Regional","United States of America; Iowa","2020-04-01","2020-05-20","Household and community samples","Adults (18-64 years)",18160.0,0.1,"","","Self-referral","IgG","High","News and Media","Jeff Montgomery","Iowa Department of Public Health","https://www.google.com/url?rct=j&sa=t&url=https://www.telegraphherald.com/coronavirus/article_b5f56348-317d-5f49-abee-0e7cff653cbb.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG6tWk8Wg2dbYV27AKz5iI4DLM97Q","Verified","United States of America","Not reported","","","Not reported","US","US-IA"
"2020-05-30","200526_AlzintanCity_Al-ZintanUniversity_GenPopulation","Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya","2020-05-26","Local","Libya; Libya; Alzintan City","2020-04-02","2020-05-18","Multiple populations","Multiple groups",142.0,0.042,"","","Simplified probability","IgM; IgG","High","Preprint","Abdulwahab Kammon","Al-Zintan University","https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1","Verified","Libya","Guangzhou Wondfo Biotech",0.864,0.996,"LFIA: Lateral flow immunoassay","LY",""
"2020-05-30","200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers","Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya","2020-05-26","Local","Libya; Libya; Alzintan City","2020-04-02","2020-05-18","Health care workers and caregivers","Multiple groups",77.0,0.0,"","","Stratified probability","IgM; IgG","High","Preprint","Abdulwahab Kammon","Al-Zintan University","https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1","Verified","Libya","Guangzhou Wondfo Biotech",0.864,0.996,"LFIA: Lateral flow immunoassay","LY",""
"2020-05-30","200617_NewYork_StateUniversityofNewYork_GeneralPopTestPopAdj","Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York","2020-06-17","Regional","United States of America; New York","2020-04-19","2020-04-28","Household and community samples","Multiple groups",15101.0,0.14,0.133,0.147,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Eli Rosenberg","New York State Department of Health","https://dx.doi.org/10.1016/j.annepidem.2020.06.004","Verified","United States of America","NYSDOH Wadsworth Center",0.879,0.998,"Microsphere immunoassay","US","US-NY"
"2020-06-02","200430_Bergamo_ATSBergamo_GeneralPopulation_AnalyzedLab1","Bergamo serological tests, the results of Nembro and Alzano arrive: 61% positive","2020-04-30","Local","Italy; Lombardy; Alzano, Nembro","2020-04-23","2020-04-28","Household and community samples","Multiple groups",750.0,0.61,"","","Unclear","Not reported","Unclear","News and Media","Armando Di Landro","ATS Bergamo","https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp","Verified","Italy","Not reported","","","Not reported","IT","IT-25"
"2020-06-02","200430_Bergamo_HospitalofBergamo_HCW","Bergamo serological tests, the results of Nembro and Alzano arrive: 61% positive","2020-04-30","Local","Italy; Lombardy; Bergamo","","2020-04-24","Health care workers and caregivers","Adults (18-64 years)",3000.0,0.13,"","","Unclear","Not reported","Unclear","News and Media","Armando Di Landro","Hospital of Bergamo","https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp","Verified","Italy","Not reported","","","Not reported","IT","IT-25"
"2020-06-02","200510_US_StanfordUniversity_MajorLeagueBaseballEmployees","MLB antibody study: 0.7% of those tested had been exposed to coronavirus","2020-05-10","National","United States of America","2020-04-08","2020-04-21","Non-essential workers and unemployed persons","Adults (18-64 years)",5603.0,0.007,0.003,0.012,"Convenience","Not reported","Unclear","News and Media","Susan Slusser","Stanford University","https://www.sfchronicle.com/athletics/article/MLB-antibody-study-7-percent-exposed-to-15260314.php","Verified","United States of America","Not reported","","","Not reported","US",""
"2020-06-02","200517_SaoPaolo_GrupoFleury_GenPop","In the neighborhoods of São Paulo most affected by Covid-19, only 5% had contact with the virus","2020-05-17","Local","Brazil; São Paulo; São Paulo","2020-05-04","2020-05-12","Household and community samples","Multiple groups",520.0,0.052,"","","Stratified probability","Not reported","Unclear","News and Media","Phillippe Watanabe","Grupo Fleury","https://www1.folha.uol.com.br/equilibrioesaude/2020/05/nos-bairros-de-sp-mais-afetados-pela-covid-19-so-5-tiveram-contato-com-o-virus.shtml","Verified","Brazil","Not reported",0.9,"","Not reported","BR","BR-SP"
"2020-06-02","200601_LongHillTownship_SummitMedicalCenter_FirstResponders","Few among Long Hill first responders test positive for COVID-19 antibodies","2020-06-01","Local","United States of America; New Jersey; Long Hill Township","2020-05-01","2020-05-14","Essential non-healthcare workers","Adults (18-64 years)",70.0,0.043,"","","Convenience","Not reported","High","News and Media","Alex Parker Magyar","Summit Medical Center","https://www.google.com/url?rct=j&sa=t&url=https://www.newjerseyhills.com/echoes-sentinel/news/few-among-long-hill-first-responders-test-positive-for-covid-19-antibodies/article_007ac367-b3b2-5375-b471-f0a817998f62.html&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWg839bXiyzOxO1Y7-QOECGMRCMw","Verified","United States of America","Not reported","","","Not reported","US","US-NJ"
"2020-06-03","200601_Israel_PandemicTaskForce_GenPop","Initial antibody tests indicate 200000  Israelis have had COVID-19 - report","2020-06-02","National","Israel; Israel","","2020-06-02","Household and community samples","Multiple groups",1700.0,0.025,"","","Stratified probability","IgG","Moderate","News and Media","Michael Bachner","Israeli Pandemic Task Force","https://www.google.com/url?rct=j&sa=t&url=https://www.timesofisrael.com/initial-antibody-tests-indicate-200000-israelis-have-had-covid-19-report/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHYeXqD2hIEiNnZoH5qLiVlZKxQjg","Verified","Israel","Not reported","","","Not reported","IL",""
"2020-06-04","200602_NewYork_IcahnSchoolofMedicineatMountSinai_HealthCareWorkers","Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City","2020-06-03","Local","United States of America; New York; New York City","2020-03-24","2020-04-04","Health care workers and caregivers","Multiple groups",285.0,0.326,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Mayce Mansour","Icahn School of Medicine at Mount Sinai","https://link.springer.com/article/10.1007/s11606-020-05926-8","Verified","United States of America","Not reported","","","ELISA","US","US-NY"
"2020-06-04","200602_Wuhan_HuazhongUniversityofScienceandTechnology_HealthCareWorkers","The prevalence of antibodies to SARS-CoV-2 in asymptomatic healthcare workers with intensive exposure to COVID-19","2020-06-02","Local","China; Hubei; Wuhan","2020-02-12","2020-03-17","Health care workers and caregivers","Adults (18-64 years)",797.0,0.044,"","","Convenience","IgG","Unclear","Preprint","Shue Xiong","Huazhong University of Science and Technology","https://www.medrxiv.org/content/10.1101/2020.05.28.20110767v1.full.pdf","Verified","China","Not reported","","","ELISA","CN","CN-42"
"2020-06-06","200605_China_NationalClinicalResearchCentre_CommunitySetting","Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China","2020-06-05","National","China; Hubei, Sichuan, Guangdong; Wuhan, Guangzhou, Chengdu","2020-03-09","2020-04-10","Multiple populations","Adults (18-64 years)",10449.0,0.008,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","National Clinical Research Centre for Kidney Disease","https://www.nature.com/articles/s41591-020-0949-6","Verified","China","Bioscience","",0.993,"Chemiluminescence Immunoassay","CN",""
"2020-06-07","200602_HumboldtCounty_HumboldtCountyDepartmentofHealthandHumanServices_GenPop","1%  of early Humboldt County coronavirus tests show antibodies","2020-06-02","Local","United States of America; California","","2020-05-26","Household and community samples","Multiple groups",1000.0,0.01,"","","Unclear","Not reported","High","News and Media","Shomik Mukherjee","Humboldt County Department of Health and Human Services","https://www.google.com/url?rct=j&sa=t&url=https://www.times-standard.com/1-of-early-humboldt-county-coronavirus-tests-show-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFdl7jBbUfA1cB9ZXhwgAM8IvQmrA","Verified","United States of America","Not reported","","","Not reported","US","US-CA"
"2020-06-12","200602_Wuhan_SunYat-senUniversity_HCW_IgG","Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study","2020-06-10","Local","China; Hubei; Wuhan","2020-02-07","2020-04-21","Health care workers and caregivers","Adults (18-64 years)",420.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Min Liu","Sun Yat-sen University","https://www.bmj.com/content/369/bmj.m2195","Verified","China","YHLO",0.978,0.979,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-06-12","200612_Guam_USNavy","SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members - USS Theodore Roosevelt, April 2020.","2020-06-12","Local","United States of America; Guam","2020-04-20","2020-04-24","Essential non-healthcare workers","Adults (18-64 years)",382.0,0.597,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Daniel Payne","US Navy","https://www.cdc.gov/mmwr/volumes/69/wr/mm6923e4.htm","Verified","United States of America","CDC",0.96,0.993,"ELISA","US",""
"2020-06-13","200612_NewJersey_MonmouthMedicalCentre_HealthCareWorkersUnadj","The Prevalence of SARS-CoV-2 IgG Antibodies in Intensive Care Unit (ICU) Healthcare Personnel (HCP) and its Implications - A Single-Center, Prospective, Pilot Study","2020-06-12","Local","United States of America; New Jersey; Long Branch","2020-05-14","2020-05-19","Health care workers and caregivers","Adults (18-64 years)",121.0,0.008,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mohsin Mughal","Monmouth Medical Centre","https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/prevalence-of-sarscov2-igg-antibodies-in-intensive-care-unit-icu-healthcare-personnel-hcp-and-its-implications-a-singlecenter-prospective-pilot-study/296957BF678E512283D4A3770467FFB7","Verified","United States of America","SD Biosensor",0.962,0.966,"LFIA: Lateral flow immunoassay","US","US-NJ"
"2020-06-15","200614_SteamboatSprings_RouttCountyBoardofHealth_GenPop","One new positive COVID-19 case in Routt County, antibody testing ramping up","2020-06-14","Local","United States of America; Colorado; Steamboat Springs","","2020-06-10","Household and community samples","Multiple groups",649.0,0.026,"","","Self-referral","Not reported","High","News and Media","Kari Harden","Routt County Board of Health","https://www.google.com/url?rct=j&sa=t&url=https://www.steamboatpilot.com/news/one-new-positive-covid-19-case-in-routt-county-antibody-testing-ramping-up/&ct=ga&cd=CAEYBSoTNzg3MTAwMjkzNzU0ODU4ODgzODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGVI81Ue1Rqm7AhmKKlvb0xWvQDKQ","Verified","United States of America","Not reported","","","Not reported","US","US-CO"
"2020-06-18","200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers","Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium","2020-06-15","Local","Belgium; Limburg; Genk","2020-04-22","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",3056.0,0.064,0.055,0.073,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Deborah Steensels","ZiekenhuisOost-Limburg","https://jamanetwork.com/journals/jama/fullarticle/2767382","Verified","Belgium","Multi-G",0.922,0.97,"LFIA: Lateral flow immunoassay","BE",""
"2020-06-18","200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPop2Sub-urban","A population-based study of the prevalence of COVID-19 infection in Espírito Santo, Brazil: methodology and results of the first stage","2020-06-16","Regional","Brazil; Espírito Santo","2020-05-13","2020-05-15","Household and community samples","Multiple groups",1163.0,0.003,0.0,0.008,"Stratified probability","IgG; IgM","High","Preprint","Cristiana Gomes","Secretaria de Estado da Saúde do Espírito Santo","https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf","Verified","Brazil","Celer Technologies Inc.",0.864,0.976,"Rapid immunochromatographic test","BR","BR-ES"
"2020-06-18","200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPopUrban","A population-based study of the prevalence of COVID-19 infection in Espírito Santo, Brazil: methodology and results of the first stage","2020-06-16","Regional","Brazil; Espírito Santo","2020-05-13","2020-05-15","Household and community samples","Multiple groups",4612.0,0.021,0.017,0.025,"Stratified probability","IgG; IgM","High","Preprint","Cristiana Gomes","Secretaria de Estado da Saúde do Espírito Santo","https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf","Verified","Brazil","Celer Technologies Inc.",0.864,0.976,"Rapid immunochromatographic test","BR","BR-ES"
"2020-06-18","200616_Madrid_UniversidadAutónomadeMadrid_TotalPop","SARS-CoV-2 antibodies in adults in Madrid, Spain","2020-06-16","Local","Spain; Community of Madrid; Madrid","2020-04-26","2020-05-16","Multiple populations","Multiple groups",674.0,0.138,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Vicente Soriano","Universidad Autónoma de Madrid","https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa769/5858269","Verified","Spain","PCL Inc.","","","Rapid immunochromatographic test","ES","ES-MD"
"2020-06-18","200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG","Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan, Implications for the Longevity of Antibodies Against SARS-CoV-2","2020-11-02","Local","China; Hubei; Wuhan","2020-02-29","2020-04-29","Household and community samples","Multiple groups",19555.0,0.046,0.043,0.049,"Convenience","IgG","Moderate","Preprint","Tao Liu","Zhongnan Hospital of Wuhan University","https://www.researchsquare.com/article/rs-99748/v1","Verified","China","YHLO",0.978,0.979,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-06-18","200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG","Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan, Implications for the Longevity of Antibodies Against SARS-CoV-2","2020-11-02","Local","China; Hubei; Wuhan","2020-02-29","2020-04-29","Health care workers and caregivers","Multiple groups",3832.0,0.04,0.034,0.047,"Convenience","IgG","Moderate","Preprint","Tao Liu","Zhongnan Hospital of Wuhan University","https://www.researchsquare.com/article/rs-99748/v1","Verified","China","YHLO",0.978,0.979,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-06-18","200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG","Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan, Implications for the Longevity of Antibodies Against SARS-CoV-2","2020-11-02","Local","China; Hubei; Wuhan","2020-02-29","2020-04-29","Residual sera","Multiple groups",1616.0,0.01,0.005,0.015,"Sequential","IgG","Moderate","Preprint","Tao Liu","Zhongnan Hospital of Wuhan University","https://www.researchsquare.com/article/rs-99748/v1","Verified","China","YHLO",0.978,0.979,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-06-19","200514_Saalfeld_Thuringia_IgG","Prevalence of antibodies against COVID-19 in the staff of a COVID-19 regular ward","2020-05-14","Local","Germany; Thuringia; Saalfeld","2020-04-16","2020-04-21","Health care workers and caregivers","Adults (18-64 years)",18.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Igor Harsch","Thuringia Clinic","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273321/pdf/HIC-15-09.pdf","Verified","Germany","EUROIMMUN","",0.985,"ELISA","DE","DE-TH"
"2020-06-23","200609_Milan_UniMilan_OverallAb","SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy","2020-06-09","Local","Italy; Lombardy; Milan","2020-03-30","2020-03-31","Household and community samples","Adults (18-64 years)",197.0,0.102,"","","Self-referral","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Gregorio Milani","University of Milan","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280100/pdf/main.pdf","Verified","Italy","Beijing Wantai Biological Pharmacy Enterprise , EUROIMMUN","","","ELISA","IT","IT-25"
"2020-06-23","200617_Gibraltar_GibraltarGovernment_HCW","After in-house GHA screening programme, Govt rethinks its plans for anti-body tests","2020-06-17","Regional","United Kingdom of Great Britain and Northern Ireland; Gibraltar","2020-06-03","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",1247.0,0.014,"","","Convenience","IgG","Unclear","News and Media","Priya Gulraj","Gibraltar Government","https://www.google.com/url?rct=j&sa=t&url=https://www.chronicle.gi/after-in-house-gha-screening-programme-govt-rethinks-its-plans-for-anti-body-tests/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWZarBh_XNDZ6O6KvR5YUdioFyGg","Verified","The United Kingdom","Not reported","","","Not reported","GB",""
"2020-06-23","200617_Indiana_IndianaUniversity_Wave2GenPop","Fairbanks study indicates that 'virus has  slowed its spread' in Indiana","2020-06-17","Regional","United States of America; Indiana","2020-06-03","2020-06-08","Household and community samples","Multiple groups",3600.0,0.015,"","","Stratified probability","Not reported","Moderate","News and Media","Shari Rudavsky","Indiana University Fairbanks School of Public Health","https://www.google.com/url?rct=j&sa=t&url=https://www.indystar.com/story/news/health/2020/06/17/indiana-coronavirus-fairbanks-study-indicates-spread-has-slowed/3208509001/&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH4O6wDIVkk1hAyMEzD78OGtB7YoQ","Verified","United States of America","Not reported","","","Not reported","US","US-IN"
"2020-06-24","200622_TruckeeMeadows_TruckeeMeadowsFireProtectionDistrict_FirstResponders","Prevalence Of COVID-19 Antibodies In Washoe Co. Expected To Be Low","2020-06-22","Local","United States of America; Nevada","2020-05-01","2020-05-31","Essential non-healthcare workers","Adults (18-64 years)",132.0,0.14,"","","Convenience","Not reported","High","News and Media","Anh Gray","Truckee Meadows Fire Protection District","https://www.kunr.org/post/prevalence-covid-19-antibodies-washoe-co-expected-be-low#stream/0","Verified","United States of America","Not reported","","","Not reported","US","US-NV"
"2020-06-26","200615_Germany_UniversityofHannover_hcw","Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff","2020-06-15","Local","Germany; Lower Saxony; Hannover","2020-04-20","2020-04-30","Health care workers and caregivers","Multiple groups",385.0,0.029,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Simone Schmidt","University of Hannover","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235417","Verified","Germany","EUROIMMUN",0.946,0.998,"ELISA","DE","DE-NI"
"2020-06-26","200625_Denmark_GeneralPopTestAdj","Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors","2020-06-25","National","Denmark","2020-04-06","2020-05-03","Blood donors","Adults (18-64 years)",20640.0,0.019,0.008,0.023,"Entire sample","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Christian Erikstrup","Copenhagen University Hospital","https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa849/5862661","Verified","Denmark","Livzon Diagnostics",0.826,0.995,"LFIA: Lateral flow immunoassay","DK",""
"2020-06-27","200424_Romania_MedLife_HCW","Concluzii preliminare, studiu MedLife: “Cel mai probabil populatia nu are imunitate dobandita natural pentru COVID 19. Respectarea masurilor de protectie si extinderea testarii reprezinta sansa noastra de a functiona in siguranta si de a reporni economia""","2020-04-24","National","Romania; Nord-Est, Sud-Est, Sud-Mutenia, Sud-Vest Oltenia, Vest, Nord-Vest, Centru, Bucuresti-Ilfov; Bucharest, Arad, Brasov, Sibiu, Piatra Neamt, Braila, Timisoara, Pitesti, Galati, Targoviste, Ploiesti","2020-03-24","2020-04-21","Health care workers and caregivers","Multiple groups",371.0,0.03,"","","Convenience","IgG; IgM","Unclear","Institutional Report","MedLife","MedLife","https://www.medlife.ro/comunicat-de-presa/concluzii-preliminare-studiu-medlife-cel-mai-probabil-populatia-nu-are-imunitate-dobandita-natural-pentru-covid-19-respectarea-masurilor-de-protectie-si-extinderea-testarii-reprezinta-sansa-noastra-de-a-functiona-in-siguranta-si-de-a","Verified","Romania","Abbott, Maglumi, YHLO","","","Chemiluminescence; ELISA","RO",""
"2020-06-27","200504_SouthCarolina_MedicalUniversitySouthCarolina_HealthcareWorkers_FirstResponders","Results show 2% of tested MUSC staff have COVID-19 antibodies","2020-05-04","Local","United States of America; South Carolina; Charleston","2020-04-27","2020-05-02","Multiple populations","Adults (18-64 years)",920.0,0.02,"","","Unclear","Not reported","High","News and Media","Nick Reagan","Medical University South Carolina","https://www.live5news.com/2020/05/04/results-show-tested-musc-staff-have-covid-antibodies/","Verified","United States of America","Abbott","","","Not reported","US","US-SC"
"2020-06-27","200520_LosAngeles_UniSouthernCalifornia_GenPop","LA County 'Still Far Away From Herd Immunity"" New Antibody Numbers Show","2020-05-20","Local","United States of America; California","2020-05-08","2020-05-12","Household and community samples","Multiple groups",1014.0,0.021,"","","Self-referral","Not reported","Unclear","News and Media","CBS Los Angeles","University of Southern California","https://www.google.com/url?rct=j&sa=t&url=https://losangeles.cbslocal.com/2020/05/20/la-county-still-far-away-from-herd-immunity-new-antibody-numbers-show/&ct=ga&cd=CAAYCDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGRZYAUZKxAbfGM7Yh_03xi5M8tDg","Verified","United States of America","Not reported","","","Not reported","US","US-CA"
"2020-06-27","200520_Madison_UWHealth_UniWisconsinHealthClinic","Antibody tests for coronavirus so far trend overwhelmingly negative","2020-05-20","Local","United States of America; Wisconsin; Madison","2020-05-13","2020-05-20","Household and community samples","Multiple groups",5303.0,0.015,"","","Self-referral","Not reported","Unclear","News and Media","Michelle Alfini","UW Health","https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ","Verified","United States of America","Not reported","","","Not reported","US","US-WI"
"2020-06-27","200520_Madison_UWHealth_UnityPointClinic","Antibody tests for coronavirus so far trend overwhelmingly negative","2020-05-20","Local","United States of America; Wisconsin; Madison","2020-05-13","2020-05-20","Household and community samples","Multiple groups",433.0,0.003,"","","Self-referral","Not reported","Unclear","News and Media","Michelle Alfini","UW Health","https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ","Verified","United States of America","Not reported","","","Not reported","US","US-WI"
"2020-06-27","200523_CoralSprings_CoralSpringsCityGovernment_CityEmployees","South Florida Cities Begin Testing Employees For COVID-19 Antibodies","2020-05-22","Local","United States of America; Florida; Coral Springs","2020-05-17","2020-05-22","Essential non-healthcare workers","Multiple groups",700.0,0.0,"","","Self-referral","Not reported","Unclear","News and Media","Jenny Staletovich","Coral Springs City Government","https://www.google.com/url?rct=j&sa=t&url=https://www.wlrn.org/post/south-florida-cities-begin-testing-employees-covid-19-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHc4oWG79OOMovZOpWOY8qd-gm3kw","Verified","United States of America","Cellex","","","Not reported","US","US-FL"
"2020-06-27","200606_Bengaluru_SJICSR_Staff","Covid-19: Jayadeva says its survey hints at herd immunity","2020-06-06","Local","India; Karnataka; Bengaluru","2020-05-23","2020-06-06","Health care workers and caregivers","Adults (18-64 years)",1000.0,0.01,"","","Convenience","IgG","Unclear","News and Media","Sunitha Rao","Sri Jayadeva Institute of Cardiovascular Sciences and Research","https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/bengaluru/covid-19-jayadeva-says-its-survey-hints-at-herd-immunity/articleshow/76228490.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrh7Scfh82driNisE_8HVxMcpd8Q","Verified","India","New Life Healthcare","","","Not reported","IN","IN-KA"
"2020-06-27","200611_Russia_NationalCouncilCombatingCoronavirus_GenPop","1 in 7 Russians Have ‘Coronavirus Immunity’ – Official","2020-06-10","National","Russian Federation","","2020-06-10","Household and community samples","Multiple groups",650000.0,0.14,"","","Unclear","Not reported","Moderate","News and Media","Sergei Kiselyov","Russian National Council for Combating Coronavirus","https://www.themoscowtimes.com/2020/06/10/1-in-7-russians-have-coronavirus-immunity-official-a70540 ; https://www.interfax.ru/russia/712617","Verified","Russian Federation","Invitro",0.95,0.98,"Not reported","RU",""
"2020-06-27","200621_Japan_SoftBank_HCW","Japanese firm's blanket testing of employees  could serve as model","2020-06-21","Local","Japan","2020-05-12","2020-05-18","Health care workers and caregivers","Multiple groups",5850.0,0.018,"","","Convenience","Not reported","Unclear","News and Media","Simon Denyer","SoftBank","https://www.google.com/url?rct=j&sa=t&url=https://www.lmtonline.com/news/article/Japanese-firm-s-blanket-testing-of-employees-15355433.php&ct=ga&cd=CAEYHCoUMTM4NjAwODY3NjE3NzkyOTU2ODYyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNGl9_tc35Q3fUbB67SoWaNsH2ltMw","Verified","","Innovita, ""Zhejiang Orient Gene Biotech Co., LTD""","","","Not reported","JP",""
"2020-06-29","200624_BaskingRidge_FellowshipVillage_Residents2_Overall","Fellowship;   Village Benefits from Covid-19 Antibody Tests","2020-06-24","Local","United States of America; New Jersey; Basking Ridge","2020-04-15","2020-05-06","Assisted living and long-term care facilities","Seniors (65+ years)",371.0,0.348,"","","Convenience","IgG; IgM","Unclear","News and Media","Tim Regan","Fellowship Village","https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g","Verified","United States of America","NR","","","","US","US-NJ"
"2020-06-29","201103_NewYorkCity_MountSinai_RoutineCare_1 _Overall","Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City","2020-11-03","Local","United States of America; New York; New York City","2020-02-02","2020-07-05","Residual sera","Multiple groups",6590.0,0.111,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Daniel Stadlbauer","Icahn School of Medicine at Mount Sinai","http://dx.doi.org/10.1038/s41586-020-2912-6","Verified","United States of America","Mount Sinai Hospital New York",0.95,1.0,"ELISA","US","US-NY"
"2020-07-04","200529_CoachellaValley_Desert Healthcare District_GenPop","Coachella Valley far from COVID-19 herd  immunity, preliminary antibody test results show","2020-05-29","Local","United States of America; California","","2020-05-28","Household and community samples","Multiple groups",896.0,0.06,"","","Self-referral","IgG; IgM","Unclear","News and Media","Nicole Hayden","Desert Healthcare District","https://www.google.com/url?rct=j&sa=t&url=https://www.desertsun.com/story/news/health/2020/05/29/coachella-valley-far-covid-19-herd-immunity-preliminary-antibody-tests-show/5280021002/&ct=ga&cd=CAAYKzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFQxOqwjTX2Kz2_mnj1RV7Upa8rEg","Verified","United States of America","Phamatech","","","LFIA: Lateral flow immunoassay","US","US-CA"
"2020-07-04","200529_NorthCarolina_Psalms/SolidRockMedicineGroup_GenPop","Antibody testing continues in Burke County","2020-05-29","Local","United States of America; North Carolina","2020-05-29","2020-05-29","Household and community samples","Multiple groups",329.0,0.015,"","","Self-referral","Not reported","Unclear","News and Media","Steve Ohnesorge","Psalms/Solid Rock Medicine Group","https://www.google.com/url?rct=j&sa=t&url=https://www.wbtv.com/2020/05/29/antibody-testing-continues-burke-county/&ct=ga&cd=CAAYGTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEvSO7bk5TLI9MT5-BeF8ILKdseXA","Verified","United States of America","Not reported","","","Not reported","US","US-NC"
"2020-07-06","200528_Michigan_MichiganDepartmentofCorrections_DetroitRC","Almost everyone at one Michigan prison tests  positive for COVID-19 antibodies","2020-05-28","Local","United States of America; Michigan; Detroit","2020-05-14","2020-05-22","Persons who are incarcerated","Multiple groups",57.0,0.35,"","","Convenience","Not reported","Unclear","News and Media","Angie Jackson","Michigan Department of Corrections","https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw","Verified","United States of America","Not reported","","","Not reported","US","US-MI"
"2020-07-06","200528_Michigan_MichiganDepartmentofCorrections_GRobertCottonCF","Almost everyone at one Michigan prison tests  positive for COVID-19 antibodies","2020-05-28","Local","United States of America; Michigan","2020-05-14","2020-05-22","Persons who are incarcerated","Multiple groups",867.0,0.122,"","","Convenience","Not reported","Unclear","News and Media","Angie Jackson","Michigan Department of Corrections","https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw","Verified","United States of America","Not reported","","","Not reported","US","US-MI"
"2020-07-06","200528_Michigan_MichiganDepartmentofCorrections_MacombCF","Almost everyone at one Michigan prison tests  positive for COVID-19 antibodies","2020-05-28","Local","United States of America; Michigan; Lenox Township","2020-05-14","2020-05-22","Persons who are incarcerated","Multiple groups",1201.0,0.656,"","","Convenience","Not reported","Unclear","News and Media","Angie Jackson","Michigan Department of Corrections","https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw","Verified","United States of America","Not reported","","","Not reported","US","US-MI"
"2020-07-06","200528_Michigan_MichiganDepartmentofCorrections_ParnallCFa","Almost everyone at one Michigan prison tests  positive for COVID-19 antibodies","2020-05-28","Local","United States of America; Michigan","2020-05-14","2020-05-22","Persons who are incarcerated","Multiple groups",1248.0,0.92,"","","Convenience","Not reported","Unclear","News and Media","Angie Jackson","Michigan Department of Corrections","https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw","Verified","United States of America","Not reported","","","Not reported","US","US-MI"
"2020-07-06","200609_Bergamo_HealthAgency_GenPop","Over half of people tested in Italy's  Bergamo have COVID-19 antibodies","2020-06-09","Regional","Italy; Lombardy","2020-04-23","2020-06-03","Household and community samples","Multiple groups",9965.0,0.57,"","","Simplified probability","Not reported","Moderate","News and Media","Angelo Amante","Bergamo Health Agency","https://www.google.com/url?rct=j&sa=t&url=https://www.thejakartapost.com/news/2020/06/09/over-half-of-people-tested-in-italys-bergamo-have-covid-19-antibodies.html&ct=ga&cd=CAAYAjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEF-NEDdVnSHZTUUTQEQL5px8dXmw","Verified","Italy","Not reported","","","Not reported","IT","IT-25"
"2020-07-06","200614_Thiruvananthapuram_HealthDepartment_GenPop","Initial trend: Positivity rate low in antibody testing","2020-06-14","Local","India; Kerala; Thiruvananthapuram","2020-06-09","2020-06-12","Household and community samples","Multiple groups",450.0,0.027,"","","Unclear","IgM; IgG","Unclear","News and Media","Aswin Kumar","Thiruvanathapuram Health Department","https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/thiruvananthapuram/initial-trend-positivity-rate-low-in-antibody-testing/articleshow/76363847.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHcN3WpGsIDw6iptLnm7KkY9Nl-tg","Verified","India","Not reported","","","Not reported","IN","IN-KL"
"2020-07-07","200603_WuhantoUSAtravel_CDC_PassengersGenPop","Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure Among Evacuees from Wuhan, China, 2020","2020-07-03","Local","China; Hubei; Wuhan","2020-01-28","2020-01-28","Household and community samples","Multiple groups",186.0,0.005,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Benjamin Hallowell","US Centers for Disease Control and Prevention","https://wwwnc.cdc.gov/eid/article/26/9/20-1590_article","Verified","China","SeraCare Life Sciences","","","ELISA","CN","CN-42"
"2020-07-09","200707_Lousiana_TulaneUniversity_AllChildren","SARS-CoV-2 Seroprevalence Rates of Children in Louisiana During the State Stay at Home Order.","2020-07-08","Local","United States of America; Louisiana; Orleans","2020-03-18","2020-05-15","Residual sera","Children and Youth (0-17 years)",812.0,0.076,"","","Convenience","IgG","High","Preprint","Monika Dietrich","Tulane University","https://www.medrxiv.org/content/10.1101/2020.07.07.20147884v1","Verified","United States of America","Author-designed","","","ELISA","US","US-LA"
"2020-07-10","200706_RiodeJaneiro_UniversidadedoEstadodoRiodeJaneiro_BloodDonors_OverallAdj","Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil","2020-07-06","Local","Brazil; Rio de Janeiro; Rio de Janeiro","2020-04-14","2020-04-27","Blood donors","Adults (18-64 years)",2857.0,0.033,0.026,0.041,"Sequential","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Amorim Filho","Universidade do Estado do Rio de Janeiro","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334006/","Verified","Brazil","MedLevensohn",0.85,0.99,"Rapid immunochromatographic test","BR","BR-RJ"
"2020-07-12","200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgGPopAdj","Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.","2020-05-18","National","Luxembourg","2020-04-15","2020-05-05","Household and community samples","Multiple groups",1820.0,0.021,0.014,0.028,"Stratified probability","IgG","Moderate","Preprint","Chantal Snoeck","Luxembourg Institute of Health","https://www.medrxiv.org/content/10.1101/2020.05.11.20092916v1","Verified","Luxembourg","EUROIMMUN",0.857,0.978,"ELISA","LU",""
"2020-07-13","200729_Philadelphia_UniversityofPennsylvania_TotalSampleTestAdj","SARS-CoV-2 Seroprevalence Among Parturient Women","2020-07-29","Local","United States of America; Pennsylvania; Philadelphia","2020-04-04","2020-06-03","Pregnant or parturient women","Adults (18-64 years)",1293.0,0.052,"","","Sequential","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Dustin Flannery","University of Pennsylvania","https://immunology.sciencemag.org/content/5/49/eabd5709","Verified","United States of America","Author-designed",1.0,0.989,"ELISA","US","US-PA"
"2020-07-15","200629_Crepy-en-Valois_PasteurInstitute_Overall","SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission","2020-06-29","Local","France; Hauts-de-France; Crepy-en-Valois","2020-04-28","2020-04-30","Multiple populations","Multiple groups",1340.0,0.104,"","","Convenience","Not reported","Moderate","Preprint","Arnaud Fontanet","Institut Pasteur","https://www.medrxiv.org/content/10.1101/2020.06.25.20140178v2","Verified","France","Institut Pasteur",0.994,1.0,"Flow cytometry assay","FR","FR-HDF"
"2020-07-16","200529_Washington_CDC_KnownContacts","Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, Washington, USA","2020-05-29","Regional","United States of America; Washington","2020-01-20","2020-02-03","Contacts of COVID patients","Multiple groups",32.0,0.0,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Victoria Chu","US Centers for Disease Control and Prevention","https://wwwnc.cdc.gov/eid/article/26/8/20-1423_article","Verified","United States of America","Author-designed",0.96,0.99,"ELISA","US","US-WA"
"2020-07-16","200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OverallPopAdj","Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020","2020-07-15","Regional","Canada; British Columbia","2020-03-05","2020-03-13","Residual sera","Multiple groups",869.0,0.003,0.0,0.01,"Stratified probability","IgA; IgM; IgG","Moderate","Preprint","Danuta Skowronski","British Columbia Centre for Disease Control","https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1","Verified","Canada","Abbott, Ortho-Clinical Diagnostics","","","Chemiluminescence Immunoassay","CA","CA-BC"
"2020-07-16","200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OverallPopAdj","Low SARS-CoV-2 sero-prevalence based on anonymized residual sero-survey before and after first wave measures in British Columbia, Canada, March-May 2020","2020-07-15","Regional","Canada; British Columbia","2020-05-15","2020-05-27","Residual sera","Multiple groups",885.0,0.006,0.002,0.014,"Stratified probability","IgA; IgM; IgG","Moderate","Preprint","Danuta Skowronski","British Columbia Centre for Disease Control","https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1","Verified","Canada","Abbott, Ortho-Clinical Diagnostics, Siemens Healthineers","","","Chemiluminescence Immunoassay","CA","CA-BC"
"2020-07-17","200515_Croatia_UniversityofSplit_IndustryWorkers_Overall","SARS-CoV-2 antibody seroprevalence in industry workers in Split-Dalmatia and Sibenik-Knin County, Croatia","2020-05-15","Local","Croatia","2020-04-23","2020-04-28","Essential non-healthcare workers","Multiple groups",1494.0,0.013,0.008,0.02,"Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Ivan Jerkovic","University of Split","https://journals.lww.com/joem/Abstract/9000/SARS_CoV_2_Antibody_Seroprevalence_in_Industry.98091.aspx","Verified","Croatia","AMP Diagnostics",0.918,0.964,"Rapid immunochromatographic test","HR",""
"2020-07-17","200604_Nanjing_NanjingUniversityMedicalSchool_HCWs/ContactsofCOVID-19patients","High SARS-CoV-2 Antibody Prevalence among Healthcare Workers Exposed to COVID-19 Patients","2020-06-04","Local","China; Jiangsu; Nanjing","2020-02-19","2020-02-19","Health care workers and caregivers","Adults (18-64 years)",105.0,0.171,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yuxin Chen","Nanjing University Medical School","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270786/pdf/main.pdf","Verified","China","Author-designed",0.933,1.0,"ELISA","CN","CN-32"
"2020-07-17","200718_BuenosAires_MinisterofHealth,BuenosAiresCity_Homeless","Community-level SARS-CoV-2 Seroprevalence Survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research.","2020-07-18","Local","Argentina; Buenos Aires; Buenos Aires","2020-06-10","2020-07-01","Persons experiencing homelessness","Multiple groups",60.0,0.36,"","","Convenience","IgG","High","Preprint","Silvana Figar","Minister of Health, Buenos Aires City","https://www.medrxiv.org/content/10.1101/2020.07.14.20153858v1","Verified","Argentina","Laboratio Lemos",0.95,1.0,"ELISA","AR","AR-B"
"2020-07-17","200721_Tokyo_NavitasClinicTachikawa_Overall","Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care Clinic–Based Point-of-Care Antibody Testing","2020-07-21","Local","Japan; Kantō, Chūbu ; Tokyo, Kangawa, Saitama, Chiba, Yamanashi","2020-04-20","2020-05-20","Household and community samples","Multiple groups",1071.0,0.038,0.028,0.052,"Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Morihito Takita","Navitas Clinic Tachikawa","https://dx.doi.org/10.1177/2150132720942695","Verified","Japan","Kurabo Industries",0.764,1.0,"Rapid immunochromatographic test","JP",""
"2020-07-17","210226_Iwate_IwatePrefecturalCentralHospital_HCW_Abbot&Roche","Orthogonal antibody testing for COVID-19 among healthcare workers in a non-epidemic place and time:Japan's Iwate Prefecture, May 18-31, 2020","2021-02-26","Local","Japan; Honshu; Morioka","2020-05-18","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",1000.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Akihiro Nakamura","Iwate Prefectural Central Hospital","https://dx.doi.org/10.5387/fms.2020-21","Verified","Japan","Abbott Laboratories: Roche","","","Chemiluminescence Immunoassay; Electro chemiluminescence immunoassay","JP",""
"2020-07-18","200507_Boise_UniversityofWashington_GenPop","Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho","2020-05-07","Local","United States of America; Idaho; Boise","2020-04-20","2020-04-26","Household and community samples","Multiple groups",4856.0,0.018,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Andrew Bryan","University of Washington School of Medicine","https://jcm.asm.org/content/early/2020/05/07/JCM.00941-20","Verified","United States of America","Abbott",1.0,1.0,"Chemiluminescence Immunoassay","US","US-ID"
"2020-07-18","200617_Italy_D.CotugnoHospital_HCW_IgG","COVID-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study","2020-06-17","Local","Italy; Campania; Naples","2020-03-23","2020-04-02","Health care workers and caregivers","Adults (18-64 years)",115.0,0.017,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Francesco Fusco","D. Cotugno’ Hospital","https://www.journalofhospitalinfection.com/article/S0195-6701(20)30306-6/fulltext","Verified","Italy","Snibe Diagnostic","","","Chemiluminescence Immunoassay","IT","IT-72"
"2020-07-18","200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week19to22","PHE England week 28","2020-07-09","National","United Kingdom of Great Britain and Northern Ireland; England","2020-05-04","2020-05-31","Blood donors","Adults (18-64 years)",7686.0,0.083,0.075,0.092,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-18","200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week23to27","PHE England week 28","2020-07-09","National","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-06-28","Blood donors","Multiple groups",10318.0,0.072,0.066,0.078,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-18","200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week13","PHE England week 35","2020-08-28","Regional","United Kingdom of Great Britain and Northern Ireland; England; London","2020-03-26","2020-03-27","Blood donors","Adults (18-64 years)",757.0,0.026,0.011,0.044,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-18","200717_Ilm-Kreis_JenaUniversityHospital_Overall","Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study","2020-07-17","Local","Germany; Thuringia","2020-05-12","2020-05-22","Household and community samples","Multiple groups",620.0,0.084,"","","Convenience","IgG","Moderate","Preprint","Sebastian Weis","Jena University Hospital","https://www.medrxiv.org/content/10.1101/2020.07.15.20154112v1","Verified","Germany","Epitope Diagnostics, EUROIMMUN, DiaSorin, Snibe Diagnostic, Abbott, Roche","","","ELISA; Chemiluminescence Immunoassay","DE","DE-TH"
"2020-07-18","200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_FebMarch","PHE England week 34","2020-08-21","National","United Kingdom of Great Britain and Northern Ireland; England","2020-02-01","2020-03-31","Residual sera","Children and Youth (0-17 years)",443.0,0.008,0.0,0.025,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","Abbott",0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-18","200821_England_PHE_WhatsTheStory_TestAdj_FebMarch","PHE England week 34","2020-08-21","National","United Kingdom of Great Britain and Northern Ireland; England","2020-02-01","2020-03-31","Household and community samples","Children and Youth (0-17 years)",106.0,0.005,0.0,0.036,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","Abbott",0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200420_Wuhan_CR&WISCOGeneralHospital_HospitalizedPatients","Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China","2020-04-20","Local","China; Hubei; Wuhan","2020-04-03","2020-04-15","Residual sera","Multiple groups",381.0,0.105,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xiaodong Wu","Wuhan University","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904","Verified","China","Innovita Biological Technology Co. Ltd",0.873,1.0,"Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-07-19","200420_Wuhan_CR&WISCOGeneralHospital_PeopleSeekingReturntoWork","Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China","2020-04-20","Local","China; Hubei; Wuhan","2020-04-03","2020-04-15","Essential non-healthcare workers","Adults (18-64 years)",1021.0,0.096,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xiaodong Wu","Wuhan University","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904","Verified","China","Innovita Biological Technology Co. Ltd",0.873,1.0,"Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-07-19","200501_France_ CentreLeonBerard_CancerPatient","Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19","2020-05-01","Local","France; Auvergne-Rhône-Alpes; Lyon","2020-03-01","2020-04-16","Patients seeking care for non-COVID-19 reasons","Multiple groups",244.0,0.053,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","M Solodky","Centre Leon Berard","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/","Verified","France","TODA Pharma",1.0,1.0,"LFIA: Lateral flow immunoassay","FR","FR-ARA"
"2020-07-19","200501_France_ CentreLeonBerard_HCW","Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19","2020-05-01","Local","France; Auvergne-Rhône-Alpes; Lyon","2020-03-01","2020-04-16","Health care workers and caregivers","Adults (18-64 years)",85.0,0.059,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","M Solodky","Centre Leon Berard","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/","Verified","France","TODA Pharma",1.0,1.0,"LFIA: Lateral flow immunoassay","FR","FR-ARA"
"2020-07-19","200509_NewYork_ColumbiaUniversityIrvingMedicalCenter_HCW","Anesthesiologists' and intensive care;   providers' exposure to COVID-19 infection in a New York City academic center:;   a prospective cohort study assessing symptoms and COVID-19 antibody testing","2020-06-09","Local","United States of America; New York; New York City","2020-03-01","2020-04-21","Health care workers and caregivers","Adults (18-64 years)",91.0,0.121,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Miguel Morcuende","Columbia University Irving Medical Center","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302070/","Verified","United States of America","""Zhejiang Orient Gene Biotech Co., LTD""",0.931,0.992,"LFIA: Lateral flow immunoassay","US","US-NY"
"2020-07-19","200527_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week16","PHE England week 35","2020-08-28","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-04-14","2020-04-16","Blood donors","Adults (18-64 years)",1017.0,0.046,0.03,0.064,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.79,0.99,"ELISA","GB","GB-ENG"
"2020-07-19","200527_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week16to17","PHE England week 35","2020-08-28","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-04-15","2020-04-20","Blood donors","Adults (18-64 years)",936.0,0.062,0.044,0.084,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.79,0.99,"ELISA","GB","GB-ENG"
"2020-07-19","200603_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week17_South","PHE England week 35","2020-08-28","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-04-24","2020-04-26","Blood donors","Adults (18-64 years)",865.0,0.05,0.032,0.07,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200615_Bergen_UniversityofBergen_HouseholdMembers","Seroconversion in household members of COVID-19 outpatients","2020-06-15","Local","Norway; Western Norway; Bergen","2020-02-28","2020-04-04","Contacts of COVID patients","Multiple groups",77.0,0.312,"","","Convenience","IgM; IgG; IgA","High","Journal Article (Peer-Reviewed)","Rebecca Cox","University of Bergen","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295487/","Verified","Norway","Amant et al.","","","ELISA","NO",""
"2020-07-19","200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week14","PHE England week 35","2020-08-28","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-04-02","2020-04-03","Blood donors","Adults (18-64 years)",916.0,0.024,0.01,0.04,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week17_Mid","PHE England week 35","2020-08-28","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-04-23","2020-04-24","Blood donors","Adults (18-64 years)",1043.0,0.073,0.054,0.094,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week15to16","PHE England week 35","2020-08-28","Regional","United Kingdom of Great Britain and Northern Ireland; England; London","2020-04-09","2020-04-13","Blood donors","Adults (18-64 years)",1085.0,0.111,0.089,0.136,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.825,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200807_England_PHE_RCGP_GenPop_TestPopAdj_Overall_euroimmun","PHE England week 32","2020-08-07","National","United Kingdom of Great Britain and Northern Ireland; England","2020-03-16","2020-06-30","Residual sera","Seniors (65+ years)",6000.0,0.039,"","","Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN","","","ELISA","GB","GB-ENG"
"2020-07-19","200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_April","PHE England week 34","2020-08-21","National","United Kingdom of Great Britain and Northern Ireland; England","2020-04-01","2020-04-30","Residual sera","Children and Youth (0-17 years)",647.0,0.061,0.041,0.084,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","Abbott",0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_May","PHE England week 37","2020-09-11","National","United Kingdom of Great Britain and Northern Ireland; England","2020-05-01","2020-05-31","Residual sera","Children and Youth (0-17 years)",1061.0,0.073,0.056,0.092,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","Abbott",0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-19","200821_England_PHE_WhatsTheStory_TestAdj_April","PHE England week 34","2020-08-21","National","United Kingdom of Great Britain and Northern Ireland; England","2020-04-01","2020-04-30","Household and community samples","Children and Youth (0-17 years)",201.0,0.038,0.012,0.075,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","Abbott",0.957,0.991,"ELISA","GB","GB-ENG"
"2020-07-20","200527_Varna_MedicalDiagnosticLaboratory_IgG/IgM","SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria","2020-05-27","Local","Bulgaria; Varna;  Varna","2020-03-26","2020-04-20","Residual sera","Multiple groups",586.0,0.048,0.032,0.068,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Denitsa Tsaneva-Damyanova","Medical Diagnostic Laboratory ""STATUS""","https://www.tandfonline.com/doi/pdf/10.1080/13102818.2020.1772105?needAccess=true","Verified","Bulgaria","""Zhejiang Orient Gene Biotech Co., LTD""","","","LFIA: Lateral flow immunoassay","BG","BG-03"
"2020-07-20","200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_HCW","SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England","2020-07-07","Local","United Kingdom of Great Britain and Northern Ireland; England","2020-05-04","2020-05-06","Health care workers and caregivers","Adults (18-64 years)",281.0,0.06,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Dimitrios Poulikakos","Salford Royal NHS Foundation Trust","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338856/","Verified","The United Kingdom","Snibe Diagnostic","","","Chemiluminescence Immunoassay","GB","GB-ENG"
"2020-07-21","200619_Rome_UniversityofRome_IgG","Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.","2020-06-19","Local","Italy; Lazio; Rome","2020-04-07","2020-04-27","Health care workers and caregivers","Adults (18-64 years)",1084.0,0.007,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Edith Lahner","University of Rome","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345358/","Verified","Italy","Medical Systems",0.5,0.991,"Chemiluminescence Immunoassay","IT","IT-62"
"2020-07-21","200625_Brussels_UniversitéLibredeBruxelles_OverallHCW","Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk health care workers and hospital staff","2020-06-25","Local","Belgium; Brussels; City of Brussels","2020-04-15","2020-05-18","Health care workers and caregivers","Adults (18-64 years)",326.0,0.11,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Charlotte Martin","Université Libre de Bruxelles","https://www.journalofhospitalinfection.com/article/S0195-6701(20)30313-3/fulltext","Verified","Belgium","EUROIMMUN","","","ELISA","BE","BE-BRU"
"2020-07-25","200605_China_NationalClinicalResearchCentre_HospitalSetting","Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China","2020-06-05","National","China; Hubei, Sichuan, Guangdong; Wuhan, Guangzhou, Jinzhou, Honghu, Chongqing, Chengdu, Foshan","2020-03-09","2020-04-10","Multiple populations","Adults (18-64 years)",6919.0,0.025,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","National Clinical Research Centre for Kidney Disease","https://www.nature.com/articles/s41591-020-0949-6","Verified","China","Bioscience","",0.993,"Chemiluminescence Immunoassay","CN",""
"2020-07-26","200710_Santiago_UniversidadDeChile_AllStaff","SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study.","2020-07-10","Local","Chile; Santiago; Vitacura","2020-05-04","2020-05-19","Essential non-healthcare workers","Adults (18-64 years)",235.0,0.166,0.121,0.219,"Stratified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Juan Pablo Torres","Universidade de Chile","https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860","Verified","Chile","Genrui Biotech",0.91,0.954,"Colloidal gold","CL",""
"2020-07-26","200710_Santiago_UniversidadDeChile_AllStudents","SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study.","2020-07-10","Local","Chile; Santiago; Vitacura","2020-05-04","2020-05-19","Students and Daycares","Children and Youth (0-17 years)",1009.0,0.099,0.086,0.115,"Stratified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Juan Pablo Torres","Universidade de Chile","https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860","Verified","Chile","Genrui Biotech",0.91,0.954,"Colloidal gold","CL",""
"2020-07-29","200709_London_UniversityCollegeLondonHospitals_HCW","Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers","2020-07-09","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-03-26","2020-04-08","Health care workers and caregivers","Adults (18-64 years)",181.0,0.453,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Catherine Houlihan","University College London Hospitals","https://dx.doi.org/10.1016/S0140-6736(20)31484-7","Verified","The United Kingdom","in-house flow cytometry and ELISA assays developed as part of the Crick-COVID-Consortium","","","ELISA; Flow cytometry assay","GB","GB-ENG"
"2020-07-30","200606_Leon_UniversidadedeLeon_HCWs_TestAdj2","Prevalence of SARS-CoV-2 infection in general practitioners and nurses in primary care and nursing homes in the Healthcare Area of Leon and associated factors","2020-06-06","Local","Spain; Léon; Léon","2020-04-01","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",676.0,0.074,0.055,0.1,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Vicente Martin","Gerencia de Atención Primaria del Área de Salud de León, Spain","https://dx.doi.org/10.1016/j.semerg.2020.05.014","Verified","Spain","Hangzhou All Test Biotech Co Ltd","","","RDT","ES",""
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr19","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil; Piaui; Teresina","2020-04-19","2020-04-19","Household and community samples","Multiple groups",900.0,0.006,0.002,0.013,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified","Brazil","Wondfo Biotech Co.",0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr26","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil; Piaui; Teresina","2020-04-26","2020-04-26","Household and community samples","Multiple groups",900.0,0.009,0.004,0.018,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified","Brazil","Wondfo Biotech Co.",0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May10","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil; Piaui; Teresina","2020-05-10","2020-05-10","Household and community samples","Multiple groups",900.0,0.02,0.012,0.031,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified","Brazil","Wondfo Biotech Co.",0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May17","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil; Piaui; Teresina","2020-05-17","2020-05-17","Household and community samples","Multiple groups",900.0,0.038,0.026,0.052,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified","Brazil","Wondfo Biotech Co.",0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May24","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil; Piaui; Teresina","2020-05-24","2020-05-24","Household and community samples","Multiple groups",900.0,0.058,0.043,0.073,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified","Brazil","Wondfo Biotech Co.",0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May3","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil; Piaui; Teresina","2020-05-03","2020-05-03","Household and community samples","Multiple groups",900.0,0.014,0.008,0.024,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified","Brazil","Wondfo Biotech Co.",0.86,0.99,"RDT","BR","BR-PI"
"2020-07-30","200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May31","Sequential serological surveys in the early stages of the coronavirus disease epidemic: limitations and  perspectives","2020-07-03","Local","Brazil; Piaui; Teresina","2020-05-31","2020-05-31","Household and community samples","Multiple groups",900.0,0.083,0.066,0.103,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcelo Vieira","Centro de Operações de Emergências em Saúde Pública","https://dx.doi.org/10.1590/0037-8682-0351-2020","Verified","Brazil","Wondfo Biotech Co.",0.86,0.99,"RDT","BR","BR-PI"
"2020-07-31","200626_Moscow_CityofMoscow","Large-scale antibody testing reveals that over 2 million Muscovites may already have contracted ...","2020-06-26","Local","Russian Federation; Central Russia; Moscow","2020-06-05","2020-06-18","Household and community samples","Multiple groups",90000.0,0.199,"","","Simplified probability","Not reported","High","News and Media","Jonny Tickle","City of Moscow","https://www.google.com/url?rct=j&sa=t&url=https://www.rt.com/russia/493055-moscow-mass-antibody-testing/&ct=ga&cd=CAEYESoUMTExMTExNDMxMTUyMzY3OTYzMDcyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNHh2eLjbkaY212mSAjMBempJCE7bA","Verified","Russian Federation","Not reported","","","Not reported","RU",""
"2020-07-31","200709_Korea_KoreaCentersforDiseaseControlandPrevention_Total","0.03% of Koreans developed coronavirus antibodies: KCDC","2020-07-09","National","Republic of Korea; Korea","","2020-07-09","Household and community samples","Multiple groups",3055.0,0.0,"","","Unclear","Not reported","Unclear","News and Media","Ock Hyun-ju","Korea Centers for Disease Control and Prevention","https://www.google.com/url?rct=j&sa=t&url=http://www.koreaherald.com/view.php%3Fud%3D20200709000787&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG8AlCeBcx2rR4FfgC726ll5TtgUw","Verified","Republic of Korea","Not reported","","","Not reported","KR",""
"2020-07-31","200720_Uppsala_UppsalaUniversity_Total","Work at inpatient care units is  associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden.","2020-07-20","Regional","Sweden; Uppsala","2020-05-27","2020-06-25","Health care workers and caregivers","Multiple groups",8679.0,0.066,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna-Karin Lidstrom","Uppsala University","https://dx.doi.org/10.1080/03009734.2020.1793039","Verified","Sweden","Abbott","","","Chemiluminescence Immunoassay","SE","SE-C"
"2020-07-31","200721_Haryana_IntegratedDiseaseSurveillanceProgramme_GenPop","Pvt lab says 16-20% sero-prevalence in Gurugram, health dept distances itself from data","2020-07-21","Regional","India; Haryana; Gurugram, Faridabad, Ambala, Panchkula, Sonipat","2020-06-21","2020-07-15","Household and community samples","Adults (18-64 years)",1544.0,0.12,"","","Stratified probability","IgG","High","News and Media","Prayag Arora Desai","Haryana Health Department","https://www.hindustantimes.com/gurugram/pvt-lab-says-16-20-sero-prevalence-in-gurugram-health-dept-distances-itself-from-data/story-265qYKX4XhRPeMVc5HrKEO.html","Verified","India","Not reported","","","ELISA","IN","IN-HR"
"2020-08-01","200630_Yerevan_ArmeniaMinistryofHealth_HCWs","Antibodies found in Armenia's 61 medical workers from 380 examinations: testing continues","2020-06-30","Local","Armenia; Yerevan; Yerevan","","2020-06-29","Health care workers and caregivers","Adults (18-64 years)",380.0,0.16,"","","Convenience","Not reported","High","News and Media","Anna Grigoryan","Ministry of Health of the Republic of Armenia","https://www.google.com/url?rct=j&sa=t&url=https://armenpress.am/eng/news/1020040/&ct=ga&cd=CAEYFioTMTc0ODAyMDA0NzI0ODEyNTQxODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHN-cSj3u7JgQAyBjN07fSTGAdlgA","Verified","Armenia","Not reported",1.0,0.998,"Not reported","AM","AM-ER"
"2020-08-01","200707_Turin_University of Turin_PregnantWomen_IgGonly","The ""scar"" of a pandemic: cumulative incidence of COVID-19 during the first trimester of pregnancy.","2020-07-07","Local","Italy; Piedmont; Turin","2020-04-16","2020-06-04","Pregnant or parturient women","Adults (18-64 years)",138.0,0.058,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Stefano Cosma","University of Turin","https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26267","Verified","Italy","Boditech","","","LFIA: Lateral flow immunoassay","IT","IT-21"
"2020-08-01","200708_WashoeCounty_WashoeCountyHealthDistrict_GenPop","Nevada COVID-19 infection rate 5 times higher, antibody tests show","2020-07-08","Local","United States of America; Nevada","2020-06-09","2020-06-10","Household and community samples","Adults (18-64 years)",234.0,0.023,"","","Stratified probability","Not reported","High","News and Media","Mary Hynes","Washoe County Health District","https://www.google.com/url?rct=j&sa=t&url=https://www.reviewjournal.com/local/local-nevada/nevada-covid-19-infection-rate-5-times-higher-antibody-tests-show-2070094/&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGG4t16ng9mGv7ghgkKQP4Qm3hotw","Verified","United States of America","Abbott","",0.996,"Not reported","US","US-NV"
"2020-08-01","200715_France_UnitedesVirusEmergents_BloodDonors","Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors","2020-07-15","National","France; Provence-Alpes-Côte d'Azur, Grand-Est, Hauts-de-France, Île-de-France","2020-03-25","2020-04-07","Blood donors","Adults (18-64 years)",998.0,0.027,"","","Sequential","Not reported","High","Journal Article (Peer-Reviewed)","Pierre Gallian","Unite des Virus Emergents","https://reader.elsevier.com/reader/sd/pii/S0166354220302941?token=72010A825B9F560E0F15AF8D56563D596F45421D41A05764732590DB465F0C2C839E77D689CCDEDEFB85BA331FE13C72","Verified","France","Author-designed","",1.0,"Neutralization assay","FR",""
"2020-08-01","200717_Chittenden_UniversityVermont_GenPop","Early results of UVM research tracking COVID's spread in Vermont","2020-07-17","Local","United States of America; Vermont","","2020-06-30","Household and community samples","Multiple groups",455.0,0.022,"","","Convenience","Not reported","High","News and Media","Cat Viglienzoni","University of Vermont","https://www.google.com/url?rct=j&sa=t&url=https://www.wcax.com/2020/07/17/early-results-of-uvm-research-tracking-covids-spread-in-vermont/&ct=ga&cd=CAAYCzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEblNmlKeakOFmkRkZMbbLnjhptxw","Verified","United States of America","University of Vermont","","","Not reported","US","US-VT"
"2020-08-01","200717_Hungary_SemmelweisUniversity__GenPop_PopAdj","Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary","2020-07-17","National","Hungary","2020-05-01","2020-05-16","Household and community samples","Multiple groups",10474.0,0.007,0.005,0.009,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Bela Merkely","Semmelweis University","https://dx.doi.org/10.1007/s11357-020-00226-9","Verified","Hungary","Abbott","","","Chemiluminescence Immunoassay","HU",""
"2020-08-01","200719_Lucknow_India_KingGeorgeMedicalUniversity_BloodDonors","4% 'healthy' blood donors in Lucknow found with Covid antibodies","2020-07-19","Local","India; Uttar Pradesh; Lucknow","2020-07-05","2020-07-19","Blood donors","Multiple groups",1235.0,0.037,"","","Convenience","IgG","High","News and Media","Yusra Husain","King George's Medical University","https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/lucknow/4-healthy-blood-donors-in-city-found-with-covid-antibodies/articleshow/77044828.cms&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrdF6GLOiOPUVeEg19jMKbusa8DA","Verified","India","Not reported","","","Not reported","IN","IN-UP"
"2020-08-01","200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgG/IgM","Serosurvey of SARS-CoV-2 among hospital visitors in China","2020-07-20","Local","China; Guangdong; Guangzhou","2020-01-20","2020-04-30","Multiple populations","Multiple groups",8782.0,0.006,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Wenhua Liang","The First Affiliated Hospital of Guangzhou Medical University","https://dx.doi.org/10.1038/s41422-020-0371-0","Verified","China","Shenzhen YHLO Biotech Co","",1.0,"Chemiluminescence Immunoassay","CN","CN-44"
"2020-08-01","200720_Tyrol_InnsbruckClinicalMicrobiologyLaboratory_Physicians_IgG","Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection","2020-07-20","Regional","Austria; Tyrol","2020-03-20","2020-03-27","Health care workers and caregivers","Adults (18-64 years)",377.0,0.003,0.0,0.015,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Dorothea Orth-Holler","Innsbruck Clinical Microbiology Laboratory","https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1793690","Verified","Austria","EUROIMMUN","","","ELISA","AT","AT-7"
"2020-08-01","200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG/IgM","Serosurvey of SARS-CoV-2 among hospital visitors in China","2020-07-20","Local","China; Hubei; Wuhan","2020-01-19","2020-04-30","Multiple populations","Multiple groups",8272.0,0.021,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Wenhua Liang","The First Affiliated Hospital of Guangzhou Medical University","https://dx.doi.org/10.1038/s41422-020-0371-0","Verified","China","Innovita",0.873,1.0,"Colloidal gold","CN","CN-42"
"2020-08-02","200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_IgGandorIgM","Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China","2020-07-03","Local","China; Hubei; Wuhan","2020-03-08","2020-03-21","Patients seeking care for non-COVID-19 reasons","Multiple groups",1027.0,0.046,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Hui Tang","Tongji Medical College","https://dx.doi.org/10.1053/j.ajkd.2020.06.008","Verified","China","""Tangshan Yingnuote Biotechnology Enterprise Co., Ltd.""",0.873,1.0,"Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-08-02","200714_CzechRepublic_ResearchCenterIBD_HCW","Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?","2020-07-14","Local","Czechia; Central Bohemian; Prague","","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",92.0,0.022,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Karin Malickova","Clinical and Research Center for Inflammatory Bowel Disease","https://dx.doi.org/10.1080/00365521.2020.1791244","Verified","Czechia","EUROIMMUN","","","ELISA","CZ","CZ-ST"
"2020-08-02","200715_WashintonDC_DCPublicHealth_GenPop","The DC health lab has tested 13706 blood samples. Only 809 people carried coronavirus antibodies.","2020-07-15","Local","United States of America; Washington D.C; Washington DC","2020-06-15","2020-07-15","Household and community samples","Multiple groups",13706.0,0.059,"","","Self-referral","Not reported","High","News and Media","Julie Zauzmer","Washington DC Public Health","https://www.google.com/url?rct=j&sa=t&url=https://www.washingtonpost.com/dc-md-va/2020/07/15/dc-health-lab-has-tested-13706-blood-samples-only-809-people-carried-coronavirus-antibodies/&ct=ga&cd=CAAYKTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFVGZ6aDeXqXAEUfikIfjfhDgkSVw","Verified","United States of America","DiaSorin LIAISON, Abbot Alinity i","","","Chemiluminescence Immunoassay","US","US-DC"
"2020-08-02","200722_France_PicardieUniversity_IBDPatients_Overall","Seroconversion of immunoglobulins to SARS-CoV2 in patients with inflammatory bowel disease patients treated by biologics","2020-07-22","Local","France; Somme; Amiens","2020-03-25","2020-05-11","Patients seeking care for non-COVID-19 reasons","Multiple groups",146.0,0.048,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mathurin Fumery","Picardie University","https://dx.doi.org/10.1093/ecco-jcc/jjaa154","Verified","France","DiaSorin",0.974,0.985,"Chemiluminescence Immunoassay","FR","FR-HDF"
"2020-08-02","200723_Delhi_IndianCentreforDiseaseControl_GenPop","Sero-prevalence study conducted by National Center for Disease Control NCDC, MoHFW, in Delhi, June 2020","2020-07-21","Regional","India; NCT Delhi","2020-06-27","2020-07-10","Household and community samples","Multiple groups",21387.0,0.235,"","","Stratified probability","IgG","Moderate","Institutional Report","Ministry of Health and Family Welfare","Indian Center for Disease Control","https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1640137","Verified","India","Zydus Cadila Healthcare",0.987,1.0,"ELISA","IN","IN-DL"
"2020-08-02","200723_Sweden_Werlabs_GenPop","14% of coronavirus antibody tests positive in Sweden in July","2020-07-23","Local","Sweden; Skåne, Västra Götaland, Uppland; Stockholm, Gothenburg, Malmo","2020-07-01","2020-07-22","Household and community samples","Multiple groups",83000.0,0.144,"","","Unclear","Not reported","High","News and Media","The Local","Werlabs","https://www.google.com/url?rct=j&sa=t&url=https://www.thelocal.se/20200723/14-of-antibody-tests-positive-in-sweden&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHl1If-XI0aCeB5tGakbaJvFktByQ","Verified","Sweden","Werlabs","","","Not reported","SE",""
"2020-08-03","200721_Idaho_UniversityofWashington_TotalPopTestAdj","High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results","2020-07-21","Local","United States of America; Idaho","2020-05-04","2020-05-19","Household and community samples","Multiple groups",917.0,0.231,0.198,0.265,"Self-referral","IgG","Moderate","Preprint","Colleen McLaughlin","University of Washington","https://www.medrxiv.org/content/10.1101/2020.07.19.20157198v1","Verified","United States of America","Abbott",0.929,0.996,"Chemiluminescence Immunoassay","US","US-ID"
"2020-08-04","200513_Indiana_IndianaUniversity_Wave1_NonRandom_PopAdj","Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020","2020-07-24","Local","United States of America; Indiana; Indianapolis","2020-05-02","2020-05-03","Household and community samples","Multiple groups",898.0,0.058,"","","Convenience","IgG","High","Institutional Report","Nir Menachemi","Indiana University Fairbanks School of Public Health","https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w","Verified","United States of America","Author derived",1.0,0.996,"Chemiluminescence Immunoassay","US","US-IN"
"2020-08-04","200723_India_Thyrocare_GenPop","COVID-19: People From Bhiwandi, Anand Vihar Have Antibodies Against Corona? Check Report","2020-07-23","National","India","2020-06-28","2020-07-19","Household and community samples","Multiple groups",53000.0,0.15,"","","Simplified probability","Not reported","High","News and Media","India com News Desk","Thyrocare","https://www.google.com/url?rct=j&sa=t&url=https://www.india.com/news/india/covid-19-people-from-bhiwandi-anand-vihar-have-antibodies-against-corona-check-report-4092355/&ct=ga&cd=CAAYBTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGDZBY0JyrN9eer5kq9FJfLncpL8Q","Verified","India","Not reported","","","ELISA; Chemiluminescence Immunoassay","IN",""
"2020-08-05","200622_Rostock_UniversitätsmedizinRostock_Mothers_IgGorIgA","Screening of Mothers in a COVID-19;   Low-Prevalence Region: Determination of SARS-CoV-2 Antibodies in 401 Mothers;   from Rostock by ELISA and Confirmation by Immunofluorescence","2020-06-22","Local","Germany; Mecklenburg-Westpomerania; Rostock","2020-04-20","2020-04-22","Household and community samples","Adults (18-64 years)",401.0,0.0,"","","Self-referral","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Emil Reisinger","Universitätsmedizin Rostock","https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1197-4293","Verified","Germany","EUROIMMUN","","","ELISA","DE","DE-MV"
"2020-08-06","200730_Ontario_PublicHealthOntario_June_GenPop_PopTestAdj","COVID-19 Seroprevalence in Ontario: March 27, 2020 to June 30, 2020","2020-07-30","Regional","Canada; Ontario","2020-06-05","2020-06-30","Residual sera","Multiple groups",7014.0,0.011,0.008,0.013,"Stratified probability","IgG","Moderate","Institutional Report","Public Health Ontario","Public Health Ontario","https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/07/covid-19-epi-seroprevalence-in-ontario.pdf?la=en","Verified","Canada","Abbott, Ortho-Clinical Diagnostics",0.904,1.0,"Chemiluminescence Immunoassay","CA","CA-ON"
"2020-08-06","200730_Ontario_PublicHealthOntario_March_GenPop_PopTestAdj","COVID-19 Seroprevalence in Ontario: March 27, 2020 to June 30, 2020","2020-07-30","Regional","Canada; Ontario","2020-03-27","2020-04-30","Residual sera","Multiple groups",827.0,0.005,0.001,0.015,"Stratified probability","IgG","Moderate","Institutional Report","Public Health Ontario","Public Health Ontario","https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/07/covid-19-epi-seroprevalence-in-ontario.pdf?la=en","Verified","Canada","Abbott, Ortho-Clinical Diagnostics",0.904,1.0,"Chemiluminescence Immunoassay","CA","CA-ON"
"2020-08-06","200730_Ontario_PublicHealthOntario_May_GenPop_PopTestAdj","COVID-19 Seroprevalence in Ontario: March 27, 2020 to June 30, 2020","2020-07-30","Regional","Canada; Ontario","2020-05-26","2020-05-31","Residual sera","Multiple groups",1061.0,0.015,0.007,0.022,"Stratified probability","IgG","Moderate","Institutional Report","Public Health Ontario","Public Health Ontario","https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/07/covid-19-epi-seroprevalence-in-ontario.pdf?la=en","Verified","Canada","Abbott, Ortho-Clinical Diagnostics",0.904,1.0,"Chemiluminescence Immunoassay","CA","CA-ON"
"2020-08-08","200805_Blantyre_Malawi-Liverpool-WellcomeTrust_HCW_TestAdj","High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi","2020-08-05","National","Malawi; Southern Region Malawi; Blantyre","2020-05-22","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",500.0,0.123,0.082,0.165,"Convenience","IgG","High","Preprint","Marah Chibwana","Malawi-Liverpool-Wellcome Trust Clinical Research Programme","https://www.medrxiv.org/content/10.1101/2020.07.30.20164970v3.full.pdf","Verified","Malawi","Omega diagnostics",0.881,0.932,"ELISA","MW","MW-S"
"2020-09-23","200807_Lome_UniversiteDeLome_Overall","Prevalence of SARS-CoV-2 among high-risk populations in Lome (Togo) in 2020","2020-08-07","Local","Togo","2020-04-23","2020-05-08","Non-essential workers and unemployed persons","Adults (18-64 years)",955.0,0.009,0.004,0.018,"Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Wemboo Halatoko","Universite de Lome","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242124","Verified","Togo","""Hangzhou Clongene Biotech Co, Ltd.""",0.771,0.954,"LFIA: Lateral flow immunoassay","TG",""
"2020-09-24","200804_Miami_DaVitaClinicalResearch_HemodialysisPatients_Overall","Assessment of a Laboratory-Based SARS-CoV-2 Antibody Test Among Hemodialysis Patients: A Quality Improvement Initiative","2020-08-04","Local","United States of America; Florida; Miami","2020-04-23","2020-04-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",677.0,0.056,0.04,0.076,"Convenience","IgG; IgM","High","Preprint","Dena Cohen","DaVita Clinical Research","https://doi.org/10.1101/2020.08.03.20163642","Verified","United States of America","Diazyme Laboratories Inc",0.571,0.85,"Chemiluminescence Immunoassay","US","US-FL"
"2020-09-24","201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Overall_PopAdj","Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study","2020-10-28","Regional","United States of America; Connecticut","2020-06-04","2020-06-23","Household and community samples","Multiple groups",567.0,0.04,0.02,0.06,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Shiwani Mahajan","Yale School of Medicine","http://dx.doi.org/10.1016/j.amjmed.2020.09.024","Verified","United States of America","Ortho-Clinical Diagnostics",0.9,1.0,"Chemiluminescence Immunoassay","US","US-CT"
"2020-09-25","200807_Bavaria_UniversityHospitalMunich","Infection with SARS-CoV-2 in primary care health care workers assessed by antibody testing","2020-08-07","Regional","Germany; Bavaria; Dachau","2020-04-02","2020-04-06","Health care workers and caregivers","Adults (18-64 years)",151.0,0.026,0.008,0.071,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Korbinian Lackermair","University Hospital Munich","http://dx.doi.org/10.1093/fampra/cmaa078","Verified","Germany","EUROIMMUN","","","ELISA","DE","DE-BY"
"2020-09-25","200808_Italy_UniversityofTurin_CLLPatients_Overall","All that glisters is not COVID: low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with Chilblain-like lesions","2020-08-08","Local","Italy; Piedmont; Turin, Novara, Alessandria, Verbania","2020-03-08","2020-04-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",24.0,0.125,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Marco Denina","University of Turin","http://dx.doi.org/10.1016/j.jaad.2020.08.021","Verified","Italy","DiaSorin, In3diagnostic, Medical Systems","","","Chemiluminescence Immunoassay; ELISA","IT","IT-21"
"2020-09-26","200716_Daegu_DaeguCatholicUniversityHospital_Overall","IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea.","2020-07-16","Local","Republic of Korea; North Gyeongsang; Daegu","2020-05-25","2020-06-05","Multiple populations","Multiple groups",198.0,0.076,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Suk-Kyoon Song","Daegu Catholic University Hospital","https://dx.doi.org/10.3346/jkms.2020.35.e269","Verified","Republic of Korea","Shin Jin Medics Inc",1.0,0.92,"Solid phase immunochromatography","KR","KR-47"
"2020-09-26","200721_NewYork_ShermanAbramsLaboratory_Overall","SARS-CoV-2 IgG antibody responses in New York City","2020-07-21","Local","United States of America; New York; New York","2020-05-15","2020-06-15","Residual sera","Multiple groups",28523.0,0.44,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Josh Reifer","Sherman Abrams Laboratory","https://dx.doi.org/10.1016/j.diagmicrobio.2020.115128","Verified","United States of America","DiaSorin LIAISON","","","Chemiluminescence Immunoassay","US","US-NY"
"2020-09-26","200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgG_T1","Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients","2020-07-24","Local","Nigeria; Cross River State; Calabar","2020-06-17","2020-06-24","Multiple populations","Adults (18-64 years)",66.0,0.26,"","","Unclear","IgG","High","Preprint","Marcus Inyama Asuquo","Joseph Ukpo Hospitals and Research Institutes","https://www.medrxiv.org/content/10.1101/2020.07.02.20145441v2","Verified","Nigeria","Healgen Scientific","","","LFIA: Lateral flow immunoassay","NG","NG-CR"
"2020-09-26","200729_RiversideCounty_RiversideUniversityHealthSystem_GenPop","Riverside County may have more than 100,000 COVID-19 cases, antibody study suggests","2020-07-27","Local","United States of America; California","2020-07-06","2020-07-20","Household and community samples","Multiple groups",1726.0,0.059,"","","Simplified probability","Not reported","Unclear","News and Media","ABC7 com staff","Riverside University Health System","https://abc7.com/health/riverside-county-may-have-100000-covid-19-cases-study-says/6337677/","Verified","United States of America","Not Reported","","","Not reported","US","US-CA"
"2020-09-27","200726_RhodeIsland_NewYorkBloodCenter_BloodDonors","Low Seroprevalence of SARS-CoV-2 in Rhode Island Blood Donors Determined using Multiple Serological Assay Formats","2020-07-26","Regional","United States of America; Rhode Island","2020-04-27","2020-05-11","Blood donors","Multiple groups",1996.0,0.039,"","","Sequential","IgG; IgM","Moderate","Preprint","Daniel Nesbitt","New York Blood Center","https://www.medrxiv.org/content/10.1101/2020.07.20.20157743v1","Verified","United States of America","Ortho-Clinical Diagnostics, SD Biosensor","","","Chemiluminescence Immunoassay; LFIA: Lateral flow immunoassay","US","US-RI"
"2020-09-27","200727_ FaroeIslands_TheFaroeseHospitalSystem_GenPop_TestAdj","Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands","2020-07-27","Regional","Faroe Islands; Faroe Islands","2020-04-27","2020-05-01","Household and community samples","Adults (18-64 years)",1075.0,0.007,"","","Simplified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Maria Skaalum Petersen","University of the Faroe Islands","http://dx.doi.org/10.3201/eid2611.202736","Verified","Faroe Islands","Beijing Wantai Biological Pharmacy Enterprise",0.944,1.0,"ELISA","FO",""
"2020-09-27","200804_Tuscany_ArezzoHospital_HealthcareWorkers_Overall","Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: results from a large-scale screening program based on rapid serological testing.","2020-08-04","Regional","Italy; Tuscany","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",17098.0,0.031,"","","Convenience","IgG; IgM","High","Preprint","Francesca Carozzi","Arezzo Hospital","https://www.medrxiv.org/content/10.1101/2020.07.30.20149567v1","Verified","Italy","Screen Italia S.R.L, ""Zhejiang Orient Gene Biotech Co., LTD""","","","LFIA: Lateral flow immunoassay","IT","IT-52"
"2020-09-27","200806_Valencia_HospitalClínicoUniversitario_HCWs_IgG_and_IgM","Caveats in interpreting SARS-CoV-2 IgM(+)/IgG(-)antibody profile in asymptomatic health care workers","2020-08-06","Local","Spain; Valencia; Valencia","2020-04-13","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",1153.0,0.035,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Arantxa Valdivia","Hospital Clínico Universitario","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26400","Verified","Spain","Snibe Diagnostic",0.956,0.96,"Chemiluminescence Immunoassay","ES","ES-VC"
"2020-09-27","200807_Zurich_UniversityofZurich_BDSCohort_AprilQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland; Zurich; Zurich","2020-04-01","2020-04-30","Blood donors","Adults (18-64 years)",1469.0,0.012,0.007,"","Sequential","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified","Switzerland","Author-designed",1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200807_Zurich_UniversityofZurich_BDSCohort_earlyJulyQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland; Zurich; Zurich","2020-07-01","2020-07-15","Blood donors","Adults (18-64 years)",1067.0,0.007,0.003,0.012,"Sequential","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified","Switzerland","Author-designed",1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200807_Zurich_UniversityofZurich_USZCohort_AprilQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland; Zurich; Zurich","2020-04-01","2020-04-30","Residual sera","Adults (18-64 years)",4275.0,0.014,0.01,0.017,"Sequential","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified","Switzerland","Author-designed",1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200807_Zurich_UniversityofZurich_USZCohort_MarchQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland; Zurich; Zurich","2020-03-15","2020-03-31","Residual sera","Adults (18-64 years)",3806.0,0.003,0.001,0.005,"Sequential","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified","Switzerland","Author-designed",1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200807_Zurich_UniversityofZurich_USZCohort_May-JulyAveQDA","Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region","2020-08-07","Local","Switzerland; Zurich; Zurich","2020-05-15","2020-07-15","Residual sera","Adults (18-64 years)",12831.0,0.009,"","","Sequential","IgG","Moderate","Preprint","Marc Emmenegger","University of Zurich","https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4","Verified","Switzerland","Author-designed",1.0,1.0,"Tripartite Automated Blood Immunoassay","CH","CH-ZH"
"2020-09-27","200813_Foggia_UniversityofFoggia_OverallIgG/IgM","Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2","2020-08-13","Local","Italy;  Apulia; Foggia","2020-05-01","2020-05-31","Blood donors","Adults (18-64 years)",904.0,0.01,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jose Ramon Fiore","University of Foggia","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26425","Verified","Italy","""New Industries Biomedical Engineering Co., Ltd""","","","Chemiluminescence Immunoassay","IT","IT-75"
"2020-09-28","200721_Arezzo_OspedaleSanDonato_Total","Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity","2020-07-21","Local","Italy; Tuscany; Arezzo","2020-03-17","2020-03-21","Residual sera","Adults (18-64 years)",516.0,0.13,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alessandro Pancrazzi","Ospedale San Donato","http://dx.doi.org/10.1016/j.clinbiochem.2020.07.002","Verified","Italy","Acro Biotech Inc.",0.37,0.94,"Rapid immunochromatographic test","IT","IT-52"
"2020-09-28","200824_Jena_UniversitätsklinikumJena_Pregnantwomen_Overall","Period Prevalence of SARS-CoV-2 in an Unselected Sample of Pregnant Women in Jena, Thuringia","2020-08-24","Local","Germany; Thuringia; Jena","2020-04-06","2020-05-13","Pregnant or parturient women","Multiple groups",180.0,0.006,0.0,0.017,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Janine Zollkau","Universitätsklinikum Jena","https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1206-1033","Verified","Germany","Epitope Diagnostics","","","ELISA","DE","DE-TH"
"2020-09-28","200904_Hannover_HannoverMedicalSchool_HCWs_S1IgG","Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals","2020-09-04","Local","Germany; Lower Saxony; Hannover","2020-03-23","2020-04-17","Health care workers and caregivers","Adults (18-64 years)",217.0,0.014,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Georg Behrens","Hannover Medical School","https://link.springer.com/article/10.1007/s40121-020-00334-1","Verified","Germany","EUROIMMUN",0.872,0.993,"ELISA","DE","DE-NI"
"2020-09-28","200904_USA_CDC_HCWs_Overall","Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network-13 Academic Medical Centers, April-June 2020","2020-09-04","National","United States of America; New York, Massachusetts, Tennessee, Colorado, California, Washington, Minnesota, Maryland, Oregon, North Carolina, Utah, Ohio; Bronx, Springfield, Nashville, Aurora, Boston, Los Angeles, Seattle, Minneapolis, Baltimore, Portland, Winston-Salem, Murray, Columbus","2020-04-03","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",3248.0,0.06,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Wesley Self","CDC COVID-19 Response Team","https://www.cdc.gov/mmwr/volumes/69/wr/mm6935e2.htm","Verified","United States of America","CDC",0.96,0.99,"ELISA","US",""
"2020-09-28","200906_Madinah_KingFahadGeneralHospital_HCWs_Overall","Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers","2020-09-06","Local","Saudi Arabia; Hejaz; Madinah","2020-04-18","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",330.0,0.242,"","","Unclear","IgM; IgA; IgG","High","Journal Article (Peer-Reviewed)","Suliman Alharbi","King Fahad General Hospital","https://assets.cureus.com/uploads/original_article/pdf/39817/1599507536-20200907-8365-icotwh.pdf","Verified","Saudi Arabia","Vircell Microbiologists","","","ELISA","SA",""
"2020-09-28","201004_SEEngland_King’sCollegeLondon","Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England","2020-10-14","Regional","United Kingdom of Great Britain and Northern Ireland; South East England","2020-04-27","2020-06-02","Household and community samples","Multiple groups",431.0,0.12,0.091,0.152,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Philippa M Wells","King’s College London","http://dx.doi.org/10.1016/j.jinf.2020.10.011","Verified","The United Kingdom","Imperial College London",0.9,1.0,"ELISA","GB","GB-ENG"
"2020-09-29","200721_Egypt_CairoUniversity_TotalHCW_Overall","SARS-CoV-2 infection among healthcare workers of a gastroenterological service in a tertiary care facility","2020-07-21","Local","Egypt","2020-06-01","2020-06-14","Health care workers and caregivers","Adults (18-64 years)",74.0,0.122,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Abdel Meguid Kassem","Cairo University","https://dx.doi.org/10.1016/j.ajg.2020.07.005","Verified","Egypt","Artron Laboratories",0.934,0.977,"LFIA: Lateral flow immunoassay","EG",""
"2020-09-29","200725_UK_TheQueenElizabethHospital_HealthCareWorkers_UnAdj","COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce.","2020-07-25","Local","United Kingdom of Great Britain and Northern Ireland; England; King's Lynn","2020-06-01","2020-06-07","Health care workers and caregivers","Adults (18-64 years)",70.0,0.214,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","D M Favara","The Queen Elizabeth Hospital","https://dx.doi.org/10.1016/j.clon.2020.07.015","Verified","The United Kingdom","Unclear","","","Luminex","GB","GB-ENG"
"2020-09-29","200725_Wuhan_WuhanInstituteofVirology_IgG","Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2","2020-07-25","Local","China; Hubei; Wuhan","2020-03-19","2020-03-20","Health care workers and caregivers","Adults (18-64 years)",325.0,0.431,"","","Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","Danna Tu","Wuhan Institute of Virology","http://dx.doi.org/10.1016/j.jinf.2020.07.023","Verified","China","Vazyme, Zhu Hai Livzon Diagnostics Ins, NZK Biotech Co","","","ELISA; Colloidal gold; Dual-target immuno-fluorescence assay (DTFA)","CN","CN-42"
"2020-09-29","200728_Prato_SantoStefanoHospital_Overall","Universal screening for SARS-CoV-2 in pregnant women admitted for delivery: how to manage antibody testing?","2020-07-28","Local","Italy; Tuscany; Prato","2020-04-04","2020-05-16","Pregnant or parturient women","Adults (18-64 years)",134.0,0.045,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Anna Cavaliere","Santo Stefano Hospital","http://dx.doi.org/10.1080/14767058.2020.1793317","Verified","Italy","Acro Biotech Inc.","","","Rapid point-of care","IT","IT-52"
"2020-09-29","200729_Milan_UniversitadegliStudidiMilano_Overall_IgG","SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital","2020-07-29","Local","Italy; Lombardy; Milan","2020-04-02","2020-04-16","Health care workers and caregivers","Adults (18-64 years)",202.0,0.074,0.038,0.11,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Giovanni Sotgiu","Università degli Studi di Milano","https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01237-0","Verified","Italy","BioMedomics",0.887,0.906,"LFIA: Lateral flow immunoassay","IT","IT-25"
"2020-09-30","200723_JeffersonCounty_UniversityofLouisville_genpop","Study Finds Rate of Exposure to COVID-19 in Louisville Higher Than Expected","2020-07-23","Local","United States of America; Kentucky","2020-06-10","2020-06-19","Household and community samples","Multiple groups",2237.0,0.04,"","","Self-referral","Not reported","High","News and Media","Spectrum News Staff","University of Louisville","https://spectrumnews1.com/ky/louisville/news/2020/07/23/uofl-coimmunity-project-phase-2-results","Verified","United States of America","Not reported","","","Not reported","US","US-KY"
"2020-10-01","200717_Germany_NorthRhineWestphaliaLowerSaxonyHesse_BloodDonors_PrimaryEstimate","SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.","2020-07-16","Regional","Germany; North Rhine-Westphalia, Lower Saxony, Hesse","2020-03-09","2020-06-03","Residual sera","Multiple groups",3186.0,0.009,0.006,0.012,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Bastian Fischer","Heart and Diabetes Center NRW","https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285","Verified","Germany","Abbott, EUROIMMUN, DiaSorin","","","ELISA","DE",""
"2020-10-01","200723_Germany_ThuringiaClinicSaalfeld_CleaningStaffIgG","Seroprevalence of COVID-19 antibodies in the cleaning and oncological staff of a municipal clinic.","2020-07-23","Local","Germany; Thuringia; Saalfeld","2020-06-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",45.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jorg Epstude","Thuringia Clinic","https://dx.doi.org/10.3205/dgkh000353","Verified","Germany","PerkinElmer Inc","",0.985,"ELISA","DE","DE-TH"
"2020-10-01","200723_Germany_ThuringiaClinicSaalfeld_OncologyStaffIgG","Seroprevalence of COVID-19 antibodies in the cleaning and oncological staff of a municipal clinic.","2020-07-23","Local","Germany; Thuringia; Saalfeld","2020-06-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",20.0,0.05,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jorg Epstude","Thuringia Clinic","https://dx.doi.org/10.3205/dgkh000353","Verified","Germany","PerkinElmer Inc","",0.985,"ELISA","DE","DE-TH"
"2020-10-01","200729_Wuhan_WuhanUniversity_Overall","Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China","2020-08-03","Local","China; Hubei; Wuhan","2020-01-14","2020-02-21","Health care workers and caregivers","Multiple groups",1060.0,0.083,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Dong Zhao","Renmin Hospital of Wuhan University","https://dx.doi.org/10.1016/j.ijid.2020.07.082","Verified","China","Shenzhen YHLO Biotech Co","","","Chemiluminescence Immunoassay","CN","CN-42"
"2020-10-01","200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMarch2020","Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19.","2020-07-30","Local","Japan; Hokkaido; Sapporo","2020-03-01","2020-03-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",300.0,0.003,0.0,0.018,"Unclear","IgG","High","Journal Article (Peer-Reviewed)","Goki Suda","Hokkaido University Graduate School of Medicine","https://dx.doi.org/10.1111/hepr.13551","Verified","Japan","Roche Diagnostics",1.0,0.998,"Electro chemiluminescence immunoassay","JP","JP-01"
"2020-10-01","200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMay2020","Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19.","2020-07-30","Local","Japan; Hokkaido; Sapporo","2020-05-01","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",300.0,0.0,0.0,0.0,"Unclear","IgG","High","Journal Article (Peer-Reviewed)","Goki Suda","Hokkaido University Graduate School of Medicine","https://dx.doi.org/10.1111/hepr.13551","Verified","Japan","Roche Diagnostics",1.0,0.998,"Electro chemiluminescence immunoassay","JP","JP-01"
"2020-10-01","200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgG_ANDOR_IgM","Risk of COVID-19 in health-care workers in Denmark: an observational cohort study","2020-08-03","Regional","Denmark; Capital Region of Denmark","2020-04-15","2020-04-22","Blood donors","Adults (18-64 years)",4672.0,0.03,0.026,0.036,"Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Kasper Iversen","University of Copenhagen","https://dx.doi.org/10.1016/S1473-3099(20)30589-2","Verified","Denmark","Livzon Diagnostics",0.734,0.999,"LFIA: Lateral flow immunoassay","DK","DK-84"
"2020-10-02","200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Overall_PopAdj","Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.","2020-07-24","Local","United States of America; Georgia","2020-04-28","2020-05-03","Household and community samples","Multiple groups",696.0,0.025,0.014,0.045,"Stratified probability","IgG; IgA; IgM","Moderate","Journal Article (Peer-Reviewed)","Holly Biggs","CDC COVID-19 Response Team","https://dx.doi.org/10.15585/mmwr.mm6929e2","Verified","United States of America","Ortho-Clinical Diagnostics",0.932,0.99,"Not reported","US","US-GA"
"2020-10-02","200727_Atahualpa_UniversidadPeruanaCayetanoHeredia_RuralOver40_Overall","SARS-CoV-2 in rural Latin America. A population-based study in coastal Ecuador","2020-07-27","Local","Ecuador; El Oro","2020-05-01","2020-05-25","Household and community samples","Multiple groups",673.0,0.45,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Oscar Del Brutto","Universidad Peruana Cayetano Heredia","http://dx.doi.org/10.1093/cid/ciaa1055","Verified","Ecuador","Biohit Health Care Ltd","","","LFIA: Lateral flow immunoassay","EC","EC-O"
"2020-10-02","200813_Selangor_UniversityMalaya_OverallPopAdj","Low postpandemic wave SARS-CoV-2 seroprevalence in Kuala Lumpur and Selangor, Malaysia","2020-08-13","Regional","Malaysia; Selangor; Kuala Lumpur","2020-01-29","2020-06-06","Residual sera","Multiple groups",588.0,0.004,0.0,0.009,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","I Ching Sam","University Malaya","https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26426","Verified","Malaysia","Author-designed","","","ELISA","MY","MY-10"
"2020-10-03","200720_Lahore_ChughtaiInstituteofPathology_Overall","Frequency of COVID-19 IgG Antibodies among Special Police Squad Lahore, Pakistan","2020-08-19","Local","Pakistan","2020-05-20","2020-05-30","Essential non-healthcare workers","Adults (18-64 years)",154.0,0.156,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Omar Chughtai","Chughtai Institute of Pathology","https://jcpsp.pk/article-detail/frequency-of-covid19-igg-antibodies-among-special-police-squad-lahore-pakistan","Verified","Pakistan","Abbott",0.968,0.99,"Chemiluminescence Immunoassay","PK",""
"2020-10-03","200806_Greece_UniversityofThessaly_Overall","Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020","2020-08-06","National","Greece; Central Macedonia, Attica, Peloponnese, Thessaly, Western Macedonia, Central Greece, Western Greece, Epirus","2020-03-01","2020-04-30","Residual sera","Multiple groups",6586.0,0.004,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Zacharoula Bogogiannidou","University of Thessaly","https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.31.2001369","Verified","Greece","Abbott",0.84,0.997,"Chemiluminescence Immunoassay","GR",""
"2020-10-03","200808_UK_PortlandHospitalforWomenandChildren_HCW","SARS-CoV-2-specific antibody detection in healthcare workers in a UK maternity Hospital: Correlation with SARS-CoV-2 RT-PCR results","2020-08-08","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-15","2020-05-28","Health care workers and caregivers","Adults (18-64 years)",190.0,0.22,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Asma Khalil","St George’s University of London","http://dx.doi.org/10.1093/cid/ciaa893","Verified","The United Kingdom","Abbott",0.969,0.999,"ELISA","GB","GB-ENG"
"2020-10-03","200810_Spain_CostadelSolHospital_HCW_IgGANDORIgM","Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience","2020-08-10","Local","Spain","2020-04-15","2020-04-25","Health care workers and caregivers","Adults (18-64 years)",498.0,0.022,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Julian Olalla","Hospital Costa del Sol","http://dx.doi.org/10.1093/qjmed/hcaa238","Verified","Spain","""Zhejiang Orient Gene Biotech Co., LTD""","","","Solid phase immunochromatography","ES",""
"2020-10-04","200725_Shenzhen_ ShenzhenSecondPeoplesHospital_Builders","Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen","2020-07-25","Local","China; Guangdong; Shenzhen","2020-02-29","2020-03-18","Non-essential workers and unemployed persons","Multiple groups",1589.0,0.004,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Cantong Zhang","Shenzhen Second People's Hospital","http://dx.doi.org/10.1002/jmv.26355","Verified","China","Shenzhen Sciarray Biotech Ltd","","","ELISA","CN","CN-44"
"2020-10-04","200803_Indiana_IndianaUniversity_healthcareworkers","Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.","2020-08-03","Regional","United States of America; Indiana; Indianapolis","2020-04-29","2020-05-08","Health care workers and caregivers","Adults (18-64 years)",734.0,0.016,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Benton Hunter","Indiana University","https://dx.doi.org/10.1017/ice.2020.390","Verified","United States of America","Abbott",1.0,0.996,"Chemiluminescence Immunoassay","US","US-IN"
"2020-10-04","200803_Italy_ItalianMinistryOfHealth_Overall","FIRST RESULTS OF THE SEROPREVALENCE SURVEY ON SARS-CoV-2","2020-08-03","National","Italy; Abruzzo, Basilicata, Calabria, Campania, Emilia Romagna, Friuli-Venezia Giulia, Lazio, Liguria, Lombardy, Marche, Molise, Piemonte, Trentino-Alto Adige, Puglia, Sardegna, Sicily, Tuscany, Umbria, Valle D'Aosta, Veneto","2020-05-25","2020-07-15","Household and community samples","Multiple groups",64660.0,0.025,"","","Stratified non-probability","IgG","Unclear","Institutional Report","Instituto Nazionale di Statistica","Italian Ministry of Health","https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf","Verified","Italy","Abbott","","","Chemiluminescence Immunoassay","IT",""
"2020-10-04","200810_London_UniversityCollegeLondon_Total","A cross-sectional study of immune seroconversion to SARS-CoV-2 in front-line maternity health professionals","2020-08-10","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-11","2020-06-05","Health care workers and caregivers","Multiple groups",200.0,0.145,0.099,0.201,"Unclear","IgG","High","Journal Article (Peer-Reviewed)","S Bampoe","University College London","https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/full/10.1111/anae.15229","Verified","The United Kingdom","Abbott",1.0,0.996,"Chemiluminescence Immunoassay","GB","GB-ENG"
"2020-10-04","200824_Seoul_KoreaUniversity_Overall","Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea","2020-08-24","Local","Republic of Korea","2020-05-25","2020-05-29","Residual sera","Multiple groups",1500.0,0.001,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Ji Noh","Korea University","https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e311","Verified","Republic of Korea","Roche elecsys",0.995,0.998,"Chemiluminescence Immunoassay","KR",""
"2020-10-04","200829_Hubei_HuazhongUniversity_HospitalizedChildren","Screening of SARS-CoV-2 in 299 Hospitalized Children with Hemato-oncological Diseases: A Multicenter Survey in Hubei, China","2020-08-29","Local","China; Hubei; Wuhan, Xiangyang","2020-01-23","2020-04-24","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",299.0,0.0,"","","Unclear","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Song mi Want","Huazhong University of Science and Technology","https://link.springer.com/article/10.1007/s11596-020-2228-7","Verified","China","Not reported","","","magnetic particle chemiluminescence","CN","CN-42"
"2020-10-05","200729_London_WhittingtonHealthNHSTrust_Overall","Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust","2020-08-04","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-15","2020-06-05","Health care workers and caregivers","Multiple groups",2004.0,0.316,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Joseph Grant","Whittington Health NHS Trust","https://dx.doi.org/10.1017/ice.2020.402","Verified","The United Kingdom","Roche Diagnostics","",0.998,"Electro chemiluminescence immunoassay","GB","GB-ENG"
"2020-10-05","200730_Belgium_IrisHospitalsSouth_HCW_UnAdj","Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.","2020-07-30","Local","Belgium; Brussels; City of Brussels","2020-05-25","2020-06-19","Health care workers and caregivers","Multiple groups",1485.0,0.146,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Laurent Blairon","Iris Hospitals South","https://dx.doi.org/10.1016/j.jinf.2020.07.033","Verified","Belgium","DiaSorin",1.0,"","Chemiluminescence Immunoassay","BE","BE-BRU"
"2020-10-05","200730_Louisiana_OschnerClinicFoundation_Overall_PopWeighted","Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020","2020-07-30","Local","United States of America; Louisiana","2020-05-09","2020-05-15","Household and community samples","Adults (18-64 years)",2640.0,0.069,0.068,0.069,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Amy K Feehan","Oschner Clinic Foundation","https://dx.doi.org/10.3201/eid2611.203029","Verified","United States of America","Abbott","","","Chemiluminescence Immunoassay","US","US-LA"
"2020-10-06","200918_Bogota_PontificiaUniversidadJaveriana_HCW_FinalEndpoint_UnAdj","Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia","2021-01-03","Local","Colombia; Capital District Cundinamarca; Bogotá","2020-06-25","2020-08-10","Health care workers and caregivers","Adults (18-64 years)",351.0,0.083,0.058,0.116,"Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Beatriz Ariza","Pontificia Universidad Javeriana","http://www.revistainfectio.org/index.php/infectio/article/view/938","Verified","Colombia","Abbott, Columbia; SD Biosensor",1.0,1.0,"Not reported","CO","CO-DC"
"2020-10-08","200617_TorrejonDeArdoz_MunicipalityOfTorrejonDeArdoz_IgGIgM","Los test serológicos de Torrejón de Ardoz arrojan un 20,18 % de personas con anticuerpos de coronavirus","2020-06-17","Local","Spain","2020-05-29","2020-06-03","Household and community samples","Multiple groups",104299.0,0.231,"","","Entire sample","IgG; IgM","Moderate","Institutional Report","Daniel Flores","Municipality of Torrejon de Ardoz","https://www.rtve.es/noticias/20200617/test-serologicos-torrejon-ardoz-arrojan-2018-habitantes-tiene-anticuerpos-coronavirus/2018787.shtml","Verified","Spain","Not reported","","","Not reported","ES",""
"2020-10-08","200814_NewYorkCity_MemorialSloanKetteringCancerCenter_CancerPatients","Results and Impact of Intensive SARS-CoV-2 Testing in a High Volume, Outpatient Radiation Oncology Clinic in a Pandemic Hotspot","2020-08-14","Local","United States of America; New York; New York City","2020-05-07","2020-06-25","Patients seeking care for non-COVID-19 reasons","Multiple groups",952.0,0.055,"","","Convenience","IgG","High","Preprint","Sean McBride","Memorial Sloan Kettering Cancer Center","https://www.medrxiv.org/content/10.1101/2020.08.11.20172551v1","Verified","United States of America","Abbott","","","chemiluminescent microparticle immunoassay","US","US-NY"
"2020-10-09","200701_HongKong_QueenMaryHospital_Evacuees_EnzymeImmunoAssay","Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study","2020-06-03","Regional","China; Hubei","2020-03-04","2020-03-17","Household and community samples","Multiple groups",452.0,0.029,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Kelvin To","Queen Mary Hospital","https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext","Verified","China","Author-designed",0.733,1.0,"Enzyme immunoassay","CN","CN-42"
"2020-10-09","200701_HongKong_QueenMaryHospital_Feb2020_EnzymeImmunoAssay","Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study","2020-06-03","Regional","China; Hong Kong","2020-02-01","2020-02-13","Residual sera","Multiple groups",233.0,0.004,0.0,0.024,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Kelvin To","Queen Mary Hospital","https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext","Verified","China","Author-designed",0.733,1.0,"Enzyme immunoassay","CN",""
"2020-10-09","200701_HongKong_QueenMaryHospital_Jan2020_EnzymeImmunoAssay","Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study","2020-06-03","Regional","China; Hong Kong","2020-01-01","2020-01-31","Residual sera","Multiple groups",580.0,0.026,0.015,0.042,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Kelvin To","Queen Mary Hospital","https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext","Verified","China","Author-designed",0.733,1.0,"Enzyme immunoassay","CN",""
"2020-10-09","200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_UnAdj","Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: A cross-sectional study","2020-08-06","Local","United States of America; Florida","2020-04-16","2020-04-17","Essential non-healthcare workers","Multiple groups",203.0,0.089,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alberto J Caban Martinez","University of Miami","http://dx.doi.org/10.1136/oemed-2020-106676","Verified","United States of America","BioMedomics",0.887,0.906,"LFIA: Lateral flow immunoassay","US","US-FL"
"2020-10-09","200811_NewYork_StFrancisHospital_Overall","Prevalence of SARS-CoV-2 Infection among Health Care Workers in a Tertiary Community Hospital","2020-08-11","Local","United States of America; New York; New York City","2020-03-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",1699.0,0.098,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Allen Jeremias","St Francis Hospital","http://dx.doi.org/10.1001/jamainternmed.2020.4214","Verified","United States of America","EUROIMMUN, Abbott","","","Not reported","US","US-NY"
"2020-10-09","200811_Wuhan_HuazhongUniversityofScienceandTechnologyIgG","Prevention of COVID-19 infection in a pediatric oncology ward in Wuhan","2020-08-11","Local","China; Hubei; Wuhan","2020-01-23","2020-03-27","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",44.0,0.0,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ai Zhang","Huazhong University of Science and Technology","https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.28424","Verified","China","Not reported","","","Chemiluminescence Immunoassay","CN","CN-42"
"2020-10-10","200814_Oregon_OregonHealthAuthority_Overall_UnAdj","Seroprevalence Estimates of SARS- CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020","2020-08-14","Regional","United States of America; Oregon","2020-05-11","2020-06-15","Residual sera","Multiple groups",897.0,0.01,0.002,0.018,"Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","Melissa Sutton","Oregon Health Authority","https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a4.htm","Verified","United States of America","Abbott",0.968,0.991,"chemiluminescent microparticle immunoassay","US","US-OR"
"2020-10-11","200629_Fulda_UniversitätsmedizinMarburg_Entirecohort_IgG","Studie zur immunitat gegen sars-cov-2","2020-06-29","Local","Germany","2020-04-09","2020-04-16","Multiple populations","Multiple groups",1780.0,0.01,0.006,0.015,"Unclear","IgG","High","Journal Article (Peer-Reviewed)","Peter Kern","Universitätsmedizin Marburg","http://dx.doi.org/10.1055/a-1198-1243","Verified","Germany","EUROIMMUN",0.938,0.99,"ELISA","DE",""
"2020-10-13","200820_Hubei_NanjingUniversity_hcw_IgG","Surveillance of SARS-CoV-2 infection among frontline health care workers in Wuhan during COVID-19 outbreak.","2020-08-20","Local","China; Hubei; Wuhan","2020-05-12","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",191.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Xin Tong","Nanjing University Medical School","https://dx.doi.org/10.1002/iid3.340","Verified","China","Shenzhen YHLO Biotech Co","","","Chemiluminescence Immunoassay","CN","CN-42"
"2020-10-13","200826_India_AllIndiaInstituteofMedicalSciences_HospitalPatients_UnAdj","Seroprevalence of anti-SARS-CoV-2 IgG antibodies in hospitalized patients at a tertiary referral center in North India","2020-08-26","Local","India; Punjab; New Delhi","2020-06-08","2020-08-08","Residual sera","Multiple groups",212.0,0.198,0.147,0.258,"Convenience","IgG","High","Preprint","Animesh Ray","All India Institute of Medical Sciences","https://www.medrxiv.org/content/10.1101/2020.08.22.20179937v2","Verified","India","""Translational Health Science and Technology Institute (THSTI), Faridabad""",0.882,0.998,"ELISA","IN","IN-PB"
"2020-10-13","200901_Iceland_deCODEGenetics_OverallPopAdj","Humoral Immune Response to SARS-CoV-2 in Iceland","2020-09-01","National","Iceland","2020-04-27","2020-06-12","Household and community samples","Multiple groups",23452.0,0.003,"","","Convenience","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Daniel Gudbjartsson","deCODE Genetics","http://dx.doi.org/10.1056/NEJMoa2026116","Verified","Iceland","Roche International, Wantai/Nordic BioSite",0.911,"","Chemiluminescence Immunoassay","IS",""
"2020-10-14","200805_Niger_IbrahimBadamasiBabangidaUniversity_IgG_GenPop_UnAdj","Seroprevalence of COVID-19 in Niger State","2020-08-05","Regional","Nigeria; Niger State","2020-06-26","2020-06-30","Household and community samples","Multiple groups",185.0,0.254,"","","Stratified probability","IgG","Moderate","Preprint","Hussaini Majiya","Ibrahim Badamasi Babangida University","https://www.medrxiv.org/content/10.1101/2020.08.04.20168112v1.full.pdf","Verified","Nigeria","Cambridge Network",1.0,1.0,"Colloidal Gold Immunochromatography Assay (LFIA)","NG","NG-NI"
"2020-10-14","200805_Stockholm_UppsalaUniversity_CaregiversOverall_IgGORIgM","High seroprevalence of SARS-CoV-2 in elderly care employees in Sweden","2020-08-05","Local","Sweden","2020-04-01","2020-04-20","Health care workers and caregivers","Adults (18-64 years)",1005.0,0.229,0.204,0.257,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Johanna Lindahl","Uppsala University","https://dx.doi.org/10.1080/20008686.2020.1789036","Verified","Sweden","Zhejiang Orient Gene Biotech Co Ltd","","","LFIA: Lateral flow immunoassay","SE",""
"2020-10-14","200907_Bari_PoliclinicoHospital_Overall","The Light and Shadow of Rapid Serological Tests for SARS-CoV-2 Infection: Results from a Study in a Large Emergency Department","2020-09-07","Local","Italy;  Apulia; Bari","2020-03-23","2020-04-21","Residual sera","Multiple groups",819.0,0.086,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Daniela Loconsole","Policlinico Hospital","https://dx.doi.org/10.3390/ijerph17186493","Verified","Italy","VivaChek Biotech",0.351,0.973,"Colloidal gold","IT","IT-75"
"2020-10-14","200922_Gateshead_NHSFoundationTrust_Overall","Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2)","2020-09-22","Local","United Kingdom of Great Britain and Northern Ireland; England; Gateshead","2020-05-28","2020-06-08","Health care workers and caregivers","Adults (18-64 years)",2521.0,0.194,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Salman Razvi","Gateshead Health NHS Foundation Trust","https://dx.doi.org/10.7861/clinmed.2020-0566","Verified","The United Kingdom","Roche","","","Chemiluminescence Immunoassay","GB","GB-ENG"
"2020-10-15","200818_Brescia_UniversityofBrescia_Overall","The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures","2020-08-18","Local","Italy; Lombardy; Brescia","2020-04-27","2020-04-27","Health care workers and caregivers","Adults (18-64 years)",76.0,0.118,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Alberto Dalla Volta","University of Brescia","http://dx.doi.org/10.3389/fonc.2020.01574","Verified","Italy","DiaSorin","","","Not reported","IT","IT-25"
"2020-10-15","200818_Cambridge_CambridgeHealthAllianceOverall","Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic","2020-08-18","Local","United States of America; Massachusetts; Cambridge","2020-04-13","2020-05-24","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",24.0,0.167,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Robert Stavert","Cambridge Health Alliance","http://dx.doi.org/10.1016/j.jaad.2020.08.049","Verified","United States of America","Abbott, DiaSorin, EUROIMMUN","","","Not reported","US","US-MA"
"2020-10-15","200823_Bergamo_HospitalPapaGiovanniXXIII_Overall","Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Under Biologic Treatment","2020-08-26","Local","Italy; Lombardy; Bergamo","2020-03-04","2020-07-10","Patients seeking care for non-COVID-19 reasons","Multiple groups",90.0,0.211,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Lorenzo Norsa","Papa Giovani XXII","http://dx.doi.org/10.1053/j.gastro.2020.08.046","Verified","Italy","VivaChek","","","LFIA: Lateral flow immunoassay","IT","IT-25"
"2020-10-15","200827_LiguriaLombardia_UniversityofGenoa_Overall","Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors","2020-08-27","Regional","Italy; Lombardy, Liguria","2020-03-01","2020-04-30","Residual sera","Adults (18-64 years)",3609.0,0.11,0.1,0.121,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Antonio Vena","University of Genoa","https://dx.doi.org/10.3390/jcm9092780","Verified","Italy","Maglumi, Realy-Tech, Biosynex","","","Chemiluminescence Immunoassay; Rapid immunochromatographic test; LFIA: Lateral flow immunoassay","IT",""
"2020-10-16","200803_NewSouthWales_UniversityOfSydney_IndividualsInEducationalSetting","Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study","2020-08-03","Regional","Australia; New South Wales","2020-01-25","2020-04-10","Contacts of COVID patients","Multiple groups",173.0,0.023,"","","Convenience","IgG; IgA; IgM","Moderate","Journal Article (Peer-Reviewed)","Kristine Macartney","University of Sydney","https://dx.doi.org/10.1016/S2352-4642(20)30251-0","Verified","Australia","Author-designed",0.913,0.989,"immunofluorescence assay (IFA)","AU","AU-NSW"
"2020-10-16","200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_TotalAbpositive","Pronounced difference in Covid-19 antibody prevalence indicates cluster transmission in Stockholm, Sweden.","2020-08-11","Local","Sweden; Södermanland, Uppland; Stockholm","2020-06-17","2020-06-18","Household and community samples","Adults (18-64 years)",123.0,0.041,0.006,0.076,"Simplified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ake Lundkvist","Uppsala University","https://dx.doi.org/10.1080/20008686.2020.1806505","Verified","Sweden","Zhejiang Orient Gene Biotech Co Ltd",1.0,0.955,"Rapid point-of care","SE","SE-AB"
"2020-10-16","200811_Stockholm_UppsalaUniversity_Tensta_TotalAbPositive","Pronounced difference in Covid-19 antibody prevalence indicates cluster transmission in Stockholm, Sweden.","2020-08-11","Local","Sweden; Södermanland, Uppland; Stockholm","2020-06-17","2020-06-18","Household and community samples","Adults (18-64 years)",90.0,0.3,0.203,0.397,"Simplified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ake Lundkvist","Uppsala University","https://dx.doi.org/10.1080/20008686.2020.1806505","Verified","Sweden","Zhejiang Orient Gene Biotech Co Ltd",1.0,0.955,"Rapid point-of care","SE","SE-AB"
"2020-10-17","200818_SanFrancisco_UniversityofCaliforniaSanFrancisco","SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco","2020-08-21","Local","United States of America; California; San Francisco","2020-04-25","2020-04-28","Household and community samples","Multiple groups",3861.0,0.034,0.029,0.041,"Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Gabriel Chamie","University of California, San Francisco","http://dx.doi.org/10.1093/cid/ciaa1234","Verified","United States of America","Abbott","","","chemiluminescent microparticle immunoassay","US","US-CA"
"2020-10-17","200826_Croatia_UniversityofZagreb_HCWsIgG","Severe acute respiratory syndrome coronavirus 2 seroprevalence among personnel in the healthcare facilities of Croatia, 2020.","2020-08-26","National","Croatia","2020-04-25","2020-05-24","Health care workers and caregivers","Adults (18-64 years)",592.0,0.027,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Tatjana Vilibic Cavlek","University of Zagreb","https://dx.doi.org/10.1590/0037-8682-0458-2020","Verified","Croatia","Vircell Spain S.L.U","","","ELISA","HR",""
"2020-10-18","200817_Ireland_HPSC_genpop_popadj","Preliminary report of the results of the  Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A national seroprevalence study, June-July  2020","2020-08-17","National","Ireland; Connaught, Leinster; Dublin, Sligo","2020-06-22","2020-07-16","Household and community samples","Adults (18-64 years)",1733.0,0.017,0.011,0.024,"Stratified probability","IgG","Moderate","Institutional Report","Derval Igoe","HSE Health Protection Surveillance Centre (HPSC)","https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/scopi/SCOPI%20report%20preliminary%20results%20final%20version.pdf","Verified","Ireland","Abbott, FORTRESS","","","Chemiluminescence Immunoassay","IE",""
"2020-10-18","200818_Oregon_EarleA.ChilesResearchInstitute_Overall","Longitudinal SARS-CoV-2 serosurveillance of over ten thousand health care workers in the Providence Oregon cohort","2020-08-18","Regional","United States of America; Oregon; Portland, Oregon City, Medford, Seaside, Hood River, Newberg, Milwaukie","2020-04-08","2020-05-22","Health care workers and caregivers","Multiple groups",10019.0,0.025,"","","Convenience","IgG","High","Preprint","Rom Leidner","Chiles Research Institute","https://www.medrxiv.org/content/10.1101/2020.08.16.20176107v1","Verified","United States of America","Author-designed",0.8,1.0,"ELISA","US","US-OR"
"2020-10-18","200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgGIgM","Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population","2020-08-19","Local","Austria","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",130.0,0.023,"","","Convenience","IgG; IgM","High","Preprint","Klaus Hackner","Karl Landsteiner University of Health Sciences","https://www.researchsquare.com/article/rs-50887/v1","Verified","Austria","Epitope Diagnostics","","","ELISA","AT",""
"2020-10-18","200819_Guangzhou_InstituteofBloodTransfusion_BloodDonors_TotalAnti","Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China","2020-08-19","Local","China; Guangdong; Guangzhou","2020-03-23","2020-04-02","Blood donors","Adults (18-64 years)",2199.0,0.003,"","","Simplified probability","IgA; IgG","High","Journal Article (Peer-Reviewed)","Ru Xu","Institute of Blood Transfusion","http://dx.doi.org/10.1002/jmv.26445","Verified","China","Wantai Biological Pharmacy Enterprise, Lizhu Diagnostics","","","ELISA","CN","CN-44"
"2020-10-19","200807_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week27to31","PHE England week 32","2020-08-07","National","United Kingdom of Great Britain and Northern Ireland; England","2020-06-29","2020-07-28","Blood donors","Multiple groups",9388.0,0.059,0.053,0.065,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.83,0.993,"ELISA","GB","GB-ENG"
"2020-10-19","200824_Rotterdam_ErasmusMedicalCentre_1_March","Homologous and heterologous antibodies to coronavirus 229E, NL63, OC43, HKU1, SARS, MERS and SARS-CoV-2 antigens in an age stratified cross-sectional serosurvey in a large tertiary hospital in The Netherlands","2020-08-24","Local","Netherlands","2020-03-02","2020-03-06","Residual sera","Multiple groups",879.0,0.002,"","","Convenience","IgG","High","Preprint","Brenda Westerhuis","Erasmus Medical Centre","https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1","Verified","Netherlands","Author-designed","",1.0,"Not reported","NL",""
"2020-10-19","200824_Rotterdam_ErasmusMedicalCentre_2_April","Homologous and heterologous antibodies to coronavirus 229E, NL63, OC43, HKU1, SARS, MERS and SARS-CoV-2 antigens in an age stratified cross-sectional serosurvey in a large tertiary hospital in The Netherlands","2020-08-24","Local","Netherlands","2020-04-03","2020-04-07","Residual sera","Multiple groups",729.0,0.025,"","","Convenience","IgG","High","Preprint","Brenda Westerhuis","Erasmus Medical Centre","https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1","Verified","Netherlands","Author-designed","",1.0,"Not reported","NL",""
"2020-10-19","200824_Wuhan_WuhanUniversity_IgG_T2","Positive Rate of Serology and RT-PCR for COVID-19 among Healthcare Workers during Different Periods in Wuhan, China","2020-08-24","Local","China; Hubei; Wuhan","2020-05-13","2020-06-10","Health care workers and caregivers","Adults (18-64 years)",1059.0,0.093,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Lu He","Wuhan University","http://dx.doi.org/10.1016/j.jinf.2020.08.027","Verified","China","Livzon Diagnostics","","","Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-10-19","200902_Lisbon_UniversityofLisbon_Overall","Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers","2020-09-02","Local","Portugal; Estremadura; Lisbon","2020-05-13","2020-07-10","Non-essential workers and unemployed persons","Adults (18-64 years)",2571.0,0.015,"","","Convenience","IgG; IgM; IgA","Moderate","Preprint","Patricia Figueiredo Campos","University of Lisbon","https://www.medrxiv.org/content/10.1101/2020.08.30.20184309v1","Verified","Portugal","Krammer, et al. [Independent third party]",0.947,0.98,"ELISA","PT",""
"2020-10-20","200726_Peru_NationalCenterforEpidemiology_Overall","Minsa publishes technical data of the study that reveals that 25.3% of Lima and Callao acquired COVID-19","2020-07-27","Local","Peru; Lima, Callao; Lima, Callao","2020-06-28","2020-07-09","Household and community samples","Multiple groups",3118.0,0.216,0.187,0.246,"Stratified probability","IgG; IgM","High","News and Media","Peruvian Government","National Center for Epidemiology, Prevention and Control of Diseases","https://gestion.pe/peru/coronavirus-peru-minsa-divulga-ficha-tecnica-del-estudio-que-revela-que-el-253-de-lima-y-callao-adquirio-el-covid-19-cuarentena-estado-de-emergencia-nndc-noticia/","Verified","Peru","Not reported",0.4,"","Rapid immunochromatographic test","PE",""
"2020-10-20","200824_Karachi_NationalInstituteofBloodDiseases&BoneMarrowTransplantation_Overall","Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan","2020-08-24","Local","Pakistan; Sindh; Karachi","2020-05-15","2020-07-15","Blood donors","Adults (18-64 years)",370.0,0.346,"","","Sequential","IgA; IgM; IgG","High","Journal Article (Peer-Reviewed)","Amber Younas","National Institute of Blood Diseases & Bone Marrow Transplantation","https://dx.doi.org/10.1016/j.transci.2020.102923","Verified","Pakistan","Roche Diagnostics","","","Electro chemiluminescence immunoassay","PK","PK-SD"
"2020-10-20","200831_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Overall_UnAdj","Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data","2020-08-31","Local","Spain; Community of Madrid; Torrejon de Ardoz","2020-06-01","2020-06-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",229.0,0.314,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luis Cabezon-Gutierrez","Hospital General Universitario Gregorio Maranon","https://dx.doi.org/10.1016/j.ctrv.2020.102102","Verified","Spain","Hangzhou Testsea Biotechnology",0.96,1.0,"Not reported","ES","ES-MD"
"2020-10-21","200826_NewYorkCity_JacobiMedicalCenter_HealthCareWorkers","Antibody evidence of SARS-CoV-2 infection in healthcare workers in the Bronx","2020-08-26","Local","United States of America; New York; New York City","2020-04-28","2020-05-04","Health care workers and caregivers","Multiple groups",1700.0,0.192,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Elana Sydney","Jacobi Medical Center","http://dx.doi.org/10.1017/ice.2020.437","Verified","United States of America","Abbott",1.0,0.996,"chemiluminescent microparticle immunoassay","US","US-NY"
"2020-10-21","200827_Paris_RothschildFoundationHospital_HealthcareProfessionals","Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study)","2020-08-27","Local","France; Paris; Paris","2020-06-08","2020-06-22","Health care workers and caregivers","Adults (18-64 years)",646.0,0.12,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Malcie Mesnil","Rothschild Foundation Hospital","http://dx.doi.org/10.1016/j.accpm.2020.08.003","Verified","France","Roche",0.995,0.998,"ELISA","FR","FR-IDF"
"2020-10-21","200828_LosAngeles_VeteransAffairsHealthcareSystem_Residents","Using Serologic Testing to Assess the Effectiveness of Outbreak Control Efforts, Serial PCR Testing, and Cohorting of Positive SARS-CoV-2 Patients in a Skilled Nursing Facility","2020-08-28","Local","United States of America; California; Los Angeles","2020-06-05","2020-06-12","Assisted living and long-term care facilities","Multiple groups",150.0,0.173,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Amy V Dora","Veterans Affairs Healthcare System","http://dx.doi.org/10.1093/cid/ciaa1286","Verified","United States of America","DiaSorin",0.92,0.98,"Chemiluminescence Immunoassay","US","US-CA"
"2020-10-21","200909_Chelsea_MassachusettsGeneralHospital_Overall_TestAdj","High seroprevalence of anti-SARS-CoV-2 antibodies in Chelsea, Massachusetts","2020-09-09","Local","United States of America; Massachusetts; Chelsea","2020-04-14","2020-04-15","Household and community samples","Adults (18-64 years)",200.0,0.328,0.272,0.388,"Convenience","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Vivek Naranbhai","Massachusetts General Hospital","http://dx.doi.org/10.1093/infdis/jiaa579","Verified","United States of America","BioMedomics",0.9,0.99,"ELISA","US","US-MA"
"2020-10-22","200911_Osaka_ToyonakaMunicipalHospital_Overall","Seroprevalence of SARS-CoV-2 Antibodies Among 925 Staff Members in an Urban Hospital Accepting COVID-19 Patients in Osaka Prefecture, Japan","2020-09-11","Local","Japan; Kansai; Osaka","2020-06-12","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",925.0,0.004,0.002,0.011,"Convenience","IgG","Moderate","Preprint","Tsutomu Nishida","Toyonaka Municipal Hospital","https://www.medrxiv.org/content/10.1101/2020.09.10.20191866v1","Verified","Japan","Abbott",1.0,0.996,"Chemiluminsescent microparticle immunoassay","JP",""
"2020-10-24","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week17_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-04-20","2020-04-26","Residual sera","Multiple groups",1200.0,0.053,0.038,0.071,"Stratified non-probability","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified","Sweden","Sci LifeLab / KTH",0.994,"","Multiplex immunoassay","SE",""
"2020-10-24","200811_Belgium_universitairesSaint-Luc_Overall","SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis","2020-08-10","Local","Belgium","2020-04-16","2020-05-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",149.0,0.027,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Silvia Berardis","Cliniques universitaires Saint-Luc","https://www.sciencedirect.com/science/article/pii/S1569199320308213","Verified","Belgium","""SNIBE – Shenzhen New Industries Biomedical Engineering Co., Ltd""",0.956,0.96,"Chemiluminescence Immunoassay","BE",""
"2020-10-24","200821_NewYorkCityHealthSystem_AlbertEinsteinCollegeofMedicine","COVID-19 Infection Among Healthcare Workers: Serological Findings Supporting Routine Testing.","2020-08-21","Local","United States of America; New York; New York City","2020-04-04","2020-04-20","Health care workers and caregivers","Adults (18-64 years)",98.0,0.153,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ariel D Stock","Albert Einstein College of Medicine","https://dx.doi.org/10.3389/fmed.2020.00471","Verified","United States of America","Epitope Diagnostics","","","ELISA","US","US-NY"
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week18_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-04-27","2020-05-03","Residual sera","Multiple groups",1200.0,0.04,0.027,0.057,"Stratified non-probability","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified","Sweden","Sci LifeLab / KTH",0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week19_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-05-04","2020-05-10","Residual sera","Multiple groups",1200.0,0.039,0.026,0.054,"Stratified non-probability","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified","Sweden","Sci LifeLab / KTH",0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week20_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-05-11","2020-05-17","Residual sera","Multiple groups",1200.0,0.045,0.031,0.062,"Stratified non-probability","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified","Sweden","Sci LifeLab / KTH",0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week21_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-05-18","2020-05-24","Residual sera","Multiple groups",1200.0,0.052,0.037,0.07,"Stratified non-probability","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified","Sweden","Sci LifeLab / KTH",0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week22_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-05-25","2020-05-31","Residual sera","Multiple groups",1200.0,0.057,0.04,0.077,"Stratified non-probability","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified","Sweden","Sci LifeLab / KTH",0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week23_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-06-01","2020-06-07","Residual sera","Multiple groups",1200.0,0.068,0.051,0.088,"Stratified non-probability","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified","Sweden","Sci LifeLab / KTH",0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week24_Overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 1)","2020-06-18","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-06-08","2020-06-14","Residual sera","Multiple groups",1200.0,0.052,0.037,0.071,"Stratified non-probability","Not reported","High","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Verified","Sweden","Sci LifeLab / KTH",0.994,"","Multiplex immunoassay","SE",""
"2020-10-25","200716_Stockholm_RegionStockholm","16 juli: Lägesrapport om arbetet med det nya coronaviruset","2020-07-16","Local","Sweden; Uppland; Stockholm","2020-06-15","2020-07-15","Household and community samples","Multiple groups",149616.0,0.176,"","","Self-referral","Not reported","High","Institutional Report","Stockholm Region","Sweden Public Health Authority","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/07/16-juli-lagesrapport-om-arbetet-med-det-nya-coronaviruset/","Verified","Sweden","Not reported","","","Not reported","SE","SE-AB"
"2020-10-25","200806_Milan_UniversityofMilan_Overall","Low seroprevalence of SARS-CoV-2 infection among healthcare workers of the largest children hospital in Milan during the pandemic wave","2020-08-06","Local","Italy; Lombardy; Milan","2020-04-15","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",663.0,0.051,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Antonella Amendola","University of Milan","http://dx.doi.org/10.1017/ice.2020.401","Verified","Italy","EUROIMMUN","","","ELISA","IT","IT-25"
"2020-10-25","200930_Scotland_PublicHealthScotland_BloodDonors_Overall_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 30 Sept 2020","2020-09-30","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-06-29","2020-08-09","Blood donors","Multiple groups",3220.0,0.031,0.025,0.038,"Sequential","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/","Verified","The United Kingdom","Not reported",0.875,0.986,"Not reported","GB","GB-SCT"
"2020-10-28","200724_UK_ChelseaandWestminsterHospital_HCW","Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study","2020-07-24","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-04-08","2020-06-12","Health care workers and caregivers","Multiple groups",504.0,0.106,0.076,0.136,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Scott Pallett","Chelsea and Westminster Hospital NHS Trust","https://dx.doi.org/10.1016/S2213-2600(20)30315-5","Verified","The United Kingdom","CTK Biotech , Zhuhai Encode Medical Engineering","","","LFIA: Lateral flow immunoassay","GB","GB-ENG"
"2020-10-29","200901_Wuhan_ZhongnanHospitalofWuhanUniversity_IgGTotal","Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey","2020-09-14","Local","China; Hubei; Wuhan","2020-03-16","2020-03-25","Health care workers and caregivers","Adults (18-64 years)",3674.0,0.017,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Fuling Zhou","Zhongnan Hospital of Wuhan University","http://dx.doi.org/10.1016/j.eclinm.2020.100510","Verified","China","Shenzhen Yahuilong Biotechnology Co.","","","Chemiluminescence Immunoassay","CN","CN-42"
"2020-10-30","200915_Tehran_IranUniversityOfMedicalSciences_Patients_Overall","Role of Screening for COVID-19 in Hemodialysis Wards, Results of a Single Center Study.","2020-09-01","Local","Iran (Islamic Republic of); Tehran; Tehran","2020-02-20","2020-03-20","Multiple populations","Multiple groups",178.0,0.18,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shahrzad Ossareh","Iran University of Medical Sciences","http://www.ijkd.org/index.php/ijkd/article/view/5832/1205","Verified","Iran (Islamic Republic of)","Pishtaz Diagnostics Iran","","","ELISA","IR","IR-07"
"2020-10-30","200920_NewYorkState_DonaldAndBarbaraZuckerSchoolOfMedicine_Patients_Overall","SARS-CoV-2 Antibodies in Pregnant Women Admitted to Labor and Delivery","2020-09-20","Regional","United States of America; New York","2020-05-27","2020-07-24","Pregnant or parturient women","Adults (18-64 years)",1671.0,0.161,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Lylach Haizler Cohen","Donald and Barbara Zucker School of Medicine","https://dx.doi.org/10.1016/j.ajog.2020.09.022","Verified","United States of America","Roche","","","","US","US-NY"
"2020-11-02","200911_NewYorkCity_WeillCornellMedicine_IgGorIgM","COVID-19 Viral and Serology Testing in New York City Health Care Workers","2020-09-11","Local","United States of America; New York; New York City","2020-04-17","2020-05-07","Health care workers and caregivers","Adults (18-64 years)",2274.0,0.354,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Sabrina Racine Brzostek","Weill Cornell Medicine","http://dx.doi.org/10.1093/ajcp/aqaa142","Verified","United States of America","ET Healthcare","",0.988,"Cyclic enhanced fluorescence assay (CEFA)","US","US-NY"
"2020-11-03","200911_Birmingham_UniversityHospitalsBirminghamNHSFoundationTrust_Overall","SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study","2020-09-11","Local","United Kingdom of Great Britain and Northern Ireland; England; Birmingham","2020-04-24","2020-04-25","Health care workers and caregivers","Adults (18-64 years)",516.0,0.244,"","","Self-referral","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Adrian Shields","University Hospitals Birmingham NHS Foundation Trust","http://dx.doi.org/10.1136/thoraxjnl-2020-215414","Verified","The United Kingdom","University of Birmingham Clinical Immunology Service",1.0,0.978,"ELISA","GB","GB-ENG"
"2020-11-04","201023_BatonRouge_LouisianaStateUniversity_Total_popadj","Racial and Workplace Disparities in Seroprevalence of SARS-CoV-2, Baton Rouge, Louisiana, USA","2020-10-23","Local","United States of America; Louisiana; Baton Rouge","2020-07-15","2020-07-31","Household and community samples","Multiple groups",2138.0,0.036,0.028,0.044,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Amy K Feehan","Louisiana State University","https://dx.doi.org/10.3201/eid2701.203808","Verified","United States of America","Abbott","","","Chemiluminescence Immunoassay","US","US-LA"
"2020-11-05","200808_Vienna_MedicalUniversityOfVienna_HCP","SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.","2020-09-02","Local","Austria; Vienna; Vienna","2020-04-01","2020-06-04","Health care workers and caregivers","Adults (18-64 years)",62.0,0.032,0.004,0.112,"Convenience","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Thorsten Fuereder","Medical University of Vienna","https://dx.doi.org/10.1136/esmoopen-2020-000889","Verified","Austria","Roche, Abbott","","","Electro chemiluminescence immunoassay; Chemiluminescence Immunoassay","AT","AT-9"
"2020-11-05","200808_Vienna_MedicalUniversityOfVienna_Patients","SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.","2020-09-02","Local","Austria; Vienna; Vienna","2020-03-21","2020-06-04","Patients seeking care for non-COVID-19 reasons","Multiple groups",84.0,0.024,0.003,0.083,"Convenience","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Thorsten Fuereder","Medical University of Vienna","https://dx.doi.org/10.1136/esmoopen-2020-000889","Verified","Austria","Roche, Abbott","","","Electro chemiluminescence immunoassay; Chemiluminescence Immunoassay","AT","AT-9"
"2020-11-05","200914_PaschimMedinipur_MedicalCollegeKolkata_Overall","Sero-surveillance (IgG) of SARS-CoV-2 among Asymptomatic General population of Paschim Medinipur District, West Bengal, India(Conducted during last week of July and 1st week of August 2020) - A Joint Venture of VRDL Lab (ICMR), Midnapore Medical College &","2020-09-14","Regional","India; West Bengal","2020-07-26","2020-08-08","Household and community samples","Multiple groups",458.0,0.042,0.025,0.064,"Stratified probability","IgG","Moderate","Preprint","Parthasarathi Satpati","Medical College Kolkata","https://www.medrxiv.org/content/10.1101/2020.09.12.20193219v1","Verified","India","Calbiotech Inc.",0.983,0.981,"ELISA","IN","IN-WB"
"2020-11-06","200903_NewDelhi_MaxSuperSpecialtyHospital_Overall","SARS-CoV-2 antibody seroprevalence and stability in a tertiary care hospital-setting","2020-09-03","Local","India; NCT Delhi; New Delhi","2020-04-15","2020-08-15","Multiple populations","Multiple groups",780.0,0.195,"","","Convenience","Total Antibody","High","Preprint","Samreen Siddiqui","Max Super Specialty Hospital","https://www.medrxiv.org/content/10.1101/2020.09.02.20186486v1","Verified","India","Roche Diagnostics",0.945,0.994,"Electrochemiluminescence","IN","IN-DL"
"2020-11-06","200917_SanFrancisco_UniversityofCalifornia_BloodDonors","SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood","2020-09-17","Local","United States of America; California; San Francisco","2020-03-01","2020-03-31","Blood donors","Multiple groups",1000.0,0.001,0.0,0.006,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Dianna Ng","University of California, San Francisco","https://dx.doi.org/10.1038/s41467-020-18468-8","Verified","United States of America","Abbott, Ortho-Clinical Diagnostics","","","Chemiluminescence Immunoassay; Neutralization assay","US","US-CA"
"2020-11-06","200917_SanFrancisco_UniversityofCalifornia_Patients","SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood","2020-09-17","Local","United States of America; California; San Francisco","2020-03-17","2020-04-13","Residual sera","Multiple groups",387.0,0.003,0.0,0.008,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Dianna Ng","University of California, San Francisco","https://dx.doi.org/10.1038/s41467-020-18468-8","Verified","United States of America","Abbott",0.99,0.998,"Chemiluminescence Immunoassay","US","US-CA"
"2020-11-09","200921_Athens_NationalandKapodistrianUniversityofAthens_OverallAdj","Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report","2020-09-21","Local","Greece","2020-06-15","2020-07-15","Non-essential workers and unemployed persons","Multiple groups",2500.0,0.009,0.003,0.021,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Ourania Tsitsilonis","National and Kapodistrian University of Athens","https://dx.doi.org/10.3390/life10090214","Verified","Greece","Roche Diagnostics",1.0,0.998,"Electro chemiluminescence immunoassay","GR",""
"2020-11-10","200903_Paris_HopitalEuropeenGeorgesPompidou_Overall","Sequential SARS-CoV-2 IgG assays as confirmatory strategy to confirm equivocal results: Hospital-wide antibody screening in 3,569 staff health care workers in Paris.","2020-09-03","Local","France;  Île-de-France; Paris","2020-05-02","2020-06-26","Health care workers and caregivers","Adults (18-64 years)",3569.0,0.119,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Helene Pere","Hopital Europeen Georges Pompidou","https://dx.doi.org/10.1016/j.jcv.2020.104617","Verified","France","Abbott","","","Chemiluminescence Immunoassay","FR","FR-IDF"
"2020-11-10","200909_BuenosAires_InstitutoNacionalDeEpidemiologia_Overall","Seroprevalence of the SARS-CoV-2 infection in health workers of the Sanitary Region VIII, at province of Buenos Aires","2020-09-09","Local","Argentina; Buenos Aires; Buenos Aires","2020-06-03","2020-07-06","Health care workers and caregivers","Multiple groups",738.0,0.008,0.0,0.081,"Stratified probability","IgG; IgM","Moderate","Preprint","Andrea Silva","Instituto Nacional de Epidemiologia","https://www.medrxiv.org/content/10.1101/2020.09.07.20189050v1","Verified","Argentina","CONICET","","","ELISA","AR","AR-B"
"2020-11-12","200916_Lajeado_UniversidadedoValedodoTaquari_Survey1","Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil","2020-09-16","Local","Brazil; Rio Grande do Sul; Lajeado","2020-05-30","2020-06-04","Household and community samples","Multiple groups",1450.0,0.04,0.031,0.052,"Stratified probability","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Rafael Picon","Universidade do Vale do Taquari","http://dx.doi.org/10.1016/j.ijid.2020.09.028","Verified","Brazil","Guangzhou Wondfo Biotech",0.762,0.996,"LFIA: Lateral flow immunoassay","BR","BR-RS"
"2020-11-12","200916_Lajeado_UniversidadedoValedodoTaquari_Survey2","Coronavirus Disease 2019 Population-based Prevalence, Risk Factors, Hospitalization, and Fatality Rates in Southern Brazil","2020-09-16","Local","Brazil; Rio Grande do Sul; Lajeado","2020-06-13","2020-06-17","Household and community samples","Multiple groups",1127.0,0.026,0.018,0.037,"Stratified probability","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Rafael Picon","Universidade do Vale do Taquari","http://dx.doi.org/10.1016/j.ijid.2020.09.028","Verified","Brazil","Guangzhou Wondfo Biotech",0.762,0.996,"LFIA: Lateral flow immunoassay","BR","BR-RS"
"2020-11-12","200918_Madrid_UniversityHospitalGregorioMarañón_Overall","SARS-CoV-2 screening of asymptomatic women admitted for delivery must be performed with a combination of microbiological techniques: an observational study","2020-09-18","Local","Spain","2020-05-06","2020-05-21","Pregnant or parturient women","Adults (18-64 years)",100.0,0.13,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Maria Vinuela","University Hospital Gregorio Marañón","http://dx.doi.org/10.37201/req/088.2020","Verified","Spain","Abbott","","","Chemiluminsescent microparticle immunoassay","ES",""
"2020-11-18","200922_Delhi_NationalCenterforDiseaseControlIndia_Survey1_PopAdj","Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease Progression","2020-09-22","Local","India; NCT Delhi; New Delhi","2020-06-26","2020-07-10","Household and community samples","Multiple groups",21387.0,0.235,0.23,0.24,"Unclear","IgG","Unclear","Preprint","Smarajit Dey","National Centre for Disease Control","https://www.researchsquare.com/article/rs-80259/v1","Verified","India","ICMR-National Institute of Virology",0.924,0.979,"ELISA","IN","IN-DL"
"2020-11-18","200922_Delhi_NationalCenterforDiseaseControlIndia_Survey2_PopAdj","Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease Progression","2020-09-22","Local","India; NCT Delhi; New Delhi","2020-08-01","2020-08-07","Household and community samples","Multiple groups",15311.0,0.291,0.285,0.3,"Unclear","IgG","Unclear","Preprint","Smarajit Dey","National Centre for Disease Control","https://www.researchsquare.com/article/rs-80259/v1","Verified","India","ICMR-National Institute of Virology",0.924,0.979,"ELISA","IN","IN-DL"
"2020-11-19","200923_Wuhan_NationalCenterforMedicalServiceAdministration_Overall","Highlighted prospects of an IgM/IgG antibodies test in identifying individuals with asymptomatic SARS CoV-2 infection","2020-09-23","Local","China; Hubei; Wuhan","2020-02-10","2020-03-22","Contacts of COVID patients","Multiple groups",300.0,0.477,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yaqing Li","National Center for Medical Service Administration","https://dx.doi.org/10.5858/arpa.2020-0310-SA","Verified","China","Innovita Biological Technology Co. Ltd",0.971,0.953,"Colloidal Gold Immunochromatography Assay (LFIA)","CN","CN-42"
"2020-11-22","200918_Tbilisi_InfectiousDiseaseResearchCenter_Total_PopTestAdj","SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia","2020-09-18","Local","Georgia; Tbilisi; Tbilisi","2020-05-18","2020-05-27","Household and community samples","Multiple groups",1086.0,0.01,0.004,0.022,"Convenience","IgG","Moderate","Preprint","Tengiz Tsertsvadze","Infectious Diseases, AIDS and Clinical Immunology Research Center","https://www.medrxiv.org/content/10.1101/2020.09.18.20195024v1","Verified","Georgia","Zhejiang Orient Gene Biotech Co Ltd",0.931,0.992,"LFIA: Lateral flow immunoassay","GE","GE-TB"
"2020-11-22","200923_Beijing_PekingUniversity_Overall","A population-based seroprevalence survey of severe acute respiratory syndrome coronavirus 2 infection in Beijing, China","2020-09-23","Local","China; Hebei; Beijing","2020-04-15","2020-04-18","Household and community samples","Multiple groups",2184.0,0.002,"","","Stratified probability","IgG; IgM","Moderate","Preprint","Xiaoli Wang","Peking University","https://www.medrxiv.org/content/10.1101/2020.09.23.20197756v1","Verified","China","Wondfo Biotech Co., Innovita Biological Technology Co Ltd","","","Colloidal gold","CN","CN-13"
"2020-11-22","200925_UnitedStates_StanfordUniversity_OverallPopAdj","Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study","2020-09-25","National","United States of America","2020-07-01","2020-07-31","Residual sera","Multiple groups",28503.0,0.093,0.088,0.099,"Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Shuchi Anand","Stanford University","https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32009-2/fulltext","Verified","United States of America","Siemens Healthineers",1.0,0.998,"Chemiluminescence","US",""
"2020-11-23","200918_Arizona_VincereCancerCenter_Total","COVID-19 Exposure among First Responders in Arizona","2020-09-18","Regional","United States of America; Arizona; Phoenix, Tempe, Glendale, Surprise, Peoria, Chandler","2020-04-24","2020-05-21","Essential non-healthcare workers","Multiple groups",3326.0,0.015,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Vershalee Shukla","Vincere Cancer Center","https://dx.doi.org/10.1097/JOM.0000000000002027","Verified","United States of America","Ray Biotech",0.904,0.983,"LFIA: Lateral flow immunoassay","US","US-AZ"
"2020-11-23","200923_AnnArbor_VeteransAffairsAnnArborHealthcareSystem","Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection Among VA Healthcare System Employees Suggests Higher Risk of Infection When Exposed to SARS-CoV-2 Outside of the Work Environment","2020-09-23","Local","United States of America; Michigan","2020-06-08","2020-07-08","Health care workers and caregivers","Multiple groups",1476.0,0.049,0.038,0.061,"Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Derek Dimcheff","Veterans Affairs Ann Arbor Healthcare System","https://dx.doi.org/10.1017/ice.2020.1220","Verified","United States of America","Abbott",1.0,0.99,"Chemiluminsescent microparticle immunoassay","US","US-MI"
"2020-11-23","200930_Sergipe_FederalUniversityofSergipe_OverallIgG","Anti-SARS-CoV-2 IgM and IgG antibodies in health workers in Sergipe, Brazil","2020-09-30","Regional","Brazil; Sergipe","2020-06-01","2020-06-30","Health care workers and caregivers","Multiple groups",471.0,0.136,"","","Convenience","IgG","High","Preprint","Monica de Melo","Federal University of Sergipe","https://www.medrxiv.org/content/medrxiv/early/2020/09/30/2020.09.24.20200873.full.pdf","Verified","Brazil","Boditech Med Inc.",0.958,0.97,"immunofluorescence assay (IFA)","BR","BR-SE"
"2020-11-24","200917_Nashville_VanderbiltUniversityMedicalCenter_60DaysOverall","Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee","2020-09-17","Local","United States of America; Tennessee; Nashville","2020-06-02","2020-06-27","Health care workers and caregivers","Multiple groups",230.0,0.035,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Manish Patel","Vanderbilt University Medical Center","http://dx.doi.org/10.1001/jama.2020.18796","Verified","United States of America","CDC",0.96,0.99,"ELISA","US","US-TN"
"2020-11-24","201008_Fujisawa_ShonanFujisawaTokushukaiHospital_MedicalStaff","SARS-CoV-2 IgG Seroprevalence among Medical Staff in a General Hospital that Treated COVID-19 Patients in Japan: Retrospective Evaluation of Nosocomial Infection Control","2020-10-08","Local","Japan; Kanagawa; Fujisawa","2020-06-01","2020-07-30","Health care workers and caregivers","Adults (18-64 years)",806.0,0.007,0.003,0.016,"Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","M Hibino","Shonan Fujisawa Tokushukai Hospital","https://dx.doi.org/10.1016/j.jhin.2020.10.001","Verified","Japan","Abbott",1.0,"","Chemiluminescence Immunoassay","JP","JP-14"
"2020-11-24","201106_BC_BCChildrensHospital_Overall_Adj","Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 months","2020-11-06","Local","Canada; British Columbia; Vancouver","2020-05-17","2020-06-19","Multiple populations","Adults (18-64 years)",276.0,0.006,0.0,0.027,"Convenience","IgA; IgG; IgM; Total Antibody","High","Preprint","Abdelilah Majdoubi","BC Children’s Hospital","https://www.medrxiv.org/content/10.1101/2020.10.05.20206664v7","Verified","Canada","Ortho-Clinical Diagnostics, Meso Scale Diagnostics","","","Chemiluminescence Immunoassay","CA","CA-BC"
"2020-11-25","200921_Wuhan_TongjiMedicalCollege_Overall","Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections.","2020-09-21","Local","China; Hubei; Wuhan","2020-02-17","2020-04-28","Multiple populations","Multiple groups",11766.0,0.005,"","","Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Qing Lei","Tongji Medical College","https://dx.doi.org/10.1111/all.14622","Verified","China","YHLO",0.667,0.995,"Chemiluminescence Immunoassay","CN","CN-42"
"2020-11-26","200917_India_MinistryofHealth&FamilyWelfare_OverallPopTestAdj","Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020","2020-09-17","National","India","2020-05-11","2020-06-04","Household and community samples","Multiple groups",28000.0,0.007,0.003,0.011,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Manoj Murhekar","Indian Council of Medical Research","http://dx.doi.org/10.4103/ijmr.IJMR_3290_20","Verified","India","Cadila Healthcare Limited, EUROIMMUN","","","ELISA","IN",""
"2020-11-28","200929_Oberspreewald-Lausitz_BrandenburgUniversityofTechnologyCottbus-Senftenberg_HCW","Testing the backbone of the healthcare system: a prospective serological-epidemiological cohort study of healthcare workers in rural Germany","2020-09-29","Local","Germany; Brandenburg; Oberspreewald-Lausitz","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",156.0,0.013,"","","Convenience","Total Antibody","High","Preprint","Stephanie Hoffmann","Brandenburg University of Technology Cottbus-Senftenberg","https://doi.org/10.21203/rs.3.rs-84703/v1","Verified","Germany","Author-designed",0.995,0.998,"chemiluminescent microparticle immunoassay","DE","DE-BB"
"2020-11-30","201119_Shanghai_FudanUniversity_Overall","Seroprevalence of antibodies to SARS-CoV-2 is particularly high in patient population with ocular surface diseases","2020-11-19","Local","China; Shanghai Municipality; Shanghai","2020-05-15","2020-10-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",6414.0,0.003,"","","Convenience","IgG; IgM","High","Preprint","Shengjie Li","Fudan University","https://www.medrxiv.org/content/10.1101/2020.09.22.20198465v2","Verified","China","Bioscience","","","","CN","CN-31"
"2020-12-02","200806_Regensburg_UniversityofRegensburg_12Wks","Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study","2020-08-06","Local","Germany; Bavaria; Regensburg","2020-03-15","2020-06-07","Health care workers and caregivers","Adults (18-64 years)",139.0,0.0,"","","Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Sara Malfertheiner","University of Regensburg","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406471/pdf/main.pdf","Verified","Germany","EUROIMMUN AG, Roche Diagnostics","","","","DE","DE-BY"
"2020-12-04","200921_Detroit_Region2SouthHealthcareCoalition_Overall","SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020.","2020-09-21","Local","United States of America; Michigan; Detroit","2020-05-18","2020-06-13","Health care workers and caregivers","Adults (18-64 years)",16397.0,0.069,0.065,0.073,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Lara Akinbami","Region 2 South Healthcare Coalition","https://dx.doi.org/10.3201/eid2612.203764","Verified","United States of America","Ortho Clinical Diagnostics",0.9,1.0,"","US","US-MI"
"2020-12-06","200922_AddisAbaba_KuwaitUniversity_GenPop","SARS-CoV-2 Serosurvey in Addis Ababa, Ethiopia","2020-09-22","Local","Ethiopia; Oromia; Addis Ababa","2020-05-18","2020-05-21","Residual sera","Multiple groups",99.0,0.03,0.006,0.086,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","John Kempen","Kuwait University","https://dx.doi.org/10.4269/ajtmh.20-0816","Verified","Ethiopia","Abbott",1.0,0.999,"","ET","ET-OR"
"2020-12-07","200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC2_Overall","SARS-CoV-2 seroprevalence among a southern U.S. population indicates limited asymptomatic spread under physical distancing measures","2020-09-29","Regional","United States of America; North Carolina","2020-03-03","2020-06-04","Residual sera","Adults (18-64 years)",1449.0,0.007,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Amir Barzin","University of North Carolina Chapel Hill","http://dx.doi.org/10.1128/mBio.02426-20","Verified","United States of America","Abbott Laboratories",1.0,0.989,"","US","US-NC"
"2020-12-07","200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC_OverallAdj","SARS-CoV-2 seroprevalence among a southern U.S. population indicates limited asymptomatic spread under physical distancing measures","2020-09-29","Regional","United States of America; North Carolina","2020-04-28","2020-06-19","Residual sera","Adults (18-64 years)",2973.0,0.0,0.0,0.009,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Amir Barzin","University of North Carolina Chapel Hill","http://dx.doi.org/10.1128/mBio.02426-20","Verified","United States of America","Abbott Laboratories",1.0,0.989,"","US","US-NC"
"2020-12-07","210205_Ontario_PublicHealthOntario_August_Abbott","SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline","2021-02-02","Regional","Canada; Ontario","2020-08-01","2020-08-21","Residual sera","Multiple groups",5764.0,0.016,"","","Stratified non-probability","IgG","High","Journal Article (Peer-Reviewed)","Shelly Bolotin","Public Health Ontario","https://dx.doi.org/10.1093/infdis/jiaa796","Verified","Canada","Abbott Laboratories",0.842,1.0,"","CA","CA-ON"
"2020-12-07","210205_Ontario_PublicHealthOntario_July_Abbott","SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline","2021-02-02","Regional","Canada; Ontario","2020-07-04","2020-07-31","Residual sera","Multiple groups",7001.0,0.014,"","","Stratified non-probability","IgG","High","Journal Article (Peer-Reviewed)","Shelly Bolotin","Public Health Ontario","https://dx.doi.org/10.1093/infdis/jiaa796","Verified","Canada","Abbott Laboratories",0.842,1.0,"","CA","CA-ON"
"2020-12-08","200922_Wuhan_WuhanUniversity_IgM/IgG","Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign","2020-10-06","Local","China; Hubei; Wuhan","2020-05-15","2020-05-26","Household and community samples","Multiple groups",61437.0,0.024,0.023,0.025,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Yunbao Pan","Wuhan University","https://dx.doi.org/10.1016/j.cmi.2020.09.044","Verified","China","Nanjing Vazyme Medical technology Co., Ltd",0.915,0.97,"","CN","CN-42"
"2020-12-10","201006_Turin_UniversityofTorino_TotalHCWs","Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy","2020-10-06","Local","Italy; Piemonte; Torino (Turin)","2020-04-17","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",5444.0,0.069,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Andrea Calcagno","University of Torino","https://dx.doi.org/10.3201/eid2701.203027","Verified","Italy","DiaSorin",0.979,0.985,"","IT","IT-21"
"2020-12-10","201008_Stockholm_DanderydHospital","SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden","2020-10-08","Local","Sweden; Sodermanland; Stockholm","2020-04-14","2020-05-08","Health care workers and caregivers","Adults (18-64 years)",2149.0,0.191,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Ann Sofie Rudberg","Danderyd Hospital","http://dx.doi.org/10.1038/s41467-020-18848-0","Verified","Sweden","Author designed",0.992,0.998,"","SE","SE-D"
"2020-12-11","201013_AddisAbaba_MinistryOfHealthEthiopia_TestAdj_PopUnAdj","Sero-prevalence of anti-SARS-CoV-2 Antibodies in Addis Ababa, Ethiopia","2020-10-13","Local","Ethiopia","2020-04-23","2020-04-28","Household and community samples","Adults (18-64 years)",301.0,0.088,0.055,0.116,"Simplified probability","IgG; IgM","Moderate","Preprint","Berhanu Alemu","Ministry of Health, Ethiopia","https://www.biorxiv.org/content/10.1101/2020.10.13.337287v1","Verified","Ethiopia","Zhejiang Orient Gene Biotech Co Ltd, Huzhou, Zhejiang, China",0.879,1.0,"","ET",""
"2020-12-15","200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_HCW","Successful management plan of COVID-19 in a pediatric hemato-oncology department: A single-centre experience","2020-09-15","Local","Italy; Campania; Naples","2020-04-03","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",249.0,0.02,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pio Stellato","Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon","http://dx.doi.org/10.1136/bmjpo-2020-000818","Verified","Italy","VivaDiag, N/A, N/A","","","","IT","IT-72"
"2020-12-15","200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_Patients&Caregivers","Successful management plan of COVID-19 in a pediatric hemato-oncology department: A single-centre experience","2020-09-15","Local","Italy; Campania; Naples","2020-04-03","2020-05-29","Multiple populations","Multiple groups",1397.0,0.004,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pio Stellato","Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon","http://dx.doi.org/10.1136/bmjpo-2020-000818","Verified","Italy","VivaDiag, N/A, N/A","","","","IT","IT-72"
"2020-12-16","200816_SaltLakeCityMilwaukee_CentersforDiseaseControl_householdcontacts","Household Transmission of SARS-CoV-2 in the United States","2020-08-16","Local","United States of America; Utah, Wisconsin; Salt Lake City, Milwaukee","2020-03-22","2020-04-25","Contacts of COVID patients","Multiple groups",178.0,0.258,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Nathaniel M Lewis","Centers for Disease Control","https://dx.doi.org/10.1093/cid/ciaa1166","Verified","United States of America","CDC","","","","US",""
"2020-12-16","201116_Tennessee_VanderbiltUniversity_HCW_Overall","Prevalence of IgG antibodies against the severe acute respiratory syndrome coronavirus-2 among healthcare workers in Tennessee during May and June, 2020","2020-11-16","Regional","United States of America; Tennessee","2020-05-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",11787.0,0.01,"","","Convenience","IgG","High","Preprint","Peter Rebeiro","Vanderbilt University","https://www.medrxiv.org/content/10.1101/2020.11.12.20230912v1","Verified","United States of America","Abbott","","","","US","US-TN"
"2020-12-17","201030_Indianapolis_IndianaUniversity_Overall","Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients","2020-10-30","Local","United States of America; Indiana; Indianapolis","2020-05-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",31.0,0.032,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Corina Nailescu","Indiana University","https://dx.doi.org/10.3389/fped.2020.601327","Verified","United States of America","Abnova, Eli Lilly and Co & IUSM, Mount Sinai medical center",0.944,0.985,"","US","US-IN"
"2020-12-17","201105_Michigan_OaklandUniversity_testadj","COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking.","2020-11-05","Local","United States of America; Michigan; Dearborn, Farmington Hills, Grosse Pointe, Royal Oak, Taylor, Trenton, Troy, Wayne, Canton","2020-04-13","2020-05-28","Health care workers and caregivers","Multiple groups",20614.0,0.081,0.068,0.089,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Matthew D Sims","Oakland University","https://dx.doi.org/10.1093/cid/ciaa1684","Verified","United States of America","EUROIMMUN Lübeck",0.981,0.993,"","US","US-MI"
"2020-12-18","201013_PimaCounty_UniversityofArizona_Overall","Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity","2020-10-13","Local","United States of America; Arizona","2020-04-30","2020-05-07","Household and community samples","Multiple groups",5882.0,0.012,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Tyler Ripperger","University of Arizona","http://dx.doi.org/10.1016/j.immuni.2020.10.004","Verified","United States of America","NR",0.976,1.0,"","US","US-AZ"
"2020-12-18","201017_Vancouver_UniversityofBritishColumbia_LTCF_overall","Serological survey following SARS-COV-2 outbreaks at long-term care facilities in metro Vancouver, British Columbia: Implications for outbreak management and infection control policies","2020-10-17","Local","Canada; British Columbia; Vancouver","2020-05-04","2020-05-14","Assisted living and long-term care facilities","Multiple groups",291.0,0.39,"","","Convenience","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Rohit Vijh","University of British Columbia","https://dx.doi.org/10.1016/j.ajic.2020.10.009","Verified","Canada","DiaSorin, Ortho Vitros , Abbott, Siemens","","","","CA","CA-BC"
"2020-12-18","201021_NewYork_Serimmune_Overall","Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York","2020-10-21","Local","United States of America; New York; New York City","2020-03-01","2020-07-07","Blood donors","Multiple groups",1559.0,0.044,"","","Sequential","IgG","High","Preprint","Kathy Kamath","Serimmune","https://www.medrxiv.org/content/10.1101/2020.10.19.20215368v1","Verified","United States of America","Serimmune",0.91,0.993,"","US","US-NY"
"2020-12-18","201027_Montreal_ShrinersHospital_accompanying_unadj","Prevalence of SARS-CoV-2 Infections in a Pediatric Orthopedic Hospital","2020-10-27","Local","Canada; Québec; Montreal","2020-06-10","2020-07-27","Hospital visitors","Adults (18-64 years)",61.0,0.115,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghalib Bardai","Shriners Hospital for Children","https://doi.org/10.1111/pan.14047","Verified","","Omega Diagnostics","",0.97,"","CA","CA-QC"
"2020-12-18","201027_Montreal_ShrinersHospital_children_unadj","Prevalence of SARS-CoV-2 Infections in a Pediatric Orthopedic Hospital","2020-10-27","Local","Canada; Québec; Montreal","2020-06-10","2020-07-27","Residual sera","Children and Youth (0-17 years)",39.0,0.08,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghalib Bardai","Shriners Hospital for Children","https://doi.org/10.1111/pan.14047","Verified","Canada","Omega Diagnostics","",0.97,"","CA","CA-QC"
"2020-12-18","201027_Montreal_ShrinersHospital_employees_unadj","Prevalence of SARS-CoV-2 Infections in a Pediatric Orthopedic Hospital","2020-10-27","Local","Canada; Québec; Montreal","2020-06-10","2020-07-27","Health care workers and caregivers","Adults (18-64 years)",99.0,0.12,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghalib Bardai","Shriners Hospital for Children","https://doi.org/10.1111/pan.14047","Verified","","Omega Diagnostics","",0.97,"","CA","CA-QC"
"2020-12-18","201107_Lubbock_TexasTechUniversity_Overall","Prevalence of Coronavirus Antibody Among First Responders in Lubbock, Texas","2020-11-07","Local","United States of America; Texas; Lubbock","2020-05-12","2020-05-13","Essential non-healthcare workers","Multiple groups",683.0,0.007,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Kenneth Iwuji","Texas Tech University","https://dx.doi.org/10.1177/2150132720971390","Verified","United States of America","Abbott",1.0,0.999,"","US","US-TX"
"2020-12-18","201201_NewHeaven_Yale_SchoolofMedicine_newborns","NEWBORN DRIED BLOOD SPOTS FOR SEROLOGIC SURVEYS OF COVID-19.","2020-12-12","Local","United States of America; Connecticut; New Haven","2020-02-19","2020-05-26","Residual sera","Children and Youth (0-17 years)",3048.0,0.059,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Feimei  Liu","Yale School of Medicine","https://dx.doi.org/10.1097/INF.0000000000002918","Verified","United States of America","In-house","","","","US","US-CT"
"2020-12-19","201003_Denmark_AarhusUniversity_HCW_testadj","Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Survey Among 17 971 Healthcare and Administrative Personnel at Hospitals, Prehospital Services, and Specialist Practitioners in the Central Denmark Region","2020-10-03","Regional","Denmark; Central Denmark Region","2020-05-18","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",17948.0,0.034,0.024,0.038,"Convenience","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Senne Jespersen","Aarhus University Hospital","https://dx.doi.org/10.1093/cid/ciaa1471","Verified","Denmark","Wantai Biological Pharmacy Enterprise Co, Ltd, Beijing,; China",0.967,0.995,"","DK","DK-82"
"2020-12-19","201015_NewYorkCity_NYCHealth+Hospitals/Lincoln_Overall","SARS-CoV-2 Seroprevalence Among Health Care Workers in a New York City Hospital: A Cross-Sectional Analysis During the COVID-19 Pandemic","2020-10-15","Local","United States of America; New York; New York City","2020-03-01","2020-05-01","Health care workers and caregivers","Adults (18-64 years)",500.0,0.27,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Usha Venugopal","NYC Health + Hospitals/Lincoln","http://dx.doi.org/10.1016/j.ijid.2020.10.036","Verified","United States of America","Abbott Laboratories",1.0,0.996,"","US","US-NY"
"2020-12-20","201006_Brazil_FederalUniversityofSergipe_genpop_IgG","Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil","2020-10-06","Regional","Brazil; Sergipe; Aracaju, Simão Dias, Itabaiana, Itabaianinha, Nossa Senhora do, São Cristóvão, Estância, Lagarto, Tobias Barreto, Nossa Senhora da Glória","2020-05-02","2020-05-09","Household and community samples","Multiple groups",2635.0,0.083,0.072,0.094,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Lysandro Pinto Borges","Federal University of Sergipe","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541966/","Verified","Brazil","Boditech Med Inc.","","","","BR","BR-SE"
"2020-12-21","201030_Cleveland_CaseWesternReserveUniversity_Overall","SARS-CoV-2 Infection Among Serially Tested Emergency Medical Services Workers","2020-10-30","Local","United States of America; Ohio; Cleveland","2020-04-20","2020-05-19","Essential non-healthcare workers","Adults (18-64 years)",296.0,0.054,0.031,0.086,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yasir Tarabichi","Case Western Reserve University","https://dx.doi.org/10.1080/10903127.2020.1831668","Verified","United States of America","Epitope Diagnostics, Inc","","","","US","US-OH"
"2020-12-28","201026_UpstateNewYork_BassettMedicalCenter_Overall","SARS-CoV-2 IgG Results Among Healthcare Workers in a Rural Upstate New York Hospital System","2020-10-26","Local","United States of America; New York; Upstate New York","2020-05-04","2020-05-29","Health care workers and caregivers","Multiple groups",764.0,0.02,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Wendy M Brunner","Bassett Medical Center","https://dx.doi.org/10.1017/ice.2020.1296","Verified","United States of America","Abbott Laboratories",1.0,0.996,"","US","US-NY"
"2021-01-03","200806_Barcelona_UniversitatdeBarcelona_PregnantWomen_Overall","Seroprevalence and presentation of SARS-CoV-2 in pregnancy","2020-08-06","Local","Spain","2020-04-14","2020-05-05","Pregnant or parturient women","Adults (18-64 years)",874.0,0.14,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Francesca Crovetto","Universitat de Barcelona","https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31714-1/fulltext","Verified","Spain","Vircell Microbiologist, Ortho Clinical Diagnostics","","","","ES",""
"2021-01-04","200901_Petrópolis_CentrodeTerapiaOncológica_HCW_IGGorIGM","Universal screening of SARS-CoV-2 of oncology healthcare workers - a Brazilian experience","2020-09-01","Local","Brazil; Rio de Janeiro; Petrópolis","2020-04-09","2020-04-29","Health care workers and caregivers","Adults (18-64 years)",61.0,0.049,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","P Ismael Amaral Silva","Centro de Terapia Oncológica","http://dx.doi.org/10.1016/j.annonc.2020.08.1825","Verified","Brazil","NR","","","","BR","BR-RJ"
"2021-01-05","200813_Northrhine-Westfalia_SpecialistPracticeAndLaboratory_IgGandOverall","The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)","2020-08-13","Regional","Germany; North Rhine-Westphalia","2020-03-26","2020-06-04","Residual sera","Multiple groups",415.0,0.012,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Burkhard Herrmann","Internal medicine and laboratory medicine specialist practice and laboratory","http://dx.doi.org/10.1007/s15006-020-0750-y","Verified","Germany","Euroimmun",0.944,0.996,"","DE","DE-NW"
"2021-01-05","200911_Santiago_HospitalClinicoUniversitariodeSantiagodeCompostela_Overall","Seroprevalence of SARS-CoV-2 Among Pediatric Healthcare Workers in Spain","2020-09-11","Local","Spain; Galicia; Santiago de Compostela","2020-04-14","2020-04-16","Health care workers and caregivers","Adults (18-64 years)",175.0,0.04,0.011,0.069,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ana Dacosta Urbieta","Hospital Clinico Universitario de Santiago de Compostela","http://dx.doi.org/10.3389/fped.2020.00547","Verified","Spain","Genobio Pharmaceutical (Shanghai; China)","","","","ES","ES-GA"
"2021-01-05","201027_Indiana_Harvard_Overall_testadj","Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States","2020-11-27","Local","United States of America; Indiana; St. John Township","2020-07-15","2020-07-20","Essential non-healthcare workers","Multiple groups",753.0,0.017,0.003,0.033,"Self-referral","IgG","Moderate","Preprint","Lilah Lopez","Harvard Medical School","https://www.medrxiv.org/content/10.1101/2020.10.23.20218651v1","Verified","United States of America","Abbott Alinity",1.0,0.99,"","US","US-IN"
"2021-01-05","201119_LosAngeles_CedarsSinaiMedicalCenter_Overall","BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers","2020-11-19","Local","United States of America; California; Los Angeles","2020-05-11","2020-06-28","Health care workers and caregivers","Adults (18-64 years)",6201.0,0.035,"","","Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Magali Rivas","Cedars-Sinai Medical Center","https://dx.doi.org/10.1172/JCI145157","Verified","United States of America","Abbott",0.969,0.999,"","US","US-CA"
"2021-01-05","201120_Rochester_MayoClinic_HighRiskCohort_1_Overall","Unrecognized SARS-CoV-2 Seroprevalence among healthcare personnel in a low prevalence area","2020-11-20","Local","United States of America; Minnesota; Rochester","2020-05-25","2020-07-09","Health care workers and caregivers","Adults (18-64 years)",320.0,0.006,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Vishal Shah","Mayo Clinic","https://dx.doi.org/10.1017/ice.2020.1341","Verified","United States of America","EUROIMMUN, Ortho-Clinical Diagnostics, Roche Diagnostics","","","","US","US-MN"
"2021-01-05","201120_Rochester_MayoClinic_LowRiskCohort_2_Overall","Unrecognized SARS-CoV-2 Seroprevalence among healthcare personnel in a low prevalence area","2020-11-20","Local","United States of America; Minnesota; Rochester","2020-05-25","2020-07-09","Health care workers and caregivers","Adults (18-64 years)",248.0,0.0,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Vishal Shah","Mayo Clinic","https://dx.doi.org/10.1017/ice.2020.1341","Verified","United States of America","EUROIMMUN, Ortho-Clinical Diagnostics, Roche Diagnostics","","","","US","US-MN"
"2021-01-06","200810_USA_Illinois_PhysicianPractice_Overall","Observational study of SARS-CoV-2 antibody immune response in a cohort of patients at a North Suburban Chicago, Illinois, in a physician's practice","2020-08-06","Local","United States of America; Illinois; Chicago","2020-04-22","2020-05-26","Residual sera","Multiple groups",113.0,0.159,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Gerald Osher","BioSolutions Services LLC","https://lymphosign.com/doi/full/10.14785/lymphosign-2020-0007","Verified","United States of America","CLUNGENE","","","","US","US-IL"
"2021-01-07","200802_AguadadePasajeros_UniversityofMedicalSciencesofCienfuegos","Surveillance and control actions before notification of confirmed cases to COVID-19. Aguada de Pasajeros, Cienfuegos. Cuba","2020-08-23","Local","Cuba; Cienfuegos; Aguada de Pasajeros","2020-03-23","2020-04-06","Contacts of COVID patients","Multiple groups",200.0,0.0,"","","Convenience","IgM; IgG","Unclear","Journal Article (Peer-Reviewed)","Alain Morejon Giraldoni","University of Medical Sciences of Cienfuegos","http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2020000400721","Verified","Cuba","NR","","","","CU","CU-06"
"2021-01-07","201013_Pittsburgh_UniversityPittsburgh_PedImmunocompPatients_Overall","Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center","2020-10-13","Local","United States of America; Pennsylvania; Pittsburgh","2020-03-15","2020-07-04","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",485.0,0.01,0.003,0.024,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Megan Freeman","University of Pittsburgh School of Medicine","http://dx.doi.org/10.1093/jpids/piaa123","Verified","United States of America","Euroimmun, Beckman Coulter, Siemens","","","","US","US-PA"
"2021-01-07","201027_Illinois_CDC_Contacts","Lack of Serologic Evidence of Infection Among Health Care Personnel and Other Contacts of First 2 Confirmed Patients With COVID-19 in Illinois, 2020","2020-10-27","Regional","United States of America; Illinois","2020-03-03","2020-03-06","Contacts of COVID patients","Adults (18-64 years)",59.0,0.0,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Tristan McPherson","US Centers for Disease Control and Prevention","https://dx.doi.org/10.1177/0033354920966064","Verified","United States of America","CDC",0.96,0.99,"","US","US-IL"
"2021-01-07","201103_Germany_UniversityofWitten","[Corona in Children: the Co-Ki Study]","2020-11-03","National","Germany","2020-06-15","2020-09-01","Residual sera","Children and Youth (0-17 years)",731.0,0.112,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Silke Schwarz","University of Witten","https://dx.doi.org/10.1007/s00112-020-01050-3","Verified","Germany","Euroimmun IgG, Diasorin IgG, Microgen IgG, Roche IgM, Cleartest IgM, Nadal IgM, Euroimmun IgA","","","","DE",""
"2021-01-07","201201_LosAngeles_UniversityofSouthernCalifornia_UniversityStudents_Overall","A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population","2020-12-01","Local","United States of America; California; Los Angeles","2020-04-29","2020-05-08","Students and Daycares","Adults (18-64 years)",790.0,0.04,0.03,0.051,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Kimberly Tilley","University of Southern California","http://dx.doi.org/10.1016/j.jadohealth.2020.09.001","Verified","United States of America","EUROIMMUN",0.9,1.0,"","US","US-CA"
"2021-01-08","200610_Munich_TechnicalUniversityofMunich_hcw","Strategies for infection control and prevalence of anti-SARS-CoV-2 IgG in 4,554 employees of a university hospital in Munich, Germany","2020-10-06","Local","Germany; Bavaria; Munich","2020-04-14","2020-05-29","Health care workers and caregivers","Multiple groups",4554.0,0.024,0.019,0.029,"Convenience","IgG","High","Preprint","Johanna Erber","Technical University of Munich","https://www.medrxiv.org/content/10.1101/2020.10.04.20206136v1","Verified","Germany","Unclear","","","","DE","DE-BY"
"2021-01-08","200911_Barcelona_SardenyaPrimaryHealthCareCenter_Overall","Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain","2020-09-11","Local","Spain; Catalonia; Barcelona","2020-04-21","2020-04-24","Household and community samples","Multiple groups",311.0,0.055,0.034,0.086,"Stratified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Patricia Montenegro","Sardenya Primary Health Care Center","http://dx.doi.org/10.1093/fampra/cmaa096","Verified","Spain","Livzlon, Lysine and Sure Screen","","","","ES","ES-CT"
"2021-01-08","201021_Spain_IVIRMA_Overall","RISK FACTOR ANALYSIS FOR SARS-COV-2 SEROPOSITIVITY WITHIN ASSISTED REPRODUCTIVE","2020-09-01","National","Spain","2020-04-27","2020-06-26","Residual sera","Adults (18-64 years)",6140.0,0.007,"","","Convenience","IgM","Unclear","Journal Article (Peer-Reviewed)","Nicolas Prados","IVIRMA Global Headquarters","http://dx.doi.org/10.1016/j.fertnstert.2020.09.077","Verified","Spain","Epitope Diagnostics","","","","ES",""
"2021-01-08","201024_Madrid_HospitalUniversitarioPrincipeDeAsturias_HCW_Overall","SARS-CoV-2 infection among hospital workers of one of the most severely affected institutions in Madrid, Spain: a surveillance cross-sectional study","2020-10-29","Local","Spain","2020-05-01","2020-05-30","Health care workers and caregivers","Adults (18-64 years)",2424.0,0.224,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Felipe Perez Garcia","Hospital Universitario Príncipe de Asturias","https://dx.doi.org/10.1017/ice.2020.1303","Verified","Spain","AllTest Biotech",0.88,1.0,"","ES",""
"2021-01-08","201103_NewYorkCity_MountSinai_UrgentCare_2_Overall","Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City","2020-11-03","Local","United States of America; New York; New York City","2020-02-02","2020-07-05","Residual sera","Multiple groups",4101.0,0.26,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Daniel Stadlbauer","Icahn School of Medicine at Mount Sinai","http://dx.doi.org/10.1038/s41586-020-2912-6","Verified","United States of America","Mount Sinai Hospital New York",0.95,1.0,"","US","US-NY"
"2021-01-09","200624_BaskingRidge_FellowshipVillage_Staff1_Overall","Fellowship;   Village Benefits from Covid-19 Antibody Tests","2020-06-24","Local","United States of America; New Jersey; Basking Ridge","2020-04-15","2020-05-06","Assisted living and long-term care facilities","Adults (18-64 years)",305.0,0.236,"","","Convenience","IgG; IgM","Unclear","News and Media","Tim Regan","Fellowship Village","https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g","Verified","United States of America","NR","","","","US","US-NJ"
"2021-01-09","201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_PartnersofParturientWomen_TestAdj","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns","2020-10-27","Local","Denmark; Capital Region of Denmark; Copenhagen","2020-04-04","2020-07-03","Hospital visitors","Adults (18-64 years)",1188.0,0.035,0.023,0.051,"Sequential","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Pia Egerup","Copenhagen University Hospital Hvidovre","https://dx.doi.org/10.1097/AOG.0000000000004199","Verified","Denmark","Shenzhen Yhlo Biotech",0.94,0.993,"","DK","DK-84"
"2021-01-09","201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_ParturientWomen_TestAdj","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns","2020-10-27","Local","Denmark; Capital Region of Denmark; Copenhagen","2020-04-04","2020-07-03","Pregnant or parturient women","Adults (18-64 years)",1313.0,0.026,0.017,0.04,"Sequential","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Pia Egerup","Copenhagen University Hospital Hvidovre","https://dx.doi.org/10.1097/AOG.0000000000004199","Verified","Denmark","Shenzhen Yhlo Biotech",0.94,0.993,"","DK","DK-84"
"2021-01-09","201103_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM","Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery.","2020-11-03","Local","Italy; Sardinia; Cagliari","2020-03-31","2020-06-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",86.0,0.058,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Fabio Medas","University of Cagliari","https://dx.doi.org/10.1016/j.amsu.2020.11.006","Verified","Italy","Snibe","","","","IT","IT-88"
"2021-01-10","201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_retired_adj","SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors - A cross-sectional study","2020-10-26","National","Denmark","2020-06-02","2020-06-19","Blood donors","Seniors (65+ years)",1200.0,0.014,0.003,0.025,"Simplified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Ole Birger Pedersen","Copenhagen University Hospital Rigshospitalet","https://dx.doi.org/10.1093/cid/ciaa1627","Verified","Denmark","Beijing Wantai Biological Pharmacy Enterprise",0.967,0.995,"","DK",""
"2021-01-10","201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_Newborns","Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns","2020-10-27","Local","Denmark; Capital Region of Denmark; Copenhagen","2020-04-04","2020-07-03","Perinatal","Children and Youth (0-17 years)",1206.0,0.014,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pia Egerup","Copenhagen University Hospital Hvidovre","https://dx.doi.org/10.1097/AOG.0000000000004199","Verified","Denmark","Shenzhen Yhlo Biotech",0.94,0.993,"","DK","DK-84"
"2021-01-10","201027_Perugia_UniversityofPerugia_HIVPositive1_PLWHIgG","Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV","2020-10-27","Local","Italy; Umbria; Perugia","2020-05-04","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",270.0,0.037,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Chiara Papalini","University of Perugia","https://dx.doi.org/10.4084/MJHID.2020.080","Verified","Italy","Screen Italia","","","","IT","IT-55"
"2021-01-12","201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_Active_adj","SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors - A cross-sectional study","2020-10-26","National","Denmark","2020-06-01","2020-06-26","Blood donors","Adults (18-64 years)",1110.0,0.025,0.013,0.038,"Sequential","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Ole Birger Pedersen","Copenhagen University Hospital Rigshospitalet","https://dx.doi.org/10.1093/cid/ciaa1627","Verified","Denmark","Beijing Wantai Biological Pharmacy Enterprise",0.967,0.995,"","DK",""
"2021-01-12","201027_Athens_NationalandKapodistrianUniversityofAthens_Overall","Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece","2020-10-27","Local","Greece; Attica; Athens","2020-04-25","2020-05-10","Health care workers and caregivers","Adults (18-64 years)",321.0,0.022,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Panayiotis Vlachoyiannopoulosa","National and Kapodistrian University of Athens/Laiko University Hospital","http://dx.doi.org/10.1016/j.clim.2020.108619","Verified","Greece","EUROIMMUN, Germany",0.93,1.0,"","GR","GR-I"
"2021-01-12","201031_Milan_SanRaffaeleScientificInstitute_HCW_IgG","SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic","2020-10-31","Local","Italy; Lombardy; Milan","2020-03-15","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",40.0,0.05,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Diana Canetti","San Raffaele Scientific Institute","https://pubmed.ncbi.nlm.nih.gov/33135083/","Verified","Italy","Prima lab SA, Diasorin","","","","IT","IT-25"
"2021-01-12","201202_DominicanRepublic_UniversidadIberoamericana_genpop_IgG","Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic","2020-12-02","National","Dominican Republic","2020-04-15","2020-06-15","Household and community samples","Multiple groups",12897.0,0.055,"","","Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Robert Paulino Ramirez","Universidad Iberoamericana","https://dx.doi.org/10.4269/ajtmh.20-0907","Verified","Dominican Republic","GenBody Inc.",0.567,1.0,"","DO",""
"2021-01-12","201207_Mumbai_KokilabenDhirubhaiAmbaniHospital_hcw_primaryest","Prevalence of COVID-19 antibodies in healthcare workers at the peak of the pandemic in Mumbai, India: A preliminary study.","2020-12-07","Local","India; Maharashtra; Mumbai","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",208.0,0.125,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Tanu Singhal","Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute","https://dx.doi.org/10.4103/ijmm.IJMM_20_308","Verified","India","1) Abbott 2) Roche","","","","IN","IN-MH"
"2021-01-13","201015_BronxNY_AlbertEinsteinCollegeofMedicine_KidneyTransplantlPatients","COVID-19 infection in kidney transplant recipients at the epicenter of pandemics","2020-10-15","Local","United States of America; New York; New York City","2020-05-03","2020-07-29","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",912.0,0.167,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Yorg Azzi","Albert Einstein College of Medicine","http://dx.doi.org/10.1016/j.kint.2020.10.004","Verified","United States of America","Abbott",1.0,1.0,"","US","US-NY"
"2021-01-13","201023_Berlin_CharitéUniversity_primary","LOW SEROPREVALENCE OF SARS-COV-2 ANTIBODIES DURING SYSTEMATIC SCREENING FOR COVID-19 INFECTION IN A GERMAN COHORT OF KIDNEY TRANSPLANT RECIPIENTS","2020-10-23","Local","Germany; Berlin; Berlin","2020-03-19","2020-05-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",223.0,0.071,"","","Unclear","IgA; IgG","High","Journal Article (Peer-Reviewed)","Mira Choi","Charité University","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690804/","Verified","Germany","Euroimmun Medizinische Labordiagnostika AG","","","","DE","DE-BE"
"2021-01-14","200920_EasternUK_CambridgeUniversityHospitalsNHSFoundationTrust_Day1Luminex","SARS-CoV-2 antigen and antibody prevalence among UK staff working with cancer patients during the COVID-19 pandemic","2020-09-20","Regional","United Kingdom of Great Britain and Northern Ireland; East of England","2020-06-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",434.0,0.184,"","","Convenience","IgG","High","Preprint","David Favara","Cambridge University Hospitals NHS Foundation Trust","https://www.medrxiv.org/content/10.1101/2020.09.18.20197590v1","Verified","The United Kingdom","Cambridge University Hospitals",0.84,1.0,"","GB","GB-ENG"
"2021-01-14","201126_Germany_RobertKochInstitute_BloodDonors_TestAdj","Serological tests of blood donations for antibodies against SARS-CoV-2 (SeBluCo study)","2020-11-26","National","Germany","2020-04-15","2020-11-05","Blood donors","Multiple groups",48976.0,0.014,"","","Simplified probability","IgG","Moderate","Institutional Report","Robert Koch Institute","Robert Koch Institute","https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html;jsessionid=0C30892A66A0F7CDD897F3809AA3F10F.internet102","Verified","Germany","NR","","","","DE",""
"2021-01-15","201027_Cuiabá_UniversidadeFederaldeMatoGrosso_Overall","PREVALENCE OF MOLECULAR AND SEROLOGICAL TESTS OF THE NEW CORONAVIRUS (SARS-CoV-2) IN CARLOS CHAGAS-SABIN LABORATORIES IN CUIABA","2020-10-27","Local","Brazil; Mato Grosso; Cuiabá","2020-04-01","2020-07-31","Residual sera","Multiple groups",6392.0,0.221,"","","Convenience","IgG; IgM","High","Preprint","Cristiane Coimbra de Paula","Universidade Federal de Mato Grosso (UFMT)","https://www.medrxiv.org/content/10.1101/2020.10.26.20219683v1","Verified","Brazil","Carlos Chagas Laboratory","","","","BR","BR-MT"
"2021-01-15","201227_Denmark_CopenhagenUniversityHospital_PregnancyLoss2_Overall","SARS-CoV-2 in first trimester pregnancy: a cohort study","2020-12-27","Local","Denmark; Copenhagen; Copenhagen","2020-04-14","2020-05-21","Pregnant or parturient women","Adults (18-64 years)",36.0,0.0,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","‪Nina Freiesleben","Copenhagen University Hospital","https://dx.doi.org/10.1093/humrep/deaa311","Verified","Denmark","YHLO Biotechnology","","","","DK","DK-84"
"2021-01-16","201007_MinistryofHealthofRussianFederation_employees","Detection of antibodies to SARS-CoV-2 in healthcare professionals of the national center during the COVID-19 pandemic (April-June 2020)","2020-10-07","Local","Russian Federation","2020-04-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",1589.0,0.089,"","","Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","LV Krechetova","Ministry of Health of Russia","http://dx.doi.org/10.18565/aig.2020.7.122-128","Verified","Russian Federation","""NMITs Hematology"" Ministry of Health of the Russian Federation","","","","RU",""
"2021-01-16","201015_Paris_ParisSaclayUniversity_unadj","Post lockdown COVID-19 seroprevalence and circulation at the time of delivery, France","2020-10-15","Local","France; Paris; Paris","2020-05-04","2020-05-31","Pregnant or parturient women","Adults (18-64 years)",249.0,0.08,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Jeremie Mattern","Paris Saclay University","http://dx.doi.org/10.1371/journal.pone.0240782","Verified","France","Abbott, Ortho-Clinical Diagnostics","","","","FR","FR-IDF"
"2021-01-16","201018_Belgium_UniversityHospitalsLeuven_Overall_unadj","Added value of anti-SARS-CoV-2 antibody testing in a Flemish nursing home during an acute COVID-19 outbreak in April 2020","2020-10-18","Local","Belgium; Limburg; Lanaken","2020-04-14","2020-04-16","Multiple populations","Multiple groups",188.0,0.186,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Frank Buntinx","University of Leuven","http://dx.doi.org/10.1080/17843286.2020.1834285","Verified","Belgium","SureScreen Diagnostics, Derby, UK",0.747,0.951,"","BE",""
"2021-01-16","201021_Italy_IRCCS_Overall_IgG_unadj","Seroconversion in patients with cancer and oncology healthcare workers infected by SARS-CoV-2","2020-10-21","Regional","Italy; Lombardy","2020-03-30","2020-05-11","Multiple populations","Multiple groups",166.0,0.416,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Antonio Marra","Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)","https://dx.doi.org/10.1016/j.annonc.2020.10.473","Verified","Italy","PRIMA Lab SA","","","","IT","IT-25"
"2021-01-16","201113_London_ImperialCollegeLondon_KidneyTransplantPatients","Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening","2020-11-13","Local","United Kingdom of Great Britain and Northern Ireland; Greater London; London","2020-06-01","2020-07-03","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",855.0,0.104,0.085,0.126,"Sequential","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Michelle Willicombe","Imperial College London","https://dx.doi.org/10.1097/TP.0000000000003526","Verified","The United Kingdom","Abbott, Fortress Diagnostics","","","","GB","GB-ENG"
"2021-01-17","201008_StGallen_CantonalHospitalStGallen_hcw","Prevalence of SARS-CoV-2 Antibodies among Swiss Hospital Workers - Results of a Prospective Cohort Study","2020-10-08","Regional","Switzerland; St. Gallen; St. Gallen","2020-03-19","2020-04-03","Health care workers and caregivers","Adults (18-64 years)",1012.0,0.01,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Phillipp Kohler","Cantonal Hospital St. Gallen","https://dx.doi.org/10.1017/ice.2020.1244","Verified","Switzerland","lateral flow immunochromatographic assay; (LFIA, Sugentech, Yuseong-gu, Daejeon, Republic of Korea), a; chemiluminescence microparticle immunoassay (CMIA, Abbott; Diagnostics, Lake Bluff, IL), and an electro-chemiluminescence; immunoassay (ECLIA, Roche Diagnostics, Basel, Switzerland)","","","","CH",""
"2021-01-17","201012_UnitedKingdom_RoyalBelfastHospitalForSickChildren","Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study","2020-11-10","National","United Kingdom of Great Britain and Northern Ireland; Ireland, Wales, Scotland, England; Belfast, Cardiff, Glasgow, London, Manchester","2020-04-16","2020-07-03","Family of essential workers","Children and Youth (0-17 years)",992.0,0.069,0.054,0.086,"Convenience","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Thomas Waterfield","Royal Belfast Hospital for Sick Children","https://dx.doi.org/10.1136/archdischild-2020-320558","Verified","The United Kingdom","Abbott, Roche, DiaSorin","","","","GB",""
"2021-01-17","201021_SaoPaulo_AdolfoLutzCentralInstitute","Prevalence of antibodies against sars-cov-2 in professionals of a public health laboratory at Sao Paulo, sp, Brazil","2020-10-21","Local","Brazil; State of Sao Paulo; Sao Paulo","2020-06-05","2020-07-31","Multiple populations","Multiple groups",406.0,0.086,"","","Convenience","IgG; IgM","High","Preprint","Valeria Oliveira Silva","Adolfo Lutz Central Institute","https://www.medrxiv.org/content/10.1101/2020.10.19.20213421v1","Verified","Brazil","Guangzhou Wondfo Biotech Co., Ltd., China; Roche Diagnostics, Rotkreuz, Switzerland","","","","BR","BR-SP"
"2021-01-17","201021_VeracruzCity_UniversidadVeracruzana_unadj","Prevalence of SARS-CoV-2 IgG antibodies in a population from Veracruz (Southeastern Mexico)","2020-10-21","Local","Mexico; Veracruz; Veracruz City","2020-06-01","2020-07-31","Residual sera","Multiple groups",2174.0,0.295,0.276,0.315,"Sequential","IgG","High","Preprint","Jose Maria Remes-Troche","Universidad Veracruzana","https://www.medrxiv.org/content/10.1101/2020.10.19.20215558v1","Verified","Mexico","Abbott, Ortho-Clinical Diagnostics","","","","MX","MX-VER"
"2021-01-17","201106_Lyon_UniversitéClaudeBernardLyon_Overall","Clinical and microbiological assessments of COVID-19 in healthcare workers: a prospective longitudinal study","2020-11-06","Local","France; Auvergne-Rhône-Alpes; Lyon","2020-04-10","2020-05-28","Health care workers and caregivers","Adults (18-64 years)",190.0,0.037,"","","Unclear","Total Antibody; IgG","High","Preprint","Antonin Bal","Université Claude Bernard Lyon","https://www.medrxiv.org/content/10.1101/2020.11.04.20225862v1","Verified","France","Wantai, Beijing, China; bioMérieux, Lyon, France","","","","FR","FR-ARA"
"2021-01-17","201108_Geneva_GenevaUniversityHospital_Overall","Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care","2020-11-08","Local","Switzerland","2020-04-01","2020-04-30","Residual sera","Children and Youth (0-17 years)",208.0,0.087,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Klara Posfay Barbe","Geneva University Hospital","https://dx.doi.org/10.1093/cid/ciaa1702","Verified","Switzerland","Euroimmun, N/A, N/A","","","","CH",""
"2021-01-17","201109_ Peshawar_HayatabadMedicalComplex_Overall","Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?","2020-11-09","Local","Pakistan; Khyber Pakhtunkhwa; Peshawar","2020-07-13","2020-07-15","Health care workers and caregivers","Multiple groups",1011.0,0.308,"","","Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mohammad Noor","Hayatabad Medical Complex","https://dx.doi.org/10.7759/cureus.11389","Verified","Pakistan","Roche",0.87,1.0,"","PK","PK-KP"
"2021-01-18","201008_Udine_UniversityofUdine_SCTrecipients","Screening Procedure for SARS-CoV-2 infection combining Triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation Recipients Undergoing Outpatient Post Transplant Follow-Up","2020-10-08","Local","Italy; Udine; Udine","2020-04-01","2020-05-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",70.0,0.014,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alessandra Sperotto","The University of Udine","https://dx.doi.org/10.1002/jmv.26586","Verified","Italy","Cellex",0.938,0.964,"","IT","IT-36"
"2021-01-18","201104_Geneva_JohnHopkins_Overall","Household Transmission of SARS-CoV-2: Insights from a Population-based Serological Survey","2021-01-16","Regional","Switzerland; Geneva","2020-04-03","2020-06-30","Household and community samples","Multiple groups",4534.0,0.066,0.06,0.07,"Convenience","IgG","Moderate","Preprint","Qifang Bi","Johns Hopkins Bloomberg School of Public Health","https://www.medrxiv.org/content/10.1101/2020.11.04.20225573v2","Verified","Switzerland","Euroimmun",0.93,0.99,"","CH","CH-GE"
"2021-01-18","201104_India_HindujaHospital_GenPop","Duration of anti-SARS-CoV-2 antibodies much shorter in India","2020-11-04","Local","India; Maharashtra; Mumbai","2020-06-01","2020-06-30","Health care workers and caregivers","Multiple groups",801.0,0.111,0.091,0.135,"Unclear","Total Antibody","High","Journal Article (Peer-Reviewed)","Nishant Kumar","Postgraduate Institute of Medical Education and Research","https://dx.doi.org/10.1016/j.vaccine.2020.10.094","Verified","India","Roche Diagnostics",0.998,1.0,"","IN","IN-MH"
"2021-01-18","201105_Corsica_UniversitédeCorse_Totaladj","Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020","2020-11-05","Regional","France; Corsica; Ajaccio; Corte","2020-04-16","2020-06-15","Residual sera","Multiple groups",1973.0,0.055,0.045,0.066,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lisandru Capai","Université de Corse","https://www.mdpi.com/2077-0383/9/11/3569","Verified","France","EUROIMMUN, Bussy-Saint Martin, France",0.864,0.962,"","FR","FR-COR"
"2021-01-18","201109_Kokalta_ApolloGleneaglesHospitals_HCW_Overall","Seroprevalence of COVID-19 Amongst Health Care Workers in a Tertiary Care Hospital of a Metropolitan City from India.","2020-11-09","Local","India; West Bengal; Kolkata","2020-07-12","2020-08-23","Health care workers and caregivers","Adults (18-64 years)",1122.0,0.119,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Mahesh Goenka","Apollo Gleneagles Hospitals","https://www.japi.org/x264a444/seroprevalence-of-covid-19-amongst-health-care-workers-in-a-tertiary-care-hospital-of-a-metropolitan-city-from-india","Verified","India","Ortho Clinical Diagnostics",0.9,1.0,"","IN","IN-WB"
"2021-01-19","200928_FrenchGuiana_InstitutPasteur_OverallPopAdjyes","Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana","2020-09-28","National","French Guiana","2020-07-15","2020-07-23","Residual sera","Multiple groups",480.0,0.154,0.093,0.244,"Sequential","IgG","Moderate","Preprint","Claude Flamand","Institut Pasteur","https://www.medrxiv.org/content/10.1101/2020.09.27.20202465v1","Verified","French Guiana","Euroimmun",0.938,0.979,"","GF",""
"2021-01-19","200930_PeshawarCity_RiphahInternationalUniversity_Overall","Seroprevalence and Risk Factors of SARS CoV-2 in Health Care Workers of Tertiary-Care Hospitals in the Province of Khyber Pakhtunkhwa, Pakistan","2020-09-30","Local","Pakistan; Khyber Pakhtunkhwa; Peshawar City","2020-06-15","2020-06-29","Health care workers and caregivers","Adults (18-64 years)",1011.0,0.307,0.278,0.336,"Stratified non-probability","Total Antibody","Moderate","Preprint","Mohsina Haq","Riphah International University","https://www.medrxiv.org/content/10.1101/2020.09.29.20203125v1","Verified","Pakistan","Roche Diagnostics",0.988,1.0,"","PK","PK-KP"
"2021-01-19","201120_LosAngeles_TheLundquistInstitute_genpop","COVID-19 IgG/IgM antibody testing in Los Angeles County, California","2020-11-25","Local","United States of America; California","2020-04-21","2020-05-22","Multiple populations","Multiple groups",244.0,0.209,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Khadije Ahmad","The Lundquist Institute","https://dx.doi.org/10.1007/s10096-020-04111-3","Verified","United States of America","Hangzhou Testsea Biotechnology Co.",0.96,1.0,"","US","US-CA"
"2021-01-20","201130_USA_AmericanRedCross_BloodDonors","Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020.","2020-11-30","National","United States of America; Massachusetts, California, Connecticut, Iowa, Michigan, Oregon, Rhode Island, Washington, Wisconsin","2019-12-13","2020-01-17","Blood donors","Multiple groups",7389.0,0.014,"","","Sequential","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sridhar V Basavaraju","American Red Cross","https://dx.doi.org/10.1093/cid/ciaa1785","Verified","United States of America","CDC",0.96,0.993,"","US",""
"2021-01-20","210112_Canada_CBS_BloodDonors_Overall_PopAdjTestAdj","COVID-19 Seroprevalence Report January 12, 2021 Report #4: November 2020 Survey","2021-01-12","National","Canada","2020-11-07","2020-11-25","Blood donors","Multiple groups",17049.0,0.015,0.013,0.017,"Sequential","IgG","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","https://slack-files.com/files-pri-safe/T011KSPAYPR-F01K401T9J9/covid-19_report_november_2020_final_12jan2021-1.pdf?c=1611144789-a5afc223a057856a","Verified","Canada","Abbott",0.927,0.999,"","CA",""
"2021-01-21","200806_Lombardy_BrunoKesslerFoundation","Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020","2020-08-06","Regional","Italy; Lombardy","2020-04-16","2020-05-25","Contacts of COVID patients","Multiple groups",4120.0,0.531,"","","Stratified non-probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Piero Poletti","Bruno Kessler Foundation","http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001383","Verified","Italy","LIAISON®",0.944,0.983,"","IT","IT-25"
"2021-01-21","201022_Oxford_UniversityOfOxford_unadj","SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020.","2020-10-22","Local","United Kingdom of Great Britain and Northern Ireland","2020-04-14","2020-06-15","Pregnant or parturient women","Adults (18-64 years)",1000.0,0.053,0.04,0.069,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Sheila F Lumley","University of Oxford","https://dx.doi.org/10.2807/1560-7917.ES.2020.25.41.2001721","Verified","The United Kingdom","University of Oxford",0.991,0.99,"","GB",""
"2021-01-21","201027_England_ImperialCollegeLondon_SamplingPeriod2_TotalAdj","Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults","2020-10-27","National","United Kingdom of Great Britain and Northern Ireland","2020-07-31","2020-08-13","Household and community samples","Multiple groups",105829.0,0.048,0.047,0.05,"Simplified probability","IgG","Moderate","Preprint","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf","Verified","The United Kingdom","Fortress Diagnostics, Northern Ireland",0.844,0.986,"","GB",""
"2021-01-21","201027_England_ImperialCollegeLondon_SamplingPeriod3_TotalAdj","Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults","2020-10-27","National","United Kingdom of Great Britain and Northern Ireland","2020-09-15","2020-09-28","Household and community samples","Multiple groups",159367.0,0.044,0.042,0.045,"Simplified probability","IgG","Moderate","Preprint","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf","Verified","The United Kingdom","Fortress Diagnostics, Northern Ireland",0.844,0.986,"","GB",""
"2021-01-21","201111_Italy_IstitutoNazionaleTumori_primaryest","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","2019-09-01","2020-03-10","Residual sera","Multiple groups",959.0,0.116,"","","Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","Italy","Mazzini et al",0.857,0.981,"","IT",""
"2021-01-21","201121_LosAngeles_UniversityofCaliforniaLosAngeles_FirstResponders","Incidence of SARS-CoV-2 infection among asymptomatic frontline health workers in Los Angeles County, California","2020-11-21","Local","United States of America; California","2020-05-19","2020-08-31","Essential non-healthcare workers","Multiple groups",679.0,0.081,"","","Unclear","IgG","Moderate","Preprint","Megan Halbrook","University of California Los Angeles","https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1","Verified","United States of America","NR","","","","US","US-CA"
"2021-01-21","201121_LosAngeles_UniversityofCaliforniaLosAngeles_HCW","Incidence of SARS-CoV-2 infection among asymptomatic frontline health workers in Los Angeles County, California","2020-11-21","Local","United States of America; California","2020-04-08","2020-08-31","Health care workers and caregivers","Multiple groups",1108.0,0.039,"","","Unclear","IgG","Moderate","Preprint","Megan Halbrook","University of California Los Angeles","https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1","Verified","United States of America","NR","","","","US","US-CA"
"2021-01-21","201123_OrangeCounty_StJudeMedicalCenter_Overall","Seroprevalence of Novel Coronavirus SARS-CoV-2 at a Community Hospital Emergency Department and Outpatient Laboratory in Northern Orange County, California","2020-11-23","Local","United States of America; California; Fullerton","2020-07-15","2020-07-27","Residual sera","Multiple groups",865.0,0.094,0.08,0.12,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Jason Yamaki","St. Jude Medical Center","https://dx.doi.org/10.1007/s40615-020-00918-0","Verified","United States of America","Abbott Laboratories",1.0,1.0,"","US","US-CA"
"2021-01-21","201127_DistrictofColumbia_DCHealth_Overall","SARS-CoV-2 Seroprevalence among First Responders in the District of Columbia, May – July 2020","2020-11-27","Regional","United States of America; Washington D.C; Washington","2020-05-28","2020-07-15","Essential non-healthcare workers","Adults (18-64 years)",310.0,0.036,"","","Self-referral","IgG","High","Preprint","Jacqueline Reuben","District of Columbia Department of Health (DC Health)","https://www.medrxiv.org/content/10.1101/2020.11.25.20225490v1","Verified","United States of America","DiaSorin Inc.",0.97,"","","US","US-DC"
"2021-01-21","201130_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_S3","Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study","2020-11-30","Local","Germany; Hamburg; Hamburg","2020-06-22","2020-07-17","Health care workers and caregivers","Adults (18-64 years)",1253.0,0.018,0.01,0.025,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Thomas Brehm","University Medical Center Hamburg-Eppendorf","https://dx.doi.org/10.1016/j.ijheh.2020.113671","Verified","Germany","Euroimmun",0.944,0.996,"","DE","DE-HH"
"2021-01-21","201218_Canada_CBS_BloodDonors_Overall_PopTestAdj","COVID-19 Seroprevalence Report December 18, 2020 Report #3: October 2020 Survey","2020-12-18","National","Canada","2020-10-12","2020-10-31","Blood donors","Multiple groups",16811.0,0.009,0.007,0.01,"Sequential","IgG","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified","Canada","Abbott",0.927,0.999,"","CA",""
"2021-01-22","200622_Brooklyn_ColumbiaUniversityMedicalCenter_Overall","COVID-19 Seroconversion in Emergency Professionals at an Urban Academic Emergency Department in New York City.","2020-06-22","Local","United States of America; New York; New York City","2020-02-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",50.0,0.46,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jordan Jeong","Columbia University Medical Center","https://dx.doi.org/10.1016/j.annemergmed.2020.06.038","Verified","United States of America","Abbott Laboratories","","","","US","US-NY"
"2021-01-22","201031_VillaCaldari_IstitutoZooprofilatticoSperimentaleDell’AbruzzoEdelMoliseG.Caporale_Overall","A COVID-19 Hotspot Area: Activities and Epidemiological Findings.","2020-10-31","Local","Italy; Abruzzo; Villa Caldari","2020-04-18","2020-04-19","Household and community samples","Multiple groups",667.0,0.109,0.088,0.135,"Entire sample","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Francesa Cito","Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise G. Caporale","https://dx.doi.org/10.3390/microorganisms8111711","Verified","Italy","Beijing Wantai Biological Pharmacy Enterprise Co., Beijing, China",0.93,1.0,"","IT","IT-65"
"2021-01-22","201117_UK_ImmunisationAndCountermeasuresDivision_ChildrenOfHCW","Secondary attack rate and family clustering of SARS-CoV-2 infection in children of healthcare workers with confirmed COVID-19","2020-11-17","National","United Kingdom of Great Britain and Northern Ireland","2020-05-01","2020-05-31","Contacts of COVID patients","Children and Youth (0-17 years)",44.0,0.362,0.09,0.634,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Shamez Ladhani","Immunisation and Countermeasures Division","https://dx.doi.org/10.1093/cid/ciaa1737","Verified","The United Kingdom","Abbott Commerce","","","","GB",""
"2021-01-22","201130_SanFrancisco_StanfordUniversity_Overall","Large-Scale Testing of Asymptomatic Healthcare Personnel for Severe Acute Respiratory Syndrome Coronavirus 2","2020-11-30","Local","United States of America; California; San Francisco","2020-04-20","2020-06-08","Health care workers and caregivers","Adults (18-64 years)",12418.0,0.009,0.007,0.011,"Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Catherine Hogan","Stanford University","https://dx.doi.org/10.3201/eid2701.203892","Verified","United States of America","Stanford Health Care","",0.998,"","US","US-CA"
"2021-01-22","201210_Atlanta_CDC_Lab_OverallPopTestAdj","Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey","2020-12-10","Local","United States of America; Georgia; Atlanta","2020-04-27","2020-05-01","Residual sera","Multiple groups",1343.0,0.049,0.033,0.066,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","Centers for Disease Control and Prevention","https://dx.doi.org/10.1093/cid/ciaa1804","Verified","United States of America","Centers for Disease Control and Prevention (CDC)",0.96,0.993,"","US","US-GA"
"2021-01-23","200826_London_ImperialCollegeLondon_LTC","High rates of SARS-CoV-2 seropositivity in nursing home residents","2020-08-26","Local","United Kingdom of Great Britain and Northern Ireland; Greater London; London","2020-06-01","2020-06-30","Assisted living and long-term care facilities","Seniors (65+ years)",241.0,0.718,0.66,0.77,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Neil Graham","Imperial College London","https://www.journalofinfection.com/article/S0163-4453(20)30574-0/fulltext","Verified","The United Kingdom","Abbott",0.939,1.0,"","GB","GB-ENG"
"2021-01-23","200904_England_PHE_BloodDonors_Overall_TestPopAdj_Week31to35","PHE England week 37","2020-09-11","National","United Kingdom of Great Britain and Northern Ireland; England","2020-07-27","2020-08-30","Blood donors","Multiple groups",8764.0,0.053,0.048,0.058,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.83,0.993,"","GB","GB-ENG"
"2021-01-23","200911_England_PHE_WhatsTheStory_Summary_5_May_August","PHE England week 37","2020-09-11","National","United Kingdom of Great Britain and Northern Ireland; England","2020-05-01","2020-08-05","Household and community samples","Children and Youth (0-17 years)",568.0,0.052,0.032,0.078,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","Abbott",0.957,0.991,"","GB","GB-ENG"
"2021-01-23","201002_England_PHE_BloodDonors_Summary_Final","PHE England week 40","2020-10-02","National","United Kingdom of Great Britain and Northern Ireland; England","2020-08-24","2020-09-18","Blood donors","Multiple groups",8230.0,0.061,0.054,0.068,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","EUROIMMUN",0.83,0.993,"","GB","GB-ENG"
"2021-01-23","201002_England_PHE_RCGP_Collection_Summary_Final_week25to33_abbott","PHE England week 40","2020-10-02","National","United Kingdom of Great Britain and Northern Ireland; England","2020-06-15","2020-08-16","Residual sera","Seniors (65+ years)",4315.0,0.065,0.055,0.076,"Stratified probability","IgG","Moderate","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","Abbott",0.957,0.991,"","GB","GB-ENG"
"2021-01-23","201002_England_PHE_SeroepiUnitPaedsSurvey_6_Final_week25to33_Abbott","PHE England week 40","2020-10-02","National","United Kingdom of Great Britain and Northern Ireland; England","2020-06-15","2020-08-16","Residual sera","Multiple groups",1212.0,0.052,0.039,0.07,"Stratified probability","IgG","Low","Institutional Report","Public Health England","Public Health England","https://www.gov.uk/government/publications/national-covid-19-surveillance-reports","Verified","The United Kingdom","Abbott",0.957,0.991,"","GB","GB-ENG"
"2021-01-23","201023_Egypt_AinShamsUniversity_Overall","Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers.","2020-10-23","Local","Egypt; Cairo Governorate; Cairo","2020-04-22","2020-05-14","Health care workers and caregivers","Multiple groups",4040.0,0.013,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Aya Mostafa","Ain Shams University","https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyaa173/5936053","Verified","Egypt","Artron Laboratories",0.833,1.0,"","EG","EG-C"
"2021-01-23","201023_Wuhan_HuazhongUniversityofScienceandTechnology_Overall_unadj","Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China","2020-10-23","Local","China; Hubei; Wuhan","2020-03-27","2020-05-26","Household and community samples","Multiple groups",35040.0,0.039,0.037,0.041,"Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Anding Liu","Huazhong University of Science and Technology","https://dx.doi.org/10.1001/jamanetworkopen.2020.25717","Verified","China","Bioscience, Tianjin, China","","","","CN","CN-42"
"2021-01-23","201027_Aarhus_AarhusDepartmentofPublicHealth_IgGorIgM","First wave of COVID-19 did not reach the homeless population in Aarhus.","2020-11-20","Local","Denmark; Central Denmark Region; Aarhus","2020-06-01","2020-06-04","Persons experiencing homelessness","Adults (18-64 years)",129.0,0.047,0.021,0.098,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Signe Storgaard","Aarhus Department of Public Health","https://pubmed.ncbi.nlm.nih.gov/33269697/#:~:text=Conclusions%3A%20Despite%20their%20vulnerable%20profile,funded%20by%20Aarhus%20University%20Hospital.","Verified","Denmark","NR",0.989,0.976,"","DK","DK-82"
"2021-01-23","201030_Colombia_UniversidadIndustrialdeSantander_primary","Performance of rapid IgM-IgG combined antibody tests in the occupational surveillance of COVID-19 in Colombian enterprises.","2020-10-30","National","Colombia","2020-04-17","2020-07-14","Essential non-healthcare workers","Multiple groups",4234.0,0.04,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alvaro J Idrovo","Universidad Industrial de Santander","https://dx.doi.org/10.7705/biomedica.5829","Verified","Colombia","NR","","","","CO",""
"2021-01-23","201103_London_PHE_LTCStaff","Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic","2020-11-03","Local","United Kingdom of Great Britain and Northern Ireland; Greater London; London","2020-06-03","2020-06-30","Health care workers and caregivers","Multiple groups",327.0,0.471,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Thomas Rowland","Public Health England","https://dx.doi.org/10.1016/j.jinf.2020.10.035","Verified","The United Kingdom","Abbott",0.939,1.0,"","GB","GB-ENG"
"2021-01-23","201103_Vaud_UniversityofLausanne_CloseContacts2_Roche","Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies","2020-11-03","Regional","Switzerland; Vaud","2020-05-04","2020-06-27","Contacts of COVID patients","Multiple groups",177.0,0.322,"","","Unclear","Total Antibody","High","Journal Article (Peer-Reviewed)","Craig Fenwick","Lausanne University Hospital and University of Lausanne","http://dx.doi.org/10.1128/JVI.01828-20","Verified","Switzerland","Roche",0.93,1.0,"","CH","CH-VD"
"2021-01-23","201103_Vaud_UniversityofLausanne_GenPop1_Roche","Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies","2020-11-03","Regional","Switzerland; Vaud","2020-05-04","2020-06-27","Household and community samples","Multiple groups",311.0,0.039,"","","Simplified probability","Total Antibody","High","Journal Article (Peer-Reviewed)","Craig Fenwick","Lausanne University Hospital and University of Lausanne","http://dx.doi.org/10.1128/JVI.01828-20","Verified","Switzerland","Roche",0.93,1.0,"","CH","CH-VD"
"2021-01-23","201104_Paris_CochinAPHP_HCW","Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries.","2020-11-04","Local","France; Île-de-France; Paris","2020-05-14","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",4607.0,0.115,0.106,0.124,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Chantal Delmas","Cochin APHP","https://dx.doi.org/10.1017/ice.2020.1309","Verified","France","Abbott Laboratories","","","","FR","FR-IDF"
"2021-01-23","201109_Milan_UniversitadegliStudidiMilano_patients_antiN_S","Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy","2020-11-20","Local","Italy; Lombardy ; Milan","2020-05-11","2020-07-05","Residual sera","Multiple groups",2753.0,0.033,"","","Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Valeria Cento","Universita degli Studi di Milano","http://dx.doi.org/10.1371/journal.pone.0242765","Verified","Italy","Abbott, Abbott Park, Illinois, US; DiaSorin S.p.A., Saluggia, Italy","","","","IT","IT-25"
"2021-01-23","201109_UK_WatfordGeneralHospital_ACU","Prevalence of COVID-19 Among Typical Ambulatory Care Patients in a District General Hospital in the United Kingdom.","2020-11-09","Local","United Kingdom of Great Britain and Northern Ireland; NR; Watford","2020-03-27","2020-06-08","Residual sera","Multiple groups",443.0,0.016,"","","Sequential","Not reported","High","Journal Article (Peer-Reviewed)","Muhammad Arif","Watford General Hospital","https://dx.doi.org/10.7759/cureus.11398","Verified","The United Kingdom","NR","","","","GB",""
"2021-01-23","201110_Tehran_TehranUniversityofMedicalSciences_unadj","Antibody Rapid Test Results in Emergency Medical Services Personnel during COVID-19 Pandemic; a Cross Sectional study.","2020-11-10","Local","Iran (Islamic Republic of); Tehran; Tehran","2020-03-20","2020-05-20","Essential non-healthcare workers","Adults (18-64 years)",243.0,0.416,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Peyman Saberian","Tehran University of Medical Sciences","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720855/","Verified","Iran (Islamic Republic of)","KarmaAzmaAndish Co.",0.711,0.587,"","IR","IR-07"
"2021-01-23","201112_Barcelona_UniversityHospitalSantJoandeDeu_HHC_primaryest","Susceptibility to Sars-COV-2 Infection Among Children And Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain","2020-11-12","Local","Spain; Catalonia; Barcelona","2020-04-28","2020-06-03","Contacts of COVID patients","Multiple groups",1084.0,0.18,"","","Convenience","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Pedro Brotons","University Hospital Sant Joan de Deu","https://dx.doi.org/10.1093/cid/ciaa1721","Verified","Spain","Innovita Tangshan Biological Technology Co",0.833,"","","ES","ES-CT"
"2021-01-23","201112_Prague_CharlesUniversityandThomayer'sHospital_Roche","Searching for COVID-19 Antibodies in Czech Children-A Needle in the Haystack","2020-11-12","Local","Czechia; Prague; Prague","2020-07-03","2020-08-19","Residual sera","Children and Youth (0-17 years)",200.0,0.0,0.0,0.005,"Sequential","Total Antibody","High","Journal Article (Peer-Reviewed)","Marketa Bloomfield","Charles University and Thomayer’s Hospital","http://dx.doi.org/10.3389/fped.2020.597736","Verified","Czechia","Roche Diagnostics",0.995,0.998,"","CZ","CZ-PR"
"2021-01-23","201113_SaoPaulo_UniversidadeSaoPaulo_primary","Prevalence of anti-SARS-CoV-2 antibodies in outpatients of a large public university hospital in Sao Paulo, Brazil","2020-11-13","Local","Brazil; State of Sao Paulo; Sao Paulo","2020-06-30","2020-08-04","Residual sera","Multiple groups",439.0,0.139,"","","Convenience","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Luanda Mara da Silva Oliveira","Universidade de São Paulo","https://dx.doi.org/10.1590/S1678-9946202062091","Verified","Brazil","DiaSorin S.p.A., Roche Diagnostics","","","","BR","BR-SP"
"2021-01-23","201118_HoChiMinhCity_OxfordUniversityClinicalResearchUnit_overall","Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.","2020-11-18","Local","Viet Nam; Đông Nam Bộ; Ho Chi Minh City","2020-08-23","2020-08-30","Health care workers and caregivers","Adults (18-64 years)",408.0,0.0,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Nguyen Van Vinh Chau","Oxford University Clinical Research Unit","https://dx.doi.org/10.1016/j.jinf.2020.11.018","Verified","Viet Nam","Roche Diagnostics",0.972,0.998,"","VN",""
"2021-01-23","201119_Italy_UniversityofCagliari_Milano1_IBDPatients","Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy","2020-11-19","Local","Italy","2020-04-15","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",354.0,0.023,0.008,0.038,"Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Roberto Berte","University of Cagliari","https://dx.doi.org/10.1093/ecco-jcc/jjaa237","Verified","Italy","University of Cagliari",0.976,0.952,"","IT",""
"2021-01-23","201119_Italy_UniversityofCagliari_MilanoGenPop3_GenPop","Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy","2020-11-19","Local","Italy; Lombardy; Milan","2020-04-15","2020-06-15","Household and community samples","Multiple groups",129.0,0.07,0.044,0.096,"Sequential","IgG; IgA","High","Journal Article (Peer-Reviewed)","Roberto Berte","University of Cagliari","https://dx.doi.org/10.1093/ecco-jcc/jjaa237","Verified","Italy","University of Cagliari",0.976,0.952,"","IT","IT-25"
"2021-01-23","201119_SaoPaulo_ClínicaDeReumatologia_RheumaticPatients","Seroconversion for SARS-CoV-2 in rheumatic patients on synthetic and biologics Disease Modifying Anti-Rheumatic Drugs in Sao Paulo, Brazil","2020-11-19","Local","Brazil; State of Sao Paulo; São Paulo","2020-03-15","2020-08-15","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",100.0,0.21,"","","Convenience","IgG; IgM","High","Preprint","Felipe Santana","Clínica de Reumatologia","https://www.researchsquare.com/article/rs-97191/v1","Verified","Brazil","Snibe Diagnostics","","","","BR","BR-SP"
"2021-01-23","201119_UK_QueensUniversityBelfast_adj","Kinetics and seroprevalence of SARS-CoV-2 antibodies in children","2020-11-19","National","United Kingdom of Great Britain and Northern Ireland","2020-06-26","2020-08-15","Family of essential workers","Children and Youth (0-17 years)",849.0,0.077,0.06,0.096,"Convenience","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Cathal Roarty","Queens University Belfast","https://dx.doi.org/10.1016/S1473-3099(20)30884-7","Verified","The United Kingdom","Roche, Basel, Switzerland; DiaSorin, Saluggia, Italy","","","","GB",""
"2021-01-23","201119_USA_QuestDiagnostics_Overall","Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March-July 2020","2020-11-19","National","United States of America","2020-04-21","2020-07-10","Household and community samples","Multiple groups",2402282.0,0.118,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Harvey W Kaufman","Quest Diagnostics","http://dx.doi.org/10.1089/pop.2020.0256","Verified","United States of America","Abbott Laboratories, Ortho-Clinical Diagnostics, EUROIMMUN","","","","US",""
"2021-01-23","201120_SaudiArabia_SaudiCDC_Overall","Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.","2020-11-20","National","Saudi Arabia; Hail, Najran, Baha, Qassim, Norther Border, Jazan, Riyadh, Emirate of the Eastern Province, Aseer, Madinah, Makkah","2020-05-20","2020-05-30","Health care workers and caregivers","Adults (18-64 years)",12621.0,0.024,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Haleema Ali Alserehi","Saudi Center for Disease Prevention and Control","https://dx.doi.org/10.1016/j.diagmicrobio.2020.115273","Verified","Saudi Arabia","Abbott Laboratories","","","","SA",""
"2021-01-23","201124_Qatar_MinistryofPublicHealth_Overall_popadj","Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar","2020-11-24","National","Qatar","2020-07-26","2020-09-09","Non-essential workers and unemployed persons","Multiple groups",2641.0,0.553,0.533,0.573,"Stratified probability","Total Antibody","Moderate","Preprint","Mohamed H Al Thani","Ministry of Public Health","https://www.medrxiv.org/content/10.1101/2020.11.24.20237719v1","Verified","Qatar","Roche, Switzerland",0.95,0.998,"","QA",""
"2021-01-23","201125_Valencia_HospitalArnauDeVilanova_Overall","Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population","2020-11-25","Local","Spain; Valencia; Valencia","2020-05-02","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",166.0,0.018,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Javier Garde Noguera","Hospital Arnau de Vilanova de Valencia, Spain","https://dx.doi.org/10.3390/cancers12123513","Verified","Spain","DiaSorin","","","","ES","ES-VC"
"2021-01-23","201127_Trento_AziendaProvincialeperiServiziSanitari_OverallAdj","Prevalence of SARS-CoV-2 IgG antibodies in an area of North-eastern Italy with a high incidence of COVID-19 cases: a population-based study.","2020-11-27","Regional","Italy; Trento","2020-05-05","2020-05-15","Household and community samples","Multiple groups",6075.0,0.257,"","","Convenience","IgG","Low","Journal Article (Peer-Reviewed)","Paola Stefanelli","Azienda Provinciale per i Servizi Sanitari","https://dx.doi.org/10.1016/j.cmi.2020.11.013","Verified","Italy","Abbott Laboratories",0.9,1.0,"","IT","IT-32"
"2021-01-23","201130_DrDYPatilMedicalCollege_Pimpri-Chinchwad_DashboardPrimary","SARS-CoV-2 Seroprevalence Study in Pimpri-Chinchwad, Maharashtra, India Coinciding with Falling Trend‚ Do the Results Suggest Imminent Herd Immunity?","2020-11-30","Local","India; Maharashtra; Pune","2020-10-07","2020-10-17","Household and community samples","Multiple groups",5000.0,0.34,0.313,0.368,"Stratified probability","IgG","Moderate","Preprint","Amitav Banerjee","Dr DY Patil Medical College","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3729394","Verified","India","Abbott Chicago, IL, USA.",0.927,0.999,"","IN","IN-MH"
"2021-01-23","201130_Spain_UniversityofZaragoza_unadj","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery","2020-11-30","Local","Spain","2020-03-31","2020-08-31","Pregnant or parturient women","Adults (18-64 years)",260.0,0.069,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ricardo Saviron Cornudella","University of Zaragoza","https://dx.doi.org/10.1016/j.ejogrb.2020.11.069","Verified","Spain","Biozek, Abbott, Vircell","","","","ES",""
"2021-01-23","201130_Strasbourg_StrasbourgUniversityHospital_Abbott","Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France","2020-11-30","Local","France; Grand-Est ; Strasbourg","2020-05-07","2020-06-26","Contacts of COVID patients","Adults (18-64 years)",11.0,0.0,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Floriane Gallais","Strasbourg University Hospital","https://dx.doi.org/10.3201/eid2701.203611","Verified","France","Abbott Laboratories",1.0,1.0,"","FR","FR-GES"
"2021-01-23","201205_Kuwait_KuwaitUniversity_Overall_unadj","Seroprevalence of SARS-CoV-2 in migrant workers in Kuwait","2020-12-05","National","Kuwait","2020-05-23","2020-06-26","Essential non-healthcare workers","Adults (18-64 years)",525.0,0.381,0.34,0.423,"Stratified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Walid Q Alali","University of Kuwait","https://dx.doi.org/10.1093/jtm/taaa223","Verified","Kuwait","Biozek Medical, Netherlands",0.66,0.97,"","KW",""
"2021-01-23","201210_ Paris_UniversitéParis-Saclay","SARS-COV-2 IgG antibody response in pregnant women at delivery","2020-12-10","Local","France; Île-de-France; Paris","2020-04-29","2020-06-26","Pregnant or parturient women","Adults (18-64 years)",529.0,0.047,0.03,0.067,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Vassilis Tsatsarisa","Université Paris-Saclay","https://dx.doi.org/10.1016/j.jogoh.2020.102041","Verified","France","Abbott",0.927,0.99,"","FR","FR-IDF"
"2021-01-23","201213_SaoPaulo_ FaculdadeDeMedicinaDaUniversidade_Overall","SARS-CoV-2 seroprevalence and risk factors among oligo/asymptomatic healthcare workers(HCW): estimating the impact of community transmission","2020-12-13","Local","Brazil; São Paulo State; São Paulo","2020-05-14","2020-05-28","Health care workers and caregivers","Adults (18-64 years)",4987.0,0.141,0.131,0.15,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Silvia Costa","Faculdade De Medicina da Universidade","https://dx.doi.org/10.1093/cid/ciaa1845","Verified","Brazil","Wondfo-China","","","","BR","BR-SP"
"2021-01-23","201214_VirginaUSA_VirginiaCommonwealthUniversity_Overall","COVID-19 seroprevalence among healthcare workers in a low prevalence region.","2020-12-14","Local","United States of America; Virginia; Richmond","2020-07-27","2020-10-02","Health care workers and caregivers","Multiple groups",1962.0,0.014,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Emily Godbout","Virginia Commonwealth University","https://dx.doi.org/10.1017/ice.2020.1374","Verified","United States of America","Abbott Laboratories","","","","US","US-VA"
"2021-01-23","201215_SanDiego_SharpHealthCare_Overall","Point prevalence survey to evaluate the seropositivity for coronavirus disease 2019 (COVID-19) among high-risk healthcare workers","2020-12-15","Local","United States of America; California; San Diego","2020-05-20","2020-06-08","Health care workers and caregivers","Multiple groups",1770.0,0.022,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Norihiro Yogo","Sharp Healthcare","https://dx.doi.org/10.1017/ice.2020.1370","Verified","United States of America","Roche Diagnostics",1.0,0.998,"","US","US-CA"
"2021-01-23","201218_Lisbon_NovaUniversityofLisbon","Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures","2020-12-18","Local","Portugal; Lisboa Region; Lisbon","2020-06-15","2020-06-30","Non-essential workers and unemployed persons","Multiple groups",1636.0,0.03,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Juliana Goncalves","NOVA University of Lisbon","https://dx.doi.org/10.3389/fmed.2020.603996","Verified","Portugal","NOVA University of Lisbon",0.947,0.995,"","PT","PT-11"
"2021-01-23","201219_Tuscany_UniversityOfFlorence_Overall","SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy)","2020-12-19","Regional","Italy; Prato","2020-05-01","2020-05-31","Multiple populations","Multiple groups",4656.0,0.03,0.025,0.035,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Vieri Lastrucci","University of Florence","https://dx.doi.org/10.3390/vaccines8040778","Verified","Italy","Hangzhou Laihe Biotech Co., Ltd, Hangzhou China",1.0,0.988,"","IT","IT-52"
"2021-01-23","201221_Guilan_TehranUniversityofMedicalSciences_overall","Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020","2020-12-21","Regional","Iran (Islamic Republic of); Guilan","2020-04-11","2020-04-19","Household and community samples","Multiple groups",528.0,0.222,0.164,0.285,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Maryam Shakiba","Tehran University of Medical Sciences","https://dx.doi.org/10.3201/eid2702.201960","Verified","Iran (Islamic Republic of)","VivaChek",0.833,0.99,"","IR","IR-19"
"2021-01-23","201222_Rome_EleemosynariaApostolica_overall","Assessment of SARS-CoV-2 infection through rapid serology testing in the homeless population in the City of Rome, Italy. Preliminary results","2020-12-22","Local","Italy; Lazio; Rome","2020-04-14","2020-07-31","Multiple populations","Multiple groups",173.0,0.018,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Massimo Ralli","Eleemosynaria Apostolica","https://dx.doi.org/10.4081/jphr.2020.1986","Verified","Italy","Inzek B.V",0.96,0.96,"","IT","IT-62"
"2021-01-23","201222_Vienna_MedicalUniversityofVienna_overall","A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms","2020-12-22","Local","Austria; Vienna; Vienna","2020-04-02","2020-04-17","Non-essential workers and unemployed persons","Adults (18-64 years)",1655.0,0.102,"","","Convenience","IgA; IgG","High","Preprint","Angelika Wagner","Medical University of Vienna","https://www.medrxiv.org/content/10.1101/2020.12.22.20248604v1","Verified","Austria","Euroimmun Medizinische Labordiagnostika","","","","AT","AT-9"
"2021-01-23","201223_Oxford_OxfordUniversityHospitals_HCW_Spike","Antibody status and incidence of SARS-CoV-2 infection in health care workers","2020-12-23","Local","United Kingdom of Great Britain and Northern Ireland","2020-04-23","2020-11-30","Health care workers and caregivers","Multiple groups",12541.0,0.101,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Sheila Lumley","Oxford University Hospitals","https://dx.doi.org/10.1056/NEJMoa2034545","Verified","The United Kingdom","University of Oxford",0.991,0.99,"","GB",""
"2021-01-23","210101_Seattle_SeattleChildren'sResearchInstitute_FollowUp_Overall","Prevalence of health care and hospital worker SARS-CoV-2 IgG antibody in a pediatric hospital","2021-01-01","Local","United States of America; Washington ; Seattle","2020-07-06","2020-08-07","Health care workers and caregivers","Adults (18-64 years)",481.0,0.01,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Yekaterina Tokareva","Seattle Childrens Research Institute","https://dx.doi.org/10.1542/hpeds.2020-003517","Verified","United States of America","Abbott Laboratories",1.0,"","","US","US-WA"
"2021-01-23","210103_Munich_LudwigMaximillianUniversityofMunich_Overall","Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany","2021-01-03","Local","Germany","2020-03-24","2020-07-07","Health care workers and caregivers","Adults (18-64 years)",300.0,0.047,"","","Convenience","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Tobias Weinberger","Ludwig Maximillian University of Munich","https://dx.doi.org/10.1093/cid/ciaa1935","Verified","Germany","1. EuroImmun; 2. Roche; 3.DiaSorin; 4.Abbott","","","","DE",""
"2021-01-23","210104_Romania_CarolDavilaUniversityofMedicineAndPharmacy_Overall_adj","Serological Testing for COVID-19 in the Fertility Setting: The Lockdown Impact and Subsequent Dynamics Reflected in the Seroprevalence of Sars-Cov-2 Antibodies","2021-01-04","Local","Romania","2020-05-17","2020-12-01","Multiple populations","Adults (18-64 years)",546.0,0.06,"","","Convenience","IgG; IgM","High","Preprint","Corina Manolea","Carol Davila University of Medicine and Pharmacy","https://www.preprints.org/manuscript/202101.0024/v1","Verified","Romania","LIAISON",0.907,0.986,"","RO",""
"2021-01-23","210115_Cairo_CairoUniversity","SARS-CoV-2 infection among asymptomatic healthcare workers of the emergency department in a tertiary care facility","2021-01-15","Local","Egypt","2020-06-01","2020-06-14","Health care workers and caregivers","Adults (18-64 years)",203.0,0.182,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Reham Abdelmoniem","Cairo University","https://dx.doi.org/10.1016/j.jcv.2020.104710","Verified","Egypt","Artron Laboratories, Burnaby, Canada",0.934,0.977,"","EG",""
"2021-01-23","210205_IledeFrance_Epicentre_Shelters","Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study","2021-02-05","Local","France; Ile de France; Paris","2020-06-23","2020-07-02","Persons experiencing homelessness","Multiple groups",818.0,0.52,"","","Convenience","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Thomas Roederer","Médecins sans Frontières (Epicentre)","https://www.thelancet.com/action/showPdf?pii=S2468-2667%2821%2900001-3","Verified","France","N/A - Author Designed","","","","FR","FR-IDF"
"2021-01-24","201128_Netherlands_CentreforInfectiousDiseaseControl_LowVaccineCoverage_overall","Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave","2020-11-28","National","Netherlands","2020-03-31","2020-05-11","Household and community samples","Multiple groups",570.0,0.029,0.014,0.063,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Eric Vos","Centre for Infectious Disease Control","https://dx.doi.org/10.1136/jech-2020-215678","Verified","Netherlands","NR",0.844,0.99,"","NL",""
"2021-01-24","201128_Netherlands_CentreforInfectiousDiseaseControl_genpop_overall","Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave","2020-11-28","National","Netherlands","2020-03-31","2020-05-11","Household and community samples","Multiple groups",2637.0,0.028,0.021,0.037,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Eric Vos","Centre for Infectious Disease Control","https://dx.doi.org/10.1136/jech-2020-215678","Verified","Netherlands","NR",0.844,0.99,"","NL",""
"2021-01-25","201201_BuenosAires_HospitalGeneraldeNiñosPedrodeElizalde_overall","Seroprevalence of SARS-CoV-2 antibodies among physicians from a children's hospital","2020-12-01","Local","Argentina; Province of Buenos Aires; Autonomous City of Buenos Aires","2020-06-08","2020-06-09","Health care workers and caregivers","Adults (18-64 years)",116.0,0.009,0.001,0.055,"Simplified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Claudia Insua","Hospital General de Niños Pedro de Elizalde","https://dx.doi.org/10.5546/aap.2020.eng.381","Verified","Argentina","Snibe (Shenzen New Industries)",0.956,0.96,"","AR","AR-B"
"2021-01-25","201212_Bavaria_UniversityofRegensburg_overall","Coronavirus antibody screening identifies children with mild to moderate courses of PMIS","2020-12-12","Regional","Germany; Bavaria","2020-05-22","2020-07-22","Household and community samples","Children and Youth (0-17 years)",2832.0,0.057,"","","Convenience","IgA; IgG; IgM","Moderate","Preprint","Otto Laub","University of Regensburg","https://www.authorea.com/users/382535/articles/498454-coronavirus-antibody-screening-identifies-children-with-mild-to-moderate-courses-of-pmis","Verified","Germany","1. Roche Diagnostics","","","","DE","DE-BY"
"2021-01-27","201026_Zaragoza_HospitalSanJuandeDios_HCW_primary","[Prevalence of SARS-CoV-2 coronavirus infection in patients and professional staff at a medium or long-stay hospital in Spain]","2020-11-13","Local","Spain; Aragon; Zaragoza","2020-03-20","2020-04-21","Health care workers and caregivers","Adults (18-64 years)",289.0,0.059,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luis Antonio Moreno Borraz","Hospital San Juan de Dios","https://dx.doi.org/10.1016/j.regg.2020.10.005","Verified","Spain","Master Labor S.L., Madrid",1.0,0.98,"","ES","ES-AR"
"2021-01-27","201026_Zaragoza_HospitalSanJuandeDios_patients_primary","[Prevalence of SARS-CoV-2 coronavirus infection in patients and professional staff at a medium or long-stay hospital in Spain]","2020-11-13","Local","Spain; Aragon; Zaragoza","2020-03-20","2020-04-21","Patients seeking care for non-COVID-19 reasons","Multiple groups",229.0,0.07,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luis Antonio Moreno Borraz","Hospital San Juan de Dios","https://dx.doi.org/10.1016/j.regg.2020.10.005","Verified","Spain","Master Labor S.L., Madrid",1.0,0.98,"","ES","ES-AR"
"2021-01-27","201111_NeustadtAmRennsteig_FriedrichSchillerUniversity_Overall","Antibody response using six different serological assays in a completely PCR-tested community after a COVID-19 outbreak - The CoNAN study.","2020-11-19","Local","Germany; Thuringia","2020-05-13","2020-05-16","Household and community samples","Multiple groups",620.0,0.084,"","","Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Sebastian Weis","Friedrich Schiller University","https://dx.doi.org/10.1016/j.cmi.2020.11.009","Verified","Germany","Epitope Diagnostics Inc., San Diego, USA; Euroimmun, Lübeck, Germany; DiaSorin, Saluggia, Italy; Snibe Co., Ltd., Shenzhen, China; Abbott, Chicago, USA; Roche, Basel Switzerland","","","","DE","DE-TH"
"2021-01-27","201203_Tirschenreuth_MunichClinic_HCW_Overall","[SARS-CoV-2 antibodies in ICU and clinic staff : From Germany's region with the highest infection rate]","2020-12-03","Local","Germany; Bavaria; Tirschenreuth, Wieden","2020-06-29","2020-07-29","Health care workers and caregivers","Adults (18-64 years)",1838.0,0.151,"","","Convenience","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","T Finkenzeller","Munich Clinic","https://dx.doi.org/10.1007/s00063-020-00761-5","Verified","Germany","Roche Diagnostics",0.995,0.998,"","DE","DE-BY"
"2021-01-27","201203_Tirschenreuth_MunichClinic_NMU_Overall","[SARS-CoV-2 antibodies in ICU and clinic staff : From Germany's region with the highest infection rate]","2020-12-03","Local","Germany; Bavaria; Tirschenreuth, Wieden","2020-06-29","2020-07-29","Essential non-healthcare workers","Adults (18-64 years)",986.0,0.037,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","T Finkenzeller","Munich Clinic","https://dx.doi.org/10.1007/s00063-020-00761-5","Verified","Germany","Roche DIagnostics",0.995,0.998,"","DE","DE-BY"
"2021-01-27","201206_Tehran_HighInstituteforResearchandEducationinTransfusionMedicine","Prevalence of SARS-CoV-2 Specific Antibodies in the Staff of a Children's Hospital, in Tehran, Iran","2020-12-06","Local","Iran (Islamic Republic of); Tehran; Tehran","2020-04-20","2020-05-05","Health care workers and caregivers","Adults (18-64 years)",475.0,0.294,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shahnaz Armin","High Institute for Research and Education in Transfusion Medicine","https://sites.kowsarpub.com/jjm/articles/108592.html","Verified","Iran (Islamic Republic of)","Hangzhou AllTest Biotech Co.",0.999,0.98,"","IR","IR-07"
"2021-01-27","201207_Massachusetts_MassachusettsGeneralHospital_Cohabitants","Low prevalence of SARS-COV-2 antibodies in people with multiple sclerosis residing in massachusetts","2020-12-07","Local","United States of America; Massachusetts; Boston","2020-05-29","2020-07-23","Multiple populations","Multiple groups",143.0,0.063,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","E Klawiter","Massachusetts General Hospital","https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1","Verified","United States of America","Massachusetts General Hospital",0.997,1.0,"","US","US-MA"
"2021-01-27","201207_Massachusetts_MassachusettsGeneralHospital_MS","Low prevalence of SARS-COV-2 antibodies in people with multiple sclerosis residing in massachusetts","2020-12-07","Local","United States of America; Massachusetts; Boston","2020-05-29","2020-07-23","Patients seeking care for non-COVID-19 reasons","Multiple groups",227.0,0.035,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","E Klawiter","Massachusetts General Hospital","https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1","Verified","United States of America","Massachusetts General Hospital",0.997,1.0,"","US","US-MA"
"2021-01-27","201215_Leicester_UniversityHospitalsofLeicesterNHSTrust","Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre","2020-12-15","Local","United Kingdom of Great Britain and Northern Ireland; England; Leicester","2020-05-29","2020-08-03","Health care workers and caregivers","Adults (18-64 years)",200.0,0.12,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","John Black","University Hospitals of Leicester NHS Trust","https://dx.doi.org/10.1111/tri.13791","Verified","The United Kingdom","Abbott Laboratories",0.927,1.0,"","GB","GB-ENG"
"2021-01-28","200901_NewYorkCity_NorthwellHealthCOVID-19ResearchConsortium","Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area","2020-08-06","Local","United States of America; New York; New York City","2020-04-20","2020-06-23","Health care workers and caregivers","Multiple groups",40329.0,0.137,"","","Convenience","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Joseph Moscola","Northwell Health COVID-19 Research Consortium","https://pubmed.ncbi.nlm.nih.gov/32780804/","Verified","United States of America","Euroimmun, AnshLabs, Abbott Laboratories, Ortho Clinical Diagnostics, DiaSorin, Roche","","","","US","US-NY"
"2021-01-28","201203_AraphoeCounty_UniversityofColorado","Risk Factors of SARS-CoV-2 Antibodies in Arapahoe County First Responders - the COVID-19 Arapahoe SErosurveillance Study (CASES) Project.","2020-12-03","Local","United States of America; Colorado","2020-07-15","2020-08-15","Essential non-healthcare workers","Adults (18-64 years)",264.0,0.04,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Katherine Sabourin","University of Colorado","https://pubmed.ncbi.nlm.nih.gov/33298759/","Verified","United States of America","Exsera BioLabs",0.85,0.986,"","US","US-CO"
"2021-01-28","201209_Liechtenstein_KantonsspitalGraubunden_Overall","Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study.","2020-12-09","National","Liechtenstein","2020-06-02","2020-10-06","Multiple populations","Multiple groups",1159.0,0.078,0.064,0.095,"Convenience","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Anna Schaffner","Kantonsspital Graunbunden","https://dx.doi.org/10.3390/jcm9123989","Verified","Liechtenstein","Roche Diagnostics, Rotkreuz, Switzerland; Abbott Diagnostics Baar, Switzerland; Diasorin; Euroimmun","","","","LI",""
"2021-01-28","201225_Wuhan_RenminHopsitalofWuhanUniversity_HCW","Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China.","2020-12-25","Local","China; Hubei; Wuhan","2020-05-15","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",4614.0,0.033,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Lu He","Renmin Hospital of Wuhan University","https://dx.doi.org/10.7883/yoken.JJID.2020.691","Verified","China","Livzon Diagnostics Inc.","","","","CN","CN-42"
"2021-01-28","201225_Wuhan_RenminHospitalofWuhanUniversity_Community","Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China.","2020-12-25","Local","China; Hubei; Wuhan","2020-05-15","2020-05-29","Household and community samples","Multiple groups",4454.0,0.029,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Lu He","Renmin Hospital of Wuhan University","https://dx.doi.org/10.7883/yoken.JJID.2020.691","Verified","China","Livzon Diagnostics Inc.","","","","CN","CN-42"
"2021-01-29","201011_Mazowieckie_MedicalUniversityofWarsaw_IgG_Overall","Prevalence of current and past SARS-CoV-2 infections among police employees in Poland, june-july 2020","2020-10-11","Regional","Poland; Mazowieckie Province","2020-06-22","2020-07-08","Essential non-healthcare workers","Multiple groups",5082.0,0.043,0.037,0.049,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Mariusz Gujski","Medical University of Warsaw","http://dx.doi.org/10.3390/jcm9103245","Verified","Poland","Vircell S.L",0.97,0.94,"","PL","PL-14"
"2021-01-29","201014_Alicante_COVID-19GroupoftheInfectionsCommission","Sero-epidemiological study of SARS-CoV-2 infection among healthcare personnel in a healthcare department","2020-10-14","Local","Spain; Alacant; Alicante","2020-04-24","2020-05-08","Health care workers and caregivers","Adults (18-64 years)",4179.0,0.066,0.058,0.073,"Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Paula Gras-Valenti","COVID-19 Group of the Infections Commission","https://dx.doi.org/10.1016/j.eimc.2020.09.015","Verified","Spain","NR","","","","ES","ES-VC"
"2021-01-29","201128_Bergen_UniversityofBergen_primaryest_HCW","SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study.","2020-11-28","Local","Norway; Midhordland; Bergen","2020-03-06","2020-04-09","Health care workers and caregivers","Multiple groups",607.0,0.053,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mai Chi Trieu","University of Bergen","https://dx.doi.org/10.1093/infdis/jiaa737","Verified","Norway","Sigma-Aldrich","","","","NO","NO-12"
"2021-01-29","201130_Sergipe_FederalUniversityofSergipe_residualsera_primary","SARS-CoV-2 has been circulating in northeastern Brazil since February 2019: evidence for antibody detection in asymptomatic patients","2020-11-30","Local","Brazil; Sergipe; Aracaju","2020-01-15","2020-04-15","Residual sera","Multiple groups",987.0,0.016,"","","Sequential","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Ricardo Queiroz Gurgel","Federal University of Sergipe","http://dx.doi.org/10.1016/j.jinf.2020.11.037","Verified","Brazil","Nantong Egens Biotechnology CO, Ltd., China and Bodytech Med Inc.","","","","BR","BR-SE"
"2021-01-29","201230_SanDiego_ScrippsClinic_Overall","Healthcare worker seroconversion for SARS-CoV-2 at two large health systems in San Diego","2020-12-30","Local","United States of America; California; San Diego","2020-04-14","2020-07-28","Health care workers and caregivers","Adults (18-64 years)",11993.0,0.009,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Laura Nicholson","Scripps Clinic","https://dx.doi.org/10.1016/j.ajic.2020.12.017","Verified","United States of America","Diazyme, Abbott Laboratories","","","","US","US-CA"
"2021-01-30","200101_Hamburg_UniversityHospitalsoftheRuhr-UniversityofBochum_Overall","Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital","2020-10-16","Local","Germany; Schleswig-Holstein; Hamburg","2020-04-14","2020-06-16","Health care workers and caregivers","Multiple groups",871.0,0.026,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jonas Herzberg","University Hospitals of the Ruhr‑University of Bochum","http://dx.doi.org/10.1016/j.ijid.2020.10.026","Verified","Germany","Mikrogen Diagnostik, Euroimmun","","","","DE","DE-SH"
"2021-01-30","201109_Kolkata_ApolloGleneaglesHospitalsGastroDept_Overall","COVID-19 prevalence among health-care workers of Gastroenterology department: An audit from a tertiary-care hospital in India","2020-11-09","Local","India; West Bengal; Kolkata","2020-08-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",117.0,0.325,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mahesh Goenka","Apollo Gleneagles Hospitals","http://dx.doi.org/10.1002/jgh3.12447","Verified","India","Ortho Clinical Diagnostics","","","","IN","IN-WB"
"2021-01-30","201201_Verona_InstitutoDiRicoveroECuraACaratterre_Overall","Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020.","2020-12-01","Local","Italy; Veneto; Verona","2020-04-25","2020-05-08","Household and community samples","Multiple groups",1515.0,0.027,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Massimo Guerriero","Instituto di Ricovero e Cura A Caratterre","https://dx.doi.org/10.3201/eid2701.202740","Verified","Italy","Abbott Laboratories","","","","IT","IT-34"
"2021-01-30","201222_Brazzaville_FondationCongolaisePourLaRechercheMédicale_GenPop_Overall","High SARS-COV2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo","2020-12-22","Local","Congo","2020-04-01","2020-07-31","Household and community samples","Adults (18-64 years)",754.0,0.197,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Armel Batchi Bouyou","Fondation Congolaise pour la Recherche Médicale","https://dx.doi.org/10.1016/j.ijid.2020.12.065","Verified","Congo","Wuhan UNniscience Biotechnology, Salofa Oy manufacturer, Finland","","","","CD",""
"2021-01-30","201228_Barcelona_InstitutCatalàdelaSalut_HCW_primary","Seroprevalence of SARS-CoV-2 IgG Specific Antibodies among Healthcare Workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave","2020-12-28","Local","Spain","2020-05-04","2020-05-22","Health care workers and caregivers","Multiple groups",7563.0,0.103,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Jaume Barallat","Institut Català de la Salut","https://dx.doi.org/10.1371/journal.pone.0244348","Verified","Spain","DiaSorin, Vercelli, Italy; Abbott Diagnostics, Sligo, Italy","","","","ES",""
"2021-01-30","210106_EspiritoSanto_SecretariadeEstadodaSaúdedoEspíritoSanto_primary","Covert cases of Severe Acute Respiratory Syndrome Coronavirus 2: An obscure but present danger in regions endemic for Dengue and Chikungunya viruses","2021-01-06","Regional","Brazil; Espírito Santo","2019-12-01","2020-06-30","Representative patient population","Multiple groups",7370.0,0.028,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Lorenzzo Lyrio Stringari","Secretaria de Estado da Saúde do Espírito Santo","https://dx.doi.org/10.1371/journal.pone.0244937","Verified","Brazil","Abbott Laboratories","","","","BR","BR-ES"
"2021-01-31","201126_Naples_UniversityofNaples_HighRisk","Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg","2020-11-26","Local","Italy; Campania; Naples","2020-05-11","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",235.0,0.106,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Nicola Capasso","University of Naples","https://dx.doi.org/10.3390/jcm9124066","Verified","Italy","Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China",0.66,0.966,"","IT","IT-72"
"2021-01-31","201126_Naples_UniversityofNaples_LowRisk","Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg","2020-11-26","Local","Italy; Campania;  Naples","2020-05-11","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",862.0,0.013,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Nicola Capasso","University of Naples","https://dx.doi.org/10.3390/jcm9124066","Verified","Italy","Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China",0.66,0.966,"","IT","IT-72"
"2021-01-31","201126_Naples_UniversityofNaples_MS","Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg","2020-11-26","Local","Italy; Campania; Naples","2020-05-11","2020-06-15","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",310.0,0.029,"","","Sequential","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Nicola Capasso","University of Naples","https://dx.doi.org/10.3390/jcm9124066","Verified","Italy","Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China",0.66,0.966,"","IT","IT-72"
"2021-01-31","201130_Bristol_NorthBristolNHSTrust_hcw","Seroprevalence of SARS-CoV-2 IgG in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis","2020-11-30","Local","United Kingdom of Great Britain and Northern Ireland; England; Bristol, South Gloucestershire, North Somerset","2020-01-15","2020-06-15","Health care workers and caregivers","Multiple groups",6858.0,0.093,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Christopher Jones","North Bristol NHS Trust","https://www.journalofinfection.com/article/S0163-4453(20)30755-6/fulltext","Verified","The United Kingdom","Abbott laboratories; RocheDiagnostics","","","","GB","GB-ENG"
"2021-01-31","201130_Madrid_UniversidadComplutensedeMadrid_primary","Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome","2020-11-30","Local","Spain","2020-02-28","2020-05-10","Pregnant or parturient women","Adults (18-64 years)",769.0,0.112,"","","Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Cecilia Villalaın","The Universidad Complutense de Madrid","https://dx.doi.org/10.1371/journal.pone.0243029","Verified","Spain","NR","","","","ES",""
"2021-01-31","201202_Tenerife_ QuironsaludTenerifeHospital_patients_primary","Pre-Procedural Antibody Testing for SARS-CoV-2 in routine endoscopic practice","2020-12-02","Local","Spain; Canary Islands; Tenerife","2020-04-27","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",211.0,0.019,0.001,0.048,"Sequential","Total Antibody","High","Journal Article (Peer-Reviewed)","Alejandro Hernandez Camba","Quironsalud Tenerife Hospital","https://dx.doi.org/10.17235/reed.2020.7434/2020","Verified","Spain","Roche Diagnostics, Unclear","","","","ES","ES-CN"
"2021-01-31","201203_Edmonton_UniversityofAlberta_Children","Increased Mask Use and Fewer Gatherings Associated with Lower SARS-CoV-2 Seropositivity Among Young School-Age Children","2020-12-03","Local","Canada; Alberta; Edmonton","2020-08-14","2020-10-23","Household and community samples","Children and Youth (0-17 years)",565.0,0.016,"","","Convenience","IgG","High","Preprint","Emilie Manny","University of Alberta","https://poseidon01.ssrn.com/delivery.php?ID=579098091025087124113094013092119126025046084059055038121105001063029013061117127066089088099029120125126127122027092067006090071077064116068026070083111035094021057114045098065076072116064007032059100097072054064094007027094015098095104082088098074069111094090004070124099079094007105068078&EXT=pdf&INDEX=TRUE","Verified","Canada","Abbott Laboratories",0.842,1.0,"","CA","CA-AB"
"2021-01-31","201204_Germany_SaarlandUniversity_overall","Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May-June 2020): implications for a testing protocol in asymptomatic individuals and estimation of the rate of undetected cases","2020-12-04","National","Germany","2020-06-16","2020-06-30","Non-essential workers and unemployed persons","Multiple groups",1007.0,0.021,0.014,0.032,"Self-referral","IgG; Not reported","High","Journal Article (Peer-Reviewed)","Dietrich Mack","Saarland University","https://dx.doi.org/10.1016/j.cmi.2020.11.033","Verified","Germany","EUROimmun, Roche, NR","","","","DE",""
"2021-01-31","201228_Beijing_CapitalMedicalUniversity_IgG","Seroprevalence of SARS-CoV-2 infections among children visiting a hospital","2020-12-28","Local","China","2020-01-01","2020-08-31","Residual sera","Children and Youth (0-17 years)",19797.0,0.001,"","","Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Ran Wang","Capital Medical University","https://dx.doi.org/10.1002/ped4.12231","Verified","China","Beijing Innovita Biological Technology","","","","CN",""
"2021-01-31","210109_GiglioIsland_UniversitàdegliStudidiMilano","The Conundrum of Giglio Island: unraveling the dynamics of an apparent resistance to COVID-19. A descriptive study","2021-01-09","Local","Italy; Tuscany; Giglio Island","2020-04-29","2020-05-03","Household and community samples","Adults (18-64 years)",723.0,0.004,"","","Self-referral","IgG; IgM","High","Preprint","Antonio Bognanni","Università degli Studi di Milano","https://www.medrxiv.org/content/10.1101/2021.01.08.20248948v1","Verified","Italy","Zhejiang Orient Gene Biotech Co Ltd, Huzhou, Zhejiang, China",0.879,1.0,"","IT","IT-52"
"2021-02-01","201207_Kyoto_NationalHospitalOrganizationKyotoMedicalCenter","Quantitative SARS-CoV-2 antibody screening of healthcare workers in the southern part of Kyoto city during the COVID-19 peri-pandemic period","2020-12-07","Local","Japan; Kansai; Kyoto","2020-04-10","2020-04-20","Health care workers and caregivers","Adults (18-64 years)",92.0,0.054,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Kohei Fujita","National Hospital Organization Kyoto Medical Center","https://dx.doi.org/10.3389/fpubh.2020.595348","Verified","Japan","DRG international, Inc.","","","","JP",""
"2021-02-01","201213_Helsinki_UniversityofHelsinki_HCW_unadj","SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: serosurvey, symptoms and risk factors.","2020-12-13","Local","Finland; Uusimaa; Helsinki","2020-04-22","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",1095.0,0.03,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Anu Kantele","University of Helsinki","https://dx.doi.org/10.1016/j.tmaid.2020.101949","Verified","Finland","Euroimmun, Abbott Laboratories, University of Helsinki (In-House)","","","","FI","FI-18"
"2021-02-01","201217_Naples_UniversityofCampania_ELISA","Assessment and Comparison of Two Serological Approaches for the Surveillance of Health Workers Exposed to SARS-CoV-2","2020-12-17","Local","Italy; Campania; Naples","2020-03-27","2020-08-30","Health care workers and caregivers","Adults (18-64 years)",65.0,0.0,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Antonio Russo","University of Campania","https://dx.doi.org/10.2147/IDR.S282652","Verified","Italy","Xiamen",1.0,1.0,"","IT","IT-72"
"2021-02-01","201231_Zagreb_ZagrebUniversity_overall","The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital","2020-12-31","Local","Croatia","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1678.0,0.006,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Ivana Lapic","Zagreb University","https://pubmed.ncbi.nlm.nih.gov/33410294/","Verified","Croatia","Abbott Laboratories",1.0,0.996,"","HR",""
"2021-02-02","201214_Ahmedabad_ MunicipalMedicalCollege_genpop_primary","Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study","2020-12-14","Local","India; Gujarat; Ahmedabad","2020-06-16","2020-07-07","Residual sera","Multiple groups",29891.0,0.176,0.172,0.18,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Om Prakash","Municipal Medical College","https://dx.doi.org/10.1136/bmjopen-2020-044101","Verified","India","Zydus Diagnostics",0.924,0.979,"","IN","IN-GJ"
"2021-02-02","201222_Newcastle_Newcastle-upon-TyneHospitalsNHSTrust","SARS-CoV-2 testing of 11,884 healthcare workers at an acute NHS hospital trust in England: a retrospective analysis","2020-12-22","Local","United Kingdom of Great Britain and Northern Ireland; England ; Newcastle-Upon-Tyne","2020-05-29","2020-07-06","Health care workers and caregivers","Adults (18-64 years)",11103.0,0.084,"","","Convenience","IgG","High","Preprint","Aidan Hanrath","Newcastle-upon-Tyne Hospitals NHS Trust","https://www.medrxiv.org/content/10.1101/2020.12.22.20242362v1","Verified","The United Kingdom","Roche Diagnostics","","","","GB","GB-ENG"
"2021-02-02","201222_Stockholm_KarolinskaUniversityHospital_LTCFstaff_primary","SARS-CoV-2 infections among personnel providing home care services for the elderly in Stockholm, Sweden","2020-12-22","Local","Sweden","2020-05-11","2020-06-17","Assisted living and long-term care facilities","Multiple groups",403.0,0.201,"","","Convenience","IgG","High","Preprint","Sadaf Sakina Hassan","Karolinska University Hospital","https://www.medrxiv.org/content/10.1101/2020.12.18.20248511v1","Verified","Sweden","(Luminex Corp)",0.992,0.998,"","SE",""
"2021-02-02","201223_RafsanjanCounty_UniversityofPecs","A contact tracing prospective cohort retrieving epidemiological facts on SARS-CoV-2 transmission aspects; a serological analysis","2020-12-23","Local","Iran (Islamic Republic of); Kerman","2020-03-01","2020-04-30","Contacts of COVID patients","Multiple groups",238.0,0.156,"","","Sequential","IgG; IgM","High","Preprint","Reza Vazirinejad","University of Pecs","https://europepmc.org/article/ppr/ppr257302#fulltext--permissions-","Verified","Iran (Islamic Republic of)","NR","","","","IR","IR-15"
"2021-02-03","201222_Wisconsin_UniversityofWisconsin_WaveII_overall_popadj","Population Changes in Seroprevalence among a Statewide Sample in the United States","2020-12-22","Regional","United States of America; Wisconsin","2020-10-18","2020-12-14","Household and community samples","Multiple groups",994.0,0.068,0.043,0.094,"Stratified probability","IgG","Moderate","Preprint","Kristen Maleck","University of Wisconsin","https://doi.org/10.1101/2020.12.18.20248479","Verified","United States of America","Abbott","",0.996,"","US","US-WI"
"2021-02-03","201222_Wisconsin_UniversityofWisconsin_WaveI_overall_popadj","Population Changes in Seroprevalence among a Statewide Sample in the United States","2020-12-22","Regional","United States of America; Wisconsin","2020-07-01","2020-08-31","Household and community samples","Multiple groups",996.0,0.016,0.006,0.025,"Stratified probability","IgG","Moderate","Preprint","Kristen Maleck","University of Wisconsin","https://doi.org/10.1101/2020.12.18.20248479","Verified","United States of America","Abbott","",0.996,"","US","US-WI"
"2021-02-03","201223_Bergamo_OspedalePapaGiovanniXXIII_overall","Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.","2020-12-23","Local","Italy; Lombardy; Bergamo","2020-04-01","2020-04-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",560.0,0.31,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alberto Zambelli","Ospedale Papa Giovanni XXIII","https://dx.doi.org/10.1002/onco.13654","Verified","Italy","Moers, Germany",0.921,0.992,"","IT","IT-25"
"2021-02-03","210105_USA_MayoClinic_overall","Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders","2021-01-05","Local","United States of America; Minnesota; Rochester","2020-05-16","2020-05-17","Essential non-healthcare workers","Adults (18-64 years)",255.0,0.012,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Sarayna S McGuire","Mayo Clinic","https://dx.doi.org/10.1017/S1049023X2000151X","Unverified","United States of America","N/A  - Author designed",0.881,0.996,"","US","US-MN"
"2021-02-03","210111_Pavia_University of Pavia_overall","Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients","2021-01-13","Local","Italy","2020-05-04","2020-06-03","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",104.0,0.135,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Giulia Mallucci","University of Pavia","https://doi.org/10.1016/j.msard.2021.102754","Verified","Italy","Roche","","","","IT",""
"2021-02-04","201106_Utah_UniversityofUtah_immunosupressed_primary","Assessing Cytokine Profiles and COVID Serology in Patients on Immunosuppression to Guide Care Recommendations","2020-11-06","Local","United States of America; Utah; Salt Lake City","2020-04-18","2020-05-21","Patients seeking care for non-COVID-19 reasons","Multiple groups",39.0,0.026,"","","Unclear","IgG","High","Preprint","Quinn Pritchett","University of Utah","https://acrabstracts.org/abstract/assessing-cytokine-profiles-and-covid-serology-in-patients-on-immunosuppression-to-guide-care-recommendations/","Verified","United States of America","in house - ARUP","","","","US","US-UT"
"2021-02-04","201126_Kupferzell_RobertKochInstitute_OverallAdj","Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020","2020-11-26","Local","Germany; Baden-Württemberg; Kupferzell","2020-05-20","2020-06-09","Household and community samples","Multiple groups",2203.0,0.12,0.104,0.14,"Simplified probability","IgG","Low","Journal Article (Peer-Reviewed)","Claudia Santos Hovener","Robert Koch Institute","https://dx.doi.org/10.2807/1560-7917.ES.2020.25.47.2001752","Verified","Germany","Euroimmun",0.883,0.992,"","DE","DE-BW"
"2021-02-04","201209_SantaClara_StanfordHealthCare","Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic.","2020-12-09","Local","United States of America; California; San Francisco Bay Area","2020-04-20","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",10449.0,0.013,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Joelle Rosser","Stanford Health Care","https://dx.doi.org/10.1017/ice.2020.1358","Verified","United States of America","Stanford Clinical Laboratory",0.87,0.998,"","US","US-CA"
"2021-02-04","201211_London_RichmondPharmacologyLtd","Why the SARS-CoV-2 antibody test results may be misleading: insights from a longitudinal analysis of COVID-19","2020-12-11","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-03-19","2020-12-02","Multiple populations","Multiple groups",6061.0,0.064,"","","Unclear","IgG","High","Preprint","Jorg Taubel","Richmond Pharmacology Ltd","https://www.medrxiv.org/content/10.1101/2020.12.08.20245894v2","Verified","The United Kingdom","NR","","","","GB","GB-ENG"
"2021-02-04","201223_NewYork_MemorialSloanKetteringCancerCenter","COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City","2020-12-23","Local","United States of America; New York; New York City","2020-05-05","2020-09-10","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",257.0,0.078,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Lauren Jimenez Kurlander","Memorial Sloan Kettering Cancer Center","https://dx.doi.org/10.1002/pbc.28857","Verified","United States of America","Abbott","","","","US","US-NY"
"2021-02-04","210104_Chennai_KanchiKamakotiCHILDSTrustHospital_overall","Seroprevalence to SARS-CoV-2 Among Healthcare Workers in an Exclusive Pediatric Hospital","2021-01-04","Local","India; Tamil Nadu; Chennai","2020-07-30","2020-08-07","Health care workers and caregivers","Adults (18-64 years)",95.0,0.168,"","","Convenience","IgG","High","Preprint","Manoj Madhusudan","Kanchi Kamakoti CHILDS Trust Hospital,","https://pubmed.ncbi.nlm.nih.gov/33408287/","Unverified","India","Shenzhen YHLO Biotech Co","","","","IN","IN-TN"
"2021-02-04","210111_Michigan_ UniversityofMichigan_overall","Seroprevalence of SARS-CoV-2 antibodies by risk of exposure in a community health system","2021-01-11","Local","United States of America; Michigan","2020-08-17","2020-09-04","Health care workers and caregivers","Adults (18-64 years)",1385.0,0.019,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jeffrey J Fletcher","Metro Health University of Michigan Health","http://dx.doi.org/10.1017/ice.2020.1438","Unverified","United States of America","Siemens, Eagle Bioscience","","","","US","US-MI"
"2021-02-04","210114_Fuenlabrada_HospitalUniversitariodeFuenlabrada_HCW_IgG","Impact of SARS-CoV-2 pandemic among health care workers in a secondary teaching hospital in Spain.","2021-01-14","Local","Spain","2020-04-14","2020-05-13","Health care workers and caregivers","Adults (18-64 years)",2439.0,0.169,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Javier Fernandez","Hospital Universitario de Fuenlabrada","https://dx.doi.org/10.1371/journal.pone.0245001","Verified","Spain","Snibe diagnostic",1.0,"","","ES",""
"2021-02-04","210119_NewJersey_CooperUniversityHospital_overall","COVID-19 Serologic Testing Among the Highest Risk Healthcare Workers","2021-01-19","Local","United States of America; New Jersey","2020-06-10","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",172.0,0.052,0.024,0.097,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Snehal Gandhi","Cooper University Hospital","https://dx.doi.org/10.1007/s11606-020-06462-1","Unverified","United States of America","1) Roche 2) EUROIMMUN","","","","US","US-NJ"
"2021-02-04","210624_NuevoLeon_AutonomousUniversityofNuevoLeon_primary","Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation.","2021-06-24","Regional","Mexico; Nuevo Leon","2020-01-01","2020-12-15","Blood donors","Adults (18-64 years)",2068.0,0.053,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Natalia Martinez-Acu a","Autonomous University of Nuevo Leon","https://dx.doi.org/10.3390/v13071225","Verified","Mexico","Abbott Laboratories",0.9,1.0,"","MX","MX-NLE"
"2021-02-05","201031_NewJersey_RutgersRobertWoodJohnsonMedicalSchool","Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospital Workers: Results From a Screening Study in New Jersey, United States in Spring 2020.","2020-10-31","Local","United States of America; New Jersey; New Brunswick, Somerville","2020-04-28","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",3907.0,0.096,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Emily Barrett","Rutgers Robert Wood Johnson Medical School","https://dx.doi.org/10.1093/ofid/ofaa534","Verified","United States of America","Abbott Laboratories",0.969,0.996,"","US","US-NJ"
"2021-02-05","201112_Monteria_UniversidaddeCórdoba_GenPopAdj","Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries?","2020-11-12","Local","Colombia; Caribbean Region; Monteria","2020-08-04","2020-09-01","Household and community samples","Multiple groups",1368.0,0.553,0.525,0.578,"Stratified probability","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Salim Mattar","Universidad de Córdoba","https://dx.doi.org/10.1093/ofid/ofaa550","Verified","Colombia","Ingenasa",0.92,1.0,"","CO",""
"2021-02-05","201213_Foggia_AziendaOspedalieraUniversitariaPoliclinicoRiunitiDiFoggia_HCW","SARS-COV-2 Serological Profile in Healthcare Professionals of a Southern Italy Hospital","2020-12-13","Local","Italy; Apulia, Province of Foggia; Foggia","2020-03-17","2020-05-18","Health care workers and caregivers","Adults (18-64 years)",3242.0,0.019,0.014,0.023,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Armando De Carlo","Azienda Ospedaliera-Universitaria Policlinico Riuniti di Foggia","https://dx.doi.org/10.3390/ijerph17249324","Verified","Italy","Shenzhen YHLO Biotech",0.97,0.988,"","IT",""
"2021-02-05","210102_Munich_MUCResearch","HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German 'hotspot'","2021-01-02","Local","Germany","2020-05-29","2020-07-15","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",500.0,0.015,0.007,0.031,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","S Noe","MUC Research","https://dx.doi.org/10.1007/s15010-020-01564-8","Unverified","Germany","Mikrogen, Neuried, Germany","","","","DE",""
"2021-02-05","210112_Dammam_KingFahadSpecialistHospital_Overall","Detection of SARS-COV-2 Antibodies in Pediatric Kidney Transplant Patients","2021-01-12","Local","Saudi Arabia; Eastern Province; Dammam","2020-08-15","2020-10-12","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",72.0,0.125,"","","Sequential","IgG","High","Preprint","Alanoud Alshami","King Fahad Specialist Hospital","https://assets.researchsquare.com/files/rs-140932/v1/a7cb2461-27b8-4eca-bf34-171b60bb1272.pdf","Verified","Saudi Arabia","DIasorine, Abbott Laboratories","","","","SA","SA-04"
"2021-02-06","200916_Kerala_AmritaInstituteofMedicalSciencesandResearchCentre","SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India","2020-09-16","Local","India; Kerala","2020-07-11","2020-07-24","Health care workers and caregivers","Multiple groups",635.0,0.0,"","","Convenience","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Anil Kumar","Amrita Institute of Medical Sciences & Research Centre","http://dx.doi.org/10.1016/j.cmi.2020.09.013","Verified","India","Abbott, Roche Diagnostics, Ortho-Clinical Diagnostics","","","Not reported","IN","IN-KL"
"2021-02-06","201022_Scotland_UniversityOfOxford_overall","Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.","2020-10-22","Regional","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-03-17","2020-05-18","Blood donors","Adults (18-64 years)",3500.0,0.032,"","","Simplified probability","Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Craig P Thompson","University of Oxford","https://dx.doi.org/10.2807/1560-7917.ES.2020.25.42.2000685","Verified","The United Kingdom","N/A - Author designed",0.94,1.0,"","GB","GB-SCT"
"2021-02-06","201104_Croatia_CroatianFootballFederation_FootballPlayers&ClubStaff","SARS-CoV-2 Seroprevalence in a Cohort of Asymptomatic, RT-PCR Negative Croatian First League Football Players","2020-11-04","Local","Croatia","2020-05-29","2020-07-31","Non-essential workers and unemployed persons","Adults (18-64 years)",305.0,0.2,"","","Convenience","IgA; IgG","Moderate","Preprint","Adriana Vince","Croatian Football Federation","https://www.medrxiv.org/content/10.1101/2020.10.30.20223230v1","Verified","Croatia","Euroimmun Medizinische Labordiagnostika AG","","","","HR",""
"2021-02-06","201215_Iran_TehranUniversityofMedicalSciences_GenPop1_overall_PopTestAdj","SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study","2020-12-15","National","Iran (Islamic Republic of)","2020-04-17","2020-06-02","Household and community samples","Multiple groups",3530.0,0.171,0.146,0.195,"Stratified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Hossein Poustchi","Tehran University of Medical Sciences","http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6","Verified","Iran (Islamic Republic of)","Pishtaz Teb",0.669,0.982,"","IR",""
"2021-02-06","201215_Iran_TehranUniversityofMedicalSciences_HighRisk2_overall_PopTestAdj","SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study","2020-12-15","National","Iran (Islamic Republic of)","2020-04-17","2020-06-02","Multiple populations","Multiple groups",5372.0,0.2,0.185,0.217,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Hossein Poustchi","Tehran University of Medical Sciences","http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6","Verified","Iran (Islamic Republic of)","Pishtaz Teb",0.669,0.982,"","IR",""
"2021-02-06","201216_Germany_Ruhr-UniversityBochum_overall","Coronavirus Disease 2019 Associated Risk Score, Behavior, and Symptom Prevalence in German Transplant Recipients.","2020-12-16","Local","Germany","2020-04-01","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",99.0,0.03,"","","Sequential","IgG; IgA","High","Journal Article (Peer-Reviewed)","Constantin J Thieme","Ruhr-University Bochum","https://dx.doi.org/10.1016/j.transproceed.2020.12.001","Verified","Germany","Euroimmun","","","","DE",""
"2021-02-06","210112_Spain_HMHospitales_overall","Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain","2021-01-12","National","Spain","2020-04-15","2020-06-30","Health care workers and caregivers","Multiple groups",6038.0,0.11,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Jose Varona","HM Hospidales","https://dx.doi.org/10.1093/ije/dyaa277","Unverified","Spain","Snibe Diagnostic",0.912,0.977,"","ES",""
"2021-02-06","210120_Antwerp_UniversityofAntwerp_primary","Hospital-wide SARS-CoV-2 antibody screening of staff in a university psychiatric centre in Belgium","2021-01-20","Local","Belgium","2020-06-03","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",431.0,0.032,0.019,0.054,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Kawtar El Abdellati","University of Antwerp","https://dx.doi.org/10.1192/bjo.2020.172","Verified","Belgium","Euroimmune, AG, Lubeck",0.8,0.985,"","BE",""
"2021-02-07","201120_Japan_TokyoNationalHospital_overall","Detection of anti-SARS-CoV-2 antibodies in patients with rheumatoid arthritis","2020-11-20","Local","Japan","2020-06-01","2020-10-30","Patients seeking care for non-COVID-19 reasons","Seniors (65+ years)",93.0,0.161,"","","Convenience","IgG; IgM","High","Preprint","Shomi Oka","Tokyo National Hospital","https://www.researchsquare.com/article/rs-112294/v1","Verified","Japan","1) Roche Diagnostics,; 2) GenBody","","","","JP",""
"2021-02-07","201203_Athens_UniversityOfAthens_Overall_BothAdj","Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19","2020-12-03","Local","Greece; Attica; Athens","2020-04-13","2020-05-15","Health care workers and caregivers","Multiple groups",1495.0,0.013,0.004,0.033,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mina Psichogiou","University of Athens","https://dx.doi.org/10.1371/journal.pone.0243025","Verified","Greece","Genebody Inc",0.741,1.0,"","GR","GR-I"
"2021-02-07","201221_Spain_HospitalClínicoUniversitarioLozanoBlesa","SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: a false friend?","2020-12-21","Local","Spain; Zaragoza; Zaragoza","2020-04-27","2020-05-29","Pregnant or parturient women","Adults (18-64 years)",169.0,0.083,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","M Fabre","Hospital Clínico Universitario Lozano Blesa","https://dx.doi.org/10.1177/0004563220980495","Verified","Spain","Guangzhou Wondfo Biotech Co. , Abbott, Vircell Microbiologists","","","","ES","ES-AR"
"2021-02-07","210107_China_WuhanUniversity","Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China","2021-01-07","Regional","China; Hubei","2020-03-06","2020-05-03","Essential non-healthcare workers","Multiple groups",63107.0,0.007,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shuhui Duan","Wuhan University","https://dx.doi.org/10.1371/journal.pntd.0008975","Unverified","China","Innovita, Tangshan, China","","","","CN","CN-42"
"2021-02-07","210113_Wakayama_WakayamaMedicalUniversity_overall","Immunochromatographic SARS-CoV-2 IgG antibody assay: a cross-sectional study conducted at Wakayama Medical University in Japan","2021-01-13","Local","Japan","2020-07-07","2020-09-15","Health care workers and caregivers","Multiple groups",1528.0,0.008,0.003,0.012,"Convenience","IgG","High","Preprint","Sadahiro Iwabuchi","Wakayama Medical University","https://www.medrxiv.org/content/10.1101/2021.01.10.21249421v1","Unverified","Japan","Kurabo Industries Ltd",0.764,1.0,"","JP",""
"2021-02-07","210116_SaudiArabia_MinistryofHealth_overall","Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early month of the pandemic in Saudi Arabia","2021-01-16","National","Saudi Arabia","2020-05-20","2020-05-25","Blood donors","Adults (18-64 years)",837.0,0.014,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Ayman Banjar","Ministry of Health (Saudi Arabia)","https://dx.doi.org/10.1016/j.ijid.2021.01.028","Verified","Saudi Arabia","Roche Diagnostics",0.998,0.995,"","SA",""
"2021-02-08","201101_ Borgosesia_ASLVercelli_overall","[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].","2020-11-01","Local","Italy; Piedmont; Borgosesia","2020-05-23","2020-05-24","Household and community samples","Multiple groups",4987.0,0.049,0.043,0.056,"Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Daniela Alessi","ASL Vercelli","https://dx.doi.org/10.19191/EP20.5-6.S2.119","Verified","Italy","Prima Lab SA",1.0,0.98,"","IT","IT-21"
"2021-02-08","211104_Karnataka_Mapmygenome_primary_adj","Prevalence of SARS-CoV-2 in Karnataka, India","2021-02-04","Regional","India; Karnataka","2020-06-15","2020-08-29","Household and community samples","Multiple groups",1197.0,0.467,0.433,0.5,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Manoj Mohanan","Mapmygenome","https://dx.doi.org/10.1001/jama.2021.0332","Verified","India","Translational Health Science and Technology Institute, India",0.847,1.0,"","IN","IN-KA"
"2021-02-09","210306_Rome_UniversitaCattolicadelSacroCuore_VenousBloodTest_overall","COVID-19 seroprevalence among healthcare workers of a large COVID Hospital in Rome reveals strengths and limits of two different serological tests","2021-03-06","Local","Italy","2020-06-04","2020-07-03","Health care workers and caregivers","Multiple groups",4694.0,0.012,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Giuseppe Vetrugno","Università Cattolica del Sacro Cuore","http://dx.doi.org/10.3390/ijerph18052650","Verified","Italy","Euroimmun",0.788,0.994,"","IT",""
"2021-02-10","210105_Jeddah_KingAbdulazizUniversity_overall","Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia","2021-01-05","Local","Saudi Arabia","2020-01-01","2020-05-31","Blood donors","Adults (18-64 years)",956.0,0.015,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Thamir Alandijany","King Abdulaziz University","https://dx.doi.org/10.3390/healthcare9010051","Verified","Saudi Arabia","Authors",1.0,0.984,"","SA",""
"2021-02-11","210111_UK_PublicHealthEngland_Round1_overall","Prospective Active National Surveillance of Preschools and Primary Schools for SARS-CoV-2 Infection and Transmission in England, June 2020","2021-01-20","National","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-06-15","Multiple populations","Multiple groups",2198.0,0.136,0.124,0.151,"Simplified probability","IgG","Moderate","Preprint","Shamez Ladhani","Public Health England","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198","Verified","The United Kingdom","Abbott","","","","GB","GB-ENG"
"2021-02-11","210111_UK_PublicHealthEngland_Round2_overall","Prospective Active National Surveillance of Preschools and Primary Schools for SARS-CoV-2 Infection and Transmission in England, June 2020","2021-01-20","National","United Kingdom of Great Britain and Northern Ireland; England","2020-07-07","2020-07-21","Household and community samples","Multiple groups",1431.0,0.121,0.105,0.139,"Simplified probability","IgG","Moderate","Preprint","Shamez Ladhani","Public Health England","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198","Verified","The United Kingdom","Abbott","","","","GB","GB-ENG"
"2021-02-11","210111_UK_PublicHealthEngland_Round3_overall","Prospective Active National Surveillance of Preschools and Primary Schools for SARS-CoV-2 Infection and Transmission in England, June 2020","2021-01-20","National","United Kingdom of Great Britain and Northern Ireland; England","2020-11-17","2020-11-30","Household and community samples","Multiple groups",1216.0,0.104,0.088,0.123,"Simplified probability","IgG","Moderate","Preprint","Shamez Ladhani","Public Health England","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198","Verified","The United Kingdom","Abbott","","","","GB","GB-ENG"
"2021-02-11","210115_Massachusetts_HarvardUniversity_Overall","Development of at-home sample collection logistics for large scale SARS-CoV-2 seroprevalence studies","2021-01-15","Regional","United States of America; Massachusetts","2020-06-16","2020-08-24","Household and community samples","Multiple groups",1872.0,0.032,"","","Convenience","IgG","Moderate","Preprint","Aishani Aatresh","Harvard University","https://www.medrxiv.org/content/10.1101/2021.01.14.21249824v1","Verified","United States of America","Euroimmun","","","","US","US-MA"
"2021-02-12","201130_PuneCity_IndianInstituteOfScienceEducationAndResearch_OverallAdj","Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in five localities in an Indian metropolitan city","2020-11-30","Local","India; Maharashtra; Pune","2020-07-20","2020-08-05","Household and community samples","Multiple groups",1659.0,0.513,0.399,0.624,"Stratified probability","IgG","Moderate","Preprint","Aurnab Ghose","Indian Institute of Science Education and Research","https://www.medrxiv.org/content/10.1101/2020.11.17.20228155v2.full-text","Verified","India","In-house developed.","","","","IN","IN-MH"
"2021-02-12","201231_Modena_OspedaleCivileS.AgostinoEstense_overall","The prevalence of antibodies to SARS-CoV-2 in healthcare workers of Modena. the screening on more than 7000 subjects","2020-12-31","Local","Italy; Emilia-Romagna Region; Modena","2020-03-30","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",7711.0,0.05,"","","Convenience","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Valentina Pecoraro","Ospedale Civile S.Agostino Estense","https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-984696","Verified","Italy","NR","","","","IT","IT-45"
"2021-02-12","210120_Iquitos_DIRESA_1monthFollowUp_overall_adj","Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru","2021-01-20","Local","Peru; Loreto; Iquitos","2020-08-13","2020-08-18","Household and community samples","Multiple groups",621.0,0.66,0.62,0.701,"Stratified probability","IgG; IgM","Low","Preprint","Carlos Alvarez-Antonio","Universidad de Ingeniería y Tecnología","https://www.medrxiv.org/content/10.1101/2021.01.17.21249913v1","Verified","Peru","Zhejiang Orient Gene (Biotech Co LTD, China)",0.958,1.0,"","PE","PE-LOR"
"2021-02-12","210204_Milan_ASSTFatebenefratelliSacco_PhaseII","Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy","2021-02-04","Local","Italy","2020-04-14","2020-04-22","Health care workers and caregivers","Adults (18-64 years)",608.0,0.042,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Milazzo","ASST Fatebenefratelli Sacco","http://dx.doi.org/10.1136/oemed-2020-107060","Unverified","Italy","Beijing Wantai Biolog- ical Pharmacy Enterprise",0.78,1.0,"","IT",""
"2021-02-12","210204_Milan_ASSTFatebenefratelliSacco_PhaseIII","Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy","2021-02-04","Local","Italy","2020-05-20","2020-05-27","Health care workers and caregivers","Adults (18-64 years)",629.0,0.046,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Milazzo","ASST Fatebenefratelli Sacco","http://dx.doi.org/10.1136/oemed-2020-107060","Unverified","Italy","Beijing Wantai Biolog- ical Pharmacy Enterprise",0.78,1.0,"","IT",""
"2021-02-12","210204_Milan_ASSTFatebenefratelliSacco_PhaseI_overall","Dynamics of the seroprevalence of SARS-CoV-2 antibodies among healthcare workers at a COVID-19 referral hospital in Milan, Italy","2021-02-04","Local","Italy","2020-03-04","2020-03-12","Health care workers and caregivers","Adults (18-64 years)",679.0,0.004,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Milazzo","ASST Fatebenefratelli Sacco","http://dx.doi.org/10.1136/oemed-2020-107060","Unverified","Italy","Beijing Wantai Biolog- ical Pharmacy Enterprise",0.78,1.0,"","IT",""
"2021-02-13","201104_Cambridge_CambridgeUniversityHospitalsNHSFoundationTrust_HCW&HospitalStaff","A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital","2020-11-04","Local","United Kingdom of Great Britain and Northern Ireland; England; Cambridge","2020-06-10","2020-08-07","Health care workers and caregivers","Multiple groups",5698.0,0.072,"","","Convenience","Total Antibody","Moderate","Preprint","Daniel Cooper","Cambridge University Hospitals NHS Foundation Trust","https://doi.org/10.1101/2020.11.03.20220699","Verified","The United Kingdom","Siemens Healthcare Limited",0.981,0.999,"","GB","GB-ENG"
"2021-02-13","201116_Leicester_UniversityofLeicester_HCW","Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff","2020-11-16","Local","United Kingdom of Great Britain and Northern Ireland; East Midlands; Leicester","2020-05-29","2020-07-13","Health care workers and caregivers","Adults (18-64 years)",10662.0,0.108,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Christopher Martin","University of Leicester","https://dx.doi.org/10.1093/pubmed/fdaa199","Verified","The United Kingdom","Abbott",0.935,1.0,"","GB","GB-ENG"
"2021-02-13","201227_Denmark_CopenhagenUniversityHospital_Pregnant1_Overall","SARS-CoV-2 in first trimester pregnancy: a cohort study","2020-12-27","Local","Denmark; Copenhagen; Copenhagen","2020-02-17","2020-04-17","Pregnant or parturient women","Adults (18-64 years)",1019.0,0.018,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","‪Nina Freiesleben","Copenhagen University Hospital","https://dx.doi.org/10.1093/humrep/deaa311","Verified","Denmark","YHLO Biotechnology","","","","DK","DK-84"
"2021-02-13","210105_SanGiovaniRotondo_FondazioneCasaSollievoDellaSofferenza_overall","Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs","2021-01-05","Local","Italy","2020-05-01","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",245.0,0.009,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Fabrizio Bossa","Fondazione Casa Sollievo della Sofferenza","http://dx.doi.org/10.1016/j.dld.2020.12.120","Verified","Italy","1) Kehua Bio- engineering; 2) Tecan","","","","IT",""
"2021-02-14","210129_Eschweiler_St.AntoniusHospitalEschweiler_IgG","[Prevalence of SARS-CoV-2 in employees of a general hospital in Northrhine-Westphalia, Germany]","2021-01-29","Local","Germany; North Rhine-Westphalia; Eschweiler","2020-04-27","2020-05-20","Health care workers and caregivers","Multiple groups",1212.0,0.033,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Martin Platten","St. Antonius Hospital Eschweiler","https://dx.doi.org/10.1055/a-1322-5355","Verified","Germany","EUROIMMUN",0.944,0.996,"","DE","DE-NW"
"2021-02-16","201230_Fukushima_ HirataCentralHospital_CLIA_IgG","The difference between IgM and IgG antibody prevalence in different serological assays for COVID-19; lessons from the examination of healthcare workers","2020-12-30","Local","Japan; Fukushima Prefecture; Hirata","2020-05-08","2020-05-28","Health care workers and caregivers","Multiple groups",637.0,0.009,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Yurie Kobashi","Hirata Central Hospital","https://dx.doi.org/10.1016/j.intimp.2020.107360","Verified","Japan","YHLO Biotech Shenzhen, China","","","","JP","JP-07"
"2021-02-16","210114_Puducherry_JawaharlalInstitute_August_primary","Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020","2021-01-14","Regional","India; Puducherry","2020-08-11","2020-08-16","Household and community samples","Multiple groups",869.0,0.049,0.035,0.064,"Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sitanshu Sekhar Kar","Jawaharlal Institute","https://dx.doi.org/10.3201/2702.204480","Verified","India","Roche",0.995,0.998,"","IN","IN-PY"
"2021-02-16","210114_Puducherry_JawaharlalInstitute_Oct_primary","Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020","2021-01-14","Regional","India; Puducherry","2020-10-12","2020-10-16","Household and community samples","Multiple groups",900.0,0.345,0.315,0.377,"Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sitanshu Sekhar Kar","Jawaharlal Institute","https://dx.doi.org/10.3201/2702.204480","Verified","India","Roche",0.995,0.998,"","IN","IN-PY"
"2021-02-16","210114_Puducherry_JawaharlalInstitute_Sep_primary","Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020","2021-01-14","Regional","India; Puducherry","2020-09-10","2020-09-16","Household and community samples","Multiple groups",898.0,0.207,0.18,0.233,"Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sitanshu Sekhar Kar","Jawaharlal Institute","https://dx.doi.org/10.3201/2702.204480","Verified","India","Roche",0.995,0.998,"","IN","IN-PY"
"2021-02-16","210129_Vienna_WroclawMedicalUniversity_overall","Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: a cross-sectional study","2021-01-29","Local","Austria; Vienna; Vienna","2020-05-18","2020-07-02","Students and Daycares","Children and Youth (0-17 years)",2042.0,0.012,"","","Convenience","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Zsolt Szepfalusi","Wroclaw Medical University","https://dx.doi.org/10.1111/pai.13459","Unverified","Austria","1) Beijing Wantai Biological Pharmacy Enterprise; 2) N/A - author designed; 3) EUROIMMUN; 4) EUROIMMUN","","","","AT","AT-9"
"2021-02-17","201206_Al-Madinah_TaibahUniversity_Overall","The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia","2020-12-11","Local","Saudi Arabia","2020-05-15","2020-07-15","Blood donors","Adults (18-64 years)",1212.0,0.193,0.171,0.216,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Waleed H Mahallawi","Taibah University","https://dx.doi.org/10.1016/j.sjbs.2020.12.009","Verified","Saudi Arabia","In-house, NR","","","","SA",""
"2021-02-17","201216_Seattle_WashingtonUniversity_fishermen_unadjusted copy","Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate","2020-10-21","Local","United States of America; Washington; Seattle","2020-05-01","2020-05-31","Essential non-healthcare workers","Adults (18-64 years)",120.0,0.025,"","","Convenience","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Amin Addetia","University of Washington","https://jcm.asm.org/content/58/11/e02107-20","Verified","United States of America","Abbott, unclear","","","","US","US-WA"
"2021-02-17","210203_Austria_MedicalUniversityOfVienna_Overall","Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel","2021-02-03","National","Austria","2020-05-11","2020-12-21","Health care workers and caregivers","Adults (18-64 years)",3301.0,0.005,"","","Convenience","IgA; IgM; IgG","High","Preprint","Iris Leister","Medical University of Vienna","10.1101/2021.02.01.21250898","Verified","Austria","LFA: TAmiRNA GmbH Austria; Roche; Diasorin","","","","AT",""
"2021-02-17","210203_England_TheUniversityofNottingham_HCW_primary","SARS-CoV-2 transmission from the healthcare setting into the home: a prospective longitudinal cohort study","2021-02-03","Local","United Kingdom of Great Britain and Northern Ireland; East Midlands","2020-04-24","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",633.0,0.18,"","","Convenience","IgG; IgA; IgM","High","Preprint","Simon Craxford","The University of Nottingham","https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1","Unverified","The United Kingdom","Study authors","","","","GB","GB-ENG"
"2021-02-17","210203_England_TheUniversityofNottingham_HHC_primary","SARS-CoV-2 transmission from the healthcare setting into the home: a prospective longitudinal cohort study","2021-02-03","Local","United Kingdom of Great Britain and Northern Ireland; England","2020-09-01","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",178.0,0.073,"","","Convenience","IgG; IgA; IgM","High","Preprint","Simon Craxford","The University of Nottingham","https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1","Unverified","The United Kingdom","Study authors","","","","GB","GB-ENG"
"2021-02-18","210107_BuenosAires_UniversityOfBuenosAires_Primary","Assesment of SARS-CoV-2 infection-in dentists and supporting staff at a university dental hospital in Argentina","2021-01-07","Local","Argentina","2020-03-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",317.0,0.03,0.02,0.05,"Stratified non-probability","Not reported","High","Journal Article (Peer-Reviewed)","Puia Sebastian","University of Buenos Aires","https://dx.doi.org/10.1016/j.jobcr.2021.01.006","Verified","Argentina","NR",0.85,0.95,"","AR",""
"2021-02-18","210107_WestBank_ArabAmericanUniversity_Households_overall_adj","Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study","2021-01-07","Local","occupied Palestinian territory - including east Jerusalem","2020-06-15","2020-06-30","Household and community samples","Multiple groups",1355.0,0.0,0.0,0.004,"Stratified probability","Total Antibody","Low","Journal Article (Peer-Reviewed)","Nouar Qutob","Arab American University","https://bmjopen.bmj.com/content/11/2/e044552","Verified","occupied Palestinian territory, including east Jerusalem","Roche",0.839,1.0,"","PS",""
"2021-02-18","210107_WestBank_ArabAmericanUniversity_LabReferrals_overall_adj","Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study","2021-01-07","Local","occupied Palestinian territory - including east Jerusalem","2020-05-01","2020-07-09","Residual sera","Multiple groups",1136.0,0.003,0.001,0.012,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Nouar Qutob","Arab American University","https://bmjopen.bmj.com/content/11/2/e044552","Verified","occupied Palestinian territory, including east Jerusalem","Roche",1.0,0.839,"","PS",""
"2021-02-19","210103_Pakistan_LiaquatUniversity_primary","Do COVID-19 Antibodies Provide Long-Term Protection?","2021-01-03","Local","Pakistan; NR; NR","2020-06-15","2020-08-15","Residual sera","Multiple groups",728.0,0.108,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Sheeba Ansari","Liaquat University","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854312/","Verified","Pakistan","nr",1.0,0.998,"","PK",""
"2021-02-19","210122_Germany_HeidelbergUniversity_Children_Overall_unadj","Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.","2021-01-22","Regional","Germany; Baden-Württemberg; Freiburg, Heidelberg, Tübingen, Ulm","2020-04-22","2020-05-15","Students and Daycares","Children and Youth (0-17 years)",2482.0,0.009,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Burkhard Tonshoff","Heidelberg University","https://dx.doi.org/10.1001/jamapediatrics.2021.0001","Verified","Germany","Euroimmun; Roche Elecsys' Mikrogen in-house","",0.996,"","DE","DE-BW"
"2021-02-19","210122_Germany_HeidelbergUniversity_Parents_Overall_unadj","Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.","2021-01-22","Regional","Germany; Baden-Württemberg; Freiburg, Heidelberg, Tübingen, Ulm","2020-04-22","2020-05-15","Household and community samples","Adults (18-64 years)",2482.0,0.019,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Burkhard Tonshoff","Heidelberg University","https://dx.doi.org/10.1001/jamapediatrics.2021.0001","Verified","Germany","Euroimmun; Roche Elecsys' Mikrogen in-house","",0.996,"","DE","DE-BW"
"2021-02-19","210208_Canada_CBS_BloodDonors_Overall_PopTestAdj","COVID-19 Seroprevalence Report February 8, 2021 Report #5: December 2020 Survey","2021-02-08","National","Canada","2020-12-10","2020-12-23","Blood donors","Multiple groups",16961.0,0.014,0.012,0.016,"Sequential","IgG","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified","Canada","Abbott",0.927,0.999,"","CA",""
"2021-02-19","210208_Paris_JeanVerdierHospital_DaycareChildren1_Overall_TestAdj","SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study","2021-02-08","National","France; Île-de-France, Auvergne-Rhône-Alpes, Normandy; Paris, Annecy, Rouen","2020-06-04","2020-07-03","Students and Daycares","Children and Youth (0-17 years)",327.0,0.037,0.013,0.068,"Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Eric Lachassinne","Jean Verdier Hospital","https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext","Verified","France","Biosynex",0.918,0.992,"","FR",""
"2021-02-20","200930_Toulouse_CentreHospitalierUniversitaireDeToulouse_HCW&Staff","Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France","2020-09-30","Local","France","2020-06-10","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",8758.0,0.032,0.028,0.035,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Chloe Dimeglio","Centre Hospitalier Universitaire (CHU) de Toulouse","http://dx.doi.org/10.1016/j.jinf.2020.09.035","Verified","France","Beijing Wantai Biological Pharmacy Enterprise Co.","","","","FR",""
"2021-02-20","210129_Philadelphia_UniversityofPennsylvania_overallmother_unadj","Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios","2021-01-29","Local","United States of America; Pennsylvania; Philadelphia","2020-04-09","2020-08-08","Pregnant or parturient women","Adults (18-64 years)",1471.0,0.06,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Dustin D Flannery","University of Pennsylvania","https://dx.doi.org/10.1001/jamapediatrics.2021.0038","Verified","United States of America","Authors","","","","US","US-PA"
"2021-02-20","210205_Ekaterinburg_RussianAcademyOfSciences_overall","SARS-CoV-2 Seropositivity among Dental Staff and the Role of Aspirating Systems.","2021-02-05","Local","Russian Federation","2020-05-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",157.0,0.115,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","M Sarapultseva","Russian Academy of Sciences","https://dx.doi.org/10.1177/2380084421993099","Verified","Russian Federation","VECTOR-BEST","","","","RU",""
"2021-02-21","210120_Chennai_NationalInstituteOfEpidemiology_primary_adj","Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India","2021-01-20","Local","India","2020-07-01","2020-07-31","Household and community samples","Multiple groups",12405.0,0.184,0.148,0.226,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Sriram Selvaraju","National Institute of Epidemiology","https://dx.doi.org/10.3201/eid2702.203938","Verified","India","Abbott",1.0,0.996,"","IN",""
"2021-02-21","210129_Stockholm_KarolinskaInstitutet_HCW","Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care","2021-01-29","Local","Sweden; Uppland; Stockholm","2020-05-11","2020-06-11","Health care workers and caregivers","Adults (18-64 years)",3981.0,0.177,"","","Convenience","IgG","Moderate","Preprint","Susanna Klevebro","Karolinska Institutet","https://doi.org/10.1101/2021.01.28.21250664","Verified","Sweden","NR",0.992,0.998,"","SE","SE-AB"
"2021-02-22","201113_Mumbai_TataInstituteforFundamentalResearch_nonslums_adj","Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India","2020-11-13","Local","India; Maharashtra; Mumbai","2020-06-29","2020-07-19","Household and community samples","Multiple groups",2702.0,0.171,0.158,0.184,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Anup Malani","Tata Institute for Fundamental Research","http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8","Verified","India","Abbott Laboratories",0.9,0.99,"","IN","IN-MH"
"2021-02-22","201113_Mumbai_TataInstituteforFundamentalResearch_slums_testpopadj","Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India","2020-11-13","Local","India; Maharashtra; Mumbai","2020-06-29","2020-07-19","Persons living in slums","Multiple groups",4202.0,0.583,0.568,0.599,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Anup Malani","Tata Institute for Fundamental Research","http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8","Verified","India","Abbott Laboratories",0.9,0.99,"","IN","IN-MH"
"2021-02-22","210117_Maryland_UniversityofMaryland_overall_adj","Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers","2021-01-17","Local","United States of America; Maryland; Baltimore","2020-06-03","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",8399.0,0.035,0.03,0.04,"Convenience","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Kristin E Mullins","University of Maryland","http://dx.doi.org/10.1016/j.clinbiochem.2021.01.004","Verified","United States of America","1) Ortho Vitros ; 2) N/A - institution desgined","","","","US","US-MD"
"2021-02-22","210129_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Overall","SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study","2021-01-29","Local","Germany","2020-11-02","2020-11-16","Household and community samples","Multiple groups",576.0,0.014,0.006,0.027,"Stratified probability","IgG","Moderate","Preprint","Stefanie Theuring","Universitätsmedizin Berlin","https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1","Verified","Germany","NR","","","","DE",""
"2021-02-22","210129_Berlin_UniversitätsmedizinBerlin_Staff_Overall","SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study","2021-01-29","Local","Germany","2020-11-02","2020-11-16","Essential non-healthcare workers","Adults (18-64 years)",141.0,0.014,0.002,0.05,"Stratified probability","IgG","Moderate","Preprint","Stefanie Theuring","Universitätsmedizin Berlin","https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1","Verified","Germany","NR","","","","DE",""
"2021-02-22","210129_Berlin_UniversitätsmedizinBerlin_Students_Overall","SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study","2021-01-29","Local","Germany","2020-11-02","2020-11-16","Students and Daycares","Children and Youth (0-17 years)",347.0,0.02,0.008,0.041,"Stratified probability","IgG","Moderate","Preprint","Stefanie Theuring","Universitätsmedizin Berlin","https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1","Verified","Germany","NR","","","","DE",""
"2021-02-22","210131_USA_NIH_primary","Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States","2021-01-31","National","United States of America","2020-04-01","2020-08-04","Household and community samples","Multiple groups",8058.0,0.046,0.026,0.065,"Stratified non-probability","IgG; IgM; IgA","Moderate","Preprint","Heather Kalish","National Institute of Health","https://pubmed.ncbi.nlm.nih.gov/33532807/","Verified","United States of America","N/A - author designed","","","","US",""
"2021-02-23","201124_Vasteras_HospitalofVastmanland_HCW","Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study.","2020-11-24","Local","Sweden","2020-05-04","2020-08-19","Health care workers and caregivers","Adults (18-64 years)",131.0,0.191,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mulki Rashid Abdi","The Hospital of Vastmanland","https://dx.doi.org/10.1080/23744235.2020.1849787","Verified","Sweden","Abbott",1.0,0.999,"","SE",""
"2021-02-23","210125_Canada_UniversityofToronto_Phase1_Overall_Popdj_sp","COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada","2021-01-25","National","Canada","2020-05-15","2020-06-15","Household and community samples","Multiple groups",7068.0,0.017,"","","Stratified non-probability","IgG","Moderate","Preprint","Xuyang Tang","University of Toronto","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659","Verified","Canada","Network Biology Collaborative; Centre at Sinai Health","","","","CA",""
"2021-02-23","210127_Merano_FranzTappeinerHospital_HCW_primary","Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers","2021-01-27","Local","Italy","2020-06-22","2020-07-17","Health care workers and caregivers","Adults (18-64 years)",36.0,0.055,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Dominic Fong","Franz Tappeiner Hospital","https://dx.doi.org/10.1007/s00508-020-01807-6","Unverified","Italy","Abbott",1.0,0.996,"","IT",""
"2021-02-23","210127_Merano_FranzTappeinerHospital_patients_primary","Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers","2021-01-27","Local","Italy","2020-06-22","2020-07-17","Patients seeking care for non-COVID-19 reasons","Multiple groups",250.0,0.008,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Dominic Fong","Franz Tappeiner Hospital","https://dx.doi.org/10.1007/s00508-020-01807-6","Verified","Italy","Abbott",1.0,0.996,"","IT",""
"2021-02-23","210205_Poland_CentralClinicalHospital_HCWs_IgG","Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","2021-02-05","National","Poland","2020-05-01","2020-06-15","Health care workers and caregivers","Multiple groups",432.0,0.016,"","","Stratified non-probability","IgG","High","Journal Article (Peer-Reviewed)","Michal Lodyga","Central Clinical Hospital of the Ministry of the Interior and Administration","https://dx.doi.org/10.20452/pamw.15796","Verified","Poland","Vircell Microbiologists",0.85,0.98,"","PL",""
"2021-02-23","210205_Poland_CentralClinicalHospital_IBDPatients_IgG","Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","2021-02-05","National","Poland","2020-05-01","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",432.0,0.046,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Michal Lodyga","Central Clinical Hospital of the Ministry of the Interior and Administration","https://dx.doi.org/10.20452/pamw.15796","Verified","Poland","Vircell Microbiologists",0.88,0.99,"","PL",""
"2021-02-24","201021_London_BartsHealthNHSTrust_primary","COVID-19 prevalence and seroconversion in an urban hemodialysis unit in the United Kingdom","2020-10-21","Local","United Kingdom of Great Britain and Northern Ireland","2020-05-01","2020-06-04","Patients seeking care for non-COVID-19 reasons","Multiple groups",1253.0,0.18,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Kieran McCafferty","Barts Health NHS Trust","http://dx.doi.org/10.1111/hdi.12883","Verified","The United Kingdom","Roche","","","","GB",""
"2021-02-24","201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_DesHCW_ELISA1","Serologic Evaluation of Healthcare Workers Caring for COVID-19 Patients in the Republic of Korea.","2020-11-20","National","Republic of Korea","2020-04-26","2020-05-09","Health care workers and caregivers","Adults (18-64 years)",309.0,0.003,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Jae Hoon Ko","Sungkyunkwan University School of Medicine","https://dx.doi.org/10.3389/fmicb.2020.587613","Verified","Republic of Korea","PCL Inc",0.982,1.0,"","KR",""
"2021-02-24","201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_NonDesHCW_ELISA1","Serologic Evaluation of Healthcare Workers Caring for COVID-19 Patients in the Republic of Korea.","2020-11-20","National","Republic of Korea","2020-04-26","2020-05-09","Health care workers and caregivers","Adults (18-64 years)",123.0,0.0,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Jae Hoon Ko","Sungkyunkwan University School of Medicine","https://dx.doi.org/10.3389/fmicb.2020.587613","Verified","Republic of Korea","PCL Inc",0.982,1.0,"","KR",""
"2021-02-24","210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodNoCases_TotalAb_TestAdj","Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study","2021-01-19","Local","China","2020-04-17","2020-04-23","Household and community samples","Multiple groups",350.0,0.0,0.0,0.011,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Zhen Zhang","Shenzhen Center for Disease Control and Prevention","https://dx.doi.org/10.1016/S2666-5247(20)30200-7","Verified","China","Beijing Wantai Biological Pharmacy Enterprise",0.98,0.99,"","CN",""
"2021-02-24","210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodReportedCases_TotalAb_TestAdj","Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study","2021-01-19","Local","China","2020-04-17","2020-04-23","Household and community samples","Multiple groups",50.0,0.0,0.0,0.068,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Zhen Zhang","Shenzhen Center for Disease Control and Prevention","https://dx.doi.org/10.1016/S2666-5247(20)30200-7","Verified","China","Beijing Wantai Biological Pharmacy Enterprise",0.98,0.99,"","CN",""
"2021-02-24","210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_contacts_TotalAb_TestAdj","Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study","2021-01-19","Local","China","2020-04-12","2020-05-04","Contacts of COVID patients","Multiple groups",880.0,0.041,0.029,0.057,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Zhen Zhang","Shenzhen Center for Disease Control and Prevention","https://dx.doi.org/10.1016/S2666-5247(20)30200-7","Verified","China","Beijing Wantai Biological Pharmacy Enterprise",0.98,0.99,"","CN",""
"2021-02-25","210121_Denmark_CopenhagenUniversityHospital_Denmark","Prevalence of SARS-CoV-2 IgG/IgM antibodies among Danish and Swedish Falck emergency and non-emergency healthcare workers","2021-01-21","National","Denmark","2020-06-22","2020-08-10","Health care workers and caregivers","Adults (18-64 years)",2024.0,0.028,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jannie Laursen","Copenhagen University Hospital","https://dx.doi.org/10.3390/ijerph18030923","Verified","Denmark","Livson Diagnostics, Zhuhai, Gunangdong, China; Guangzhou Wondfo Biotech","","","","DK",""
"2021-02-25","210121_Sweden_CopenhagenUniversityHospital_Sweden","Prevalence of SARS-CoV-2 IgG/IgM antibodies among Danish and Swedish Falck emergency and non-emergency healthcare workers","2021-01-21","National","Sweden","2020-06-22","2020-08-10","Health care workers and caregivers","Adults (18-64 years)",1248.0,0.083,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jannie Laursen","Copenhagen University Hospital","https://dx.doi.org/10.3390/ijerph18030923","Verified","Sweden","Livson Diagnostics, Zhuhai, Gunangdong, China; Guangzhou Wondfo Biotech","","","","SE",""
"2021-02-25","210201_Minnesota_UniversityofMinnesota_HCW_Primary","Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA","2021-02-01","Regional","United States of America; Minnesota","2020-04-13","2020-05-21","Health care workers and caregivers","Multiple groups",1282.0,0.03,0.02,0.039,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Stefani Thomas","University of Minnesota","https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010","Verified","United States of America","N/A - author designed",0.861,1.0,"","US","US-MN"
"2021-02-25","210201_Minnesota_UniversityofMinnesota_OutPatients_Primary","Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA","2021-02-01","Regional","United States of America; Minnesota","2020-04-13","2020-05-21","Residual sera","Multiple groups",2379.0,0.045,0.036,0.053,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Stefani Thomas","University of Minnesota","https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010","Verified","United States of America","N/A - author designed",0.861,1.0,"","US","US-MN"
"2021-02-26","210118_France_SorbonneUniversité_primary","Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population","2021-01-18","National","France; Île-de-France and Grand Est","2020-05-15","2020-06-15","Household and community samples","Multiple groups",9782.0,0.035,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Nathanael Lapidus","Sorbonne Université","https://dx.doi.org/10.1016/j.idnow.2020.12.007","Verified","France","1) EuroImmun; 2) EuroImmun; 3) N/A - author desgined","","","","FR",""
"2021-02-26","210226_Estonia_UniversityOfTartu_Stage14_Overall","The study on the prevalence of the coronavirus in Estonia","2021-12-13","National","Estonia","2021-02-11","2021-02-22","Household and community samples","Multiple groups",2626.0,0.115,0.103,0.128,"Stratified probability","IgG","Moderate","Institutional Report","University of Tartu","University of Tartu","https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire","Verified","Estonia","Synlab","","","","EE",""
"2021-02-27","201026_UpstateNewYork_BassettMedicalCenter_Overall copy","SARS-CoV-2 IgG Results Among Healthcare Workers in a Rural Upstate New York Hospital System","2020-10-26","Local","United States of America; New York; Upstate New York","2020-05-04","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",762.0,0.045,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Wendy M Brunner","Bassett Medical Center","https://dx.doi.org/10.1017/ice.2020.1296","Verified","United States of America","Ortho-Clinical Diagnostics, Linden, NJ",1.0,0.996,"","US","US-NY"
"2021-02-27","201027_Perugia_UniversityofPerugia_HIVNegative2_Overall","Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV","2020-10-27","Local","Italy; Umbria; Perugia","2020-05-04","2020-05-31","Multiple populations","Multiple groups",2843.0,0.054,"","","Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Chiara Papalini","University of Perugia","https://dx.doi.org/10.4084/MJHID.2020.080","Verified","Italy","Screen Italia","","","","IT","IT-55"
"2021-02-27","210115_Norway_NorwegianArmedForcesJointMedicalServices_primary","Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts","2021-01-15","National","Norway","2020-04-19","2020-04-27","Essential non-healthcare workers","Adults (18-64 years)",1170.0,0.007,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Einar Kristian Borud","Norwegian Armed Forces Joint Medical Services","https://dx.doi.org/10.1002/hsr2.233","Verified","Norway","Roche","","","","NO",""
"2021-02-27","210125_Canada_UniversityofToronto_Phase2_Overall_PopAdj","COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada","2021-01-25","National","Canada","2020-08-15","2020-09-15","Household and community samples","Multiple groups",1899.0,0.019,"","","Stratified non-probability","IgG","Moderate","Preprint","Xuyang Tang","University of Toronto","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659","Verified","Canada","Network Biology Collaborative; Centre at Sinai Health","","","","CA",""
"2021-02-27","210127_Madrid_UH-FundacionJimenezDiazUAM_primary","Clinical Features of Asymptomatic SARS-CoV-2 Infection in Hemodialysis Patients","2021-01-27","Local","Spain; Community of Madrid; Madrid","2020-03-01","2020-03-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",28.0,0.429,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Soledad Pizarro Sanchez","UH-Fundacion Jimenez Diaz UAM","https://dx.doi.org/10.1159/000512535","Verified","Spain","Vircell","","","","ES","ES-MD"
"2021-02-28","201119_Paris_CentreHospitalierIntercommunalDeCréteil_Children","Assessment of SARS-CoV-2 infection by Reverse transcription-PCR and serology in the Paris area: A cross-sectional study","2020-11-19","Local","France; Île-de-France; Paris","2020-04-14","2020-05-12","Residual sera","Children and Youth (0-17 years)",605.0,0.107,0.084,0.135,"Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Robert Cohen","Centre Hospitalier Intercommunal de Créteil","http://dx.doi.org/10.1136/bmjpo-2020-000887","Verified","France","Biosynex",0.918,0.992,"","FR","FR-IDF"
"2021-02-28","210120_Japan_ResearchInstituteOfTuberculosis_GenPop","Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020","2021-01-20","National","Japan","2020-06-01","2020-06-07","Household and community samples","Multiple groups",7950.0,0.001,0.0,0.002,"Stratified probability","Total Antibody; IgG","Low","Journal Article (Peer-Reviewed)","Takashi Yoshiyama","Government of Japan","https://dx.doi.org/10.3201/eid2702.204088","Verified","Japan","Roche Diagnostics, Abbott Laboratories, NA","","","","JP",""
"2021-03-01","210101_London_LewishamGreenwichNHSTrust_HCW_Overall","Prevalence and socio-demographic factors of SARS-CoV-2 antibody in multi-ethnic healthcare workers","2021-01-01","Local","United Kingdom of Great Britain and Northern Ireland; England; Lewisham, Greenwich","2020-05-27","2020-06-24","Health care workers and caregivers","Adults (18-64 years)",6212.0,0.26,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Mehool Patel","Lewisham and greenwich NHS Trust","https://dx.doi.org/10.7861/clinmed.2020-0619","Verified","The United Kingdom","Abbott",0.99,1.0,"","GB","GB-ENG"
"2021-03-03","200928_CapeTown_UniversityofCapeTown_overall_testadj","SARS-CoV-2 Seroprevalence in the Cape Town Metropolitan sub-districts after the peak of infectons","2020-09-20","Local","South Africa","2020-06-15","2020-08-07","Residual sera","Adults (18-64 years)",2791.0,0.446,0.426,0.466,"Sequential","IgG; IgM","High","Institutional Report","Marvin Hsiao","University of Cape Town","https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Special-Public-Health-Surveillance-Bulletin_Issue-5.pdf","Verified","South Africa","Roche Diagnostics",0.912,0.997,"","ZA",""
"2021-03-03","210201_Chennai_KanchiKamakotiCHILDSTrustHospital_overall_IgG","Correlation of SARS-CoV-2 serology and clinical phenotype amongst hospitalised children in a tertiary children's hospital in India","2021-02-01","Local","India; Tamil Nadu; Chennai","2020-06-01","2020-09-30","Residual sera","Children and Youth (0-17 years)",463.0,0.196,0.154,0.225,"Convenience","IgG","High","Preprint","Aishwarya Venkataraman","Bristol Royal Hospital for Children","https://www.medrxiv.org/content/10.1101/2021.01.29.21250660v1","Verified","India","YHLO Biotechnology Corporation","","","","IN","IN-TN"
"2021-03-04","201123_Quebec_InstitutNationaldeSantePublique_overall","COVID-19 : Étude de séroprévalence chez des travailleurs de la santé de centres hospitaliers au Québec","2020-11-23","Regional","Canada; Québec","2020-07-06","2020-09-24","Health care workers and caregivers","Multiple groups",2056.0,0.117,"","","Stratified non-probability","IgG","High","Institutional Report","Nicholas Brousseau","Institut National de Sante Publique","https://www.inspq.qc.ca/publications/3084-etude-seroprevalence-travailleurs-sante-centres-hospitaliers-quebec-covid19","Verified","Canada","DiaSorin",0.884,"","","CA","CA-QC"
"2021-03-04","210112_ArianoIrpino_Zoo-ProphylacticInstituteOfSouthernItaly_overall","Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based study","2021-01-12","Local","Italy; Province of Avellino in the Campania region; Ariano Irpino","2020-05-16","2020-05-19","Household and community samples","Multiple groups",13218.0,0.056,0.052,0.06,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Pellegrino Cerino","The Zoo-Prophylactic Institute of Southern Italy","https://www.future-science.com/doi/10.2144/fsoa-2020-0203","Verified","Italy","Roche","","","","IT","IT-72"
"2021-03-04","210131_Riyadh_KingAbdullahInternationalMedicalResearchCenter_HCW_overall","Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia","2021-01-31","Local","Saudi Arabia","2020-06-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",400.0,0.075,0.05,0.102,"Unclear","IgG","High","Preprint","Naif Khalaf Alharbi","King Abdullah International Medical Research Center","https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1","Verified","Saudi Arabia","N/A - Author designed","","","","SA",""
"2021-03-04","210131_SaudiArabia_KingAbdullahInternationalMedicalResearchCenter_genpop_overall","Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia","2021-01-31","National","Saudi Arabia; Riyadh, Jazan, Qassim, Hail, Al-Ahsa, Makkah","2020-06-15","2020-11-15","Multiple general populations","Multiple groups",11275.0,0.109,0.103,0.116,"Convenience","IgG","Moderate","Preprint","Naif Khalaf Alharbi","King Abdullah International Medical Research Center","https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1","Verified","Saudi Arabia","1) N/A - author designed; 2) EUROIMMUN","","","","SA",""
"2021-03-04","210201_Washington_ChildrensNationalHospital_Overall_TestAdj","Estimated SARS-CoV-2 Seroprevalence in Healthy Children and Those with Chronic Illnesses in The Washington Metropolitan Area as of October 2020","2021-02-01","Local","United States of America; Washington, D.C, Maryland, Virginia, West Virginia; Washington D.C","2020-07-07","2020-10-29","Residual sera","Children and Youth (0-17 years)",385.0,0.095,0.067,0.13,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Burak Bahar","Children's National Hospital","https://www.medrxiv.org/content/10.1101/2021.01.30.21250830v1.full-text","Verified","United States of America","Diasorin",0.976,0.993,"","US",""
"2021-03-04","210203_NewYorkCity_IcahnSchoolOfMedicine_Overall","Seroprevalence of SARS-CoV-2 during pregnancy and associated outcomes: results from an ongoing prospective cohort study, New York City","2021-02-03","Local","United States of America; New York; New York City","2020-04-20","2020-08-15","Pregnant or parturient women","Adults (18-64 years)",696.0,0.15,"","","Convenience","IgG","Moderate","Preprint","Nina Molenaar","Icahn School of Medicine at Mount Sinai","10.1101/2021.02.01.21250943","Verified","United States of America","Icahn School of Medicine at Mount Sinai (FDA EUA)",0.95,1.0,"","US","US-NY"
"2021-03-05","210125_NewYork_CDC+NewYorkCity_Total","Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020","2021-01-25","Local","United States of America; New York; New York City","2020-05-18","2020-07-02","Essential non-healthcare workers","Multiple groups",22647.0,0.225,0.219,0.23,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Samira Sami","CDC and New York City Department of Health and Mental Hygiene","https://dx.doi.org/10.3201/eid2703.204340","Unverified","United States of America","ORTHO Clinical Diagnostics Inc., https://www.orthoclinicaldiagnostics.com",0.9,1.0,"","US","US-NY"
"2021-03-06","201214_Maricopa_MaricopaCountyDepartmentOfPublicHealth_overall","Maricopa County COVID-19 serosurvey results reported","2020-12-14","Local","United States of America; Arizona","2020-09-11","2020-09-21","Household and community samples","Multiple groups",260.0,0.107,"","","Stratified probability","Not reported","Unclear","News and Media","Fountain Hills Times","Maricopa County Department of Public Health","https://www.fhtimes.com/news/local_news/maricopa-county-covid-19-serosurvey-results-reported/article_6be4ab0a-3983-11eb-ab22-a3b73c8957c7.html","Verified","United States of America","NR","","","","US","US-AZ"
"2021-03-06","210209_Singapore_MinistryOfHealthSingapore","Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore","2021-02-09","Local","Singapore; Singapore; Singapore","2020-03-25","2020-07-25","Multiple populations","Adults (18-64 years)",135760.0,0.601,"","","Convenience","Not reported","Moderate","Journal Article (Peer-Reviewed)","Iain Tan","Ministry of Health Singapore","https://dx.doi.org/10.1001/jama.2020.24071","Verified","Singapore","Siemens, Abbott, or Roche","","","","SG",""
"2021-03-07","200830_VenturaCounty_OxnardFireDepartment_overall","Study reveals data on COVID-19 antibody prevalence in Ventura County","2020-08-30","Local","United States of America; California","2020-06-22","2020-07-06","Household and community samples","Multiple groups",6794.0,0.013,"","","Self-referral","Not reported","High","News and Media","Jeremy Childs","Oxnard Fire Department","https://www.vcstar.com/story/news/2020/08/30/covid-19-data-coronavirus-antibodies-ventura-county/3436858001/","Verified","United States of America","1) Abbott; 2) Bio-Rad","","","","US","US-CA"
"2021-03-07","201005_Wisconsin_UW-Madison_overall","Less than 2% of Wisconsinites have coronavirus antibodies, preliminary results from study show","2020-10-05","Regional","United States of America; Wisconsin","2020-07-15","2020-08-15","Household and community samples","Multiple groups",1056.0,0.016,"","","Stratified probability","Not reported","Unclear","News and Media","Madeline Heim","UW-Madison","https://www.postcrescent.com/story/news/2020/10/05/wisconsin-covid-19-less-than-2-of-state-population-have-antibodies/3457334001/","Verified","United States of America","NR","","","","US","US-WI"
"2021-03-07","201031_Bhubaneswar_RegionalMedicalResearchCentre_overall","Survey: 50% of Bhubaneswar residents have antibodies","2020-10-31","Local","India","2020-10-16","2020-10-18","Household and community samples","Multiple groups",1403.0,0.5,"","","Simplified probability","Not reported","Unclear","News and Media","Riyan Ramanath","The Regional Medical Research Centre in Bhubaneswar","https://timesofindia.indiatimes.com/city/bhubaneswar/survey-50-of-bhubaneswar-residents-have-antibodies/articleshow/78966615.cms","Verified","India","NR","","","","IN",""
"2021-03-07","201123_Korea_KoreaDiseaseControlAndPreventionAgency_genpop","COVID-19 Serology Tests Still Show Low Antibody Rate of 0.07%","2020-11-23","National","Republic of Korea","2020-08-15","2020-10-15","Household and community samples","Multiple groups",1379.0,0.002,"","","Unclear","Not reported","Unclear","News and Media","KBS World","Korea Disease Control and Prevention Agency","https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801","Verified","Republic of Korea","NR","","","","KR",""
"2021-03-07","201123_Korea_KoreaDiseaseControlAndPreventionAgency_military","COVID-19 Serology Tests Still Show Low Antibody Rate of 0.07%","2020-11-23","National","Republic of Korea","2020-08-15","2020-10-15","Essential non-healthcare workers","Adults (18-64 years)",6900.0,0.004,"","","Unclear","Not reported","Unclear","News and Media","KBS World","Korea Disease Control and Prevention Agency","https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801","Verified","Republic of Korea","NR","","","","KR",""
"2021-03-07","201203_Florida_FloridaDepartmentOfHealth_primary","Lake, Sumter residents testing positive for COVID antibody remain below state average","2020-12-03","Regional","United States of America; Florida","2020-05-01","2020-11-30","Household and community samples","Multiple groups",630838.0,0.11,"","","Self-referral","IgG; Total Antibody","Unclear","News and Media","Frank Jolley","Florida Department of Health","https://www.dailycommercial.com/story/news/2020/12/03/area-residents-covid-antibody-below-state-average/6475413002/","Verified","United States of America","NR","","","","US","US-FL"
"2021-03-07","201222_Warsaw_CentralClinicalHospitalMSWiA","The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy.","2020-12-22","Local","Poland","2020-04-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",61.0,0.164,"","","Sequential","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Piotr Ciechanowicz","Central ClinicalHospital MSWiA","https://dx.doi.org/10.1080/09546634.2020.1861177","Verified","Poland","Vircell Microbiologist, Granada, Spain:","","","","PL",""
"2021-03-08","200824_Louiseville_UniversityOfLouiseville_HCW_July","New Co-Immunity Project data show COVID-19 infection among health care workers may be lower than the general population","2020-08-24","Local","United States of America; Kentucky; Louiseville","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1100.0,0.022,"","","Convenience","Not reported","Unclear","News and Media","Betty Coffman","University of Louiseville","http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/","Verified","United States of America","NR","","","","US","US-KY"
"2021-03-08","201124_JeffersonCounty_UniversityofLouiseville_ProbabilitySampling","Co-Immunity Project shows COVID-19 infection rate in Jefferson County increased tenfold since September","2020-11-24","Local","United States of America; Kentucky","2020-11-09","2020-11-16","Household and community samples","Multiple groups",1091.0,0.02,"","","Stratified probability","Not reported","Unclear","News and Media","Betty Coffman","University of Louiseville","https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/","Verified","United States of America","NR","","","","US","US-KY"
"2021-03-08","201124_JeffersonCounty_UniversityofLouiseville_SelfReferal_overall","Co-Immunity Project shows COVID-19 infection rate in Jefferson County increased tenfold since September","2020-11-24","Local","United States of America; Kentucky","2020-11-09","2020-11-16","Household and community samples","Multiple groups",1709.0,0.033,"","","Self-referral","Not reported","Unclear","News and Media","Betty Coffman","University of Louiseville","https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/","Verified","United States of America","NR","","","","US","US-KY"
"2021-03-09","200824_Louiseville_UniversityOfLouiseville_HCW_AprilMay","New Co-Immunity Project data show COVID-19 infection among health care workers may be lower than the general population","2020-08-24","Local","United States of America; Kentucky; Louiseville","2020-04-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1372.0,0.01,"","","Convenience","Not reported","Unclear","News and Media","Betty Coffman","University of Louiseville","http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/","Verified","United States of America","NR","","","","US","US-KY"
"2021-03-09","210128_XikrinofBacaja_InstitutodeCiênciasBiológicasdaUniversidadeFederaldoPará_overall","High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacaja (Kayapo) indigenous population in the brazilian Amazon","2021-01-28","Local","Brazil; Pará; Xikrin of Bacaja Villages","2020-09-01","2020-09-30","Household and community samples","Multiple groups",100.0,0.73,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Eliene Putira Sacuema Rodrigues","Instituto de Ciências Biológicas da Universidade Federal do Pará","https://dx.doi.org/10.1186/s12939-021-01392-8","Verified","Brazil","Euroimmun, Brazil","","","Rapid immunochromatographic test; ELISA","BR","BR-PA"
"2021-03-09","210203_Dusseldorf_InstituteOfMedicalSociology_SERODUSII_overall_TestAdj","Seroprevalence COVID-19 Düsseldorf: SERODUS I & II","2021-02-03","Local","Germany","2020-11-23","2020-11-27","Essential non-healthcare workers","Adults (18-64 years)",745.0,0.044,0.031,0.062,"Convenience","IgG; IgM; IgA","High","Institutional Report","Insa Backhaus","Institute Of Medical Sociology","https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus","Verified","Germany","Roche",0.9,0.998,"","DE",""
"2021-03-09","210203_Dusseldorf_InstituteOfMedicalSociology_overall_TestAdj","Seroprevalence COVID-19 Düsseldorf: SERODUS I & II","2021-02-03","Local","Germany","2020-11-02","2020-11-23","Household and community samples","Adults (18-64 years)",2186.0,0.031,0.024,0.04,"Simplified probability","IgG; IgA; IgM","Low","Institutional Report","Insa Backhaus","Institute Of Medical Sociology","https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus","Verified","Germany","Roche",0.9,0.998,"","DE",""
"2021-03-11","200731_Bremen_UniversityOfBremen_IgG/IgA","Low anti-SARS-CoV-2 seroprevalence among public sector employees in Bremen","2020-07-31","Local","Germany","2020-03-31","2020-05-16","Multiple populations","Adults (18-64 years)",281.0,0.021,"","","Unclear","IgG; IgA","High","Journal Article (Peer-Reviewed)","Jan Neumann","University of Bremen","https://www.asu-arbeitsmedizin.com/node/153868/print","Verified","Germany","Euroimmun","","","","DE",""
"2021-03-11","200920_Leningrad_Saint-PetersburgPasteurResearchInstitute_Overall","Assessment of the Herd Immunity to SARS-CoV-2 among the Population of the Leningrad Region during the COVID-19 Epidemic","2020-09-16","Regional","Russian Federation; Northwestern Federal District","2020-06-23","2020-06-26","Household and community samples","Multiple groups",3130.0,0.207,"","","Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Anna Popova","Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology","https://journal.microbe.ru/jour/article/view/1371/1150#","Verified","Russian Federation","State Scientific Center of Applied Microbiology and Biotechnology (Obolensk)","","","","RU",""
"2021-03-11","210115_France_InstitutNationaldelaStatistiqueetdesÉtudesÉconomiques_Overall","In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2","2021-01-15","National","France","2020-05-02","2020-06-02","Household and community samples","Multiple groups",12114.0,0.045,0.039,0.05,"Stratified probability","IgG","Low","Institutional Report","Josiane Warszawski","l’Institut national de la santé et de la recherche médicale (Inserm)","https://drees.solidarites-sante.gouv.fr/sites/default/files/2021-01/er1167-en.pdf","Verified","France","EUROIMMUN",0.944,1.0,"","FR",""
"2021-03-11","210127_UniversityHospitalofBari_UniversityofBari_overall_IgG_unadj","Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: perspectives for public health","2021-01-27","Local","Italy; Puglia; Bari","2020-04-08","2020-06-07","Health care workers and caregivers","Adults (18-64 years)",2407.0,0.024,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Luigi Vimercati","University of Bari","https://dx.doi.org/10.1016/j.envres.2021.110793","Verified","Italy","Abbott",0.5,0.98,"","IT","IT-75"
"2021-03-11","210131_Calgary_UniversityOfCalgary_overall","Alberta Childhood COVID-19 Cohort (AB3C) Aim 3: Longitudinal Sero-Epidemiology Study First Interim Report January 31, 2021","2021-01-31","Local","Canada; Alberta; Calgary","2020-07-30","2020-11-18","Household and community samples","Children and Youth (0-17 years)",911.0,0.003,0.001,0.01,"Self-referral","IgG","Moderate","Institutional Report","James Kellner","University of Calgary","https://prism.ucalgary.ca/bitstream/handle/1880/113084/AB3C%20Aim%203%201st%20Interim%20Report-final.pdf?sequence=5&isAllowed=y","Unverified","Canada","Abbott",0.761,"","","CA","CA-AB"
"2021-03-11","210201_Portugal_InstitutoNacionalDeSaúdeDoutorRicardoJorge_overall_TestAdj_PopAdj","Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19)","2021-02-01","National","Portugal; Norte Region, Centro Region, Lisboa Region, Alentejo Region, Algarve Region, Madeira, Azores","2020-05-21","2020-07-08","Residual sera","Multiple groups",2301.0,0.017,0.0,0.033,"Stratified non-probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Irina Kislaya","Instituto Nacional de Saúde Doutor Ricardo Jorge","https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15122","Verified","Portugal","1) Wantai; 2) EUROIMMUN","","","","PT",""
"2021-03-11","210209_Madrid_HospitalUniversitarioVirgendelRocio","High Rates of SARS-CoV-2 Family Transmission in Children of Healthcare Workers During the First Pandemic Wave in Madrid, Spain: Serologic Study","2021-02-09","Local","Spain; Community of Madrid; Madrid","2020-03-15","2020-05-15","Contacts of COVID patients","Children and Youth (0-17 years)",113.0,0.416,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ana Mendez Echevarria","Hospital Universitario Virgen del Rocio","https://dx.doi.org/10.1097/INF.0000000000003088","Verified","Spain","Vircell","","","","ES","ES-MD"
"2021-03-12","200626_UK_OfficeforNationalStatistics_May_June2020_England_Genpop","Coronavirus (COVID-19) Infection Survey: May_June 2020","2020-06-25","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-05-08","2020-06-04","Household and community samples","Multiple groups",1575.0,0.063,0.045,0.087,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200726_UK_OfficeforNationalStatistics_June_July2020_England_Genpop","Coronavirus (COVID-19) Infection Survey: June_July 2020","2020-07-31","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-06-05","2020-07-02","Household and community samples","Multiple groups",2392.0,0.042,"","","Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200826_UK_OfficeforNationalStatistics_July_020_England_genpop","Coronavirus (COVID-19) Infection Survey: July_August2020","2020-08-28","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-07-03","2020-07-30","Household and community samples","Multiple groups",3236.0,0.065,0.052,0.081,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200826_UK_OfficeforNationalStatistics_July_August2020_England_genpop","Coronavirus (COVID-19) Infection Survey: July_August2020","2020-08-28","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-07-31","2020-08-27","Household and community samples","Multiple groups",6189.0,0.056,0.047,0.065,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200926_UK_OfficeforNationalStatistics_August_Sept2020_England_genpop","Coronavirus (COVID-19) Infection Survey: August_September2020","2020-09-25","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-08-28","2020-09-24","Household and community samples","Multiple groups",8742.0,0.058,0.051,0.065,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","200926_UK_OfficeforNationalStatistics_August_Sept2020_Wales_Genpop","Coronavirus (COVID-19) Infection Survey: August_September2020","2020-09-25","Regional","United Kingdom of Great Britain and Northern Ireland; Wales","2020-08-28","2020-09-24","Household and community samples","Multiple groups",236.0,0.047,0.02,0.092,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-WLS"
"2021-03-12","201026_UK_OfficeforNationalStatistics_Sept_Oct2020_England_Genpop","Coronavirus (COVID-19) Infection Survey: September_October2020","2020-10-23","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-09-25","2020-10-22","Household and community samples","Multiple groups",15687.0,0.069,0.064,0.075,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","201026_UK_OfficeforNationalStatistics_Sept_Oct2020_NorthernIreland_genpop","Coronavirus (COVID-19) Infection Survey: September_October2020","2020-10-23","Regional","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2020-09-25","2020-10-22","Household and community samples","Multiple groups",249.0,0.028,0.012,0.055,"Stratified probability","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-NIR"
"2021-03-12","201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Scotland_Genpop","Coronavirus (COVID-19) Infection Survey: September_October2020","2020-10-23","Regional","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-09-25","2020-10-22","Household and community samples","Multiple groups",383.0,0.068,0.043,0.102,"Stratified probability","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-SCT"
"2021-03-12","201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Wales_Genpop","Coronavirus (COVID-19) Infection Survey: September_October2020","2020-10-23","Regional","United Kingdom of Great Britain and Northern Ireland; Wales","2020-09-25","2020-10-22","Household and community samples","Multiple groups",473.0,0.047,0.029,0.073,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-WLS"
"2021-03-12","201102_Singapore_NationalCentreForInfectiousDiseases_overall","SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study","2020-11-02","National","Singapore","2020-01-23","2020-04-03","Contacts of COVID patients","Multiple groups",1150.0,0.038,"","","Entire sample","Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Oon Tek Ng","National Centre for Infectious Diseases, Singapore","https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30833-1/fulltext?dgcid=raven_jbs_etoc_email","Verified","Singapore","N/A - author designed",0.989,1.0,"","SG",""
"2021-03-12","201126_UK_OfficeforNationalStatistics_Oct_Nov2020 _Scotland_Genpop","Coronavirus (COVID-19) Infection Survey: October_November2020","2020-11-26","Regional","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-10-23","2020-11-19","Household and community samples","Multiple groups",397.0,0.078,0.05,0.117,"Stratified probability","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-SCT"
"2021-03-12","201126_UK_OfficeforNationalStatistics_Oct_Nov2020_England_genpop","Coronavirus (COVID-19) Infection Survey: October_November2020","2020-11-26","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-10-23","2020-11-19","Household and community samples","Multiple groups",15834.0,0.087,0.081,0.094,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","201126_UK_OfficeforNationalStatistics_Oct_Nov2020_NorthernIreland_Genpop","Coronavirus (COVID-19) Infection Survey: October_November2020","2020-11-26","Regional","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2020-10-23","2020-11-19","Household and community samples","Multiple groups",333.0,0.035,0.016,0.064,"Stratified probability","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-NIR"
"2021-03-12","201126_UK_OfficeforNationalStatistics_Oct_Nov2020_Wales_genpop","Coronavirus (COVID-19) Infection Survey: October_November2020","2020-11-26","Regional","United Kingdom of Great Britain and Northern Ireland; Wales","2020-10-23","2020-11-19","Household and community samples","Multiple groups",497.0,0.061,0.04,0.09,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-WLS"
"2021-03-12","201226_UK_OfficeforNationalStatistics_Nov_Dec2020_England_genpop","Coronavirus (COVID-19) Infection Survey: November_December 2020","2020-12-24","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-11-20","2020-12-17","Household and community samples","Multiple groups",21684.0,0.101,0.096,0.106,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","201226_UK_OfficeforNationalStatistics_Nov_Dec2020_NortherIreland_genpop","Coronavirus (COVID-19) Infection Survey: November_December 2020","2020-12-24","Regional","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2020-11-20","2020-12-17","Household and community samples","Multiple groups",248.0,0.037,0.017,0.071,"Stratified probability","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-NIR"
"2021-03-12","201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Scotland_genpop","Coronavirus (COVID-19) Infection Survey: November_December 2020","2020-12-24","Regional","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-11-20","2020-12-17","Household and community samples","Multiple groups",1034.0,0.059,0.044,0.076,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-SCT"
"2021-03-12","201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Wales_genpop","Coronavirus (COVID-19) Infection Survey: November_December 2020","2020-12-24","Regional","United Kingdom of Great Britain and Northern Ireland; Wales","2020-11-20","2020-12-17","Household and community samples","Multiple groups",631.0,0.072,0.051,0.099,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-WLS"
"2021-03-12","210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_England_Genpop","Coronavirus (COVID-19) Infection Survey: December_January2021","2021-01-29","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-12-18","2021-01-14","Household and community samples","Multiple groups",24150.0,0.153,0.147,0.159,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-03-12","210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_NortherIreland_genpop","Coronavirus (COVID-19) Infection Survey: December_January2021","2021-01-29","Regional","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2020-12-18","2021-01-14","Household and community samples","Multiple groups",313.0,0.12,0.078,0.174,"Stratified probability","IgG","High","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-NIR"
"2021-03-12","210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Scotland_genpop","Coronavirus (COVID-19) Infection Survey: December_January2021","2021-01-29","Regional","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-12-18","2021-01-14","Household and community samples","Multiple groups",1832.0,0.107,0.091,0.124,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-SCT"
"2021-03-12","210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Wales_genpop","Coronavirus (COVID-19) Infection Survey: December_January2021","2021-01-29","Regional","United Kingdom of Great Britain and Northern Ireland; Wales","2020-12-18","2021-01-14","Household and community samples","Multiple groups",732.0,0.115,0.086,0.149,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office of National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-WLS"
"2021-03-13","201028_Connecticut_YaleSchoolOfMedicine_Black2Overall_PopAdj","Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study","2020-10-28","Regional","United States of America; Connecticut","2020-06-23","2020-07-22","Household and community samples","Multiple groups",148.0,0.064,0.009,0.119,"Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Shiwani Mahajan","Yale School of Medicine","http://dx.doi.org/10.1016/j.amjmed.2020.09.024","Verified","United States of America","Ortho-Clinical Diagnostics",0.9,1.0,"","US","US-CT"
"2021-03-13","201028_Connecticut_YaleSchoolOfMedicine_Hispanic3_Overall_PopAdj","Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study","2020-10-28","Regional","United States of America; Connecticut","2020-06-23","2020-07-22","Household and community samples","Multiple groups",171.0,0.199,0.132,0.266,"Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Shiwani Mahajan","Yale School of Medicine","http://dx.doi.org/10.1016/j.amjmed.2020.09.024","Verified","United States of America","Ortho-Clinical Diagnostics",0.9,1.0,"","US","US-CT"
"2021-03-13","201130_Fribourg_UniversitéDeFribourg_overall","Corona Immunitas Fribourg Immunté de la population Episode 1/2020","2020-11-30","Regional","Switzerland; Canton of Fribourg","2020-07-08","2020-10-14","Household and community samples","Multiple groups",418.0,0.08,0.04,0.12,"Simplified probability","IgG; IgA","Moderate","Institutional Report","Daniela Anker","Université de Fribourg","https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2020-PopHealthLab-Corona-Immunitas-E1.pdf","Verified","Switzerland","N/A - institutionally designed (Centre Hospitalier Universitaire Vaudois (CHUV), l'École Polytechnique Fédérale de Lausanne (EPFL) et l’Institut Suisse de Recherche sur les Vaccins)",0.966,0.997,"","CH","CH-FR"
"2021-03-13","210107_Austria_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Austria","2020-07-17","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",196.0,0.0,0.0,0.019,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Unverified","Austria","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","","","","AT",""
"2021-03-13","210107_CapeTown_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","South Africa; NR; Capetown","2020-06-10","2020-08-17","Health care workers and caregivers","Adults (18-64 years)",222.0,0.104,0.07,0.151,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified","South Africa","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","","","","ZA",""
"2021-03-13","210107_Estonia_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Estonia; NR; NR","2020-06-10","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",130.0,0.0,0.0,0.029,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified","Estonia","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","","","","EE",""
"2021-03-13","210107_Greece_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Greece; NR; NR","2020-06-19","2020-07-16","Health care workers and caregivers","Adults (18-64 years)",77.0,0.013,0.002,0.07,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified","Greece","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","","","","GR",""
"2021-03-13","210107_Latvia_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Latvia; NR; NR","2020-05-19","2020-06-20","Health care workers and caregivers","Adults (18-64 years)",177.0,0.0,0.0,0.021,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified","Latvia","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","","","","LV",""
"2021-03-13","210107_Lithuania_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Lithuania; NR; NR","2020-06-01","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",300.0,0.007,0.002,0.024,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified","Lithuania","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","","","","LT",""
"2021-03-13","210107_London_UniversityCollegeLondon_June_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",1134.0,0.169,0.149,0.192,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified","The United Kingdom","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","","","","GB","GB-ENG"
"2021-03-13","210107_London_UniversityCollegeLondon_May_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1754.0,0.153,0.137,0.171,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Unverified","The United Kingdom","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","","","","GB","GB-ENG"
"2021-03-13","210107_Romania_UniversityCollegeLondon_PaediatricHCW","Cross Sectional Prevalence of SARS-CoV-2 antibodies in Health Care Workers in Paediatric Facilities in Eight Countries","2021-01-27","Local","Romania; NR; NR","2020-05-14","2020-05-27","Health care workers and caregivers","Adults (18-64 years)",124.0,0.008,0.001,0.043,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","D Goldblatt","University College London","http://dx.doi.org/10.1016/j.jhin.2020.12.019","Verified","Romania","Epitope Diagnostics, MSD SARS-Coronavirus Plate 1, Rockville, MD, USA)","","","","RO",""
"2021-03-13","210122_Bogota_InstitutoNacionaldeSalud_OverallTestAdj","Seroprevalence and seroconversions for SARS-CoV-2 infections in workers at Bogota Airport, Colombia, 2020","2021-01-22","Local","Colombia; Capital District Cundinamarca; Bogota","2020-06-01","2020-09-30","Essential non-healthcare workers","Adults (18-64 years)",212.0,0.16,0.104,0.216,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Jeadran Malagon Rojas","Instituto Nacional de Salud","https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab006/6106252?searchresult=1","Verified","Colombia","Abbott Laboratories",0.855,0.973,"","CO","CO-DC"
"2021-03-13","210122_USA_YourCareChoice_GenPop","COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders","2021-01-22","National","United States of America","2020-04-24","2020-05-13","Household and community samples","Multiple groups",407.0,0.216,"","","Stratified probability","Not reported","High","Journal Article (Peer-Reviewed)","Robert Morlock","YourCareChoice","https://dx.doi.org/10.1371/journal.pone.0245586","Verified","United States of America","NR","","","","US",""
"2021-03-13","210123_Norfolk_NavalMedicalCenterPortsmouth_Overall","SARS-CoV-2 Infections and Serologic Responses Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 Pandemic","2021-01-23","Local","United States of America; Virginia; Norfolk","2020-04-28","2020-05-12","Essential non-healthcare workers","Adults (18-64 years)",432.0,0.03,0.016,0.051,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Tahaniyat Lalani","Naval Medical Center Portsmouth","https://dx.doi.org/10.1093/ofid/ofaa654","Verified","United States of America","LakePharma, Inc",0.98,1.0,"","US","US-VA"
"2021-03-13","210201_France_TissueBankofLille_overall_unadj","Retrospective study of COVID-19 seroprevalence among tissue donors at the onset of the outbreak before implementation of strict lockdown measures in France","2021-02-01","Local","France","2019-11-01","2020-03-16","Tissue donor","Multiple groups",235.0,0.017,"","","Sequential","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Nicolas Germain","CHU Lille","https://dx.doi.org/10.1007/s10561-021-09901-3","Verified","France","1) Abbott ; 2)Wantai","","","","FR",""
"2021-03-13","210203_StLouis_WashingtonUniversitySchoolofMedicine_Adults_overall_adj","Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA","2021-02-03","Local","United States of America; Missouri; St Louis","2020-04-27","2020-05-12","Residual sera","Multiple groups",21.0,0.031,0.009,0.053,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Brittany K Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.01207-20","Verified","United States of America","Authors",0.982,0.987,"","US","US-MO"
"2021-03-13","210203_StLouis_WashingtonUniversitySchoolofMedicine_Children_overall_adj","Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA","2021-02-03","Local","United States of America; Missouri; St Louis","2020-04-14","2020-05-08","Residual sera","Children and Youth (0-17 years)",15.0,0.017,0.0,0.034,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Brittany K Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.01207-20","Verified","United States of America","Authors",0.982,0.987,"","US","US-MO"
"2021-03-13","210219_Jena_JenaUniversityHospital_Overall","Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff","2021-02-19","Local","Germany; Thuringia; Jena","2020-05-19","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",660.0,0.027,0.016,0.043,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Christina Bahrs","Jena University Hospital","https://dx.doi.org/10.1111/tbed.14041","Verified","Germany","Epitope Diagnostics Inc.; Roche Diagnostics","","","","DE","DE-TH"
"2021-03-13","210309_Zambia_ZambiaMinistryofHealth_overall","Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey","2021-03-09","National","Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi","2020-07-04","2020-07-27","Household and community samples","Multiple groups",2704.0,0.021,0.011,0.031,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Lloyd B Mulenga","Zambia Ministry of Health","https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00053-X/fulltext","Verified","Zambia","PerkinElmer","","","","ZM",""
"2021-03-14","201001_SouthwesternGermany_UniversityMedicalCenterofTheJohannesGutenbergUniversityMainz_BloodDonors_Overall","Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic","2020-10-01","Regional","Germany; Southwest","2020-03-15","2020-06-15","Blood donors","Multiple groups",3880.0,0.009,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Stefan Runkel","University Medical Center of The Johannes Gutenberg-University Mainz","https://pubmed.ncbi.nlm.nih.gov/33073955/","Verified","Germany","Abbott Laboratories","",0.996,"","DE",""
"2021-03-14","201019_Irkutsk_SaintPetersburgPasteurResearchInstitute_Overall","Experience in Studying Seroprevalence to SARS-CoV-2 Virus in the Population of the Irkutsk Region during COVID-19 Outbreak","2020-10-10","Regional","Russian Federation; Irkutsk Region","2020-06-28","2020-07-19","Household and community samples","Multiple groups",2674.0,0.058,0.054,0.062,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","Saint-Petersburg Pasteur Research Institute","https://journal.microbe.ru/jour/article/view/1370/1149","Verified","Russian Federation","State Scientific Center Applied Microbiology and Biotechnology","","","","RU","RU-IRK"
"2021-03-14","210109_Taiwan_NationalTaiwanUniversityHospital_HCW_Overall","A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan","2021-01-09","Local","China; Taiwan; Taipei","2020-07-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",194.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Sung Ching Pan","National Taiwan University Hospital","https://dx.doi.org/10.1016/j.jfma.2021.01.002","Unverified","China","Abbott; Roche; Mikrogen Diagnostik","","","","CN",""
"2021-03-14","210120_NorthDakota_NorthDakotaStateUniversity_PharmacyPersonnel","Prevalence of SARS-CoV-2 antibodies among North Dakota community pharmacy personnel: A seroprevalence survey","2021-01-20","Regional","United States of America; North Dakota; Fargo, Grand Forks","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",247.0,0.146,0.104,0.196,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Amanda Johnson","North Dakota State University","https://www.japha.org/article/S1544-3191(21)00025-X/abstract","Verified","United States of America","BioSys Laboratories",0.935,1.0,"","US","US-ND"
"2021-03-14","2101_Zahedan_TehranUniversityofMedicalSciences","The seroprevalence of COVID-19 in intravenous drug users in comparison to non-drug users","2021-01-01","Local","Iran (Islamic Republic of); Sistan and Balouchestan; Zahedan","2020-07-01","2020-07-31","Persons experiencing homelessness","Adults (18-64 years)",167.0,0.097,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Zahra Mohammadi","Tehran University of Medical Sciences","http://dx.doi.org/10.34172/mejdd.2021.206a","Verified","Iran (Islamic Republic of)","Pishtaz Teb, Tehran, Iran","","","","IR","IR-13"
"2021-03-14","2101_Zahedan_TehranUniversityofMedicalSciences_NonDrugUsers","The seroprevalence of COVID-19 in intravenous drug users in comparison to non-drug users","2021-01-01","Local","Iran (Islamic Republic of); Sistan and Balouchestan; Zahedan","2020-07-01","2020-07-31","Household and community samples","Adults (18-64 years)",134.0,0.048,"","","Simplified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Zahra Mohammadi","Tehran University of Medical Sciences","http://dx.doi.org/10.34172/mejdd.2021.206a","Verified","Iran (Islamic Republic of)","Pishtaz Teb Tehran, Iran","","","","IR","IR-13"
"2021-03-14","210209_Catania_UniversityofCatania","SARS-CoV-2 Seroprevalence Post-First Wave among Primary Care Physicians in Catania (Italy)","2021-02-09","Local","Italy; Sicily; Catania","2020-06-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",133.0,0.03,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Caterina Ledda","University of Catania","https://dx.doi.org/10.3390/tropicalmed6010021","Verified","Italy","NovaTec Immundiagnostics GmbH, Dietzenbach, Germany","","","","IT","IT-82"
"2021-03-14","210212_Arizona_KingmanRegionalMedicalCenter_Overall","The seroprevalence of SARS-CoV-2 in a rural southwest community","2021-02-12","Local","United States of America; Arizona; Kingman","2020-09-28","2020-10-09","Household and community samples","Adults (18-64 years)",566.0,0.08,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Anthony Santarelli","Kingman Regional Medical Center","https://dx.doi.org/10.1515/jom-2020-0287","Verified","United States of America","Ortho-Clinical Diagnostics Inc.",0.875,1.0,"","US","US-AZ"
"2021-03-14","210216_Bukavu_UniversitéLibredeBruxelles_OverallELISA","High SARS-CoV-2 Seroprevalence in Healthcare Workers in Bukavu, Eastern Democratic Republic of Congo","2021-02-16","Local","Democratic Republic of the Congo; South-Kivu; Bukavu","2020-07-02","2020-08-19","Health care workers and caregivers","Adults (18-64 years)",359.0,0.412,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Denis Mukwege","Université Libre de Bruxelles (ULB)","https://dx.doi.org/10.4269/ajtmh.20-1526","Verified","Democratic Republic of the Congo","Euroimmun",0.617,0.986,"","CD","CD-SK"
"2021-03-14","210225_Denver_UniversityofColorado_EstablishedDiabetes","Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes","2021-02-25","Local","United States of America; Colorado; Denver","2020-01-03","2020-10-16","Patients seeking care for non-COVID-19 reasons","Multiple groups",94.0,0.043,0.017,0.104,"Sequential","Total Antibody","High","Journal Article (Peer-Reviewed)","Xiaofan Jia","University of Colorado","https://dx.doi.org/10.1089/dia.2020.0609","Verified","United States of America","In-House: University of Colorado",1.0,0.999,"","US","US-CO"
"2021-03-14","210225_Denver_UniversityofColorado_GenPopAdults","Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes","2021-02-25","Local","United States of America; Colorado; Denver","2020-07-08","2020-10-23","Household and community samples","Adults (18-64 years)",102.0,0.039,0.015,0.097,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Xiaofan Jia","University of Colorado","https://dx.doi.org/10.1089/dia.2020.0609","Verified","United States of America","In-House: University of Colorado",1.0,0.999,"","US","US-CO"
"2021-03-14","210225_Denver_UniversityofColorado_GenPopChildren","Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes","2021-02-25","Local","United States of America; Colorado; Denver","2020-07-08","2020-10-23","Household and community samples","Children and Youth (0-17 years)",562.0,0.028,0.018,0.046,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Xiaofan Jia","University of Colorado","https://dx.doi.org/10.1089/dia.2020.0609","Verified","United States of America","In-House: University of Colorado",1.0,0.999,"","US","US-CO"
"2021-03-14","210225_Denver_UniversityofColorado_NewOnsetDiabetes","Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes","2021-02-25","Local","United States of America; Colorado; Denver","2020-01-03","2020-10-16","Patients seeking care for non-COVID-19 reasons","Multiple groups",129.0,0.008,0.001,0.042,"Sequential","Total Antibody","High","Journal Article (Peer-Reviewed)","Xiaofan Jia","University of Colorado","https://dx.doi.org/10.1089/dia.2020.0609","Verified","United States of America","In-House: University of Colorado",1.0,0.999,"","US","US-CO"
"2021-03-15","210219_England_PHE_UniversityStudents_Overall","Seroprevalence of SARS-CoV-2 Antibodies in University Students: Cross-sectional Study, December 2020, England","2021-02-19","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-12-02","2020-12-11","Students and Daycares","Adults (18-64 years)",2905.0,0.178,0.165,0.193,"Convenience","IgG","Moderate","Preprint","Amoolya Vusirikala","Public Health England","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3787684","Verified","The United Kingdom","Abbott Laboratories; In-House (PHE)","","","","GB","GB-ENG"
"2021-03-16","201027_DistrictSrinagar_GovernmentMedicalCollege_Overall","SARS-CoV-2 seroprevalence in healthcare workers of dedicated-COVID hospitals and nonâ€“COVID hospitals of District Srinagar, Kashmir","2020-10-27","Local","India; Kashmir","2020-06-15","2020-06-29","Health care workers and caregivers","Adults (18-64 years)",2905.0,0.025,0.02,0.031,"Convenience","IgG","Moderate","Preprint","Muhammad Salim Khan","Government Medical College","https://www.medrxiv.org/content/10.1101/2020.10.23.20218164v1.full-text","Verified","India","Abbott Laboratories",1.0,"","","IN","IN-JK"
"2021-03-16","201031_Veneto_NationalAssociationofCompanyandCompetentDoctors","Effectiveness of the measures aimed at containing Sars-cov-2 virus spreading in work settings: a survey in companies based in the Veneto region of Italy","2020-10-31","Local","Italy; Veneto","2020-04-11","2020-04-29","Essential non-healthcare workers","Adults (18-64 years)",1267.0,0.016,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Danilo Bontadi","National Association of Company and Competent Doctors","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809981/","Verified","Italy","NR, MAGLUMI, NR","","","","IT","IT-34"
"2021-03-16","210119_Madrid_HospitalInfantilUniversitarioNiñoJesús","Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a pediatric monographic hospital in Madrid (Spain)","2021-01-19","Local","Spain; Community of Madrid; Madrid","2020-04-13","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",1292.0,0.172,0.152,0.194,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Eva Escribano Ceruelo","Hospital Infantil Universitario Niño Jesús","https://dx.doi.org/10.1016/j.eimc.2020.12.011","Verified","Spain","All Test","","","","ES","ES-MD"
"2021-03-16","210206_Kaunas_HospitalofLithuanianUniversityofHealthSciencesKaunoKlinikos_LFIA","SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic","2021-02-06","Local","Lithuania","2020-06-15","2020-09-21","Health care workers and caregivers","Multiple groups",432.0,0.012,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Laura Pereckaite","The Hospital of Lithuanian University of Health Sciences Kauno Klinikos","https://dx.doi.org/10.3390/medicina57020148","Verified","Lithuania","AMEDA Labordiagnostik GmbH",0.918,0.964,"","LT",""
"2021-03-16","210217_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj","Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya","2021-02-17","National","Kenya","2020-09-30","2020-10-23","Essential non-healthcare workers","Adults (18-64 years)",830.0,0.423,0.384,0.463,"Convenience","IgG","Moderate","Preprint","E Wangeci Kagucia","KEMRI-Wellcome Trust Research Programme","https://www.medrxiv.org/content/10.1101/2021.02.12.21251294v1","Verified","Kenya","NR",0.93,0.99,"","KE",""
"2021-03-17","210105_Mazandaran_MazandaranUniversityofMedicalSciences_OverallPopAdj","Seroprevalence of SARS-CoV-2 in Mazandaran province, Iran","2021-01-05","Regional","Iran (Islamic Republic of); Mazandaran","2020-03-15","2020-05-15","Household and community samples","Multiple groups",1588.0,0.173,0.148,0.178,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Seyed Abbas Mousavi","Mazandaran University of Medical Sciences","https://www.apjtm.org/article.asp?issn=1995-7645;year=2021;volume=14;issue=1;spage=10;epage=16;aulast=Mousavi","Verified","Iran (Islamic Republic of)","Danesh Bonyan Pishtaz Teb Company",0.59,1.0,"","IR","IR-21"
"2021-03-17","210127_India_ICRM_overall_adj","SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey","2021-01-27","National","India","2020-08-18","2020-09-20","Household and community samples","Multiple groups",29082.0,0.066,0.058,0.074,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Manoj V Murhekar","The Indian Council of Medical Research (ICMR)","https://dx.doi.org/10.1016/S2214-109X(20)30544-1","Verified","India","Abbott",1.0,0.996,"","IN",""
"2021-03-17","210127_UK_UniversityCollegeLondon_overall","Longitudinal Assessment of Symptoms and Risk of SARS-CoV-2 Infection in Healthcare Workers Across 5 Hospitals to Understand Ethnic Differences in Infection Risk","2021-01-27","Regional","United Kingdom of Great Britain and Northern Ireland; England; Nottingham, London","2020-03-23","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",1364.0,0.199,"","","Convenience","IgG","High","Preprint","Ana Valdes","University College London","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3754805","Verified","The United Kingdom","Euroimmun; Roche Diagnostics; In House ELISA","","","","GB","GB-ENG"
"2021-03-17","210202_ParrisIsland_IcahnSchoolofMedicineatMountSinai","SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020","2021-02-02","Local","United States of America; North Carolina; Parris Island","2020-05-11","2020-09-07","Essential non-healthcare workers","Adults (18-64 years)",3196.0,0.09,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Andrew Letizia","Icahn School of Medicine at Mount Sinai","http://dx.doi.org/10.3201/eid2704.204732","Verified","United States of America","Independent authors, Amanat et al",0.961,0.971,"","US","US-NC"
"2021-03-17","210205_India_ICRM_overall","ICMR sero survey: One in five Indians exposed to Covid-19","2021-02-05","National","India","2020-12-17","2021-01-08","Household and community samples","Multiple groups",28589.0,0.215,"","","Stratified probability","Not reported","Unclear","News and Media","BBC News","The Indian Council of Medical Research (ICMR)","https://www.bbc.com/news/world-asia-india-55945382","Verified","India","NR","","","","IN",""
"2021-03-17","210209_Atlanta_EmoryUniversity","Occupational Risk Factors for SARS-CoV-2 Infection among Healthcare Personnel: A Cross-Sectional Analysis of Subjects Enrolled in the COPE Study","2021-02-09","Local","United States of America; Georgia; Atlanta","2020-05-06","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",353.0,0.065,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jessica Howard Anderson","Emory University","https://dx.doi.org/10.1017/ice.2021.54","Verified","United States of America","NR",0.867,0.993,"","US","US-GA"
"2021-03-17","210226_CentreCounty_PennsylvaniaStateUniversity_Community","SARS-CoV-2 Seroprevalence in a University Community: A Longitudinal Study of the Impact of Student Return to Campus on Infection Risk Among Community Members","2021-02-26","Local","United States of America; Pennsylvania","2020-08-07","2020-12-20","Household and community samples","Adults (18-64 years)",345.0,0.082,"","","Convenience","IgG","High","Preprint","Callum Arnold","Pennsylvania State University","https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3","Verified","United States of America","In-House: Pennsylvania State University",0.933,0.99,"","US","US-PA"
"2021-03-17","210226_CentreCounty_PennsylvaniaStateUniversity_Students","SARS-CoV-2 Seroprevalence in a University Community: A Longitudinal Study of the Impact of Student Return to Campus on Infection Risk Among Community Members","2021-02-26","Local","United States of America; Pennsylvania","2020-10-26","2020-11-23","Students and Daycares","Adults (18-64 years)",625.0,0.312,"","","Convenience","IgG","Moderate","Preprint","Callum Arnold","Pennsylvania State University","https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3","Verified","United States of America","In-House: Pennsylvania State University",0.933,0.99,"","US","US-PA"
"2021-03-18","210106_TimisCounty_VictorBabesUniversityofMedicineandPharmacy_Overall","Seroprevalence of SARS-CoV-2 antibodies In 2115 blood donors from Romania","2021-01-06","Local","Romania","2020-07-08","2020-09-01","Blood donors","Adults (18-64 years)",2115.0,0.015,0.011,0.021,"Sequential","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Tudor Rares Olariu","Victor Babes University of Medicine and Pharmacy","http://dx.doi.org/10.1016/j.cmi.2020.12.027","Verified","Romania","Roche Diagnostics GmbH, Mannheim, Germany",1.0,0.998,"","RO",""
"2021-03-18","210129_Botuacato_InstitutoButantan_Primary","COVID-19 in long-term care facilities in Brazil: serological survey in a post-outbreak setting","2021-01-29","Local","Brazil; Sao Paolo; Botucato","2020-06-22","2020-07-08","Assisted living and long-term care facilities","Multiple groups",209.0,0.115,0.071,0.166,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Eliana Nogueira Castro de Barros","Instituto Butantan","https://dx.doi.org/10.1590/S1678-9946202163010","Verified","Brazil","Guangzhou Wondfo Biotech Co., Ltd",0.864,0.996,"","BR","BR-SP"
"2021-03-18","210201_NewYorkCity_ColumbiaUniversity","919 Rates of seroprevalance of COVID-19 among pregnant patients in New York City","2021-02-01","Local","United States of America; New York; ; New York City","2020-06-24","2020-07-16","Pregnant or parturient women","Adults (18-64 years)",47.0,0.404,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Caitlin Baptiste","Columbia University","http://dx.doi.org/10.1016/j.ajog.2020.12.944","Verified","United States of America","NR",0.92,"","","US","US-NY"
"2021-03-18","210203_Sydney_Children'sHospitalAtWestmead_GeneralPathology_overall_TestAdj","Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020","2021-02-03","Local","Australia; New South Wales; Sydney","2020-04-20","2020-05-22","Residual sera","Multiple groups",3231.0,0.002,0.0,0.004,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Heather F Gidding","Children's Hospital at Westmead","https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940","Unverified","Australia","N/A - Authors designed",0.907,0.993,"","AU","AU-NSW"
"2021-03-18","210204_UnitedStates_DaVitaClinicalResearch_Overall","SARS-CoV-2 Antibody Seroprevalence Among Maintenance Dialysis Patients in the United States.","2021-02-04","National","United States of America","2020-05-27","2020-07-01","Patients seeking care for non-COVID-19 reasons","Multiple groups",12932.0,0.058,0.054,0.062,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Adam Walker","DaVita Clinical Research","https://dx.doi.org/10.1016/j.xkme.2021.01.002","Verified","United States of America","Diazyme Laboratories","","","","US",""
"2021-03-18","210208_Virginia_UniversityOfVirginia_Overall_PopAdj","Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia","2021-02-08","Regional","United States of America; Virginia","2020-06-01","2020-08-14","Residual sera","Multiple groups",4675.0,0.024,0.018,0.031,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Elizabeth T Rogawski McQuade","University of Virginia","https://dx.doi.org/10.1001/jamanetworkopen.2020.35234","Verified","United States of America","Abbott",0.927,0.999,"","US","US-VA"
"2021-03-18","210211_Kingston_UniversityOfTheWestIndies_Overall","SARS-CoV-2 Seroprevalence Among Antenatal Clinic Attendees in Kingston, Jamaica, September-November 2020","2021-02-11","Local","Jamaica","2020-03-01","2020-11-30","Pregnant or parturient women","Adults (18-64 years)",249.0,0.149,"","","Sequential","IgG","High","Preprint","TeAnne Chisolm","University of the West Indies","10.1101/2021.02.08.21251367","Verified","Jamaica","Abbott",0.8,0.962,"","JM",""
"2021-03-18","210212_Bavaria_ GermanResearchCenterForEnvironmentalHealth_Newborns_overall","A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children","2021-02-12","Regional","Germany; Bavaria","2020-04-01","2020-06-30","Pregnant or parturient women","Adults (18-64 years)",1916.0,0.005,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Markus Hippich","German Research Center for Environmental Health","https://www.cell.com/med/fulltext/S2666-6340(20)30020-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666634020300209%3Fshowall%3Dtrue","Verified","Germany","N/A - author desgined",0.973,1.0,"","DE","DE-BY"
"2021-03-18","210212_Copenhagen_Herlev-GentofteHospital_Overall","Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen","2021-02-12","Local","Denmark; Capital Region; Copenhagen","2020-10-19","2020-10-26","Health care workers and caregivers","Adults (18-64 years)",1096.0,0.346,0.318,0.375,"Convenience","IgG; IgA; IgM","Moderate","Preprint","Johannes R Madsen","Herlev-Gentofte Hospital","https://www.medrxiv.org/content/10.1101/2021.02.09.21251421v1","Verified","Denmark","Beijing Wantai Biological Pharmacy Enterprise",0.97,0.995,"","DK","DK-84"
"2021-03-18","210318_Barcelona_UniversitatDeBarcelona_overall","Impact of SARS-CoV-2 Infection on Pregnancy Outcomes: A Population-Based Study","2021-02-08","Local","Spain","2020-03-15","2020-05-31","Pregnant or parturient women","Adults (18-64 years)",2225.0,0.141,"","","Sequential","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Francesca Crovetto","Universitat de Barcelona","https://dx.doi.org/10.1093/cid/ciab104","Unverified","Spain","1) Vircell; 2) Ortho Clinical Diagnostics; 3) N/A - institution designed","","","","ES",""
"2021-03-19","201223_Paris_InstitutCurie_overall","High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris","2020-12-23","Local","France;  Île-de-France; Paris","2020-04-28","2020-07-31","Health care workers and caregivers","Multiple groups",1847.0,0.116,0.102,0.132,"Convenience","IgG; Total Antibody; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Francois Anna","Institut Curie","https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202049058","Verified","France","Institut Curie - author designed","",0.99,"","FR","FR-IDF"
"2021-03-19","210108_Linz_OrdensklinikumLinzBarmherzigeSchwestern_OverallHCW","Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria","2021-01-08","Local","Austria; Upper Austria; Linz","2020-06-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",1757.0,0.02,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Margot Egger","Ordensklinikum Linz Barmherzige Schwestern and Konventhospital Barmherzige Brueder Linz","https://dx.doi.org/10.1515/cclm-2020-1681","Verified","Austria","1) Roche Diagnostics; 2) Abbott Diagnostics",1.0,1.0,"","AT","AT-4"
"2021-03-19","210109_Australia_AustralianNationalUniversity_overall_adj","Prevalence of asymptomatic SARS‐CoV‐2 infection in elective surgical patients in Australia: a prospective surveillance study","2021-01-09","National","Australia; New South Wales, South Australia, Victoria and Western Australia","2020-06-02","2020-07-17","Residual sera","Multiple groups",2991.0,0.002,0.0,0.005,"Sequential","IgG","Low","Journal Article (Peer-Reviewed)","Nicholas Coatsworth","Australian National University","https://onlinelibrary.wiley.com/doi/full/10.1111/ans.16564","Verified","Australia","N/A - in house",1.0,0.989,"","AU",""
"2021-03-19","210115_UK_UKBiobank_Overall","UK Biobank SARS-CoV-2 Serology Study","2021-01-15","National","United Kingdom of Great Britain and Northern Ireland; England, Scotland, Wales","2020-05-27","2020-12-04","Household and community samples","Multiple groups",18893.0,0.09,"","","Convenience","Not reported","Unclear","Institutional Report","UK Biobank","UK Biobank","https://www.ukbiobank.ac.uk/media/x0nd5sul/ukb_serologystudy_report_revised_6months_jan21.pdf","Unverified","The United Kingdom","NR","","","","GB",""
"2021-03-19","210129_Atlanta_EmoryUniversityHospital_primary","Quantification of occupational and community risk factors for SARS-CoV-2 seropositivity among healthcare workers in a large U.S. healthcare system","2021-01-29","Local","United States of America; Georgia; Atlanta","2020-04-19","2020-06-26","Health care workers and caregivers","Adults (18-64 years)",10275.0,0.038,0.034,0.043,"Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Julia M Baker","Emory University Hospital","https://dx.doi.org/10.7326/M20-7145","Verified","United States of America","Emory University",0.975,0.98,"","US","US-GA"
"2021-03-19","210130_USA_UniversityofArizona_primary","Coronavirus Disease 2019 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel, May-July 2020","2021-01-30","Local","United States of America","2020-05-17","2020-07-02","Health care workers and caregivers","Multiple groups",40938.0,0.162,0.159,0.166,"Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Lara J Akinbami","University of Arizona","https://dx.doi.org/10.1093/cid/ciab080","Verified","United States of America","VITROS Immunodiagnostic Products","","","","US",""
"2021-03-19","210203_Sydney_Children'sHospitalAtWestmead_AntenatalScreening_overall_TestAdj","Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020","2021-02-03","Local","Australia; New South Wales; Sydney","2020-05-04","2020-05-23","Pregnant or parturient women","Adults (18-64 years)",560.0,0.008,0.0,0.019,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Heather F Gidding","Children's Hospital at Westmead","https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940","Unverified","Australia","N/A - Authors designed",0.907,0.993,"","AU","AU-NSW"
"2021-03-19","210203_Sydney_Children'sHospitalAtWestmead_PlasmapheresisDonors_overall_TestAdj","Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020","2021-02-03","Local","Australia; New South Wales; Sydney","2020-05-05","2020-06-02","Blood donors","Adults (18-64 years)",1548.0,0.003,0.0,0.008,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Heather F Gidding","Children's Hospital at Westmead","https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940","Unverified","Australia","N/A - Authors designed",0.907,0.993,"","AU","AU-NSW"
"2021-03-19","210204_Milan_UniversityOfMilan_Overall","Serological Profile of Children and Young Adults with at Least One SARS-CoV-2 Positive Cohabitant: An Observational Study","2021-02-04","Local","Italy; Lombardy; Milan","2020-06-13","2020-08-06","Contacts of COVID patients","Children and Youth (0-17 years)",49.0,0.163,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Marco Farronato","University of Milan","https://dx.doi.org/10.3390/ijerph18041488","Verified","Italy","Livzon","","","","IT","IT-25"
"2021-03-19","210218_WashingtonDC_GovernmentOfTheDistrictOfColumbia_overall","SARS-CoV-2 Seroprevalence Survey Among District Residents Presenting for Serologic Testing at Three Community-Based Test Sites â€” Washington, DC, July-August, 2020","2021-02-18","Local","United States of America","2020-07-27","2020-08-21","Household and community samples","Multiple groups",671.0,0.076,0.057,0.099,"Convenience","IgG","High","Preprint","Adrienne Sherman","Government of the District of Columbia","10.1101/2021.02.15.21251764","Verified","United States of America","DiaSorin",0.97,"","","US",""
"2021-03-19","210301_London_King’sCollegeHospital_primary","Severe Acute Respiratory Syndrome Coronavirus-2 Infections in Critical Care Staff: Beware the Risks Beyond the Bedside","2021-03-01","Local","United Kingdom of Great Britain and Northern Ireland","2020-04-22","2020-04-24","Health care workers and caregivers","Adults (18-64 years)",625.0,0.21,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Kat El Bouzidi","King’s College Hospital","https://dx.doi.org/10.1097/CCM.0000000000004878","Verified","The United Kingdom","NR","","","","GB",""
"2021-03-20","200923_Saint-Petersburg_Saint-PetersburgPasteurResearchInstituteofEpidemiologyandMicrobiology_Overall","Herd Immunity to SARS-CoV-2 among the Population in Saint-Petersburg during the COVID-19 Epidemic","2020-09-23","Local","Russian Federation","2020-06-15","2020-06-20","Household and community samples","Multiple groups",2713.0,0.26,0.243,0.277,"Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Anna Popova","Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology","https://journal.microbe.ru/jour/article/view/1372/1151","Verified","Russian Federation","State Scientific Center for Applied Microbiology and Biotechnologies (Obolensk)","","","","RU",""
"2021-03-20","200924_Estonia_UniversityofTartu_overall","Seroprevalence of SARS‐CoV‐2 antibodies among pregnant women in Estonia: A call for epidemiological studies","2020-09-24","National","Estonia","2020-05-04","2020-06-10","Pregnant or parturient women","Adults (18-64 years)",433.0,0.005,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Piret Veerus","University of Tartu","https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/aogs.13995","Verified","Estonia","Abbott","","","","EE",""
"2021-03-20","201001_TyumenRegion_SaintPetersburgPasteurInstitute","Distribution of SARS-CоV-2 seroprevalence among residents of the Tyumen Region during the COVID-19 epidemic period","2020-10-01","Regional","Russian Federation; Tyumen region","2020-06-07","2020-06-20","Household and community samples","Multiple groups",2758.0,0.245,0.229,0.261,"Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Anna Popova","Saint Petersburg Pasteur Institute","https://microbiol.elpub.ru/jour/article/view/890/520","Verified","Russian Federation","State Research Center for Applied Microbiology and Biotechnology of Rospotrebnadzor","","","","RU","RU-TYU"
"2021-03-20","201124_USA_CDC_August/September3_Alabama","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Alabama","2020-08-26","2020-09-08","Residual sera","Multiple groups",955.0,0.099,0.072,0.128,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AL"
"2021-03-20","201124_USA_CDC_August/September3_Alaska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Alaska","2020-08-26","2020-09-09","Residual sera","Multiple groups",610.0,0.01,0.002,0.022,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AK"
"2021-03-20","201124_USA_CDC_August/September3_Arizona","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Arizona","2020-08-26","2020-09-09","Residual sera","Multiple groups",1030.0,0.049,0.03,0.071,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AZ"
"2021-03-20","201124_USA_CDC_August/September3_Arkansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Arkansas","2020-08-24","2020-09-08","Residual sera","Multiple groups",992.0,0.049,0.035,0.064,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AR"
"2021-03-20","201124_USA_CDC_August/September3_California","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; California","2020-08-28","2020-09-09","Residual sera","Multiple groups",983.0,0.06,0.042,0.078,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CA"
"2021-03-20","201124_USA_CDC_August/September3_Colorado","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Colorado","2020-08-24","2020-09-04","Residual sera","Multiple groups",1025.0,0.036,0.023,0.051,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CO"
"2021-03-20","201124_USA_CDC_August/September3_Connecticut","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Connecticut","2020-08-26","2020-09-04","Residual sera","Multiple groups",983.0,0.043,0.029,0.057,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CT"
"2021-03-20","201124_USA_CDC_August/September3_Delaware","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Delaware","2020-08-26","2020-09-10","Residual sera","Multiple groups",914.0,0.045,0.024,0.071,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-DE"
"2021-03-20","201124_USA_CDC_August/September3_Florida","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Florida","2020-08-27","2020-09-09","Residual sera","Multiple groups",981.0,0.057,0.039,0.075,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-FL"
"2021-03-20","201124_USA_CDC_August/September3_Georgia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Georgia","2020-08-25","2020-09-10","Residual sera","Multiple groups",1020.0,0.087,0.067,0.111,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-GA"
"2021-03-20","201124_USA_CDC_August/September3_Idaho","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Idaho","2020-08-26","2020-09-10","Residual sera","Multiple groups",790.0,0.057,0.029,0.097,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ID"
"2021-03-20","201124_USA_CDC_August/September3_Illinois","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Illinois","2020-08-26","2020-09-03","Residual sera","Multiple groups",979.0,0.056,0.039,0.077,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IL"
"2021-03-20","201124_USA_CDC_August/September3_Indiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Indiana","2020-08-26","2020-09-09","Residual sera","Multiple groups",984.0,0.024,0.014,0.035,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IN"
"2021-03-20","201124_USA_CDC_August/September3_Iowa","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Iowa","2020-08-25","2020-09-10","Residual sera","Multiple groups",1006.0,0.084,0.062,0.107,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IA"
"2021-03-20","201124_USA_CDC_August/September3_Kansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Kansas","2020-08-24","2020-09-03","Residual sera","Multiple groups",1025.0,0.029,0.016,0.043,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-KS"
"2021-03-20","201124_USA_CDC_August/September3_Kentucky","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Kentucky","2020-08-26","2020-09-08","Residual sera","Multiple groups",983.0,0.031,0.019,0.043,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-KY"
"2021-03-20","201124_USA_CDC_August/September3_Louisiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Louisiana","2020-08-26","2020-09-08","Residual sera","Multiple groups",1001.0,0.086,0.066,0.113,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-LA"
"2021-03-20","201124_USA_CDC_August/September3_Maine","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Maine","2020-08-26","2020-09-10","Residual sera","Multiple groups",759.0,0.015,0.004,0.032,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ME"
"2021-03-20","201124_USA_CDC_August/September3_Maryland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Maryland","2020-08-26","2020-09-08","Residual sera","Multiple groups",980.0,0.079,0.057,0.104,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MD"
"2021-03-20","201124_USA_CDC_August/September3_Massachusetts","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Massachusetts","2020-08-27","2020-09-05","Residual sera","Multiple groups",981.0,0.036,0.024,0.051,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MA"
"2021-03-20","201124_USA_CDC_August/September3_Michigan","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Michigan","2020-08-26","2020-09-03","Residual sera","Multiple groups",976.0,0.034,0.022,0.05,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MI"
"2021-03-20","201124_USA_CDC_August/September3_Minnesota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Minnesota","2020-08-26","2020-09-08","Residual sera","Multiple groups",974.0,0.092,0.067,0.12,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MN"
"2021-03-20","201124_USA_CDC_August/September3_Mississippi","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Mississippi","2020-08-26","2020-09-10","Residual sera","Multiple groups",987.0,0.084,0.049,0.127,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MS"
"2021-03-20","201124_USA_CDC_August/September3_Missouri","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Missouri","2020-08-24","2020-09-10","Residual sera","Multiple groups",1024.0,0.029,0.017,0.042,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MO"
"2021-03-20","201124_USA_CDC_August/September3_Montana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Montana","2020-08-24","2020-09-09","Residual sera","Multiple groups",518.0,0.009,0.002,0.018,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MT"
"2021-03-20","201124_USA_CDC_August/September3_Nebraska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Nebraska","2020-08-24","2020-09-10","Residual sera","Multiple groups",938.0,0.063,0.045,0.083,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NE"
"2021-03-20","201124_USA_CDC_August/September3_Nevada","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Nevada","2020-08-27","2020-08-29","Residual sera","Multiple groups",980.0,0.065,0.046,0.086,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NV"
"2021-03-20","201124_USA_CDC_August/September3_NewHampshire","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Hampshire","2020-08-26","2020-09-03","Residual sera","Multiple groups",1147.0,0.016,0.007,0.028,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NH"
"2021-03-20","201124_USA_CDC_August/September3_NewJersey","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Jersey","2020-08-26","2020-09-07","Residual sera","Multiple groups",944.0,0.128,0.105,0.154,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NJ"
"2021-03-20","201124_USA_CDC_August/September3_NewMexico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Mexico","2020-08-25","2020-09-08","Residual sera","Multiple groups",985.0,0.037,0.023,0.056,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NM"
"2021-03-20","201124_USA_CDC_August/September3_NewYork","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New York","2020-08-26","2020-09-10","Residual sera","Multiple groups",1043.0,0.195,0.169,0.224,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NY"
"2021-03-20","201124_USA_CDC_August/September3_NorthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  North Carolina","2020-08-26","2020-09-09","Residual sera","Multiple groups",982.0,0.038,0.023,0.053,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NC"
"2021-03-20","201124_USA_CDC_August/September3_NorthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  North Dakota","2020-08-26","2020-09-09","Residual sera","Multiple groups",109.0,0.002,0.0,0.01,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ND"
"2021-03-20","201124_USA_CDC_August/September3_Ohio","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Ohio","2020-08-27","2020-09-10","Residual sera","Multiple groups",983.0,0.05,0.032,0.071,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OH"
"2021-03-20","201124_USA_CDC_August/September3_Oklahoma","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Oklahoma","2020-08-24","2020-09-01","Residual sera","Multiple groups",979.0,0.054,0.038,0.073,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OK"
"2021-03-20","201124_USA_CDC_August/September3_Oregon","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Oregon","2020-08-26","2020-09-10","Residual sera","Multiple groups",968.0,0.019,0.009,0.029,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OR"
"2021-03-20","201124_USA_CDC_August/September3_Pennsylvania","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Pennsylvania","2020-08-26","2020-09-09","Residual sera","Multiple groups",845.0,0.095,0.066,0.136,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-PA"
"2021-03-20","201124_USA_CDC_August/September3_PuertoRico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Puerto Rico","2020-08-24","2020-09-03","Residual sera","Multiple groups",980.0,0.025,0.014,0.038,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-PR"
"2021-03-20","201124_USA_CDC_August/September3_RhodeIsland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Rhode Island","2020-08-27","2020-09-10","Residual sera","Multiple groups",786.0,0.031,0.017,0.046,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-RI"
"2021-03-20","201124_USA_CDC_August/September3_SouthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  South Carolina","2020-08-26","2020-09-10","Residual sera","Multiple groups",927.0,0.072,0.051,0.096,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-SC"
"2021-03-20","201124_USA_CDC_August/September3_SouthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  South Dakota","2020-08-26","2020-09-10","Residual sera","Multiple groups",97.0,0.007,0.0,0.025,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-SD"
"2021-03-20","201124_USA_CDC_August/September3_Tennessee","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Tennessee","2020-08-25","2020-09-08","Residual sera","Multiple groups",950.0,0.054,0.036,0.073,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-TN"
"2021-03-20","201124_USA_CDC_August/September3_Texas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Texas","2020-08-25","2020-09-02","Residual sera","Multiple groups",979.0,0.058,0.04,0.079,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-TX"
"2021-03-20","201124_USA_CDC_August/September3_Utah","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Utah","2020-08-24","2020-09-08","Residual sera","Multiple groups",1104.0,0.049,0.028,0.077,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-UT"
"2021-03-20","201124_USA_CDC_August/September3_Vermont","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Vermont","2020-08-26","2020-09-10","Residual sera","Multiple groups",485.0,0.004,0.0,0.009,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-VT"
"2021-03-20","201124_USA_CDC_August/September3_Virginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Virginia","2020-08-26","2020-09-08","Residual sera","Multiple groups",1007.0,0.035,0.02,0.053,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-VA"
"2021-03-20","201124_USA_CDC_August/September3_Washington","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Washington","2020-08-25","2020-09-10","Residual sera","Multiple groups",820.0,0.045,0.026,0.069,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WA"
"2021-03-20","201124_USA_CDC_August/September3_WashingtonD.C","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Washington D.C","2020-08-27","2020-09-10","Residual sera","Multiple groups",643.0,0.05,0.028,0.076,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-DC"
"2021-03-20","201124_USA_CDC_August/September3_WestVirginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  West Virginia","2020-08-26","2020-09-10","Residual sera","Multiple groups",1128.0,0.015,0.008,0.024,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WV"
"2021-03-20","201124_USA_CDC_August/September3_Wisconsin","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Wisconsin","2020-08-25","2020-09-10","Residual sera","Multiple groups",976.0,0.026,0.015,0.04,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WI"
"2021-03-20","201124_USA_CDC_August2_Alabama","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Alabama","2020-08-12","2020-08-26","Residual sera","Multiple groups",974.0,0.076,0.053,0.098,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AL"
"2021-03-20","201124_USA_CDC_August2_Alaska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Alaska","2020-08-12","2020-08-26","Residual sera","Multiple groups",704.0,0.013,0.005,0.023,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AK"
"2021-03-20","201124_USA_CDC_August2_Arizona","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Arizona","2020-08-12","2020-08-26","Residual sera","Multiple groups",1304.0,0.047,0.027,0.076,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AZ"
"2021-03-20","201124_USA_CDC_August2_Arkansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Arkansas","2020-08-11","2020-08-25","Residual sera","Multiple groups",998.0,0.03,0.018,0.044,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AR"
"2021-03-20","201124_USA_CDC_August2_California","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; California","2020-08-13","2020-08-19","Residual sera","Multiple groups",980.0,0.043,0.028,0.061,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CA"
"2021-03-20","201124_USA_CDC_August2_Colorado","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Colorado","2020-08-10","2020-08-25","Residual sera","Multiple groups",1019.0,0.033,0.018,0.048,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CO"
"2021-03-20","201124_USA_CDC_August2_Connecticut","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Connecticut","2020-08-11","2020-08-24","Residual sera","Multiple groups",983.0,0.024,0.014,0.035,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CT"
"2021-03-20","201124_USA_CDC_August2_Delaware","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Delaware","2020-08-12","2020-08-27","Residual sera","Multiple groups",1004.0,0.085,0.058,0.112,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-DE"
"2021-03-20","201124_USA_CDC_August2_Florida","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Florida","2020-08-14","2020-08-14","Residual sera","Multiple groups",978.0,0.045,0.032,0.061,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-FL"
"2021-03-20","201124_USA_CDC_August2_Georgia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Georgia","2020-08-13","2020-08-26","Residual sera","Multiple groups",1031.0,0.074,0.055,0.095,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-GA"
"2021-03-20","201124_USA_CDC_August2_Idaho","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Idaho","2020-08-12","2020-08-26","Residual sera","Multiple groups",651.0,0.046,0.017,0.091,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ID"
"2021-03-20","201124_USA_CDC_August2_Illinois","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Illinois","2020-08-12","2020-08-27","Residual sera","Multiple groups",985.0,0.049,0.034,0.066,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IL"
"2021-03-20","201124_USA_CDC_August2_Indiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Indiana","2020-08-12","2020-08-26","Residual sera","Multiple groups",906.0,0.031,0.015,0.048,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IN"
"2021-03-20","201124_USA_CDC_August2_Iowa","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Iowa","2020-08-12","2020-08-27","Residual sera","Multiple groups",980.0,0.094,0.071,0.116,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IA"
"2021-03-20","201124_USA_CDC_August2_Kansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Kansas","2020-08-11","2020-08-25","Residual sera","Multiple groups",1016.0,0.037,0.02,0.055,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-KS"
"2021-03-20","201124_USA_CDC_August2_Kentucky","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Kentucky","2020-08-12","2020-08-26","Residual sera","Multiple groups",1126.0,0.031,0.02,0.045,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-KY"
"2021-03-20","201124_USA_CDC_August2_Louisiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Louisiana","2020-08-12","2020-08-25","Residual sera","Multiple groups",989.0,0.118,0.093,0.148,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-LA"
"2021-03-20","201124_USA_CDC_August2_Maine","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Maine","2020-08-12","2020-08-27","Residual sera","Multiple groups",609.0,0.006,0.0,0.014,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ME"
"2021-03-20","201124_USA_CDC_August2_Maryland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Maryland","2020-08-10","2020-08-26","Residual sera","Multiple groups",1174.0,0.07,0.049,0.093,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MD"
"2021-03-20","201124_USA_CDC_August2_Massachusetts","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Massachusetts","2020-08-12","2020-08-27","Residual sera","Multiple groups",980.0,0.037,0.023,0.052,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MA"
"2021-03-20","201124_USA_CDC_August2_Michigan","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Michigan","2020-08-12","2020-08-25","Residual sera","Multiple groups",983.0,0.042,0.029,0.058,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MI"
"2021-03-20","201124_USA_CDC_August2_Minnesota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Minnesota","2020-08-11","2020-08-27","Residual sera","Multiple groups",978.0,0.045,0.03,0.059,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MN"
"2021-03-20","201124_USA_CDC_August2_Mississippi","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Mississippi","2020-08-12","2020-08-27","Residual sera","Multiple groups",968.0,0.1,0.067,0.147,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MS"
"2021-03-20","201124_USA_CDC_August2_Missouri","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Missouri","2020-08-12","2020-08-21","Residual sera","Multiple groups",1021.0,0.035,0.022,0.051,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MO"
"2021-03-20","201124_USA_CDC_August2_Montana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Montana","2020-08-12","2020-08-24","Residual sera","Multiple groups",383.0,0.013,0.004,0.025,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MT"
"2021-03-20","201124_USA_CDC_August2_Nebraska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Nebraska","2020-08-11","2020-08-25","Residual sera","Multiple groups",990.0,0.079,0.055,0.106,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NE"
"2021-03-20","201124_USA_CDC_August2_Nevada","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Nevada","2020-08-12","2020-08-26","Residual sera","Multiple groups",972.0,0.079,0.061,0.098,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NV"
"2021-03-20","201124_USA_CDC_August2_NewHampshire","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Hampshire","2020-08-13","2020-08-25","Residual sera","Multiple groups",1125.0,0.008,0.003,0.012,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NH"
"2021-03-20","201124_USA_CDC_August2_NewJersey","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Jersey","2020-08-10","2020-08-26","Residual sera","Multiple groups",1127.0,0.122,0.102,0.145,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NJ"
"2021-03-20","201124_USA_CDC_August2_NewMexico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Mexico","2020-08-10","2020-08-27","Residual sera","Multiple groups",976.0,0.025,0.015,0.038,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NM"
"2021-03-20","201124_USA_CDC_August2_NewYork","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New York","2020-08-10","2020-08-26","Residual sera","Multiple groups",1122.0,0.206,0.18,0.231,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NY"
"2021-03-20","201124_USA_CDC_August2_NorthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  North Carolina","2020-08-11","2020-08-27","Residual sera","Multiple groups",982.0,0.038,0.023,0.053,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NC"
"2021-03-20","201124_USA_CDC_August2_NorthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  North Dakota","2020-08-12","2020-08-26","Residual sera","Multiple groups",135.0,0.006,0.0,0.014,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ND"
"2021-03-20","201124_USA_CDC_August2_Ohio","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Ohio","2020-08-12","2020-08-27","Residual sera","Multiple groups",985.0,0.021,0.011,0.033,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OH"
"2021-03-20","201124_USA_CDC_August2_Oklahoma","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Oklahoma","2020-08-10","2020-08-18","Residual sera","Multiple groups",979.0,0.04,0.027,0.055,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OK"
"2021-03-20","201124_USA_CDC_August2_Oregon","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Oregon","2020-08-10","2020-08-27","Residual sera","Multiple groups",1086.0,0.024,0.014,0.036,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OR"
"2021-03-20","201124_USA_CDC_August2_Pennsylvania","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Pennsylvania","2020-08-10","2020-08-26","Residual sera","Multiple groups",887.0,0.101,0.075,0.137,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-PA"
"2021-03-20","201124_USA_CDC_August2_PuertoRico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Puerto Rico","2020-08-10","2020-08-17","Residual sera","Multiple groups",986.0,0.022,0.012,0.033,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-PR"
"2021-03-20","201124_USA_CDC_August2_RhodeIsland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Rhode Island","2020-08-12","2020-08-27","Residual sera","Multiple groups",570.0,0.036,0.017,0.059,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-RI"
"2021-03-20","201124_USA_CDC_August2_SouthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  South Carolina","2020-08-12","2020-08-27","Residual sera","Multiple groups",1063.0,0.06,0.044,0.08,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-SC"
"2021-03-20","201124_USA_CDC_August2_SouthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  South Dakota","2020-08-12","2020-08-26","Residual sera","Multiple groups",83.0,0.0,0.0,0.044,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-SD"
"2021-03-20","201124_USA_CDC_August2_Tennessee","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Tennessee","2020-08-12","2020-08-26","Residual sera","Multiple groups",1029.0,0.067,0.051,0.086,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-TN"
"2021-03-20","201124_USA_CDC_August2_Texas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Texas","2020-08-12","2020-08-24","Residual sera","Multiple groups",1001.0,0.065,0.047,0.085,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-TX"
"2021-03-20","201124_USA_CDC_August2_Utah","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Utah","2020-08-15","2020-08-25","Residual sera","Multiple groups",871.0,0.055,0.029,0.087,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-UT"
"2021-03-20","201124_USA_CDC_August2_Vermont","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Vermont","2020-08-13","2020-08-27","Residual sera","Multiple groups",382.0,0.003,0.0,0.008,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-VT"
"2021-03-20","201124_USA_CDC_August2_Virginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Virginia","2020-08-10","2020-08-26","Residual sera","Multiple groups",1243.0,0.047,0.025,0.072,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-VA"
"2021-03-20","201124_USA_CDC_August2_Washington","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Washington","2020-08-12","2020-08-27","Residual sera","Multiple groups",1238.0,0.03,0.018,0.045,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WA"
"2021-03-20","201124_USA_CDC_August2_Washington D.C","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Washington D.C","2020-08-13","2020-08-27","Residual sera","Multiple groups",781.0,0.068,0.046,0.092,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-DC"
"2021-03-20","201124_USA_CDC_August2_WestVirginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  West Virginia","2020-08-13","2020-08-27","Residual sera","Multiple groups",637.0,0.022,0.005,0.049,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WV"
"2021-03-20","201124_USA_CDC_August2_Wisconsin","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Wisconsin","2020-08-12","2020-08-27","Residual sera","Multiple groups",838.0,0.033,0.02,0.047,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WI"
"2021-03-20","201124_USA_CDC_August2_Wyoming","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Wyoming","2020-08-13","2020-08-24","Residual sera","Multiple groups",86.0,0.008,0.0,0.031,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WY"
"2021-03-20","201124_USA_CDC_July/August1_Alabama","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Alabama","2020-07-29","2020-08-13","Residual sera","Multiple groups",938.0,0.058,0.042,0.077,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AL"
"2021-03-20","201124_USA_CDC_July/August1_Alaska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Alaska","2020-08-06","2020-08-11","Residual sera","Multiple groups",242.0,0.003,0.0,0.011,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AK"
"2021-03-20","201124_USA_CDC_July/August1_Arizona","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Arizona","2020-07-31","2020-08-11","Residual sera","Multiple groups",591.0,0.082,0.041,0.136,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AZ"
"2021-03-20","201124_USA_CDC_July/August1_Arkansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Arkansas","2020-07-29","2020-08-13","Residual sera","Multiple groups",937.0,0.041,0.027,0.056,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AR"
"2021-03-20","201124_USA_CDC_July/August1_California","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; California","2020-07-30","2020-08-05","Residual sera","Multiple groups",980.0,0.057,0.04,0.078,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CA"
"2021-03-20","201124_USA_CDC_July/August1_Colorado","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Colorado","2020-07-30","2020-08-07","Residual sera","Multiple groups",1001.0,0.024,0.009,0.045,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CO"
"2021-03-20","201124_USA_CDC_July/August1_Connecticut","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Connecticut","2020-07-30","2020-08-03","Residual sera","Multiple groups",994.0,0.034,0.02,0.047,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CT"
"2021-03-20","201124_USA_CDC_July/August1_Delaware","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Delaware","2020-07-29","2020-08-13","Residual sera","Multiple groups",804.0,0.057,0.036,0.082,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-DE"
"2021-03-20","201124_USA_CDC_July/August1_Florida","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Florida","2020-07-31","2020-08-03","Residual sera","Multiple groups",980.0,0.043,0.028,0.059,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-FL"
"2021-03-20","201124_USA_CDC_July/August1_Georgia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Georgia","2020-08-02","2020-08-11","Residual sera","Multiple groups",985.0,0.068,0.048,0.088,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-GA"
"2021-03-20","201124_USA_CDC_July/August1_Idaho","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Idaho","2020-08-04","2020-08-11","Residual sera","Multiple groups",246.0,0.045,0.018,0.08,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ID"
"2021-03-20","201124_USA_CDC_July/August1_Illinois","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Illinois","2020-07-29","2020-08-10","Residual sera","Multiple groups",1004.0,0.039,0.025,0.052,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IL"
"2021-03-20","201124_USA_CDC_July/August1_Indiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Indiana","2020-07-31","2020-08-11","Residual sera","Multiple groups",579.0,0.022,0.011,0.036,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IN"
"2021-03-20","201124_USA_CDC_July/August1_Iowa","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Iowa","2020-07-29","2020-08-13","Residual sera","Multiple groups",811.0,0.086,0.06,0.113,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IA"
"2021-03-20","201124_USA_CDC_July/August1_Kansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Kansas","2020-07-29","2020-08-08","Residual sera","Multiple groups",962.0,0.016,0.007,0.028,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-KS"
"2021-03-20","201124_USA_CDC_July/August1_Kentucky","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Kentucky","2020-07-30","2020-08-13","Residual sera","Multiple groups",975.0,0.024,0.013,0.036,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-KY"
"2021-03-20","201124_USA_CDC_July/August1_Louisiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Louisiana","2020-07-28","2020-08-13","Residual sera","Multiple groups",1002.0,0.096,0.069,0.123,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-LA"
"2021-03-20","201124_USA_CDC_July/August1_Maine","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Maine","2020-07-30","2020-08-11","Residual sera","Multiple groups",598.0,0.005,0.0,0.012,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ME"
"2021-03-20","201124_USA_CDC_July/August1_Maryland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Maryland","2020-07-31","2020-08-11","Residual sera","Multiple groups",783.0,0.097,0.073,0.129,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MD"
"2021-03-20","201124_USA_CDC_July/August1_Massachusetts","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Massachusetts","2020-07-30","2020-08-10","Residual sera","Multiple groups",978.0,0.042,0.029,0.058,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MA"
"2021-03-20","201124_USA_CDC_July/August1_Michigan","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Michigan","2020-07-30","2020-08-11","Residual sera","Multiple groups",982.0,0.034,0.022,0.048,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MI"
"2021-03-20","201124_USA_CDC_July/August1_Minnesota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Minnesota","2020-07-29","2020-08-13","Residual sera","Multiple groups",879.0,0.035,0.021,0.05,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MN"
"2021-03-20","201124_USA_CDC_July/August1_Mississippi","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Mississippi","2020-07-30","2020-08-13","Residual sera","Multiple groups",769.0,0.071,0.038,0.111,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MS"
"2021-03-20","201124_USA_CDC_July/August1_Missouri","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Missouri","2020-07-28","2020-08-10","Residual sera","Multiple groups",979.0,0.025,0.014,0.036,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MO"
"2021-03-20","201124_USA_CDC_July/August1_Montana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Montana","2020-07-29","2020-08-10","Residual sera","Multiple groups",199.0,0.005,0.0,0.017,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MT"
"2021-03-20","201124_USA_CDC_July/August1_Nebraska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Nebraska","2020-07-28","2020-08-13","Residual sera","Multiple groups",954.0,0.074,0.052,0.098,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NE"
"2021-03-20","201124_USA_CDC_July/August1_Nevada","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Nevada","2020-07-30","2020-08-02","Residual sera","Multiple groups",979.0,0.051,0.036,0.067,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NV"
"2021-03-20","201124_USA_CDC_July/August1_NewHampshire","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Hampshire","2020-07-30","2020-08-11","Residual sera","Multiple groups",809.0,0.008,0.002,0.015,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NH"
"2021-03-20","201124_USA_CDC_July/August1_NewJersey","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Jersey","2020-07-31","2020-08-11","Residual sera","Multiple groups",871.0,0.148,0.122,0.176,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NJ"
"2021-03-20","201124_USA_CDC_July/August1_NewMexico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Mexico","2020-07-29","2020-08-13","Residual sera","Multiple groups",964.0,0.02,0.011,0.03,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NM"
"2021-03-20","201124_USA_CDC_July/August1_NewYork","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New York","2020-07-31","2020-08-11","Residual sera","Multiple groups",846.0,0.233,0.201,0.263,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NY"
"2021-03-20","201124_USA_CDC_July/August1_NorthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  North Carolina","2020-07-29","2020-08-10","Residual sera","Multiple groups",928.0,0.025,0.013,0.037,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NC"
"2021-03-20","201124_USA_CDC_July/August1_NorthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  North Dakota","2020-07-29","2020-08-12","Residual sera","Multiple groups",121.0,0.073,0.013,0.143,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ND"
"2021-03-20","201124_USA_CDC_July/August1_Ohio","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Ohio","2020-07-29","2020-08-11","Residual sera","Multiple groups",786.0,0.023,0.011,0.036,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OH"
"2021-03-20","201124_USA_CDC_July/August1_Oklahoma","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Oklahoma","2020-07-28","2020-08-04","Residual sera","Multiple groups",979.0,0.016,0.008,0.025,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OK"
"2021-03-20","201124_USA_CDC_July/August1_Oregon","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Oregon","2020-08-05","2020-08-11","Residual sera","Multiple groups",658.0,0.023,0.01,0.038,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OR"
"2021-03-20","201124_USA_CDC_July/August1_Pennsylvania","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Pennsylvania","2020-07-31","2020-08-11","Residual sera","Multiple groups",575.0,0.102,0.057,0.172,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-PA"
"2021-03-20","201124_USA_CDC_July/August1_PuertoRico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Puerto Rico","2020-07-27","2020-08-07","Residual sera","Multiple groups",984.0,0.011,0.004,0.018,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-PR"
"2021-03-20","201124_USA_CDC_July/August1_RhodeIsland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Rhode Island","2020-07-30","2020-08-11","Residual sera","Multiple groups",684.0,0.03,0.012,0.055,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-RI"
"2021-03-20","201124_USA_CDC_July/August1_SouthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  South Carolina","2020-07-30","2020-08-13","Residual sera","Multiple groups",840.0,0.081,0.058,0.107,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-SC"
"2021-03-20","201124_USA_CDC_July/August1_Tennessee","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Tennessee","2020-07-30","2020-08-11","Residual sera","Multiple groups",1003.0,0.063,0.044,0.082,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-TN"
"2021-03-20","201124_USA_CDC_July/August1_Texas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Texas","2020-07-29","2020-08-05","Residual sera","Multiple groups",986.0,0.059,0.04,0.08,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-TX"
"2021-03-20","201124_USA_CDC_July/August1_Utah","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Utah","2020-07-30","2020-08-11","Residual sera","Multiple groups",880.0,0.032,0.017,0.05,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-UT"
"2021-03-20","201124_USA_CDC_July/August1_Vermont","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Vermont","2020-07-30","2020-08-11","Residual sera","Multiple groups",346.0,0.005,0.0,0.018,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-VT"
"2021-03-20","201124_USA_CDC_July/August1_Virginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Virginia","2020-07-31","2020-08-11","Residual sera","Multiple groups",730.0,0.041,0.018,0.069,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-VA"
"2021-03-20","201124_USA_CDC_July/August1_Washington","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Washington","2020-07-29","2020-08-11","Residual sera","Multiple groups",684.0,0.021,0.008,0.037,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WA"
"2021-03-20","201124_USA_CDC_July/August1_Washington D.C","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Washington D.C","2020-07-30","2020-08-13","Residual sera","Multiple groups",717.0,0.039,0.022,0.058,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-DC"
"2021-03-20","201124_USA_CDC_July/August1_WestVirginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  West Virginia","2020-07-30","2020-08-13","Residual sera","Multiple groups",317.0,0.012,0.002,0.025,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WV"
"2021-03-20","201124_USA_CDC_July/August1_Wisconsin","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Wisconsin","2020-07-30","2020-08-13","Residual sera","Multiple groups",814.0,0.018,0.008,0.032,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WI"
"2021-03-20","201124_USA_CDC_September4_Alabama","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Alabama","2020-09-09","2020-09-18","Residual sera","Multiple groups",905.0,0.087,0.062,0.113,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AL"
"2021-03-20","201124_USA_CDC_September4_Alaska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Alaska","2020-09-09","2020-09-18","Residual sera","Multiple groups",681.0,0.004,0.001,0.008,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AK"
"2021-03-20","201124_USA_CDC_September4_Arizona","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Arizona","2020-09-09","2020-09-23","Residual sera","Multiple groups",1208.0,0.054,0.031,0.085,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AZ"
"2021-03-20","201124_USA_CDC_September4_Arkansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Arkansas","2020-09-09","2020-09-18","Residual sera","Multiple groups",990.0,0.063,0.046,0.08,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-AR"
"2021-03-20","201124_USA_CDC_September4_California","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; California","2020-09-10","2020-09-16","Residual sera","Multiple groups",979.0,0.049,0.032,0.068,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CA"
"2021-03-20","201124_USA_CDC_September4_Colorado","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Colorado","2020-09-09","2020-09-18","Residual sera","Multiple groups",1032.0,0.033,0.019,0.049,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CO"
"2021-03-20","201124_USA_CDC_September4_Connecticut","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Connecticut","2020-09-09","2020-09-14","Residual sera","Multiple groups",982.0,0.031,0.021,0.044,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-CT"
"2021-03-20","201124_USA_CDC_September4_Delaware","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Delaware","2020-09-09","2020-09-24","Residual sera","Multiple groups",980.0,0.075,0.049,0.105,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-DE"
"2021-03-20","201124_USA_CDC_September4_Florida","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Florida","2020-09-11","2020-09-11","Residual sera","Multiple groups",979.0,0.085,0.066,0.107,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-FL"
"2021-03-20","201124_USA_CDC_September4_Georgia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Georgia","2020-09-09","2020-09-18","Residual sera","Multiple groups",1100.0,0.13,0.105,0.158,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-GA"
"2021-03-20","201124_USA_CDC_September4_Hawaii","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Hawaii","2020-09-08","2020-09-22","Residual sera","Multiple groups",516.0,0.008,0.0,0.022,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-HI"
"2021-03-20","201124_USA_CDC_September4_Idaho","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Idaho","2020-09-08","2020-09-18","Residual sera","Multiple groups",732.0,0.052,0.027,0.085,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ID"
"2021-03-20","201124_USA_CDC_September4_Illinois","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Illinois","2020-09-08","2020-09-17","Residual sera","Multiple groups",992.0,0.045,0.031,0.061,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IL"
"2021-03-20","201124_USA_CDC_September4_Indiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Indiana","2020-09-09","2020-09-23","Residual sera","Multiple groups",1155.0,0.04,0.014,0.088,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IN"
"2021-03-20","201124_USA_CDC_September4_Iowa","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Iowa","2020-09-09","2020-09-24","Residual sera","Multiple groups",977.0,0.076,0.056,0.1,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-IA"
"2021-03-20","201124_USA_CDC_September4_Kansas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Kansas","2020-09-09","2020-09-19","Residual sera","Multiple groups",1007.0,0.035,0.023,0.048,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-KS"
"2021-03-20","201124_USA_CDC_September4_Kentucky","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Kentucky","2020-09-09","2020-09-18","Residual sera","Multiple groups",980.0,0.036,0.023,0.052,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-KY"
"2021-03-20","201124_USA_CDC_September4_Louisiana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Louisiana","2020-09-09","2020-09-19","Residual sera","Multiple groups",952.0,0.125,0.1,0.156,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-LA"
"2021-03-20","201124_USA_CDC_September4_Maine","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Maine","2020-09-08","2020-09-24","Residual sera","Multiple groups",987.0,0.005,0.001,0.009,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ME"
"2021-03-20","201124_USA_CDC_September4_Maryland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Maryland","2020-09-10","2020-09-23","Residual sera","Multiple groups",1242.0,0.102,0.079,0.127,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MD"
"2021-03-20","201124_USA_CDC_September4_Massachusetts","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Massachusetts","2020-09-09","2020-09-15","Residual sera","Multiple groups",988.0,0.037,0.022,0.052,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MA"
"2021-03-20","201124_USA_CDC_September4_Michigan","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Michigan","2020-09-08","2020-09-22","Residual sera","Multiple groups",980.0,0.037,0.025,0.049,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MI"
"2021-03-20","201124_USA_CDC_September4_Minnesota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Minnesota","2020-09-09","2020-09-23","Residual sera","Multiple groups",1033.0,0.08,0.047,0.114,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MN"
"2021-03-20","201124_USA_CDC_September4_Mississippi","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Mississippi","2020-09-09","2020-09-22","Residual sera","Multiple groups",980.0,0.079,0.054,0.109,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MS"
"2021-03-20","201124_USA_CDC_September4_Missouri","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Missouri","2020-09-08","2020-09-24","Residual sera","Multiple groups",1031.0,0.035,0.022,0.05,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MO"
"2021-03-20","201124_USA_CDC_September4_Montana","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Montana","2020-09-09","2020-09-23","Residual sera","Multiple groups",508.0,0.022,0.007,0.044,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-MT"
"2021-03-20","201124_USA_CDC_September4_Nebraska","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Nebraska","2020-09-09","2020-09-18","Residual sera","Multiple groups",976.0,0.067,0.048,0.089,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NE"
"2021-03-20","201124_USA_CDC_September4_Nevada","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Nevada","2020-09-09","2020-09-12","Residual sera","Multiple groups",979.0,0.078,0.059,0.1,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NV"
"2021-03-20","201124_USA_CDC_September4_NewHampshire","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Hampshire","2020-09-09","2020-09-17","Residual sera","Multiple groups",1034.0,0.007,0.003,0.013,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NH"
"2021-03-20","201124_USA_CDC_September4_NewJersey","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Jersey","2020-09-09","2020-09-23","Residual sera","Multiple groups",1050.0,0.151,0.126,0.176,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NJ"
"2021-03-20","201124_USA_CDC_September4_NewMexico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New Mexico","2020-09-08","2020-09-24","Residual sera","Multiple groups",1014.0,0.024,0.012,0.036,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NM"
"2021-03-20","201124_USA_CDC_September4_NewYork","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  New York","2020-09-11","2020-09-24","Residual sera","Multiple groups",1168.0,0.17,0.147,0.192,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NY"
"2021-03-20","201124_USA_CDC_September4_NorthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  North Carolina","2020-09-09","2020-09-17","Residual sera","Multiple groups",925.0,0.068,0.048,0.089,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-NC"
"2021-03-20","201124_USA_CDC_September4_NorthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  North Dakota","2020-09-09","2020-09-24","Residual sera","Multiple groups",113.0,0.012,0.0,0.034,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-ND"
"2021-03-20","201124_USA_CDC_September4_Ohio","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Ohio","2020-09-10","2020-09-22","Residual sera","Multiple groups",978.0,0.028,0.017,0.042,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OH"
"2021-03-20","201124_USA_CDC_September4_Oklahoma","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Oklahoma","2020-09-09","2020-09-18","Residual sera","Multiple groups",980.0,0.05,0.034,0.065,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OK"
"2021-03-20","201124_USA_CDC_September4_Oregon","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Oregon","2020-09-08","2020-09-22","Residual sera","Multiple groups",971.0,0.026,0.015,0.041,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-OR"
"2021-03-20","201124_USA_CDC_September4_Pennsylvania","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Pennsylvania","2020-09-09","2020-09-23","Residual sera","Multiple groups",1341.0,0.111,0.088,0.137,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-PA"
"2021-03-20","201124_USA_CDC_September4_PuertoRico","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Puerto Rico","2020-09-08","2020-09-15","Residual sera","Multiple groups",970.0,0.03,0.018,0.043,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-PR"
"2021-03-20","201124_USA_CDC_September4_RhodeIsland","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Rhode Island","2020-09-09","2020-09-24","Residual sera","Multiple groups",795.0,0.027,0.012,0.049,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-RI"
"2021-03-20","201124_USA_CDC_September4_SouthCarolina","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  South Carolina","2020-09-09","2020-09-18","Residual sera","Multiple groups",975.0,0.078,0.056,0.102,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-SC"
"2021-03-20","201124_USA_CDC_September4_SouthDakota","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  South Dakota","2020-09-09","2020-09-23","Residual sera","Multiple groups",99.0,0.018,0.0,0.048,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-SD"
"2021-03-20","201124_USA_CDC_September4_Tennessee","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Tennessee","2020-09-08","2020-09-16","Residual sera","Multiple groups",1028.0,0.067,0.05,0.086,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-TN"
"2021-03-20","201124_USA_CDC_September4_Texas","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Texas","2020-09-09","2020-09-24","Residual sera","Multiple groups",988.0,0.082,0.062,0.105,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-TX"
"2021-03-20","201124_USA_CDC_September4_Utah","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Utah","2020-09-09","2020-09-18","Residual sera","Multiple groups",1022.0,0.051,0.033,0.079,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-UT"
"2021-03-20","201124_USA_CDC_September4_Vermont","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Vermont","2020-09-09","2020-09-24","Residual sera","Multiple groups",497.0,0.017,0.003,0.042,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-VT"
"2021-03-20","201124_USA_CDC_September4_Virginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Virginia","2020-09-10","2020-09-23","Residual sera","Multiple groups",1111.0,0.032,0.018,0.051,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-VA"
"2021-03-20","201124_USA_CDC_September4_Washington","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Washington","2020-09-09","2020-09-22","Residual sera","Multiple groups",968.0,0.025,0.013,0.038,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WA"
"2021-03-20","201124_USA_CDC_September4_Washington D.C","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America; Washington D.C","2020-09-08","2020-09-24","Residual sera","Multiple groups",976.0,0.065,0.045,0.083,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-DC"
"2021-03-20","201124_USA_CDC_September4_WestVirginia","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  West Virginia","2020-09-09","2020-09-22","Residual sera","Multiple groups",968.0,0.013,0.005,0.022,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WV"
"2021-03-20","201124_USA_CDC_September4_Wisconsin","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Wisconsin","2020-09-09","2020-09-24","Residual sera","Multiple groups",976.0,0.038,0.022,0.057,"Stratified non-probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WI"
"2021-03-20","201124_USA_CDC_September4_Wyoming","Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.","2020-11-24","Regional","United States of America;  Wyoming","2020-09-09","2020-09-24","Residual sera","Multiple groups",111.0,0.015,0.0,0.04,"Stratified non-probability","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Kristina Bajema","CDC COVID-19 Response","https://dx.doi.org/10.1001/jamainternmed.2020.7976","Verified","United States of America","Roche, Abbott, Ortho-Clinical Diagnostics","","","","US","US-WY"
"2021-03-20","210129_Hyogo_KobeUniversityGraduateSchoolOfMedicine_Overall","Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, Japan","2021-01-29","Regional","Japan; Kansai","2020-08-06","2020-10-01","Residual sera","Multiple groups",10377.0,0.006,"","","Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Koichi Furukawa","Kobe University Graduate School of Medicine","https://dx.doi.org/10.31662/jmaj.2020-0094","Verified","Japan","1) Roche Diagnostics; 2) Sysmex","","","","JP",""
"2021-03-20","210129_NewYork_NorthwellHealth","610 ABO and Rh blood groups and SARS-CoV-2 susceptibility in pregnancy","2021-01-29","Regional","United States of America; New York","2020-05-27","2020-08-23","Pregnant or parturient women","Adults (18-64 years)",2930.0,0.153,"","","Sequential","Not reported","Unclear","Journal Article (Peer-Reviewed)","Lylach Haizler Cohen","Northwell Health","http://dx.doi.org/10.1016/j.ajog.2020.12.631","Verified","United States of America","NR","","","","US","US-NY"
"2021-03-21","201127_Germany_IfoInstitue_overall_PopAdj","Die Deutschen und Corona Schlussbericht der BMG-„Corona-BUND-Studie“","2020-11-27","National","Germany","2020-10-26","2020-11-18","Household and community samples","Multiple groups",9929.0,0.011,0.009,0.013,"Convenience","Total Antibody","Unclear","Institutional Report","Clemens Fuest","ifo Institute","https://www.ifo.de/en/publikationen/2020/monograph-authorship/die-deutschen-und-corona","Verified","Germany","Roche","",0.998,"","DE",""
"2021-03-21","210127_London_King'sCollegeLondon_September_PostgradStudents&Staff","The King’s College London Coronavirus Health and Experiences of Colleagues at King’s Study: SARS-CoV-2 antibody response in a higher education sample","2021-01-27","Local","United Kingdom of Great Britain and Northern Ireland","2020-09-01","2020-09-30","Essential non-healthcare workers","Adults (18-64 years)",1675.0,0.054,"","","Convenience","IgG; IgM","High","Preprint","Daniel Leightley","King's College London","https://doi.org/10.1101/2021.01.26.21249744","Verified","The United Kingdom","SureScreen Diagnostics","","","","GB",""
"2021-03-21","210201_Canada_CanadianBloodServices_Overall_adj","SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada","2021-02-01","National","Canada; All provinces & territories except Quebec","2020-05-09","2020-07-21","Blood donors","Multiple groups",74642.0,0.007,0.006,0.008,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Sahar Saeed","Canadian Blood Services","http://dx.doi.org/10.1111/trf.16296","Verified","Canada","Abbott",0.927,0.999,"","CA",""
"2021-03-21","210217_Kinhasa_InstitutNationaldeRechercheBiomedicale_EUROIMMUN","Challenges in interpreting SARS-CoV-2 serological results in African countries","2021-02-17","Local","Democratic Republic of the Congo; Kinhasa; Kinhasa","2020-07-17","2020-08-13","Health care workers and caregivers","Adults (18-64 years)",562.0,0.36,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Antoine Nkuba Ndaye","Institut National de Recherche Biomedicale","https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00060-7/fulltext","Verified","Democratic Republic of the Congo","EUROIMMUN, Lübeck, Germany",0.946,0.998,"","CD","CD-KN"
"2021-03-21","210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_December_Adults","Rapid increase of SARS-CoV-2 seroprevalence during the 2020 pandemic year in the population of the city of Tirana, Albania","2021-02-20","Local","Albania","2020-12-21","2020-12-28","Household and community samples","Adults (18-64 years)",815.0,0.482,0.448,0.517,"Stratified probability","IgG","High","Preprint","Genc Sulcebe","University of Medicine and University Hospital Center of Tirana","https://doi.org/10.1101/2021.02.18.21251776","Verified","Albania","Euroimmun","","","","AL",""
"2021-03-21","210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_July_Adults","Rapid increase of SARS-CoV-2 seroprevalence during the 2020 pandemic year in the population of the city of Tirana, Albania","2021-02-20","Local","Albania","2020-06-27","2020-07-03","Household and community samples","Adults (18-64 years)",266.0,0.075,0.043,0.107,"Stratified probability","IgG","High","Preprint","Genc Sulcebe","University of Medicine and University Hospital Center of Tirana","https://doi.org/10.1101/2021.02.18.21251776","Verified","Albania","Euroimmun","","","","AL",""
"2021-03-22","201021_UniversidadeDeLisboa_UniversidadeDeLisboa_overall","Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to 6 months post disease onset","2020-10-21","Local","Portugal","2020-05-13","2020-07-10","Non-essential workers and unemployed persons","Adults (18-64 years)",2715.0,0.026,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Patricia Figueiredo Campos","Universidade de Lisboa","https://onlinelibrary.wiley.com/doi/10.1002/eji.202048970","Verified","Portugal","N/A - author designed",0.99,1.0,"","PT",""
"2021-03-22","210120_LosAngelesCounty_CedarsSinaiMedicalCenter_overall_adj","Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study","2021-02-12","Local","United States of America","2020-05-11","2020-05-11","Health care workers and caregivers","Multiple groups",6062.0,0.041,0.031,0.057,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Joseph Ebinger","Cedars-Sinai Medical Center","https://dx.doi.org/10.1136/bmjopen-2020-043584","Verified","United States of America","Abbott",0.883,"","","US",""
"2021-03-22","210205_UnitedStates_BrownUniversity","SARS-CoV-2 antibody detection in skilled nursing facility residents","2021-02-05","National","United States of America; Multiple states","","2020-08-01","Assisted living and long-term care facilities","Seniors (65+ years)",272.0,0.43,"","","Convenience","IgG; IgM; Total Antibody","High","Journal Article (Peer-Reviewed)","Elizabeth White","Brown University","http://dx.doi.org/10.1111/jgs.17061","Verified","United States of America","NR","","","","US",""
"2021-03-22","210216_Toronto_UniversityHealthNetwork_Euroimmun+Microarray","Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center","2021-02-16","Local","Canada; Ontario; Toronto","2020-04-17","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",996.0,0.005,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Victor Ferreira","University Health Network","https://dx.doi.org/10.1371/journal.pone.0247258","Verified","Canada","EUROIMMUN; In-House","","","","CA","CA-ON"
"2021-03-22","210305_Chicago_NorthwesternUniversity_overall","Geographic disparities in COVID-19 case rates are not reflected in seropositivity rates using a neighborhood survey in Chicago","2021-03-05","Local","United States of America; Illinois; Chicago","2020-06-24","2020-11-23","Household and community samples","Multiple groups",1667.0,0.187,"","","Stratified non-probability","IgG","Moderate","Preprint","Brian Mustanski","Northwestern University","https://www.medrxiv.org/content/10.1101/2021.03.02.21252767v1","Verified","United States of America","In-House - Northwestern University","","","","US","US-IL"
"2021-03-22","210316_UnitedStates_ClinicalReferenceLaboratoryInc_OverallGenPop","Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020","2021-03-16","National","United States of America","2020-09-01","2020-09-30","Household and community samples","Multiple groups",61910.0,0.066,"","","Sequential","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Robert Stout","Clinical Reference Laboratory Inc","https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777502?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621","Verified","United States of America","Roche Diagnostics",0.995,0.998,"","US",""
"2021-03-23","210223_Lorenskog_AkershusUniversityHospital_Overall","Comparison of SARS-CoV-2 infections in healthcare workers with high and low exposures to Covid-19 patients in a Norwegian University Hospital","2021-02-23","Local","Norway","2020-05-11","2020-06-11","Health care workers and caregivers","Adults (18-64 years)",360.0,0.033,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Nina Handal","Akershus University Hospital","https://dx.doi.org/10.1080/23744235.2021.1885734","Verified","Norway","Roche Diagnostics, Basel, Switzerland","","","","NO",""
"2021-03-24","201218_Madrid_HospitalUniversitarioFundaciónAlcorcón_HCW_Overall","Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital","2020-12-18","Local","Spain","2020-04-14","2020-04-27","Health care workers and caregivers","Adults (18-64 years)",2590.0,0.316,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Isabel Galan","Hospital Universitario Fundación Alcorcón","https://dx.doi.org/10.1016/j.eimc.2020.11.015","Verified","Spain","Palex",0.889,0.918,"","ES",""
"2021-03-24","210201_Indianapolis_IndianaUniversity_HCW_primary","Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit","2021-02-01","Local","United States of America; Indiana; Indianapolis","2020-04-01","2020-06-24","Health care workers and caregivers","Adults (18-64 years)",34.0,0.35,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jorge J Canas","Indiana University","https://dx.doi.org/10.1016/j.kint.2020.11.014","Verified","United States of America","1) Abnova ; 2-5) N/A (author or institutiona desgined)",0.944,0.985,"","US","US-IN"
"2021-03-24","210201_Indianapolis_IndianaUniversity_HDpatients_primary","Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit","2021-02-01","Local","United States of America; Indiana; Indianapolis","2020-04-01","2020-06-24","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",14.0,0.36,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jorge J Canas","Indiana University","https://dx.doi.org/10.1016/j.kint.2020.11.014","Verified","United States of America","1) Abnova ; 2-5) N/A (author or institutiona desgined)",0.944,0.985,"","US","US-IN"
"2021-03-24","210203_VaticanCity_UniversitàCattolicadelSacroCuore_Overall","SARS-CoV-2 seroprevalence in the Vatican City State","2021-02-03","National","Vatican City; Vatican City State; Vatican City","2020-06-08","2021-01-04","Household and community samples","Multiple groups",1539.0,0.044,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Massimo Ralli","Università Cattolica del Sacro Cuore","https://dx.doi.org/10.1016/j.ejim.2021.01.029","Verified","Vatican City","Siemens Healthineers AG",0.975,0.998,"","VA",""
"2021-03-24","210206_China_ChineseCenterforDiseaseControlandPrevention_Overall","Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China","2021-02-06","National","China","2020-04-10","2020-04-18","Household and community samples","Multiple groups",34857.0,0.012,"","","Stratified probability","IgM; IgG; Neutralizing ; Total Antibody","Low","Journal Article (Peer-Reviewed)","Zhongjie Li","Chinese Center for Disease Control and Prevention","https://dx.doi.org/10.1016/j.lanwpc.2021.100094","Verified","China","Wondfo, Innovita, Bioscience, In-House (China CDC)","","","","CN",""
"2021-03-24","210222_Vorarlberg_VorarlbergInstituteforVascularInvestigationandTreatment","SARS-CoV-2 serostatus of healthcare worker in the Austrian state Vorarlberg between June 2020 and January 2021","2021-02-22","Regional","Austria; Vorarlberg","2020-06-26","2021-01-20","Health care workers and caregivers","Adults (18-64 years)",395.0,0.18,"","","Convenience","IgG","High","Preprint","Michele Atzl","Vorarlberg Institute for Vascular Investigation and Treatment","https://www.medrxiv.org/content/10.1101/2021.02.19.21252045v1","Verified","Austria","Technoclone","","","","AT","AT-8"
"2021-03-24","210225_England_ImperialCollegeLondon_Round4_overall_adj","REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England","2021-02-25","National","United Kingdom of Great Britain and Northern Ireland; England","2020-10-27","2020-11-10","Household and community samples","Multiple groups",161537.0,0.056,0.054,0.057,"Stratified probability","IgG","Moderate","Institutional Report","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1","Verified","The United Kingdom","Fortress Diagnostics",0.844,0.986,"","GB","GB-ENG"
"2021-03-24","210301_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall","Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India","2021-03-01","Local","India; NCT Delhi; New Delhi","2020-06-22","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",3739.0,0.13,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ritu Gupta","All India Institute of Medical Sciences","https://pubmed.ncbi.nlm.nih.gov/33642348/","Verified","India","Siemens AG, Munich, Germany","","","","IN","IN-DL"
"2021-03-24","210302_Milan_FondazioneIRCCSIstitutoNazionaleDeiTumori_HCW_overall","Sars-cov-2 serology monitoring of a cancer center staff in the pandemic most infected italian region","2021-03-02","Local","Italy","2020-04-09","2020-09-09","Health care workers and caregivers","Adults (18-64 years)",110.0,0.2,"","","Simplified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Chiara Maura Ciniselli","Fondazione IRCCS Istituto Nazionale dei Tumori (INT)","http://dx.doi.org/10.3390/cancers13051035","Verified","Italy","Diagnostic Bioprobes, Dia.Pro, Sesto San Giovanni, Milan, Italy; PRIMA LAB SA, Switzerland), DiaSorin, Saluggia, Italy; FDA-EUA)","","","","IT",""
"2021-03-24","210320_Wuhan_ChineseAcademyOfMedicalSciences_overall_Roche","Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study","2021-03-20","Regional","China; Wuhan","2020-04-14","2020-04-15","Household and community samples","Multiple groups",9542.0,0.069,0.064,0.074,"Stratified probability","Total Antibody","Low","Journal Article (Peer-Reviewed)","Zhenyu He","Chinese Academy of Medical Sciences & Peking Union Medical College","https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00238-5/fulltext?dgcid=raven_jbs_etoc_email","Verified","China","Roche",1.0,1.0,"","CN","CN-42"
"2021-03-25","210119_Kaliningrad_RussianAcademyOfSciences_overall","Herd immunity of sars-CoV-2 among the population of Kalinigrad region amid the COVID-19 epidemic","2021-01-19","Regional","Russian Federation; Kaliningrad Region","2020-08-03","2020-08-07","Household and community samples","Multiple groups",2939.0,0.502,0.49,0.511,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","A Yu Popova","The Russian Academy of Sciences","http://dx.doi.org/10.22625/2072-6732-2020-12-5-62-71","Verified","Russian Federation","FBSI"" State Research Center for Applied Microbiology and Biotechnology","","","","RU","RU-KGD"
"2021-03-25","210119_Lacashire_PublicHealthEngland_overall","Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys high throughput immunoassay","2021-01-19","Local","United Kingdom of Great Britain and Northern Ireland; England; Lacashire","2020-06-03","2020-06-04","Essential non-healthcare workers","Adults (18-64 years)",195.0,0.092,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Ranya Mulchandani","Public Health England","http://dx.doi.org/10.1016/j.jcv.2021.104739","Verified","The United Kingdom","Roche","","","","GB","GB-ENG"
"2021-03-25","210224_NortheastItaly_PaduaUniversityHospital_HCW","A longitudinal study of healthcare workers surveillance during the ongoing COVID-19 Epidemics in Italy: is SARS-CoV-2 still a threat for the Health-care System?","2021-02-24","Local","Italy; Veneto Region; Padua","2020-04-08","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",344.0,0.078,"","","Convenience","IgG; IgM","High","Preprint","F Barbaro","Padua University Hospital","https://doi.org/10.1101/2021.02.23.21249481","Verified","Italy","Snibe Diagnostic",0.912,0.973,"","IT","IT-34"
"2021-03-25","210323_Estonia_UniversityOfTartu_Stage15_Overall","The study on the prevalence of the coronavirus in Estonia","2021-12-13","National","Estonia","2021-03-11","2021-03-22","Household and community samples","Multiple groups",2382.0,0.214,0.198,0.231,"Stratified probability","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire","Verified","Estonia","Synlab","","","","EE",""
"2021-03-26","210202_UK_SalfordRoyalNHS_primary","Investigating the Utility of COVID-19 Antibody Testing in End-Stage Renal Disease Patients Receiving Haemodialysis: A Cohort Study in the United Kingdom","2021-02-02","Local","United Kingdom of Great Britain and Northern Ireland","2020-03-15","2020-10-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",237.0,0.051,"","","Convenience","IgG","High","Preprint","Olivia Wickens","Salford Royal NHS","https://www.researchsquare.com/article/rs-154513/v1","Verified","The United Kingdom","SNIBE and Siemens","","","","GB",""
"2021-03-26","210212_Dublin_RotundaHospital","Persistence of SARS-CoV-2 antibodies and symptoms in an Irish Healthcare Worker (HCW) setting: Results of the CAST Study","2021-02-12","Local","Ireland; Leinster; Dublin","2020-05-12","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",51.0,0.04,"","","Convenience","IgG","High","Preprint","Joanna Griffin","Rotunda Hospital","https://www.medrxiv.org/content/10.1101/2021.02.10.20248323v1.full-text","Verified","Ireland","Trinity Biotech",0.959,1.0,"","IE","IE-L"
"2021-03-27","120301_RhodeIsland_CDC","Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July-August 2020","2021-03-01","Regional","United States of America; Rhode Island","2020-07-17","2020-08-28","Health care workers and caregivers","Multiple groups",9863.0,0.046,0.042,0.05,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Lara Akinbami","Centers for Disease Control","https://dx.doi.org/10.3201/eid2703.204508","Verified","United States of America","ORTHO Clinical Diagnostics",0.9,1.0,"","US","US-RI"
"2021-03-27","201020_DipartimentoOncologicoAziendaUslToscanaCentroFirenze_Florence","Sars-cov-2 screening and monitoring in cancer patients: Azienda USL toscana centro oncology department experience","2020-10-20","Local","Italy; Tuscany; Florence","2020-05-11","2020-05-17","Patients seeking care for non-COVID-19 reasons","Multiple groups",1145.0,0.023,"","","Sequential","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Francesca Martella","Azienda Usl Toscana Centro Oncology","http://dx.doi.org/10.1177/0300891620953388","Verified","Italy","NR","","","","IT","IT-52"
"2021-03-27","201020_Milan_UniversitàdegliStudidiMilano_Patients1_Overall","Incidence of sars-cov-2 infection in patients with active cancer: Mono-institutional series of a comprehensive cancer institution in lombardy during the covid-19 pandemic (Niguarda Cancer Center, Milano, Italy)","2020-10-20","Local","Italy; Lombardy; Milan","2020-04-15","2020-05-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",42.0,0.095,"","","Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Andrea Sartore Bianchi","Università degli Studi di Milano","http://dx.doi.org/10.1177/0300891620953388","Verified","Italy","Abbott Laboratories, Diasorin","","","","IT","IT-25"
"2021-03-27","210116_SaoPaulo_UniversityOfSãoPaulo_overall_IgG","The ""false-positive"" conundrum: IgA reference level overestimates the seroprevalence of antibodies to SARS-CoV-2","2021-01-16","Local","Brazil; Sao Paulo; Sao Paulo","2020-05-20","2020-05-22","Multiple populations","Multiple groups",938.0,0.058,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Bruno Caramelli","University of São Paulo","https://dx.doi.org/10.7189/jogh.11.05001","Verified","Brazil","EUROIMMUN","","","","BR","BR-SP"
"2021-03-27","210127_Nice_UniversitéCôted'Azur","Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study","2021-01-27","Local","France; Provence-Alpes-Côte d'Azur; Nice","2020-04-15","2020-05-26","Health care workers and caregivers","Adults (18-64 years)",196.0,0.15,"","","Convenience","IgA; IgG","High","Journal Article (Peer-Reviewed)","Marion Cremoni","Université Côte d'Azur","https://dx.doi.org/10.3389/fmed.2020.608804","Verified","France","EUROIMMUN",1.0,"","","FR","FR-PAC"
"2021-03-27","210208_Chicago_NorthwesternUniversity_overall","Symptoms of COVID-19 infection and magnitude of antibody response in a large community-based study","2021-02-08","Local","United States of America; Illinois; Chicago","2020-06-24","2020-11-11","Household and community samples","Multiple groups",3365.0,0.178,"","","Self-referral","IgG","High","Preprint","Thomas McDade","Northwestern University","https://www.medrxiv.org/content/10.1101/2021.02.04.21251170v1","Verified","United States of America","N/A - in-house","","","","US","US-IL"
"2021-03-27","210209_Sergipe_FederalUniversityofSergipe","Seroprevalence of SARS-CoV-2 antibodies in low-income university students","2021-02-09","Regional","Brazil; Sergipe; Aracaji, Itabaiana, Lagarto, Larangeiras, Nossa Senhora da Gloria, Sao Cristovao","2020-09-15","2020-10-06","Students and Daycares","Adults (18-64 years)",276.0,0.225,0.179,0.277,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Adriano Antunes de Souza Araujo","Federal University of Sergipe","https://dx.doi.org/10.17179/excli2021-3459","Verified","Brazil","iChroma II, BioSys + Kovalent",0.958,0.97,"","BR","BR-SE"
"2021-03-27","210212_Ischgl_MedicalUniversityofInnsbruck_overall","Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: Development of a prediction model based on data from Ischgl, Austria","2021-02-12","Local","Austria; Tyrol; Ischgl","2020-04-21","2020-04-27","Household and community samples","Multiple groups",451.0,0.437,"","","Entire sample","IgG; IgA","High","Journal Article (Peer-Reviewed)","Jens Lehmann","Medical University of Innsbruck","https://dx.doi.org/10.1017/S0950268821000418","Verified","Austria","1) Euroimmun; 2)Abbott","","","","AT","AT-7"
"2021-03-27","210212_Oxford_UniversityofOxford","Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic","2021-02-12","Local","United Kingdom of Great Britain and Northern Ireland","2020-04-15","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",404.0,0.03,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Colleen GC McGregor","University of Oxford","https://dx.doi.org/10.1136/gutjnl-2021-324116","Verified","The United Kingdom","Abbott","","","","GB",""
"2021-03-27","210215_USA_SpaceX_overall","Discrete SARS-CoV-2 antibody titers track with functional humoral stability","2021-02-15","Local","United States of America; Multiple; Multiple","2020-04-01","2020-06-10","Non-essential workers and unemployed persons","Adults (18-64 years)",4300.0,0.028,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Yannic Bartsch","Ragon Institute of MGH, MIT and Harvard","https://dx.doi.org/10.1038/s41467-021-21336-8","Verified","United States of America","Author designed",0.995,"","","US",""
"2021-03-27","210216_Alicante_UniversityofAlicante_overall_PopAdj_TestAdj","Seroprevalence study and cross-sectional survey on COVID-19 for a plan to reopen the university of alicante (Spain)","2021-02-16","Local","Spain; Alicante; Alicante","2020-07-06","2020-07-22","Non-essential workers and unemployed persons","Adults (18-64 years)",1479.0,0.029,0.021,0.037,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Jose Tuells","University of Alicante","http://dx.doi.org/10.3390/ijerph18041908","Verified","Spain","Cellex Inc., Durham, NC, USA",0.878,0.999,"","ES","ES-VC"
"2021-03-27","210220_Lazio_ UniversitàCattolicadelSacroCuore_Overall","Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients","2021-02-20","Local","Italy; Lazio; Rome","2020-05-25","2020-08-10","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",202.0,0.015,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Fabio Del Zompo","Università Cattolica del Sacro Cuore","https://dx.doi.org/10.1016/j.dld.2021.02.015","Verified","Italy","NR","","","","IT","IT-62"
"2021-03-27","210221_Iowa_UniversityofIowa","SARS-CoV-2 Infection during Pregnancy in a Rural Midwest All-delivery Cohort and Associated Maternal and Neonatal Outcomes","2021-02-21","Local","United States of America; Iowa","2020-05-01","2020-09-22","Pregnant or parturient women","Adults (18-64 years)",1000.0,0.058,"","","Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Haley Steffen","University of Iowa","https://dx.doi.org/10.1055/s-0041-1723938","Verified","United States of America","DiaSorin; Roche","","","","US","US-IA"
"2021-03-27","210225_CapeTown_StellenboschUniversity_Overall","Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa","2021-02-25","Local","South Africa","2020-08-17","2020-09-04","Essential non-healthcare workers","Adults (18-64 years)",405.0,0.237,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jane Shaw","Stellenbosch University","https://dx.doi.org/10.1371/journal.pone.0247852","Verified","South Africa","Abbott Laboratories","",0.985,"","ZA",""
"2021-03-27","210226_California_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Local","United States of America; California","2020-03-23","2020-08-14","Residual sera","Multiple groups",4980.0,0.019,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-CA"
"2021-03-27","210226_Connecticut_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America; Connecticut","2020-03-23","2020-08-14","Residual sera","Multiple groups",8929.0,0.057,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-CT"
"2021-03-27","210226_Florida_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America; Florida","2020-03-23","2020-08-14","Residual sera","Multiple groups",7787.0,0.048,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-FL"
"2021-03-27","210226_Louisiana_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America; Louisiana","2020-03-23","2020-08-14","Residual sera","Multiple groups",2849.0,0.077,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-LA"
"2021-03-27","210226_Minnesota_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America; Minnesota; Minneapolis, St. Paul, St. Cloud","2020-03-23","2020-08-14","Residual sera","Multiple groups",7944.0,0.049,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-MN"
"2021-03-27","210226_Missouri_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America; Missouri","2020-03-23","2020-08-14","Residual sera","Multiple groups",9356.0,0.025,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-MO"
"2021-03-27","210226_NewYork_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Local","United States of America; New York; New York City","2020-03-23","2020-08-14","Residual sera","Multiple groups",7746.0,0.172,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-NY"
"2021-03-27","210226_Pennsylvania_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Local","United States of America; Pennsylvania; Philadelphia","2020-03-23","2020-08-14","Residual sera","Multiple groups",8657.0,0.043,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-PA"
"2021-03-27","210226_Utah_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America; Utah","2020-03-23","2020-08-14","Residual sera","Multiple groups",8769.0,0.027,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-UT"
"2021-03-27","210226_Washington_CentersforDiseaseControlandPrevention_Overall","Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020","2021-02-26","Regional","United States of America; Washington","2020-03-23","2020-08-14","Residual sera","Multiple groups",7544.0,0.02,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Travis Lim","Centers for Disease and Control","https://dx.doi.org/10.1093/cid/ciab185","Verified","United States of America","In-House (CDC)",0.96,0.993,"","US","US-WA"
"2021-03-27","210920_Serdivan_SakaryaUniversity","COVID-19 prevalence and oncologic outcomes of asymptomatic patients with active cancer who received chemotherapy","2021-01-15","Local","Turkey; Sakarya; Serdivan","2020-04-07","2020-05-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",198.0,0.035,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Cemil Bilir","Sakarya University","http://dx.doi.org/10.19193/0393-6384_2021_1_103","Verified","Turkey","NR","","","","TR","TR-54"
"2021-03-28","210117_OrangeCounty_HoagMemorialHospitalPresbyterian_First_responders","Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers","2021-01-17","Local","United States of America; California","2020-07-15","2020-08-15","Essential non-healthcare workers","Adults (18-64 years)",92.0,0.044,0.012,0.108,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Michael Brant Zawadzki","Hoag Memorial Hospital Presbyterian","https://dx.doi.org/10.1093/ofid/ofab015","Verified","United States of America","Ortho Diagnostics",0.936,1.0,"","US","US-CA"
"2021-03-28","210117_OrangeCounty_HoagMemorialHospitalPresbyterian_HCW","Prevalence and Longevity of SARS-CoV-2 Antibodies Among Health Care Workers","2021-01-17","Local","United States of America; California","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",2754.0,0.028,0.022,0.034,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Michael Brant Zawadzki","Hoag Memorial Hospital Presbyterian","https://dx.doi.org/10.1093/ofid/ofab015","Verified","United States of America","Ortho Diagnostics",0.936,1.0,"","US","US-CA"
"2021-03-28","210204_OrangeCounty_UniversityofCaliforniaIrvine_Overall_PopTestAdj","Estimated Seroprevalence of SARS-CoV-2 Antibodies Among Adults in Orange County, California","2021-02-04","Local","United States of America; California","2020-07-10","2020-08-16","Household and community samples","Multiple groups",2979.0,0.113,0.081,0.132,"Stratified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Tim Bruckner","University of California Irvine","https://dx.doi.org/10.1038/s41598-021-82662-x","Verified","United States of America","NR",0.94,1.0,"","US","US-CA"
"2021-03-28","210213_Makkah_KingAbdulazizUniversity_HCW","Seroprevalence of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Healthcare Workers in Makkah, Saudi Arabia","2021-02-13","Local","Saudi Arabia; Mecca Province; Makkah (Mecca)","2020-06-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",204.0,0.063,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Waleed Ahmed","King Abdulaziz University","https://www.sciencedirect.com/science/article/pii/S1018364721000276?via%3Dihub","Verified","Saudi Arabia","In-House; MN assay unclear (GeurtsvanKessel et al., 2020; Kohmeret al., 2021; Lisboa Bastos et al., 2020).","","","","SA","SA-02"
"2021-03-28","210222_SantaClaraCounty_UniversityofStanford_GenPop_PopTestAdj","COVID-19 Antibody Seroprevalence in Santa Clara County, California","2021-02-22","Local","United States of America; California","2020-04-03","2020-04-04","Household and community samples","Multiple groups",3328.0,0.028,0.013,0.042,"Stratified non-probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Eran Bendavid","Stanford University School of Medicine","https://dx.doi.org/10.1093/ije/dyab010","Verified","United States of America","Premier Biotech",0.856,0.995,"","US","US-CA"
"2021-03-29","210317_UniversidadDeLosAndes_UniversidadDeLosAndes_overall","Seroreactivity to SARS-CoV-2 in individuals attending a university campus in Bogotá Colombia","2021-03-17","Local","Colombia; Capital District Cundinamarca; Bogotá","2020-11-23","2020-12-06","Essential non-healthcare workers","Adults (18-64 years)",237.0,0.135,"","","Convenience","IgG","High","Preprint","John M Gonzalez","Universidad de Los Andes","https://www.medrxiv.org/content/10.1101/2021.03.15.21253609v1","Verified","Colombia","Abbott","","","","CO","CO-DC"
"2021-03-30","210212_Gurugram_Medanta-TheMedicity","Is Covid-19 seroprevalence different in health care workers as per their risk of exposure? A study from a tertiary care hospital in National Capital Region of India","2021-02-12","Local","India; Haryana; Gurugram","2021-01-12","2021-02-13","Health care workers and caregivers","Adults (18-64 years)",3258.0,0.462,0.444,0.479,"Convenience","IgG","High","Preprint","Sushila Kataria","Madanta- The Medicity","https://www.medrxiv.org/content/10.1101/2021.02.10.21251543v1","Verified","India","DiaSorin","","","","IN","IN-HR"
"2021-03-30","210309_Massachusetts_UniversityofMassachusetts-Amherst_LocalPop_Primary","Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study","2021-03-09","Local","United States of America; Massachusetts ; Amherst","2020-07-15","2020-08-15","Non-essential workers and unemployed persons","Multiple groups",292.0,0.04,0.016,0.065,"Simplified probability","IgG","High","Preprint","Teah Snyder","University of Massachusetts-Amherst","https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf","Verified","United States of America","NR","","","","US","US-MA"
"2021-03-30","210309_Massachusetts_UniversityofMassachusetts-Amherst_Undergrad_Primary","Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional study","2021-03-09","Local","United States of America; Massachusetts ; Amherst","2020-07-15","2020-08-15","Multiple populations","Multiple groups",779.0,0.053,0.031,0.075,"Stratified probability","IgG","High","Preprint","Teah Snyder","University of Massachusetts-Amherst","https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf","Verified","United States of America","NR","","","","US","US-MA"
"2021-03-30","210311_Vellore_UniversityOfEdinburgh_CommunitySurvey1_overall","The Burden of COVID-19 Infection in a Rural Tamil Nadu Community","2021-03-11","Local","India; Tamil Nadu","2020-07-06","2020-08-20","Household and community samples","Multiple groups",501.0,0.022,0.008,0.034,"Simplified probability","IgG","Moderate","Preprint","Rita Isaac","University of Edinburgh","https://www.researchsquare.com/article/rs-289385/v1","Verified","India","1) Roche; 2) Siemens","","","","IN","IN-TN"
"2021-03-30","210311_Vellore_UniversityOfEdinburgh_CommunitySurvey2_overall","The Burden of COVID-19 Infection in a Rural Tamil Nadu Community","2021-03-11","Local","India; Tamil Nadu","2020-11-06","2020-11-20","Household and community samples","Multiple groups",200.0,0.22,0.163,0.277,"Simplified probability","IgG","Moderate","Preprint","Rita Isaac","University of Edinburgh","https://www.researchsquare.com/article/rs-289385/v1","Verified","India","1) Roche; 2) Siemens","","","","IN","IN-TN"
"2021-03-31","210212_Nancy_UniversitéDeLorraine_overall","Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France","2021-02-12","Local","France","2020-06-26","2020-07-24","Household and community samples","Multiple groups",2006.0,0.025,0.018,0.033,"Stratified probability","Total Antibody; IgM; IgG; IgA","Low","Preprint","Anne Gegout petit","Université de Lorraine","10.1101/2021.02.10.21250862","Verified","France","1) BioRad; 2) Biosynex; 3)Euroimmun","","","","FR",""
"2021-03-31","210223_Barcelona_UniversitatDeBarcelona_primary","Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19","2021-02-23","Local","Spain","2020-09-29","2020-10-20","Health care workers and caregivers","Adults (18-64 years)",507.0,0.164,0.133,0.199,"Simplified probability","IgA; IgG; IgM","Moderate","Preprint","Natalia Ortega","Universitat de Barcelona","https://www.medrxiv.org/content/10.1101/2021.02.22.21252150v1.full-text","Verified","Spain","N/A - in house",0.958,1.0,"","ES",""
"2021-03-31","210303_Lodi_IRCCSPoliclinico_overall_CLIA","Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area","2021-03-03","Local","Italy; Lombardy region; Lodi","2020-03-18","2020-06-24","Blood donors","Multiple groups",1922.0,0.197,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Irene Cassaniti","IRCCS Policlinico","https://dx.doi.org/10.1016/j.cmi.2021.01.030","Verified","Italy","DiaSorin","","","","IT","IT-25"
"2021-03-31","210303_London_NorthMiddlesexUniversityHospitalNHSTrust_Overall","Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital","2021-03-03","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-06-04","2020-07-03","Health care workers and caregivers","Adults (18-64 years)",3285.0,0.357,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Emily Martin","North Middlesex University Hospital NHS Trust","https://dx.doi.org/10.1016/j.jinf.2021.02.027","Verified","The United Kingdom","NR","","","","GB","GB-ENG"
"2021-03-31","210312_Cincinnati_UniversityOfCincinnati_overall","Seroprevalence of SARS-CoV-2 Infection in Cincinnati Ohio USA from August to December 2020","2021-03-12","Local","United States of America; Ohio; Greater Cincinnati Metropolitan Area","2020-08-13","2020-12-08","Blood donors","Multiple groups",9550.0,0.084,"","","Simplified probability","IgG","Moderate","Preprint","Greg Davis","University of Cincinnati","10.1101/2021.03.11.21253263","Verified","United States of America","N/A - in house","","","","US","US-OH"
"2021-03-31","210312_Strasbourg_UniversityHospitalStrasbourg_overall","Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients","2021-03-12","Local","France","2021-02-18","2021-02-25","Patients seeking care for non-COVID-19 reasons","Multiple groups",241.0,0.108,"","","Unclear","IgG","High","Preprint","Ilies Benotmane","University Hospital, Strasbourg","https://www.medrxiv.org/content/10.1101/2021.03.08.21252741v1.full-text","Verified","France","Abbott","","","","FR",""
"2021-04-01","210131_NorthernVirginia_InovaChildren’sHospital_primary","SARS-CoV-2 Seroepidemiology in Children and Adolescents","2021-01-31","Local","United States of America; Virginia; Northern Virginia","2020-07-31","2020-10-13","Multiple general populations","Children and Youth (0-17 years)",1038.0,0.085,0.069,0.103,"Convenience","Total Antibody","High","Preprint","Rebecca E Levorson","Inova Children’s Hospital","https://www.medrxiv.org/content/10.1101/2021.01.28.21250466v1","Verified","United States of America","Ortho diagnostics","",1.0,"","US","US-VA"
"2021-04-01","210309_SkåneRegion_LundUniversity_HCWs","Association between SARS-CoV-2 and exposure risks in health care workers and university employees - a cross-sectional study","2021-03-09","Local","Sweden; Skåne Region","2020-09-08","2020-11-10","Health care workers and caregivers","Adults (18-64 years)",271.0,0.059,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","David Nygren","Lund University","https://dx.doi.org/10.1080/23744235.2021.1892819","Verified","Sweden","Zeta Gene Ltd.","","","","SE","SE-M"
"2021-04-01","210309_SkåneRegion_LundUniversity_UniversityEmployees","Association between SARS-CoV-2 and exposure risks in health care workers and university employees - a cross-sectional study","2021-03-09","Local","Sweden; Skåne Region; Lund","2020-09-08","2020-11-10","Non-essential workers and unemployed persons","Adults (18-64 years)",192.0,0.06,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","David Nygren","Lund University","https://dx.doi.org/10.1080/23744235.2021.1892819","Verified","Sweden","Zeta Gene Ltd.","","","","SE","SE-M"
"2021-04-01","210312_Paris_SorbonneUniversite_M3","Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris, France: the SEROCOV prospective cohort study","2021-03-12","Local","France","2020-06-16","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",938.0,0.13,0.111,0.152,"Convenience","IgG","Moderate","Preprint","Pierre Hausfater","Sorbonne Universite","10.1101/2021.03.09.21253200","Verified","France","Abbott","","","","FR",""
"2021-04-02","210211_UnitedKingdom_ImperialCollegeNHSTrust_GlomerularDiseasePatients","Serological screening for COVID-19 in patients with glomerular disease","2021-02-11","Local","United Kingdom of Great Britain and Northern Ireland","2020-05-19","2020-07-21","Patients seeking care for non-COVID-19 reasons","Multiple groups",493.0,0.077,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Tabitha Turner Stokes","Imperial College Healthcare NHS Trust","https://dx.doi.org/10.1016/j.ekir.2021.02.006","Verified","The United Kingdom","Abbott","","","","GB",""
"2021-04-02","210218_RhodeIsland_BrownUniversity_overall_adj","Seroprevalence of SARS-CoV-2 Antibodies in Rhode Island From a Statewide Random Sample","2021-02-18","Regional","United States of America; Rhode Island","2020-05-05","2020-05-22","Household and community samples","Multiple groups",1032.0,0.029,0.01,0.062,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Philip A Chan","Brown University","https://dx.doi.org/10.2105/AJPH.2020.306115","Verified","United States of America","Abbot",0.884,0.996,"","US","US-RI"
"2021-04-02","210226_Mallorca_SonLlatzerUniversityHospital_overall","Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of COVID-19 pandemic","2021-02-26","Local","Spain","2020-04-28","2020-06-11","Health care workers and caregivers","Adults (18-64 years)",2210.0,0.028,0.025,0.031,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Adrian Rodriguez","Son Llatzer University Hospital","https://dx.doi.org/10.1016/j.ijid.2021.02.104","Verified","Spain","Abbott",0.967,0.996,"","ES",""
"2021-04-02","210308_Perpignan_CentreHospitalierDePerpignan_Overall_PopAdj","High seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in Perpignan, France","2021-03-08","Local","France; Occitanie; Perpignan","2020-06-29","2020-07-17","Household and community samples","Multiple groups",700.0,0.354,0.302,0.41,"Stratified probability","IgG; IgM","Low","Preprint","Adeline Beaumont","Centre Hospitalier de Perpignan","https://www.medrxiv.org/content/10.1101/2021.03.05.21252835v1.full-text","Verified","France","Roche Diagnostics",0.995,0.998,"","FR","FR-OCC"
"2021-04-02","210309_UnitedStates_StanfordUniversity_OverallPopAdj","SARS-COV-2 antibody prevalence in patients on dialysis in the US in January 2021","2021-03-09","National","United States of America","2021-01-01","2021-01-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",21424.0,0.213,0.203,0.223,"Unclear","Total Antibody","Moderate","Preprint","Shuchi Anand","Stanford University","https://doi.org/10.1101/2021.03.07.21252786","Verified","United States of America","Siemens Healthineers",1.0,0.998,"","US",""
"2021-04-03","210204_Milan_ FoundationIRCCS Ca'GrandaOspedaleMaggiorePoliclinico_overall_adj","Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study","2021-02-22","Local","Italy; Lombardy; Milan","2020-04-27","2020-06-12","Health care workers and caregivers","Multiple groups",4055.0,0.064,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Andrea Lombardi","Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico","https://dx.doi.org/10.1136/bmjopen-2020-047216","Verified","Italy","DiaSorin, Saluggia, Italy",0.974,0.985,"","IT","IT-25"
"2021-04-03","210312_Amsterdam_PublicHealthServiceOfAmsterdam_overall","SARS-CoV-2 antibody prevalence and determinants of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020","2021-03-12","Local","Netherlands","2020-06-24","2020-10-09","Household and community samples","Multiple groups",2483.0,0.091,"","","Stratified probability","IgG; IgA; IgM","High","Preprint","Liza Coyer","Public Health Service of Amsterdam","10.1101/2021.03.08.21252788","Verified","Netherlands","Wantai Biological Pharmacy Enterprise Co","","","","NL",""
"2021-04-03","210312_Spain_ InstitutoDeSalud CarlosIII_overall_Abbott","Evolution of antibodies against SARS-CoV-2 over seven months: experience of the Nationwide Seroprevalence ENE-COVID Study in Spain","2021-03-12","National","Spain","2020-11-16","2020-11-29","Household and community samples","Multiple groups",5827.0,0.049,"","","Stratified probability","IgG","Moderate","Preprint","Mayte Perez Olmeda","Instituto de Salud Carlos III","https://www.medrxiv.org/content/10.1101/2021.03.11.21253142v1","Verified","Spain","Abbott",0.996,1.0,"","ES",""
"2021-04-03","210321_NewYork_WeillCornellMedicine_Pediatrics","Association of Age With SARS-CoV-2 Antibody Response","2021-03-22","Local","United States of America; New York ; New York City","2020-04-09","2020-08-31","Residual sera","Children and Youth (0-17 years)",1194.0,0.165,0.144,0.187,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","He Yang","NewYork–Presbyterian Hospital/Weill Cornell Medical Center","https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743","Verified","United States of America","ET Healthcare; COV2T","","","","US","US-NY"
"2021-04-04","201020_Sondrio_AltoLario-OncologiaMedicaSondrio_Overall","Rapid serological test in the covid-19 era: Our experience","2020-10-20","Local","Italy; Lombardy; Sondrio","2020-03-01","2020-10-19","Health care workers and caregivers","Adults (18-64 years)",220.0,0.114,"","","Convenience","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","G Caponigro","ASST della Valtellina ; Alto Lario-Oncologia Medica Sondrio","http://dx.doi.org/10.1177/0300891620953388","Verified","Italy","Nal Von Minden GmbH (Germany)",0.941,0.992,"","IT","IT-25"
"2021-04-04","201105_London_ImperialCollegeLondon","Prevalence of SARS-CoV-2 infection in patients with chronic myeloidleukemia","2020-11-05","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-06-01","2020-07-27","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",161.0,0.112,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Simone Claudiani","Imperial College London","http://dx.doi.org/10.1182/blood-2020-142454","Verified","The United Kingdom","Imperial College London",0.948,"","","GB","GB-ENG"
"2021-04-04","210206_YokohamaCity_YokohamaCityUniversity","SARS-CoV-2 prevalence in saliva and gastric and intestinal fluid in patients undergoing gastrointestinal endoscopy in COVID-19 endemic areas: prospective cross-sectional study in Japan","2021-02-06","Local","Japan; Kanagawa Prefecture; Yokohama City","2020-06-01","2020-07-31","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",432.0,0.039,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Shigeta Miyake","Yokohama City University","http://dx.doi.org/10.1111/den.13945","Verified","Japan","NR","","","","JP","JP-14"
"2021-04-04","210321_NewYork_WeillCornellMedicine_Adults","Association of Age With SARS-CoV-2 Antibody Response","2021-03-22","Local","United States of America; New York ; New York City","2020-04-09","2020-08-31","Residual sera","Multiple groups",30232.0,0.186,0.182,0.191,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","He Yang","NewYork–Presbyterian Hospital/Weill Cornell Medical Center","https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743","Verified","United States of America","ET Healthcare; COV2T","","","","US","US-NY"
"2021-04-05","210116_Philadelphia_UniversityofPennsylvania_Overall","SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapy","2021-01-16","Local","United States of America; Pennsylvania; Philadelphia","2020-05-21","2020-10-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",124.0,0.016,"","","Sequential","IgG; IgM","High","Preprint","Lova Sun","University of Pennsylvania","https://dx.doi.org/10.1101/2021.01.15.21249810","Verified","United States of America","N/A - In house","","","","US","US-PA"
"2021-04-05","210202_Turin_UniversityofTurin_Overall","Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery","2021-02-02","Local","Italy; Piedmont; Turin","2020-04-15","2020-06-15","Pregnant or parturient women","Adults (18-64 years)",164.0,0.098,"","","Sequential","IgG; IgM; Neutralizing","High","Journal Article (Peer-Reviewed)","Stefano Cosma","University of Turin","https://dx.doi.org/10.1016/j.jri.2021.103285","Verified","Italy","Boditech Med Inc, Gang-won-do, Korea; Diasorin, Italy","","","","IT","IT-21"
"2021-04-05","210206_France_ParisUniversity_ELISA","Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based ""CONSTANCES"" cohort","2021-02-06","National","France","2019-11-04","2020-03-16","Residual sera","Multiple groups",9144.0,0.039,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Fabrice Carrat","Paris University","http://dx.doi.org/10.1007/s10654-020-00716-2","Unverified","France","EUROIMMUN","",1.0,"","FR",""
"2021-04-05","210206_France_ParisUniversity_ELISA+NT","Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based ""CONSTANCES"" cohort","2021-02-06","National","France","2019-11-04","2020-03-16","Residual sera","Multiple groups",9144.0,0.005,"","","Simplified probability","Neutralizing ; IgG","Moderate","Journal Article (Peer-Reviewed)","Fabrice Carrat","Paris University","http://dx.doi.org/10.1007/s10654-020-00716-2","Verified","France","EUROIMMUN; In-House ;  - Paris University","",1.0,"","FR",""
"2021-04-05","210210_London_KingsCollegeLondon","Indicators of past COVID-19 infection status: Findings from a large occupational cohort of staff and postgraduate research students from a UK university","2021-02-10","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-06-01","2020-06-30","Multiple populations","Adults (18-64 years)",1882.0,0.07,"","","Convenience","IgG; IgM","High","Preprint","Katrina Davis","King's College London","https://www.medrxiv.org/content/10.1101/2020.12.07.20245183v2","Verified","The United Kingdom","Sure Screen Diagnostics",0.94,0.963,"","GB","GB-ENG"
"2021-04-05","210401_Ranong_ChulalongkornUniversity","Seroprevalence of hospital staff in a province with zero COVID-19 cases","2021-04-01","Local","Thailand; Ranong","2020-04-17","2020-05-17","Health care workers and caregivers","Adults (18-64 years)",844.0,0.008,0.004,0.017,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Tanawin Nopsopon","Chulalongkorn University","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238088","Unverified","Thailand","Baiya Phytopharm, Thailand",0.941,0.98,"","TH","TH-85"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Apr_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Amazonas; Manaus","2020-04-06","2020-04-17","Blood donors","Multiple groups",829.0,0.05,0.029,0.074,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Aug_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Amazonas; Manaus","2020-08-08","2020-08-19","Blood donors","Multiple groups",881.0,0.456,0.411,0.501,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Feb_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Amazonas; Manaus","2020-02-07","2020-02-13","Blood donors","Multiple groups",821.0,0.004,0.0,0.033,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Jul_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Amazonas; Manaus","2020-07-06","2020-07-15","Blood donors","Multiple groups",1147.0,0.49,0.442,0.536,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Jun_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Amazonas; Manaus","2020-06-05","2020-06-15","Blood donors","Multiple groups",911.0,0.554,0.507,0.601,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Mar_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Amazonas; Manaus","2020-03-06","2020-03-12","Blood donors","Multiple groups",832.0,0.0,0.0,0.008,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_May_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Amazonas; Manaus","2020-05-05","2020-05-14","Blood donors","Multiple groups",901.0,0.434,0.384,0.486,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Oct_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Amazonas; Manaus","2020-10-10","2020-10-17","Blood donors","Multiple groups",882.0,0.446,0.393,0.5,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_Manaus_UniversidadedeSãoPaulo_Sept_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Amazonas; Manaus","2020-09-05","2020-09-14","Blood donors","Multiple groups",868.0,0.473,0.421,0.525,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-AM"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Apr_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-04-08","2020-04-30","Blood donors","Multiple groups",900.0,0.04,0.018,0.066,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Aug_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-08-10","2020-08-29","Blood donors","Multiple groups",906.0,0.155,0.123,0.182,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_DonorsTestOverall","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-07-01","2020-07-31","Blood donors","Multiple groups",1000.0,0.133,"","","Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories; Roche Diagnostics","","","","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Feb_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-02-08","2020-02-29","Blood donors","Multiple groups",799.0,0.01,0.0,0.029,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Jul_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-07-13","2020-07-25","Blood donors","Multiple groups",879.0,0.106,0.081,0.135,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Jun_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-06-08","2020-06-20","Blood donors","Multiple groups",880.0,0.131,0.103,0.163,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Mar_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-03-09","2020-03-21","Blood donors","Multiple groups",2454.0,0.028,0.018,0.039,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_May_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-05-08","2020-05-21","Blood donors","Multiple groups",826.0,0.047,0.026,0.073,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Oct_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-10-12","2020-10-24","Blood donors","Multiple groups",877.0,0.182,0.15,0.217,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-SP"
"2021-04-07","210115_SaoPaulo_UniversidadedeSãoPaulo_Sept_PopTestAdj","Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","2021-01-16","Local","Brazil; Sao Paulo State; Sao Paulo","2020-09-07","2020-09-29","Blood donors","Multiple groups",933.0,0.151,0.123,0.182,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Lewis Buss","Universidade de Sao Paulo","https://science.sciencemag.org/content/371/6526/288","Verified","Brazil","Abbott Laboratories",0.922,0.961,"","BR","BR-SP"
"2021-04-07","210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_BloodDonors","Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama","2021-03-02","Local","Panama","2020-04-30","2020-07-07","Blood donors","Multiple groups",255.0,0.133,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alcibiades Villarreal","Instituto de Investigaciones Científicas y; Servicios de Alta Tecnología","https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full","Verified","Panama","Dr. Chong Li’s group from Institute of Biophysics, Chinese Academy of Science",0.87,0.989,"","PA",""
"2021-04-07","210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_HCWs","Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama","2021-03-02","Local","Panama","2020-04-30","2020-07-07","Health care workers and caregivers","Multiple groups",351.0,0.128,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alcibiades Villarreal","Instituto de Investigaciones Científicas y; Servicios de Alta Tecnología","https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full","Verified","Panama","Dr. Chong Li’s group from Institute of Biophysics, Chinese Academy of Science",0.87,0.989,"","PA",""
"2021-04-08","200825_Wuhan_ChineseCenterforDiseaseControlandPrevention_primary","Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China: a cross-sectional study","2020-08-25","Local","China; Hubei; Wuhan","2020-03-25","2020-04-28","Household and community samples","Multiple groups",18712.0,0.033,0.03,0.035,"Self-referral","IgG; IgM","Moderate","Preprint","Ruijie Ling","Chinese Center for Disease Control and Prevention","https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v3","Verified","China","Innovita",0.895,0.99,"","CN","CN-42"
"2021-04-08","200826_Veneto_UniversityHospitalOfPadova","SARS-CoV-2 serosurvey in health care workers of the Veneto Region","2020-08-26","Regional","Italy; Veneto","2020-02-22","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",8285.0,0.046,0.041,0.05,"Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mario Plebani","University Hospital Of Padova","https://www.degruyter.com/document/doi/10.1515/cclm-2020-1236/html","Verified","Italy","SNIBE – Shenzhen New Industries Biomedical Engineering Co.",0.73,0.98,"","IT","IT-34"
"2021-04-08","200901_Seattle_FredHutchinsonCancerResearchCenter_Overall","Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak","2020-09-01","Local","United States of America; Washington; Seattle","2020-03-03","2020-04-24","Residual sera","Children and Youth (0-17 years)",1076.0,0.009,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Adam S Dingens","Fred Hutchinson Cancer Research Center","https://www.nature.com/articles/s41467-020-18178-1","Verified","United States of America","N/A, Abbott","","","","US","US-WA"
"2021-04-08","2010330_Bolinas_UniversityofCalifornia_Abbott+ELISA","Universal polymerase chain reaction and antibody testing demonstrate little to no transmission of severe acute respiratory syndrome coronavirus 2 in a rural community","2020-10-30","Local","United States of America; California; Bolinas","2020-04-20","2020-04-24","Household and community samples","Multiple groups",1880.0,0.0,"","","Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Ayesha Appa","University of California San Francisco","http://dx.doi.org/10.1093/ofid/ofaa531","Verified","United States of America","Abbott Laboratories; University of California","","","","US","US-CA"
"2021-04-08","201216_Heidelberg_UniversityHospitalHeidelberg_Overall","SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study","2020-12-16","Local","Germany; Baden-Württemberg; Heidelberg","2020-05-05","2020-08-06","Patients seeking care for non-COVID-19 reasons","Multiple groups",219.0,0.032,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Conrad Rauber","University Hospital Heidelberg","https://www.sciencedirect.com/science/article/abs/pii/S0041134520329043?via%3Dihub","Verified","Germany","EUROIMMUN™",0.946,0.998,"","DE","DE-BW"
"2021-04-09","201111_Srinagar_GovernmentMedicalCollegeSrinagar","Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India – A cross-sectional study","2020-11-11","Regional","India; Srinagar; District Srinagar","2020-07-01","2020-07-15","Residual sera","Multiple groups",2906.0,0.036,0.029,0.043,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","S Muhammad Salim Khan","Government Medical College Srinagar","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239303","Verified","India","Abbott",1.0,0.996,"","IN","IN-JK"
"2021-04-09","210203_HeinsbergDistrict_UniversityHospitalDusseldorf_NeutralizationAssay","Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting","2021-02-03","Local","Germany","2020-04-09","2020-04-09","Contacts of COVID patients","Multiple groups",42.0,0.619,"","","Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Lisa Muller","University Hospital Dusseldorf","https://dx.doi.org/10.1007/s10096-021-04169-7","Verified","Germany","NR","","","","DE",""
"2021-04-09","210223_France_MontpellierUniversity_NursingHomeResidents","Atypical symptoms, SARS-CoV-2 test results, and immunization rates in 456 residents from eight nursing homes facing a COVID-19 outbreak","2021-02-23","Regional","France; Occitanie","2020-04-21","2020-07-29","Assisted living and long-term care facilities","Seniors (65+ years)",456.0,0.307,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Hubert Blain","Montpellier University","https://dx.doi.org/10.1093/ageing/afab050","Verified","France","NR","","","","FR","FR-OCC"
"2021-04-09","210224_USA_NationalInstitutesofHealth_primary","Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection","2021-02-24","National","United States of America","2020-01-01","2020-08-26","Residual sera","Multiple groups",3257478.0,0.116,"","","Convenience","IgG; IgA; IgM","Moderate","Journal Article (Peer-Reviewed)","Raymond Harvey","National Institutes of Health","https://dx.doi.org/10.1001/jamainternmed.2021.0366","Verified","United States of America","NR","","","","US",""
"2021-04-09","210226_Turin_UniversityofTurin_Pharmacists","Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence","2021-02-26","Regional","Italy; Turin","2020-07-01","2020-07-31","Essential non-healthcare workers","Adults (18-64 years)",286.0,0.035,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Francesca Baratta","University of Turin","https://dx.doi.org/10.3390/ijerph18052302","Verified","Italy","Prima Lab",1.0,0.98,"","IT","IT-21"
"2021-04-09","210305_EssexCounty_RutgersUniversity_overall_unadj","Self-reported symptoms, self-reported viral testing result and seroprevalence of SARS CoV-2 among a community sample in Essex County New Jersey: A brief report","2021-03-05","Local","United States of America; New Jersey","2020-09-15","2020-12-22","Household and community samples","Multiple groups",924.0,0.09,"","","Simplified probability","IgG","Moderate","Preprint","Henry F Raymond","Rutgers University","10.1101/2021.03.02.21252766","Verified","United States of America","Wang et al.","","","","US","US-NJ"
"2021-04-09","210312_Atlanta_EmoryUniversitySchoolOfMedicine_Overall","Prevalence of SARS-CoV-2 Antibodies in Pediatric Healthcare Workers","2021-03-12","Local","United States of America; Georgia; Atlanta","2020-04-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",642.0,0.04,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Claudia Morris","Emory University School of Medicine","https://dx.doi.org/10.1016/j.ijid.2021.03.017","Verified","United States of America","Emory University - In-House, Suthar et al., 2020.","","","","US","US-GA"
"2021-04-09","210322_TheUnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust_Overall","Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab","2021-03-22","National","United Kingdom of Great Britain and Northern Ireland","2020-09-22","2020-12-23","Patients seeking care for non-COVID-19 reasons","Multiple groups",6935.0,0.043,0.038,0.048,"Sequential","Not reported","Moderate","Journal Article (Peer-Reviewed)","Nicholas Kennedy","Royal Devon and Exeter NHS Foundation Trust","https://dx.doi.org/10.1136/gutjnl-2021-324388","Verified","The United Kingdom","Roche","","","","GB",""
"2021-04-09","210324_NorthernItaly_UniversitàDegliStudiDelPiemonteOrientale_HCW","High seroprevalence of sars-cov-2 among healthcare workers in a north italy hospital","2021-03-24","Local","Italy; Piedmont; Vercelli","2020-05-08","2020-06-03","Health care workers and caregivers","Adults (18-64 years)",2250.0,0.171,0.156,0.187,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Chiara Airoldi","Università degli Studi del Piemonte Orientale","http://dx.doi.org/10.3390/ijerph18073343","Verified","Italy","DiaSorin",0.979,0.985,"","IT","IT-21"
"2021-04-09","210325_Rome_UniversityofRomeTorVergata_IBDPatients","Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease","2021-03-25","Local","Italy","2020-05-27","2020-07-21","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",218.0,0.014,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ludovica Scucchi","University of Rome Tor Vergata","https://www.europeanreview.org/wp/wp-content/uploads/2418-2424.pdf","Verified","Italy","Abbott Diagnostics","","","","IT",""
"2021-04-09","210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_December_AnaesthesiaHCW","Seroprevalence of IgG antibody against SARS-CoV-2 among health care workers of anaesthesia departments from various hospital settings in India","2021-03-26","Local","India","2020-12-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",164.0,0.384,0.309,0.463,"Unclear","IgG","High","Preprint","Debaprasad Parai","ICMR-Regional Medical Research Centre (Government of India)","https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2","Verified","India","Abbott Laboratories",1.0,0.996,"","IN",""
"2021-04-09","210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_September_AnaesthesiaHCW","Seroprevalence of IgG antibody against SARS-CoV-2 among health care workers of anaesthesia departments from various hospital settings in India","2021-03-26","Local","India","2020-09-01","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",128.0,0.125,0.073,0.195,"Unclear","IgG","High","Preprint","Debaprasad Parai","ICMR-Regional Medical Research Centre (Government of India)","https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2","Verified","India","Abbott Laboratories",1.0,0.996,"","IN",""
"2021-04-09","210326_Duhok_UniversityOfDuhok_Overall","COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study","2021-03-26","Local","Iraq","2021-01-10","2021-01-30","Household and community samples","Multiple groups",743.0,0.626,"","","Stratified probability","IgG","Moderate","Preprint","Nawfal Hussein","University of Duhok","10.1101/2021.03.23.21254169","Verified","Iraq","Roche","","","","IQ",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c1_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","2020-03-30","2020-04-05","Residual sera","Multiple groups",3910.0,0.018,0.01,0.026,"Stratified probability","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified","Belgium","Euroimmun",0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c2_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","2020-04-20","2020-04-26","Residual sera","Multiple groups",3397.0,0.052,0.042,0.064,"Stratified probability","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified","Belgium","Euroimmun",0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c3_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","2020-05-18","2020-05-25","Residual sera","Multiple groups",3242.0,0.062,0.05,0.073,"Stratified probability","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified","Belgium","Euroimmun",0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c4_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","2020-06-08","2020-06-13","Residual sera","Multiple groups",2960.0,0.047,0.036,0.058,"Stratified probability","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified","Belgium","Euroimmun",0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c5_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","2020-06-29","2020-07-04","Residual sera","Multiple groups",3023.0,0.037,0.026,0.047,"Stratified probability","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified","Belgium","Euroimmun",0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c6_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","2020-09-07","2020-09-12","Residual sera","Multiple groups",3047.0,0.033,0.023,0.043,"Stratified probability","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified","Belgium","Euroimmun",0.849,0.987,"","BE",""
"2021-04-09","210407_Belgium_UniversityofAntwerp_c7_PopAdj","Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples","2021-04-07","National","Belgium","2020-10-12","2020-10-17","Residual sera","Multiple groups",2966.0,0.042,0.031,0.052,"Stratified probability","IgG","Moderate","Preprint","Sereina Herzog","University of Antwerp","https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v5","Verified","Belgium","Euroimmun",0.849,0.987,"","BE",""
"2021-04-10","210101_Pakistan_ColSultan’sLab_Overall","A Single-centre Study of COVID-19 antibody","2021-01-01","Local","Pakistan; NR; NR","2020-06-13","2020-07-08","Residual sera","Multiple groups",453.0,0.638,"","","Self-referral","Not reported","High","Journal Article (Peer-Reviewed)","Sidra Ghazanfer","Col Sultan’s Lab","https://dx.doi.org/10.29271/jcpsp.2021.01.S55","Verified","Pakistan","Roche Holding AG","","","","PK",""
"2021-04-10","210212_London_RoyalFreeHospital","Transmission of infection among health care personnel performing surgical tracheostomies on COVID-19 patients","2021-02-12","Local","United Kingdom of Great Britain and Northern Ireland","2020-03-26","2020-06-24","Health care workers and caregivers","Adults (18-64 years)",43.0,0.186,"","","Unclear","Not reported","High","Journal Article (Peer-Reviewed)","Natarajan Angamuthu","Royal Free Hospital","https://dx.doi.org/10.1016/j.surge.2021.01.007","Verified","The United Kingdom","NR","","","","GB",""
"2021-04-10","210302_Vietnam_UniversitatsklinikumTubingen_HCW_ELISA_TotalAb","Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam","2021-03-02","Local","Viet Nam; Red River Delta; Hanoi","2020-03-01","2021-01-08","Health care workers and caregivers","Adults (18-64 years)",1065.0,0.006,"","","Unclear","Total Antibody","High","Journal Article (Peer-Reviewed)","Le Huu Song","Universitätsklinikum Tübingen","https://dx.doi.org/10.1016/j.lanwpc.2021.100113","Verified","Viet Nam","WANTAI Biological Pharmacy, Beijing, China","","","","VN",""
"2021-04-10","210302_Vietnam_UniversitatsklinikumTubingen_patients_ELISA_TotalAb","Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam","2021-03-02","Local","Viet Nam; Red River Delta; Hanoi","2020-03-01","2021-01-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",288.0,0.0,"","","Unclear","Total Antibody","High","Journal Article (Peer-Reviewed)","Le Huu Song","Universitätsklinikum Tübingen","https://dx.doi.org/10.1016/j.lanwpc.2021.100113","Verified","Viet Nam","WANTAI Biological Pharmacy, Beijing, China","","","","VN",""
"2021-04-10","210331_Lima_PeruvianMinistryOfHealth_Overall_PopAdj_TestAdj","SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru","2021-03-31","Local","Peru; Lima and Callao; Lima metropolitan area","2020-06-28","2020-07-09","Household and community samples","Multiple groups",3212.0,0.208,0.172,0.235,"Stratified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Mary F Reyes Vega","Peruvian Ministry of Health","https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00081-X/fulltext#%20","Verified","Peru","SD BIOSENSOR",0.969,0.962,"","PE","PE-LIM"
"2021-04-11","200920_Tokyo_NationalCenterForGlobalHealthAndMedicine_Overall","Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers","2020-09-09","Local","Japan","2020-02-14","2020-04-03","Health care workers and caregivers","Adults (18-64 years)",49.0,0.0,"","","Convenience","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Tetsuya Suzuki","National Center for Global Health and Medicine","http://dx.doi.org/10.1016/j.jiac.2020.09.006","Verified","Japan","N/A - in house","","","","JP",""
"2021-04-11","210315_Vancouver_BCChildren’sHospitalResearchInstitute_OverallPrimary","A majority of uninfected adults show pre-existing antibody reactivity against SARS-CoV-2","2021-03-15","Local","Canada; British Columbia; Vancouver","2020-05-17","2020-06-19","Household and community samples","Adults (18-64 years)",276.0,0.006,0.0,0.027,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Abdelilah Majdoubi","BC Children’s Hospital Research Institute","https://dx.doi.org/10.1172/jci.insight.146316","Verified","Canada","1) Meso Scale Diagnostics ; 2) Ortho-Clinical Diagnostics","","","","CA","CA-BC"
"2021-04-11","210330_ Aichi_JapanMinistryOfHealth3_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan; Aichi Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",2960.0,0.007,"","","Unclear","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","Japan","Not reported","","","","JP","JP-23"
"2021-04-11","210330_ Fukuoka_JapanMinistryOfHealth5_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan; Fukuoka Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",3078.0,0.004,"","","Unclear","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","Japan","Not reported","","","","JP","JP-40"
"2021-04-11","210330_Miyagi_JapanMinistryOfHealth4_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan; Miyagi Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",2860.0,0.001,"","","Unclear","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","Japan","Not reported","","","","JP","JP-04"
"2021-04-11","210330_Osaka_JapanMinistryOfHealth2_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan; Osaka Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",2746.0,0.007,"","","Unclear","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","Japan","Not reported","","","","JP","JP-27"
"2021-04-11","210330_Tokyo_JapanMinistryOfHealth1_overall","1.35% in Tokyo have antibodies against the coronavirus","2021-03-30","Regional","Japan; Tokyo Prefecture","2020-12-14","2020-12-26","Household and community samples","Multiple groups",3399.0,0.014,"","","Unclear","Not reported","High","News and Media","The Bharat Express News","Japan Ministry of Health","https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/","Unverified","Japan","Not reported","","","","JP","JP-13"
"2021-04-11","210401_London_PublicHealthEngland_Overall","Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK","2021-04-01","Local","United Kingdom of Great Britain and Northern Ireland","2020-03-30","2020-07-21","Health care workers and caregivers","Multiple groups",1069.0,0.29,0.26,0.32,"Unclear","IgG; IgM; IgA","Unclear","Journal Article (Peer-Reviewed)","Madhumita Shrotri","Public Health England","https://dx.doi.org/10.3201/eid2704.204554","Verified","The United Kingdom","Roche","","","","GB",""
"2021-04-12","201105_Italy_UniversityofVerona_overall_unadj","Serological prevalence of SARS-CoV-2 infection among chronicmyeloid leukemia patients undergoing tyrosine kinase inhibitortreatment in italy (COVID-19-hem study)","2020-11-05","National","Italy; Veneto, Lazio and Friuli-Venezia Giulia","2020-05-18","2020-07-29","Patients seeking care for non-COVID-19 reasons","Multiple groups",339.0,0.015,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Massimiliano Bonifacio","University of Verona","http://dx.doi.org/10.1182/blood-2020-140032","Verified","Italy","Menarini Diagnostics","","","","IT",""
"2021-04-12","210302_London_UniversityCollegeLondon_HCW_Overall","Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS-CoV-2 infection","2021-03-02","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-03-23","2020-08-17","Health care workers and caregivers","Adults (18-64 years)",729.0,0.215,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Charlotte Manisty","University College London","https://dx.doi.org/10.1016/j.ebiom.2021.103259","Unverified","The United Kingdom","1) Euroimmun; 2) Roche","","","","GB","GB-ENG"
"2021-04-12","210302_Shenzhen_ChineseAcademyofMedicalSciences2_overall_adj","The prevalence of antibodies to SARS-CoV-2 among blood donors in China","2021-03-02","Local","China","2020-01-15","2020-04-15","Blood donors","Multiple groups",6810.0,0.0,0.0,0.003,"Convenience","IgG; Total Antibody; IgM","Moderate","Journal Article (Peer-Reviewed)","Le Chang","Chinese Academy of Medical Sciences","https://dx.doi.org/10.1038/s41467-021-21503-x","Unverified","China","Not reported","","","","CN",""
"2021-04-12","210302_Shijiazhuang_ChineseAcademyofMedicalSciences3_overall_adj","The prevalence of antibodies to SARS-CoV-2 among blood donors in China","2021-03-02","Local","China; Hebei Province; Shijiazhuang","2020-01-15","2020-04-15","Blood donors","Adults (18-64 years)",13540.0,0.0,0.0,0.002,"Convenience","IgG; Total Antibody; IgM","Moderate","Journal Article (Peer-Reviewed)","Le Chang","Chinese Academy of Medical Sciences","https://dx.doi.org/10.1038/s41467-021-21503-x","Verified","China","Not reported","","","","CN","CN-13"
"2021-04-12","210302_Wuhan_ChineseAcademyofMedicalSciences1_overall_adj","The prevalence of antibodies to SARS-CoV-2 among blood donors in China","2021-03-02","Local","China; Hubei Province; Wuhan","2020-01-15","2020-04-15","Blood donors","Adults (18-64 years)",17794.0,0.027,0.022,0.031,"Convenience","IgG; Total Antibody; IgM","Moderate","Journal Article (Peer-Reviewed)","Le Chang","Chinese Academy of Medical Sciences","https://dx.doi.org/10.1038/s41467-021-21503-x","Verified","China","Not reported","","","","CN","CN-42"
"2021-04-13","210118_Nouakchott_CentreHospitalierNationalDeNouakchott_Overall","Serological tests for SARS-CoV-2 in a health workers population in Nouakchott-Mauritania","2021-01-18","Local","Mauritania","2020-05-05","2020-05-27","Health care workers and caregivers","Adults (18-64 years)",835.0,0.017,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mohamed Lemine Ould Salem","Centre Hospitalier National de Nouakchott","http://dx.doi.org/10.11604/pamj.2021.38.55.24259","Verified","Mauritania","Biotime",0.964,0.987,"","MR",""
"2021-04-13","210125_TerreRoveresche_UniversityOfUrbinoCarloBo_Overall","Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection in an Italian cohort in Marche Region, Italy","2021-01-25","Local","Italy; Le Marche Region; Municipality of Terre Roveresche","2020-03-15","2020-06-15","Household and community samples","Multiple groups",341.0,0.144,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mauro De Santi","University of Urbino Carlo Bo","https://dx.doi.org/10.23750/abm.v92i1.10847","Verified","Italy","Diagnostic Bioprobes Srl","","","","IT","IT-57"
"2021-04-14","210411_India_BanarasHinduUniversity_Overall","Estimation of real-infection and immunity against SARS-CoV-2 in Indian populations","2021-04-11","National","India","2020-09-15","2020-12-15","Household and community samples","Adults (18-64 years)",2301.0,0.306,0.287,0.325,"Simplified probability","IgM; IgA; IgG; Total Antibody","Moderate","Preprint","Prajjval Singh","Banaras Hindu University","https://www.medrxiv.org/content/10.1101/2021.02.05.21251118v2","Unverified","India","Biosense Technologies",1.0,0.99,"","IN",""
"2021-04-15","210127_Bukavu_CliniqueSaint-LucDeBukavu_Overall","Seroprevalence of SARS-CoV-2 antibodies among travellers and workers screened at the saint luc clinic in Bukavu, a city in eastern democratic Republic of the Congo, from may to august 2020","2021-01-27","Local","Democratic Republic of the Congo","2020-05-15","2020-08-30","Multiple populations","Multiple groups",684.0,0.408,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Philippe Bianga Katchunga","Clinique Saint-Luc de Bukavu","https://www.panafrican-med-journal.com/content/article/38/93/full/","Verified","Democratic Republic of the Congo","Cellex",0.938,0.96,"","CD",""
"2021-04-15","210202_Delhi_DelhiGovernment","After Delhi's 5th serosurvey, health minister Jain says don’t let guard down","2021-02-02","Local","India","2021-01-15","2021-01-23","Household and community samples","Multiple groups",28000.0,0.561,"","","Unclear","Not reported","Unclear","News and Media","Mallika Soni","Delhi Government","https://www.hindustantimes.com/india-news/after-5th-serosurvey-health-minister-jain-says-don-t-let-your-guard-down-101612264692531.html","Verified","India","NR","","","","IN",""
"2021-04-15","210208_Kenya_KEMRI-WellcomeTrust_Kilifi_Overall_TestAdj","Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals","2021-02-08","Local","Kenya; Kilifi; Kilifi","2020-11-01","2020-11-24","Pregnant or parturient women","Adults (18-64 years)",154.0,0.11,0.062,0.167,"Sequential","IgG","Moderate","Preprint","R Lucinde","KEMRI-Wellcome Trust","https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text","Verified","Kenya","N/A - in house",0.927,0.99,"","KE","KE-14"
"2021-04-15","210208_Kenya_KEMRI-WellcomeTrust_Nairobi_Overall_TestAdj","Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals","2021-02-08","Local","Kenya; Nairobi; Nairobi","2020-07-30","2020-08-25","Pregnant or parturient women","Adults (18-64 years)",196.0,0.499,0.427,0.58,"Sequential","IgG","Moderate","Preprint","R Lucinde","KEMRI-Wellcome Trust","https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text","Verified","Kenya","N/A - in house",0.927,0.99,"","KE","KE-30"
"2021-04-15","210215_Patna_AllIndiaInstituteOfMedicalSciences_Overall","Seroprevalence of igg against sars-cov-2 and its determinants among healthcare workers of a covid-19 dedicated hospital of India","2021-02-15","Local","India; Bihar; Patna","2020-09-01","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",919.0,0.133,0.112,0.156,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mala Mahto","All India Institute of Medical Sciences","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010601/","Verified","India","ADVIA Centaur",1.0,0.998,"","IN","IN-BR"
"2021-04-15","210225_Brescia_UniversityofBrescia_HCW","Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy","2021-02-25","Local","Italy; Lombardy; Brescia","2020-04-26","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1893.0,0.229,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Agnese Comelli","University of Brescia","https://dx.doi.org/10.3390/microorganisms9030488","Verified","Italy","DiaSorin",0.957,0.985,"","IT","IT-25"
"2021-04-15","210226_WestMidlands_BirminghamCommunityHealthcareTrust_Baseline","Longitudinal protection following natural SARS-CoV-2 infection and early vaccine responses: insights from a cohort of community based dental health care professionals","2021-02-26","Local","United Kingdom of Great Britain and Northern Ireland","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",1507.0,0.163,"","","Convenience","IgG; IgM; IgA","Moderate","Preprint","Adrian Shields","Birmingham Community Healthcare Trust","10.1101/2021.02.24.21252368","Verified","The United Kingdom","The Binding Site (TBS), Birmingham",0.986,0.983,"","GB",""
"2021-04-15","210316_Sussex_UniversityofSussex_AbbottWSHT","Real-world experience of SARS-CoV-2 antibody assays in UK healthcare workers","2021-03-16","Local","United Kingdom of Great Britain and Northern Ireland; England; West Sussex","2020-05-19","2020-10-20","Health care workers and caregivers","Adults (18-64 years)",12388.0,0.079,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Alyss Robinson","University of Sussex","https://dx.doi.org/10.7861/clinmed.2020.1007","Verified","The United Kingdom","Abbott Laboratories",1.0,0.996,"","GB","GB-ENG"
"2021-04-15","210316_Sussex_UniversityofSussex_RocheBSUH","Real-world experience of SARS-CoV-2 antibody assays in UK healthcare workers","2021-03-16","Local","United Kingdom of Great Britain and Northern Ireland; England; Brighton and Sussex","2020-05-19","2020-09-29","Health care workers and caregivers","Adults (18-64 years)",14473.0,0.13,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alyss Robinson","University of Sussex","https://dx.doi.org/10.7861/clinmed.2020.1007","Verified","The United Kingdom","Roche Diagnostics",0.995,0.998,"","GB","GB-ENG"
"2021-04-15","210318_IvoryCoast_CentreHospitalierRegionald’Orleans_Overall","SARS-CoV-2 Infection in Ivory Coast: A Serosurveillance Survey among Gold Mine Workers","2021-03-18","National","Côte d'Ivoire","2020-07-15","2020-10-13","Essential non-healthcare workers","Adults (18-64 years)",1687.0,0.251,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Jean Milleliri","Centre Hospitalier Regional d’Orleans","https://dx.doi.org/10.4269/ajtmh.21-0081","Unverified","Côte d'Ivoire","AAZ LMB, Boulogne Billanco",1.0,1.0,"","CI",""
"2021-04-16","201217_Honduras_ColegioMédico_OverallGenpop","Seroepidemiological surveillance of SARS-CoV-2 circulation in 41 municipalities in Honduras wth no reports of active cases, COVID-19, June 16-23, 2020","2020-12-17","National","Honduras","2020-06-16","2020-06-23","Household and community samples","Multiple groups",792.0,0.062,"","","Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mario Rene Mejia Nunez","Colegio Médico","https://revistas.ucr.ac.cr/index.php/psm/article/view/43261/46175","Verified","Honduras","NR",0.934,0.977,"","HN",""
"2021-04-16","210217_Shiraz_ShirazUniversityOfMedicalSciences_Overall","Prevalence of anti-sars-cov-2 antibody in hospital staff in double-center setting: A preliminary report of a cohort study from Iran","2021-02-17","Local","Iran (Islamic Republic of); Fars; Shiraz City","2020-07-13","2020-08-05","Health care workers and caregivers","Multiple groups",494.0,0.059,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Kamran Bagheri Lankarani","Shiraz University of Medical Sciences","http://dx.doi.org/10.5812/semj.112681","Verified","Iran (Islamic Republic of)","Pishtaz Co","","","","IR","IR-14"
"2021-04-16","210302_NewYork_RenaissanceStonyBrookSchoolofMedicine","Prevalence of IgM and IgG antibodies to SARS-CoV-2 in health care workers at a tertiary care New York hospital during the Spring COVID-19 surge","2021-03-02","Local","United States of America; New York","2020-04-02","2020-04-18","Health care workers and caregivers","Adults (18-64 years)",474.0,0.169,0.136,0.206,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Lilian Talbot","Renaissance Stony Brook School of Medicine","https://dx.doi.org/10.1186/s13741-021-00177-5","Verified","United States of America","Chembio Diagnostics, Inc Medford, New York, USA",0.843,0.889,"","US","US-NY"
"2021-04-16","210309_Qatar_HamadMedicalCorporation_CemetaryWorkers","SARS-CoV-2 Infection in Mortuary and Cemetery Workers","2021-03-09","Local","Qatar; NR; NR","2020-09-01","2020-09-01","Essential non-healthcare workers","Adults (18-64 years)",64.0,0.344,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Moza Alishaq","Hamad Medical Corporation","http://dx.doi.org/10.1016/j.ijid.2021.03.012","Verified","Qatar","Roche, Switzerland","","","","QA",""
"2021-04-16","210309_Qatar_HamadMedicalCorporation_MortuaryWorkers","SARS-CoV-2 Infection in Mortuary and Cemetery Workers","2021-03-09","Local","Qatar; NR; NR","2020-09-17","2020-09-17","Essential non-healthcare workers","Adults (18-64 years)",32.0,0.25,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Moza Alishaq","Hamad Medical Corporation","http://dx.doi.org/10.1016/j.ijid.2021.03.012","Verified","Qatar","Roche, Switzerland","","","","QA",""
"2021-04-16","210310_Bavaria_BrandenburgMedicalSchoolTheodorFontane","Risk to Radiology Staff for Occupational COVID-19 Infection in a High-Risk and a Low-Risk Region in Germany: Lessons from the ""First Wave""","2021-03-10","Local","Germany; Bavaria; Wieden","2020-07-17","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1838.0,0.151,0.134,0.167,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Thomas Finkenzeller","Brandenburg Medical School Theodor Fontane","https://dx.doi.org/10.1055/a-1393-6668","Verified","Germany","Roche Diagnostics","","","","DE","DE-BY"
"2021-04-16","210310_Brandenburg_BrandenburgMedicalSchoolTheodorFontane","Risk to Radiology Staff for Occupational COVID-19 Infection in a High-Risk and a Low-Risk Region in Germany: Lessons from the ""First Wave""","2021-03-10","Local","Germany; Brandenburg; NR","2020-07-17","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",585.0,0.021,0.012,0.038,"Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Thomas Finkenzeller","Brandenburg Medical School Theodor Fontane","https://dx.doi.org/10.1055/a-1393-6668","Verified","Germany","EUROIMMUN","","","","DE","DE-BB"
"2021-04-16","210331_Bulawayo_UniversityofEdinburgh_Primary","SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe","2021-03-31","Regional","Zimbabwe; Bulawayo","2020-06-09","2020-06-22","Health care workers and caregivers","Multiple groups",635.0,0.089,0.069,0.115,"Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Simbarashe Rusakaniko","University of Edinburgh","https://dx.doi.org/10.1371/journal.pntd.0009254","Verified","Zimbabwe","Wuhan UNscience Biotechnology Companies",0.985,0.882,"","ZW","ZW-BU"
"2021-04-16","210417_Leicestershire_UniversityofLeicester_Diasorin+Siemens","Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale","2021-03-17","Local","United Kingdom of Great Britain and Northern Ireland; England; NR","2019-10-01","2020-03-31","Residual sera","Multiple groups",428.0,0.0,"","","Simplified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Paul William Bird","University of Leicester","https://dx.doi.org/10.1016/j.jinf.2021.03.007","Unverified","The United Kingdom","Diasorin Ltd.; Siemens","","","","GB","GB-ENG"
"2021-04-17","210224_Castiglioned'Adda_UniversityofMilan_Overall","Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy","2021-02-24","Local","Italy; Lombardy; Castiglione D’Adda","2020-05-18","2020-06-07","Household and community samples","Multiple groups",4143.0,0.222,"","","Entire sample","IgG","Low","Journal Article (Peer-Reviewed)","Gabriele Pagani","University of Milan","https://dx.doi.org/10.1371/journal.pone.0246513","Verified","Italy","Prisma Lab",1.0,0.96,"","IT","IT-25"
"2021-04-17","210226_UniversityOfTurin_Turin","Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control Study","2021-02-26","Local","Italy; Piedmont; Turin","2020-04-16","2020-06-22","Pregnant or parturient women","Adults (18-64 years)",164.0,0.097,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Stefano Cosma","University of Turin","https://dx.doi.org/10.3390/diagnostics11030398","Verified","Italy","Boditech Med Inc, Gang-won-do, Korea","","","","IT","IT-21"
"2021-04-17","210301_Ahmedabad_SmtNHLMunicipalMedicalCollege_Overall","Prevalence of seropositivity to sars-cov-2 among health care workers in tertiary covid-19 hospital, ahmedabad, gujarat","2021-03-01","Local","India; Gujarat; Ahmedabad","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1333.0,0.278,"","","Unclear","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jemil Makadia","Smt NHL Municipal Medical College","http://dx.doi.org/10.7860/JCDR/2021/46817.14599","Verified","India","Siemens",1.0,0.998,"","IN","IN-GJ"
"2021-04-17","210303_Turkey_UniversityofHealthSciences_Overall","Seroprevalence of Coronavirus Disease 2019 (COVID-19) Among Health Care Workers from Three Pandemic Hospitals of Turkey","2021-03-03","National","Turkey","2020-05-30","2020-06-06","Health care workers and caregivers","Adults (18-64 years)",813.0,0.027,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gizem Alkurt","University of Health Sciences","https://dx.doi.org/10.1371/journal.pone.0247865","Verified","Turkey","Abbott Laboratories","","","","TR",""
"2021-04-17","210311_USA_IgenomixUSAandCanada_Overall","SARS-CoV-2 immunity, infective and naive incidence in fertility clinics after lockdown","2021-03-11","National","United States of America; Utah, Massachuetts; Boston","2020-06-18","2020-07-30","Multiple populations","Adults (18-64 years)",337.0,0.015,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Russel Foulk","Igenomix USA and Canada","https://dx.doi.org/10.1016/j.ajog.2021.03.008","Verified","United States of America","Abbott Laboratories","","","","US",""
"2021-04-17","210317_Boston_HarvardMedicalSchool_Primary","SARS-CoV-2 antibody seroprevalence after the first wave among workers at a community healthcare system in the Greater Boston area","2021-03-17","Local","United States of America; Massachusetts; Boston","2020-06-16","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",433.0,0.113,"","","Self-referral","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Lou Ann Bruno-Murtha","Harvard Medical School","https://dx.doi.org/10.1080/20477724.2021.1901041","Verified","United States of America","NR",0.8,0.995,"","US","US-MA"
"2021-04-17","210323_Surrey_RoyalHollowayUniversityofLondon","SARS-CoV-2 antibody seroprevalence in NHS healthcare workers in a large double-sited UK hospital","2021-03-23","Local","United Kingdom of Great Britain and Northern Ireland; England; Chertsey","2020-10-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",3119.0,0.196,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gie Ken Dror","Royal Holloway University of London","https://dx.doi.org/10.7861/clinmed.2020-1096","Verified","The United Kingdom","Abbott Laboratories",0.825,0.95,"","GB","GB-ENG"
"2021-04-17","210329_PortoAlegre_UniversidadeFederaldeCienciasdaSaudedePortoAlegre_HCW_July","Prevalence of COVID-19 in healthcare professionals working in hospital emergencies during first wave peak in 2020, Porto Alegre - Brazil","2021-03-29","Local","Brazil; Rio Grande do Sul; Porto Alegre","2020-07-20","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",1163.0,0.055,"","","Unclear","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Ana Dubiela","Universidade Federal de Ciencias da Saude de Porto Alegre","https://dx.doi.org/10.1017/ice.2021.139","Verified","Brazil","Biosensor",0.943,0.951,"","BR","BR-RS"
"2021-04-18","201217_UnitedStates_UniversityofIowa","Diagnosed and Undiagnosed COVID-19 in US Emergency Department Health Care Personnel: A Cross-sectional Analysis","2020-12-17","National","United States of America","2020-05-13","2020-07-08","Health care workers and caregivers","Multiple groups",1606.0,0.017,"","","Stratified non-probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Nicholas M Mohr","University of Iowa","http://dx.doi.org/10.1016/j.annemergmed.2020.12.007","Verified","United States of America","Abbott Laboratories, Chicago, IL; EUROIMMUN","","","","US",""
"2021-04-18","210223_Regensberg_HospitalStHedwigOfTheOrderOfStJohn_IgG+","Peripartal anti-SARS-CoV-2-IgA/IgG in asymptomatic pregnant women during regional SARS-CoV-2-outbreak","2021-02-23","Local","Germany; Bavaria; Regensberg","2020-04-09","2020-04-30","Pregnant or parturient women","Adults (18-64 years)",151.0,0.02,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Sebastian Hausler","Hospital St Hedwig of the Order of St John","https://dx.doi.org/10.1515/jpm-2021-0001","Verified","Germany","EUROIMMUN AG, Lübeck,; Germany","","","","DE","DE-BY"
"2021-04-18","210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Patients_Overall","Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study","2021-02-27","Local","France","2020-05-25","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",1011.0,0.017,"","","Convenience","IgG; IgM; IgA; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sylvain Ladoire","Centre Georges Francois Leclerc","https://dx.doi.org/10.1016/j.ejca.2021.02.027","Verified","France","Roche Diagnostics",1.0,0.998,"","FR",""
"2021-04-18","210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Staff_Overall","Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study","2021-02-27","Local","France","2020-05-11","2020-05-25","Health care workers and caregivers","Adults (18-64 years)",663.0,0.018,"","","Convenience","IgG; IgM; IgA; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sylvain Ladoire","Centre Georges Francois Leclerc","https://dx.doi.org/10.1016/j.ejca.2021.02.027","Verified","France","Roche Diagnostics",1.0,0.998,"","FR",""
"2021-04-18","210308_Bissau_UniversityofSouthernDenmark_Overall","SARS-CoV2 sero-survey among adults involved in health care and health research in Guinea-Bissau, West Africa","2021-03-08","Local","Guinea-Bissau; NR; Bissau","2020-11-09","2020-11-24","Health care workers and caregivers","Adults (18-64 years)",140.0,0.18,"","","Convenience","IgG","High","Preprint","Christine Benn","University of Southern Denmark","https://www.medrxiv.org/content/10.1101/2021.03.06.21253046v1.full-text","Verified","Guinea-Bissau","CTK Biotech",0.9,1.0,"","GW",""
"2021-04-18","210311_NewDelhi_AllIndiaInstituteOfMedicalSciences_Overall","Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation","2021-03-11","Local","India","2020-04-15","2020-07-15","Blood donors","Adults (18-64 years)",1191.0,0.095,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Hem Chandra Pandey","All India Institute of Medical Sciences","https://dx.doi.org/10.1016/j.transci.2021.103118","Verified","India","Abbott","","","","IN",""
"2021-04-18","210321_KlangValley_MalaysianMinistryofHealth_HCW","Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia","2021-03-21","Local","Malaysia; Klang Valley","2020-04-13","2020-05-12","Health care workers and caregivers","Adults (18-64 years)",400.0,0.0,0.0,0.0,"Self-referral","Not reported","High","Journal Article (Peer-Reviewed)","Yuan Liang Woon","Malaysian Ministry of Health","https://dx.doi.org/10.1016/j.lanwpc.2021.100123","Verified","Malaysia","GenScript Biotech",0.913,1.0,"","MY",""
"2021-04-18","210322_GrandEst_StrasbourgUniversityHospital_KidneyTransplantPatients","SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a ""High Risk"" Zone","2021-03-22","Local","France; Grand Est","","2020-09-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",780.0,0.062,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Sophie Caillard","Strasbourg University Hospital","https://dx.doi.org/10.1097/TP.0000000000003766","Verified","France","Abbott Laboratories, Euroimmun, Roche Diagnostic, Orient Gene Biotech, Biosynex, BioMérieux, SNIBE - Shenzhen New Industries Biomedical Engineering, Bio‐Rad","","","","FR","FR-GES"
"2021-04-18","210324_SaoPaulo_UniversityofSaoPaulo_overall","SARS-Cov-2 seroprevalence and risk factors among Health Care Workers: estimating the risk of COVID-19 dedicated units","2021-03-24","Local","Brazil; Sao Paulo; Sao Paulo","2020-06-17","2020-07-08","Health care workers and caregivers","Adults (18-64 years)",1996.0,0.055,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Maura Salaroli de Oliveira","University of São Paulo","https://dx.doi.org/10.1016/j.ajic.2021.03.010","Verified","Brazil","Unclear",0.95,1.0,"","BR","BR-SP"
"2021-04-18","210402_Cairo_CairoUniversity_HCW","Asymptomatic SARS-CoV-2 infection among healthcare workers in a non-COVID-19 Teaching University Hospital","2021-04-02","Local","Egypt","2020-05-05","2020-06-11","Health care workers and caregivers","Adults (18-64 years)",455.0,0.079,0.058,0.108,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ahmed Mukhtar","Cairo University","https://dx.doi.org/10.4081/jphr.2021.2102","Verified","Egypt","SD-Biosensor; YHLO Biotech","","","","EG",""
"2021-04-19","201125_Washington_GeorgeWashingtonUniversity_hcw","COVID-19 infection among emergency department healthcare providers in a large tertiary academic medical center following the peak of the pandemic","2021-02-01","Local","United States of America; District of Columbia; Washington","2020-05-26","2020-06-14","Health care workers and caregivers","Adults (18-64 years)",138.0,0.051,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Eric Murakami","George Washington University","https://pubmed.ncbi.nlm.nih.gov/33340874/","Verified","United States of America","1. Biolidics; 2. Author","","","","US","US-DC"
"2021-04-19","210212_London_UniversityofOxford_Overall","Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic","2021-02-12","Local","United Kingdom of Great Britain and Northern Ireland","2020-04-15","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",236.0,0.085,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Colleen GC McGregor","University of Oxford","https://dx.doi.org/10.1136/gutjnl-2021-324116","Verified","The United Kingdom","Abbott","","","","GB",""
"2021-04-19","210308_ZhongnanHospital_Wuhan","Safety and Effectiveness of Orthopaedic Medical Staff in Providing Support in Combating the COVID-19 Pandemic: A Retrospective Investigation from Wuhan, China","2021-03-08","Local","China; Hubei; Wuhan","2020-01-01","2020-04-08","Health care workers and caregivers","Adults (18-64 years)",112.0,0.0,"","","Entire sample","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yin-xian Wen","Zhongnan Hospital of Wuhan University","https://dx.doi.org/10.1111/os.12898","Verified","China","NR","","","","CN","CN-42"
"2021-04-19","210419_Fribourg_UniversitédeFribourg_Overall_TestPopAdj","Corona Immunitas Fribourg Immunité de la population Episode 2/2021","2021-04-01","Regional","Switzerland; Canton of Fribourg","2020-11-30","2021-02-05","Household and community samples","Multiple groups",449.0,0.19,0.15,0.23,"Simplified probability","IgG","Moderate","Institutional Report","Emna El May","Université de Fribourg","https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2021-PopHealthLab-Corona-Immunitas-E2.pdf","Verified","Switzerland","N/A - Institution designed",0.966,0.997,"","CH","CH-FR"
"2021-04-20","201020_Milan_UniversitàdegliStudidiMilano_Physicians2_Overall","Incidence of sars-cov-2 infection in patients with active cancer: Mono-institutional series of a comprehensive cancer institution in lombardy during the covid-19 pandemic (Niguarda Cancer Center, Milano, Italy)","2020-10-20","Local","Italy; Lombardy; Milan","2020-04-15","2020-05-15","Health care workers and caregivers","Multiple groups",34.0,0.059,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Andrea Sartore Bianchi","Università degli Studi di Milano","http://dx.doi.org/10.1177/0300891620953388","Verified","Italy","Abbott Laboratories, Diasorin","","","","IT","IT-25"
"2021-04-21","200721_Lodi_A.S.S.T.Lodi_HCW_overall","SARS-CoV-2 Antibody Prevalence in Health Care Workers of Lodi Hospital, the COVID-19 Italian Epicentre","2020-07-21","Local","Italy; Lombardy Region","2020-04-23","2020-05-05","Health care workers and caregivers","Adults (18-64 years)",2415.0,0.168,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Alessandro  Baracco","A.S.S.T. Lodi","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227","Verified","Italy","DiaSorin","","","","IT","IT-25"
"2021-04-21","200721_Lodi_A.S.S.T.Lodi_genpop","SARS-CoV-2 Antibody Prevalence in Health Care Workers of Lodi Hospital, the COVID-19 Italian Epicentre","2020-07-21","Local","Italy; Lombardy region; Lodi","2020-04-23","2020-05-05","Household and community samples","Multiple groups",1792.0,0.298,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Alessandro  Baracco","A.S.S.T.Lodi","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227","Verified","Italy","DiaSorin","","","","IT","IT-25"
"2021-04-21","200828_VillaAzul_MinisterioDeSaludDeLaProvinciaDeBuenosAires_overall","Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina","2020-08-28","Local","Argentina; Buenos Aires; Quilmes","2020-07-15","2020-07-16","Household and community samples","Multiple groups",284.0,0.148,0.111,0.195,"Stratified non-probability","IgG","Moderate","Preprint","Laura Munoz","Ministerio de Salud de la Provincia de Buenos Aires","https://preprints.scielo.org/index.php/scielo/preprint/view/1147","Verified","Argentina","COVIDAR",0.95,1.0,"","AR","AR-B"
"2021-04-21","201113_London_ImperialCollegeLondon_KidneyTransplantPatients copy","Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening","2020-11-13","Local","United Kingdom of Great Britain and Northern Ireland; Greater London; London","2020-06-01","2020-07-03","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",855.0,0.081,0.064,0.101,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Michelle Willicombe","Imperial College London","https://dx.doi.org/10.1097/TP.0000000000003526","Verified","The United Kingdom","Abbott",0.684,1.0,"","GB","GB-ENG"
"2021-04-21","210121_BarrioMugica_MinistryOfHealthOfTheCityOfBuenosAires","SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SEROEPIDEMIOLOGY STUDY IN ARGENTINIAN SLUM","2021-01-21","Local","Argentina; Buenos Aires; Buenos Aires","2020-06-10","2020-06-26","Persons living in slums","Multiple groups",873.0,0.534,0.528,0.541,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Silvana Figar","Ministry of Health of the City of Buenos Aires","https://www.medicinabuenosaires.com/revistas/vol81-21/destacado/original_7453.pdf","Verified","Argentina","Laboratio Lemos",0.9,1.0,"","AR","AR-B"
"2021-04-21","210227_Belgium_AntwerpUniversityHospital_HCW_DiaSorin","Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests","2021-02-27","Local","Belgium","2020-03-24","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",92.0,0.12,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Peter van Dam","Antwerp University Hospital","https://dx.doi.org/10.1016/j.ejca.2021.02.024","Verified","Belgium","DiaSorin, Saluggia, Italy","","","","BE",""
"2021-04-21","210227_Belgium_AntwerpUniversityHospital_PediatricCancer_DiaSorin","Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests","2021-02-27","Local","Belgium","2020-03-24","2020-05-31","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",11.0,0.091,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Peter van Dam","Antwerp University Hospital","https://dx.doi.org/10.1016/j.ejca.2021.02.024","Verified","Belgium","DiaSorin, Saluggia, Italy","","","","BE",""
"2021-04-21","210309_Benevento_UniversitàdegliStudidelSannio_Overall","Seroprevalence of Anti-SARS-CoV-2 IgG and IgM among Adults over 65 Years Old in the South of Italy","2021-03-09","Local","Italy; Campania; NR","2020-09-01","2020-09-30","Household and community samples","Seniors (65+ years)",1383.0,0.047,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Immacolata Polvere","Università degli Studi del Sannio","https://dx.doi.org/10.3390/diagnostics11030483","Verified","Italy","LEPU MEDICAL TECHNOLOGY Co.",0.986,0.976,"","IT","IT-72"
"2021-04-21","210316_Lancashire_LancashireTeachingHospitalsNHSTrust_OverallHCW","Seroprevalence of SARS-CoV-2 infection in healthcare workers in a large teaching hospital in the North West of England: a period prevalence survey","2021-03-16","Local","United Kingdom of Great Britain and Northern Ireland; England; Chorley, Preston, South Ribble","2020-05-29","2020-07-04","Health care workers and caregivers","Adults (18-64 years)",4474.0,0.174,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Robert Shorten","Lancashire Teaching Hospitals NHS Foundation Trust","https://dx.doi.org/10.1136/bmjopen-2020-045384","Verified","The United Kingdom","Roche Diagnostics",0.92,1.0,"","GB","GB-ENG"
"2021-04-21","210404_Marche_UniversitàPolitecnicadelleMarche_ConfirmationAssay","Seroprevalence of sars-cov-2-specific antibodies in cancer patients undergoing active systemic treatment: A single-center experience from the marche region, italy","2021-04-04","Local","Italy; Marche; Ancona","2020-07-01","2020-10-26","Patients seeking care for non-COVID-19 reasons","Multiple groups",949.0,0.007,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luca Cantini","Università Politecnica delle Marche","http://dx.doi.org/10.3390/jcm10071503","Verified","Italy","Zhejiang Orient Gene Biotech; Shenzen YHLO BioTech Co. Ltd.","","","","IT","IT-57"
"2021-04-21","210420_Estonia_UniversityOfTartu_Stage16_Overall","The study on the prevalence of the coronavirus in Estonia","2021-12-13","National","Estonia","2021-04-08","2021-04-19","Household and community samples","Multiple groups",2491.0,0.359,0.34,0.378,"Stratified probability","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire","Verified","Estonia","Synlab","","","","EE",""
"2021-04-22","200727_Japan_HealthandWelfareDepartment_primary","About  the results of the antibody prevalence survey against the new coronavirus at  medical institutions in the prefecture","2020-07-27","Regional","Japan; prefecture 3","2020-06-15","2020-06-28","Residual sera","Multiple groups",3000.0,0.0,"","","Convenience","IgG","Unclear","News and Media","Okuda","Health and Welfare Department","http://wave.pref.wakayama.lg.jp/news/kensei/shiryo.php?sid=31587","Verified","Japan","NR","","","","JP",""
"2021-04-22","200930_Scotland_PublicHealthScotland_ResidualSera_Overall_UnAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 30 Sept 2020","2020-09-30","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-04-20","2020-08-09","Residual sera","Multiple groups",9802.0,0.049,"","","Stratified non-probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/","Verified","The United Kingdom","Not reported",0.875,0.986,"","GB","GB-SCT"
"2021-04-22","201017_Ujjain_TheTimesOfIndia_primary","11.9%  seroprevalence in Ujjain, finds survey","2020-09-17","Regional","India; Madhya Pradesh","2020-08-27","2020-08-30","Household and community samples","Multiple groups",3000.0,0.119,"","","Unclear","Not reported","Unclear","News and Media","Amarjeet Singh","The Times of India","https://timesofindia.indiatimes.com/city/bhopal/11-9-seroprevalence-in-ujjain-finds-survey/articleshow/78159395.cms","Verified","India","NR","","","","IN","IN-MP"
"2021-04-22","201103_Haryan_TheHindu_primary","6% rise in seropositivity among Delhi’s neighbours","2020-11-03","Regional","India; Haryan","2020-10-18","2020-10-24","Household and community samples","Multiple groups",16477.0,0.148,"","","Stratified probability","Not reported","Unclear","News and Media","Ashok Kumar","Unclear","https://www.thehindu.com/news/cities/Delhi/6-rise-in-seropositivity-among-delhis-neighbours/article33006634.ece","Verified","India","NR","","","","IN","IN-HR"
"2021-04-22","201215_CiudaddelEste_MinisteriodeSaludPública_primary","30% of those tested in the East had Covid","2020-12-15","Local","Paraguay","2020-11-29","2020-12-15","Household and community samples","Multiple groups",1675.0,0.3,"","","Unclear","Not reported","Unclear","News and Media","Not reported","Ministerio de Salud Pública","https://www.ultimahora.com/el-30-testeados-el-este-tuvieron-covid-n2918654.html","Verified","Paraguay","NR","","","","PY",""
"2021-04-22","210111_Burlington_UniversityOfVermont_overall","Jobs, Housing, and Mask Wearing: Cross-Sectional Study of Risk Factors for COVID-19","2021-01-11","Local","United States of America; Vermont; Burlington","2020-06-25","2020-06-28","Household and community samples","Multiple groups",454.0,0.022,0.008,0.036,"Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","Eline M van den Broek Altenburg","University of Vermont","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800904/","Verified","United States of America","1) N/A - in house","","","","US","US-VT"
"2021-04-22","210305_Mississippi_CDCCOVID-19ResponseTeam_Overall","Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years - Mississippi, May-September 2020","2021-03-05","Regional","United States of America; Mississippi","2020-05-17","2020-09-19","Residual sera","Children and Youth (0-17 years)",1603.0,0.109,0.094,0.124,"Sequential","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Charlotte Hobbs","CDC COVID-19 Response Team","https://dx.doi.org/10.15585/mmwr.mm7009a4","Unverified","United States of America","Ortho Clinical Diagnostics; In-House (CDC)","","","","US","US-MS"
"2021-04-22","210312_NorthCarolina_WakeForestBaptistHealth","Analysis of Accumulated SARS-CoV-2 Seroconversion in North Carolina: The COVID-19 Community Research Partnership","2021-03-12","Regional","United States of America; North Carolina","2020-04-16","2020-12-20","Household and community samples","Adults (18-64 years)",17688.0,0.326,0.284,0.35,"Stratified non-probability","IgM; IgG","Moderate","Preprint","John Williamson","Wake Forest Baptist Health","https://www.medrxiv.org/content/10.1101/2021.03.11.21253226v1","Verified","United States of America","Syntron Bioresearch Inc;  Innovita Biological Technology Co","","","","US","US-NC"
"2021-04-23","200602_Biguacu_SecretariaMunicipaldeSaude_primary","Check out a study on the Covid-19 pandemic in Biguaçu in graphs","2020-06-02","Local","Brazil","2020-05-30","2020-05-30","Household and community samples","Multiple groups",217.0,0.004,"","","Stratified probability","Not reported","Unclear","News and Media","Ozias Alves Jr","Secretaria Municipal de Saude","http://jbfoco.com.br/2020/06/confira-um-estudo-sobre-a-pandemia-de-covid-19-em-biguacu-em-graficos/","Verified","Brazil","NR","","","","BR",""
"2021-04-23","200929_Ticino_InstituteofPublicHealth_primary","Corona Immunitas Ticino, the first results are in","2020-09-29","Local","Switzerland","2020-07-01","2020-07-31","Household and community samples","Adults (18-64 years)",647.0,0.11,"","","Simplified probability","Not reported","Unclear","News and Media","Universita della Svizzera Italiana","The Institute of Public Health on the Università della Svizzera italiana","https://www.biomed.usi.ch/en/feeds/8913","Verified","Switzerland","Centre Hospitalier Universitaire Vaudois (CHUV) in collaboration with the Swiss Federal Institute of Technology in Lausanne (EFPL) and the Swiss Centre for Vaccine Research.","","","","CH",""
"2021-04-23","201008_BneiBrak_CentralBureauofStatistics_primary","Antibody Tests  Show a Third in Israeli ultra-Orthodox Hot Spot Had Coronavirus","2020-10-08","Local","Israel","2020-06-15","2020-08-15","Household and community samples","Multiple groups",3500.0,0.146,"","","Stratified probability","Not reported","Moderate","News and Media","Aaron Rabinowitz","The Central Bureau of Statistics","https://www.haaretz.com/israel-news/.premium-antibody-tests-30-percent-of-bnei-brak-residents-have-been-infected-with-covid-1.9217689","Verified","Israel","NR","","","","IL",""
"2021-04-23","210303_MontereyCounty_UniversityofCaliforniaBerkeley_Overall","Prevalence and Clinical Profile of Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Farmworkers, California, June-November 2020.","2021-03-03","Local","United States of America; California","2020-07-16","2020-11-30","Essential non-healthcare workers","Adults (18-64 years)",1058.0,0.19,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Joseph Lewnard","University of California, Berkeley","https://dx.doi.org/10.3201/eid2705.204949","Verified","United States of America","Authors","","","","US","US-CA"
"2021-04-23","210316_Spain_HospitalUniversitarioPuertadeHierro_LymphomaPatients","Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel)","2021-03-16","National","Spain","2020-05-22","2020-06-11","Patients seeking care for non-COVID-19 reasons","Multiple groups",150.0,0.06,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Fernando Franco","Hospital Universitario Puerta de Hierro","https://dx.doi.org/10.3390/curroncol28020118","Unverified","Spain","NR","","","","ES",""
"2021-04-23","210319_Geneva_GenevaUniversityHospitals_HospitalEmployees","SARS-CoV-2 seroconversion and occupational exposure of employees at a Swiss university hospital: a large longitudinal cohort study","2021-03-19","Local","Switzerland","2020-03-30","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",3421.0,0.079,0.07,0.088,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Romain Martischang","Geneva University Hospitals","https://dx.doi.org/10.1017/ice.2021.117","Unverified","Switzerland","EUROIMMUN; Roche Diagnostics","","","","CH",""
"2021-04-23","210326_RiodeJaneiro_InstitutoD’OrdePesquisaeEnsino","Screening of COVID-19 in outpatient children with cancer or solid organ transplantation: preliminary report","2021-03-26","Local","Brazil; Rio de Janeiro; Rio de Janeiro","2020-06-30","2020-08-28","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",114.0,0.307,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Thais Cleto Yamane","Instituto D’Or de Pesquisa e Ensino","https://dx.doi.org/10.1007/s00431-021-04044-9","Unverified","Brazil","Beijing LEPU-Medical Technology",0.66,0.97,"","BR","BR-RJ"
"2021-04-23","210409_Vienna_MedicalUniversityofVienna","COVID-19 serology in nephrology healthcare workers","2021-04-09","Local","Austria; Vienna; Vienna","2020-03-22","2020-03-31","Health care workers and caregivers","Adults (18-64 years)",235.0,0.255,0.204,0.315,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Thomas Reiter","Medical University of Vienna","https://dx.doi.org/10.1007/s00508-021-01848-5","Unverified","Austria","ImmunoDiagnostics,; HongKong","","","","AT","AT-9"
"2021-04-24","210324_Milan_UniversityofMilan_UniversityEmployees","Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: the UNICORN study","2021-03-24","Local","Italy","2020-05-13","2020-06-23","Non-essential workers and unemployed persons","Multiple groups",1826.0,0.113,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gregorio Milani","University of Milan","https://dx.doi.org/10.1136/bmjopen-2020-046800","Unverified","Italy","Sino Biological, Beijing, China",0.857,0.981,"","IT",""
"2021-04-24","210402_Switzerland_UniversitàdellaSvizzeraItaliana_overall","Seroprevalence of anti-SARS-CoV-2 IgG among adolescents at military fitness-for-duty evaluation","2021-04-02","Regional","Switzerland; Southern Switzerland","2020-07-15","2020-12-15","Household and community samples","Adults (18-64 years)",301.0,0.033,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Elena Giuliano","Università della Svizzera Italiana","https://dx.doi.org/10.1136/bmjmilitary-2021-001828","Verified","Switzerland","Euroimmun","","","","CH",""
"2021-04-24","210408_Germany_HeinrichHeineUniversityDuesseldorf_Physicians","Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV)","2021-04-08","National","Germany","2020-06-16","2020-07-02","Health care workers and caregivers","Adults (18-64 years)",516.0,0.031,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Detlef Kindgen Milles","Heinrich-Heine University Duesseldorf","https://dx.doi.org/10.1371/journal.pone.0248813","Unverified","Germany","Roche Diagnostics GmbH, Mannheim,; Germany","","","","DE",""
"2021-04-25","210401_Madrid_HospitalUniversitarioRamonyCajal_HCW","SARS-CoV-2 Antibodies and utility of point of care testing in Health Care Workers from a Spanish University Hospital in Madrid","2021-04-01","Local","Spain","2020-05-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",5875.0,0.231,0.221,0.243,"Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Mario Rodriguez Dominguez","Hospital Universitario Ramon y Cajal","https://dx.doi.org/10.1016/j.cmi.2021.03.018","Unverified","Spain","Hangzhou ALLTEST; Biotech Co. Ltd, Hangzhou, China; Vircell Spain S.L.U., Granada, Spain","","","","ES",""
"2021-04-26","200820_Punjab_PunjabSeroSurvey_genpop","Punjab Sero-survey Report: 27.7% people in containment zones have antibodies against Covid","2020-08-20","Regional","India; Punjab","2020-08-01","2020-08-17","Household and community samples","Multiple groups",1250.0,0.277,"","","Simplified probability","IgM; IgG","Unclear","News and Media","Express News Service","NR","https://indianexpress.com/article/india/punjab-sero-survey-report-27-7-people-in-containment-zones-have-antibodies-against-covid-6563226/","Verified","India","NR","","","","IN","IN-PB"
"2021-04-26","200901_Aurangabad_GovernmentMedicalSchool_overall","SEROPREVALENCE OF COVID-19 IN AURANGABAD DISTRICT","2020-09-01","Local","India; Maharashtra","2020-08-10","2020-08-19","Household and community samples","Multiple groups",6571.0,0.058,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","J V Dixit","Government Medical School, Aurangabad","https://ijcrt.org/papers/IJCRT2009467.pdf","Verified","India","NR","","","","IN","IN-MH"
"2021-04-26","200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 1","COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context","2020-09-28","Local","Brazil; São Paulo state; Baixada Santista","2020-04-29","2020-05-01","Household and community samples","Multiple groups",2314.0,0.014,"","","Stratified probability","Total Antibody","High","Preprint","Arthur Chioro","Baixada Santista Metropolitan Region","https://preprints.scielo.org/index.php/scielo/preprint/view/1270","Verified","Brazil","Wondfo","","","","BR","BR-SP"
"2021-04-26","200929_Atahualpa_UniversidadPeruanaCayetanoHeredia_overall","Late incidence of SARS-CoV-2 infection in a highly-endemic remote rural village. A prospective population-based cohort study","2020-09-29","Local","Ecuador","2020-06-25","2020-06-30","Household and community samples","Adults (18-64 years)",362.0,0.077,"","","Simplified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oscar H Del Brutto","Universidad Peruana Cayetano Heredia","https://www.tandfonline.com/doi/full/10.1080/20477724.2020.1826152","Verified","Ecuador","BIOHIT Health Care","","","","EC",""
"2021-04-26","200929_Benghazi_TheCenterOfInfectiousDiseases-Benghazi_overall","Population-Based Random Survey for detection of COVID-19 Infection and Seroprevalence in Benghazi- Libya May/2020","2020-09-29","Local","Libya","2020-05-02","2020-05-07","Household and community samples","Multiple groups",600.0,0.0,"","","Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Amal A Elfakhri","The Center of Infectious Diseases- Benghazi","https://preventive-medicine.imedpub.com/populationbased-random-survey-for-detection-of-covid19-infection-and-seroprevalence-in-benghazi-libya-may2020.pdf","Verified","Libya","Biotest",0.817,0.967,"","LY",""
"2021-04-26","201117_Gangelt_UniversityofBonn_ v3_overall_TestAdj_IgG","Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany","2020-11-17","Local","Germany; Heinsberg; Gangelt","2020-03-31","2020-04-06","Household and community samples","Multiple groups",919.0,0.141,0.112,0.173,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Hendrik Streeck","University of Bonn","https://www.nature.com/articles/s41467-020-19509-y","Verified","Germany","EUROIMMUN",0.909,0.991,"ELISA","DE","DE-NW"
"2021-04-26","20201231_Moscow_MoscowResearchInstituteofEpidemiologyAndMicrobiology_Overall","The structure of seroprevalence to the SARS-COV-2 virus among residents of the Moscow region during the period of epidemic incidence of COVID-19","2020-10-14","Regional","Russian Federation; Central Russia; Moscow Region","2020-06-22","2020-07-11","Household and community samples","Multiple groups",2688.0,0.21,"","","Simplified probability","IgG","Unclear","Journal Article (Peer-Reviewed)","A Popova","Moscow Research Insistute of Epidemiology and Microbiology named after V.I G.N Gabrichevsky","http://dx.doi.org/10.20953/1729-9225-2020-4-17-26","Verified","Russian Federation","FBSI ""State scientific center for applied microbiology and biotechnology""","","","","RU",""
"2021-04-27","200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 2","COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context","2020-09-28","Local","Brazil; São Paulo state; Baixada Santista","2020-05-13","2020-05-15","Household and community samples","Multiple groups",2415.0,0.022,"","","Stratified probability","Total Antibody","High","Preprint","Arthur Chioro","Baixada Santista Metropolitan Region","https://preprints.scielo.org/index.php/scielo/preprint/view/1270","Verified","Brazil","Wondfo","","","","BR","BR-SP"
"2021-04-27","201027_FernandoNoronha_UniversidadeFederaldoCeará","Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil","2020-10-27","Local","Brazil; State of Pernambuco; Fernando de Noronha","2020-05-22","2020-05-31","Household and community samples","Multiple groups",904.0,0.043,0.032,0.059,"Simplified probability","IgG; IgM","Moderate","Preprint","Mozart Julio Tabosa Sales","Universidade Federal do Ceará","https://www.medrxiv.org/content/10.1101/2020.10.22.20216010v1.full-text","Verified","Brazil","Guangzhou Wondfo Biotech Co., Ltd.","","","","BR","BR-PE"
"2021-04-27","210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseIII","RÉSULTATS DE L'ÉTUDE - CORONA IMMUNITAS","2021-03-31","Regional","Switzerland; Canton of Neuchâtel","2020-12-23","2021-03-17","Household and community samples","Multiple groups",559.0,0.22,0.179,0.263,"Stratified probability","IgG; IgA","Moderate","News and Media","Republique et Canton de Neuchatel","École suisse de santé publique","https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx","Verified","Switzerland","CHUV, the Swiss Federal Institute of Technology in Lausanne (EPFL) and the Swiss Vaccine Center",0.966,0.997,"","CH","CH-NE"
"2021-04-27","210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseII_overall","RÉSULTATS DE L'ÉTUDE - CORONA IMMUNITAS","2021-03-31","Regional","Switzerland; Canton of Neuchâtel","2020-08-21","2020-10-29","Household and community samples","Multiple groups",381.0,0.049,0.024,0.081,"Stratified probability","IgG; IgA","Moderate","News and Media","Republique et Canton de Neuchatel","École suisse de santé publique","https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx","Verified","Switzerland","CHUV, the Swiss Federal Institute of Technology in Lausanne (EPFL) and the Swiss Vaccine Center",0.966,0.997,"","CH","CH-NE"
"2021-04-27","210301_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_IgG","Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran","2021-03-01","Local","Iran (Islamic Republic of); Tehran Province; Tehran","2020-04-04","2020-04-06","Multiple general populations","Multiple groups",2021.0,0.144,"","","Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Sahar Mortezagholi","Shahid Beheshti University Of Medical Sciences","https://dx.doi.org/10.22034/iji.2021.88168.1851","Unverified","Iran (Islamic Republic of)","NR","","","","IR","IR-07"
"2021-04-27","210303_Jabalpur_NationalCentreForDiseaseControl_TestPopAdj","Cross-sectional Study on Sero-Prevalence of SARS-CoV-2 Infection in Jabalpur, Madhya Pradesh, India","2021-03-31","Local","India; Madya Pradesh; Jabalpur","2020-12-11","2020-12-21","Household and community samples","Multiple groups",9279.0,0.294,0.284,0.304,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Sudarshan Ramaswamy","National Centre for Disease Control","https://web.archive.org/web/20210410213821/http://medical.advancedresearchpublications.com/index.php/Journal-CommunicableDiseases/article/view/536","Verified","India","ICMR",0.924,0.979,"","IN","IN-MP"
"2021-04-29","200604_Goiania_CityOfGoiania_overall","Survey shows that 1% of the;   population has already had Covid-19 in Goiânia","2020-06-04","Local","Brazil; Goiás; Goiania","2020-05-30","2020-05-30","Household and community samples","Multiple groups",2400.0,0.008,"","","Simplified probability","Not reported","Unclear","News and Media","Mauro Junio","City of Goiania","https://www.goiania.go.gov.br/inquerito-aponta-que-1-das-pessoas-ja-tiveram-covid-19-em-goiania/","Verified","Brazil","NR","","","","BR","BR-GO"
"2021-04-29","210108_CapeVerde_MestreEmSaúdeEDesenvolvimento_overall","Sero-Epidemiological Survey and Profile of SARS-CoV-2 Infection in Cape Verde","2021-01-08","National","Cabo Verde","2020-06-26","2020-07-04","Household and community samples","Multiple groups",5348.0,0.004,"","","Stratified probability","IgG; IgM","Moderate","Preprint","Lara Ferrero Gomez","Mestre em Saúde e Desenvolvimento","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3762489","Verified","Cabo Verde","Guangzhou Wondfo Biotech Co",0.864,0.996,"","CV",""
"2021-04-30","200707_Jersey_StatisticsJersey_Round3_TestAdj_PopAdj","SARS-CoV-2: Prevalence of antibodies in Jersey Community Survey - Round 3","2020-07-07","National","Jersey","2020-06-21","2020-06-27","Household and community samples","Multiple groups",1386.0,0.04,0.028,0.052,"Simplified probability","IgG; IgM","Low","Institutional Report","Statistics Jersey","Statistics Jersey","https://www.gov.je/SiteCollectionDocuments/Government%20and%20administration/R%20Prevalence%20of%20antibodies%2020200707%20SJ.pdf","Verified","Jersey","DNA World / CTK Biotech",0.9,0.994,"","JE",""
"2021-04-30","200828_CendeadeCizur_ISGlobal_primary","Coronavirus: New Seroprevalence Data for a Municipality in Navarra, Spain","2020-08-28","Local","Spain; Navarra; Cendea de Cizur","2020-06-01","2020-06-30","Household and community samples","Multiple groups",728.0,0.079,"","","Unclear","IgA; IgG; IgM","Unclear","News and Media","Barcelona Institute for Global Health","ISGlobla","https://www.isglobal.org/en_GB/-/coronavirus-nuevos-datos-de-seroprevalencia-para-un-municipio-en-navarra","Verified","Spain","NR","","","","ES","ES-NC"
"2021-04-30","201211_BadFeilnbach_RobertKochInstitute_primary","Corona monitoring locally - First key data for Bad Feilnbach","2020-12-11","Local","Germany","2020-06-23","2020-07-04","Household and community samples","Multiple groups",2152.0,0.091,"","","Simplified probability","IgG","Moderate","News and Media","Robert Koch Institute","Robert Koch Institute","https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Bad_Feilnbach.html","Verified","Germany","NR",0.883,0.994,"","DE",""
"2021-04-30","210212_Hiroshima_HiroshimaUniversity_overall","About the result of the 2nd new coronavirus antibody prevalence survey","2021-02-12","Regional","Japan; Hiroshima Prefecture; Hiroshima, Fukuyama, Miyoshi, and Higashi-Hiroshima","2020-10-15","2020-11-15","Household and community samples","Multiple groups",2396.0,0.002,"","","Simplified probability","Not reported","High","Institutional Report","Prefecture of Hiroshima","Hiroshima University","https://www.chugoku-np.co.jp/local/news/article.php?comment_id=726622&comment_sub_id=0&category_id=256","Verified","Japan","Roche","","","","JP","JP-34"
"2021-04-30","210305_Illinois-Wisconsin_AdvocateAuroraHealth","Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System","2021-03-05","Regional","United States of America; Illinois, Wisconsin (Midwest)","2020-06-08","2020-07-10","Health care workers and caregivers","Multiple groups",16233.0,0.038,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Veronica Fitzpatrick","Advocate Aurora Health","https://dx.doi.org/10.1177/0033354921999168","Unverified","United States of America","Abbott",0.987,0.992,"","US",""
"2021-04-30","210310_UnitedStatesofAmerica_EmoryUniversity","Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel","2021-03-10","Regional","United States of America; Georgia, Maryland, Illinois; Atlanta, Baltimore, Chicago","2020-04-19","2020-08-30","Health care workers and caregivers","Adults (18-64 years)",24749.0,0.044,0.041,0.046,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Jesse Jacob","Emory University","https://dx.doi.org/10.1001/jamanetworkopen.2021.1283","Unverified","United States of America","Abbott, author-made, Euroimmun, Ortho Clinical","","","","US",""
"2021-04-30","210331_Naples_IstitutoNazionaleTumori_CancerPatients","Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis","2021-03-31","Local","Italy","2020-03-30","2020-05-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",885.0,0.054,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Isgro","Istituto Nazionale Tumori","https://dx.doi.org/10.1186/s12967-021-02798-2","Verified","Italy","Lepu Medical Technology – Beijing – Co., Ltd","","","","IT",""
"2021-04-30","210331_Naples_IstitutoNazionaleTumori_HCWs","Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis","2021-03-31","Local","Italy","2020-03-30","2020-05-15","Health care workers and caregivers","Multiple groups",1050.0,0.046,0.033,0.059,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Isgro","Istituto Nazionale Tumori","https://dx.doi.org/10.1186/s12967-021-02798-2","Verified","Italy","Lepu Medical Technology – Beijing – Co., Ltd","","","","IT",""
"2021-05-02","200923_Ecuador_UniversidadCatólicaDelEcuador_Patients","Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Ecuadorian Population","2020-09-23","National","Ecuador","2020-05-12","2020-07-20","Household and community samples","Multiple groups",11540.0,0.19,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Camilo Zurita Salinas","Universidad Católica Del Ecuador","https://www.researchgate.net/publication/344477310_SEROPREVALENCE_OF_ANTI-SARS-COV-2_IGG_ANTIBODIES_IN_ECUADORIAN_POPULATION","Verified","Ecuador","NovaTec Inmundiagnostica GmbH","","","","EC",""
"2021-05-02","201023_Khartoum_FederalMinistryofHealthSudan","Sudan FETP Conducts Targeted Testing for COVID-19 in Khartoum State","2020-10-23","Regional","Sudan; Khartoum","2020-05-22","2020-07-05","Household and community samples","Multiple groups",967.0,0.183,"","","Unclear","Not reported","Unclear","News and Media","William McCollum","Federal Ministry of Health (MOH) in Sudan","https://www.tephinet.org/sudan-fetp-conducts-targeted-testing-for-covid-19-in-khartoum-state","Verified","Sudan","NR","","","","SD","SD-KH"
"2021-05-02","201220_Afghanistan_UnitedStatesAirForce","Using serosurveillance for SARS-CoV-2 to conserve PCR tests in a resource constrained combat environment","2020-12-31","Local","Afghanistan; NR; NR","2020-04-17","2020-06-01","Essential non-healthcare workers","Adults (18-64 years)",1957.0,0.019,"","","Unclear","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Brian White","United States Air Force","http://dx.doi.org/10.1093/ofid/ofaa439.666","Verified","Afghanistan","NR","","","","AF",""
"2021-05-02","210225_Florida_FloridaDepartmentOfHealth_overall","SARS-COV-2 ANTIBODY PREVALENCE AMONG HEALTHCARE WORKERS AND FIRST RESPONDERS, FLORIDA, MAY-JUNE 2020","2021-04-12","Regional","United States of America; Florida","2020-05-06","2020-06-03","Health care workers and caregivers","Multiple groups",5776.0,0.041,0.026,0.082,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","James Matthias","Florida Department of Health","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040388/","Verified","United States of America","Cellex Inc",0.938,0.96,"","US","US-FL"
"2021-05-02","210302_Dresden_TechnischeUniversitätDresden","Lower Household Transmission Rates of SARS-CoV-2 from Children Compared to Adults - Results from the FamilyCoviDD19-Study","2021-03-02","Local","Germany; Saxony; Dresden","2020-06-15","2021-01-15","Contacts of COVID patients","Multiple groups",248.0,0.343,"","","Sequential","IgG","High","Preprint","Lukas Galow","Technische Universität Dresden","10.2139/ssrn.3790443","Unverified","Germany","Diasorin ; Abbott; Euroimmun","","","","DE","DE-SN"
"2021-05-02","210330_Zambia_ZambiaMinistryofHealth_HCW","Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Health Care Workers-Zambia, July 2020","2021-03-30","National","Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi, Pooled","2020-07-02","2020-07-31","Health care workers and caregivers","Multiple groups",575.0,0.022,0.005,0.039,"Stratified non-probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Sombo Fwoloshi","Zambia Ministry of Health","https://dx.doi.org/10.1093/cid/ciab273","Unverified","Zambia","PerkinElmer, Waltham, Massachusetts",0.9,1.0,"","ZM",""
"2021-05-02","210331_SchleswigHolstein_RuhrUniversityBochum_HCW","Half Year Longitudinal Seroprevalence of SARS-CoV-2-antibodies and Rule Compliance in German Hospital Employees","2021-03-31","Local","Germany; Schleswig-Holstein","2020-04-14","2020-10-20","Health care workers and caregivers","Adults (18-64 years)",268.0,0.008,"","","Convenience","IgG","High","Preprint","Jonas Herzberg","Ruhr University Bochum","https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1","Unverified","Germany","Euroimmun, Abbott, DiaSorin","","","","DE","DE-SH"
"2021-05-02","210401_Warsaw_Children’sMemorialHealthInstitute_HCW","Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland","2021-04-01","Local","Poland","2020-07-01","2020-08-09","Health care workers and caregivers","Adults (18-64 years)",1879.0,0.008,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Beata Kasztelewicz","Children’s Memorial Health Institute","https://dx.doi.org/10.1371/journal.pone.0249550","Unverified","Poland","Abbot",0.99,1.0,"","PL",""
"2021-05-02","210402_Italy_FondazioneIstitutoStomatologicoItaliano_DentalStaff","SARS-CoV-2 Infection among the Dental Staff from Lombardy Region, Italy","2021-04-02","National","Italy; Como, Lecco, Monza-Brianza, Sondrio, Varese, Bergamo, Brescia  Cremona, Lodi, Mantova, Pavia, Milan","2020-05-28","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",499.0,0.108,"","","Convenience","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Silvano Gallus","Fondazione Istituto Stomatologico Italiano","http://dx.doi.org/10.3390/ijerph18073711","Unverified","Italy","KHB, Shanghai, China",0.951,0.993,"","IT",""
"2021-05-02","210405_California_StanfordUniversitySchoolofMedicine_overall","SARS-CoV-2 IgG Seropositivity and Acute Asymptomatic Infection Rate Among Firefighter First Responders in an Early Outbreak County in California","2021-05-06","Local","United States of America; California","2020-06-15","2020-08-15","Essential non-healthcare workers","Adults (18-64 years)",983.0,0.025,0.016,0.037,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Jennifer Newberry","Stanford University","http://dx.doi.org/10.1080/10903127.2021.1912227","Verified","United States of America","Abbott Architect","","","","US","US-CA"
"2021-05-02","210412_Stockholm_KarolinskaInstitutet_hcw","SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden","2021-04-12","Local","Sweden; Södermanland and Uppland; Stockholm","2020-05-11","2020-06-17","Health care workers and caregivers","Adults (18-64 years)",403.0,0.201,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","S Hassan","Karolinska Institutet","https://dx.doi.org/10.1111/joim.13274","Verified","Sweden","NR",0.992,0.998,"","SE","SE-AB"
"2021-05-02","211231_Denver_DenverPublicHealth","SARS-Cov-2 RNA and antibodies among people experiencing homelessness and staying in shelters or outdoor encampments in Denver, Colorado, May-July 2020","2020-12-20","Local","United States of America; Colorado; Denver","2020-06-02","2020-07-28","Persons experiencing homelessness","Adults (18-64 years)",334.0,0.167,"","","Convenience","Not reported","Unclear","Journal Article (Peer-Reviewed)","David McCormick","Denver Public Health","http://dx.doi.org/10.1093/ofid/ofaa515.1909","Verified","United States of America","NR","","","","US","US-CO"
"2021-05-03","200527_RioGrandeDoSul_FederalUniversityOfPelotas_overall","Fourth stage of research shows;   stability in the total number of coronavirus","2020-05-27","Regional","Brazil; Rio Grande do Sul","2020-05-23","2020-05-25","Household and community samples","Multiple groups",4500.0,0.002,0.001,0.003,"Unclear","Not reported","Unclear","News and Media","Governo do Estato do Rio Grande do Sul","Governo do Estato do Rio Grande do Sul","https://estado.rs.gov.br/quarta-etapa-de-pesquisa-aponta-estabilidade-no-total-de-infectados-por-coronavirus-no-rs","Verified","Brazil","NR","","","","BR","BR-RS"
"2021-05-03","200624_Cusco_ RegionalHealthDirectorateOfCusco_overall","PREVALENCE COVID-19 PROVINCE;   OF CUSCO","2020-06-25","Regional","Peru; Cusco","2020-06-08","2020-06-20","Household and community samples","Multiple groups",491.0,0.026,"","","Stratified probability","Not reported","High","News and Media","Regional Health Directorate of Cusco","Regional Health Directorate of Cusco","https://web.archive.org/web/20201220094258/http://www.diresacusco.gob.pe/new/archivos/4335","Unverified","Peru","NR","","","","PE","PE-CUS"
"2021-05-03","200629_Goiania_CityOfGoiania_overall","Research shows that 31,838,000;   people have already been infected with COVID-19 in Goiânia","2020-06-29","Local","Brazil; Goiás; Goiania","2020-06-10","2020-06-10","Household and community samples","Multiple groups",2628.0,0.021,"","","Simplified probability","Not reported","Unclear","News and Media","City of Goiania","Municipal Health Department of the City of Goiania","https://www.goiania.go.gov.br/pesquisa-aponta-que-31-838-mil-pessoas-ja-foram-infectadas-por-covid-19-em-goiania/","Verified","Brazil","NR","","","","BR","BR-GO"
"2021-05-03","210317_Sweden_TheSwedishPublicHealthAgency_BloodDonors_overall","Påvisning av antikroppar efter genomgången covid-19 hos blodgivare (Delrapport 2)","2021-03-17","National","Sweden; Regions of: Jämtland-Härjedalen, Jönköping, Kalmar,; Skåne, Stockholm, Uppsala, Västerbotten, Västra Götaland and Örebro","2020-11-23","2020-12-04","Blood donors","Multiple groups",3183.0,0.07,0.058,0.085,"Convenience","Not reported","Unclear","Institutional Report","Swedish Public Health Agency","The Swedish Public Health Agency (Folkhälsomyndigheten)","https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf","Verified","Sweden","Sci Life Lab / KTH",0.994,0.989,"","SE",""
"2021-05-03","210415_NewYork_NewYorkUniversity_hcw","Seroepidemiology among Employees of New York City Health and Hospitals during the First Wave of the SARS-CoV-2 Epidemic","2021-04-15","Local","United States of America; New York ; New York","2020-04-30","2020-06-30","Health care workers and caregivers","Multiple groups",727.0,0.294,"","","Convenience","Not reported","High","Preprint","Alexander Bryan","New York University","https://www.medrxiv.org/content/10.1101/2021.04.12.21255344v1","Verified","United States of America","NR","","","","US","US-NY"
"2021-05-04","201204_SantaClara_O’ConnorHospital_Overall","Effectiveness of an infection prevention strategy to limit exposure of high-risk patients to COVID-19 in a hospital-based subacute unit: a descriptive report","2020-12-04","Local","United States of America; California; San Jose","2020-05-06","2020-05-06","Patients seeking care for non-COVID-19 reasons","Multiple groups",24.0,0.0,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Brian D McBeth","O'Connor Hospital","https://dx.doi.org/10.1177/1757177420976814","Unverified","United States of America","Poway, CA, USA","","","","US","US-CA"
"2021-05-05","200501_SanMiguelCounty_UnitedBiomedical_overall","San Miguel County, CO IgG Antibody Tests","2020-05-01","Local","United States of America; Colorado","2020-03-26","2020-04-15","Household and community samples","Multiple groups",5283.0,0.005,"","","Entire sample","IgG","Moderate","Institutional Report","San Miguel County","United Biomedical Group","https://www.sanmiguelcountyco.gov/DocumentCenter/View/5717/San-Miguel-County-IgG-Antibody-Test-Statistics-and-Demographics-PDF","Verified","United States of America","NR","","","","US","US-CO"
"2021-05-05","200626_BomJesus_InstitutoPiaunienseDeOpiniaoPubilca_overall","Pesquisa Sobre Status Sorológico da População Quanto a Infecção por SARS‐COV‐2 em Situação de Pandemia","2020-06-26","Local","Brazil; Piauí; Bom Jesus","2020-06-24","2020-06-26","Household and community samples","Multiple groups",200.0,0.08,"","","Simplified probability","IgG; IgM","High","Institutional Report","Instituto Piauniense de Opiniao Publica","Instituto Piauniense de Opinião Pública","https://portalpontox.com/wp-content/uploads/2020/06/PESQUISA-BOM-JESUS-COVID-24a26-06.2020.pdf","Verified","Brazil","NR","","","","BR","BR-PI"
"2021-05-05","200831_KingCounty_UniversityOfWashington_overall","King County, Washington Anti-SARS-CoV-2 Seroprevalence Survey, August 2020","2020-08-31","Local","United States of America; Washington","2020-08-08","2020-08-29","Household and community samples","Multiple groups",1364.0,0.039,0.024,0.06,"Stratified probability","IgG; IgM; IgA","Moderate","Institutional Report","Karen Cowgill","University of Washington","https://www.kingcounty.gov/depts/health/covid-19/data/~/media/depts/health/communicable-diseases/documents/C19/serosurvey-report-covid19.ashx https://kingcounty.gov/depts/health/covid-19/seroprevalence.aspx https://www.kingcounty.gov/depts/health/covid-19/seroprevalence-study.aspx page 9: http://www.co.cowlitz.wa.us/DocumentCenter/View/20793/8122020-Cowlitz-County-COVID-update-to-Board-of-County-Commissioners","Verified","United States of America","1) Bio-Rad 2) EuroImmun",0.829,1.0,"","US","US-WA"
"2021-05-05","201231_SanDiego_UniversityofCaliforniaSanDiegoHealth_HCW","Asymptomatic healthcare worker COVID-19 testing program","2020-12-31","Local","United States of America; California; San Diego","2020-04-22","2020-06-02","Health care workers and caregivers","Adults (18-64 years)",5589.0,0.01,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Lucy E Horton","University of California San Diego Health","http://dx.doi.org/10.1093/ofid/ofaa439.630","Verified","United States of America","Diazyme Laboratories","","","","US","US-CA"
"2021-05-05","201231_WestVirginia_WestVirginiaUniversityMedicine_HCW","Serum IgG antibody testing against severe acute respiratory syndrome coronavirus 2 in healthcare workers","2020-12-31","Local","United States of America; West Virginia; Morgantown","2020-05-26","2020-06-05","Health care workers and caregivers","Adults (18-64 years)",1042.0,0.009,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Joy J Juskowich","West Virginia University Medicine","http://dx.doi.org/10.1093/ofid/ofaa439.694","Verified","United States of America","NR","","","","US","US-WV"
"2021-05-05","210101_MurmanskRegion_StPetersburgPasteurInstitute_Overall","Humoral immunity to SARS-CoV-2 in the population of the Murmansk region against the background of the incidence of COVID-19","2021-01-01","Regional","Russian Federation; Murmansk Region","2020-08-03","2020-08-11","Household and community samples","Multiple groups",3117.0,0.312,0.304,0.32,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St. Petersburg Pasteur Institute","https://hiv.bmoc-spb.ru/jour/article/view/605#","Verified","Russian Federation","FBSI State Scientific Center Applied Microbiology and Biotechnology","","","","RU","RU-MUR"
"2021-05-05","210320_Japan_NationalCenterForGlobalHealthAndMedicine","Evaluation of serum antibodies against SARSâ€CoVâ€2 in healthcare workers who participated in the operation of charter flights for the evacuation of Japanese residents from Hubei Province","2021-03-20","National","Japan","2020-02-14","2020-03-13","Health care workers and caregivers","Adults (18-64 years)",10.0,0.0,"","","Convenience","Not reported","High","Preprint","Tetsuya Suzuki","National Center for Global Health and Medicine","10.1101/https://www.medrxiv.org/content/10.1101/2021.03.17.21251964v1","Unverified","Japan","NR","","","","JP",""
"2021-05-06","200812_Cajamar_MunicipalSecretariatOfCajamar_overall","Department of Health releases;   balance sheet of active search for antibodies to Sars-Cov-2","2020-08-12","Local","Brazil; São Paulo; Municipality of Cajamar","2020-07-21","2020-07-27","Household and community samples","Multiple groups",1015.0,0.04,"","","Convenience","Not reported","High","News and Media","Municipal Secretariat of Cajamar","Municipal Secretariat of Cajamar","https://cajamar.sp.gov.br/noticias/2020/08/12/secretaria-de-saude-divulga-balanco-da-pesquisa-de-busca-ativa-de-anticorpos-para-sars-cov-2/","Verified","Brazil","Not reported","","","","BR","BR-SP"
"2021-05-06","200831_Mumbai_NITI-Aayog_HCW","SARS-CoV2 Serological Survey in Mumbai by NITI-BMC-TIFR: Preliminary Report of Round-2","2020-08-31","Local","India","2020-08-16","2020-08-29","Health care workers and caregivers","Adults (18-64 years)",728.0,0.273,0.241,0.306,"Unclear","IgG","Unclear","Institutional Report","Ullas Kolthur Seetharam","NITI-Aayog","https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf","Verified","India","Abbott",0.93,1.0,"","IN",""
"2021-05-06","200831_Mumbai_NITI-Aayog_Non-Slum_overall","SARS-CoV2 Serological Survey in Mumbai by NITI-BMC-TIFR: Preliminary Report of Round-2","2020-08-31","Local","India","2020-08-16","2020-08-29","Household and community samples","Multiple groups",2176.0,0.175,0.159,0.191,"Stratified probability","IgG","Low","Institutional Report","Ullas Kolthur Seetharam","NITI-Aayog","https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf","Verified","India","Abbott",0.93,1.0,"","IN",""
"2021-05-06","200831_Mumbai_NITI-Aayog_Slums_overall","SARS-CoV2 Serological Survey in Mumbai by NITI-BMC-TIFR: Preliminary Report of Round-2","2020-08-31","Local","India","2020-08-16","2020-08-29","Persons living in slums","Multiple groups",3024.0,0.449,0.432,0.467,"Stratified probability","IgG","Low","Institutional Report","Ullas Kolthur Seetharam","NITI-Aayog","https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf","Verified","India","Abbott",0.93,1.0,"","IN",""
"2021-05-06","201231_LosAngeles_UniversityofCaliforniaLosAngeles","Lack of SARS-CoV-2 antibody seroconversion after prompt identification and cohorting of sentinel SARS-CoV-2-positive residents in a skilled nursing facility","2020-12-31","Local","United States of America; California; Los Angeles","2020-06-01","2020-06-15","Assisted living and long-term care facilities","Adults (18-64 years)",121.0,0.016,"","","Convenience","IgG","High","Presentation or Conference","Debika Bhattacharya","University of California Los Angeles","https://academic.oup.com/ofid/article/7/Supplement_1/S165/6058251","Unverified","United States of America","DiaSorin","","","","US","US-CA"
"2021-05-06","210415_France_InstitutPasteur_HighSchool1_overall","SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020","2021-04-15","Local","France; Hauts-de-France","2020-03-30","2020-04-04","Students and Daycares","Multiple groups",664.0,0.251,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Arnaud Fontanet","Institut Pasteur","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695","Unverified","France","Institut Pasteur",0.994,0.99,"","FR","FR-HDF"
"2021-05-06","210415_France_InstitutPasteur_PrimarySchool2_overall","SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020","2021-04-15","Local","France; Hauts-de-France","2020-04-28","2020-04-30","Students and Daycares","Multiple groups",1340.0,0.104,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Arnaud Fontanet","Institut Pasteur","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695","Unverified","France","Institut Pasteur",0.994,0.99,"","FR","FR-HDF"
"2021-05-07","210408_Germany_BundeswehrInstituteofMicrobiology_overall","Sars-cov-2 seroprevalence among health care workers-a voluntary screening study in a regional medical center in southern germany","2021-04-08","Local","Germany","2020-04-02","2020-04-08","Health care workers and caregivers","Adults (18-64 years)",198.0,0.035,"","","Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Katharina Muller","Bundeswehr Institute of Microbiology","http://dx.doi.org/10.3390/ijerph18083910","Verified","Germany","Euroimmun","","","","DE",""
"2021-05-08","201231_Charleston_MedicalUniversityofSouthCarolina","Point-of-care, in-home SARS-CoV-2 IgG antibody testing to assess seroprevalence in at-risk health care workers","2020-12-31","Local","United States of America; South Carolina ; Charleston","2020-04-14","2020-05-06","Health care workers and caregivers","Adults (18-64 years)",439.0,0.014,"","","Convenience","IgG","High","Presentation or Conference","Eric G Meissner","Medical University of South Carolina","http://dx.doi.org/10.1093/ofid/ofaa439.653","Unverified","United States of America","RayBiotech",0.76,0.95,"","US","US-SC"
"2021-05-09","210312_UnitedStatesOlympicandParalympicTrainingfacilities_MassachusettsGeneralHospital","Resumption of Sport at the United States Olympic and Paralympic Training Facilities During the COVID-19 Pandemic","2021-03-12","National","United States of America; Colorado; Colorado Springs","2020-07-01","2020-07-31","Non-essential workers and unemployed persons","Adults (18-64 years)",301.0,0.036,"","","Convenience","Not reported","Unclear","Journal Article (Peer-Reviewed)","Ankit B Shah","Massachusetts General Hospital","https://dx.doi.org/10.1177/19417381211002761","Unverified","United States of America","Not reported","","","","US","US-CO"
"2021-05-10","20210226_Zurich_UniversityofZurich_carehomeworkers","Zurich studies on the seroprevalence of home and home staff as well as on the immune response and long-term consequences in those who tested positive for corona","2021-02-26","Regional","Switzerland; Canton of Zurich","2020-09-09","2020-10-23","Health care workers and caregivers","Adults (18-64 years)",296.0,0.149,"","","Convenience","Not reported","Unclear","Institutional Report","Canton Zurich","University of Zurich","https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html","Unverified","Switzerland","NR","","","","CH","CH-ZH"
"2021-05-10","20210226_Zurich_UniversityofZurich_spitexworkers","Zurich studies on the seroprevalence of home and home staff as well as on the immune response and long-term consequences in those who tested positive for corona","2021-02-26","Regional","Switzerland; Canton of Zurich","2020-09-09","2020-10-23","Health care workers and caregivers","Adults (18-64 years)",131.0,0.038,"","","Convenience","Not reported","Unclear","Institutional Report","Canton Zurich","University of Zurich","https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html","Unverified","Switzerland","NR","","","","CH","CH-ZH"
"2021-05-10","210208_Paris_JeanVerdierHospital_DaycareStaff2_Overall_TestAdj","SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study","2021-02-08","National","France; Île-de-France, Auvergne-Rhône-Alpes, Normandy; Paris, Annecy, Rouen","2020-06-04","2020-07-03","Essential non-healthcare workers","Adults (18-64 years)",197.0,0.068,0.032,0.115,"Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Eric Lachassinne","Jean Verdier Hospital","https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext","Verified","France","Biosynex",0.918,0.992,"","FR",""
"2021-05-10","210208_Paris_JeanVerdierHospital_HCW3_Overall_TestAdj","SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study","2021-02-08","National","France; Île-de-France, Auvergne-Rhône-Alpes, Normandy; Paris, Annecy, Rouen","2020-06-04","2020-07-03","Health care workers and caregivers","Adults (18-64 years)",164.0,0.05,0.016,0.098,"Unclear","IgM; IgG","High","Journal Article (Peer-Reviewed)","Eric Lachassinne","Jean Verdier Hospital","https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext","Verified","France","Biosynex",0.918,0.992,"","FR",""
"2021-05-10","210309_HarrisCounty_HarrisCountyPublicHealth_genpop","Harris County Public Health announces initial results of COVID-19 antibody project","2021-03-09","Local","United States of America; Texas","2020-11-15","2020-12-15","Household and community samples","Multiple groups",646.0,0.16,"","","Simplified probability","Not reported","Unclear","News and Media","Harris County Public Health","Harris County Public Health","https://publichealth.harriscountytx.gov/Portals/27/Documents/HCPH%20Antibody%20Results%20NR.pdf?ver=ZkoB5qeX0P1G--8gfGH8fg%3d%3d","Verified","United States of America","NR","","","","US","US-TX"
"2021-05-10","210311_Egypt_CenterofScientificExcellenceforInfluenzaViruses_October3","Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort.","2021-03-11","National","Egypt; Sharkiyah Governorate, Gharbiyah Governorate, Kafr El Sheikh Governorate, Qalyubiyah Governorate, Fayyoum Governorate","2020-10-01","2020-10-31","Household and community samples","Multiple groups",1260.0,0.348,"","","Simplified probability","Neutralizing","Unclear","Journal Article (Peer-Reviewed)","Mokhtar R Gomaa","Center of Scientific Excellence for Influenza Viruses","https://dx.doi.org/10.1371/journal.ppat.1009413","Verified","Egypt","N/A - Author Designed","","","","EG",""
"2021-05-10","210316_Netherlands_SanquinResearch_blooddonors","Low awareness of past SARS-CoV-2 infection in healthy plasma donors","2021-03-16","National","Netherlands","2020-05-11","2020-05-18","Blood donors","Multiple groups",3676.0,0.065,"","","Entire sample","Not reported","Moderate","Journal Article (Peer-Reviewed)","Katj van den HUrk","Sanquin Research","https://dx.doi.org/10.1016/j.xcrm.2021.100222","Verified","Netherlands","Wantai Biological Pharmacy Enterprise Co.",0.987,0.996,"","NL",""
"2021-05-10","210427_Germany_HelmholtzCentreForInfectionResearch","SARS-CoV-2 Seroprevalence in Germany - A Population Based Sequential Study in Five Regions","2021-04-27","National","Germany","2020-07-15","2020-12-15","Household and community samples","Multiple groups",13405.0,0.02,"","","Stratified probability","IgG","Moderate","Preprint","Daniela Gornyk","Helmholtz Centre for Infection Research","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3834300","Verified","Germany","Euroimmun","","","","DE",""
"2021-05-11","200831_Limeira_LimeriaCityHall_overall","Study suggests that almost;   36,000 residents of Limeira had covid-19","2020-08-31","Local","Brazil; São Paulo; Limeira","2020-08-24","2020-08-29","Household and community samples","Multiple groups",1291.0,0.146,0.119,0.173,"Simplified probability","IgG; IgM","High","News and Media","Redacao Educadora","Limeira City Hall","https://elimeira.com.br/noticias/limeira/estudo-sugere-que-quase-36-mil-moradores-de-limeira-tiveram-covid-19/","Verified","Brazil","NR","","","","BR","BR-SP"
"2021-05-11","210308_Berlin_UniversitatmedizinBerlin","Sars-cov-2 infection, risk perception, behaviour and preventive measures at schools in berlin, germany, during the early post-lockdown phase: A cross-sectional study","2021-03-08","Local","Germany","2020-06-11","2020-06-19","Multiple populations","Multiple groups",527.0,0.013,"","","Stratified non-probability","IgG","High","Journal Article (Peer-Reviewed)","Franziska Hommes","Universitatmedizin Berlin","http://dx.doi.org/10.3390/ijerph18052739","Unverified","Germany","Euroimmun AG","","","","DE",""
"2021-05-11","210312_Lima_InstitutoNacionalDeSalud_Overall","Household transmission of SARS-CoV-2 (COVID-19) in Lima, Peru","2021-03-12","Local","Peru","2020-04-23","2020-05-02","Contacts of COVID patients","Multiple groups",236.0,0.53,"","","Stratified non-probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yolanda Angulo Bazan","Instituto Nacional de Salud","https://dx.doi.org/10.1590/0102-311X00238720","Verified","Peru","Core Technology Co., Beijing, China",0.976,1.0,"","PE",""
"2021-05-12","210320_GardenaValley_HospitalOfBolzano_PopAdj_TestAdj","Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena Valley","2021-03-20","Local","Italy","2020-05-26","2020-06-08","Household and community samples","Multiple groups",2106.0,0.269,0.252,0.286,"Stratified probability","IgG","Low","Preprint","Roberto Melotti","Hospital of Bolzano","10.1101/2021.03.19.21253883","Verified","Italy","Abbott",0.969,0.999,"","IT",""
"2021-05-13","200803_Italy_InstitutoNazionaleDiStatistica_overall","FIRST RESULTS OF THE SEROPREVALENCE SURVEY ON SARS-CoV-2","2020-08-03","National","Italy","2020-05-25","2020-07-15","Household and community samples","Multiple groups",64660.0,0.025,0.023,0.026,"Stratified probability","IgG","Moderate","Institutional Report","Instituto Nazionale di Statistica","The Institute for National Statistics","https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf","Verified","Italy","NR","","","","IT",""
"2021-05-13","201216_Utsunomiya_TokyoMedicalandDentalUniversity_PopAdj","Seroprevalence of SARS‐CoV‐2 in Utsunomiya City, Greater Tokyo, after the first pandemic in 2020","2020-12-16","Local","Japan; Tochigi Prefecture; Utsunomiya City","2020-06-14","2020-07-05","Household and community samples","Multiple groups",742.0,0.012,0.002,0.023,"Simplified probability","IgG","Low","Journal Article (Peer-Reviewed)","Nobutoshi Nawa","Tokyo Medical and Dental University","https://onlinelibrary.wiley.com/doi/full/10.1002/jgf2.408","Verified","Japan","Shenzhen YHLO Biotech Co",0.973,0.963,"","JP","JP-09"
"2021-05-13","210118_Lithuania_210118_Lithuania_LithuanianUniversityofHealthSciences_TestAdj","SARS-CoV-2 Seroprevalence in Lithuania: Results of National Population Survey","2021-01-18","National","Lithuania; Vilnius County, Kaunas county, Klaipėda County, Tauragė County, Utena county; ; Vilnius, Kaunas, Klaipėda","2020-08-10","2020-09-10","Household and community samples","Multiple groups",3089.0,0.014,0.009,0.02,"Simplified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Kastytis Smigelskas","Lithuanian University of Health Sciences","https://www.journals.vu.lt/AML/article/view/22344","Verified","Lithuania","AMP Diagnostics",0.92,0.994,"","LT",""
"2021-05-13","210210_Joinville_CityHallofJoinville_PopAdj","Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil","2021-02-10","Local","Brazil; Santa Catarina; Joinville","2020-06-15","2020-08-07","Household and community samples","Multiple groups",4403.0,0.048,"","","Stratified probability","IgG; IgM","Moderate","Preprint","Henrique Diegoli","City Hall of Joinville","https://www.medrxiv.org/content/10.1101/2021.02.08.21251009v1.full","Verified","Brazil","Celer",0.864,0.996,"","BR","BR-SC"
"2021-05-13","210315_FukuokaCity_KanenokumaHospital_Residents","Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan","2021-03-15","Local","Japan","2020-04-23","2020-06-15","Assisted living and long-term care facilities","Seniors (65+ years)",76.0,0.079,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yong Chong","Kanenokuma Hospital","https://dx.doi.org/10.1186/s12879-021-05972-5","Verified","Japan","Abbott","","","","JP",""
"2021-05-13","210315_FukuokaCity_KanenokumaHospital_Staff","Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan","2021-03-15","Local","Japan","2020-04-23","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",40.0,0.0,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yong Chong","Kanenokuma Hospital","https://dx.doi.org/10.1186/s12879-021-05972-5","Verified","Japan","Abbott","","","","JP",""
"2021-05-13","210322_England_PublicHealthEnglandColindale_Overall","Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers","2021-03-22","Local","United Kingdom of Great Britain and Northern Ireland; England; London, Wythenshawe, Porton","2020-03-23","2020-11-18","Multiple populations","Adults (18-64 years)",2246.0,0.118,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Robert Harris","Public Health England Colindale","https://dx.doi.org/10.1016/j.jinf.2021.03.015","Unverified","The United Kingdom","Euroimmun; Roche; Abbott; Author-designed","","","","GB","GB-ENG"
"2021-05-13","210405_Japan_SOUSEIKAI_Overall","Sars-cov-2 seroprevalence among healthcare workers in general hospitals and clinics in Japan","2021-04-05","Local","Japan; Fukuoka, Kumamoto, Tokyo","2020-08-15","2020-10-15","Health care workers and caregivers","Multiple groups",2160.0,0.017,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Tatsuya Yoshihara","SOUSEIKAI Medical Group","http://dx.doi.org/10.3390/ijerph18073786","Verified","Japan","INNOVITA Biological Technol-ogy Co., Ltd., Tangshan, China",0.873,1.0,"","JP",""
"2021-05-13","210427_Bhubaneswar_IndianCouncilOfMedicalResearch_overall","Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from 3 rounds of community surveys","2021-04-27","Local","India; Odisha; Bhubaneswar","2020-09-01","2020-09-30","Household and community samples","Multiple groups",1403.0,0.49,0.464,0.517,"Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jaya Singh Kshatri","Indian Council of Medical Research","https://www.cambridge.org/core/journals/epidemiology-and-infection/article/seroprevalence-of-sarscov2-in-bhubaneswar-india-findings-from-3-rounds-of-community-surveys/29A7905F297A1EFA68749AC3C6383300","Verified","India","Roche","","","","IN","IN-OR"
"2021-05-13","211006_Goiânia_MunicipalityofGoiâniaHealthDepartment","Population Survey helps identify areas of higher concentration of Covid-19","2020-10-06","Local","Brazil; Goiás","2020-09-19","2020-09-19","Household and community samples","Multiple groups",2436.0,0.14,"","","Unclear","IgG","High","News and Media","Prefeitura De Goiania","Health Department of the Municipality of Goiânia","https://www.goiania.go.gov.br/inquerito-populacional-ajuda-identificar-areas-de-maior-concentracao-da-covid-19/","Verified","Brazil","Nr","","","","BR","BR-GO"
"2021-05-14","201011_Assam_Srijanasom_overall","Assam’s sero-survey found 23.7;   per cent Seroprevalence in the state","2020-10-11","Regional","India; Assam","2020-08-23","2020-09-26","Household and community samples","Multiple groups",2390.0,0.237,"","","Unclear","IgG","Unclear","News and Media","Bikash Singh","Srijanasom","https://economictimes.indiatimes.com/news/politics-and-nation/assams-sero-survey-found-23-7-per-cent-seroprevalence-in-the-state/articleshow/78606153.cms","Verified","India","NR","","","","IN","IN-AS"
"2021-05-14","210302_Athens_NationalandKapodistrianUniversityofAthens_PopTestAdj","Sars-cov-2 infection is asymptomatic in nearly half of adults with robust anti-spike protein receptor-binding domain antibody response","2021-03-02","Local","Greece; Attica; Athens","2020-06-15","2020-11-15","Non-essential workers and unemployed persons","Multiple groups",4996.0,0.016,0.009,0.025,"Simplified probability","IgG; IgA; IgM","Low","Journal Article (Peer-Reviewed)","Ourania Tsitsilonis","National and Kapodistrian University of Athens","http://dx.doi.org/10.3390/vaccines9030207","Verified","Greece","Roche Diagnostics",1.0,0.998,"","GR","GR-I"
"2021-05-14","210315_Thuringia_ThuringiaClinic_COVIDStaff_overall","Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and ""Covid-19"" wards.","2021-03-15","Local","Germany; Thuringia; Saalfeld/Saale","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",18.0,0.056,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jorg Epstude","Thuringia Clinic","https://dx.doi.org/10.3205/dgkh000382","Verified","Germany","EUROIMMUN™","",0.985,"","DE","DE-TH"
"2021-05-14","210315_Thuringia_ThuringiaClinic_ICU_Overall","Antibody titers and rapid antigen testing in elderly patients with SARS-CoV-2 pneumonia vs. staff of ICU and ""Covid-19"" wards.","2021-03-15","Local","Germany; Thuringia; Saalfeld/Saale","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",50.0,0.0,"","","Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Jorg Epstude","Thuringia Clinic","https://dx.doi.org/10.3205/dgkh000382","Verified","Germany","EUROIMMUN™","","","","DE","DE-TH"
"2021-05-14","210320_Cogne_UniversitàDiTorino_genpop_overall","The effects of physical distancing and lockdown to restrain SARS-CoV-2 outbreak in the Italian Municipality of Cogne","2021-03-20","Local","Italy; Valle D'Aosta; Cogne","2020-06-04","2020-06-05","Household and community samples","Multiple groups",857.0,0.034,"","","Entire sample","IgG; IgM","Low","Preprint","F Truc","Università di Torino","https://www.medrxiv.org/content/10.1101/2021.03.19.21253962v1.full-text","Verified","Italy","YHLO","","","","IT","IT-23"
"2021-05-14","210331_Poznań_PolishAcademyofSciences_Primary","Prevalence of anti-SARS-CoV-2 antibodies in Poznan Poland, after the first wave of the COVID-19 pandemic","2021-03-31","Local","Poland; Greater Poland; Poznań","2020-07-15","2020-09-15","Household and community samples","Multiple groups",1500.0,0.009,0.006,0.016,"Simplified probability","IgG","Moderate","Preprint","Dagny Lorent","Polish Academy of Sciences","https://www.medrxiv.org/content/10.1101/2021.03.29.21254544v1.full","Verified","Poland","EuroImmun; Polycheck","","","","PL","PL-30"
"2021-05-14","210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_Households_TestAdj.","Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study","2021-04-24","Regional","United Arab Emirates; Emirate of Abu Dhabi; Abu Dhabi, Al Ain, Al Dhafra","2020-07-19","2020-08-14","Household and community samples","Multiple groups",8831.0,0.104,0.095,0.114,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Ahmed R Alsuwaidi","Abu Dhabi Public Health Center","https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207","Unverified","United Arab Emirates","Roche Diagnostics USA- Roche Elecsys® Anti-SARS-CoV-2 assay; Diasorin-LIAISON® SARS-CoV-2 S1/S2 IgG assay",0.974,0.985,"","AE","AE-AZ"
"2021-05-14","210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_LabourCamps_TestAdj.","Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study","2021-04-24","Regional","United Arab Emirates; Emirate of Abu Dhabi; Abu Dhabi, Al Ain, Al Dhafra","2020-07-19","2020-08-14","Essential non-healthcare workers","Multiple groups",4855.0,0.686,0.617,0.747,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Ahmed R Alsuwaidi","Abu Dhabi Public Health Center","https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207","Unverified","United Arab Emirates","Roche Diagnostics USA- Roche Elecsys® Anti-SARS-CoV-2 assay; Diasorin-LIAISON® SARS-CoV-2 S1/S2 IgG assay",0.974,0.985,"","AE","AE-AZ"
"2021-05-14","210429_Munich_GermanResearchCenterForEnvironmentalHealth_overall_popadj_testadj","From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)","2021-04-29","Local","Germany","2020-11-02","2021-01-31","Household and community samples","Multiple groups",4433.0,0.036,0.029,0.043,"Simplified probability","Not reported","Low","Preprint","Katja Radon","German Research Center for Environmental Health","https://www.medrxiv.org/content/10.1101/2021.04.27.21256133v1","Verified","Germany","Roche",0.992,0.987,"","DE",""
"2021-05-16","201215_Straubing_RobertKochInstitut_ELISA_poptestadj","Corona monitoring locally -;   Key data for Straubing","2020-12-15","Local","Germany; Bavaria; Straubing","2020-09-08","2020-09-26","Household and community samples","Multiple groups",2361.0,0.017,"","","Simplified probability","IgG","Moderate","News and Media","Robert Koch Institute","Robert Koch Institute","https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Straubing.html","Verified","Germany","Euroimmun",0.883,0.994,"","DE","DE-BY"
"2021-05-16","210324_Morioka_IwatePrefecturalCentralHospital_hcw","Seroprevalence of antibodies to SARS‐CoV‐2 in healthcare workers in a nonepidemic region, Japan: A hospital‐based study on May, 2020","2021-03-24","Local","Japan; Tonoku; Morioka","2020-05-18","2020-05-19","Health care workers and caregivers","Adults (18-64 years)",1404.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Akihiro Nakamura","Iwate Prefectural Central Hospital","https://onlinelibrary.wiley.com/doi/10.1002/jmv.26962","Verified","Japan","Abbott Laboratories, Abbott Park; Roche Diagnostics","","","","JP",""
"2021-05-17","200814_Pakistan_GetzPharma_Overall","Sero-prevalence findings from metropoles in Pakistan: implications for assessing COVID-19 prevalence and case-fatality within a dense, urban working population","2020-08-14","Regional","Pakistan; NR; Karachi, Lahore, Multan, Peshawar and Quetta","","2020-07-06","Household and community samples","Adults (18-64 years)",24210.0,0.175,"","","Simplified probability","IgG; IgM","Moderate","Preprint","Wajiha Javed","Getz Pharma","https://www.medrxiv.org/content/10.1101/2020.08.13.20173914v1","Verified","Pakistan","Getz Pharma (inferred)","","","","PK",""
"2021-05-17","201210_MatoGrosso_StateUniversityOfMatoGrosso","Unemat coordinates study on;   health conditions of MT population during pandemic","2020-12-20","Regional","Brazil; Mato Grosso; Água Boa, Alta Floresta, Barra do Garças, Cáceres, Cuiabá, Juína, Rondonópolis, Sinop, Tangará da Serra and Várzea Grande","2020-09-16","2020-10-15","Household and community samples","Multiple groups",4206.0,0.125,"","","Simplified probability","IgG","High","News and Media","Lygia Lima","State University of Mato Gross","http://www.mt.gov.br/-/16042707-unemat-coordena-estudo-sobre-condicoes-de-saude-da-populacao-de-mt-durante-pandemia","Unverified","Brazil","NR","","","","BR","BR-MT"
"2021-05-17","201221_London_PublicHealthEngland_overall_unadj","Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation.","2020-12-21","Local","United Kingdom of Great Britain and Northern Ireland","2020-05-05","2020-05-05","Multiple populations","Adults (18-64 years)",193.0,0.13,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Hannah Taylor","Public Health England","https://dx.doi.org/10.1016/j.lanepe.2020.100015","Verified","The United Kingdom","NA - in house","","","","GB",""
"2021-05-17","201225_Seattle_UniversityofWashington_GenPop_ELISA+Neutralizaion","SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing","2020-12-25","Local","United States of America; Washington; Seattle","2020-03-26","2020-04-15","Household and community samples","Multiple groups",100.0,0.04,"","","Simplified probability","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Jennifer Rathe","University of Washington","http://dx.doi.org/10.1093/infdis/jiaa797","Verified","United States of America","In-House (University of Washington) and Abbott","","","","US","US-WA"
"2021-05-17","210122_BuenosAires_GovernmentOfTheProvinceOfBuenosAires","ONLY 13 PERCENT OF THE;   NEIGHBOURS OF 30 PEOPLE'S NEIGHBOURHOODS OF THE AMBA HAD CORONAVIRUS","2021-01-22","Local","Argentina; Buenos Aires; Metropolitan Area of Buenos Aires","2020-07-15","2020-12-15","Household and community samples","Multiple groups",9000.0,0.13,"","","Unclear","Not reported","High","News and Media","Government of the Province of Buenos Aires","Government of the Province of Buenos Aires","https://www.gba.gob.ar/saludprovincia/noticias/s%C3%B3lo_el_13_por_ciento_de_los_vecinos_y_vecinas_de_30_barrios_populares_del","Unverified","Argentina","NR","","","","AR","AR-B"
"2021-05-17","210220_Dresden_DresdenUniversityOfTechnology_December","SARS-CoV-2 transmissions in students and teachers: Seroprevalence follow-up study in a German secondary school in November and December 2020","2021-03-24","Local","Germany; Saxony; Dresden","2020-12-10","2020-12-11","Students and Daycares","Multiple groups",237.0,0.068,0.038,0.101,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jakob Armann","Dresden University of Technology","http://dx.doi.org/10.1136/bmjpo-2021-001036","Unverified","Germany","DiaSorin; Abbott; Euroimmun","","","","DE","DE-SN"
"2021-05-17","210301_Uzbekistan_ResearchInstituteofVirology","FORMATION of HERD IMMUNITY to SARS-CoV-2 in the REGIONS of UZBEKISTAN","2021-03-01","National","Uzbekistan","2020-08-27","2020-09-11","Residual sera","Multiple groups",86879.0,0.231,0.23,0.232,"Convenience","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","R A Rakhimov","Research Institute of Virology","https://ejmcm.com/article_9453.html","Unverified","Uzbekistan","Wantai","","","","UZ",""
"2021-05-17","210310_Ankara_HacettepeUniversity_Overall","SARS-CoV-2;   Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data;   From A University Hospital in Turkey","2021-03-10","Local","Turkey; Central Anatolia; Ankara","2020-03-24","2020-09-10","Health care workers and caregivers","Adults (18-64 years)",774.0,0.074,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Adem Ozdemir","Hacettepe University","http://www.mikrobiyolbul.org/linkout.aspx?pmid=33882653","Verified","Turkey","Euroimmun","","","","TR",""
"2021-05-17","210317_Bavaria_LudwigMaximiliansUniversityMunich_Overall","[Pandemic management in a psychiatric care hospital : SARS-CoV-2 antibody tests as a tool for risk estimation].","2021-03-17","Local","Germany; Bavaria; Wasserburg","2020-05-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",1342.0,0.088,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","M Rentrop","Ludwig Maximilians University Munich","https://dx.doi.org/10.1007/s00115-021-01101-4","Verified","Germany","Roche GmbH",1.0,0.998,"","DE","DE-BY"
"2021-05-17","210317_Bolzano_HospitalofBolzano","Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.","2021-03-17","Local","Italy; Trentino-Alto Adige/Südtirol; Bolzano","2020-10-29","2020-12-28","Residual sera","Multiple groups",3033.0,0.345,"","","Sequential","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Thomas Mueller","Hospital of Bolzano","https://dx.doi.org/10.1016/j.cca.2021.03.007","Verified","Italy","Roche Diagnostics","","","","IT","IT-32"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase1East_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan; Karachi; District East","2020-04-15","2020-04-25","Household and community samples","Multiple groups",500.0,0.004,0.0,0.013,"Simplified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified","Pakistan","Roche Diagnostics",1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase1Malir_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan; Karachi; District Malir","2020-04-15","2020-04-25","Household and community samples","Multiple groups",500.0,0.002,0.0,0.007,"Simplified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified","Pakistan","Roche Diagnostics",1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase2East_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan; Karachi; District East","2020-06-25","2020-07-11","Household and community samples","Multiple groups",500.0,0.151,0.094,0.217,"Simplified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified","Pakistan","Roche Diagnostics",1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase2Malir_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan; Karachi; District Malir","2020-06-25","2020-07-11","Household and community samples","Multiple groups",504.0,0.087,0.051,0.131,"Simplified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified","Pakistan","Roche Diagnostics",1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase3East_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan; Karachi; District East","2020-08-17","2020-08-22","Household and community samples","Multiple groups",500.0,0.215,0.156,0.28,"Simplified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified","Pakistan","Roche Diagnostics",1.0,0.998,"","PK","PK-SD"
"2021-05-17","210321_Karachi_AgaKhanUniversity_Phase3Malir_PopAdj_TestAdj","Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan","2021-03-15","Local","Pakistan; Karachi; District Malir","2020-08-17","2020-08-22","Household and community samples","Multiple groups",501.0,0.128,0.083,0.177,"Simplified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Muhammed Imran Nisar","Aga Khan University","http://dx.doi.org/10.1016/j.ijid.2021.03.040","Verified","Pakistan","Roche Diagnostics",1.0,0.998,"","PK","PK-SD"
"2021-05-17","210331_Bergen_UniversityOfBergen_overall_unadj","Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study.","2021-03-31","Local","Norway","2020-02-28","2020-04-04","Contacts of COVID patients","Multiple groups",179.0,0.45,0.38,0.53,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Kanika Kuwelker","University of Bergen","https://dx.doi.org/10.1016/j.lanepe.2020.100014","Verified","Norway","N/A - in house","","","","NO",""
"2021-05-17","210404_Vienna_MedicalUniversityofVienna_Overall_2months","A longitudinal seroprevalence study evaluating infection control and prevention strategies at a large tertiary care center with low covid-19 incidence","2021-04-15","Local","Austria; Vienna; Vienna","2020-04-01","2020-06-01","Health care workers and caregivers","Adults (18-64 years)",553.0,0.015,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Lorenz Schubert","Medical University of Vienna","http://dx.doi.org/10.3390/ijerph18084201","Verified","Austria","Abott Architect i2000","","","","AT","AT-9"
"2021-05-17","210422_RioGrandeDoSul_SantaCasaDeMisericordiaDePortoAlegre_police","COVID-19 seroprevalence in military police force, Southern Brazil","2021-04-22","Regional","Brazil; Rio Grande do Sul State; Porto Alegre, Caxias do Sul, Canoas, Pelotas, Santa Maria, Passo Fundo, Uruguaiana, Santa Cruz do Sul, Ijui, and Lajeado","2020-07-23","2020-07-25","Essential non-healthcare workers","Adults (18-64 years)",1592.0,0.033,"","","Stratified probability","IgG; IgA","Moderate","Journal Article (Peer-Reviewed)","Alessandro Pasqualotto","Molecular Biology Laboratory at Santa Casa de Misericordia de Porto Alegre","https://dx.doi.org/10.1371/journal.pone.0249672","Verified","Brazil","EUROIMMUN®","","","","BR","BR-RS"
"2021-05-17","210424_SouthKorea_KoreaAssociationofHealthPromotion_Primary","Nationwide;   seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in;   South Korea: a cross-sectional study","2021-04-24","National","Republic of Korea; N/A; Seoul (Dongbu), Chuncheon, Chungju, Daegu (Dong-gu), Daegu (Buk-gu), Ulsan, Busan, Changwon, Kwangju, Jeonju, Daejeon, Suwon, Seoul (Kangnam), Incheon, Seoul (Seobu), Jeju","2020-09-24","2020-12-09","Residual sera","Multiple groups",4085.0,0.004,0.002,0.006,"Stratified probability","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Eun Hee Nah","Korea Association of Health Promotion","https://bmjopen.bmj.com/content/11/4/e049837.abstract","Unverified","Republic of Korea","Roche Elecsys, Mannheim, Germany",0.995,0.998,"","KR",""
"2021-05-17","210426_Portugal_DepartmentofEpidemiologyandInfectiousDiseasesoftheNationalInstitutesofHealth","The second national serological survey showed that 15.5% of the Portuguese population has antibodies against SARS-CoV-2","2021-04-26","National","Portugal","2021-02-02","2021-03-31","Household and community samples","Multiple groups",8463.0,0.155,"","","Convenience","IgG; IgM","Unclear","News and Media","Pedro Simas","Department of Epidemiology and Infectious Diseases of the National Institutes of Health (INSA)","https://newsline.news/the-second-national-serological-survey-showed-that-15-5-of-the-portuguese-population-has-antibodies-against-sars-cov-2/","Verified","Portugal","Unclear","","","","PT",""
"2021-05-17","210427_NewYorkCity_AlbertEinsteinCollegeofMedicine","COVID‐19 in heart transplant recipients—A seroprevalence survey","2021-04-27","Local","United States of America; New York state; New York City","2020-06-01","2020-08-01","Patients seeking care for non-COVID-19 reasons","Multiple groups",232.0,0.134,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Snehal R Patel","Albert Einstein College of Medicine","https://onlinelibrary.wiley.com/doi/10.1111/ctr.14329","Unverified","United States of America","NR","","","","US","US-NY"
"2021-05-17","210428_ChungbukProvince_ChungbukNationalUniversity_NonEpicenter_OverallAdj","Differences;   in seroprevalence between epicenter and non-epicenter areas of the COVID-19;   outbreak in South Korea","2021-04-28","Local","Republic of Korea; Chungbuk Province","2020-05-01","2020-07-17","Residual sera","Multiple groups",3981.0,0.009,0.007,0.011,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Hye Won Jeong","Chungbuk National University","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/","Verified","Republic of Korea","NR",0.995,1.0,"","KR","KR-43"
"2021-05-17","210428_DaeguCity_ChungbukNationalUniversity_Epicenter_OverallAdj","Differences;   in seroprevalence between epicenter and non-epicenter areas of the COVID-19;   outbreak in South Korea","2021-04-28","Local","Republic of Korea; North Gyeongsang Province; Daegu","2020-05-01","2020-07-17","Residual sera","Multiple groups",3268.0,0.013,0.01,0.015,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Hye Won Jeong","Chungbuk National University","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/","Verified","Republic of Korea","NR",0.995,1.0,"","KR","KR-47"
"2021-05-18","200808_Lima_NationalMaternalPerinatalInstitute_overall","SARS-COVID-19 antibodies in pregnant women at a level III hospital in Peru","2020-08-08","Local","Peru; Lima Province; Lima","2020-04-15","2020-05-15","Pregnant or parturient women","Adults (18-64 years)",2419.0,0.07,0.061,0.081,"Sequential","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Enrique Guevara Rios","National Maternal Perinatal; Institut","http://www.scielo.org.pe/scielo.php?pid=S2304-51322020000300002&script=sci_abstract&tlng=en","Verified","Peru","NR",0.976,0.988,"","PE","PE-LMA"
"2021-05-18","201007_Turin_UniversityofTurin_primary","Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients","2021-04-01","Local","Italy","2020-02-22","2020-05-21","Pregnant or parturient women","Adults (18-64 years)",225.0,0.093,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Stefano Cosma","University of Turin","http://dx.doi.org/10.1016/j.ajog.2020.10.005","Verified","Italy","Boditech, DiaSorin","","","","IT",""
"2021-05-18","201021_RepublicOfTartarstan_SaintPetersburgPasteurInstitute_overall","Distribution of SARS-CоV-2 seroprevalence among residents of the Republic of Tatarstan during the COVID-19 epidemic period","2020-10-21","Regional","Russian Federation; Republic of Tartarstan","2020-09-20","2020-09-27","Household and community samples","Multiple groups",2946.0,0.313,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Yu Popova","Saint Petersburg Pasteur Institute","https://microbiol.elpub.ru/jour/article/view/940?locale=en_US","Verified","Russian Federation","FBSI ""State National Research Center for Applied Microbiology; gii and biotechnology ""Rospotrebnadzor.","","","","RU","RU-TA"
"2021-05-18","210104_Louisville_UniversityOfLouisville","COVID-19 rates continue to;   increase, with highest rates among 18-34-year-olds","2021-01-04","Regional","United States of America; Kentucky; Louisville","2020-12-10","2020-12-14","Household and community samples","Multiple groups",700.0,0.112,"","","Simplified probability","Not reported","Unclear","News and Media","Betty Coffman","University of Louisville","https://www.uoflnews.com/post/uofltoday/covid-19-rates-continue-to-increase-with-highest-rates-among-18-34-year-olds/","Unverified","United States of America","NR","","","","US","US-KY"
"2021-05-18","210203_Ticino_UniversitàdellaSvizzeraitaliana_primary","Corona Immunitas Ticino: together to react - here are the results of the  second phase of serological tests","2021-02-03","Regional","Switzerland; Ticino","2020-11-01","2021-01-13","Household and community samples","Multiple groups",1463.0,0.16,"","","Simplified probability","Not reported","Unclear","News and Media","Institute of Public Health of the Universita della Svizzera italiana","Università della Svizzera italiana","https://www.biomed.usi.ch/it/feeds/9035","Verified","Italy","NR","","","","CH","CH-TI"
"2021-05-18","210217_Berlin-Mitte_RobertKochInstit_ELISA_testadj_popadj","Corona monitoring locally -;   Key data for Berlin-Mitte","2021-02-17","Local","Germany; Berlin; Berlin-Mitte","2020-11-17","2020-12-05","Household and community samples","Multiple groups",2287.0,0.044,"","","Simplified probability","IgG","Moderate","News and Media","Robert Koch Institut","Robert Koch Institut","https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Berlin-Mitte.html","Verified","Germany","Euroimmun","","","","DE","DE-BE"
"2021-05-18","210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_firstwave_primary","Main Differences Between the First and Second Waves of COVID-19 in Madrid, Spain.","2021-04-01","Local","Spain","2020-03-15","2020-06-30","Residual sera","Multiple groups",968.0,0.126,"","","Sequential","Not reported","Moderate","Journal Article (Peer-Reviewed)","Vicente Soriano","UNIR Health Sciences School and Medical Centre","https://dx.doi.org/10.1016/j.ijid.2021.02.115","Verified","Spain","N/A","","","","ES",""
"2021-05-18","210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_secondwave_primary","Main Differences Between the First and Second Waves of COVID-19 in Madrid, Spain.","2021-04-01","Local","Spain","2020-09-15","2020-12-24","Residual sera","Multiple groups",601.0,0.077,"","","Sequential","Not reported","Moderate","Journal Article (Peer-Reviewed)","Vicente Soriano","UNIR Health Sciences School and Medical Centre","https://dx.doi.org/10.1016/j.ijid.2021.02.115","Verified","Spain","N/A","","","","ES",""
"2021-05-18","210312_Venice_TheVenetoEyeBankFoundation","Corneal transplantation during the COVID-19 pandemic: An operational guide.","2021-03-27","Local","Italy; Veneto region; Venice","2020-03-15","2020-05-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",30.0,0.033,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Antonella Franch","The Veneto Eye Bank Foundation","https://dx.doi.org/10.1177/11206721211006565","Verified","Italy","Snibe","","","","IT","IT-34"
"2021-05-18","210315_NewMexico_DiaSorinInc_overall_unadj","Evaluation of the automated LIAISON SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies","2021-03-15","Regional","United States of America; New Mexico","2020-09-01","2020-09-30","Residual sera","Multiple groups",1931.0,0.02,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Fabrizio Bonelli","Dia Sorin Inc","http://dx.doi.org/10.1515/cclm-2021-0023","Verified","United States of America","1) DiaSorin; 2) Beckman","","","","US","US-NM"
"2021-05-18","210315_NewYork_DiaSorinInc_overall_unadj","Evaluation of the automated LIAISON SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies","2021-03-15","Regional","United States of America; New York","2020-09-01","2020-09-30","Residual sera","Multiple groups",1491.0,0.244,"","","Sequential","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Fabrizio Bonelli","Dia Sorin Inc","http://dx.doi.org/10.1515/cclm-2021-0023","Verified","United States of America","1) DiaSorin; 2) Siemens","","","","US","US-NY"
"2021-05-18","210317_SilesianVoivodeship_JanKochanowskiUniversity","Rapid serological tests for SARS-CoV-2 IgG/IgM - not worth attention?.","2021-03-17","Regional","Poland; Silesian Voivodeship","2020-05-15","2020-06-15","Non-essential workers and unemployed persons","Adults (18-64 years)",516.0,0.019,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Rafal Krygier","Jan Kochanowski University","https://dx.doi.org/10.13075/ijomeh.1896.01756","Verified","Poland","Vazyme","","","","PL","PL-24"
"2021-05-18","210326_Norway_ArcticUniversityOfNorway_PopAdj_TestAdj","Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period","2021-03-26","National","Norway","2020-11-25","2021-02-15","Household and community samples","Multiple groups",27700.0,0.009,0.007,0.01,"Stratified probability","IgG","Low","Preprint","Erik Anda","Arctic University of Norway","https://www.medrxiv.org/content/10.1101/2021.03.23.21253730v1","Verified","Norway","Euroimmun","","","","NO",""
"2021-05-18","210401_Colorado_AnschutzMedicalCampus_primary","Development and validation of a multiplex microsphere immunoassay using dried blood spots for SARS-CoV-2 seroprevalence: application in first responders in Colorado, USA.","2021-04-01","Local","United States of America; Colorado; Aurora","2020-07-01","2020-08-31","Essential non-healthcare workers","Adults (18-64 years)",264.0,0.042,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jonathan S Schultz","Anschutz Medical Campus","https://dx.doi.org/10.1128/JCM.00290-21","Verified","United States of America","N/A -Author designed","","","","US","US-CO"
"2021-05-18","210415_Belgium_UniversiteCatholiquedeLouvain_T4_overall","A longitudinal, 3-month serologic assessment of sars-cov-2 infections in a belgian hemodialysis facility","2021-04-15","Local","Belgium; Brussels; Brussels","2020-07-07","2020-07-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",96.0,0.083,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Laura Labriola","University Catholique de Louvain","http://dx.doi.org/10.2215/CJN.12490720","Verified","Belgium","Roche Diagnostics","","","","BE","BE-BRU"
"2021-05-18","210429_SanFrancisco_UniversityOfCaliforniaSanFrancisco_HIV1_TestAdj","SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study","2021-04-29","Local","United States of America; California; San Francisco","2020-08-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",955.0,0.037,0.024,0.05,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Matthew A Spinelli","University of California San Francisco","https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00072-2/fulltext","Unverified","United States of America","ET HealthCare",0.89,1.0,"","US","US-CA"
"2021-05-18","210502_SergipeState_FederalUniversityofSergipe","Seroprevalence;   of SARS-CoV-2 antibodies in broadcast media workers","2021-05-02","Regional","Brazil; Sergipe; N/A","2020-12-01","2020-12-20","Essential non-healthcare workers","Adults (18-64 years)",113.0,0.247,0.177,0.335,"Convenience","IgG; IgM","High","Preprint","Paulo Ricardo Martins Filho","Federal University of Sergipe, Aracaju","https://www.medrxiv.org/content/10.1101/2021.04.29.21256360v1","Unverified","Brazil","NR","","","","BR","BR-SE"
"2021-05-18","210506_EastJava_KobeUniversity","Seroepidemiological;   study of SARS-CoV-2 infection in East Java, Indonesia","2021-05-06","Regional","Indonesia; East Java; Surabaya, Jombang","2020-06-15","2020-12-15","Household and community samples","Multiple groups",1819.0,0.114,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Ni Luh Ayu Megasari","Kobe University","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0251234","Verified","Indonesia","Nanjing Vazyme Medical Technology",0.915,0.97,"","ID","ID-JI"
"2021-05-19","200801_Afghanistan_AfghanistanMinistryofPublicHealth","Prevalence of COVID-19 and its Related Deaths in Afghanistan: A Nationwide, Population-Based Seroepidemiological Study July 202","2020-08-01","National","Afghanistan; NR; NR","2020-06-01","2020-06-15","Household and community samples","Multiple groups",9514.0,0.315,"","","Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Sayed Ataullah Saeedzai","Afghanistan Ministry of Public Health","https://moph.gov.af/sites/default/files/2020-08/Final%20COVID-19%20Survey%20English%20Report.pdf","Verified","Afghanistan","NR","","","","AF",""
"2021-05-19","201228_Moscow_SaintPetersburgPasteurInstitute_primary","Collective immunity to SARS-COV-2 of moscow residents during the COVID-19 epidemic period","2021-04-06","Local","Russian Federation","2020-07-01","2020-07-30","Household and community samples","Multiple groups",2688.0,0.221,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Popova A Yu","Saint-Petersburg Pasteur Institute","http://dx.doi.org/10.20953/1729-9225-2020-4-8-16","Verified","Russian Federation","FBIS SRCAMB","","","","RU",""
"2021-05-19","210315_SanFranciscoBayArea_StanfordUniversity_overall_unadj","Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results.","2021-03-15","Local","United States of America; California","2020-08-03","2020-08-15","Residual sera","Multiple groups",1080.0,0.107,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Hannah Wang","Stanford University","https://dx.doi.org/10.1093/clinchem/hvab045","Verified","United States of America","1) Abbott; 2) EUROIMMUN","","","","US","US-CA"
"2021-05-19","210320_Ahmedabad_AMCMETMedicalCollege_Overall","Severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody: Seroprevalence among contacts of COVID-19 cases.","2021-03-20","Local","India; Gujarat; Ahmedabad","2020-08-17","2020-08-31","Contacts of COVID patients","Multiple groups",3973.0,0.319,0.305,0.334,"Stratified non-probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Om Prakash","AMC MET Medical College","https://pubmed.ncbi.nlm.nih.gov/33753682/","Verified","India","NR",0.924,0.979,"","IN","IN-GJ"
"2021-05-19","210330_NorthCarolina_UniversityOfNorthCarolina_Cohort1_PopTestAdj","Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period","2021-03-30","Regional","United States of America; North Carolina","2020-04-19","2020-06-13","Residual sera","Multiple groups",3463.0,0.029,0.017,0.043,"Convenience","IgG","Moderate","Preprint","Cesar Lopez","University of North Carolina","https://www.medrxiv.org/content/10.1101/2021.03.25.21254320v2","Verified","United States of America","Author designed",0.98,1.0,"","US","US-NC"
"2021-05-19","210330_NorthCarolina_UniversityOfNorthCarolina_Cohort2_PopTestAdj","Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period","2021-03-30","Regional","United States of America; North Carolina","2020-06-14","2020-08-08","Residual sera","Multiple groups",3528.0,0.088,0.071,0.106,"Convenience","IgG","Moderate","Preprint","Cesar Lopez","University of North Carolina","https://www.medrxiv.org/content/10.1101/2021.03.25.21254320v2","Verified","United States of America","Author designed",0.98,1.0,"","US","US-NC"
"2021-05-19","210330_NorthCarolina_UniversityOfNorthCarolina_Cohort3_PopTestAdj","Disparities in SARS-CoV-2 seroprevalence among individuals presenting for care in central North Carolina over a six-month period","2021-03-30","Regional","United States of America; North Carolina","2020-08-09","2020-10-03","Residual sera","Multiple groups",2633.0,0.091,0.072,0.111,"Convenience","IgG","Moderate","Preprint","Cesar Lopez","University of North Carolina","https://www.medrxiv.org/content/10.1101/2021.03.25.21254320v2","Verified","United States of America","Author designed",0.98,1.0,"","US","US-NC"
"2021-05-19","210401_Denmark_SlagelseSygehus_blooddonors_primary","Prevalence of SARS-CoV-2-Antibodies in Danish Children and Adults","2021-04-01","Regional","Denmark; Capital Region and Region Zealand","2020-06-22","2020-07-03","Blood donors","Adults (18-64 years)",750.0,0.02,0.011,0.033,"Simplified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Maren J H Rytter","Slagelse Sygehus","http://dx.doi.org/10.1097/INF.0000000000003048","Verified","Denmark","Zhuhai, Guangdon, China",0.93,0.98,"","DK","DK-84"
"2021-05-19","210401_Denmark_SlagelseSygehus_children_primary","Prevalence of SARS-CoV-2-Antibodies in Danish Children and Adults","2021-04-01","Regional","Denmark; Capital Region and Region Zealand","2020-06-22","2020-07-03","Residual sera","Children and Youth (0-17 years)",1033.0,0.016,0.01,0.026,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Maren J H Rytter","Slagelse Sygehus","http://dx.doi.org/10.1097/INF.0000000000003048","Verified","Denmark","Zhuhai, Guangdon, China",0.93,0.98,"","DK","DK-84"
"2021-05-19","210401_Srinagar_GovernmentMedicalCollegeSrinagar_Primary","Seroprevalence of SARS CoV 2 specific Ig G antibodies in District Srinagar, Kashmir: a population based study","2021-04-01","Local","India; Kashmir; Srinagar","2020-10-17","2020-10-20","Household and community samples","Multiple groups",2418.0,0.406,0.387,0.426,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Taha Ayub","Government Medical College Srinagar","https://www.ijcmph.com/index.php/ijcmph/article/view/7827","Verified","India","Abbott Laboratories",1.0,0.996,"","IN","IN-JK"
"2021-05-19","210402_Bavaria_GermanResearchCenterforEnvironmentalHealth_firstwave_primary","A Public Health Antibody Screening Indicates a Marked Increase of SARS-CoV-2 Exposure Rate in Children during the Second Wave.","2021-04-02","Regional","Germany; Bavaria","2020-01-15","2020-08-15","Household and community samples","Children and Youth (0-17 years)",15523.0,0.007,0.006,0.008,"Unclear","Not reported","High","Journal Article (Peer-Reviewed)","Markus Hippich","German Research Center for Environmental Health","https://dx.doi.org/10.1016/j.medj.2021.03.019","Verified","Germany","NR","","","","DE","DE-BY"
"2021-05-19","210402_Bavaria_GermanResearchCenterforEnvironmentalHealth_secondwave_primary","A Public Health Antibody Screening Indicates a Marked Increase of SARS-CoV-2 Exposure Rate in Children during the Second Wave.","2021-04-02","Regional","Germany; Bavaria","2020-09-15","2021-02-15","Household and community samples","Children and Youth (0-17 years)",11380.0,0.039,0.036,0.043,"Unclear","Not reported","High","Journal Article (Peer-Reviewed)","Markus Hippich","German Research Center for Environmental Health","https://dx.doi.org/10.1016/j.medj.2021.03.019","Verified","Germany","NR","","","","DE","DE-BY"
"2021-05-19","210403_Mainz_JohannesGutenbergUniversity_overall_unadj","Covid-19-importance for patients on the waiting list and after kidney transplantation-a single center evaluation in 2020-2021","2021-04-03","Local","Germany; Rhineland-Palatinate; Mainz","2020-01-01","2021-02-28","Patients seeking care for non-COVID-19 reasons","Multiple groups",248.0,0.052,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Simone C Boedecker","Johannes Gutenberg University","http://dx.doi.org/10.3390/pathogens10040429","Verified","Germany","Abbott","","","","DE","DE-RP"
"2021-05-19","210404_Tirschenreuth_ FriedrichAlexanderUniversity_primary","Estimates and determinants of SARS-CoV-2 seroprevalence and infection fatality ratio using latent class analysis: the population-based Tirschenreuth study in the hardest-hit German county in spring 2020","2021-04-04","Local","Germany; Bavaria","2020-06-28","2020-07-10","Household and community samples","Multiple groups",4201.0,0.086,"","","Simplified probability","IgG","Moderate","Preprint","Ralf Wagner","Friedrich-Alexander University","https://www.medrxiv.org/content/10.1101/2021.03.29.21254343v1","Verified","Germany","Shenzhen Yhlo Biotech Co , Roche Diagnostics","","","","DE","DE-BY"
"2021-05-19","210406_Lambayeque_UniversidadParticulardeChiclayo_PopTestAdj","SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020","2021-04-06","Regional","Peru; Lambayeque Province","2020-06-24","2020-07-10","Household and community samples","Multiple groups",2010.0,0.295,0.276,0.315,"Stratified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Cristian Diaz Velez","Universidad Particular de Chiclayo","https://dx.doi.org/10.7717/peerj.11210","Verified","Peru","Core Technology",0.66,0.97,"","PE","PE-LAM"
"2021-05-19","210408_Taiwan_NationalChengKungUniversityHospital_overall","A seroprevalence study of COVID-19 at a campus in southern Taiwan","2021-04-08","National","China; Taiwan","2020-08-15","2020-09-13","Residual sera","Adults (18-64 years)",969.0,0.0,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Ming Chi Li","National Cheng Kung University Hospital","https://dx.doi.org/10.1016/j.jmii.2021.03.018","Unverified","China","Roche Diagnostics Basel, Switzerland","","","","CN",""
"2021-05-19","210412_ValMesolcina_UniversitàdellaSvizzeraItaliana_HCW","SARS-CoV-2 Ig G among Healthcare Workers and the General Population.","2021-04-12","Local","Switzerland; Grisons; NR","2020-05-15","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",289.0,0.159,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gregorio Milani","Università della Svizzera Italiana","https://dx.doi.org/10.3390/pathogens10040465","Verified","Switzerland","Euroimmun","","","","CH","CH-GR"
"2021-05-19","210412_ValMesolcina_UniversitàdellaSvizzeraItaliana__Genpop","SARS-CoV-2 Ig G among Healthcare Workers and the General Population.","2021-04-12","Local","Switzerland; Grisons; NR","2020-05-15","2020-05-31","Household and community samples","Multiple groups",423.0,0.026,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gregorio Milani","Università della Svizzera Italiana","https://dx.doi.org/10.3390/pathogens10040465","Verified","Switzerland","Euroimmun","","","","CH","CH-GR"
"2021-05-19","210413_Melbourne_EasternHealth_OverallHCW","SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia.","2021-08-01","Local","Australia; Victoria; Melbourne","2020-11-09","2020-12-04","Health care workers and caregivers","Multiple groups",736.0,0.022,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Jillian SY Lau","Eastern Health","https://dx.doi.org/10.1016/j.idh.2021.03.004","Verified","Australia","Roche Diagnostics; NR","","","","AU","AU-VIC"
"2021-05-19","210413_NewOrleans_OchsnerClinicFoundation_HospitalStaff","The Surgeon’s Risk of SARS-CoV-2 Infection During the Initial Peak of the COVID-19 Pandemic in New Orleans","2021-04-13","Local","United States of America; Louisiana; New Orleans","2020-04-22","2020-05-01","Health care workers and caregivers","Adults (18-64 years)",13343.0,0.08,0.075,0.085,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Tung Vu","Ochsner Clinic Foundation","https://journals.sagepub.com/doi/10.1177/00031348211011090","Unverified","United States of America","Abbott","","","","US","US-LA"
"2021-05-19","210413_NewOrleans_OchsnerClinicFoundation_Surgeons","The Surgeon’s Risk of SARS-CoV-2 Infection During the Initial Peak of the COVID-19 Pandemic in New Orleans","2021-04-13","Local","United States of America; Louisiana; New Orleans","2020-03-01","2020-04-22","Health care workers and caregivers","Adults (18-64 years)",105.0,0.019,0.002,0.067,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Tung Vu","Ochsner Clinic Foundation","https://journals.sagepub.com/doi/10.1177/00031348211011090","Unverified","United States of America","Abbott","","","","US","US-LA"
"2021-05-19","210413_Tabriz_TabrizUniversityOfMedicalSciences_overall_unadj_IgG_anti-S","Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation.","2021-04-13","Local","Iran (Islamic Republic of)","2020-04-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",609.0,0.061,"","","Unclear","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mohammad Sadegh Soltani Zangbar","Tabriz University of Medical Sciences","https://dx.doi.org/10.1016/j.genrep.2021.101140","Verified","Iran (Islamic Republic of)","N/A - institution designed",0.938,0.98,"","IR",""
"2021-05-19","210415_Mexico_InstitutodeSaludparaelBienestar_Overall","SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020.","2021-04-15","National","Mexico; NR; NR","2020-02-10","2020-12-31","Residual sera","Multiple groups",24273.0,0.159,"","","Stratified non-probability","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Jose Munoz-Medina","Instituto de Salud para el Bienestar","https://dx.doi.org/10.3390/microorganisms9040850","Verified","Mexico","DiaSorin; Genscript","","","","MX",""
"2021-05-19","210419_Lublin_MedicalUniversityofLublin_HealthyControls","Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study.","2021-04-19","Local","Poland; Lublin Voivodeship; Lublin","2020-06-01","2020-09-30","Household and community samples","Children and Youth (0-17 years)",32.0,0.063,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Violetta Opoka Winiarska","Medical University of Lublin","https://dx.doi.org/10.3390/jcm10081771","Verified","Poland","Euroimmun","",0.919,"","PL","PL-06"
"2021-05-19","210419_Lublin_MedicalUniversityofLublin_JIA","Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study.","2021-04-19","Local","Poland; Lublin Voivodeship; Lublin","2020-06-01","2020-09-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",62.0,0.048,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Violetta Opoka Winiarska","Medical University of Lublin","https://dx.doi.org/10.3390/jcm10081771","Verified","Poland","Euroimmun","",0.919,"","PL","PL-06"
"2021-05-19","210419_Philadelphia_UniversityofPennsylvania","Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity","2021-04-19","Local","United States of America; Pennsylvania; ; Philadelphia","2020-04-13","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",2043.0,0.02,"","","Convenience","IgG; IgM","Moderate","Preprint","Sigrid Gouma","University of Pennsylvania","https://www.medrxiv.org/content/10.1101/2021.04.12.21255324v1.full-text","Unverified","United States of America","In-House (University of Pennsylvania)","","","","US","US-PA"
"2021-05-19","210419_Sergipe_UniversidadeFederalDeSergipe_Stage1_overall_unadj","Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Resultados da Terceira Fase: 18 de fevereiro a 30 de março de 2021.","2021-04-19","Regional","Brazil; Sergipe","2020-07-01","2020-07-31","Household and community samples","Multiple groups",5615.0,0.093,0.085,0.101,"Stratified probability","IgG; IgM","Moderate","Institutional Report","Adriano Araujo","The Federal Univeristy of Sergipe","https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021","Unverified","Brazil","1) Kovalent; 2) iChroma II, BioSys + Kovalent","","","","BR","BR-SE"
"2021-05-19","210419_Sergipe_UniversidadeFederalDeSergipe_Stage2_overall_unadj copy","Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Resultados da Terceira Fase: 18 de fevereiro a 30 de março de 2021.","2021-04-19","Regional","Brazil; Sergipe","2020-08-11","2020-11-17","Household and community samples","Multiple groups",5405.0,0.079,0.068,0.091,"Stratified probability","IgG; IgM","Moderate","Institutional Report","Adriano Araujo","The Federal Univeristy of Sergipe","https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021","Unverified","Brazil","1) Kovalent; 2) iChroma II, BioSys + Kovalent","","","","BR","BR-SE"
"2021-05-19","210419_Sergipe_UniversidadeFederalDeSergipe_Stage3_overall_unadj copy","Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Resultados da Terceira Fase: 18 de fevereiro a 30 de março de 2021.","2021-04-19","Regional","Brazil; Sergipe","2021-02-18","2021-03-30","Household and community samples","Multiple groups",5527.0,0.154,0.145,0.164,"Stratified probability","IgG; IgM","Moderate","Institutional Report","Adriano Araujo","The Federal Univeristy of Sergipe","https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021","Unverified","Brazil","1) Kovalent; 2) iChroma II, BioSys + Kovalent","","","","BR","BR-SE"
"2021-05-19","210419_Wuhan_ChineseAcademyofSciences","Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.","2021-04-19","Local","China; Hubei; Wuhan","2020-05-30","2020-06-12","Essential non-healthcare workers","Adults (18-64 years)",508.0,0.059,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Yong Yang","Chinese Academy of Sciences","https://dx.doi.org/10.1080/22221751.2021.1919032","Verified","China","In-House (Chinese Academy of Sciences)","","","","CN","CN-42"
"2021-05-19","210420_Libreville_CentreHospitalierUniversitaire(CHU)‐Mère‐Enfant_overall_unadj","Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!.","2021-04-20","Local","Gabon","2020-07-15","2020-10-15","Residual sera","Multiple groups",1495.0,0.362,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Amandine Mveang Nzoghe","Centre Hospitalier Universitaire (CHU) ‐ Mère‐ Enfant","https://dx.doi.org/10.1186/s13104-021-05570-3","Verified","Gabon","1) Roche; 2) Biomerieux","","","","GA",""
"2021-05-19","210421_Pakistan_MemorialCancerHospitalandResearchCenter_overall","Seroprevalence of SARS-CoV-2 Antibodies Among Health Care Personnel at a Health Care System in Pakistan","2021-04-21","Local","Pakistan; Punjab; Lahore","2020-07-29","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",2162.0,0.396,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Salma Abbas","Shaukat Khanum Memorial Cancer Hospital and Research Centre","https://dx.doi.org/10.1177/10105395211011010","Verified","Pakistan","Roche Diagnostics International Ltd","","","","PK","PK-PB"
"2021-05-19","210422_Orlando_JohnsHopkinsUniversity","SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason.","2021-04-22","Local","United States of America; Florida; Orlando","2020-06-11","2020-10-19","Non-essential workers and unemployed persons","Adults (18-64 years)",3648.0,0.009,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Christina Mack","Johns Hopkins University School of Medicine","https://dx.doi.org/10.1001/jamainternmed.2021.2114","Verified","United States of America","Siemens; Abbott Laboratories; Ortho-Clinical Diagnostics; Roche Diagnostics","","","","US","US-FL"
"2021-05-19","210423_Connecticut_YaleUniversity","Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel","2021-04-23","Regional","United States of America; Connecticut","2020-04-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",995.0,0.103,"","","Self-referral","IgG","High","Preprint","Joseph Zell","Yale University","https://www.medrxiv.org/content/10.1101/2021.04.21.21255881v1","Verified","United States of America","NR","","","","US","US-CT"
"2021-05-19","210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Kalulushi1_HCW","Comparable;   exposure to SARS-CoV-2 in young children and healthcare workers in Zambia","2021-05-06","Local","Zambia; Copperbelt Province ; Kalulushi","2020-08-01","2020-08-30","Health care workers and caregivers","Adults (18-64 years)",237.0,0.08,"","","Convenience","IgG","High","Preprint","Natasha Makabilo Laban","Centre for Infectious Disease Research in Zambia","https://wellcomeopenresearch.org/articles/6-97/v1","Verified","Zambia","N/A- author designed","","","","ZM","ZM-08"
"2021-05-19","210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Lusaka2_Infants","Comparable;   exposure to SARS-CoV-2 in young children and healthcare workers in Zambia","2021-05-06","Local","Zambia; Lusaka Province; Lusaka","2020-08-15","2020-12-15","Household and community samples","Children and Youth (0-17 years)",150.0,0.06,"","","Convenience","IgG","High","Preprint","Natasha Makabilo Laban","Centre for Infectious Disease Research in Zambia","https://wellcomeopenresearch.org/articles/6-97/v1","Verified","Zambia","N/A- author designed","","","","ZM","ZM-09"
"2021-05-19","210519_Rochester_MayoClinic_primary","Providing safe care for patients in the coronavirus disease 2019 (COVID-19) era: A case series evaluating risk for hospital-associated COVID-19.","2021-04-05","Local","United States of America; Minesota; Rochester","2020-05-15","2020-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",1339.0,0.019,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Elizabeth B Habermann","Mayo Clinic","https://dx.doi.org/10.1017/ice.2021.38","Verified","United States of America","EUROIMMUN, Ortho-Clinical Diagnostics, Roche diagnostics","","","","US","US-MN"
"2021-05-20","200515_Regensburg_UniversityOfRegensburg","Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.","2020-05-15","Local","Germany; Bavaria; Regensburg","2020-03-01","2020-03-31","Health care workers and caregivers","Adults (18-64 years)",201.0,0.204,"","","Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Susanne Brandstetter","University of Regensburg","https://onlinelibrary.wiley.com/doi/abs/10.1111/pai.13278?af=R","Unverified","Germany","EUROIMMUN AG","","","","DE","DE-BY"
"2021-05-20","200821_Campinas_CampinasMunicipalHealthDepartment","Campinas City Hall presents;   second Covid-19 Serological Survey","2020-08-21","Local","Brazil; Sao Paulo; Campinas","2020-08-03","2020-08-15","Household and community samples","Multiple groups",1876.0,0.037,"","","Simplified probability","Not reported","High","News and Media","Campinas City Hall","Campinas Municipal Health Department","https://covid-19.campinas.sp.gov.br/prefeitura-de-campinas-apresenta-segundo-inqu-rito-sorol-gico-da-covid-19","Verified","Brazil","NR","","","","BR","BR-SP"
"2021-05-20","200930_Karachi_NationalInstituteOfBloodDiseasesAndBoneMarrowTransplantation","is karachi knocking at herd immunity? a possible reason for decline in sars-cov-2 infections","2020-09-30","Local","Pakistan; Sindh; Kararchi","2020-08-30","2020-09-12","Household and community samples","Adults (18-64 years)",2404.0,0.55,"","","Convenience","IgG; IgM; IgA","High","Preprint","Faiza Rezwan","National Institute of Blood Diseases and Bone Marrow Transplantation","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3700931","Unverified","Pakistan","Roche diagnostics International Ltd","","","","PK","PK-SD"
"2021-05-20","200930_Kerala_GovernmentOfKerala_August","ICMR Sero Surveillance 2nd Round-Kerala","2020-09-30","Regional","India; Kerala; Ernakulam, Palakkad, Thrissur","2020-08-24","2020-08-26","Household and community samples","Multiple groups",1281.0,0.008,"","","Unclear","Not reported","Unclear","Institutional Report","Government of Kerala","Indian Medical Research Council","https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf","Verified","India","Not reported","","","","IN","IN-KL"
"2021-05-20","200930_Kerala_GovernmentOfKerala_May","ICMR Sero Surveillance 2nd Round-Kerala","2020-09-30","Regional","India; Kerala; Ernakulam, Palakkad, Thrissur","2020-05-18","2020-05-23","Household and community samples","Multiple groups",1193.0,0.003,"","","Unclear","Not reported","Unclear","Institutional Report","Government of Kerala","Indian Medical Research Council","https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf","Verified","India","Not reported","","","","IN","IN-KL"
"2021-05-20","201110_Maranhao_UniversidadeFederaldoMaranhao_Phase2_OverallPopAdj","Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, Brasil Relatório Final de Pesquisa Fase II","2020-11-10","Regional","Brazil; Maranhão","2020-10-19","2020-10-30","Household and community samples","Multiple groups",4563.0,0.381,0.348,0.414,"Stratified probability","Total Antibody","Moderate","Institutional Report","Antonio da Silva","Universidade Federal do Maranhao","https://www.saude.ma.gov.br/wp-content/uploads/2020/11/Inquerito-Sorologico-Maranhao-Fase-2.pdf","Verified","Brazil","Roche","","","","BR","BR-MA"
"2021-05-20","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Household and community samples","Multiple groups",9756.0,0.014,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","Mozambique","Qingdao Hightop Biotech","","","","MZ","MZ-B"
"2021-05-20","201202_Utah_UniversityofUtah_Phase1BCache_TestAdj","Utah HERO Project Tracking Covid-19 to Inform Decision-Makers Summary of Key Findings, Current Trends, and Implications","2020-12-02","Local","United States of America; Utah; NR","2020-05-01","2020-07-01","Household and community samples","Multiple groups",1622.0,0.023,0.007,0.057,"Simplified probability","Not reported","Moderate","Institutional Report","University of Utah","University of Utah","https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front","Unverified","United States of America","NR",0.83,0.996,"","US","US-UT"
"2021-05-20","201202_Utah_UniversityofUtah_Phase1BWashington_TestAdj","Utah HERO Project Tracking Covid-19 to Inform Decision-Makers Summary of Key Findings, Current Trends, and Implications","2020-12-02","Local","United States of America; Utah; NR","2020-05-01","2020-07-01","Household and community samples","Multiple groups",1594.0,0.005,0.0,0.016,"Simplified probability","Not reported","Moderate","Institutional Report","University of Utah","University of Utah","https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front","Unverified","United States of America","NR",0.83,0.996,"","US","US-UT"
"2021-05-20","201202_Utah_UniversityofUtah_Phase1BWeber_TestAdj","Utah HERO Project Tracking Covid-19 to Inform Decision-Makers Summary of Key Findings, Current Trends, and Implications","2020-12-02","Local","United States of America; Utah; NR","2020-05-01","2020-07-01","Household and community samples","Multiple groups",1211.0,0.014,0.003,0.037,"Simplified probability","Not reported","Moderate","Institutional Report","University of Utah","University of Utah","https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front","Unverified","United States of America","NR",0.83,0.996,"","US","US-UT"
"2021-05-20","201202_Utah_UniversityofUtah_Phase2Prelim_TestAdj","Utah HERO Project Tracking Covid-19 to Inform Decision-Makers Summary of Key Findings, Current Trends, and Implications","2020-12-02","Local","United States of America; Utah; NR","2020-07-07","2020-08-15","Household and community samples","Multiple groups",1622.0,0.028,0.01,0.064,"Simplified probability","Not reported","Moderate","Institutional Report","University of Utah","University of Utah","https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front","Unverified","United States of America","NR",0.83,0.996,"","US","US-UT"
"2021-05-20","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Overall","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Household and community samples","Multiple groups",1360.0,0.025,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","Mozambique","Qingdao Hightop biotech","","","","MZ","MZ-P"
"2021-05-20","210101_Montpellier_UniversityHospitalMontpellier_HCW","Increased risks of SARS-CoV-2 nosocomial acquisition in highrisk COVID-19 units justify personal protective equipment: a cross-sectional study","2020-10-30","Local","France","2020-04-21","2020-06-03","Health care workers and caregivers","Adults (18-64 years)",647.0,0.02,0.009,0.031,"Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Marie Bistoquet","University Hospital Montpellier","https://www.journalofhospitalinfection.com/article/S0195-6701(20)30505-3/fulltext","Verified","France","ID.Vet","","","","FR",""
"2021-05-20","210111_SanFrancisco_UniversityofCalifornia_EDproviders","Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers","2021-01-11","Local","United States of America; California; San Francisco","2020-09-01","2020-10-15","Health care workers and caregivers","Adults (18-64 years)",139.0,0.029,0.008,0.072,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ralph Wang","University of California","https://dx.doi.org/10.1016/j.annemergmed.2021.01.010","Verified","United States of America","Abbott Laboratories; Diasorin Inc","","","","US","US-CA"
"2021-05-20","210305_Stockholm_Västerås_primary","No findings of SARS-CoV-2 in conjunctival swabs from patients at an emergency outpatient ophthalmological healthcare facility in a Swedish county hospital: a cross-sectional study","2021-03-05","Local","Sweden","2020-06-04","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",70.0,0.043,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Elisabet Granstam","Västerås","https://bmjophth.bmj.com/content/6/1/e000616","Verified","Sweden","Abbott",1.0,0.996,"","SE",""
"2021-05-20","210309_Texas_UTSouthwesternMedicalCenter_Dallas_overall_unadj","DFW COVID-19 Prevlance Study Update for Dallas & Tarrant Counties – March 2021","2021-03-09","Local","United States of America","2020-08-15","2021-02-15","Household and community samples","Multiple groups",11580.0,0.072,"","","Self-referral","Not reported","High","Institutional Report","UT Southwestern Medical Center","UT Southwestern Medical Center","https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf","Verified","United States of America","NR","","","","US",""
"2021-05-20","210309_Texas_UTSouthwesternMedicalCenter_Employees_overall_unadj","DFW COVID-19 Prevlance Study Update for Dallas & Tarrant Counties – March 2021","2021-03-09","Local","United States of America","2020-08-15","2021-02-15","Essential non-healthcare workers","Multiple groups",4098.0,0.052,"","","Self-referral","Not reported","High","Institutional Report","UT Southwestern Medical Center","UT Southwestern Medical Center","https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf","Verified","United States of America","NR","","","","US",""
"2021-05-20","210309_Texas_UTSouthwesternMedicalCenter_Tarrant_overall_unadj","DFW COVID-19 Prevlance Study Update for Dallas & Tarrant Counties – March 2021","2021-03-09","Local","United States of America","2020-08-15","2021-02-15","Household and community samples","Multiple groups",5697.0,0.085,"","","Self-referral","Not reported","High","Institutional Report","UT Southwestern Medical Center","UT Southwestern Medical Center","https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf","Verified","United States of America","NR","","","","US",""
"2021-05-20","210407_Slovenia_UniversityofLjubljana_FirstRound_GenPop_ElecsysTestAdj","Seroprevalence of SARS-CoV-2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned","2021-04-07","National","Slovenia","2020-04-20","2020-05-01","Household and community samples","Multiple groups",1316.0,0.009,0.004,0.014,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Mario Poljak","University of Ljubljana","https://dx.doi.org/10.1016/j.cmi.2021.03.009","Verified","Slovenia","Roche Diagnostics","","","","SI",""
"2021-05-20","210415_Croatia_ChildrensHospitalZagreb_timepoint1_primary","Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia","2021-04-15","Local","Croatia","2020-05-13","2020-05-29","Residual sera","Children and Youth (0-17 years)",240.0,0.029,"","","Convenience","IgA; IgM; IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Jasna Lenicek Krleza","Children's Hospital Zagreb","https://dx.doi.org/10.11613/BM.2021.020706","Verified","Croatia","Vircell, Granada, Spain","","","","HR",""
"2021-05-20","210415_Croatia_ChildrensHospitalZagreb_timepoint2_primary","Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia","2021-04-15","Local","Croatia","2020-10-24","2020-11-23","Residual sera","Children and Youth (0-17 years)",308.0,0.084,"","","Convenience","IgG; IgM; Neutralizing","High","Journal Article (Peer-Reviewed)","Jasna Lenicek Krleza","Children's Hospital Zagreb","https://dx.doi.org/10.11613/BM.2021.020706","Verified","Croatia","Roche Cobas Elecysis","","","","HR",""
"2021-05-20","210419_Milwakee_UniversityOfWisconsin","Seroprevalence of SARS-CoV-2 Antibody in Echocardiography and Stress Laboratory","2021-04-19","Local","United States of America; Wisconsin; Milwaukee","2020-06-15","2020-07-03","Health care workers and caregivers","Adults (18-64 years)",43.0,0.07,0.02,0.2,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Renuka Jain","University of Wisconsin","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060043/","Verified","United States of America","Abbott","",0.992,"","US","US-WI"
"2021-05-20","210419_NewZealand_UniversityOfAuckland_BloodDonors","Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand","2021-04-19","National","New Zealand","2020-12-03","2021-01-06","Blood donors","Adults (18-64 years)",9806.0,0.001,0.001,0.001,"Sequential","IgG","Moderate","Preprint","Lauren Carlton","University of Auckland","https://www.medrxiv.org/content/10.1101/2021.04.12.21255282v1","Verified","New Zealand","Euroimmun; GenScript; NA - Author Designed",0.817,1.0,"","NZ",""
"2021-05-20","210419_Turin_AziendaOspedalieraOrdineMauriziano_Primary","Risk factors of SARS‐CoV‐2 seroprevalence among hospital employees in Italy: a single‐centre study","2021-04-19","Local","Italy; Piedmont; Turin","2020-05-08","2020-05-15","Health care workers and caregivers","Multiple groups",1562.0,0.098,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Marco Daperno","Azienda Ospedaliera Ordine Mauriziano","https://onlinelibrary.wiley.com/doi/10.1111/imj.15201","Verified","Italy","DiaSorin",0.841,0.937,"","IT","IT-21"
"2021-05-20","210420_Foggia_UniversityOfFoggia","Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy","2021-04-20","Local","Italy; Apulia; Foggia","2020-03-15","2020-06-15","Blood donors","Adults (18-64 years)",1797.0,0.01,"","","Sequential","Total Antibody; IgG","High","Journal Article (Peer-Reviewed)","Mariantonietta Di Stefano","University of Foggia","https://www.karger.com/Article/Abstract/515258","Verified","Italy","Ortho Clinical Diagnostics","","","","IT","IT-75"
"2021-05-20","210420_Singapore_NationalUniversityOfSingapore_Community_TestAdj","Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population","2021-04-20","National","Singapore","2020-11-15","2020-12-15","Household and community samples","Multiple groups",937.0,0.002,0.0,0.007,"Convenience","Neutralizing","High","Preprint","Hannah E Clapham","National University of Singapore","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3826194","Verified","Singapore","GenScript",0.803,0.993,"","SG",""
"2021-05-20","210420_Singapore_NationalUniversityOfSingapore_MigrantWorkers_TestAdj","Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population","2021-04-20","Local","Singapore","2020-05-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",478.0,0.638,0.579,0.703,"Simplified probability","Neutralizing","High","Preprint","Hannah E Clapham","National University of Singapore","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3826194","Verified","Singapore","GenScript",0.803,0.993,"","SG",""
"2021-05-20","210421_Israel_MinistryofHealth_genpop_primary","Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel","2021-04-21","National","Israel","2020-06-28","2020-09-14","Household and community samples","Multiple groups",54357.0,0.046,0.044,0.048,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Shay Reicher","Ministry of Health","https://dx.doi.org/10.1007/s10654-021-00749-1","Verified","Israel","Abbott and DiaSorin","","","","IL",""
"2021-05-20","210421_Lima_HarvardMedicalSchool_BusDepot2","Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru.","2021-04-21","Local","Peru; Lima Province; Lima","2020-06-05","2020-07-18","Essential non-healthcare workers","Adults (18-64 years)",477.0,0.363,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Marco Tovar","Harvard Medical School","https://dx.doi.org/10.1093/cid/ciab323","Unverified","Peru","SD Biosensor, Suwon, Korea",0.9,0.99,"","PE","PE-LMA"
"2021-05-20","210421_Lima_HarvardMedicalSchool_Market1","Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru.","2021-04-21","Local","Peru; Lima Province; Lima","2020-06-05","2020-07-18","Essential non-healthcare workers","Adults (18-64 years)",1285.0,0.45,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Marco Tovar","Harvard Medical School","https://dx.doi.org/10.1093/cid/ciab323","Unverified","Peru","SD Biosensor, Suwon, Korea",0.9,0.99,"","PE","PE-LMA"
"2021-05-20","210421_London_DMGDental-MaterialGesellschaftmbH_overall_unadj","COVID-19 testing in a UK dental practice - results of a pilot study.","2021-04-21","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",14.0,0.214,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Linda Greenwall","DMG Dental-Material Gesellschaft mbH","https://dx.doi.org/10.1038/s41415-021-2849-7","Verified","The United Kingdom","SureScreen Diagnostics","","","","GB","GB-ENG"
"2021-05-20","210422_Brandenburg_MedicalSchoolTheodorFontane_followup_primary","Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study.","2021-04-22","Regional","Germany; Brandenburg; Brandenburg/Havel, Neuruppin","2020-05-31","2020-06-06","Health care workers and caregivers","Adults (18-64 years)",811.0,0.022,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mark Reinwald","Brandenburg Medical School Theodor Fontane","https://dx.doi.org/10.3390/healthcare9050498","Verified","Germany","Medizinische Labordiagnostika",0.95,0.962,"","DE","DE-BB"
"2021-05-20","210423_Blackpool_NHSFoundationTrust_primaryAbbott","EXPRESS: Comparison of four high throughput, automated immunoassays for the detection of SARS-CoV-2 antibodies.","2021-04-23","Local","United Kingdom of Great Britain and Northern Ireland","2020-08-01","2020-08-31","Residual sera","Multiple groups",225.0,0.053,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jane Oakey","NHS Foundation Trust","https://dx.doi.org/10.1177/00045632211015711","Verified","The United Kingdom","Abbott Diagnostics",1.0,"","","GB",""
"2021-05-20","210423_Monterrey_UniversidadAutónomaDeNuevoLeón","Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients.","2021-04-23","Local","Mexico; Nuevo Leon; Monterrey","2020-05-22","2020-05-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",154.0,0.117,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Giovanna Yazmin Arteaga Muller","Universidad Autónoma de Nuevo León","https://dx.doi.org/10.1007/s11255-021-02852-4","Unverified","Mexico","Healgen",0.901,0.985,"","MX","MX-NLE"
"2021-05-20","210425_Essen_UniversityHospitalEssen","SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study.","2021-04-25","Local","Germany; North Rhine-Westphalia; Essen","2020-10-01","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",315.0,0.051,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Johannes Korth","University Hospital Essen","https://dx.doi.org/10.3390/ijerph18094540","Verified","Germany","Euroimmun",0.944,0.996,"","DE","DE-NW"
"2021-05-21","200617_Norbotten_UmeaUniversity_overall","The seroprevalence of covid-19 antibodies in Norrbotten County, Sweden","2020-06-17","Regional","Sweden; Norbotten; Piteå, Luleå/Boden, Gällivare, Kalix, Kiruna","2020-05-25","2020-06-05","Household and community samples","Multiple groups",425.0,0.019,0.008,0.037,"Simplified probability","IgG","Moderate","Institutional Report","Mats Eliasson","Umea University","https://web.archive.org/web/20200623000020/https://www.norrbotten.se/publika/lg/kom/Corona/Rapport%20-%20förekomst%20av%20antikroppar/Förekomst%20av%20antikroppar%20mot%20covid-19%20i%20Norrbottens%20befolkning%20maj%202020%20-%20Region%20Norrbotten%20rapport%20200618.pdf","Verified","Sweden","1)Abbott; 2)Euroimmun","","","","SE","SE-BD"
"2021-05-21","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Household and community samples","Multiple groups",1769.0,0.05,0.04,0.06,"Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified","Mozambique","STANDARD Q","","","","MZ","MZ-N"
"2021-05-21","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","2020-08-03","2020-08-21","Household and community samples","Multiple groups",4717.0,0.038,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","Mozambique","Abbott","","","","MZ",""
"2021-05-21","200901_Loreto_HospitalRegionaldeLoreto_primary","Seroprevalence of COVID-19 in workers in a hospital in the Peruvian Amazon","2020-09-01","Local","Peru","2020-05-19","2020-06-06","Health care workers and caregivers","Adults (18-64 years)",1147.0,0.583,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ricci Alonso Chafloque Vasquez","Hospital Regional de Loreto","https://amp.cmp.org.pe/index.php/AMP/article/view/1050","Verified","Peru","NR","","","","PE",""
"2021-05-21","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Household and community samples","Multiple groups",1946.0,0.007,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-T"
"2021-05-21","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Household and community samples","Multiple groups",5069.0,0.025,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-Q"
"2021-05-21","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Household and community samples","Multiple groups",4940.0,0.052,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-S"
"2021-05-21","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Household and community samples","Multiple groups",1635.0,0.003,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-A"
"2021-05-21","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Household and community samples","Multiple groups",5394.0,0.036,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-MPM"
"2021-05-21","201123_PuertoRico_PuertoRicoPublicHealthTrust_Primary","Resultados Primera Fase Proyecto CASPER - Primer Estudio de Seroprevalencia de COVID-19 en Puerto Rico","2020-11-23","National","Puerto Rico","2020-11-20","2020-11-23","Household and community samples","Multiple groups",1816.0,0.028,"","","Stratified probability","IgM; IgG","High","Institutional Report","Puerto Rico Public Health Trust","Puerto Rico Public Health Trust","https://sites.google.com/view/casperpr/análisis-y-resultados?authuser=0","Verified","Puerto Rico","NR","","","","PR",""
"2021-05-21","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Household and community samples","Multiple groups",2451.0,0.053,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-05-21","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Household and community samples","Multiple groups",4932.0,0.037,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-05-21","201211_Austria_StatistikAustria_overall_PopAdj","COVID-19 Prävalenz und Seroprävalenz","2020-12-11","National","Austria","2020-11-12","2020-11-14","Household and community samples","Multiple groups",2229.0,0.047,0.038,0.056,"Simplified probability","Not reported","Moderate","Institutional Report","Statistik Austria","StatistikAustria","http://www.statistik.at/wcm/idc/idcplg?IdcService=GET_PDF_FILE&dDocName=124957","Unverified","Austria","NR","","","","AT",""
"2021-05-21","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Household and community samples","Multiple groups",3974.0,0.055,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-05-21","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Genpop_Primary","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Household and community samples","Multiple groups",1577.0,0.074,"","","Stratified probability","IgG; IgM","Moderate","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-05-21","201221_Lombardy_ATSMilan_cohabitants","SARS-CoV-2 pandemia in Lombardy: the impact on family Paediatricians","2020-12-21","Regional","Italy; Lombardy","2020-04-01","2020-04-30","Family of essential workers","Adults (18-64 years)",755.0,0.244,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Rinaldo Missaglia","University of Milano-Bicocca","https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0","Verified","Italy","ACRO BIOTECH, Inc",0.96,0.792,"","IT","IT-25"
"2021-05-21","201221_Lombardy_ATSMilan_peds","SARS-CoV-2 pandemia in Lombardy: the impact on family Paediatricians","2020-12-21","Regional","Italy; Lombardy","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",377.0,0.149,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Rinaldo Missaglia","University of Milano-Bicocca","https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0","Verified","Italy","ACRO BIOTECH, Inc",0.96,0.792,"","IT","IT-25"
"2021-05-21","201221_Lombardy_ATSMilan_staff","SARS-CoV-2 pandemia in Lombardy: the impact on family Paediatricians","2020-12-21","Regional","Italy; Lombardy","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",108.0,0.157,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Rinaldo Missaglia","University of Milano-Bicocca","https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0","Verified","Italy","ACRO BIOTECH, Inc",0.96,0.792,"","IT","IT-25"
"2021-05-21","201230_ArgentinaHurlingham_UniversidadNacionalHurlingham","Se presentaron los resultados del estudio de seroprevalencia de COVID-19 que realizó la Universidad en el Municipio de Hurlingham","2020-12-30","Local","Argentina; Buenos Aires; Buenos Aires","2020-12-01","2020-12-30","Household and community samples","Multiple groups",1182.0,0.121,0.1,0.142,"Stratified probability","IgG","High","Institutional Report","Universidad Nacional De Hurlingham","Universidad Nacional De Hurlingham","http://www.unahur.edu.ar/es/se-presentaron-los-resultados-del-estudio-de-seroprevalencia-de-covid-19-que-realizo-la-universidad","Verified","Argentina","Molecular Virology Laboratory of the Leloir Institute Foundation","","","","AR","AR-B"
"2021-05-21","210112_PlacerCounty_StanfordUniversity","CA-FACTS Seroprevalence for SARS- CoV-2 in Placer County","2021-01-12","Local","United States of America; California","2020-11-01","2020-11-30","Household and community samples","Multiple groups",810.0,0.023,"","","Simplified probability","Not reported","High","Institutional Report","Julie Parsonnet","Stanford University","https://www.placer.ca.gov/DocumentCenter/View/49523/2021-011221-PowerPoint-Item-02A","Verified","United States of America","Not reported","","","","US","US-CA"
"2021-05-21","210113_SaoPaulo_CidadeDeSaoPaolo_2021_Phase1_overall","Novo inquérito sorológico 2021 - fase 1","2021-01-13","Local","Brazil; Sao Paulo; Sao Paulo","2021-01-05","2021-01-07","Household and community samples","Multiple groups",1960.0,0.141,0.117,0.168,"Simplified probability","IgG; IgM","Moderate","Institutional Report","City of Sao Paulo","Cidade de São Paulo","http://www.capital.sp.gov.br/arquivos/pdf/2021/coletiva_saude_14-01.pdf","Verified","","Wondfo",0.979,"","","BR","BR-SP"
"2021-05-21","210121_Abuja_MolecularPathologyInstituteEnugu","Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria","2021-01-21","Local","Nigeria; NR; Abuja, Enugu","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",113.0,0.42,0.34,0.52,"Convenience","IgG","High","Preprint","Ijeoma Ifeorah","Molecular Pathology Institute","https://www.researchsquare.com/article/rs-151037/v1","Unverified","Nigeria","NOVA TECH Germany",1.0,1.0,"","NG",""
"2021-05-21","210204_SaoPaulo_CityOfSaoPaulo_2021_Phase2","inquérito sorológico adultos (>18) para sars-cov-2 evolução da prevalência da infecção no msp 2021 - resultado da fase 2 de 2021","2021-02-04","Local","Brazil; Sao Paulo; Sao Paulo","2021-01-07","2021-01-21","Household and community samples","Multiple groups",1841.0,0.139,0.117,0.164,"Simplified probability","IgG; IgM","High","Institutional Report","City of Sao Paulo","City of Sao Paulo","http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-02_2021.pdf/view","Verified","Brazil","Wondfo",0.979,"","","BR","BR-SP"
"2021-05-21","210321_Jamshedpur_TataMainHospital_OverallHCW","Serosurveillance of Health Care Workers in a COVID Hospital: Immune Response, and Its Longevity","2021-03-21","Local","India; Jharkhand; Jamshedpur","2020-10-07","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",2110.0,0.438,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Minakshi Mishra","Tata Main Hospital","https://pubmed.ncbi.nlm.nih.gov/33898113/","Verified","India","Beckman Coulter Inc.",1.0,0.986,"","IN","IN-JH"
"2021-05-21","210323_Tabriz_TabrizUniversityofMedicalSciences","Prevalence of SARS-CoV-2 Specific Antibodies in Asymptomatic Hemodialysis Patients.","2021-03-23","Local","Iran (Islamic Republic of); East Azerbaijan Province; Tabriz","2020-06-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",288.0,0.101,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jalal Etemadi","Tabriz University of Medical Sciences","https://dx.doi.org/10.1080/08820139.2021.1899202","Verified","Iran (Islamic Republic of)","In-House (assembled from Florian Krammer et al.)",0.93,0.98,"","IR","IR-01"
"2021-05-21","210415_KentCounty_UniversityofMichigan_S1","Health Care Acquired COVID-19 is Less Symptomatic than Community Acquired Disease Among Healthcare Workers.","2021-04-15","Local","United States of America; Michigan; NR","2020-08-17","2020-09-04","Health care workers and caregivers","Adults (18-64 years)",1385.0,0.019,0.012,0.026,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jeffrey Fletcher","University of Michigan","https://dx.doi.org/10.1017/ice.2021.167","Verified","United States of America","Siemens; bioMerieux","","","","US","US-MI"
"2021-05-21","210415_KentCounty_UniversityofMichigan_S2","Health Care Acquired COVID-19 is Less Symptomatic than Community Acquired Disease Among Healthcare Workers.","2021-04-15","Local","United States of America; Michigan; NR","2020-12-02","2020-12-23","Health care workers and caregivers","Adults (18-64 years)",1445.0,0.137,0.119,0.155,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jeffrey Fletcher","University of Michigan","https://dx.doi.org/10.1017/ice.2021.167","Verified","United States of America","Siemens; bioMerieux","","","","US","US-MI"
"2021-05-21","210420_Bytom1_UniversityofOpole","SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study.","2021-04-20","Local","Poland; Silesian; Bytom","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",90.0,0.1,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Rafal Jakub Buldak","University of Opole","https://dx.doi.org/10.3390/ijerph18084376","Unverified","Poland","Euroimmun Medizinische Labordiagnostik [Anti-SARS-CoV-2 ELISA (IgG)","",0.99,"","PL","PL-24"
"2021-05-21","210420_MiasteczkoSlaskie2_UniversityofOpole","SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study.","2021-04-20","Local","Poland; Silesian; Miasteczko Slaskie","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",25.0,0.04,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Rafal Jakub Buldak","University of Opole","https://dx.doi.org/10.3390/ijerph18084376","Unverified","Poland","Euroimmun Medizinische Labordiagnostik [Anti-SARS-CoV-2 ELISA (IgG)","",0.99,"","PL","PL-24"
"2021-05-21","210420_Opole3_UniversityofOpole","SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study.","2021-04-20","Local","Poland; Opole; Opole","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",84.0,0.012,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Rafal Jakub Buldak","University of Opole","https://dx.doi.org/10.3390/ijerph18084376","Unverified","Poland","Euroimmun Medizinische Labordiagnostik [Anti-SARS-CoV-2 ELISA (IgG)","",0.99,"","PL","PL-16"
"2021-05-21","210425_Florence_UniversityofFlorence_BloodDonors","SARS-CoV-2 was already circulating in Italy, in early December 2019","2021-04-25","Local","Italy; Tuscany; Florence","2020-01-22","2020-03-09","Blood donors","Multiple groups",56.0,0.036,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Laura Gragnani","University of Florence","https://dx.doi.org/10.26355/eurrev_202104_25746","Verified","Italy","CHIL; MP Biomedicals","","","","IT","IT-52"
"2021-05-21","210425_Florence_UniversityofFlorence_HP","SARS-CoV-2 was already circulating in Italy, in early December 2019","2021-04-25","Local","Italy; Tuscany; Florence","2019-11-04","2020-03-09","Patients seeking care for non-COVID-19 reasons","Multiple groups",234.0,0.043,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Laura Gragnani","University of Florence","https://dx.doi.org/10.26355/eurrev_202104_25746","Verified","Italy","CHIL; MP Biomedicals","","","","IT","IT-52"
"2021-05-21","210427_Cuenca_UniversityOfAntwerp_overall_UnAdj","Seroprevalence of SARS-CoV-2 Infection and Adherence to Preventive Measures in Cuenca, Ecuador, October 2020, a Cross-Sectional Study","2021-04-27","Local","Ecuador; Azuay","2020-08-11","2020-11-01","Household and community samples","Multiple groups",2457.0,0.132,"","","Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","David Acurio Paez","University of Antwerp","https://www.mdpi.com/1660-4601/18/9/4657","Verified","Ecuador","SD BIOSNSOR",0.879,0.943,"","EC","EC-A"
"2021-05-21","210428_Austria_HanuschHospital","Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe.","2021-04-28","National","Austria","2020-07-01","2020-07-31","Non-essential workers and unemployed persons","Adults (18-64 years)",7858.0,0.011,0.009,0.014,"Convenience","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Johann Bartko","Hanusch Hospital","https://dx.doi.org/10.3390/jcm10091909","Verified","Austria","Abbott Rapid Diagnostics; In-House (Hanusch Hospital)","","","","AT",""
"2021-05-21","210429_Johannesburg_NationalHealthLaboratoryService_PopTestAdj_Primary","Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020","2021-04-29","Local","South Africa; Gauteng; Johannesburg","2020-08-01","2020-10-31","Residual sera","Multiple groups",4393.0,0.273,0.238,0.299,"Simplified probability","IgM; IgG","Moderate","Preprint","Jaya George","National Health Laboratory Service","https://www.medrxiv.org/content/10.1101/2021.04.27.21256099v1","Verified","South Africa","Roche Diagnostics","","","","ZA","ZA-GT"
"2021-05-21","210429_Phoenix_VincereCancerCenter_December_IgG_Unadj","COVID-19 Trends in the Phoenix Metropolitan Area from a Mobile Testing Program: Last Quarter of 2020.","2021-04-29","Regional","United States of America; Arizona; Phoenix Metropolitan Area","2020-12-05","2020-12-11","Household and community samples","Multiple groups",3038.0,0.165,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Christine Lau","Vincere Cancer Center,","https://dx.doi.org/10.1007/s10900-021-00991-4","Verified","United States of America","Assure",1.0,0.988,"","US","US-AZ"
"2021-05-21","210429_Phoenix_VincereCancerCenter_November_IgG_Unadj","COVID-19 Trends in the Phoenix Metropolitan Area from a Mobile Testing Program: Last Quarter of 2020.","2021-04-29","Regional","United States of America; Arizona; Phoenix Metropolitan Area","2020-11-07","2020-11-13","Household and community samples","Multiple groups",2037.0,0.166,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Christine Lau","Vincere Cancer Center,","https://dx.doi.org/10.1007/s10900-021-00991-4","Verified","United States of America","Assure",1.0,0.988,"","US","US-AZ"
"2021-05-21","210429_Phoenix_VincereCancerCenter_October_IgG_Unadj","COVID-19 Trends in the Phoenix Metropolitan Area from a Mobile Testing Program: Last Quarter of 2020.","2021-04-29","Regional","United States of America; Arizona; Phoenix Metropolitan Area","2020-10-10","2020-10-16","Household and community samples","Multiple groups",1635.0,0.087,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Christine Lau","Vincere Cancer Center,","https://dx.doi.org/10.1007/s10900-021-00991-4","Verified","United States of America","Assure",1.0,0.988,"","US","US-AZ"
"2021-05-21","210501_CastillaYLeon_CentroDeHemoterapiaYHemodonación","Sustained;   seroprevalence of anti SARS-CoV-2 total immunoglobulins in asymptomatic blood;   donors","2021-05-01","National","Spain; Castilla y Leon","2019-07-15","2020-10-15","Blood donors","Multiple groups",9886.0,0.067,"","","Simplified probability","Total Antibody","Moderate","Preprint","Carmen Martin","Centro de Hemoterapia y Hemodonación de Castilla y León","https://www.medrxiv.org/content/10.1101/2021.04.28.21256242v1","Verified","Spain","Elecsys®","","","","ES","ES-CL"
"2021-05-22","201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_firstfase_primary","Avaliação da prevalência de marcadores virológicos e sorológicos da infecção pelo SARS-CoV-2 na população de Pitangueiras-SP: inquérito epidemiológico populacional","2020-12-11","Local","Brazil","2020-08-24","2020-08-29","Household and community samples","Multiple groups",150.0,0.017,0.005,0.029,"Stratified probability","IgG; IgM","Moderate","Institutional Report","Ana Celeste Crotti Peixoto","Prefeitura Municipal de Pitangueiras","https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf","Unverified","Brazil","NR","","","","BR",""
"2021-05-22","201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_secondfase_primary","Avaliação da prevalência de marcadores virológicos e sorológicos da infecção pelo SARS-CoV-2 na população de Pitangueiras-SP: inquérito epidemiológico populacional","2020-12-11","Local","Brazil","2020-09-24","2020-09-29","Household and community samples","Multiple groups",125.0,0.08,"","","Stratified probability","IgG; IgM","Moderate","Institutional Report","Ana Celeste Crotti Peixoto","Prefeitura Municipal de Pitangueiras","https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf","Unverified","Brazil","NR","","","","BR",""
"2021-05-22","210212_Netherlands_NationalInstituteforPublicHealthandtheEnvironment","Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands","2021-02-12","National","Netherlands","2020-06-09","2020-08-24","Household and community samples","Multiple groups",6813.0,0.045,0.038,0.052,"Stratified probability","IgG","Low","Preprint","Eric Vos","National Institute for Public Health and the Environment","https://www.medrxiv.org/content/10.1101/2021.02.10.21251477v1.full-text","Verified","Netherlands","NR",0.943,0.999,"","NL",""
"2021-05-22","210215_Chile_UniversityOfChile_HCW","SARS-CoV-2 Antibody Prevalence Among 85,529 Healthcare Workers Following the First Wave of COVID-19 in Chile","2021-02-15","National","Chile","2020-09-11","2020-10-24","Health care workers and caregivers","Multiple groups",85528.0,0.072,"","","Entire sample","IgG; IgM","Low","Preprint","Marcela Zuniga","Universidad de Chile","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3785998","Verified","Chile","Zhukai Livzon Diagnostic Inc. China",0.958,1.0,"","CL",""
"2021-05-22","210301_Madrid_HospitalUniversitarioLaPaz_primary","Low rate of SARS-CoV-2 infection in picu workers caring for COVID-19 adults and children","2021-03-01","Local","Spain","2020-03-15","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",105.0,0.057,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","G Santos Simarro","Hospital Universitario La Paz","http://dx.doi.org/10.1097/01.pcc.0000741352.50491.98","Verified","Spain","nr","","","","ES",""
"2021-05-22","210312_SouthAfrica_NationalHealthLaboratoryService_overall_Unadj","COVID-19 SEROPREVALENCE DURING THE SECOND WAVE OF THE PANDEMIC IN THREE DISTRICTS OF SOUTH AFRICA - PRELIMINARY FINDINGS","2021-03-12","National","South Africa; Western Cape Province, KwaZulu-Natal Province, North West Province; Mitchell’s Plain, Pietermaritzburg, and Klerksdorp","2020-11-23","2021-01-31","Household and community samples","Multiple groups",927.0,0.358,"","","Simplified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sue Aitken","National Health Laboratory Service","https://www.nicd.ac.za/wp-content/uploads/2021/03/COVID-19-Special-Public-Health-Surveillance-Bulletin-9-12-March-2021_.pdf","Verified","South Africa","Beijing Wantai Biological Pharmacy Enterprise",0.967,0.975,"","ZA",""
"2021-05-22","210324_India_UniversityofToronto_genpop_overall_unadj","SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020","2021-03-24","National","India; Maharashtra, West Bengal, Tamil Nadu, Karnataka, Gujarat, Rajasthan, Bihar, Andhra Pradesh; Mumbia, Delhi, Kolkata, Chennai, Bangalore, Ahmedabad, Pune, Surat, Jaipur, Nagpur, Coimbatore, Visakhapatnam","2020-06-12","2020-12-31","Household and community samples","Multiple groups",448518.0,0.31,"","","Self-referral","IgG; Total Antibody","Moderate","Preprint","Arokiaswamy Velumani","University of Toronto","10.1101/2021.03.19.21253429","Verified","India","Abbott; Roche","","","","IN",""
"2021-05-22","210324_UniversiteCatholiquedeLouvain_Piedmont_workers","Diagnostic value of igm and igg detection in covid-19 diagnosis by the mobile laboratory b-life: A massive testing strategy in the piedmont region","2021-03-24","Regional","Italy; PIedmont","2020-06-20","2020-07-23","Multiple populations","Multiple groups",6033.0,0.048,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Omar Nyabi","Université Catholique de Louvain","http://dx.doi.org/10.3390/ijerph18073372","Verified","Italy","ZenTech","","","","IT","IT-21"
"2021-05-22","210404_Nepal_GovernmentOfNepal_overall_PopAdj","ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION","2021-04-04","National","Nepal","2020-10-09","2020-10-22","Household and community samples","Multiple groups",3040.0,0.144,0.118,0.17,"Stratified probability","Total Antibody","Low","Institutional Report","Government of Nepal","Government of Nepal","https://mohp.gov.np/attachments/article/708/First%20Sero-prevalence_final_report_04-04-2021.pdf","Verified","Nepal","Beijing Wantai Biological Pharmacy",0.967,0.975,"","NP",""
"2021-05-22","210408_London_St.Thomas’NHSFoundationTrust_Primary","IgG SARS-CoV-2 antibodies persist at least for 10 months in patients on hemodialysis.","2021-04-08","Local","United Kingdom of Great Britain and Northern Ireland","2020-07-01","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",681.0,0.186,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Caroline Dudreuilh","St. Thomas’ NHS Foundation Trust","https://dx.doi.org/10.1016/j.ekir.2021.03.900","Verified","The United Kingdom","DiaSorin, Saluggia, Italy",0.974,"","","GB",""
"2021-05-22","210409_Bonn_UniversityOfBonn_RhinelandStudy1_overall_Unadj_ELISA","Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany","2021-04-09","Local","Germany; North Rhine-Westphalia; Bonn","2020-04-24","2020-06-30","Household and community samples","Multiple groups",4755.0,0.01,0.007,0.013,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","N Ahmad Aziz","University of Bonn","https://dx.doi.org/10.1038/s41467-021-22351-5","Verified","Germany","EUROIMMUN",0.944,0.996,"","DE","DE-NW"
"2021-05-22","210409_Bonn_UniversityOfBonn_Voluntary2_overall_Unadj_ELISA","Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany","2021-04-09","Local","Germany; North Rhine-Westphalia; Bonn","2020-04-24","2020-06-30","Household and community samples","Multiple groups",360.0,0.019,0.008,0.044,"Self-referral","IgG","High","Journal Article (Peer-Reviewed)","N Ahmad Aziz","University of Bonn","https://dx.doi.org/10.1038/s41467-021-22351-5","Verified","Germany","EUROIMMUN",0.944,0.996,"","DE","DE-NW"
"2021-05-22","210409_England_PublicHealthEngland","SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).","2021-04-09","National","United Kingdom of Great Britain and Northern Ireland","2020-06-18","2020-12-31","Health care workers and caregivers","Multiple groups",25661.0,0.294,"","","Convenience","Not reported","Unclear","Journal Article (Peer-Reviewed)","Victoria Jane Hall","Public Health England","https://dx.doi.org/10.1016/S0140-6736(21)00675-9","Verified","The United Kingdom","NR","","","","GB",""
"2021-05-22","210409_NewYorkCity_NYCdepthealth_overall","Seroprevalence of SARS-CoV-2 following the largest initial epidemic wave in the United States: Findings from New York City, May 13-July 21, 2020","2021-04-09","Local","United States of America; New York; New York","2020-05-13","2020-07-21","Household and community samples","Multiple groups",45367.0,0.236,0.232,0.24,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Preeti Pathela","New York City Department of Health and Mental Hygiene","https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab200/6219118","Verified","United States of America","DiaSorin",0.976,0.993,"","US","US-NY"
"2021-05-22","210412_NewYork_CityUniversityofNewYork_Primary","The emergence, surge and subsequent wave of the SARS-CoV-2 pandemic in New York metropolitan area: The view from a major region-wide urgent care provider","2021-04-12","Regional","United States of America; New York ; New York City; Bronx; Brooklyn; Long Island; Manhatten; Metro North; Queens; Staten Island","2020-03-08","2021-01-01","Household and community samples","Multiple groups",693205.0,0.216,0.215,0.217,"Sequential","IgG","High","Preprint","Madhura S Rane","City University of New York","https://www.medrxiv.org/content/10.1101/2021.04.06.21255009v3","Verified","United States of America","NR","","","","US","US-NY"
"2021-05-22","210412_TelAviv_TelAvivUniversity","Prevalence of COVID-19 and Seroprevalence to SARS-CoV-2 in a Rheumatologic Patients Population from a Tertiary Referral Clinic in Israel.","2021-04-12","Local","Israel","2020-05-01","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",242.0,0.021,"","","Sequential","IgG; IgA","High","Journal Article (Peer-Reviewed)","Tali Eviatar","Tel Aviv University","https://dx.doi.org/10.1111/imj.15202","Verified","Israel","EUROIMMUN (Medizinische Labordiagnostika AG)",1.0,0.985,"","IL",""
"2021-05-22","210415_Campania_UniversityofNapoli","Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence.","2021-04-15","Regional","Italy; Campania","2020-05-11","2020-05-18","Household and community samples","Multiple groups",388.0,0.018,0.007,0.029,"Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Valeria Caturano","University of Napoli","https://dx.doi.org/10.1186/s12879-021-06054-2","Verified","Italy","NovaTec GmbH, Germany",0.949,0.962,"","IT","IT-72"
"2021-05-22","210415_MadridZaragoza_GeneralUniversityHospital_pregnant","Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing","2021-04-15","Local","Spain; NA & Zaragoza; Madrid & Zaragoza","2020-03-31","2020-09-30","Pregnant or parturient women","Adults (18-64 years)",1211.0,0.05,"","","Unclear","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Ricardo Saviron Cornudella","University of Zaragoza","http://dx.doi.org/10.1016/j.lfs.2021.119200","Verified","Spain","Author developed","","","","ES","ES-AR"
"2021-05-22","210416_Itabaianinha_FederalUniversityofSergipe_ControlCohort2","Individuals with isolated congenital GH deficiency due to a GHRH receptor gene mutation appear to cope better with SARS-CoV-2 infection than controls.","2021-04-16","Local","Brazil; Sergipe; Itabaianinha","2020-10-01","2020-10-03","Patients seeking care for non-COVID-19 reasons","Multiple groups",27.0,0.185,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Manuela A Melo","Federal University of Sergipe, Aracaju","https://dx.doi.org/10.1007/s12020-021-02728-8","Unverified","Brazil","Boditech Med Inc., South Korea",0.958,0.97,"","BR","BR-SE"
"2021-05-22","210416_Itabaianinha_FederalUniversityofSergipe_IGHDCohort1","Individuals with isolated congenital GH deficiency due to a GHRH receptor gene mutation appear to cope better with SARS-CoV-2 infection than controls.","2021-04-16","Local","Brazil; Sergipe; Itabaianinha","2020-10-01","2020-10-03","Household and community samples","Multiple groups",27.0,0.037,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Manuela A Melo","Federal University of Sergipe, Aracaju","https://dx.doi.org/10.1007/s12020-021-02728-8","Unverified","Brazil","Boditech Med Inc., South Korea",0.958,0.97,"","BR","BR-SE"
"2021-05-22","210416_Safed_ZivMedicalCentre_overall_unadj","SARS-CoV-2 Immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021: Implications for vaccination policy","2021-04-16","Local","Israel","2020-12-15","2021-03-15","Health care workers and caregivers","Adults (18-64 years)",725.0,0.034,"","","Convenience","IgG","High","Preprint","Kamal Abu Jabal","Ziv Medical Centre","10.1101/2021.04.11.21255273","Verified","Israel","1) Abbott; 2) DiaSorin","","","","IL",""
"2021-05-22","210416_Tokyo_JuntendoUniversity_HCW_Overall_testadj","SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo","2021-04-16","Local","Japan; Kantō; Tokyo","2020-07-06","2020-08-21","Health care workers and caregivers","Multiple groups",4147.0,0.004,0.002,0.006,"Convenience","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Hiroshi Fukuda","Juntendo Univesity","https://dx.doi.org/10.1038/s41598-021-87688-9","Verified","Japan","Roche Diagnostics",1.0,0.998,"","JP",""
"2021-05-22","210421_Wuhan_WuhanUniversity_overall","SARS-CoV-2;   Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020","2021-04-21","Local","China; Hubei; Wuhan","2020-04-23","2020-05-24","Household and community samples","Multiple groups",35326.0,0.038,0.036,0.04,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Huan Han","Wuhan University","https://pubmed.ncbi.nlm.nih.gov/33883260/","Verified","China","Vazyme, Nanjing China; YHLO Biotech,; Shenzhen, China","","","","CN","CN-42"
"2021-05-22","210425_Bucaramanga_FundaciónCardiovascularDeColombia_overall_popadj_testadj","Seroprevalence of sars-cov-2 infection among occupational groups from the bucaramanga metropolitan area, Colombia","2021-04-15","Local","Colombia","2020-09-28","2020-12-24","Essential non-healthcare workers","Adults (18-64 years)",7045.0,0.195,0.186,0.204,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Claudia Colmenares-Mejia","Fundación Cardiovascular de Colombia","http://dx.doi.org/10.3390/ijerph18084172","Verified","Colombia","Abbot",0.852,0.973,"","CO",""
"2021-05-22","210429_Germany_BoehringerIngelheim_primary","Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical company","2021-04-29","National","Germany","2020-04-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",121.0,0.016,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Petra C Moroni Zentgraf","Boehringer Ingelheim","https://dx.doi.org/10.1080/03007995.2021.1914943","Verified","Germany","Euroimmun AG, L€ubeck, Germany",0.55,1.0,"","DE",""
"2021-05-22","210429_Mali_UniversityofSciences_Visit2_Overall_adj","Rapidly;   increasing SARS-CoV-2 seroprevalence and limited clinical disease in three;   Malian communities: a prospective cohort study","2021-04-29","Local","Mali","2020-12-14","2021-01-29","Household and community samples","Multiple groups",2353.0,0.547,0.444,0.65,"Convenience","IgG","Moderate","Preprint","Issaka Sagara","University of Sciences","https://www.medrxiv.org/content/10.1101/2021.04.26.21256016v1","Verified","Mali","MRTC/DEAP Immunology Laboratory",0.739,0.994,"","ML",""
"2021-05-22","210429_SouthernItaly_UniversityofCampania","Seroprevalence;   of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy","2021-04-29","Regional","Italy; Southern Italy; Caserta, Naples","2020-09-21","2020-12-31","Multiple populations","Multiple groups",2394.0,0.058,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Francesco Napolitano","University of Campania","https://www.mdpi.com/1660-4601/18/9/4761","Unverified","Italy","Ortho-Clinical; Diagnostics, Abbott Diagnostics, DiaSorin","","","","IT",""
"2021-05-22","210501_Ahmedabad_MunicipalMedicalCollege_Genpop_primary","Reassessing the population based Seroprevalence for IgG antibodies against SARS COV2 in Ahmedabad","2021-05-01","Local","India","2020-10-15","2020-10-31","Household and community samples","Multiple groups",17009.0,0.242,0.236,0.249,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Om Prakash","Municipal Medical College","https://www.nepjol.info/index.php/AJMS/article/view/35099","Verified","India","Zydus Diagnostics",0.924,0.979,"","IN",""
"2021-05-22","210501_SãoPaulo_Ipec_overall_Unadj","SoroEpi MSP – Inquéritos soroepidemiológicos seriados para monitorar a prevalência da  infecção por SARS-CoV-2 no Município de São Paulo, SP, Brasil: Fase 6","2021-05-01","Local","Brazil; São Paulo; São Paulo","2021-04-22","2021-05-01","Household and community samples","Multiple groups",1187.0,0.416,"","","Stratified probability","IgG; IgM","Moderate","Institutional Report","Beatriz Tess","Inteligência em Pesquisa e Consultoria","https://www.monitoramentocovid19.org/resultados","Verified","Brazil","1) Abbott; 2) Roche","","","","BR","BR-SP"
"2021-05-22","210507_Salamanca_UniversityofSalamanca","Seroprevalence;   of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the;   University of Salamanca: The DIANCUSAL Study","2021-05-07","Local","Spain; Province of Salamanca; Salamanca","2020-07-15","2020-10-15","Non-essential workers and unemployed persons","Multiple groups",8197.0,0.082,"","","Convenience","IgG; IgM","High","Preprint","Vicente Santiago Belen","University of Salamanca","https://www.researchsquare.com/article/rs-489321/v1","Unverified","Spain","Diasorin","","","","ES","ES-CL"
"2021-05-22","210602_Dublin_UniversityCollegeDublin_overall_Unadj","EXPRESS: Performance characteristics of five SARS-CoV-2 serological assays: clinical utility in healthcare workers.","2021-06-02","Local","Ireland; Leinster; Dublin","2020-06-15","2020-09-15","Multiple populations","Adults (18-64 years)",109.0,0.009,"","","Unclear","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Emma Heffernan","University College Dublin","https://dx.doi.org/10.1177/00045632211012728","Verified","Ireland","1) Roche; 2) Euroimmun; 3) Euroimmun; 4) Fortress Diagnostics; 5) DIAsource","","","","IE","IE-L"
"2021-05-23","201226_Scotland_UniversityofGlasgow_overall_unaj","Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting","2020-12-26","Local","United Kingdom of Great Britain and Northern Ireland; Scotland; Greater Glasgow area","2020-03-16","2020-05-24","Residual sera","Multiple groups",6635.0,0.078,0.072,0.085,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Ellen C Hughes","University of Glasgow","http://dx.doi.org/10.1093/infdis/jiaa788","Verified","The United Kingdom","N/A - in house",0.953,0.972,"","GB","GB-SCT"
"2021-05-23","210223_Osaka_KyotoUniversity_RLA_Overall","Radioligand Assay-Based Detection of Antibodies against; SARS-CoV-2 in Hospital Workers Treating Patients with Severe COVID-19 in Japan","2021-02-23","Local","Japan; Honshu; Osaka","2020-07-08","2020-07-22","Health care workers and caregivers","Adults (18-64 years)",1000.0,0.004,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Hidenori Matsunaga","Kyoto University","https://www.mdpi.com/1999-4915/13/2/347","Verified","Japan","N/A - In-House","","","","JP",""
"2021-05-23","210316_UK_OfficeForNationalStatistics_England_overall","Coronavirus (COVID-19) antibody and vaccination data for the UK_Feb4-March3","2021-03-30","Regional","United Kingdom of Great Britain and Northern Ireland; England","2021-02-04","2021-03-03","Household and community samples","Multiple groups",34623.0,0.346,0.34,0.353,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office For National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-ENG"
"2021-05-23","210316_UK_OfficeForNationalStatistics_NorthernIreland_overall","Coronavirus (COVID-19) antibody and vaccination data for the UK_Feb4-March3","2021-03-30","Regional","United Kingdom of Great Britain and Northern Ireland; Northern Ireland","2021-02-04","2021-03-03","Household and community samples","Multiple groups",632.0,0.312,0.273,0.352,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office For National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-NIR"
"2021-05-23","210316_UK_OfficeForNationalStatistics_Scotland_overall","Coronavirus (COVID-19) antibody and vaccination data for the UK_Feb4-March3","2021-03-30","Regional","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-02-04","2021-03-03","Household and community samples","Multiple groups",2737.0,0.223,0.206,0.241,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office For National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-SCT"
"2021-05-23","210316_UK_OfficeForNationalStatistics_Wales_overall","Coronavirus (COVID-19) antibody and vaccination data for the UK_Feb4-March3","2021-03-30","Regional","United Kingdom of Great Britain and Northern Ireland; Wales","2021-02-04","2021-03-03","Household and community samples","Multiple groups",1224.0,0.305,0.275,0.336,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office For National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021","Verified","The United Kingdom","University of Oxford",0.99,0.991,"","GB","GB-WLS"
"2021-05-23","210317_NewYorkCity_IcahnSchoolOfMedicine","Safety of administering biologics to IBD patients at an outpatient infusion center In New York City during the COVID-19 pandemic: Sars-CoV-2 seroprevalence and clinical and social characteristics","2021-03-17","Local","United States of America; New York; Mount Sinai","2020-05-26","2020-07-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",383.0,0.104,"","","Convenience","Not reported","High","Preprint","Serre Yu Wong","Icahn School Of Medicine","https://www.medrxiv.org/content/10.1101/2021.03.15.21253615v1","Verified","United States of America","N/A - author designed","","","","US","US-NY"
"2021-05-23","210324_London_ImperialCollegeLondon_Overall","Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection","2021-03-24","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-02-24","2021-01-01","Patients seeking care for non-COVID-19 reasons","Multiple groups",301.0,0.429,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Candice L Clarke","Imperial College London","https://dx.doi.org/10.1016/j.kint.2021.03.009","Verified","The United Kingdom","Abbott","","","","GB","GB-ENG"
"2021-05-23","210330_Munich_UniversityHospitalLMUMunich_TestAdj","Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich","2021-03-30","Local","Germany; Bavaria; Munich","2020-04-05","2020-06-12","Household and community samples","Multiple groups",5313.0,0.018,0.013,0.024,"Stratified probability","Total Antibody","Low","Journal Article (Peer-Reviewed)","Michael Pritsch","University Hospital LMU Munich","https://dx.doi.org/10.3390/ijerph18073572","Verified","Germany","Roche",0.886,0.997,"","DE","DE-BY"
"2021-05-23","210415_ParrisIsland_IchanSchoolofMedicine","SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study","2021-04-15","Local","United States of America; South Carolina; Port Royal","2020-05-11","2020-11-02","Essential non-healthcare workers","Adults (18-64 years)",3076.0,0.073,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Andrew G Letizia","Icahn School of Medicine at Mount Sinai","https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00158-2/fulltext","Verified","United States of America","Author designed","",1.0,"","US","US-SC"
"2021-05-23","210418_Delhi_CouncilofScientificandIndustrialResearchInstituteofGenomicsandIntegrativeBiology_HCW","Effect Monitoring and Insights from Vaccination program of Healthcare Workforce from a tertiary level hospital in India against SARS-CoV-2","2021-04-18","Regional","India; Delhi","2021-01-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",307.0,0.42,"","","Convenience","Not reported","High","Preprint","Rajat Ujjainia","Council of Scientific and Industrial Research Institute of Genomics and Integrative Biology","https://www.medrxiv.org/content/10.1101/2021.02.28.21252621v3","Unverified","India","Roche Diagnostics","","","","IN","IN-DL"
"2021-05-23","210420_Barcelona_CIBERESP","Antibody Conversion rates to SARS-CoV-2 in Saliva from Children Attending Summer Schools in Barcelona, Spain","2021-04-20","Local","Spain","2020-06-29","2020-07-31","Students and Daycares","Multiple groups",1518.0,0.032,"","","Convenience","IgG; IgM; IgA","High","Preprint","Carlota Dobano","Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Públic","10.1101/2021.04.20.440593","Unverified","Spain","Luminex Corporation","","","","ES",""
"2021-05-23","210421_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj","Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya","2021-04-24","National","Kenya; Central, Coastal, Western","2020-07-30","2020-12-04","Health care workers and caregivers","Adults (18-64 years)",684.0,0.208,0.175,0.244,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Anthony Etyang","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1093/cid/ciab346","Verified","Kenya","Krammer",0.927,0.99,"","KE",""
"2021-05-23","210428_NewYorkCity_NewYorkBloodCenter_Ortho+Neut","Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and “Reopening”","2021-04-28","Local","United States of America; New York; New York City","2020-06-15","2020-07-15","Blood donors","Multiple groups",1000.0,0.09,"","","Sequential","Total Antibody; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Daniel Jin","New York Blood Centre","https://dx.doi.org/10.1371/journal.pone.0250319","Verified","United States of America","Ortho Clinical Diagnostics, Vyriad IMMUNO-COV","","","","US","US-NY"
"2021-05-23","210501_Qatar_CornellUniversity","Herd;   Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in;   10 Communities, Qatar","2021-05-01","National","Qatar","2020-06-21","2020-09-09","Essential non-healthcare workers","Adults (18-64 years)",4970.0,0.644,0.63,0.657,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Andrew Jeremijenko","Cornell University","https://wwwnc.cdc.gov/eid/article/27/5/20-4365_article","Unverified","Qatar","Roche Diagnostics",0.995,0.998,"","QA",""
"2021-05-24","210227_Belgium_AntwerpUniversityHospital_AdultCancer_DiaSorin","Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests","2021-02-27","Local","Belgium","2020-03-24","2020-05-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",827.0,0.062,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Peter van Dam","Antwerp University Hospital","https://dx.doi.org/10.1016/j.ejca.2021.02.024","Verified","Belgium","DiaSorin, Saluggia, Italy","","","","BE",""
"2021-05-24","210227_Belgium_AntwerpUniversityHospital_Adult_nonCancer_DiaSorin","Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests","2021-02-27","Local","Belgium","2020-03-24","2020-05-31","Residual sera","Multiple groups",90.0,0.056,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Peter van Dam","Antwerp University Hospital","https://dx.doi.org/10.1016/j.ejca.2021.02.024","Verified","Belgium","DiaSorin, Saluggia, Italy","","","","BE",""
"2021-05-24","210331_SchleswigHolstein_RuhrUniversityBochum_NonHCW","Half Year Longitudinal Seroprevalence of SARS-CoV-2-antibodies and Rule Compliance in German Hospital Employees","2021-03-31","Local","Germany; Schleswig-Holstein","2020-04-14","2020-10-20","Health care workers and caregivers","Adults (18-64 years)",138.0,0.007,"","","Convenience","IgG","High","Preprint","Jonas Herzberg","Ruhr University Bochum","https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1","Unverified","Germany","Euroimmun, Abbott, DiaSorin","","","","DE","DE-SH"
"2021-05-25","210417_Itami_ItamiCityHospital","Challenges and responses of elective orthopaedic surgery during the second wave of COVID-19.","2021-04-17","Local","Japan; Kansai; Itami","2020-05-15","2020-11-20","Residual sera","Multiple groups",592.0,0.022,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Tsuyoshi Nakai","Itami City Hospital","https://dx.doi.org/10.1016/j.jos.2021.02.017","Unverified","Japan","NR","","","","JP",""
"2021-05-25","210422_Illinois+Wisconsin_AdvocateAuroraHealth_Overall","Incidence of COVID-19 recurrence among large cohort of healthcare employees.","2021-04-22","Regional","United States of America; Illinois, Wisconsin","2020-06-08","2020-07-10","Health care workers and caregivers","Multiple groups",14921.0,0.036,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Fitzpatrick Veronica","Advocate Aurora Health","https://dx.doi.org/10.1016/j.annepidem.2021.04.005","Verified","United States of America","Abbott",0.987,0.992,"","US",""
"2021-05-25","210427_Turkey_SakaryaUniversity_Overall","Novel coronavirus seropositivity and related factors among healthcare workers at a university hospital during the prevaccination period: a cross-sectional study.","2021-04-27","Local","Turkey","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",2988.0,0.036,"","","Entire sample","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Aziz Ogutlu","Sakarya University","https://dx.doi.org/10.1186/s12941-021-00436-9","Verified","Turkey","Hotgen Biotech","","","","TR",""
"2021-05-25","210430_Amsterdam_AmsterdamUniversityMedicalCenter","SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort.","2021-04-30","Local","Netherlands; North Holland; Amsterdam","2020-07-31","2020-12-18","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",546.0,0.117,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Zoe van Kempen","Amsterdam University Medical Center","https://dx.doi.org/10.1001/jamaneurol.2021.1364","Unverified","Netherlands","NR",0.981,0.995,"","NL","NL-NH"
"2021-05-25","210501_UnitedStates_MayoClinic","Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical Center.","2021-03-26","Regional","United States of America; Minnesota, Wisconsin, Florida, Arizona, Iowa; Rochester","2020-06-15","2020-08-08","Health care workers and caregivers","Multiple groups",29606.0,0.006,0.005,0.007,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Rickey Carter","The Mayo Clinic","https://dx.doi.org/10.1016/j.mayocp.2021.03.015","Verified","United States of America","Euroimmun, Roche, Ortho-Clinical Diagnostics","","","","US",""
"2021-05-25","210512_Denmark_CopenhagenUniversityHospital_PEH1_Overall","SARS-CoV-2 antibody prevalence among homeless people, sex workers and shelter workers in Denmark: a nationwide cross-sectional study","2021-05-12","National","Denmark; Central, North, Capital, South;  Copenhagen, Aarhus, Aalborg and Odense","2020-11-02","2020-11-20","Persons experiencing homelessness","Adults (18-64 years)",628.0,0.068,"","","Convenience","IgG; IgM","Moderate","Preprint","Alexandra R Rothlin Eriksen","Copenhagen University Hospital","https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2","Verified","Denmark","CTK Biotech",0.969,0.994,"","DK",""
"2021-05-25","210512_Denmark_CopenhagenUniversityHospital_ShelterWorkers2_Overall","SARS-CoV-2 antibody prevalence among homeless people, sex workers and shelter workers in Denmark: a nationwide cross-sectional study","2021-05-12","National","Denmark; Central, North, Capital, South;  Copenhagen, Aarhus, Aalborg and Odense","2020-11-02","2020-11-20","Essential non-healthcare workers","Adults (18-64 years)",191.0,0.063,"","","Convenience","IgG; IgM","High","Preprint","Alexandra R Rothlin Eriksen","Copenhagen University Hospital","https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2","Verified","Denmark","CTK Biotech",0.969,0.994,"","DK",""
"2021-05-26","210420_Kashmir_GovernmentMedicalCollege","SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.","2021-04-20","Regional","India; Kashmir","2020-06-15","2020-06-29","Health care workers and caregivers","Multiple groups",2905.0,0.025,0.02,0.031,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Muhammad Salim Khan","Government Medical College","https://dx.doi.org/10.12788/jhm.3609","Unverified","India","NR",1.0,0.99,"","IN","IN-JK"
"2021-05-26","210420_NewYorkCity_BronxCareHealthSystem","SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.","2021-04-20","Local","United States of America; New York State; New York City","2020-05-18","2020-06-26","Health care workers and caregivers","Multiple groups",2749.0,0.302,0.29,0.32,"Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Murli U Purswani","BronxCare Health System","https://dx.doi.org/10.12788/jhm.3627","Unverified","United States of America","Roche",0.971,1.0,"","US","US-NY"
"2021-05-27","201202_Rome_UniversitàCattolicaDelSacroCuore_overall","No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy","2020-12-02","Local","Italy; Lazio; Rome","2019-12-01","2020-02-29","Patients seeking care for non-COVID-19 reasons","Multiple groups",451.0,0.0,0.0,0.0,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Francesca Lombardi","Università Cattolica del Sacro Cuore","http://dx.doi.org/10.1016/j.cmi.2020.11.026","Verified","Italy","1) DiaPro; 2) Eagle Bioscience","","","","IT","IT-62"
"2021-05-27","201205_Maryland_MarylandDepartmentOfHealth_overall","Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Status in Decedents Undergoing Forensic Postmortem Examination in Maryland, May 24 to June 30, 2020","2020-12-15","Regional","United States of America; Maryland","2020-05-24","2020-06-30","Residual sera","Multiple groups",500.0,0.1,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Keri N Althoff","The Maryland Department of Health","https://dx.doi.org/10.1093/ofid/ofaa611","Unverified","United States of America","Hangzhou Biotest Bioctech Co.",0.95,1.0,"","US","US-MD"
"2021-05-27","210420_Iran_TehranUniversityOfMedicalSciences","SARS-CoV-2 serological assay and viral testing: a report of professional football setting.","2021-04-20","National","Iran (Islamic Republic of)","2020-09-15","2020-10-15","Non-essential workers and unemployed persons","Adults (18-64 years)",1243.0,0.179,0.158,0.201,"Entire sample","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Bahar Hassanmirzaei","Tehran University of Medical Sciences","https://dx.doi.org/10.1136/postgradmedj-2021-140176","Verified","Iran (Islamic Republic of)","Pishtaxz Teb Diagnostics",0.794,0.973,"","IR",""
"2021-05-27","210426_England_CambridgeUniversityHospitalsNHS","SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic","2021-04-24","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-06-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",434.0,0.078,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","DM Favara","Cambridge University Hospitals NHS Foundation Trust","https://dx.doi.org/10.1016/j.clon.2021.04.005","Unverified","The United Kingdom","Abbexa",0.985,0.979,"","GB","GB-ENG"
"2021-05-27","210427_Connecticut_HartfordHealthcare_overall","Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.","2021-04-27","Regional","United States of America; Connecticut; Hartford","2020-05-11","2020-08-16","Health care workers and caregivers","Multiple groups",6863.0,0.063,0.057,0.069,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Pavlos Papasavas","Hartford Healthcare","https://dx.doi.org/10.1016/j.jhin.2021.04.021","Verified","United States of America","Abbott",1.0,0.996,"","US","US-CT"
"2021-05-27","210429_Fortaleza_StateUniversityofCearáCampusdoItaperi_Overall","Prevalence of COVID-19 in children, adolescents, and adults in remote education situation in the city of Fortaleza - Brazil.","2021-05-01","Local","Brazil; Ceará; Fortaleza","2020-11-09","2020-12-09","Multiple populations","Multiple groups",1559.0,0.267,"","","Simplified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Valdester Cavalcante Pinto Junior","State University of Ceará, Campus do Itaperi","https://dx.doi.org/10.1016/j.ijid.2021.04.086","Verified","Brazil","Beijing Lepu Medical Technology Co., Ltd.",0.989,0.976,"","BR","BR-CE"
"2021-05-27","210506_Boston_BostonMedicalCenter_overall","Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.","2021-05-06","Local","United States of America; Massachusetts; Boston","2020-07-13","2020-07-26","Health care workers and caregivers","Adults (18-64 years)",1743.0,0.055,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Yachana Kataria","Boston Medical Center","https://dx.doi.org/10.1038/s41598-021-89107-5","Unverified","United States of America","Abbott","","","","US","US-MA"
"2021-05-27","210521_Bengaluru_BangaloreMedicalCollege","One in five has antibodies against Covid in slums in Bengalu: Study","2021-05-21","Local","India; Karnataka; Bangalore","2021-04-15","2021-04-22","Persons living in slums","Multiple groups",728.0,0.203,"","","Convenience","Not reported","High","News and Media","Ranganath TS","Bangalore Medical College and Research Institute","https://timesofindia.indiatimes.com/city/bengaluru/one-in-five-has-antibodies-against-covid-in-slums-in-bengaluru-study/articleshow/82825325.cms","Unverified","India","NR","","","","IN","IN-KA"
"2021-05-27","210522_UK_UniversityCollegeLondon_overall","Household overcrowding and risk of SARS-CoV-2: analysis of the Virus Watch prospective community cohort study in England and Wales","2021-05-22","National","United Kingdom of Great Britain and Northern Ireland; England and Wales","2021-02-01","2021-05-03","Household and community samples","Multiple groups",10330.0,0.082,"","","Convenience","Total Antibody","Moderate","Preprint","Robert W Aldridge","University College London","https://www.medrxiv.org/content/10.1101/2021.05.10.21256912v2","Verified","The United Kingdom","Roche","","","","GB","GB-ENG"
"2021-05-28","210118_Hangzhou_ZhejiangUniversitySchoolofMedicine_Overall","Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting.","2021-01-18","Local","China; Zhejiang; Hangzhou","2020-04-24","2020-05-08","Multiple populations","Multiple groups",16043.0,0.005,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jun Huang","Zhejiang University School of Medicine","https://dx.doi.org/10.21037/atm-20-7163","Verified","China","Livzon, Zhuhai, Guangzhou, China; Vazyme, Nanjing, Jiangsu, China)","","","","CN","CN-33"
"2021-05-28","210415_Poland_MedicalUniversityOfSilesiaInKatowice_Overall","Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland.","2021-04-21","Regional","Poland; Silesian Voivodeship; Katowice, Gliwice, Sosnowiec","2020-10-15","2020-11-15","Household and community samples","Multiple groups",5479.0,0.229,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Małgorzata Kowalska","Medical University of SilesiaIn Katowice","https://dx.doi.org/10.3390/vaccines9050415","Verified","Poland","EUROIMMUN POLSKA Sp. z o.o.","","","","PL","PL-24"
"2021-05-28","210428_Europe_SorbonneUniversité_2Île-de-France","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","France; Île-de-France","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",593.0,0.071,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","France","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","","","","FR","FR-IDF"
"2021-05-28","210501_Rome_SapienzaUniversity","Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab.","2021-05-01","Local","Italy; Lazio; Rome","2020-05-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",17377.0,0.012,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Guido Antonelli","Sapienza University","https://dx.doi.org/10.1016/S2666-5247(21)00083-5","Verified","Italy","DiaSorin; Roche Diagnostics","","","","IT","IT-62"
"2021-05-28","210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareResidents1","The Demography and Characteristic of SARS-CoV-2 Sero-positive Residents and Staff of Nursing Homes for Older Adults in the Community of Madrid: the SeroSOS Study.","2021-05-04","Local","Spain","2020-07-07","2020-10-23","Assisted living and long-term care facilities","Seniors (65+ years)",9332.0,0.554,0.544,0.564,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Francisco Javier Candel","Hospital General Universitario La Paz","https://dx.doi.org/10.1093/ageing/afab096","Verified","Spain","Abbott",1.0,0.996,"","ES",""
"2021-05-28","210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareWorkers2","The Demography and Characteristic of SARS-CoV-2 Sero-positive Residents and Staff of Nursing Homes for Older Adults in the Community of Madrid: the SeroSOS Study.","2021-05-04","Local","Spain","2020-07-07","2020-10-23","Health care workers and caregivers","Adults (18-64 years)",10614.0,0.315,0.306,0.324,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Francisco Javier Candel","Hospital General Universitario La Paz","https://dx.doi.org/10.1093/ageing/afab096","Verified","Spain","Abbott",1.0,0.996,"","ES",""
"2021-05-28","210506_Berlin_FreieUniversitätBerlin","SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany - a cross sectional study.","2021-05-06","Local","Germany; Berlin; Berlin","2020-09-28","2020-10-02","Students and Daycares","Multiple groups",720.0,0.001,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Marlene Thielecke","Freie Universität Berlin","https://dx.doi.org/10.1093/eurpub/ckab079","Unverified","Germany","Euroimmun AG, Lübeck, Germany","","","","DE","DE-BE"
"2021-05-28","210506_Gabon_CHUMèreEnfantFondationJeanneEbori","Dynamic and features of SARS-CoV-2 infection in Gabon.","2021-05-06","National","Gabon","2020-03-15","2020-08-15","Contacts of COVID patients","Multiple groups",319.0,0.55,"","","Convenience","Not reported","Unclear","Journal Article (Peer-Reviewed)","Amandine Mveang Nzoghe","CHU Mère Enfant Fondation Jeanne Ebori","https://dx.doi.org/10.1038/s41598-021-87043-y","Verified","Gabon","Roche; bioMerieux","","","","GA",""
"2021-05-28","210507_Ethiopia_EthiopianPublicHealthInstitute_AddisAbaba","Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic","2021-05-07","Local","Ethiopia; Oromia Region; Addis Ababa","2020-07-22","2020-09-02","Household and community samples","Multiple groups",956.0,0.035,0.017,0.054,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saro Abdella","Ethiopian Public Health Institute","http://dx.doi.org/10.1016/j.eclinm.2021.100880","Verified","Ethiopia","Core Technology Co.",0.69,0.97,"","ET","ET-OR"
"2021-05-28","210507_Ethiopia_EthiopianPublicHealthInstitute_JimmaRegion","Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic","2021-05-07","Local","Ethiopia; Oromia Region; Jimma","2020-07-22","2020-09-02","Household and community samples","Multiple groups",900.0,0.006,0.001,0.018,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saro Abdella","Ethiopian Public Health Institute","http://dx.doi.org/10.1016/j.eclinm.2021.100880","Verified","Ethiopia","Core Technology Co.",0.69,0.97,"","ET","ET-OR"
"2021-05-28","210508_NorthCarolina_FirstHealthoftheCarolinas_Overall","SARS-CoV2 Antibody Positivity Rates and Employee Expectations of Positivity Rates among Health Care Workers at a Community Hospital in North Carolina.","2021-05-08","Regional","United States of America; North Carolina","2020-06-10","2020-07-17","Health care workers and caregivers","Multiple groups",2076.0,0.03,0.019,0.033,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","GS Arnoczy","FirstHealth of the Carolinas","https://dx.doi.org/10.1016/j.ajic.2021.04.086","Unverified","United States of America","Abbott","","","","US","US-NC"
"2021-05-28","210512_Vienna_LudwigBoltzmannInstituteForLungHealth_overall","Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown.","2021-05-12","Local","Austria","2020-04-20","2020-05-20","Household and community samples","Multiple groups",12419.0,0.013,"","","Stratified probability","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Marie Kathrin Breyer","Ludwig Boltzmann Institute for Lung Health","https://dx.doi.org/10.1038/s41598-021-89711-5","Verified","Austria","1) Roche ; 2) N/A - in house ; 3) Euroimmun","","","","AT",""
"2021-05-28","210513_Ulm_UlmUniversity_Overall","Longitudinal SARS-CoV-2 infection study at Ulm University: Test and hygiene concepts for classroom teaching during the pandemic in medical school","2021-05-13","Local","Germany; Baden-Württemberg; Ulm","2020-11-15","2021-03-07","Multiple populations","Adults (18-64 years)",818.0,0.145,"","","Convenience","IgG; IgM; IgA","Moderate","Preprint","Michael Schon","Ulm University","https://www.medrxiv.org/content/10.1101/2021.05.04.21256382v2.full-text","Unverified","Germany","Roche Diagnostics",0.988,1.0,"","DE","DE-BW"
"2021-05-28","210514_Madrid_HospitalUniversitarioLaPaz","Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases. Cross-sectional study from a reference centre in Spain","2021-05-14","Local","Spain; Madrid; Madrid","2020-09-15","2021-02-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",105.0,0.2,"","","Convenience","IgG","High","Preprint","Clara Udaondo","Hospital Universitario La Paz","https://www.researchsquare.com/article/rs-505561/v1","Verified","Spain","NR","","","","ES","ES-MD"
"2021-05-28","210518_Stockholm_KarolinskaInstitutet","Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden","2021-05-18","Local","Sweden; Uppland; Stockholm","2020-03-14","2021-02-28","Multiple general populations","Adults (18-64 years)",5100.0,0.192,0.151,0.244,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Xaquin Castro Dopico","Karolinska Institutet","https://onlinelibrary.wiley.com/doi/full/10.1111/joim.13304","Verified","Sweden","NR; In house","","","","SE","SE-AB"
"2021-05-29","210318_Sarajevo_InternationalBurchUniversity_DrAbdulahNakasGeneralHospital1_overall","Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report.","2021-03-18","Local","Bosnia and Herzegovina","2020-04-15","2020-05-15","Residual sera","Multiple groups",1720.0,0.034,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Adna Asic","International Burch University","https://dx.doi.org/10.5114/aoms/134143","Verified","Bosnia and Herzegovina","Artron","","","","BA",""
"2021-05-29","210318_Sarajevo_InternationalBurchUniversity_EurofarmCentreLaboratory2_overall","Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report.","2021-03-18","Local","Bosnia and Herzegovina","2020-04-21","2020-07-17","Residual sera","Multiple groups",1121.0,0.043,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Adna Asic","International Burch University","https://dx.doi.org/10.5114/aoms/134143","Verified","Bosnia and Herzegovina","Dynamiker Biotechnology Co.","","","","BA",""
"2021-05-29","210504_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM","Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study.","2021-05-04","Local","Italy; Sardinia; Cagliari","2020-09-01","2020-12-10","Patients seeking care for non-COVID-19 reasons","Multiple groups",121.0,0.107,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Federico Cappellacci","University of Cagliari","https://dx.doi.org/10.1016/j.amsu.2021.102375","Verified","Italy","Snibe","","","","IT","IT-88"
"2021-05-29","210505_Johannesburg_UniversityoftheWitwatersrand","SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study.","2021-05-05","Local","South Africa; Gauteng Province; Johannesburg","2020-04-22","2020-09-15","Health care workers and caregivers","Adults (18-64 years)",395.0,0.413,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Marta Nunes","University of the Witwatersrand","https://dx.doi.org/10.1093/cid/ciab398","Verified","South Africa","In-House: University of the Witwatersrand",1.0,1.0,"","ZA","ZA-GT"
"2021-05-29","210507_Stockholm_KarolinskaUniversityHospital","SARS-CoV-2 Infections Among Healthcare Workers Outside Hospitals","2021-05-07","Local","Sweden; Uppland; Stockholm","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",839.0,0.12,"","","Convenience","IgG","Moderate","Preprint","Maria Froberg","Karolinska University Hospital","https://www.researchsquare.com/article/rs-493146/v1","Verified","Sweden","NR",0.992,0.998,"","SE","SE-AB"
"2021-05-29","210513_Lyon_CentreHospitalierSaintJosephSaintLuc","Specific exposure of ICU staff to SARS-CoV-2 seropositivity: a wide seroprevalence study in a French city-center hospital.","2021-05-13","Local","France; Auvergne-Rhône-Alpes; Lyon","2020-06-08","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",971.0,0.09,0.088,0.092,"Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Emmanuel Vivier","Centre Hospitalier Saint Joseph Saint Luc","https://dx.doi.org/10.1186/s13613-021-00868-8","Verified","France","Roche Diagnostic",0.99,0.99,"","FR","FR-ARA"
"2021-05-29","210527_Estonia_UniversityOfTartu_Stage17_Overall","The study on the prevalence of the coronavirus in Estonia","2021-12-13","National","Estonia","2021-05-13","2021-05-24","Household and community samples","Multiple groups",2290.0,0.495,0.475,0.516,"Stratified probability","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire","Verified","Estonia","Synlab","","","","EE",""
"2021-05-30","210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_Dallas1","Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST).","2021-04-13","Local","United States of America; Texas; Dallas","2020-03-01","2021-03-31","Residual sera","Multiple groups",2533.0,0.389,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Madhusudhanan Narasimhan","University of Texas Southwestern Medical Center","https://dx.doi.org/10.3390/vaccines9040376","Unverified","United States of America","Abbott","","","","US","US-TX"
"2021-05-30","210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_DallasFortWorth2","Expanding COVID-19 Vaccine Availability: Role for Combined Orthogonal Serology Testing (COST).","2021-04-13","Local","United States of America; Texas; Dallas-Fort Worth","2020-06-01","2021-02-28","Residual sera","Multiple groups",21101.0,0.071,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Madhusudhanan Narasimhan","University of Texas Southwestern Medical Center","https://dx.doi.org/10.3390/vaccines9040376","Unverified","United States of America","Abbott","","","","US","US-TX"
"2021-05-30","210428_Europe_SorbonneUniversité_1Nordrhein-Westfalen","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","Germany; Nordrhein-Westfalen","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",624.0,0.008,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","Germany","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","","","","DE","DE-NW"
"2021-05-30","210428_Europe_SorbonneUniversité_3Centro","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","Portugal; Região do Centro","2020-07-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",526.0,0.011,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","Portugal","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","","","","PT",""
"2021-05-30","210428_Europe_SorbonneUniversité_5EmiliaRomagna","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","Italy; Emilia Romagna","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",522.0,0.015,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","Italy","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","","","","IT","IT-45"
"2021-05-30","210430_Tokyo_NationalCenterForGlobalHealthAndMedicine_Primary","Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan.","2021-04-30","Local","Japan; Tokyo Prefecture; Tokyo","2020-07-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1228.0,0.001,0.0,0.005,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Shohei Yamamoto","National Center for Global Health and Medicine","https://dx.doi.org/10.35772/ghm.2021.01022","Verified","Japan","Abbott",1.0,0.999,"","JP","JP-13"
"2021-05-30","210506_Luanda_InstitutoNacionaldeInvestigaçãoemSaúde_IgG","Serological identification of past and recent SARS-CoV-2 infection through antibody screening in Luanda, Angola.","2021-05-06","Local","Angola; Luanda Province; NR","2020-07-15","2020-09-15","Residual sera","Multiple groups",660.0,0.011,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Cruz Sebastiao","Instituto Nacional de Investigação em Saúde","https://dx.doi.org/10.1002/hsr2.280","Verified","Angola","bioMérieux SA","","","","AO","AO-LUA"
"2021-05-30","210510_Denmark_CopenhagenUniversityHospital_BloodDonorsOverall","Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark","2021-05-10","National","Denmark","2021-01-08","2021-01-31","Blood donors","Multiple groups",22677.0,0.058,"","","Entire sample","Not reported","Moderate","Preprint","Kamille Fogh","Copenhagen University Hospital","https://doi.org/10.1101/2021.05.07.21256725","Verified","Denmark","Beijing Wantai Biological Pharmacy Enterprise","","","","DK",""
"2021-05-30","210510_Denmark_CopenhagenUniversityHospital_SHOverall","Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark","2021-05-10","National","Denmark","2021-01-08","2021-01-31","Household and community samples","Multiple groups",13279.0,0.173,"","","Stratified non-probability","IgG; IgM","Moderate","Preprint","Kamille Fogh","Copenhagen University Hospital","https://doi.org/10.1101/2021.05.07.21256725","Verified","Denmark","CTK Biotech inc",0.9,1.0,"","DK",""
"2021-05-30","210518_Sergipe_FederalUniversityofSergipe_overall","Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.","2021-05-18","Regional","Brazil; Sergipe","2020-07-01","2020-07-31","Household and community samples","Multiple groups",5615.0,0.093,0.085,0.101,"Stratified probability","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Adriano Antunes de Souza Araújo","Federal University of Sergipe","https://dx.doi.org/10.1017/S0950268821001163","Verified","Brazil","Guangzhou Wondfo Biotech Co., Ltd.; BioSys + Kovalent","","","","BR","BR-SE"
"2021-05-31","210409_NewDelhi_MaulanaAzadMedicalCollege","Seroprevalence of antibodies to SARS-CoV-2 and predictors of seropositivity among employees of a teaching hospital in New Delhi, India.","2021-04-09","Local","India; National Capital Territory of Delhi; New Delhi","2020-08-15","2020-09-15","Health care workers and caregivers","Adults (18-64 years)",1401.0,0.121,0.104,0.138,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Pragya Sharma","Maulana Azad Medical College","https://dx.doi.org/10.24171/j.phrp.2021.12.2.06","Verified","India","ICMR-NIV",0.924,0.979,"","IN","IN-DL"
"2021-05-31","210427_Oman_Directorate-GeneralforDiseasesSurveillanceandControl_Primary","The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: a multicenter seroprevalence study.","2021-04-27","Regional","Oman; Al Dakhilia, North Batinah, and South Batinah goveronates","2020-09-14","2020-09-28","Health care workers and caregivers","Adults (18-64 years)",1078.0,0.21,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Amal Al Maani","Directorate-General for Diseases Surveillance and Control","https://dx.doi.org/10.1016/j.ijid.2021.04.071","Verified","Oman","DiaSorin","","","","OM",""
"2021-05-31","210428_Europe_SorbonneUniversité_4ComunidaddeMadrid","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","Spain; Comunidad de Madrid","2020-07-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",524.0,0.134,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","Spain","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","","","","ES","ES-MD"
"2021-05-31","210428_Europe_SorbonneUniversité_6London","SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study.","2021-04-28","Regional","United Kingdom of Great Britain and Northern Ireland; London; London","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",239.0,0.146,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","David Saadoun","Sorbonne Université","https://dx.doi.org/10.1016/S2665-9913(21)00112-0","Verified","The United Kingdom","Abbott, Roche, Siemen, DiaSorin, Beckman-Coulter","","","","GB","GB-ENG"
"2021-05-31","210510_Cantabria_UniversityofCantabria_Overall","Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home.","2021-05-10","Regional","Spain; Cantabria; NR","2020-04-27","2020-05-29","Household and community samples","Multiple groups",1022.0,0.031,0.022,0.044,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Paula Iruzubieta","University of Cantabria","https://dx.doi.org/10.1038/s41598-021-89236-x","Verified","Spain","Hangzhou Clongene Biotech Co., Ltd., China",0.974,0.989,"","ES","ES-CB"
"2021-05-31","210511_SkåneUniversityHospital_LundUniversity_HCW","Post-outbreak serological screening for SARS-CoV-2 infection in healthcare workers at a Swedish University Hospital","2021-05-11","Local","Sweden","2020-08-01","2020-08-22","Health care workers and caregivers","Adults (18-64 years)",107.0,0.355,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Rasmus Strand","Lund University","https://dx.doi.org/10.1080/23744235.2021.1925739","Verified","Sweden","ZetaGene",0.95,0.97,"","SE",""
"2021-06-01","210413_Tubingen_EberhardKarlsUniversitatTubingen","Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre","2021-04-13","Local","Germany; Baden-Württemberg; Tubingen","2020-05-01","2020-05-01","Essential non-healthcare workers","Adults (18-64 years)",318.0,0.028,0.015,0.053,"Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Focke Ziemssen","Eberhard Karls Universitat Tubingen","https://bmjophth.bmj.com/content/bmjophth/6/1/e000688.full.pdf","Unverified","Germany","Roche Diagnostics, Siemens Healthcare Diagnostics, Mediagnost","","","","DE","DE-BW"
"2021-06-01","210427_EastLondon_QueenMaryUniversityofLondon","Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK.","2021-04-27","Local","United Kingdom of Great Britain and Northern Ireland","2020-06-15","2020-08-15","Health care workers and caregivers","Multiple groups",2001.0,0.253,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Naheed Choudhry","Queen Mary University of London","https://dx.doi.org/10.3389/fmed.2021.642723","Unverified","The United Kingdom","Panbio Abbott; Abbott; Roche","","","","GB",""
"2021-06-01","210430_Baltimore_JohnsHopkinsUniversity_Overall","Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department.","2021-04-30","Local","United States of America; Maryland; Baltimore","2020-03-16","2020-05-31","Residual sera","Multiple groups",3255.0,0.035,0.029,0.042,"Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oliver Laeyendecker","Johns Hopkins University","https://dx.doi.org/10.1016/j.ajem.2021.04.081","Verified","United States of America","1) Euroimmun; 2) Hangzhou Biotest Biotech Co.",0.84,1.0,"","US","US-MD"
"2021-06-01","210518_Mid-WestIreland_UniversityofLimerick_Staff1","Seroprevalence study of SARS-CoV-2 infection in General Practice in Ireland.","2021-05-18","Regional","Ireland; Munster","2020-06-15","2020-07-10","Health care workers and caregivers","Multiple groups",172.0,0.111,0.04,0.19,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Michael Edmund O'Callaghan","University of Limerick","https://dx.doi.org/10.3399/BJGPO.2021.0038","Unverified","Ireland","Maccura Biotechnology Ltd, Chengdu, China","","","","IE","IE-M"
"2021-06-02","200515_Tokyo_UniversityOfTokyo","About antibody positive rate test results in Tokyo","2020-05-15","Local","Japan; Tokyo Prefecture; Tokyo","2020-05-01","2020-05-02","Residual sera","Multiple groups",500.0,0.006,"","","Convenience","IgG; IgM","High","Presentation or Conference","Tatsuhiko Kodama","University of Tokyo","https://www.rcast.u-tokyo.ac.jp/ja/news/release/20200515.html","Verified","Japan","JSR Corporation","","","","JP","JP-13"
"2021-06-02","210403_Majadahonda_HospitalUniversitarioPuertaDeHierro_overall_Unadj","Impact of COVID-19 pandemic on patients and health professionals of a radiation oncology department at a Spanish tertiary hospital","2021-04-03","Local","Spain","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",50.0,0.12,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Jesus Romero","Hospital Universitario Puerta de Hierro","10.5603/RPOR.a2021.0036","Unverified","Spain","Vircell","","","","ES",""
"2021-06-02","210427_Juba_WorldHealthOrganization_Overall_PopTestAdj","Seroprevalence of severe acute respiratory syndrome coronavirus 2 IgG in Juba, South Sudan, 2020","2021-04-27","Local","South Sudan; Central Equatoria; Juba","2020-08-10","2020-09-11","Household and community samples","Multiple groups",2214.0,0.383,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Kirsten E Wiens","World Health Organization","https://dx.doi.org/10.3201/eid2706.210568","Verified","South Sudan","NR",0.655,1.0,"","SS",""
"2021-06-02","210512_Lübeck_UniversityofLübeck_TotalStudy","Cohort-based surveillance of SARS-CoV2 transmission mirrors infection rates at the population level a one-year longitudinal study","2021-05-12","Local","Germany","2020-05-06","2021-02-01","Household and community samples","Multiple groups",3051.0,0.034,"","","Self-referral","IgG","High","Preprint","Christine Klein","University of Lübeck","https://www.medrxiv.org/content/10.1101/2021.05.10.21256966v1.full-text","Verified","Germany","EUROIMMUN","","","","DE",""
"2021-06-02","210518_Mid-WestIreland_UniversityofLimerick_Patients2","Seroprevalence study of SARS-CoV-2 infection in General Practice in Ireland.","2021-05-18","Regional","Ireland; Munster","2020-06-15","2020-07-10","Health care workers and caregivers","Multiple groups",799.0,0.126,0.08,0.17,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Michael Edmund O'Callaghan","University of Limerick","https://dx.doi.org/10.3399/BJGPO.2021.0038","Unverified","Ireland","Maccura Biotechnology Ltd, Chengdu, China","","","","IE","IE-M"
"2021-06-03","210430_UnitedStates_MedicalUniversityofSouthCarolina","Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients.","2021-04-30","Regional","United States of America; South Carolina, North Carolina, Georgia","2020-05-15","2020-07-15","Blood donors","Multiple groups",60835.0,0.026,"","","Sequential","IgG; Neutralizing ; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Connor Dwyer","Medical University of South Carolina","https://dx.doi.org/10.1016/j.isci.2021.102489","Verified","United States of America","In-House (Medical University of South Carolina); Genscript","","","","US",""
"2021-06-03","210508_Ahmedabad_GujaratUniversity","SARS-CoV2 IgG antibody: Seroprevalence among health care workers.","2021-05-08","Local","India; Gujarat; Ahmedabad","2020-08-15","2020-08-31","Health care workers and caregivers","Multiple groups",1710.0,0.236,0.217,0.257,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Om Prakash","Smt. Nathiba Hargovandas Lakhmichand (NHL) Municipal Medical College, Gujarat University","https://dx.doi.org/10.1016/j.cegh.2021.100766","Unverified","India","Zydus Diagnostics",0.924,0.979,"","IN","IN-GJ"
"2021-06-03","210517_Quebec_Héma-Québec_PopAdj","SARS-CoV-2 seroprevalence among blood donors in Quebec, and analysis of symptoms associated with seropositivity: a nested case-control study.","2021-05-17","Regional","Canada; Québec","2020-05-25","2020-07-09","Blood donors","Adults (18-64 years)",7691.0,0.022,0.019,0.026,"Convenience","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Antoine Lewin","Héma-Québec","https://dx.doi.org/10.17269/s41997-021-00531-6","Verified","Canada","NA- author designed",0.989,0.985,"","CA","CA-QC"
"2021-06-03","210519_UnitedStates_QuestDiagnostics","Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults.","2021-05-19","National","United States of America","2020-08-15","2020-11-15","Non-essential workers and unemployed persons","Adults (18-64 years)",18148.0,0.05,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Yonghong Li","Quest Diagnostics","https://dx.doi.org/10.1001/jamanetworkopen.2021.11634","Verified","United States of America","Ortho Clinical Diagnostics; Abbott Laboratories","","","","US",""
"2021-06-04","210316_MetropolitanDetroit_HenryFordHealthSystem","SARS-CoV-2 RT-PCR positivity and antibody prevalence among asymptomatic hospital-based health care workers.","2021-03-16","Local","United States of America; Michigan; Detroit","2020-06-17","2020-07-24","Health care workers and caregivers","Adults (18-64 years)",374.0,0.024,0.013,0.045,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Christine C Johnson","Henry Ford Health System","https://dx.doi.org/10.1016/j.jcv.2021.104794","Unverified","United States of America","Beckman Coulter","","","","US","US-MI"
"2021-06-04","210512_Canada_UniversityofAlberta_April1","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard","2021-05-12","National","Canada","2020-04-01","2020-04-30","Blood donors","Adults (18-64 years)",8999.0,0.031,"","","Convenience","IgG","High","Preprint","Sahar Saeed","University of Alberta","https://www.medrxiv.org/content/10.1101/2021.05.11.21256992v1.full-text#T1","Unverified","Canada","N/A- author designed",0.891,"","","CA",""
"2021-06-04","210512_Canada_UniversityofAlberta_September2","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard","2021-05-12","National","Canada","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",8999.0,0.027,"","","Simplified probability","IgG","Moderate","Preprint","Sahar Saeed","University of Alberta","https://www.medrxiv.org/content/10.1101/2021.05.11.21256992v1.full-text#T1","Unverified","Canada","N/A- author designed",0.891,0.982,"","CA",""
"2021-06-05","210226_Vorarlberg_VorarlberbInstituteForVascularInvestigationAndTreatment_overall","SARS-CoV-2 serostatus of healthcare worker in the Austrian state Vorarlberg between June 2020 and January 2021","2021-02-26","Regional","Austria; Vorarlberg","2020-06-26","2021-01-20","Health care workers and caregivers","Adults (18-64 years)",395.0,0.18,"","","Convenience","IgG","High","Preprint","Michele Atzl","Vorarlberg Institute for Vascular Investigation and Treatment","https://www.medrxiv.org/content/10.1101/2021.02.19.21252045v2","Verified","Austria","Technoclone","","","","AT","AT-8"
"2021-06-05","210504_Texas_UniversityofTexasSouthwestern","Front line provider risk for SARS-CoV- 2 over time in an urban county","2021-05-04","Local","United States of America; Texas; Dallas","2020-06-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",549.0,0.033,"","","Self-referral","IgG","High","Presentation or Conference","Gilberto Salazar","University of Texas Southwestern","http://dx.doi.org/10.1111/acem.14249","Verified","United States of America","Abbott","","","","US","US-TX"
"2021-06-05","210510_Paris_GroupeHospitalierNordEssonneLongjumeau","Contribution of Serological Rapid Diagnostic Tests to the Strategy of Contact Tracing in Households Following SARS-CoV-2 Infection Diagnosis in Children.","2021-05-10","Local","France; Île-de-France; Paris","2020-05-08","2020-07-27","Contacts of COVID patients","Multiple groups",120.0,0.39,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Lorelei Charbonnier","Groupe Hospitalier Nord Essonne Longjumeau","https://dx.doi.org/10.3389/fped.2021.638502","Unverified","France","NR",1.0,1.0,"","FR","FR-IDF"
"2021-06-05","210510_UK_PublicHealthEngland_Primary_RocheS","Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021","2021-05-10","National","United Kingdom of Great Britain and Northern Ireland","2021-02-22","2021-03-21","Blood donors","Multiple groups",7720.0,0.464,0.454,0.475,"Convenience","Not reported","Moderate","Journal Article (Peer-Reviewed)","Heather J Whitaker","Public Health England","http://dx.doi.org/10.1016/j.jinf.2021.04.037","Verified","The United Kingdom","Roche",0.97,0.998,"","GB",""
"2021-06-05","210525_UnitedStates_RutgersUniversity_Primary","A Nationwide Survey of COVID-19 Testing in LGBTQ+ Populations in the United States.","2021-05-25","National","United States of America","2020-05-07","2020-07-31","Household and community samples","Multiple groups",124.0,0.363,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Richard Martino","Rutgers University","https://dx.doi.org/10.1177/00333549211018190","Verified","United States of America","NR","","","","US",""
"2021-06-05","210601_Providence_BrownUniversity","Seroprevalence of SARS-CoV-2 among Internal Medicine Residents at a Major Academic Medicine Residency Program.","2021-06-01","Local","United States of America; Rhode Island; Providence","2020-06-08","2020-06-23","Health care workers and caregivers","Adults (18-64 years)",101.0,0.029,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthew Murphy","Brown University","http://rimed.org/rimedicaljournal/2021/06/2021-06-20-contribution-murphy.pdf","Verified","United States of America","Abbott, Lake Forest, IL","","","","US","US-RI"
"2021-06-06","201216_Mexico_GovernmentOfMexico_overall","Secretaría de Salud presenta resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19","2020-12-16","National","Mexico","2020-08-15","2020-11-15","Household and community samples","Multiple groups",7098.0,0.25,"","","Unclear","Not reported","Unclear","News and Media","Secretaria de Salud","Government of Mexico","https://www.gob.mx/salud/prensa/255-secretaria-de-salud-presenta-resultados-preliminares-de-la-encuesta-nacional-de-salud-y-nutricion-covid-19?idiom=es","Verified","Mexico","NR","","","","MX",""
"2021-06-06","20210524_NCGM_Japan_hcw","Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.","2021-05-24","Regional","Japan","2020-10-01","2020-12-31","Essential non-healthcare workers","Adults (18-64 years)",2563.0,0.007,0.004,0.011,"Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Shohei Yamamoto","The National Center for Global Health and Medicine (NCGM)","https://dx.doi.org/10.1016/j.jinf.2021.05.017","Unverified","Japan","Abbott; Roche; EUROIMMUN","","","","JP",""
"2021-06-06","210319_Ecuador_ InstitutoEcuatorianodeEnfermedadesDigestivas","Rapid covid-19 antibodies screening testing combined with clinical evaluation for resuming activities in the endoscopy unit: A single-center experience","2021-03-19","Local","Ecuador; Guayas; Guayaquil","2020-04-15","2020-05-22","Residual sera","Adults (18-64 years)",127.0,0.071,"","","Convenience","IgM","High","Journal Article (Peer-Reviewed)","C Robles Medranda","Instituto Ecuatoriano de Enfermedades Digestivas","http://dx.doi.org/10.1055/s-0041-1724977","Verified","Ecuador","Not reported","","","","EC","EC-G"
"2021-06-06","210408_Malegaon_MunicipalCorporationofMalegaon_genpop_overall","Seroprevalence of anti-SARS-CoV-2 of IgG antibody by ELISA: Community-based, cross-sectional study from urban area of Malegaon, Maharashtra.","2021-04-08","Local","India","2020-07-25","2020-08-20","Household and community samples","Multiple groups",336.0,0.4,0.35,0.45,"Stratified non-probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Pallavi Saple","The Municipality of Malegaon","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140273/","Verified","India","NR",0.93,1.0,"","IN",""
"2021-06-06","210521_Zurich_UniversityofZurich_overall","Long-term symptoms after SARS-CoV-2 infection in school children: population-based cohort with 6-months follow-up. Short Report","2021-05-21","Local","Switzerland","2020-06-15","2021-04-15","Students and Daycares","Children and Youth (0-17 years)",1355.0,0.08,"","","Simplified probability","IgG; IgM; IgA","Moderate","Preprint","Thomas Radtke","University of Zurich","https://www.medrxiv.org/content/10.1101/2021.05.16.21257255v2","Unverified","Switzerland","Institute of Medical Virology, University of ZUrich",0.943,0.99,"","CH",""
"2021-06-06","210526_Chile_UniversidadDelDesarrollo_Overall2_Overall","Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.","2021-05-26","Local","Chile; Santiago; Santiago","2020-04-27","2020-07-31","Health care workers and caregivers","Multiple groups",446.0,0.24,0.202,0.283,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mirentxu Iruretagoyena","Universidad del Desarrollo","https://dx.doi.org/10.1186/s12879-021-06208-2","Verified","Chile","Vircell, Euroimmun","","","","CL",""
"2021-06-06","210526_HospitalUniversitarioFundacionJimenezDiaz_Madrid_hcw","Serological study of healthcare workers in four different hospitals in Madrid (Spain) with no previous history of COVID-19.","2021-05-26","Local","Spain","2020-04-06","2020-04-25","Health care workers and caregivers","Multiple groups",5995.0,0.162,"","","Convenience","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Fabian Vazquez Rivas","Fundación Jiménez Díaz University Hospital","https://dx.doi.org/10.1136/oemed-2020-107001","Unverified","Spain","Biozek Medical","","","","ES",""
"2021-06-06","210901_LimaPeru_HospitalNacionalDocenteMadreNinoSanBartolome_primary","Gestation in times of COVID-19 pandemic. Hospital nacional docente Madre Nino San Bartolome, Lima, Peru","2020-09-01","Local","Peru","2020-04-15","2020-07-15","Pregnant or parturient women","Adults (18-64 years)",1869.0,0.185,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Edy Martin Vera Loyola","Hospital Nacional Docente Madre Nino San Bartolome","http://www.spog.org.pe/web/revista/index.php/RPGO/article/download/2265/pdf","Verified","Peru","Not reported","","","","PE",""
"2021-06-07","201212_Europe_UniversityOfGlasgow_Austria3","SARS-Cov-2 viral and serological screening of staff in 31 European fertility units.","2020-12-12","National","Austria","2020-04-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",72.0,0.028,0.008,0.096,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Scott M Nelson","University of Glasgow","https://dx.doi.org/10.1093/hropen/hoaa056","Verified","Austria","Abbott",1.0,0.996,"","AT",""
"2021-06-07","201212_Europe_UniversityOfGlasgow_Denmark4","SARS-Cov-2 viral and serological screening of staff in 31 European fertility units.","2020-12-12","National","Denmark","2020-04-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",34.0,0.029,0.005,0.149,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Scott M Nelson","University of Glasgow","https://dx.doi.org/10.1093/hropen/hoaa056","Verified","Denmark","Abbott",1.0,0.996,"","DK",""
"2021-06-07","201212_Europe_UniversityOfGlasgow_Germany2","SARS-Cov-2 viral and serological screening of staff in 31 European fertility units.","2020-12-12","National","Germany","2020-04-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",137.0,0.029,0.011,0.073,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Scott M Nelson","University of Glasgow","https://dx.doi.org/10.1093/hropen/hoaa056","Verified","Germany","Abbott",1.0,0.996,"","DE",""
"2021-06-07","201212_Europe_UniversityOfGlasgow_UK1","SARS-Cov-2 viral and serological screening of staff in 31 European fertility units.","2020-12-12","National","United Kingdom of Great Britain and Northern Ireland","2020-04-15","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",311.0,0.068,0.045,0.101,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Scott M Nelson","University of Glasgow","https://dx.doi.org/10.1093/hropen/hoaa056","Verified","The United Kingdom","Abbott",1.0,0.996,"","GB",""
"2021-06-07","210408_Indore_NationalCentreforDiseaseControl_Primary","Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: A community-based cross-sectional study, August 2020.","2021-04-08","Local","India; Madhya Pradesh; Indore","2020-08-11","2020-08-23","Household and community samples","Multiple groups",7103.0,0.078,0.071,0.084,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Salil Sakalle","National Centre for Disease Control","https://dx.doi.org/10.4103/jfmpc.jfmpc_2015_20","Unverified","India","Indian Council of Medical Research",0.921,0.977,"","IN","IN-MP"
"2021-06-07","210429_Indianapolis_IndianaUniversity_overall","Placement on COVID-19 Units Does Not Increase Seroconversion Rate of Pediatric Graduate Medical Residents.","2021-04-29","Local","United States of America; Indiana; Indianapolis","2020-05-18","2020-05-22","Health care workers and caregivers","Adults (18-64 years)",44.0,0.273,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Timothy Crisci","Indiana Univeristy","https://dx.doi.org/10.3389/fped.2021.633082","Verified","United States of America","Abnova","","","","US","US-IN"
"2021-06-07","210503_USA_HIV_ClinicalReferenceLaboratory","HIV and the Seroprevalence of SARS-CoV-2","2021-05-03","National","United States of America","2020-01-01","2021-03-31","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",1191.0,0.128,"","","Convenience","Total Antibody","Moderate","Preprint","Robert Stout","Clinical Reference Laboratory","10.1101/2021.04.29.21256302","Verified","United States of America","Roche",0.995,0.998,"","US",""
"2021-06-07","210504_DallasTexas_UniversityofTexasSouthwestern","Childcare providers anxiety levels and SARS-CoV- 2 testing","2021-05-04","Local","United States of America","2020-10-01","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",37.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Lauren Diercks","University of Texas Southwestern","http://dx.doi.org/10.1111/acem.14249","Unverified","United States of America","Abbot","","","","US",""
"2021-06-07","210504_Okinawa_OkinawaInstituteOfScienceAndTechnology","COVID-19 serological survey using micro blood sampling.","2021-05-04","Local","Japan; Okinawa Prefecture; Okinawa","2020-08-01","2020-08-31","Multiple populations","Adults (18-64 years)",675.0,0.0,"","","Convenience","Not reported","Moderate","Journal Article (Peer-Reviewed)","Melissa M Matthews","Okinawa Institute of Science and Technology","https://dx.doi.org/10.1038/s41598-021-88850-z","Verified","Japan","N/A - institution designed",0.925,1.0,"ELISA","JP","JP-47"
"2021-06-07","210513_Greece_UniversityThessaly_TestPopAdj","Repeated Leftover Serosurvey of SARS-CoV-2 IgG Antibodies in Greece, May to August 2020.","2021-05-13","National","Greece","2020-05-01","2020-08-31","Household and community samples","Multiple groups",20110.0,0.002,0.001,0.003,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Zacharoula Bogogiannidou","University of Thessaly","https://dx.doi.org/10.3390/vaccines9050504","Unverified","Greece","Abbott",0.84,0.997,"","GR",""
"2021-06-07","210518_UK_UniversityCollegeLondon_overall","Occupation, Work-Related Contact, and SARS-CoV-2 Anti-Nucleocapsid Serological Status: Findings from the Virus Watch prospective cohort study","2021-05-18","National","United Kingdom of Great Britain and Northern Ireland; England and Wales","2021-02-01","2021-04-28","Household and community samples","Adults (18-64 years)",3761.0,0.116,"","","Convenience","Total Antibody","High","Preprint","Sarah Beale","University College London","10.1101/2021.05.13.21257161","Verified","The United Kingdom","Roche","","","","GB","GB-ENG"
"2021-06-07","210521_France_SantePubliqueFrance_April2_Overall_PopAdj_TestAdj","Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.","2021-05-21","National","France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","2020-04-06","2020-04-12","Residual sera","Multiple groups",3595.0,0.041,0.033,0.05,"Stratified probability","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Stephane Le Vu","Santé publique France","https://dx.doi.org/10.1038/s41467-021-23233-6","Verified","France","N/A - Author Designed",1.0,1.0,"","FR",""
"2021-06-07","210521_France_SantePubliqueFrance_March1_Overall_PopAdj_TestAdj","Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.","2021-05-21","National","France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","2020-03-09","2020-03-15","Residual sera","Multiple groups",3834.0,0.004,0.0,0.009,"Stratified probability","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Stephane Le Vu","Santé publique France","https://dx.doi.org/10.1038/s41467-021-23233-6","Verified","France","N/A - Author Designed",1.0,1.0,"","FR",""
"2021-06-07","210521_France_SantePubliqueFrance_May3_Overall_PopAdj_TestAdj","Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.","2021-05-21","National","France; Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur","2020-05-11","2020-05-17","Residual sera","Multiple groups",3592.0,0.049,0.04,0.059,"Stratified probability","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Stephane Le Vu","Santé publique France","https://dx.doi.org/10.1038/s41467-021-23233-6","Verified","France","N/A - Author Designed",1.0,1.0,"","FR",""
"2021-06-07","210523_Istanbul_KocUniversity","Predictors of SARS CoV-2 Infection Among Healthcare Workers: The Impact of Community-Hospital Gradient","2021-05-23","Regional","Turkey; Istanbul; Istanbul","2020-05-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",1732.0,0.15,"","","Convenience","IgG; IgM; IgA","High","Preprint","Fatihan Pınarlık","Koc University","10.1101/2021.05.20.21257518","Unverified","Turkey","Roche","","","","TR","TR-34"
"2021-06-07","210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Residents1","Seroprevalence of SARS-CoV-2 Among Skilled Nursing Facility Residents and Staff Members - Los Angeles County, August-September 2020.","2021-05-24","Regional","United States of America; California","2020-08-18","2020-09-24","Patients seeking care for non-COVID-19 reasons","Multiple groups",1806.0,0.25,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jason H Malenfant","Los Angeles County Department of Public Health","https://dx.doi.org/10.1093/infdis/jiab281","Unverified","United States of America","Abbott, Diasorin","","","","US","US-CA"
"2021-06-07","210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Staff2","Seroprevalence of SARS-CoV-2 Among Skilled Nursing Facility Residents and Staff Members - Los Angeles County, August-September 2020.","2021-05-24","Regional","United States of America; California","2020-08-18","2020-09-24","Health care workers and caregivers","Multiple groups",856.0,0.4,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jason H Malenfant","Los Angeles County Department of Public Health","https://dx.doi.org/10.1093/infdis/jiab281","Unverified","United States of America","Abbott, Diasorin","","","","US","US-CA"
"2021-06-07","210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_July1_overall","Seroprevalence of SARS-CoV-2 antibodies in South Korea.","2021-05-24","National","Republic of Korea","2020-04-21","2020-06-16","Residual sera","Multiple groups",1500.0,0.0,"","","Convenience","Neutralizing","High","Journal Article (Peer-Reviewed)","Kwangmin Lee","Korea Disease Control and Prevention Agency","https://dx.doi.org/10.1007/s42952-021-00131-7","Verified","Democratic People's Republic of Korea","N/A - in house",0.933,0.971,"","KR",""
"2021-06-07","210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_November3_TestAdj","Seroprevalence of SARS-CoV-2 antibodies in South Korea.","2021-05-24","National","Republic of Korea","2020-08-14","2020-10-31","Residual sera","Multiple groups",1379.0,0.006,"","","Convenience","Neutralizing","High","Journal Article (Peer-Reviewed)","Kwangmin Lee","Korea Disease Control and Prevention Agency","https://dx.doi.org/10.1007/s42952-021-00131-7","Verified","Democratic People's Republic of Korea","N/A - in house",0.933,0.971,"","KR",""
"2021-06-07","210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_September2","Seroprevalence of SARS-CoV-2 antibodies in South Korea.","2021-05-24","National","Republic of Korea","2020-06-10","2020-08-13","Residual sera","Multiple groups",1440.0,0.001,"","","Convenience","Neutralizing","High","Journal Article (Peer-Reviewed)","Kwangmin Lee","Korea Disease Control and Prevention Agency","https://dx.doi.org/10.1007/s42952-021-00131-7","Verified","Democratic People's Republic of Korea","N/A - in house",0.933,0.971,"","KR",""
"2021-06-07","210525_Pakistan_RiphahInternationalUniversity","SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?.","2021-05-25","National","Pakistan","2020-07-15","2020-07-31","Household and community samples","Multiple groups",15390.0,0.424,0.415,0.431,"Stratified probability","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Mohsina Haq","Riphah International University","https://dx.doi.org/10.1007/s15010-021-01629-2","Verified","Pakistan","Roche",0.988,1.0,"","PK",""
"2021-06-07","210526_Ireland_TrinityCollege","SARS-CoV-2 Antibody Testing in Healthcare Workers: a comparison of the clinical performance of three commercially available antibody assays","2021-05-26","Regional","Ireland","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",5787.0,0.095,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Niamh Allen","Trinity College, University of Dublin","https://europepmc.org/article/PPR/PPR347943","Unverified","Ireland","Roche",1.0,0.998,"","IE",""
"2021-06-07","210527_NewYorkCity_NewYorkUniversityGrossmanSchoolofMedicine_primary","Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.","2021-05-27","Local","United States of America; New York; New York City","2020-04-29","2021-02-09","Patients seeking care for non-COVID-19 reasons","Multiple groups",329.0,0.16,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Amit Saxena","New York University Grossman School of Medicine","https://dx.doi.org/10.1016/S2665-9913(21)00114-4","Unverified","United States of America","NA","","","","US","US-NY"
"2021-06-07","210528_Tokyo_NationalCancerCenterHospital_HCW_primary","Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.","2021-05-28","Local","Japan","2020-09-01","2020-10-30","Health care workers and caregivers","Multiple groups",1190.0,0.007,0.003,0.013,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shu Yazaki","National Cancer Center Hospital","https://dx.doi.org/10.1001/jamaoncol.2021.2159","Unverified","Japan","N/A- Author designed","","","","JP",""
"2021-06-07","210528_Tokyo_NationalCancerCenterHospital_patients_primary","Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.","2021-05-28","Local","Japan","2020-08-03","2020-08-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",500.0,0.01,0.003,0.023,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shu Yazaki","National Cancer Center Hospital","https://dx.doi.org/10.1001/jamaoncol.2021.2159","Unverified","Japan","N/A- Author designed","","","","JP",""
"2021-06-07","210531_Denmark_AarhusUniversity_BloodDonors2","Isolation, behavioral changes and low seroprevalence of SARS-CoV-2 antibodies in patients with Systemic Lupus Erythematosus or Rheumatoid arthritis.","2021-05-31","National","Denmark","2020-06-08","2020-06-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",513.0,0.019,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Christian Ammitzboll","Aarhus University","https://dx.doi.org/10.1002/acr.24716","Unverified","Denmark","Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China",0.967,0.995,"","DK",""
"2021-06-07","210531_Denmark_AarhusUniversity_CRDPatients1","Isolation, behavioral changes and low seroprevalence of SARS-CoV-2 antibodies in patients with Systemic Lupus Erythematosus or Rheumatoid arthritis.","2021-05-31","National","Denmark","2020-06-08","2020-06-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",365.0,0.003,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Christian Ammitzboll","Aarhus University","https://dx.doi.org/10.1002/acr.24716","Unverified","Denmark","Wantai Biological Pharmacy Enterprise Co., Ltd., Beijing, China",0.967,0.995,"","DK",""
"2021-06-07","210531_Marseille_HôpitauxdeMarseille","Seroprevalence of SARS-CoV-2 Antibodies Among Homeless People Living Rough, in Shelters and Squats: A Large Population-Based Study in France","2021-05-31","Local","France; Provence-Alpes-Côte d'Azur; Marseille","2020-06-01","2020-08-05","Persons experiencing homelessness","Adults (18-64 years)",1156.0,0.056,0.029,0.072,"Convenience","IgG; IgM","Moderate","Preprint","Sandrine Loubiere","Hôpitaux de Marseille","https://europepmc.org/article/PPR/PPR350578","Unverified","France","Biosynex",1.0,0.995,"","FR","FR-PAC"
"2021-06-07","210602_SouthEastAsia_MaulanaAzadMedicalCollege","SARS-CoV-2 Immunoglobulin g (IgG) Kinetics in Healthcare Workers and Their Close Contacts Reduced Risk of Re-infection: South-East Asian Region","2021-06-02","Local","India","2020-06-22","2020-12-22","Contacts of COVID patients","Multiple groups",166.0,0.373,"","","Convenience","IgG","High","Preprint","Mradul Kumar Daga","Maulana Azad Medical College","https://www.researchsquare.com/article/rs-540165/v1","Unverified","India","Erba Mannheim and Calbiotech","","","","IN",""
"2021-06-07","210602_UK_dental_UniversityBirmingham_Follow-up","COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals.","2021-06-02","Regional","United Kingdom of Great Britain and Northern Ireland; West midlands","2021-01-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",944.0,0.514,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","A M Shields","University of Birmingham","https://dx.doi.org/10.1177/00220345211020270","Unverified","The United Kingdom","Development; of this assay was undertaken by the authors at the University of Birmingham in collaboration; with The Binding Site.",0.986,0.983,"","GB","GB-ENG"
"2021-06-07","210603_UnitedStates_EmoryUniversity","Us population-based survey of vaccine willingness and sars-cov- 2 antibody prevalence","2021-06-03","National","United States of America; NR; NR","2020-08-09","2020-12-08","Household and community samples","Multiple groups",1454.0,0.047,"","","Simplified probability","Not reported","Unclear","Presentation or Conference","Aaron Siegler","Emory University","https://www.croiconference.org/abstract/us-population-based-survey-of-vaccine-willingness-and-sars-cov-2-antibody-prevalence/","Verified","United States of America","NR","","","","US",""
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Brno/South Moravian Region","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Regional","Czechia; Brno / South Moravian","2020-04-23","2020-05-01","Household and community samples","Multiple groups",5049.0,0.001,0.0,0.002,"Stratified non-probability","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified","Czechia","Fortress",0.95,1.0,"","CZ","CZ-JM"
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litomerice","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Local","Czechia","2020-04-23","2020-05-01","Household and community samples","Multiple groups",3106.0,0.002,0.001,0.004,"Stratified non-probability","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified","Czechia","Fortress",0.95,1.0,"","CZ",""
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litovel_Unicov","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Local","Czechia","2020-04-23","2020-05-01","Household and community samples","Multiple groups",2409.0,0.018,0.012,0.023,"Stratified non-probability","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified","Czechia","Fortress",0.95,1.0,"","CZ",""
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Olomouc/Olomouckykraj","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Regional","Czechia; Olomouc / Olomouc","2020-04-23","2020-05-01","Household and community samples","Multiple groups",6686.0,0.007,0.005,0.009,"Stratified non-probability","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified","Czechia","Fortress",0.95,1.0,"","CZ","CZ-712"
"2021-06-08","200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Prague","Studie SARS-CoV-2-CZ-Preval","2020-05-06","Local","Czechia","2020-04-23","2020-05-01","Household and community samples","Multiple groups",5021.0,0.002,0.0,0.003,"Stratified non-probability","Not reported","Moderate","Presentation or Conference","Ladislav Dušek","Ministry o fHealth of the Czech Republic","https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf","Unverified","Czechia","Fortress",0.95,1.0,"","CZ",""
"2021-06-08","210323_Budel_MaastrichtUniversity_Overall","[Experiences of (care) professionals during a COVID-19 outbreak and results of serological tests in the staff of a heavily affected nursing home.].","2021-03-23","Local","Netherlands; North Brabant; Budel","2020-06-04","2020-06-16","Health care workers and caregivers","Adults (18-64 years)",240.0,0.392,"","","Convenience","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Joyce Heffels","Maastricht University","https://dx.doi.org/10.36613/tgg.1875-6832/2021.01.01","Verified","Netherlands","NR",0.961,0.98,"","NL","NL-NB"
"2021-06-08","210416_Jordan_KingHusseinCancerCenter_Grp1_June","Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic","2021-04-19","National","Jordan; North, Center, South","2020-01-15","2020-06-15","Blood donors","Adults (18-64 years)",736.0,0.0,0.0,0.005,"Sequential","Total Antibody","High","Journal Article (Peer-Reviewed)","Maher Sughayer","King Hussein Cancer Center","http://dx.doi.org/10.1016/j.ijid.2021.04.059","Verified","Jordan","Roche Diagnostics",1.0,0.998,"","JO",""
"2021-06-08","210416_Jordan_KingHusseinCancerCenter_Grp2_September","Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic","2021-04-19","National","Jordan; North, Center, South","2020-09-01","2020-09-15","Blood donors","Adults (18-64 years)",348.0,0.0,0.0,0.005,"Sequential","Total Antibody","High","Journal Article (Peer-Reviewed)","Maher Sughayer","King Hussein Cancer Center","http://dx.doi.org/10.1016/j.ijid.2021.04.059","Verified","Jordan","Roche Diagnostics",1.0,0.998,"","JO",""
"2021-06-08","210416_Jordan_KingHusseinCancerCenter_Grp3_January_TestAdj","Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic","2021-04-19","National","Jordan; North, Center, South","2021-01-28","2021-02-05","Blood donors","Adults (18-64 years)",292.0,0.273,0.225,0.329,"Sequential","Total Antibody","High","Journal Article (Peer-Reviewed)","Maher Sughayer","King Hussein Cancer Center","http://dx.doi.org/10.1016/j.ijid.2021.04.059","Verified","Jordan","Roche Diagnostics",1.0,0.998,"","JO",""
"2021-06-08","210427_Sweden_SwedishPublicHealthAgency_Outpatients_10_Week48-49_Overall","Påvisning av antikroppar efter genomgången covid-19 i blodprov från öppenvården (Delrapport 1)","2021-04-27","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-11-23","2020-12-04","Residual sera","Multiple groups",4500.0,0.079,0.068,0.092,"Stratified probability","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Unverified","Sweden","Sci LifeLab / KTH",0.994,"","","SE",""
"2021-06-08","210427_Sweden_SwedishPublicHealthAgency_Outpatients_11_Week9-10_2021_Overall","Påvisning av antikroppar efter genomgången covid-19 i blodprov från öppenvården (Delrapport 1)","2021-04-27","National","Sweden; Jönköping, Kalmar, Skåne,Stockholm, Uppsala, Västerbotten, Västra Götaland, Örebo","2021-03-01","2021-03-12","Residual sera","Multiple groups",4749.0,0.207,0.194,0.221,"Stratified probability","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Unverified","Sweden","Sci LifeLab / KTH",0.994,"","","SE",""
"2021-06-08","210427_Sweden_SwedishPublicHealthAgency_Outpatients_9_Week42-43_Overall","Påvisning av antikroppar efter genomgången covid-19 i blodprov från öppenvården (Delrapport 1)","2021-04-27","National","Sweden; Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro","2020-10-12","2020-10-23","Residual sera","Multiple groups",4500.0,0.067,0.057,0.078,"Stratified probability","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf","Unverified","Sweden","Sci LifeLab / KTH",0.994,"","","SE",""
"2021-06-08","210502_England_ImperialCollegeLondon_TestPopAdj","Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults.","2021-05-02","National","United Kingdom of Great Britain and Northern Ireland; England","2020-06-20","2020-09-28","Household and community samples","Multiple groups",365104.0,0.049,0.048,0.05,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Helen Ward","Imperial College London","https://dx.doi.org/10.1016/j.lanepe.2021.100098","Unverified","The United Kingdom","Fortress Diagnostics",0.844,0.986,"","GB","GB-ENG"
"2021-06-08","210510_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report May 10, 2021 Report #7: January 2021 Survey","2021-05-10","National","Canada","2021-01-01","2021-01-27","Blood donors","Multiple groups",33400.0,0.028,0.026,0.03,"Sequential","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified","Canada","Roche",0.988,0.996,"","CA",""
"2021-06-08","210521_Karnataka_IndianInstituteOfPublicHealth_Primary","The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India","2021-05-21","Regional","India; Karnataka","2020-09-03","2020-09-16","Household and community samples","Multiple groups",15624.0,0.168,0.155,0.181,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Giridhara Babu","Indian Institute of Public Health","http://dx.doi.org/10.1016/j.ijid.2021.05.043","Verified","India","Zydus Cadila",0.921,0.977,"","IN","IN-KA"
"2021-06-08","210528_Bari_IRCCSIstitutoTumoriGiovanniPaoloII_Baseline","Prospective Observational COVID-19 Screening and Monitoring of Asymptomatic Cancer Center Health-Care Workers with a Rapid Serological Test.","2021-05-28","Local","Italy; Puglia; Bari","2020-03-26","2020-03-31","Health care workers and caregivers","Multiple groups",606.0,0.011,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Angelo Virgilio Paradiso","IRCCS Istituto Tumori “Giovanni Paolo II”","https://dx.doi.org/10.3390/diagnostics11060975","Unverified","Italy","VivaChek Biotech, Hangzhou, China","","","","IT","IT-75"
"2021-06-15","210518_Taiwan_NationalTaiwanUniversity_GroupH1","Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003.","2021-05-18","National","China; Taiwan; Taipei, Zhubei","2020-06-25","2020-07-29","Health care workers and caregivers","Adults (18-64 years)",464.0,0.0,0.0,0.008,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Wen Pin Tseng","National Taiwan University","https://dx.doi.org/10.3389/fimmu.2021.626609","Unverified","","NR","","","","CN",""
"2021-06-16","210505_Brussels_CliniquesUniversitairesSaint-Luc","Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity","2021-05-05","Local","Belgium; Brussels-Capital; City of Brussels","2020-06-19","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",3255.0,0.078,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Anais Scohy","Cliniques universitaires Saint-Luc","http://dx.doi.org/10.1016/j.diagmicrobio.2021.115414","Unverified","","NR",1.0,0.95,"","BE","BE-BRU"
"2021-06-16","210518_Taiwan_NationalTaiwanUniversity_GroupC2","Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003.","2021-05-18","National","China; Taiwan; Taipei, Zhubei","2020-06-25","2020-07-29","Health care workers and caregivers","Adults (18-64 years)",1142.0,0.001,0.0,0.005,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Wen Pin Tseng","Researchers at the National Taiwan University studied symptomatic patients with frontline healthcare workers (n=464) and found a stringently judged seroprevalence of 0%.","https://dx.doi.org/10.3389/fimmu.2021.626609","Unverified","","NR","","","","CN",""
"2021-06-16","210530_Cameroon_UniversityofYaoundé_primary","Serologic Response to SARS-CoV-2 in an African Population.","2021-05-30","Regional","Cameroon","2020-06-15","2020-08-15","Multiple populations","Multiple groups",999.0,0.32,0.27,0.35,"Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Karl Njuwa Fai","University of Yaoundé","https://dx.doi.org/10.1016/j.sciaf.2021.e00802","Unverified","","NR","","","","CM",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoApril_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-04-01","2020-04-30","Blood donors","Adults (18-64 years)",157.0,0.0,0.0,0.0,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-08-01","2020-08-30","Blood donors","Adults (18-64 years)",432.0,0.413,0.411,0.415,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-07-01","2020-07-31","Blood donors","Adults (18-64 years)",428.0,0.354,0.352,0.356,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",308.0,0.028,0.027,0.029,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMarch_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-03-01","2020-03-30","Blood donors","Adults (18-64 years)",496.0,0.0,0.0,0.0,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMay_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-05-01","2020-05-31","Blood donors","Adults (18-64 years)",598.0,0.0,0.0,0.0,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",502.0,0.38,0.379,0.382,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",495.0,0.432,0.43,0.434,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",481.0,0.435,0.433,0.438,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",227.0,0.492,0.489,0.495,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-07-01","2020-07-31","Blood donors","Adults (18-64 years)",182.0,0.512,0.508,0.516,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",82.0,0.437,0.431,0.443,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",282.0,0.233,0.231,0.235,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",199.0,0.33,0.326,0.333,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",213.0,0.362,0.359,0.365,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-16","210604_Qatar_CornellUniversity_Overall1","Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population.","2021-06-04","National","Qatar","2020-07-26","2020-09-09","Non-essential workers and unemployed persons","Adults (18-64 years)",394.0,0.465,0.416,0.514,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gheyath K Nasrallah","Cornell University","https://dx.doi.org/10.1038/s41598-021-91235-x","Verified","","NR","","","","QA",""
"2021-06-17","201708_Pune_AshokaUniversity_primary","First sero survey shows extensive spread of Covid-19: From 36.1% to 65.4% in selected areas sampled in Pune","2020-08-17","Local","India; Maharashtra; Pune","2020-07-20","2020-08-05","Household and community samples","Multiple groups",1664.0,0.515,"","","Stratified probability","IgG","Unclear","News and Media","Anuradha Mascarenhas","Ashoka University","https://indianexpress.com/article/cities/pune/first-sero-survey-shows-extensive-spread-of-covid-19-from-36-1-to-65-4-in-selected-areas-sampled-in-pune-6558853/","Unverified","India","NR","","","","IN","IN-MH"
"2021-06-17","210508_SouthDakota_SouthDakotaStateUniversity_Phase3","Seroprevalence of SARS-CoV-2 Antibodies Among Rural Healthcare Workers","2021-06-08","Regional","United States of America; South Dakota, Minnesota","2020-10-16","2020-12-22","Health care workers and caregivers","Adults (18-64 years)",7.0,0.148,"","","Convenience","IgG; IgM; IgA","High","Preprint","Jordan Neises","South Dakota State University","https://www.medrxiv.org/content/10.1101/2021.06.07.21258375v1","Unverified","","NR","","","","US",""
"2021-06-17","210529_Pakistan_CombinedMilitaryHospitalKharianMedicalCollege","Seroprevalence of COVID-19 and associated factors in a medical institution in Pakistan.","2021-05-29","National","Pakistan","2020-09-01","2020-09-30","Non-essential workers and unemployed persons","Multiple groups",442.0,0.17,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Iffat Naiyar","Combined Military Hospital Kharian Medical College","https://dx.doi.org/10.1016/j.jtumed.2021.04.004","Unverified","","NR",0.958,0.967,"","PK",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",120.0,0.104,0.102,0.106,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-07-01","2020-07-30","Blood donors","Adults (18-64 years)",142.0,0.0,0.0,0.0,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",129.0,0.0,0.0,0.0,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",172.0,0.162,0.16,0.164,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",152.0,0.187,0.185,0.189,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",173.0,0.219,0.216,0.221,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",107.0,0.445,0.441,0.448,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-07-01","2020-07-31","Blood donors","Adults (18-64 years)",98.0,0.0,0.0,0.001,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",50.0,0.0,0.0,0.0,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",30.0,0.215,0.209,0.22,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",26.0,0.296,0.289,0.302,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",53.0,0.26,0.259,0.261,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraAugust_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-08-01","2020-08-31","Blood donors","Adults (18-64 years)",167.0,0.079,0.077,0.081,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJuly_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-07-01","2020-07-31","Blood donors","Adults (18-64 years)",147.0,0.0,0.0,0.0,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJune_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",87.0,0.0,0.0,0.001,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraNovember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-11-01","2020-11-30","Blood donors","Adults (18-64 years)",199.0,0.235,0.232,0.238,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraOctober_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-10-01","2020-10-31","Blood donors","Adults (18-64 years)",139.0,0.277,0.273,0.28,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraSeptember_Adj","SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.","2021-06-04","Local","Madagascar","2020-09-01","2020-09-30","Blood donors","Adults (18-64 years)",185.0,0.242,0.239,0.244,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Matthieu Schoenhals","Institut Pasteur de Madagascar","https://dx.doi.org/10.1016/j.ebiom.2021.103419","Verified","","NR",0.926,0.996,"","MG",""
"2021-06-17","210605_Kinshasa_InstitutNationaldeRechercheBiomédicale_primary","High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey.","2021-06-05","Local","Democratic Republic of the Congo","2020-10-22","2020-11-08","Household and community samples","Multiple groups",1080.0,0.166,0.14,0.195,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Antoine N Nkuba","Institut National de Recherche Biomédicale","https://dx.doi.org/10.1093/cid/ciab515","Verified","","NR",1.0,0.997,"","CD",""
"2021-06-17","210609_SouthBrazil_UniversidadeFederaldoParaná","SARS-CoV-2 in asymptomatic pregnant women in South Brazil: RT-PCR and serological detection.","2021-06-09","Regional","Brazil; Mato Grosso do Sul; Curitiba","2020-09-15","2020-10-15","Pregnant or parturient women","Adults (18-64 years)",195.0,0.087,"","","Convenience","IgG; IgM","High","Preprint","Jullie Anne Chiste","Complexo Hospital de Clínicas da Universidade Federal do Paraná","https://dx.doi.org/10.1515/jpm-2021-0173","Unverified","","NR","","","","BR","BR-MS"
"2021-06-17","210611_Quebec_Héma-Québec_overall_PopAdj","Phase 2 de l’étude sur la séroprévalence des anticorps dirigés contre le SRAS-CoV-2 au Québec","2021-06-11","Regional","Canada; Québec","2021-01-25","2021-04-22","Blood donors","Multiple groups",7924.0,0.147,0.138,0.156,"Sequential","Not reported","Moderate","Institutional Report","Hema-Quebec","Héma-Québec","https://www.hema-quebec.qc.ca/userfiles/file/coronavirus/COVID-rapport-final-ph2-11-06-2021.pdf","Verified","","NR",0.989,0.985,"","CA","CA-QC"
"2021-06-18","210225_England_ImperialCollegeLondon_Round5_overall_Primary","REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England","2021-02-25","National","United Kingdom of Great Britain and Northern Ireland; England","2021-01-25","2021-02-08","Household and community samples","Multiple groups",155172.0,0.139,0.137,0.141,"Stratified probability","IgG","Low","Institutional Report","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1","Verified","The United Kingdom","Fortress Diagnostics",0.844,0.986,"","GB","GB-ENG"
"2021-06-18","210607_LosAngeles_UniversityofSouthernCalifornia","SARS-CoV-2 Seroprevalence Among Firefighters in Los Angeles, California","2021-06-07","Local","United States of America; California; Los Angeles","2020-10-20","2020-10-28","Essential non-healthcare workers","Adults (18-64 years)",686.0,0.089,"","","Convenience","IgG; IgM","High","Preprint","Karen Mulligan","University of Southern California","10.1101/2021.06.03.21258299","Unverified","","NR","","","","US","US-CA"
"2021-06-19","210608_Warsaw_CentralClinicalHospitalOfTheMinistryOfInterior","Dynamics of humoral response to coronavirus antigens among employees of COVID-dedicated hospital: an observational study.","2021-06-08","Local","Poland; Mazovia; Warsaw","2020-04-21","2020-07-20","Health care workers and caregivers","Adults (18-64 years)",1572.0,0.227,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Radosław Rzeplinski","Central Clinical Hospital of the Ministry of Interior and Administration","https://dx.doi.org/10.20452/pamw.16025","Unverified","","NR","","","","PL","PL-14"
"2021-06-20","210409_OrangeCounty_UniversityofCaliforniaIrvine_Primary","Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence.","2021-04-09","Local","United States of America; California; Orange County","2020-04-14","2020-05-13","Health care workers and caregivers","Adults (18-64 years)",143.0,0.105,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Theodore W. Heyming","University of California Irvine","https://dx.doi.org/10.5811/westjem.2021.1.50058","Verified","","NR",1.0,0.838,"","US","US-CA"
"2021-06-20","210518_NewZealand_SouthernCommunityLaboratories_MostAdj","SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020.","2021-05-18","Regional","New Zealand; Southern Region","2020-06-04","2020-08-04","Contacts of COVID patients","Multiple groups",1127.0,0.008,0.004,0.015,"Convenience","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Alyson Craigie","Southern Community Laboratories","https://dx.doi.org/10.1016/j.pathol.2021.04.001","Verified","","NR","","","","NZ",""
"2021-06-20","210527_Austria_UniversitätsklinikfürInnereMedizinII_HCWs_PeriodB","Seroprevalence of SARS-CoV-2 antibodies in healthcare workers and an unselected all comer patient population","2021-05-27","Local","Austria; NR; Vienna","2020-09-08","2021-02-22","Health care workers and caregivers","Adults (18-64 years)",498.0,0.072,0.053,0.098,"Convenience","Total Antibody","Unclear","Presentation or Conference","M. Riesenhuber","Universitätsklinik für Innere; Medizin II","https://link.springer.com/content/pdf/10.1007/s00508-021-01884-1.pdf","Verified","","NR","","","","AT",""
"2021-06-20","210527_Austria_UniversitätsklinikfürInnereMedizinII_Patients","Seroprevalence of SARS-CoV-2 antibodies in healthcare workers and an unselected all comer patient population","2021-05-27","Local","Austria; NR; Vienna","2020-08-24","2021-02-22","Residual sera","Multiple groups",6092.0,0.057,"","","Sequential","Total Antibody","Unclear","Presentation or Conference","M. Riesenhuber","Universitätsklinik für Innere Medizin II","https://link.springer.com/content/pdf/10.1007/s00508-021-01884-1.pdf","Verified","","NR","","","","AT",""
"2021-06-20","210611_Cordoba_UniversidadNacionaldeColombia_Primary","Using serological studies to assess COVID-19 infection fatality rate in developing countries. A case study from one Colombian department.","2021-06-11","Regional","Colombia; Cordoba","2020-03-15","2020-10-02","Household and community samples","Multiple groups",2447.0,0.408,"","","Stratified probability","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Nelson Alvis Guzma","Universidad de Cordoba","https://dx.doi.org/10.1016/j.ijid.2021.06.018","Verified","","NR",0.93,0.95,"","CO","CO-COR"
"2021-06-20","210614_Barcelona_HospitalUniversitariValld’Hebron","Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.","2021-06-14","Local","Spain; Province of Barcelona; Barcelona","2020-05-10","2020-10-26","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",294.0,0.031,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Isabel Campos-Varela","Hospital Universitari Vall d’Hebron","https://dx.doi.org/10.1111/tri.13946","Verified","","NR","","","","ES","ES-CT"
"2021-06-20","210614_Verona_UniversityofVerona","Sars-cov-2 infection in health workers: Analysis from verona sieroepid study during the pre-vaccination era","2021-06-14","Local","Italy; Province of Verona; Verona","2020-04-28","2020-07-20","Health care workers and caregivers","Adults (18-64 years)",5299.0,0.06,0.053,0.066,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Stefano Porru","University of Verona","http://dx.doi.org/10.3390/ijerph18126446","Unverified","Italy","NR","","","","IT","IT-34"
"2021-06-21","210501_Poltava_UkranianMedicalStomatologicalAcademy_IgG2","EPIDEMIOLOGICAL DATA ON THE DETECTION OF IMMUNOGLOBULINS OF CLASS IGM, IGG TO SARS-COV-2 AMONG POPULATION OF POLTAVA REGION.","2021-05-01","Local","Ukraine; Poltava Oblast; Poltava","2020-07-15","2020-12-15","Household and community samples","Multiple groups",468.0,0.477,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Alla Marchenko","Ukranian Medical Stomatological Academy","https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf","Verified","","NR","","","","UA","UA-53"
"2021-06-21","210501_Poltava_UkranianMedicalStomatologicalAcademy_IgM1","EPIDEMIOLOGICAL DATA ON THE DETECTION OF IMMUNOGLOBULINS OF CLASS IGM, IGG TO SARS-COV-2 AMONG POPULATION OF POLTAVA REGION.","2021-05-01","Local","Ukraine; Poltava Oblast; Poltava","2020-07-15","2020-12-15","Household and community samples","Multiple groups",2375.0,0.057,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Alla Marchenko","Ukranian Medical Stomatological Academy","https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf","Verified","","NR","","","","UA","UA-53"
"2021-06-21","210503_USA_IndianaUniversity_Primary","A Cross-Sectional Analysis of Demographic and Behavioral Risk Factors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Among a Sample of U.S. College Students.","2021-06-07","Local","United States of America; Indiada","2020-09-08","2020-09-30","Students and Daycares","Adults (18-64 years)",1076.0,0.046,0.033,0.058,"Simplified probability","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Sina Kianersi","Indiana University School of Public Health-Bloomington","https://dx.doi.org/10.1016/j.jadohealth.2021.05.003","Unverified","","NR","","","","US","US-IN"
"2021-06-21","210505_Trieste_ItalianNationalInstituteOfHealth","Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study.","2021-06-05","Regional","Italy; NR; Trieste","2021-01-05","2021-01-31","Blood donors","Children and Youth (0-17 years)",169.0,0.095,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Manola Comar","Italian National Institute of Health","https://dx.doi.org/10.1186/s13052-021-01074-9","Unverified","","NR","","","","IT",""
"2021-06-21","210602_USA_MontantaStateUniversity_Primary","Titers, prevalence, and duration of sars-cov-2 antibodies in a local covid-19 outbreak and following vaccination","2021-06-02","Local","United States of America; Montana; Bozeman","2020-04-15","2020-11-15","Blood donors","Adults (18-64 years)",168.0,0.19,"","","Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Jodi Hedges","Montana State University","http://dx.doi.org/10.3390/vaccines9060587","Unverified","","NR","","","","US","US-MT"
"2021-06-21","210607_EastScotland_UniversityofDundee_Control2","The protective effect of sars-cov-2 antibodies in scottish healthcare workers","2021-06-07","Regional","United Kingdom of Great Britain and Northern Ireland; Scotland; Dundee","2020-05-28","2020-09-02","Residual sera","Multiple groups",231.0,0.048,"","","Sequential","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Hani Abo-Leyah","University of Dundee","http://dx.doi.org/10.1183/23120541.00080-2021","Verified","","NR",0.95,"","","GB","GB-SCT"
"2021-06-21","210607_EastScotland_UniversityofDundee_HCW1","The protective effect of sars-cov-2 antibodies in scottish healthcare workers","2021-06-07","Regional","United Kingdom of Great Britain and Northern Ireland; Scotland; Dundee","2020-05-28","2020-09-02","Health care workers and caregivers","Adults (18-64 years)",2063.0,0.145,"","","Convenience","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Hani Abo-Leyah","University of Dundee","http://dx.doi.org/10.1183/23120541.00080-2021","Verified","","NR",0.95,"","","GB","GB-SCT"
"2021-06-21","210607_Italy_UniversityofMilan_Cohabitants3","Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression.","2021-06-07","National","Italy","2020-07-15","2020-09-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",271.0,0.03,"","","Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","William Morello","University of Milan","https://dx.doi.org/10.2215/CJN.00330121","Unverified","","NR","","","","IT",""
"2021-06-21","210607_Italy_UniversityofMilan_Patients1","Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression.","2021-06-07","National","Italy","2020-07-15","2020-09-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",178.0,0.017,"","","Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","William Morello","University of Milan","https://dx.doi.org/10.2215/CJN.00330121","Unverified","","NR","","","","IT",""
"2021-06-21","210607_Italy_UniversityofMilan_Siblings2","Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression.","2021-06-07","National","Italy","2020-07-15","2020-09-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",90.0,0.07,"","","Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","William Morello","University of Milan","https://dx.doi.org/10.2215/CJN.00330121","Unverified","","NR","","","","IT",""
"2021-06-21","210608_Tokyo_BostonChildrensHospital_August19-September2","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","Japan; Tokyo Prefecture; Tokyo","2020-08-19","2020-09-02","Non-essential workers and unemployed persons","Adults (18-64 years)",62.0,0.468,"","","Convenience","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","NR","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_August5-August18","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","Japan; Tokyo Prefecture; Tokyo","2020-08-05","2020-08-18","Non-essential workers and unemployed persons","Adults (18-64 years)",115.0,0.417,"","","Convenience","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","NR","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_July22-August4","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","Japan; Tokyo Prefecture; Tokyo","2020-07-22","2020-08-04","Non-essential workers and unemployed persons","Adults (18-64 years)",175.0,0.389,"","","Convenience","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","NR","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_July8-July21","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","Japan; Tokyo Prefecture; Tokyo","2020-07-08","2020-07-21","Non-essential workers and unemployed persons","Adults (18-64 years)",256.0,0.371,"","","Convenience","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","NR","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_June10-June23","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","Japan; Tokyo Prefecture; Tokyo","2020-06-10","2020-06-23","Non-essential workers and unemployed persons","Adults (18-64 years)",119.0,0.05,"","","Convenience","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","NR","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_June24-July7","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","Japan; Tokyo Prefecture; Tokyo","2020-06-24","2020-07-07","Non-essential workers and unemployed persons","Adults (18-64 years)",187.0,0.257,"","","Convenience","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","NR","","","","JP","JP-13"
"2021-06-21","210608_Tokyo_BostonChildrensHospital_May26-June9","Dynamic change of COVID-19 seroprevalence among asymptomatic office workers in Tokyo from May through Dec 2020 during the second waves of COVID-19","2021-06-08","Local","Japan; Tokyo Prefecture; Tokyo","2020-05-26","2020-06-09","Non-essential workers and unemployed persons","Adults (18-64 years)",51.0,0.059,"","","Convenience","IgG; IgM","High","Preprint","Sawako Hibino","Medical Corporation Koshikai","https://www.researchsquare.com/article/rs-564670/v1","Verified","","NR","","","","JP","JP-13"
"2021-06-21","210609_CentralDenmarkRegion_AarhusUniversity","Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020.","2021-06-09","Regional","Denmark; Central Denmark Region","2020-05-18","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",11138.0,0.04,"","","Convenience","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Kathrine Agergard Kaspersen","Aarhus University","https://dx.doi.org/10.1016/j.ijid.2021.06.017","Unverified","","NR",0.967,0.995,"","DK","DK-82"
"2021-06-21","210609_England_PublicHealthEngland_Staff_Round2","SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020","2021-06-09","National","United Kingdom of Great Britain and Northern Ireland; England","2020-12-03","2020-12-17","Essential non-healthcare workers","Adults (18-64 years)",872.0,0.134,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Shamez Ladhani","Public Health England","http://dx.doi.org/10.1016/j.eclinm.2021.100948","Unverified","","NR","","","","GB","GB-ENG"
"2021-06-21","210609_England_PublicHealthEngland_Students_Round2","SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020","2021-06-09","National","United Kingdom of Great Britain and Northern Ireland; England","2020-12-03","2020-12-17","Students and Daycares","Children and Youth (0-17 years)",893.0,0.131,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Shamez Ladhani","Public Health England","http://dx.doi.org/10.1016/j.eclinm.2021.100948","Unverified","","NR","","","","GB","GB-ENG"
"2021-06-21","210610_Lombardy_HumanitasUniversity_HCW_overall","SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy.","2021-06-10","Regional","Italy; Lombardy ; Milan, Rozzano, Varese, Castellanza and Bergamo","2020-04-28","2020-05-16","Health care workers and caregivers","Multiple groups",3985.0,0.13,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Maria Teresa Sandri","Humanitas University","https://dx.doi.org/10.1038/s41598-021-91773-4","Verified","","NR",0.904,0.985,"","IT","IT-25"
"2021-06-21","210610_Vietnam_TheUniversityOfSydney_GenPop1_overall","Sero-prevalence of sars-cov-2 antibodies in high-risk populations in vietnam","2021-06-11","National","Viet Nam; Hanoi Capital, Quang Nam Province, Da Nang Province; Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang","2020-09-04","2020-11-23","Household and community samples","Multiple groups",3034.0,0.004,"","","Unclear","IgG","Moderate","Journal Article (Peer-Reviewed)","Tasnim Hasan","The University of Sydney","http://dx.doi.org/10.3390/ijerph18126353","Verified","","NR",0.968,0.998,"","VN",""
"2021-06-21","210610_Vietnam_TheUniversityOfSydney_HCW2_overall","Sero-prevalence of sars-cov-2 antibodies in high-risk populations in vietnam","2021-06-11","Local","Viet Nam; Da Nang","2020-11-24","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",148.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Tasnim Hasan","The University of Sydney","http://dx.doi.org/10.3390/ijerph18126353","Verified","","NR",0.968,0.998,"","VN","VN-DN"
"2021-06-21","210611_SanFrancisco_UniversityofCaliforniaSanFrancisco_mostadj","Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records.","2021-06-11","Local","United States of America; California; San Francisco","2020-03-28","2020-06-26","Residual sera","Multiple groups",4735.0,0.042,0.021,0.063,"Stratified non-probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Isobel Routledge","University of California San Francisco","https://dx.doi.org/10.1038/s41467-021-23651-6","Verified","","NR",0.937,0.996,"","US","US-CA"
"2021-06-22","210604_NewYorkCity_NewYorkCityDepartmentOfHealthAndMentalHygiene_Overall","Prevalence of SARS-CoV-2 antibodies in New York City adults, June-October, 2020: a population-based survey.","2021-06-04","Local","United States of America; New York State; New York City","2020-06-01","2020-10-09","Household and community samples","Multiple groups",1074.0,0.243,0.207,0.283,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Jannae Parrott","New York City Department of Health and Mental Hygiene","https://dx.doi.org/10.1093/infdis/jiab296","Verified","","NR",0.976,0.993,"","US","US-NY"
"2021-06-22","210607_NuevoLeon_HealthServicesOfTheStateOfNuevoLeon_Overall","Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico","2021-06-07","Regional","Mexico; Nuevo Leon","2020-08-15","2020-11-15","Household and community samples","Multiple groups",4495.0,0.271,0.258,0.284,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Edgar Rodriguez-Vidales","Health Services of the State of Nuevo Leon","https://dx.doi.org/10.1002/jmv.27131","Verified","","NR","","","","MX","MX-NLE"
"2021-06-22","210610_Saxony_TechnischeUniversitätDresden_Students_SeptOct_2_overall","SARS-CoV-2 seroprevalence in students and teachers: a longitudinal study from May to October 2020 in German secondary schools.","2021-06-10","Regional","Germany; Saxony","2020-09-15","2020-10-13","Students and Daycares","Children and Youth (0-17 years)",1334.0,0.008,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Carolin Kirsten","Technische Universität Dresden","https://dx.doi.org/10.1136/bmjopen-2021-049876","Unverified","","NR","","","","DE","DE-SN"
"2021-06-22","210610_Saxony_TechnischeUniversitätDresden_Teachers_SeptOct_4_overall","SARS-CoV-2 seroprevalence in students and teachers: a longitudinal study from May to October 2020 in German secondary schools.","2021-06-10","Regional","Germany; Saxony","2020-09-15","2020-10-13","Essential non-healthcare workers","Adults (18-64 years)",445.0,0.002,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Carolin Kirsten","Technische Universität Dresden","https://dx.doi.org/10.1136/bmjopen-2021-049876","Unverified","","NR","","","","DE","DE-SN"
"2021-06-22","210610_USA_BostonHeartDiagnostics","Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging","2021-06-10","National","United States of America","2020-04-06","2020-12-01","Residual sera","Multiple groups",81624.0,0.052,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Ernst J. Schaefer","Boston Heart Diagnostics","http://dx.doi.org/10.1371/journal.pone.0252818","Unverified","","NR",0.984,0.974,"","US",""
"2021-06-22","210615_USA_JohnsHopkinsUniversity","Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020.","2021-06-15","National","United States of America","2020-01-02","2020-03-18","Household and community samples","Multiple groups",24079.0,0.0,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Keri N. Althoff","Johns Hopkins University","https://dx.doi.org/10.1093/cid/ciab519","Unverified","","NR",0.907,1.0,"","US",""
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_Agartala5","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","India; Tripura; Agartala","2021-03-26","2021-06-01","Household and community samples","Multiple groups",1001.0,0.519,"","","Stratified probability","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","NR",0.944,1.0,"","IN","IN-TR"
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_Bhubaneswar3","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","India; Odisha; Bhubaneswar","2021-03-22","2021-05-07","Household and community samples","Multiple groups",1000.0,0.526,"","","Stratified probability","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","NR",0.944,1.0,"","IN","IN-OR"
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_DelhiRural2","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","India; Haryana; ; Faridabad","2021-04-12","2021-05-22","Household and community samples","Multiple groups",1059.0,0.593,"","","Stratified probability","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","NR",0.944,1.0,"","IN","IN-HR"
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_DelhiUrban1","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","India; National Capital Territory of Delhi; New Delhi","2021-03-15","2021-03-31","Household and community samples","Multiple groups",1001.0,0.747,"","","Stratified probability","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","NR",0.944,1.0,"","IN","IN-DL"
"2021-06-22","210616_India_AllIndiaInstituteOfMedicalSciences_Gorakhpur4","Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study","2021-06-16","Local","India; Uttar Pradesh; Gorakhpur","2021-04-22","2021-06-10","Household and community samples","Multiple groups",448.0,0.879,"","","Stratified probability","Total Antibody","Moderate","Preprint","Puneet Misra","All India Institute of Medical Sciences","https://europepmc.org/article/PPR/PPR357490","Verified","","NR",0.944,1.0,"","IN","IN-UP"
"2021-06-23","200826_Andhra_CollegeOfVeterinary Sciences_Anantapur2","Andhra’s second sero survey begins today, 45,000 samples to be collected from 9 districts","2020-08-26","Regional","India; Andhra","2020-08-07","2020-08-12","Household and community samples","Multiple groups",3750.0,0.167,"","","Unclear","IgG","High","News and Media","Dr K Rambabu","College of Veterinary Sciences","https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/","Unverified","","NR","","","","IN","IN-AP"
"2021-06-23","200826_Andhra_CollegeOfVeterinary Sciences_EastGodavari3","Andhra’s second sero survey begins today, 45,000 samples to be collected from 9 districts","2020-08-26","Regional","India; Andhra","2020-08-07","2020-08-12","Household and community samples","Multiple groups",3750.0,0.144,"","","Unclear","IgG","High","News and Media","Dr K Rambabu","College of Veterinary Sciences","https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/","Unverified","","NR","","","","IN","IN-AP"
"2021-06-23","200826_Andhra_CollegeOfVeterinary Sciences_Nellore4","Andhra’s second sero survey begins today, 45,000 samples to be collected from 9 districts","2020-08-26","Regional","India; Andhra","2020-08-07","2020-08-12","Household and community samples","Multiple groups",3750.0,0.082,"","","Unclear","IgG","High","News and Media","Dr K Rambabu","College of Veterinary Sciences","https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/","Unverified","","NR","","","","IN","IN-AP"
"2021-06-23","200826_Andhra_CollegeOfVeterinarySciences_Krishna1","Andhra’s second sero survey begins today, 45,000 samples to be collected from 9 districts","2020-08-26","Regional","India; Andhra","2020-08-07","2020-08-12","Household and community samples","Multiple groups",3750.0,0.217,"","","Unclear","IgG","High","News and Media","Dr K Rambabu","College of Veterinary Sciences","https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/","Unverified","","NR","","","","IN","IN-AP"
"2021-06-23","200903_Ahmedabad_AhmedabadMunicipalCorporation","Second survey in Ahmedabad: Sero-positivity up by 5.6 per cent since June, no herd immunity yet","2020-09-03","Local","India; Gujarat; Ahmedabad","2020-08-15","2020-08-29","Household and community samples","Multiple groups",10310.0,0.232,"","","Unclear","Not reported","High","News and Media","Express News Service","Ahmedabad Municipal Corporation","https://indianexpress.com/article/cities/ahmedabad/second-survey-in-ahmedabad-sero-positivity-up-by-5-6-per-cent-since-june-no-herd-immunity-yet-6580951/","Unverified","","NR","","","","IN","IN-GJ"
"2021-06-23","210201_Yamagata_YamagataUniversity_Overall","Seroepidemiology of SARS-CoV-2, Yamagata, Japan, June 2020.","2021-02-01","Local","Japan; Yamagata prefecture; Yamagata","2020-06-01","2020-06-04","Residual sera","Multiple groups",1009.0,0.005,0.001,0.009,"Sequential","Total Antibody","High","Institutional Report","Keita Morikane","Yamagata University","https://dx.doi.org/10.5365/wpsar.2020.11.3.012","Verified","","NR","",0.998,"","JP","JP-06"
"2021-06-23","210208_Kenya_KEMRI-WellcomeTrust_KilifiOct_TestAdj","Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals","2021-02-08","Local","Kenya; NR; Kilifi","2020-10-01","2020-10-31","Pregnant or parturient women","Adults (18-64 years)",183.0,0.015,0.001,0.041,"Sequential","IgG","Moderate","Preprint","R Lucinde","KEMRI-Wellcome Trust","https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text","Verified","","NR",0.927,0.99,"","KE",""
"2021-06-23","210208_Kenya_KEMRI-WellcomeTrust_KilifiSept_TestAdj","Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals","2021-02-08","Local","Kenya","2020-09-18","2020-09-30","Pregnant or parturient women","Adults (18-64 years)",82.0,0.013,0.0,0.047,"Sequential","IgG","Moderate","Preprint","R Lucinde","KEMRI-Wellcome Trust","https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text","Verified","","NR",0.927,0.99,"","KE",""
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Non-essential workers and unemployed persons","Adults (18-64 years)",369.0,0.054,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","Mozambique","Qingdao Hightop biotech","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenseForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Essential non-healthcare workers","Adults (18-64 years)",513.0,0.037,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","Mozambique","Qingdao Hightop biotech","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_DisplacedPeople","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Persons experiencing homelessness","Multiple groups",66.0,0.061,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","Mozambique","Qingdao Hightop biotech","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Fishermen","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Non-essential workers and unemployed persons","Adults (18-64 years)",80.0,0.05,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","Mozambique","Qingdao Hightop biotech","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_HealthProfessionals","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Health care workers and caregivers","Adults (18-64 years)",506.0,0.055,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","Mozambique","Qingdao Hightop biotech","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Essential non-healthcare workers","Adults (18-64 years)",248.0,0.048,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","Mozambique","Qingdao Hightop biotech","","","","MZ","MZ-P"
"2021-06-25","201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Vendors/Merchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Pemba (InCOVID 2020)","2020-07-27","Local","Mozambique; Cabo Delgado; Pemba","2020-07-06","2020-07-13","Non-essential workers and unemployed persons","Adults (18-64 years)",928.0,0.065,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","República de Moçambique Ministério da Saúde","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf","Verified","Mozambique","Qingdao Hightop biotech","","","","MZ","MZ-P"
"2021-06-28","210622_Estonia_UniversityOfTartu_Stage18_Overall","The study on the prevalence of the coronavirus in Estonia","2021-12-13","National","Estonia","2021-06-10","2021-06-21","Household and community samples","Multiple groups",2330.0,0.679,0.66,0.698,"Stratified probability","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire","Verified","","NR","","","","EE",""
"2021-06-29","210525_Paris_SamusocialDeParis_Residents_Overall","Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020)","2021-05-25","Local","France; Ile de France; Paris","2020-03-01","2020-05-31","Persons experiencing homelessness","Multiple groups",96.0,0.698,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Maya Husain","Samusocial de Paris","http://dx.doi.org/10.1016/j.cmi.2021.05.039","Unverified","","NR",0.96,0.993,"","FR","FR-IDF"
"2021-06-29","210525_Paris_SamusocialDeParis_Staff_Overall","Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020)","2021-05-25","Local","France; Ile de France; Paris","2020-03-01","2020-05-31","Essential non-healthcare workers","Multiple groups",81.0,0.185,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Maya Husain","Samusocial de Paris","http://dx.doi.org/10.1016/j.cmi.2021.05.039","Unverified","","NR",0.96,0.993,"","FR","FR-IDF"
"2021-06-29","210531_Madrid_CentroDeTransfusiónDeLaComunidadDeMadrid_overall","Anti SARS-CoV-2 antibodies prevalence in Madrid blood donors prior to first outbreak","2021-05-31","Local","Spain","2020-01-01","2020-03-22","Blood donors","Multiple groups",2419.0,0.001,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","R. Alenda","Centro de Transfusión de la Comunidad de Madrid","http://dx.doi.org/10.1111/vox.13117","Verified","","NR","","","","ES",""
"2021-06-29","210601_Chennai_GovernmentKilpaukMedicalCollege","Evaluation of IgG antibody response to severe acute respiratory syndrome Coronavirus-2 in healthcare workers in a tertiary care centre, Chennai, India","2021-06-01","Local","India; Tamil Nadu; Chennai","2020-04-15","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",45.0,0.267,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Therese Dhason","Government Kilpauk Medical College","http://dx.doi.org/10.7860/JCDR/2021/48889.14995","Unverified","","NR","","","","IN","IN-TN"
"2021-06-29","210606_Pennsylvania_UniversityOfPittsburgh_Fall1_overall","A cross-sectional study of sars-cov-2 seroprevalence between fall 2020 and february 2021 in allegheny county, western pennsylvania, usa","2021-06-06","Regional","United States of America; Pennsylvania","2020-09-21","2020-11-04","Multiple general populations","Multiple groups",199.0,0.02,0.01,0.05,"Convenience","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Lingqing Xu","University of Pittsburgh","http://dx.doi.org/10.3390/pathogens10060710","Verified","","NR","","","","US","US-PA"
"2021-06-29","210606_Pennsylvania_UniversityOfPittsburgh_Feb2","A cross-sectional study of sars-cov-2 seroprevalence between fall 2020 and february 2021 in allegheny county, western pennsylvania, usa","2021-06-06","Local","United States of America; Pennsylvania; Pittsburgh","2021-02-01","2021-02-05","Residual sera","Multiple groups",194.0,0.165,0.12,0.22,"Sequential","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Lingqing Xu","University of Pittsburgh","http://dx.doi.org/10.3390/pathogens10060710","Verified","","NR","","","","US","US-PA"
"2021-06-29","210622_UnitedStatesOfAmerica_NationalInstitutesOfHealth_PopAdj","Undiagnosed SARS-CoV-2 Seropositivity During the First Six Months of the COVID-19 Pandemic in the United States.","2021-06-22","National","United States of America","2020-04-01","2020-08-04","Household and community samples","Multiple groups",8058.0,0.046,0.026,0.065,"Stratified non-probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Heather Kalish","National Institutes of Health","https://dx.doi.org/10.1126/scitranslmed.abh3826","Unverified","","NR","","","","US",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Dec2019","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","2019-12-01","2019-12-31","Residual sera","Multiple groups",147.0,0.075,"","","Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","Italy","Mazzini et al",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Feb2020","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","2020-02-01","2020-03-10","Residual sera","Multiple groups",105.0,0.2,"","","Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","Italy","Mazzini et al",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Jan2020","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","2020-01-01","2020-01-31","Residual sera","Multiple groups",106.0,0.028,"","","Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","Italy","Mazzini et al",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Nov2019","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","2019-11-01","2019-11-30","Residual sera","Multiple groups",273.0,0.095,"","","Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","Italy","Mazzini et al",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Oct2019","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","2019-10-01","2019-10-31","Residual sera","Multiple groups",166.0,0.163,"","","Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","Italy","Mazzini et al",0.857,0.981,"","IT",""
"2021-06-30","201111_Italy_IstitutoNazionaleTumori_Sept2019","Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy","2020-11-11","National","Italy","2019-09-01","2019-09-30","Residual sera","Multiple groups",162.0,0.142,"","","Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Giovanni Apolone","Istituto Nazionale Tumori","https://dx.doi.org/10.1177/0300891620974755","Verified","Italy","Mazzini et al",0.857,0.981,"","IT",""
"2021-06-30","210302_Vietnam_UniversitatsklinikumTubingen_patients_RDT","Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam","2021-03-02","Local","Viet Nam; Red River Delta; Hanoi","2020-03-01","2021-01-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",288.0,0.0,"","","Unclear","Total Antibody","High","Journal Article (Peer-Reviewed)","Le Huu Song","Universitätsklinikum Tübingen","https://dx.doi.org/10.1016/j.lanwpc.2021.100113","Verified","Viet Nam","WANTAI Biological Pharmacy, Beijing, China","","","","VN",""
"2021-06-30","210604_Nancy_UniversiteDeLorraine","Seroprevalence of sars-cov-2, symptom profiles and sero-neutralization in a suburban area, france","2021-06-04","Local","France; Grand Est; Nancy","2020-06-26","2020-07-04","Household and community samples","Multiple groups",2006.0,0.025,0.018,0.033,"Convenience","IgG; IgM; IgA; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Anne Gegout Petit","Université de Lorraine","http://dx.doi.org/10.3390/v13061076","Unverified","","NR","","","","FR","FR-GES"
"2021-06-30","210608_Geneva_UniversityOfGeneva_overall","Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland","2021-06-08","Regional","Switzerland; Canton of Geneva","2020-05-18","2020-09-18","Essential non-healthcare workers","Adults (18-64 years)",10513.0,0.098,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Silvia Stringhini","The University of Geneva","http://dx.doi.org/10.1038/s41467-021-23796-4","Unverified","","NR","","","","CH","CH-GE"
"2021-06-30","210608_SouthWestOfIreland_CorkUniversityHospital","Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland","2021-06-08","Regional","Ireland; Munster; Cork","2020-05-27","2020-07-07","Health care workers and caregivers","Adults (18-64 years)",404.0,0.015,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Eamonn Faller","Cork University Hospital","http://dx.doi.org/10.1136/bmjopen-2021-051415","Unverified","","NR","","","","IE","IE-M"
"2021-06-30","210612_Tokyo_TheUniversityOfTokyo_overall","Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).","2021-06-12","Local","Japan","2020-06-11","2020-10-28","Multiple populations","Multiple groups",6609.0,0.005,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Akihisa Mitani","The University of Tokyo","https://dx.doi.org/10.1016/j.jiac.2021.06.008","Verified","","NR","","","","JP",""
"2021-06-30","210618_Sweden_PublicHealthAgencyOfSweden","Stable IgG-antibody levels in patients with mild SARS-CoV-2 infection","2021-06-18","National","Sweden","2020-10-30","2020-12-08","Household and community samples","Multiple groups",324.0,0.086,"","","Convenience","IgG","High","Preprint","Thomas Akerlund","Public Health Agency of Sweden","https://www.medrxiv.org/content/10.1101/2021.06.16.21258960v1.full-text","Unverified","","NR",0.997,1.0,"","SE",""
"2021-06-30","210618_Vancouver_UniversityOfBritishColumbia_BloodDonors_TestAdj","SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada","2021-06-18","Local","Canada; British Columbia; Vancouver","2021-01-01","2021-01-31","Blood donors","Adults (18-64 years)",2502.0,0.023,0.017,0.03,"Convenience","IgG; IgM; IgA","High","Preprint","David Goldfarb","University of British Columbia","10.1101/2021.06.16.21258861","Unverified","","NR","","","","CA","CA-BC"
"2021-06-30","210618_Vancouver_UniversityOfBritishColumbia_TestAdj","SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada","2021-06-18","Local","Canada; British Columbia; Vancouver","2021-02-10","2021-05-15","Essential non-healthcare workers","Adults (18-64 years)",1556.0,0.023,0.016,0.032,"Self-referral","IgG; IgM; IgA","Moderate","Preprint","David Goldfarb","University of British Columbia","10.1101/2021.06.16.21258861","Unverified","","NR","","","","CA","CA-BC"
"2021-06-30","210620_Delhi_AllIndiaInstituteOfMedicalScience","Seroprevalence of COVID-19 in HIV Population","2021-06-20","Local","India","2020-09-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",164.0,0.14,0.091,0.203,"Convenience","IgG","High","Preprint","Shivdas Rajaram Naik","All India Institute Of Medical Science","https://www.medrxiv.org/content/10.1101/2021.06.17.21259066v1.full-text","Verified","","NR",0.94,1.0,"","IN",""
"2021-06-30","210621_Jacksonville_MayoClinic","Seroprevalence of SARS-CoV-2 antibodies in healthcare workers in a surgical environment.","2021-06-21","Local","United States of America; Florida; Jacksonville","2020-05-06","2020-07-01","Health care workers and caregivers","Adults (18-64 years)",292.0,0.027,0.012,0.053,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Martin L.De Ruyter","Mayo Clinic","https://dx.doi.org/10.1093/bjs/znab109","Unverified","","NR",1.0,1.0,"","US","US-FL"
"2021-06-30","210625_Osaka_ ToyonakaMunicipalHospital_Overall","Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.","2021-06-25","Local","Japan; Osaka Prefecture; Osaka","2020-06-12","2020-06-19","Health care workers and caregivers","Adults (18-64 years)",925.0,0.004,0.002,0.011,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Tsutomu Nishida","Toyonaka Municipal Hospital","https://dx.doi.org/10.1097/MD.0000000000026433","Verified","","NR",1.0,0.996,"","JP","JP-27"
"2021-07-01","210525_London_PublicHealthEngland_Week18_Euroimmun_Primary","Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK.","2021-05-25","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-01","2020-05-03","Blood donors","Multiple groups",974.0,0.149,0.121,0.18,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Gayatri Amirthalingam","Public Health England","https://dx.doi.org/10.3201/eid2707.203167","Verified","","NR",0.825,0.991,"","GB","GB-ENG"
"2021-07-01","210531_Skopje_InstituteForTransfusionMedicine","Seroprevalence of SARS-CoV-2 among blood donors","2021-05-31","Local","North Macedonia; Skopje; Skopje","2020-11-15","2021-03-15","Blood donors","Multiple groups",9773.0,0.25,"","","Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Tatjana Makarovska Bojadjieva","Institute for Transfusion Medicine","http://dx.doi.org/10.1111/vox.13117","Verified","","NR","","","","MK","MK-"
"2021-07-01","210615_Nashville_VanderbiltUniversityMedicalCenter_FollowUp2_Overall","Low in-school COVID-19 transmission and asymptomatic infection despite high community prevalence.","2021-06-15","Local","United States of America; Tennessee; Nashville","2021-01-27","2021-01-27","Essential non-healthcare workers","Adults (18-64 years)",34.0,0.147,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Sophie E. Katz","Vanderbilt University Medical Center","https://dx.doi.org/10.1016/j.jpeds.2021.06.015","Verified","","NR","","","","US","US-TN"
"2021-07-01","210617_Barcelona_UniversitatDeBarcelona_Overall_PopAdj","Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain","2021-06-17","Local","Spain; Catalonia; Barcelona","2020-12-14","2021-02-25","Multiple populations","Adults (18-64 years)",2775.0,0.142,"","","Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","Sebastian Videla","Universitat de Barcelona","http://dx.doi.org/10.3390/ijerph18126526","Verified","","NR","","","","ES","ES-CT"
"2021-07-02","210621_Portugal_LosAlamosNationalLaboratory_overall_PopAdj_TestAdj","Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic","2021-06-21","National","Portugal","2021-03-01","2021-03-17","Household and community samples","Multiple groups",2435.0,0.173,0.158,0.188,"Stratified probability","Total Antibody","Moderate","Preprint","Luisa Canto e Castro","Los Alamos National Laboratory","https://europepmc.org/article/PPR/PPR359402","Verified","","NR",0.981,0.999,"","PT",""
"2021-07-05","210212_Kaunas_LithuanianUniversityOfHealthSciences_HidradenitisSuppurativa","SARS-CoV-2 seroprevalence in patients with hidradenitis suppurativa in Lithuania","2021-02-12","Local","Lithuania","2020-08-12","2020-12-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",26.0,0.077,0.021,0.241,"Convenience","IgG; IgM","High","Presentation or Conference","Vaiva Jariene","Lithuanian University of Health Sciences","https://www.researchgate.net/publication/349992124_SARS-CoV-2_Seroprevalence_in_Patients_with_Hidradenitis_Suppurativa_in_Lithuania","Verified","","NR","","","","LT",""
"2021-07-05","210414_Holyoke_CityofHolyoke_Overall_PopAdj","City of Holyoke Serosurvey Report","2021-06-23","Local","United States of America; Massachusetts; Holyoke","2020-11-05","2021-01-31","Household and community samples","Multiple groups",328.0,0.139,0.078,0.218,"Simplified probability","IgM; IgG","Moderate","Institutional Report","City of Holyoke","City of Holyoke","https://www.holyoke.org/documents/city-of-holyoke-serosurvey-report/","Verified","United States of America","NR","","","","US","US-MA"
"2021-07-05","210603_Italy_UniversityHospitalCittaDellaSalute_Healthcare","Prevalence, persistence, and factors associated with sars-cov-2 igg seropositivity in a large cohort of healthcare workers in a tertiary care university hospital in northern italy","2021-06-03","Local","Italy; Piedmont; Turin","2020-05-04","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",8769.0,0.076,0.071,0.082,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gitana Scozzari","University Hospital Città Della Salute e Della Scienza di Torino","http://dx.doi.org/10.3390/v13061064","Unverified","","NR","","","","IT","IT-21"
"2021-07-05","210603_Italy_UniversityHospitalCittaDellaSalute_University","Prevalence, persistence, and factors associated with sars-cov-2 igg seropositivity in a large cohort of healthcare workers in a tertiary care university hospital in northern italy","2021-06-03","Local","Italy; Piedmont; Turin","2020-06-29","2020-07-29","Non-essential workers and unemployed persons","Adults (18-64 years)",1185.0,0.033,0.024,0.045,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gitana Scozzari","University Hospital Città Della Salute e Della Scienza di Torino","http://dx.doi.org/10.3390/v13061064","Unverified","","NR","","","","IT","IT-21"
"2021-07-05","210615_SantaFe_UniversidadNacionalDelLitoral_genpop_overall","Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina.","2021-06-15","Local","Argentina","2020-07-01","2020-11-30","Multiple general populations","Multiple groups",3000.0,0.088,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Luz Maria Rodeles","Universidad Nacional del Litoral","https://dx.doi.org/10.26633/RPSP.2021.66","Unverified","","NR",0.967,1.0,"","AR",""
"2021-07-05","210623_KathmanduValley_NepalHealthResearchCouncil_TestAdj","Seroprevalence of COVID-19 among health workers in the Kathmandu valley, Nepal (SEVID-KaV): a longitudinal cohort study","2021-06-23","Regional","Nepal; Bagmati Pradesh Province; Kathmandu Valley","2020-12-03","2020-12-25","Health care workers and caregivers","Adults (18-64 years)",800.0,0.39,0.291,0.439,"Stratified probability","IgG","Moderate","Preprint","Kiran Raj Pandey","Nepal Health Research Council","10.21203/rs.3.rs-626260/v1","Unverified","","NR",0.893,0.992,"","NP",""
"2021-07-05","210629_Belgium_Sciensano_Dec25","Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study.","2021-06-29","National","Belgium","2020-12-25","2020-12-25","Health care workers and caregivers","Adults (18-64 years)",308.0,0.197,0.12,0.306,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Laure Mortgat","Sciensano","https://dx.doi.org/10.1136/bmjopen-2021-050824","Unverified","","NR",0.93,0.99,"","BE",""
"2021-07-05","210630_Dublin_TrinityCollegeDublin_Overall","High anti-SARS-CoV-2 antibody seroprevalence in healthcare workers in an Irish university teaching hospital.","2021-06-30","Local","Ireland","2020-07-15","2020-10-15","Health care workers and caregivers","Adults (18-64 years)",1176.0,0.179,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Ann Leonard","Trinity College Dublin","https://dx.doi.org/10.1007/s11845-021-02690-4","Verified","","NR",0.861,1.0,"","IE",""
"2021-07-06","210602_UnitedStates_TranslationalPulmonaryAndImmunologyResearchCenter_Overall","Immune response to sars-cov-2 in an asymptomatic pediatric allergic cohort","2021-06-02","National","United States of America","2020-02-01","2020-04-20","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",172.0,0.04,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Nathan Marsteller","Translational Pulmonary and Immunology Research Center","http://dx.doi.org/10.3390/antib10020022","Verified","","NR","","","","US",""
"2021-07-06","210605_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_Overall","Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.","2021-06-05","Local","Iran (Islamic Republic of); Tehran; Tehran","2020-06-15","2020-07-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",168.0,0.173,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Maliheh Arab","Shahid Beheshti University of Medical Sciences","https://dx.doi.org/10.31557/APJCP.2021.22.6.1667","Unverified","","NR",1.0,"","","IR","IR-07"
"2021-07-06","210610_Cairo_CairoUniversity_GenPop2_overall_TotalAbCLIA","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","2021-06-10","Local","Egypt","2020-06-01","2020-06-14","Household and community samples","Adults (18-64 years)",725.0,0.294,"","","Simplified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Sherief Musa","Cairo University","https://dx.doi.org/10.1016/j.jiph.2021.06.001","Verified","","NR",0.9,1.0,"","EG",""
"2021-07-06","210610_Cairo_CairoUniversity_HCW1_overall","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","2021-06-10","Local","Egypt","2020-06-01","2020-06-14","Health care workers and caregivers","Adults (18-64 years)",386.0,0.158,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Sherief Musa","Cairo University","https://dx.doi.org/10.1016/j.jiph.2021.06.001","Verified","","NR",0.9,1.0,"","EG",""
"2021-07-06","210611_Padova_UniversityOfPadova_HCW_Overall","SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology.","2021-06-11","Local","Italy; Province of Padova; Padova","2020-06-01","2020-08-07","Health care workers and caregivers","Multiple groups",95.0,0.084,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Augusta Ortolan","University of Padova","https://dx.doi.org/10.3389/fimmu.2021.682850","Unverified","","NR","","","","IT","IT-34"
"2021-07-06","210611_Padova_UniversityOfPadova_SpAPatients_Overall","SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology.","2021-06-11","Local","Italy; Province of Padova; Padova","2020-06-01","2020-08-07","Patients seeking care for non-COVID-19 reasons","Multiple groups",200.0,0.125,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Augusta Ortolan","University of Padova","https://dx.doi.org/10.3389/fimmu.2021.682850","Unverified","","NR","","","","IT","IT-34"
"2021-07-06","210617_Stockholm_KTHRoyalInstituteofTechnology","Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2.","2021-06-17","Local","Sweden","2020-04-15","2020-05-15","Household and community samples","Multiple groups",878.0,0.125,0.103,0.147,"Simplified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Niclas Roxhed","KTH Royal Institute of Technology","https://dx.doi.org/10.1038/s41467-021-23893-4","Verified","","NR",1.0,0.96,"","SE",""
"2021-07-06","210618_Bonn_BonnUniversityHospital_primary","SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study).","2021-06-18","Local","Germany","2020-12-15","2021-01-15","Health care workers and caregivers","Multiple groups",118.0,0.14,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Kathrin van Bremen","Bonn University Hospital","https://dx.doi.org/10.1007/s15010-021-01641-6","Unverified","","NR",0.995,0.995,"","DE",""
"2021-07-06","210621_SaintPetersburg_EuropeanUniversity_ELISA_Overall_PopTestAdj","Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study.","2021-06-21","Local","Russian Federation; Northwestern; Saint Petersburg","2020-05-27","2020-06-26","Household and community samples","Multiple groups",988.0,0.091,0.072,0.109,"Simplified probability","IgG","Low","Journal Article (Peer-Reviewed)","Anton Barchuk","European University at St. Petersburg","https://dx.doi.org/10.1038/s41598-021-92206-y","Verified","","NR",0.996,1.0,"","RU",""
"2021-07-06","210622_Madrid_HospitalCentralDeLaDefensaGomezUlla","SARS-COV-2 Infection and Specific Antibody Detection on Health Care Workers from a Military Hospital in Madrid, Spain.","2021-06-22","Local","Spain","2020-04-27","2020-06-10","Health care workers and caregivers","Adults (18-64 years)",2781.0,0.162,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Maria Simon Sacristan","Hospital Central de la Defensa Gómez Ulla","https://dx.doi.org/10.1007/s00284-021-02541-6","Unverified","","NR","","","","ES",""
"2021-07-06","210623_Marseille_Aix-MarseilleUniversity","SARS-CoV-2 rapid serological tests for field-based healthcare workers in homeless communities: a mixed-methods exploratory analysis.","2021-06-23","Local","France; Provence; Marseille","2020-06-01","2020-07-31","Health care workers and caregivers","Multiple groups",99.0,0.061,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Emilie Mosnier","Aix-Marseille University","https://dx.doi.org/10.1016/j.puhip.2021.100154","Verified","","NR","","","","FR",""
"2021-07-06","210624_Brazil_UniversidadeFederalDePelotas_overall","High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2.","2021-06-24","National","Brazil","2020-06-21","2020-06-24","Household and community samples","Multiple groups",31869.0,0.027,"","","Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Ana M. B. Menezes","Universidade Federal de Pelotas","https://dx.doi.org/10.1038/s41598-021-92775-y","Verified","","NR",0.848,1.0,"","BR",""
"2021-07-06","210625_Ekaterinburg_DentalCollegeYamunanagar","Do aspirating systems have a role in preventing COVID-19 transmission among dental healthcare workers?.","2021-06-25","Local","Russian Federation; Ural; Ekaterinburg","2020-05-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",157.0,0.121,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Neeraj Gugnani","Dental College Yamunanagar","https://dx.doi.org/10.1038/s41432-021-0171-5","Unverified","","NR","","","","RU",""
"2021-07-06","210625_Wroclaw_RegionalSpecialistHospitalInWrocław_overall","Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021","2021-06-25","Local","Poland; Silesia; Wroclaw","2021-05-15","2021-05-22","Household and community samples","Multiple groups",501.0,0.591,"","","Unclear","IgG; IgA","High","Preprint","Wiktoria Budziar","Regional Specialist Hospital in Wrocław","10.1101/2021.06.22.21258711","Verified","","NR","","","","PL","PL-24"
"2021-07-06","210629_Cordoba_ColombiaUniversidadDeCordoba_Overall","SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes.","2021-06-29","Regional","Colombia; Cordoba Department","2020-07-15","2020-11-15","Household and community samples","Multiple groups",2564.0,0.408,"","","Stratified non-probability","IgA; IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Evelin Garay","Colombia-Universidad de Cordoba","https://dx.doi.org/10.1093/trstmh/trab094","Verified","","NR","","","","CO","CO-COR"
"2021-07-06","210629_StPetersburg_Saint-PetersburgStateUniversityHospital_overall","Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection.","2021-06-29","Local","Russian Federation","2020-05-27","2021-03-19","Non-essential workers and unemployed persons","Adults (18-64 years)",180.0,0.156,"","","Unclear","IgA","Unclear","Journal Article (Peer-Reviewed)","Andrei Ivanov","B.P.Konstantinov St Petersburg Nuclear Physics Institute","https://dx.doi.org/10.1002/jmv.27166","Verified","","NR","","","","RU",""
"2021-07-06","210630_Porto_UniversidadeDoPorto_primary","Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal: a cross-sectional study.","2021-06-30","Local","Portugal; Norte; Porto","2020-05-21","2020-07-31","Essential non-healthcare workers","Multiple groups",4592.0,0.025,0.001,0.053,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Paula Meireles","Universidade do Porto","https://dx.doi.org/10.1136/oemed-2021-107519","Verified","","NR","","","","PT",""
"2021-07-07","201010_Taipei_TaipeiVeteransGeneralHospital_popadj","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","2020-10-10","Local","China","2020-05-25","2020-07-08","Residual sera","Multiple groups",14765.0,0.0,0.0,0.001,"Sequential","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Hsiang-Ling Ho","Taipei Veterans General Hospital","https://dx.doi.org/10.1016/j.lanwpc.2020.100041","Verified","","NR","","","","CN",""
"2021-07-07","201207_Ticino_UniversitaDellaSvizzeraItaliana","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","2020-12-17","Regional","Switzerland; Canton of Ticino","2020-04-16","2020-04-30","Health care workers and caregivers","Multiple groups",4726.0,0.096,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Luca Piccoli","Università della Svizzera italiana","https://dx.doi.org/10.1016/j.lanepe.2020.100013","Unverified","","NR","","","","CH",""
"2021-07-07","210607_Iran_TehranUniversityofMedicalSciences_Primary","Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme","2021-06-07","National","Iran (Islamic Republic of)","2020-08-03","2020-10-31","Household and community samples","Multiple groups",11256.0,0.142,0.133,0.152,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Kazem Khalagi","Tehran University of Medical Sciences","http://dx.doi.org/10.1016/j.cmi.2021.06.002","Verified","","NR",0.74,0.98,"","IR",""
"2021-07-07","210609_Chelyabinsk_SouthUralStateUniversity_HighRisk_testadj","Seroprevalence of sars-cov-2 antibodies in symptomatic individuals is higher than in persons who are at increased risk exposure: The results of the single-center, prospective, cross-sectional study","2021-06-09","Local","Russian Federation","2020-09-28","2020-12-30","Health care workers and caregivers","Adults (18-64 years)",1091.0,0.172,0.172,0.173,"Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alexandr Zurochka","South Ural State University","http://dx.doi.org/10.3390/vaccines9060627","Unverified","","NR","","","","RU",""
"2021-07-07","210618_LosAngeles_UniversityCaliforniaLosAngeles","Sars-cov-2 infection detection by pcr and serologic testing in clinical practice","2021-06-18","Local","United States of America; California; Los Angeles","","2020-08-10","Residual sera","Multiple groups",3075.0,0.088,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Douglas Murad","University of California Los Angeles","http://dx.doi.org/10.1128/JCM.00431-21","Verified","","NR","","","","US","US-CA"
"2021-07-07","210619_Tokyo_KeioUniversityHealthCenter","SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan.","2021-06-19","Local","Japan","2020-08-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",2320.0,0.009,0.005,0.013,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Tomoyasu Nishimura","Keio University Health Center","https://dx.doi.org/10.2169/internalmedicine.7033-21","Verified","","NR","","","","JP",""
"2021-07-07","210621_Geneva_GenevaUniversityHospitals_overall","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic","2021-06-21","Local","Switzerland","2020-06-01","2020-06-30","Residual sera","Multiple groups",1167.0,0.059,0.047,0.074,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Stephanie Baggio","Geneva University Hospitals","http://dx.doi.org/10.1016/j.ypmed.2021.106696","Verified","","NR","","","","CH",""
"2021-07-07","210625_Germany_RobertKochInstitute_overall","Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort","2021-06-25","National","Germany","2020-10-15","2021-02-15","Household and community samples","Multiple groups",15122.0,0.013,"","","Simplified probability","IgG","Moderate","Preprint","Jens Hoebel","German Institute for Economic Research","https://www.medrxiv.org/content/10.1101/2021.06.21.21259001v1.full-text","Verified","","NR","","","","DE",""
"2021-07-07","210625_Kenya_KEMRI-WellcomeTrustResearchProgramme_overall_adj","Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.","2021-06-25","National","Kenya","2020-04-30","2020-09-30","Blood donors","Adults (18-64 years)",9922.0,0.079,0.067,0.09,"Sequential","IgG","Low","Journal Article (Peer-Reviewed)","Ifedayo M. O. Adetifa","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1038/s41467-021-24062-3","Verified","","NR",0.927,0.99,"","KE",""
"2021-07-07","210626_Leicester_UniversityOfLeicester","Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the UK.","2021-06-26","Local","United Kingdom of Great Britain and Northern Ireland; England; Leicester","2020-03-16","2020-06-03","Household and community samples","Multiple groups",1779.0,0.114,"","","Simplified probability","IgG","Low","Journal Article (Peer-Reviewed)","Paul William Bird","University of Leicester","https://dx.doi.org/10.1002/jmv.27162","Verified","","NR",0.97,0.989,"","GB","GB-ENG"
"2021-07-07","210626_Spain_HospitalGregorioMaranon_popadj","Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort.","2021-06-26","National","Spain","2020-04-01","2020-09-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",1076.0,0.081,0.065,0.1,"Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Juan Berenguer","Hospital Gregorio Maranon","https://dx.doi.org/10.1016/j.cmi.2021.06.023","Verified","","NR","","","","ES",""
"2021-07-07","210628_Jeddah_KingAbdulazizUniversity","Prevalence of COVID-19 antibodies among operating room and critical care staff at a tertiary teaching hospital: A cross-sectional study.","2021-06-28","Local","Saudi Arabia; Mecca; Jeddah","2020-08-09","2020-11-02","Health care workers and caregivers","Adults (18-64 years)",319.0,0.122,"","","Convenience","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Sara Farsi","King Abdulaziz University","https://dx.doi.org/10.15537/smj.2021.42.7.20210348","Verified","","NR","","","","SA","SA-02"
"2021-07-07","210630_Hwaseong_DongtanSacredHeartHospital","Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers.","2021-06-30","Local","Republic of Korea; Gyeonggi; Hwaseong","2021-03-04","2021-03-12","Health care workers and caregivers","Adults (18-64 years)",298.0,0.0,"","","Convenience","IgG; IgM; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Seri Jeong","Dongtan Sacred Heart Hospital","https://dx.doi.org/10.1128/JCM.01105-21","Unverified","","NR",0.954,0.908,"","KR","KR-41"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Non-essential workers and unemployed persons","Multiple groups",188.0,0.069,"","","Convenience","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-S"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Essential non-healthcare workers","Multiple groups",324.0,0.028,"","","Convenience","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-S"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Health care workers and caregivers","Multiple groups",787.0,0.039,"","","Convenience","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-S"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Essential non-healthcare workers","Multiple groups",473.0,0.087,"","","Convenience","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-S"
"2021-07-09","201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Beira (InCOVID 2020)","2020-10-15","Local","Mozambique; Sofala; Beira","2020-09-21","2020-10-02","Non-essential workers and unemployed persons","Multiple groups",1585.0,0.083,"","","Convenience","IgG; IgM","High","Presentation or Conference","Nedio Mabunda","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-S"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Non-essential workers and unemployed persons","Adults (18-64 years)",250.0,0.05,0.02,0.07,"Convenience","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified","Mozambique","STANDARD Q","","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",1427.0,0.07,0.06,0.09,"Convenience","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified","Mozambique","STANDARD Q","","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_MerchantsVendors","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Non-essential workers and unemployed persons","Adults (18-64 years)",1493.0,0.1,0.08,0.11,"Convenience","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified","Mozambique","STANDARD Q","","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Essential non-healthcare workers","Adults (18-64 years)",564.0,0.06,0.04,0.08,"Convenience","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified","Mozambique","STANDARD Q","","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Refugees","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Persons experiencing homelessness","Multiple groups",221.0,0.06,0.02,0.08,"Convenience","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified","Mozambique","STANDARD Q","","","","MZ","MZ-N"
"2021-07-12","200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Nampula","2020-07-07","Local","Mozambique; Nampula; Nampula","2020-06-17","2020-06-30","Essential non-healthcare workers","Adults (18-64 years)",554.0,0.03,0.01,0.04,"Convenience","IgG; IgM","High","Presentation or Conference","Eduardo Samo Gudo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf","Verified","Mozambique","STANDARD Q","","","","MZ","MZ-N"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Non-essential workers and unemployed persons","Adults (18-64 years)",172.0,0.047,"","","Convenience","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","Mozambique","Qingdao Hightop Biotech","","","","MZ","MZ-B"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Essential non-healthcare workers","Adults (18-64 years)",407.0,0.049,"","","Convenience","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","Mozambique","Qingdao Hightop Biotech","","","","MZ","MZ-B"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Health care workers and caregivers","Adults (18-64 years)",380.0,0.013,"","","Convenience","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","Mozambique","Qingdao Hightop Biotech","","","","MZ","MZ-B"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Essential non-healthcare workers","Adults (18-64 years)",287.0,0.01,"","","Convenience","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","Mozambique","Qingdao Hightop Biotech","","","","MZ","MZ-B"
"2021-07-12","201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Chimoio (InCOVID 2020)","2020-11-27","Local","Mozambique; Manica Province; Chimoio","2020-11-02","2020-11-17","Non-essential workers and unemployed persons","Adults (18-64 years)",643.0,0.019,"","","Convenience","IgG; IgM","High","Presentation or Conference","Arlete Mahumane","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf","Verified","Mozambique","Qingdao Hightop Biotech","","","","MZ","MZ-B"
"2021-07-12","210626_Torno_SaccoUniversityHospital_Residents1","Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out.","2021-06-26","Local","Italy; Lombardy; Torno","2020-06-01","2020-06-22","Assisted living and long-term care facilities","Seniors (65+ years)",74.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mario Tagliabue","Sacco University Hospital","https://dx.doi.org/10.1016/j.pmedr.2021.101471","Unverified","","NR","","","","IT","IT-25"
"2021-07-12","210626_Torno_SaccoUniversityHospital_Staff2","Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out.","2021-06-26","Local","Italy; Lombardy; Torno","2020-06-01","2020-06-22","Health care workers and caregivers","Adults (18-64 years)",51.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mario Tagliabue","Sacco University Hospital","https://dx.doi.org/10.1016/j.pmedr.2021.101471","Unverified","","NR","","","","IT","IT-25"
"2021-07-12","210628_Lombardy_UniversityofPavia_patients_primary","A Pilot Study on Covid and Autism: Prevalence, Clinical Presentation and Vaccine Side Effects.","2021-06-28","Local","Italy","2020-05-15","2020-05-31","Assisted living and long-term care facilities","Adults (18-64 years)",36.0,0.361,"","","Convenience","IgA; IgG","High","Journal Article (Peer-Reviewed)","Natascia Brondino","University of Pavia","https://dx.doi.org/10.3390/brainsci11070860","Unverified","","NR",0.97,0.86,"","IT",""
"2021-07-12","210628_Lombardy_UniversityofPavia_staff_primary","A Pilot Study on Covid and Autism: Prevalence, Clinical Presentation and Vaccine Side Effects.","2021-06-28","Local","Italy","2020-05-15","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",35.0,0.343,"","","Convenience","IgA; IgG","High","Journal Article (Peer-Reviewed)","Natascia Brondino","University of Pavia","https://dx.doi.org/10.3390/brainsci11070860","Unverified","","NR",0.97,0.86,"","IT",""
"2021-07-12","210630_RioDeJaneiro_HospitalFederaldosServidoresdoEstado","Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders.","2021-06-30","Local","Brazil","2020-04-13","2020-06-17","Pregnant or parturient women","Adults (18-64 years)",115.0,0.235,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Maria de Lourdes Benamor Teixeira","Hospital Federaldo dos Servidores do Estado","https://dx.doi.org/10.3390/v13071277","Verified","","NR","","","","BR",""
"2021-07-12","210701_Prague_InstituteForClinicalAndExperimentalMedicine_HCWs","Humoral Response To SARS-CoV-2 Is Well-Preserved And Symptom-Dependent In Kidney Transplant Recipients.","2021-07-01","Local","Czechia","2020-10-01","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",512.0,0.119,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Maria Magicova","Institute for Clinical and Experimental Medicine","https://dx.doi.org/10.1111/ajt.16746","Unverified","","NR",0.912,0.902,"","CZ",""
"2021-07-12","210701_Prague_InstituteForClinicalAndExperimentalMedicine_Patients","Humoral Response To SARS-CoV-2 Is Well-Preserved And Symptom-Dependent In Kidney Transplant Recipients.","2021-07-01","Local","Czechia","2020-10-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",1002.0,0.068,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Maria Magicova","Institute for Clinical and Experimental Medicine","https://dx.doi.org/10.1111/ajt.16746","Unverified","","NR",0.912,0.902,"","CZ",""
"2021-07-12","210703_Melbourne_RoyalChildrensHospital_Primary","Seroprevalence of SARS-CoV-2 antibodies in health-care workers at a tertiary paediatric hospital.","2021-07-03","Local","Australia","2020-10-21","2020-10-30","Health care workers and caregivers","Adults (18-64 years)",318.0,0.0,"","","Convenience","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Jane Tuckerman","Royal Children's Hospital","https://dx.doi.org/10.1111/jpc.15585","Verified","","NR","","","","AU",""
"2021-07-12","210703_Rome_FondazionePoliclinicoUniversitario_Primary","Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak.","2021-07-03","Local","Italy","2020-03-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",1106.0,0.007,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Francesca Lombardi","Fondazione Policlinico Universitario","https://dx.doi.org/10.3390/diagnostics11071154","Unverified","","NR","","","","IT",""
"2021-07-13","210430_AghiaSophiaChildrensHospital_Athens_HCW","SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods.","2021-07-05","Local","Greece; Atica; Athens","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",1216.0,0.007,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Elizabeth‑Barbara Tatsi","The ""Aghia Sophia"" Children's Hospital","https://dx.doi.org/10.1007/s15010-021-01653-2","Verified","","NR","","","","GR","GR-I"
"2021-07-13","210620_Croatia_CroatianInstituteOfPublicHealth_FirstWave_Overall","SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia.","2021-06-20","National","Croatia","2020-05-15","2020-07-15","Multiple general populations","Multiple groups",1088.0,0.022,0.014,0.033,"Convenience","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Tatjana Vilibic-Cavlek","Croatian Institute of Public Health","https://dx.doi.org/10.3390/pathogens10060774","Verified","","NR","","","","HR",""
"2021-07-13","210620_Croatia_CroatianInstituteOfPublicHealth_SecondWave_Overall","SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia.","2021-06-20","National","Croatia","2020-12-15","2021-02-14","Multiple general populations","Multiple groups",1436.0,0.251,0.228,0.274,"Convenience","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Tatjana Vilibic-Cavlek","Croatian Institute of Public Health","https://dx.doi.org/10.3390/pathogens10060774","Verified","","NR","","","","HR",""
"2021-07-13","210702_USA_DaVitaClinicalResearch","Antibody Status, Disease History, and Incidence of SARS-CoV-2 Infection Among Patients on Chronic Dialysis.","2021-07-02","National","United States of America; California, Connecticut, Minnesota, Nevada, New York, Ohio, Texas, Virginia, and Wisconsin","2020-07-01","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",2337.0,0.095,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Dena Cohen","DaVita Clinical Research","https://dx.doi.org/10.1681/ASN.2021030387","Verified","","NR","","","","US",""
"2021-07-13","210705_Lausanne_UniversityOfLausanne_Overall","SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.","2021-07-05","Local","Switzerland","2020-05-18","2020-06-12","Health care workers and caregivers","Multiple groups",1874.0,0.1,0.087,0.115,"Stratified non-probability","IgG","High","Journal Article (Peer-Reviewed)","Sylvain Meylan","Lausanne University Hospital and University of Lausanne","https://dx.doi.org/10.1136/bmjopen-2021-049232","Unverified","","NR",0.97,0.98,"","CH",""
"2021-07-13","210705_SierraLeone_HarvardMedicalSchool_WeightedOverall","SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.","2021-07-05","National","Sierra Leone","2021-03-01","2021-03-31","Household and community samples","Multiple groups",1893.0,0.026,0.019,0.034,"Stratified probability","IgG; IgM","Low","Preprint","Mohamed Bailor Barrie","Harvard Medical School","https://dx.doi.org/10.1101/2021.06.27.21259271","Unverified","","NR",1.0,1.0,"","SL",""
"2021-07-13","210706_France_InstitutdeCancérologiedel’Ouest_HCW_primary","Anosmia but not ageusia as a covid-19-related symptom among cancer patients-first results from the papesco-19 cohort study","2021-07-06","Regional","France; Western France, Eastern France, Central France","2020-07-17","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",940.0,0.078,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ke Zhou","Institut de Cancérologie de l’Ouest","http://dx.doi.org/10.3390/cancers13143389","Unverified","","NR",1.0,0.953,"","FR",""
"2021-07-13","210706_France_InstitutdeCancérologiedel’Ouest_patients_primary","Anosmia but not ageusia as a covid-19-related symptom among cancer patients-first results from the papesco-19 cohort study","2021-07-06","Regional","France; Western France, Eastern France, Central France","2020-07-17","2020-11-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",878.0,0.067,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ke Zhou","Institut de Cancérologie de l’Ouest","http://dx.doi.org/10.3390/cancers13143389","Unverified","","NR",1.0,0.953,"","FR",""
"2021-07-13","210706_Ghana_UniversityOfGhana_Phase1_Overall","Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana","2021-07-06","National","Ghana; Greater Acra Region, Central Region, Eastern Region, Upper East Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","2020-07-27","2020-09-14","Multiple general populations","Multiple groups",1305.0,0.19,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Peter Kojo Quashie","University of Ghana","https://wellcomeopenresearch.org/articles/6-173","Unverified","","NR",0.66,0.94,"","GH",""
"2021-07-13","210706_Ghana_UniversityOfGhana_Phase2_Overall","Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana","2021-07-06","National","Ghana; Greater Acra Region, Central Region, Eastern Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","2020-10-01","2020-10-31","Multiple general populations","Multiple groups",395.0,0.152,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Peter Kojo Quashie","University of Ghana","https://wellcomeopenresearch.org/articles/6-173","Unverified","","NR",0.66,0.94,"","GH",""
"2021-07-13","210706_Ghana_UniversityOfGhana_Phase3_Overall","Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana","2021-07-06","National","Ghana; Greater Acra Region, Central Region, Eastern Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","2020-12-01","2020-12-31","Multiple general populations","Multiple groups",393.0,0.097,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Peter Kojo Quashie","University of Ghana","https://wellcomeopenresearch.org/articles/6-173","Unverified","","NR",0.66,0.94,"","GH",""
"2021-07-13","210706_Ghana_UniversityOfGhana_Phase4_Overall","Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana","2021-07-06","National","Ghana; Greater Acra Region, Central Region, Eastern Region; Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","2021-02-01","2021-02-28","Multiple general populations","Multiple groups",636.0,0.228,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Peter Kojo Quashie","University of Ghana","https://wellcomeopenresearch.org/articles/6-173","Unverified","","NR",0.66,0.94,"","GH",""
"2021-07-13","210706_Kathmandu_ManmohanMemorialMedicalCollege_primary","ANTI - SARS-CoV-2 ANTIBODY SCREENING IN HEALTH CARE WORKERS AND ITS CORRELATION WITH CLINICAL PRESENTATION","2021-07-06","Local","Nepal","2020-11-15","2021-01-15","Health care workers and caregivers","Adults (18-64 years)",185.0,0.222,"","","Convenience","IgM; IgG","High","Preprint","Suraj Aryal","Manmohan Memorial Medical College","https://www.medrxiv.org/content/10.1101/2021.07.01.21259884v1.full-text","Verified","","NR","","","","NP",""
"2021-07-13","210706_SouthAfrica_SouthAfricanNationalBloodService_Overall_PopAdj","Prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa during the period January-May 2021","2021-07-06","National","South Africa","2021-01-15","2021-05-15","Blood donors","Multiple groups",16762.0,0.474,0.462,0.486,"Sequential","Total Antibody","Low","Preprint","Marion Vermeulen","South African National Blood Service","https://assets.researchsquare.com/files/rs-690372/v2_covered.pdf?c=1627923426","Verified","","NR",1.0,0.995,"","ZA",""
"2021-07-13","210707_Monrovia_OakCrestInstituteOfScience_Overall","Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints.","2021-07-07","Local","United States of America; California; Monrovia","2020-03-27","2020-05-26","Non-essential workers and unemployed persons","Adults (18-64 years)",33.0,0.061,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Manjula Gunawardana","Oak Crest Institute of Science","https://dx.doi.org/10.1128/mSphere.00542-21","Verified","","NR","","","","US","US-CA"
"2021-07-14","210309_Madrid_FundacionRenalInigoAlvarezDeToledo","Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study.","2021-03-09","Local","Spain","2020-03-01","2020-04-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",672.0,0.15,"","","Convenience","IgM; IgA","High","Journal Article (Peer-Reviewed)","Roberto Alcazar Arroyo","Fundación Renal Íñigo Álvarez de Toledo","https://dx.doi.org/10.1093/ckj/sfab048","Unverified","","NR",0.88,0.99,"","ES",""
"2021-07-14","210518_Paris_HopitalBichat-ClaudeBernard","Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France.","2021-05-18","Local","France","2020-05-12","2020-06-02","Health care workers and caregivers","Adults (18-64 years)",72.0,0.153,0.069,0.237,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Charlotte Charpentier","Hopital Bichat-Claude Bernard","https://dx.doi.org/10.1016/j.diagmicrobio.2021.115430","Unverified","","NR","","","","FR",""
"2021-07-14","210624_Modiin_IsraelMinistryOfHealth_Primary","SARS-CoV-2 outbreak in a synagogue community: Longevity and strength of anti-SARS-CoV-2 IgG responses","2021-06-24","Local","Israel","2020-09-01","2020-09-30","Household and community samples","Multiple groups",283.0,0.166,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Yael Gozlan","Israel Ministry of Health","http://dx.doi.org/10.1017/S0950268821001369","Verified","","NR","","","","IL",""
"2021-07-14","210701_Heilbronn_SLKClinicsHeilbronn_Primary","Assessment of sars-cov-2 infection among healthcare workers of a german covid-19 treatment center","2021-07-01","Local","Germany; Baden-Württemberg; Heilbronn","2020-07-01","2020-07-21","Health care workers and caregivers","Multiple groups",3066.0,0.031,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Lionel Larribere","SLK Clinics Heilbronn","http://dx.doi.org/10.3390/ijerph18137057","Verified","","NR",1.0,"","","DE","DE-BW"
"2021-07-14","210701_RioDeJaneiro_OswaldoCruzFoundation_Primarysam","SARS-CoV-2 infection dynamics in children and household contacts in a slum in Rio de Janeiro","2021-07-01","Local","Brazil; Rio de Janeiro; Rio de Janeiro","2020-05-18","2020-09-24","Multiple general populations","Multiple groups",515.0,0.293,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Pamella Lugon","Oswaldo Cruz Foundation","https://europepmc.org/article/MED/33863845","Verified","","NR","","","","BR","BR-RJ"
"2021-07-14","210702_RibeiraoPreto_UniversidadedeSãoPaulo_Followup","Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeirao Preto, Southeast Brazil: an epidemiological survey.","2021-07-02","Local","Brazil; São Paulo; Ribeirão Preto (RP)","2020-06-11","2020-06-14","Household and community samples","Multiple groups",646.0,0.028,"","","Stratified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Edson Zangiacomi Martinez","Universidade de São Paulo","https://dx.doi.org/10.1590/0037-8682-0210-2021","Verified","","NR",0.864,0.996,"","BR","BR-SP"
"2021-07-14","210703_Atlanta_CentersForDiseaseControlAndPrevention","Epidemiologic, immunologic, and virus characteristics in patients with paired SARS-CoV-2 serology and reverse transcription polymerase chain reaction testing.","2021-07-03","Local","United States of America; Georgia; Atlanta","2020-08-31","2020-11-23","Residual sera","Multiple groups",592.0,0.179,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Talya Shragai","United States Centers for Disease Control and Prevention","https://dx.doi.org/10.1093/infdis/jiab349","Verified","","NR","","","","US","US-GA"
"2021-07-14","210707_Dublin_StJames'sHospital","SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months.","2021-07-07","Local","Ireland; Leinster; Dublin","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",49.0,0.29,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Colm Kerr","St. James’s Hospital","https://dx.doi.org/10.1007/s11845-021-02700-5","Unverified","","NR","","","","IE","IE-L"
"2021-07-15","210616_Lisbon_ UniversidadeNOVAdeLisboa_primary","Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic.","2021-06-16","Local","Portugal","2020-06-15","2020-06-30","Non-essential workers and unemployed persons","Multiple groups",1624.0,0.031,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","David G. Lopes","Universidade NOVA de Lisboa","https://dx.doi.org/10.3389/fpubh.2021.689919","Unverified","","NR",0.947,0.995,"","PT",""
"2021-07-16","210702_Ohio_UniversityHospitalsClevelandMedicalCenter_Overall","SARS-CoV-2 Seroprevalence among First Responders in Northeastern Ohio","2021-07-02","Regional","United States of America; Northeastern Ohio","2020-05-22","2020-09-15","Essential non-healthcare workers","Multiple groups",3080.0,0.024,"","","Convenience","IgG","Moderate","Preprint","Xiaochun Zhang","University Hospitals Cleveland Medical Center","https://www.medrxiv.org/content/10.1101/2021.06.27.21259432v1.full-text","Unverified","","NR",1.0,0.996,"","US",""
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Non-essential workers and unemployed persons","Adults (18-64 years)",404.0,0.005,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-T"
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Health care workers and caregivers","Adults (18-64 years)",569.0,0.007,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-T"
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Essential non-healthcare workers","Adults (18-64 years)",554.0,0.029,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-T"
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Essential non-healthcare workers","Adults (18-64 years)",334.0,0.015,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-T"
"2021-07-17","200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Tete (InCOVID 2020)","2020-09-24","Local","Mozambique; Tete; Tete","2020-08-31","2020-10-12","Non-essential workers and unemployed persons","Adults (18-64 years)",1556.0,0.008,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-T"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Non-essential workers and unemployed persons","Adults (18-64 years)",200.0,0.01,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-Q"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",390.0,0.031,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-Q"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Health care workers and caregivers","Adults (18-64 years)",543.0,0.037,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-Q"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",367.0,0.074,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-Q"
"2021-07-17","201003_Quelimane_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Quelimane (InCOVID 2020)","2020-10-03","Local","Mozambique; Zambezia; Quelimane","2020-08-10","2020-08-21","Non-essential workers and unemployed persons","Adults (18-64 years)",1123.0,0.016,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-QUELIMANE_-RESULTADOS-PRELIMINARES_1.1_03.09.2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-Q"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Non-essential workers and unemployed persons","Adults (18-64 years)",122.0,0.0,"","","Convenience","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-A"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Health care workers and caregivers","Adults (18-64 years)",454.0,0.018,"","","Convenience","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-A"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Essential non-healthcare workers","Adults (18-64 years)",471.0,0.015,"","","Convenience","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-A"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Essential non-healthcare workers","Adults (18-64 years)",230.0,0.004,"","","Convenience","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-A"
"2021-07-17","201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Lichinga (InCOVID 2020)","2020-10-19","Local","Mozambique; Niassa; Lichinga","2020-09-28","2020-10-09","Non-essential workers and unemployed persons","Adults (18-64 years)",871.0,0.002,"","","Convenience","IgG; IgM","High","Presentation or Conference","Jeronimo Langa","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-A"
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Airport&PortWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","2020-08-03","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",362.0,0.033,"","","Convenience","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","Mozambique","Abbott","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","2020-08-03","2020-08-21","Non-essential workers and unemployed persons","Adults (18-64 years)",595.0,0.045,"","","Convenience","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","Mozambique","Abbott","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","2020-08-03","2020-08-21","Health care workers and caregivers","Adults (18-64 years)",1443.0,0.026,"","","Convenience","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","Mozambique","Abbott","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_NursingHomeWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","2020-08-03","2020-08-21","Health care workers and caregivers","Adults (18-64 years)",85.0,0.012,"","","Convenience","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","Mozambique","Abbott","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","2020-08-03","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",559.0,0.039,"","","Convenience","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","Mozambique","Abbott","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","2020-08-03","2020-08-21","Essential non-healthcare workers","Adults (18-64 years)",623.0,0.022,"","","Convenience","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","Mozambique","Abbott","","","","MZ",""
"2021-07-18","200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maputo (InCOVID 2020)","2020-08-31","Local","Mozambique","2020-08-03","2020-08-21","Non-essential workers and unemployed persons","Adults (18-64 years)",1246.0,0.052,"","","Convenience","IgG; IgM","High","Presentation or Conference","Edna Viegas","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf","Verified","Mozambique","Abbott","","","","MZ",""
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Non-essential workers and unemployed persons","Adults (18-64 years)",323.0,0.059,"","","Convenience","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-MPM"
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",793.0,0.039,"","","Convenience","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-MPM"
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Essential non-healthcare workers","Adults (18-64 years)",456.0,0.044,"","","Convenience","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-MPM"
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Essential non-healthcare workers","Adults (18-64 years)",282.0,0.032,"","","Convenience","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-MPM"
"2021-07-18","201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Província de Maputo (InCOVID 2020)","2020-10-21","Local","Mozambique; Maputo; Matolo","2020-09-14","2020-09-30","Non-essential workers and unemployed persons","Adults (18-64 years)",1288.0,0.05,"","","Convenience","IgG; IgM","High","Presentation or Conference","Ivalda Macicame","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-MPM"
"2021-07-18","210604_RepublicOfSrpska_InstituteforTransfusionMedicine_Primary","Anti-SARS-CoV-2 IgG seroprevalence study among blood donors in the Republic of Srpska: A 30-day survey","2021-06-04","National","Bosnia and Herzegovina; Republic of Srpska","2020-06-17","2020-07-16","Blood donors","Adults (18-64 years)",807.0,0.027,"","","Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Gordana Guzijan","Institute for Transfusion Medicine of the Republic of Srpska","http://dx.doi.org/10.2298/VSP200122059G","Verified","","NR","","","","BA",""
"2021-07-18","210616_LomaLinda_LomaLindaUniversityChildren'sHospital_Overall","COVID-19 diagnosis and testing in pediatric heart transplant recipients.","2021-06-16","Local","United States of America; California; Loma Linda","2020-03-15","2021-03-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",146.0,0.062,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Matthew J. Bock","Loma Linda University Children's Hospital","https://dx.doi.org/10.1016/j.healun.2021.06.009","Verified","","NR","","","","US","US-CA"
"2021-07-18","210709_Dublin_HSENationalDrugTreatmentCentre_overall","A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment.","2021-07-09","Local","Ireland","2020-07-15","2020-10-15","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",103.0,0.019,"","","Convenience","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Fiona Fenton","HSE National Drug Treatment Centre","https://dx.doi.org/10.1007/s11845-021-02660-w","Unverified","","NR","","","","IE",""
"2021-07-18","210714_Baden-Württemberg_UlmUniversityHospital_Employees2_overall","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","2021-07-14","Local","Germany; Baden-Württemberg; Alb-Danube district and Ulm","2020-07-27","2020-08-25","Health care workers and caregivers","Adults (18-64 years)",394.0,0.002,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Lukas Perkhofer","Ulm University Hospital","https://dx.doi.org/10.1007/s00391-021-01931-6","Unverified","","NR","","","","DE","DE-BW"
"2021-07-18","210714_Baden-Württemberg_UlmUniversityHospital_Residents1_overall","[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].","2021-07-14","Local","Germany; Baden-Württemberg; Alb-Danube district and Ulm","2020-07-27","2020-08-25","Assisted living and long-term care facilities","Multiple groups",100.0,0.01,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Lukas Perkhofer","Ulm University Hospital","https://dx.doi.org/10.1007/s00391-021-01931-6","Unverified","","NR","","","","DE","DE-BW"
"2021-07-19","210614_Fukushima_HirataCentralHospital_May_CLIA_IgG","Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study.","2021-06-14","Local","Japan; Fukushima; Ishikawa District","2020-05-08","2020-05-28","Health care workers and caregivers","Multiple groups",515.0,0.01,0.003,0.022,"Entire sample","IgG","Low","Journal Article (Peer-Reviewed)","Yurie Kobashi","Hirata Central Hospital","https://dx.doi.org/10.1016/j.intimp.2021.107884","Unverified","","NR",0.973,0.963,"","JP","JP-07"
"2021-07-19","210614_Fukushima_HirataCentralHospital_Oct_CLIA_IgG","Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study.","2021-06-14","Local","Japan; Fukushima; Ishikawa District","2020-10-05","2020-10-23","Health care workers and caregivers","Multiple groups",515.0,0.004,0.0,0.014,"Entire sample","IgG","Low","Journal Article (Peer-Reviewed)","Yurie Kobashi","Hirata Central Hospital","https://dx.doi.org/10.1016/j.intimp.2021.107884","Unverified","","NR",0.973,0.963,"","JP","JP-07"
"2021-07-19","210625_Emilia-Romagna_UniversityofMilan_primary","Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.","2021-06-25","Regional","Italy; Calerno, Parma, Spilamberto","2020-06-01","2020-06-30","Essential non-healthcare workers","Adults (18-64 years)",815.0,0.038,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Susanna Esposito","University of Milan","https://dx.doi.org/10.3389/fpubh.2021.628098","Unverified","","NR","","","","IT",""
"2021-07-19","210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_MiscarriagePatients","Did the SARS-CoV-2 effect pregnancy complications?","2021-07-06","Local","Turkey","2020-06-01","2020-07-31","Pregnant or parturient women","Adults (18-64 years)",230.0,0.0,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ozge Yucel Celik","Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital","https://dx.doi.org/10.5603/GP.a2021.0134","Verified","","NR","","","","TR",""
"2021-07-19","210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_PROMPatients","Did the SARS-CoV-2 effect pregnancy complications?","2021-07-06","Local","Turkey","2020-06-01","2020-07-31","Pregnant or parturient women","Adults (18-64 years)",205.0,0.029,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ozge Yucel Celik","Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital","https://dx.doi.org/10.5603/GP.a2021.0134","Verified","","NR","","","","TR",""
"2021-07-19","210706_Ethiopia_ArmauerHansenResearchInstitute_HCW","High Seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers","2021-07-06","National","Ethiopia; Oromiya, Sidama, Amhara; Addis Ababa","2020-12-15","2021-02-14","Health care workers and caregivers","Adults (18-64 years)",1997.0,0.396,0.374,0.417,"Self-referral","IgG","High","Preprint","Tesfaye Gelanew","Armauer Hansen Research Institute","10.1101/2021.07.01.21259687","Unverified","","NR",1.0,0.977,"","ET",""
"2021-07-19","210707_UnitedStates_NationalInstitutesOfHealth_Overall","Undiagnosed sars-cov-2 seropositivity during the first 6 months of the covid-19 pandemic in the united states","2021-07-07","National","United States of America","2020-04-01","2020-08-04","Household and community samples","Multiple groups",8058.0,0.046,0.026,0.065,"Stratified non-probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Heather Kalish","National Institutes of Health","http://dx.doi.org/10.1126/scitranslmed.abh3826","Verified","","NR","","","","US",""
"2021-07-19","210710_EthiopiaDireDawa_JimmaUniversityInstituteofHealth_Primary","Seroprevalence of SARS-CoV-2 antibody among individuals aged above 15 years and residing in congregate settings in Dire Dawa city administration, Ethiopia.","2021-07-10","Local","Ethiopia","2020-06-15","2020-07-30","Household and community samples","Multiple groups",684.0,0.032,0.02,0.048,"Simplified probability","IgG","Low","Journal Article (Peer-Reviewed)","Tamrat Shaweno","Jimma University Institute of Health","https://dx.doi.org/10.1186/s41182-021-00347-7","Verified","","NR",1.0,0.996,"","ET",""
"2021-07-19","210710_SouthIndia_AravindEyeHospital_Primary","Seroprevalence of SARS-CoV-2 specific IgG antibodies among eye care workers in South India.","2021-07-10","Regional","India; South India","2020-08-19","2020-08-28","Health care workers and caregivers","Multiple groups",1313.0,0.158,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","RajapandianSiva Ganesa Karthikeyan","Aravind Eye Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.06.014","Unverified","","NR",0.921,0.997,"","IN",""
"2021-07-19","210710_USA_EmoryUniversity_overall_PopAdj_TestAdj","SARS-CoV-2 cumulative incidence, United States, August-December 2020.","2021-07-10","National","United States of America","2020-08-09","2020-12-08","Household and community samples","Multiple groups",4654.0,0.047,0.033,0.061,"Stratified probability","Total Antibody","Low","Journal Article (Peer-Reviewed)","Patrick Sean Sullivan","Emory University","https://dx.doi.org/10.1093/cid/ciab626","Verified","","NR",0.98,0.993,"","US",""
"2021-07-19","210714_Thailand_MinistryOfPublicHealthThailand_Overall","Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.","2021-07-14","National","Thailand; Eastern, Western, Central Thailand","2021-01-18","2021-03-05","Health care workers and caregivers","Adults (18-64 years)",600.0,0.002,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Wanitchaya Kittikraisak","Ministry of Public Health, Thailand","https://dx.doi.org/10.1371/journal.pone.0254563","Unverified","","NR","","","","TH",""
"2021-07-19","210715_Egypt_NationalResearchCentre_Primary","Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.","2021-07-15","Local","Egypt","2020-08-15","2020-10-15","Multiple general populations","Multiple groups",888.0,0.3,"","","Convenience","Not reported","Moderate","Journal Article (Peer-Reviewed)","Amira S. El Rifay","National Research Centre","https://dx.doi.org/10.1111/irv.12889","Unverified","","NR","","","","EG",""
"2021-07-20","201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Adults2","Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain","2020-11-20","Local","Spain","2020-04-28","2020-06-03","Household and community samples","Multiple groups",412.0,0.187,0.15,0.228,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pedro Brotons","University Hospital Sant Joan de Deu Barcelona","http://dx.doi.org/10.1093/cid/ciaa1721","Unverified","","NR","","","","ES",""
"2021-07-20","201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Children1","Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain","2020-11-20","Local","Spain","2020-04-28","2020-06-03","Household and community samples","Multiple groups",672.0,0.176,0.148,0.207,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Pedro Brotons","University Hospital Sant Joan de Deu Barcelona","http://dx.doi.org/10.1093/cid/ciaa1721","Unverified","","NR","","","","ES",""
"2021-07-20","210312_SaoPaulo_CityOfSaoPaulo_2021_Phase4_overall","inquérito sorológico adultos (>18)para sars-cov-2 - resultado da fase 4 de 2021","2021-03-12","Local","Brazil; São Paulo; São Paulo","2021-02-16","2021-02-18","Household and community samples","Multiple groups",1793.0,0.25,0.217,0.287,"Simplified probability","IgG; IgM","High","Institutional Report","City of Sao Paulo","City of São Paulo","http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-04_2021.pdf/","Verified","","NR","","","","BR","BR-SP"
"2021-07-20","210624_Israel_TelAvivUniversity_overall","Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination.","2021-06-24","National","Israel","2020-04-15","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",874.0,0.011,0.006,0.021,"Convenience","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Khitam Muhsen","Tel Aviv University","https://dx.doi.org/10.3389/fmed.2021.689994","Verified","","NR","","","","IL",""
"2021-07-20","210713_Strasbourg_HôpitauxUniversitairesdeStrasbourg_primary","Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.","2021-07-13","Local","France","2020-05-18","2020-07-02","Patients seeking care for non-COVID-19 reasons","Multiple groups",469.0,0.066,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Renaud Felten","Hôpitaux Universitaires de Strasbourg studied patienst with rare autoimmune diseases (n=469) and found a seroprevalence of 6.6%","https://dx.doi.org/10.1186/s13075-021-02565-0","Unverified","","NR","","","","FR",""
"2021-07-20","210714_Iran_TarbiatModaresUniversity_primary","SARS-CoV-2 seroprevalence in asymptomatic or mild symptomatic people and symptomatic patients with negative PCR results: The hidden perspective in epidemiological reports","2021-07-14","National","Iran (Islamic Republic of)","2020-05-30","2020-06-17","Multiple populations","Multiple groups",716.0,0.173,0.088,0.258,"Unclear","IgG","High","Preprint","Nazila Hajiahmadi","Tarbiat Modares University","10.1101/2021.07.11.21260336","Unverified","","NR",0.941,0.983,"","IR",""
"2021-07-20","210716_Foggia_UniversityHospitalOfFoggia_May-Sept1_Primary","Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders","2021-07-16","Local","Italy; Foggia; Foggia","2020-05-01","2020-09-30","Blood donors","Multiple groups",4018.0,0.005,0.0,0.005,"Sequential","IgA; IgM; IgG","High","Preprint","Francescopaolo Antonucci","University Hospital “Riuniti” of Foggia","10.1101/2021.07.12.21260358","Verified","","NR","","","","IT","IT-75"
"2021-07-20","210716_Foggia_UniversityHospitalOfFoggia_Oct-Mar2_Primary","Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders","2021-07-16","Local","Italy; Foggia; Foggia","2020-10-01","2021-03-31","Blood donors","Multiple groups",4165.0,0.119,"","","Sequential","IgA; IgM; IgG","High","Preprint","Francescopaolo Antonucci","University Hospital “Riuniti” of Foggia","10.1101/2021.07.12.21260358","Verified","","NR","","","","IT","IT-75"
"2021-07-20","210724_Brescia-Lombardy_UniversityOfBrescia_Residents1","Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.","2021-07-24","Local","Italy; Province of Brescia; Brescia","2020-05-19","2020-06-30","Assisted living and long-term care facilities","Multiple groups",246.0,0.24,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Antonella Savio","University Of Brescia","https://dx.doi.org/10.3389/fpubh.2021.649524","Unverified","","NR",0.976,1.0,"","IT","IT-25"
"2021-07-20","210724_Brescia-Lombardy_UniversityOfBrescia_Staff2","Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.","2021-07-24","Local","Italy; Province of Brescia; Brescia","2020-04-23","2020-05-14","Health care workers and caregivers","Multiple groups",286.0,0.168,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Antonella Savio","University Of Brescia","https://dx.doi.org/10.3389/fpubh.2021.649524","Unverified","","NR",0.976,1.0,"","IT","IT-25"
"2021-07-21","210618_Brazil_UniversidadeFederaldePelotas_primary","COVID-19 and social distancing among children and adolescents in Brazil.","2021-06-18","National","Brazil","2020-05-14","2020-06-23","Household and community samples","Multiple groups",89362.0,0.023,"","","Stratified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Fernando C Barros","Universidade Federal de Pelotas","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225319/","Verified","","NR",0.848,0.99,"","BR",""
"2021-07-21","210706_Lombardy_BrunoKesslerFoundation_HCW","Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.","2021-07-06","Regional","Italy; Lombardy region","2020-04-01","2020-06-26","Health care workers and caregivers","Multiple groups",82961.0,0.122,0.12,0.124,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Piero Poletti","Bruno Kessler Foundation","https://dx.doi.org/10.1001/jamanetworkopen.2021.15699","Unverified","","NR",0.944,0.983,"","IT","IT-25"
"2021-07-21","210709_Vojvodina_UniversityOfNoviSad_LFIA_September4_Overall","Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.","2021-07-09","Regional","Serbia; Vojvodina","2020-09-17","2020-09-30","Household and community samples","Multiple groups",1041.0,0.146,0.125,0.168,"Stratified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mioljub Ristic","University Of Novi Sad","https://dx.doi.org/10.1371/journal.pone.0254516","Verified","","NR",0.873,1.0,"","RS","RS-VO"
"2021-07-21","210709_Vojvodina_UniversityOfNoviSad_Unadj_April1_Overall","Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.","2021-07-09","Regional","Serbia; Vojvodina","2020-04-17","2020-04-30","Household and community samples","Multiple groups",1267.0,0.026,0.018,0.036,"Stratified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mioljub Ristic","University Of Novi Sad","https://dx.doi.org/10.1371/journal.pone.0254516","Verified","","NR",0.873,1.0,"","RS","RS-VO"
"2021-07-21","210709_Vojvodina_UniversityOfNoviSad_Unadj_June3_Overall","Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.","2021-07-09","Regional","Serbia; Vojvodina","2020-06-17","2020-06-30","Household and community samples","Multiple groups",1014.0,0.061,0.047,0.078,"Stratified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mioljub Ristic","University Of Novi Sad","https://dx.doi.org/10.1371/journal.pone.0254516","Verified","","NR",0.873,1.0,"","RS","RS-VO"
"2021-07-21","210709_Vojvodina_UniversityOfNoviSad_Unadj_May2_Overall","Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.","2021-07-09","Regional","Serbia; Vojvodina","2020-05-18","2020-05-31","Household and community samples","Multiple groups",1068.0,0.039,0.028,0.053,"Stratified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mioljub Ristic","University Of Novi Sad","https://dx.doi.org/10.1371/journal.pone.0254516","Verified","","NR",0.873,1.0,"","RS","RS-VO"
"2021-07-21","210710_Athens_UniversityofGeorgia_PopTestAdj","Prevalence of previous infection with SARS-CoV-2 and persistent symptoms at a large university","2021-07-10","Local","United States of America; Georgia; Athens","2021-01-22","2021-03-22","Students and Daycares","Adults (18-64 years)",432.0,0.41,0.314,0.507,"Convenience","IgA","Moderate","Preprint","Mark H Ebell","University of Georgia","https://www.medrxiv.org/content/10.1101/2021.07.08.21260201v1","Unverified","","NR",0.889,0.889,"","US","US-GA"
"2021-07-21","210712_UnitedStates_StanfordUniversity_Overall","Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.","2021-07-12","National","United States of America","2021-01-01","2021-01-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",21464.0,0.187,0.181,0.192,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Shuchi Anand","Stanford University","https://dx.doi.org/10.1001/jamanetworkopen.2021.16572","Unverified","","NR",1.0,0.998,"","US",""
"2021-07-21","210713_England_DepartmentofHealthandSocialCare","National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.","2021-07-13","Regional","United Kingdom of Great Britain and Northern Ireland; England; NR","2020-05-26","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",1146310.0,0.163,0.162,0.164,"Convenience","IgM; IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Cordelia Coltart","Department of Health and Social Care","https://dx.doi.org/10.1136/bmjopen-2021-049703","Unverified","","NR","","","","GB","GB-ENG"
"2021-07-22","210316_England_PublicHealthEngland_Round1_Staff_Primary","SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.","2021-06-01","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-06-19","Essential non-healthcare workers","Adults (18-64 years)",1379.0,0.151,0.119,0.189,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Shamez Ladhani","Public Health England","https://dx.doi.org/10.1016/S2352-4642(21)00061-4","Verified","The United Kingdom","NR","","","","GB","GB-ENG"
"2021-07-22","210316_England_PublicHealthEngland_Round1_Students_Primary","SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.","2021-06-01","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-06-19","Students and Daycares","Children and Youth (0-17 years)",816.0,0.112,0.079,0.151,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Shamez Ladhani","Public Health England","https://dx.doi.org/10.1016/S2352-4642(21)00061-4","Verified","The United Kingdom","NR","","","","GB","GB-ENG"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Non-essential workers and unemployed persons","Adults (18-64 years)",145.0,0.075,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Essential non-healthcare workers","Adults (18-64 years)",67.0,0.104,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Health care workers and caregivers","Adults (18-64 years)",165.0,0.103,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_TransporationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Essential non-healthcare workers","Adults (18-64 years)",112.0,0.161,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Chokwe","2020-11-16","2020-11-21","Non-essential workers and unemployed persons","Adults (18-64 years)",472.0,0.068,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Non-essential workers and unemployed persons","Adults (18-64 years)",272.0,0.033,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Essential non-healthcare workers","Adults (18-64 years)",116.0,0.017,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_HCWs","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Health care workers and caregivers","Adults (18-64 years)",281.0,0.057,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_TransporationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Essential non-healthcare workers","Adults (18-64 years)",209.0,0.038,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020)","2020-12-08","Local","Mozambique; Gaza; Xai-Xai","2020-11-02","2020-11-12","Non-essential workers and unemployed persons","Adults (18-64 years)",460.0,0.059,"","","Convenience","IgG; IgM","High","Presentation or Conference","Paulo Arnaldo","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf","Verified","Mozambique","Abbott","","","","MZ","MZ-G"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Non-essential workers and unemployed persons","Adults (18-64 years)",255.0,0.035,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_DefenceForcesy","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Essential non-healthcare workers","Multiple groups",174.0,0.092,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Health care workers and caregivers","Adults (18-64 years)",342.0,0.02,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Essential non-healthcare workers","Adults (18-64 years)",153.0,0.046,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-24","201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_VendorsMerchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Maxixe","2020-11-07","2020-11-21","Non-essential workers and unemployed persons","Adults (18-64 years)",1001.0,0.045,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_CommercialEstablishments","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Non-essential workers and unemployed persons","Adults (18-64 years)",128.0,0.109,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_DefenceForces","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Essential non-healthcare workers","Adults (18-64 years)",116.0,0.181,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_HCW","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Health care workers and caregivers","Adults (18-64 years)",131.0,0.061,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_TransportationWorkers","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Essential non-healthcare workers","Adults (18-64 years)",34.0,0.059,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-24","201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Vendors/Merchants","Inquérito Sero-epidemiológico de SARS-CoV-2 na Cidade de Maxixe e Vila de Massinga (InCOVID 2020)","2020-12-16","Local","Mozambique; Inhambane; Massinga","2020-11-26","2020-12-03","Non-essential workers and unemployed persons","Adults (18-64 years)",517.0,0.089,"","","Convenience","IgG; IgM","High","Presentation or Conference","Mussagy Mahomed","Republica de Mocambique Ministerio da Saude","https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf","Verified","Mozambique","QINGDAO HIGHTOP Biotech","","","","MZ","MZ-I"
"2021-07-26","210719_Arkansas_UniversityOfArkansasForMedicalSciences_1_Overall","Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas","2021-07-19","Regional","United States of America; Arkansas; Little Rock, Springdale, Pine Bluff","2020-08-15","2020-09-05","Residual sera","Multiple groups",1301.0,0.026,0.017,0.035,"Convenience","IgG","Moderate","Preprint","Joshua Kennedy","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1","Verified","","NR","","","","US","US-AR"
"2021-07-26","210719_Arkansas_UniversityOfArkansasForMedicalSciences_2_Overall","Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas","2021-07-19","Regional","United States of America; Arkansas; Little Rock, Springdale, Pine Bluff, Fort Smith","2020-09-12","2020-10-24","Residual sera","Multiple groups",2098.0,0.041,0.031,0.051,"Convenience","IgG","Moderate","Preprint","Joshua Kennedy","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1","Verified","","NR","","","","US","US-AR"
"2021-07-26","210719_Arkansas_UniversityOfArkansasForMedicalSciences_3_Overall","Temporal Variations in Seroprevalence of SARS-CoV-2 Infections by Race and Ethnicity in Arkansas","2021-07-19","Regional","United States of America; Arkansas; Little Rock, Springdale, Pine Bluff, Fort Smith","2020-11-07","2020-12-19","Residual sera","Multiple groups",2405.0,0.074,0.06,0.087,"Convenience","IgG","Moderate","Preprint","Joshua Kennedy","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1","Verified","","NR","","","","US","US-AR"
"2021-07-26","210721_India_IndianCouncilOfMedicalResearch_genpop_overall","Antibodies in 68% Indians","2021-07-21","National","India","2021-06-20","2021-07-10","Household and community samples","Multiple groups",28975.0,0.676,"","","Simplified probability","IgG","Unclear","News and Media","Rhythma Kaul","Indian Council of Medical Research","https://www.hindustantimes.com/india-news/antibodies-in-68-indians-101626804217418.html","Verified","","NR","","","","IN",""
"2021-07-27","210720_LongIsland_StonyBrookUniversity_Totaladj","COVID-19 cumulative incidence, asymptomatic infections, and fatality in Long Island, NY, January-August 2020: A cohort of World Trade Center responders.","2021-07-20","Local","United States of America; New York; Long Island","2020-03-25","2020-09-18","Household and community samples","Multiple groups",1042.0,0.213,0.195,0.232,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Olga Morozova","Stony Brook University","https://dx.doi.org/10.1371/journal.pone.0254713","Verified","","NR",0.934,1.0,"","US","US-NY"
"2021-07-27","210721_Nancy_CHRUNancy_Primary","SARS-CoV-2 seroprevalence among Laboratory staff: Safe handling of COVID-19 samples.","2021-07-21","Local","France","2020-04-01","2020-04-30","Health care workers and caregivers","Multiple groups",396.0,0.023,"","","Entire sample","IgG; IgM","High","Journal Article (Peer-Reviewed)","C Hartard","Nancy University Hospital","https://dx.doi.org/10.1017/ice.2021.334","Unverified","","NR","","","","FR",""
"2021-07-27","210722_Wuhan_HospitalofHubeiProvince_HCW_primary","Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China.","2021-07-22","Local","China; Hubei; Wuhan","2020-04-01","2020-04-30","Health care workers and caregivers","Adults (18-64 years)",385.0,0.018,"","","Entire sample","IgG; IgM","High","Journal Article (Peer-Reviewed)","Hongwen Ma","Hospital of Hubei Province","https://dx.doi.org/10.1007/s12026-021-09213-4","Verified","","NR","","","","CN","CN-42"
"2021-07-27","210722_Wuhan_HospitalofHubeiProvince_partners_primary","Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China.","2021-07-22","Local","China; Hubei; Wuhan","2020-04-01","2020-12-30","Multiple general populations","Adults (18-64 years)",15671.0,0.007,"","","Entire sample","IgG; IgM","High","Journal Article (Peer-Reviewed)","Hongwen Ma","Hospital of Hubei Province","https://dx.doi.org/10.1007/s12026-021-09213-4","Verified","","NR","","","","CN","CN-42"
"2021-07-27","210722_Wuhan_HospitalofHubeiProvince_pregnant_primary","Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China.","2021-07-22","Local","China; Hubei; Wuhan","2020-04-01","2020-12-30","Pregnant or parturient women","Adults (18-64 years)",15953.0,0.007,"","","Entire sample","IgG; IgM","High","Journal Article (Peer-Reviewed)","Hongwen Ma","Hospital of Hubei Province","https://dx.doi.org/10.1007/s12026-021-09213-4","Verified","","NR","","","","CN","CN-42"
"2021-07-27","210801_Zambia_USCDC_Outpatient_Primary_Adj","SARS-CoV-2 Prevalence among Outpatients during Community Transmission, Zambia, July 2020.","2021-08-01","National","Zambia; Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi; NR","2020-07-02","2020-07-31","Residual sera","Multiple groups",1657.0,0.082,0.051,0.114,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jonas Z Hines","US Centers for Disease Control and Prevention","https://wwwnc.cdc.gov/eid/article/27/8/21-0502_article","Verified","","NR",0.657,1.0,"","ZM",""
"2021-07-28","200720_Sweden_TheSwedishPublicHealthAgency_Primary","Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021","2021-07-20","National","Sweden","2021-04-26","2021-05-09","Blood donors","Multiple groups",2860.0,0.328,0.306,0.351,"Self-referral","IgG","Moderate","Institutional Report","Swedish Public Health Agency","The Swedish Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/45eafde72689438a8a21efa93a5591a4/forekomsten-antikroppar-mot-sars-cov-2.pdf","Unverified","","NR","","","","SE",""
"2021-07-28","210601_England_UniversityCollegeLondon_residents_primary","Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study","2021-06-01","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-10-01","2021-02-01","Assisted living and long-term care facilities","Seniors (65+ years)",682.0,0.33,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Maria Krutikov","University College London","https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext","Verified","","NR","","","","GB","GB-ENG"
"2021-07-28","210601_England_UniversityCollegeLondon_staff_primary","Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study","2021-06-01","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-10-01","2021-02-01","Health care workers and caregivers","Adults (18-64 years)",1429.0,0.29,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Maria Krutikov","University College London","https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext","Verified","","NR","","","","GB","GB-ENG"
"2021-07-28","210622_London_LondonSchoolOfHygieneAndTropicalMedicine_HCWs","Association between SARS-CoV-2 exposure and antibody status among healthcare workers in two London hospitals: a cross-sectional study","2021-06-22","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-04","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",615.0,0.407,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Admire Murongazvombo","London School Of Hygiene And Tropical Medicine","http://dx.doi.org/10.1016/j.infpip.2021.100157","Verified","","NR","","","","GB","GB-ENG"
"2021-07-28","210707_Istanbul_FlorenceNightingaleHospital_primary","Interventional pain management during sars-cov-2 pandemic","2021-07-07","Local","Turkey; Istanbul; Istanbul","2020-03-20","2020-06-20","Patients seeking care for non-COVID-19 reasons","Multiple groups",83.0,0.036,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Savas Comlek","Florence Nightingale Hospital","http://dx.doi.org/10.22514/sv.2021.008","Unverified","","NR","","","","TR","TR-34"
"2021-07-28","210713_LaoPDR_InstitutPasteurDuLaos_GeneralCommunity_Primary_Adjusted","Low seroprevalence of COVID-19 in Lao PDR, late 2020","2021-07-13","National","Lao People's Democratic Republic; Vientiane Prefecture, Oudomxay, Luangprabang, Savannakhet, Champassak","2020-08-12","2020-09-25","Household and community samples","Multiple groups",2433.0,0.052,0.042,0.065,"Stratified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Siriphone Virachith","Institut Pasteur du Laos","https://dx.doi.org/10.1016/j.lanwpc.2021.100197","Verified","","NR","","","","LA",""
"2021-07-28","210713_LaoPDR_InstitutPasteurDuLaos_HCW_Primary_Adjusted","Low seroprevalence of COVID-19 in Lao PDR, late 2020","2021-07-13","National","Lao People's Democratic Republic; Vientiane Prefecture, Oudomxay, Luangprabang, Savannakhet, Champassak","2020-08-12","2020-09-25","Health care workers and caregivers","Adults (18-64 years)",666.0,0.02,0.011,0.033,"Convenience","Not reported","Moderate","Journal Article (Peer-Reviewed)","Siriphone Virachith","Institut Pasteur du Laos","https://dx.doi.org/10.1016/j.lanwpc.2021.100197","Verified","","NR","","","","LA",""
"2021-07-28","210713_LaoPDR_InstitutPasteurDuLaos_WildlifeContacts_Primary","Low seroprevalence of COVID-19 in Lao PDR, late 2020","2021-07-13","Regional","Lao People's Democratic Republic; Vientiane Province","2020-08-12","2020-09-25","Non-essential workers and unemployed persons","Multiple groups",74.0,0.203,0.126,0.31,"Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Siriphone Virachith","Institut Pasteur du Laos","https://dx.doi.org/10.1016/j.lanwpc.2021.100197","Verified","","NR","","","","LA","LA-VI"
"2021-07-28","210719_Kanagawa_OsakaCityUniversity","Serological testing reveals the hidden COVID-19 burden among healthcare workers experiencing a SARS-CoV-2 nosocomial outbreak","2021-07-19","Local","Japan; Kanagawa; Yokohama City","2020-06-30","2020-07-02","Health care workers and caregivers","Adults (18-64 years)",377.0,0.072,"","","Convenience","IgG; Neutralizing ; IgM","High","Preprint","Yu Nakagama","Osaka City University","https://www.medrxiv.org/content/10.1101/2021.07.15.21260585v1.full-text","Unverified","","NR","","","","JP","JP-14"
"2021-07-28","210720_Italy_UniversityofGenoa","Effect of SARS-CoV-2 mRNA Vaccination in MS Patients Treated With Disease Modifying Therapies","2021-07-20","National","Italy","2021-03-04","2021-07-09","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",1022.0,0.112,"","","Convenience","Not reported","High","Preprint","Maria Pia Sormani","University of Genoa","10.2139/ssrn.3886420","Unverified","","NR","","","","IT",""
"2021-07-28","210722_Kolkata_IndianStatisticalInstitute_Primary","Seroprevalence and Dynamics of anti-SARS-CoV-2 antibody among healthcare workers following ChAdOx1 nCoV-19 vaccination","2021-07-22","Local","India; West Bengal; Kolkata","2020-11-15","2021-01-15","Health care workers and caregivers","Adults (18-64 years)",313.0,0.4,"","","Simplified probability","Total Antibody","Moderate","Preprint","Soma Sarkar","Indian Statistical Institute","10.1101/2021.07.20.21260278","Verified","","NR","","","","IN","IN-WB"
"2021-07-29","210520_NorthRhine-Westphalia_RuhrUniversityBochum","COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study","2021-05-20","Local","Germany; North Rhine-Westphalia","2020-07-01","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",907.0,0.014,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Anke Hildebrandt","Ruhr University Bochum","10.1016/j.ijheh.2021.113771","Unverified","","NR",0.99,0.99,"","DE","DE-NW"
"2021-07-29","210521_Andorra_ISGlobal_Overall","Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra","2021-05-21","National","Andorra","2020-05-04","2020-05-28","Household and community samples","Multiple groups",72964.0,0.11,"","","Entire sample","IgM; IgG","Low","Journal Article (Peer-Reviewed)","Cristina Royo Cebrecos","ISGlobal","https://www.sciencedirect.com/science/article/pii/S266677622100096X","Verified","","NR",0.92,1.0,"","AD",""
"2021-07-29","210701_LaRinconada_GrenobleAlpesUniversity_overall","High-Altitude Environment and COVID-19: SARS-CoV-2 Seropositivity in the Highest City in the World","2021-07-01","Local","Peru; Puno; La Riconanda","2020-10-11","2020-10-18","Household and community samples","Multiple groups",159.0,0.484,0.405,0.564,"Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Benoit Champigneulle","Grenoble Alpes University","http://dx.doi.org/10.1089/ham.2021.0020","Verified","","NR",1.0,1.0,"","PE","PE-PUN"
"2021-07-29","210708_Sheffield_SheffieldTeachingHospitalsNHSFoundationTrust_PopAdjusted","Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.","2021-07-08","Local","United Kingdom of Great Britain and Northern Ireland; England; Sheffield","2020-05-15","2020-06-12","Health care workers and caregivers","Adults (18-64 years)",1275.0,0.231,0.141,0.333,"Convenience","IgG; IgA","High","Preprint","David Hodgson","Sheffield Teaching Hospitals NHS Foundation Trust","https://dx.doi.org/10.1101/2021.07.07.21260151","Unverified","","NR",0.995,0.996,"","GB","GB-ENG"
"2021-07-29","210710_Jordan_WorldHealthOrganization_August2020_","A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan","2021-07-10","National","Jordan","2020-08-01","2020-08-31","Household and community samples","Multiple groups",4704.0,0.003,0.002,0.004,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saverio Bellizzi","World Health Organization","http://dx.doi.org/10.1016/j.onehlt.2021.100292","Verified","","NR","","","","JO",""
"2021-07-29","210710_Jordan_WorldHealthOrganization_January2021","A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan","2021-07-10","National","Jordan","2020-12-27","2021-01-06","Household and community samples","Multiple groups",5044.0,0.342,0.338,0.346,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saverio Bellizzi","World Health Organization","http://dx.doi.org/10.1016/j.onehlt.2021.100292","Verified","","NR","","","","JO",""
"2021-07-29","210710_Jordan_WorldHealthOrganization_October2020","A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan","2021-07-10","National","Jordan","2020-10-01","2020-10-31","Household and community samples","Multiple groups",5470.0,0.07,0.068,0.072,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Saverio Bellizzi","World Health Organization","http://dx.doi.org/10.1016/j.onehlt.2021.100292","Verified","","NR","","","","JO",""
"2021-07-29","210719_Brussels_UniversitéLibredeBruxelles","Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium.","2021-07-19","Local","Belgium; NR; Brussels","2020-03-15","2021-02-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",75.0,0.2,"","","Sequential","Not reported","High","Journal Article (Peer-Reviewed)","Anissa Messaaoui","Université Libre de Bruxelles","https://dx.doi.org/10.1515/jpem-2021-0289","Unverified","","NR","","","","BE",""
"2021-07-29","210722_Hyderabad_CSIR-CentreForCellularAndMolecularBiology_Primary","SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021","2021-07-22","Local","India; Telangana; Hyderabad","2021-01-08","2021-01-24","Household and community samples","Multiple groups",9363.0,0.542,0.532,0.552,"Simplified probability","Total Antibody","High","Preprint","Avula Laxmaiah","CSIR-CentreForCellularAndMolecularBiology","10.1101/2021.07.18.21260555","Verified","","NR","","","","IN","IN-TG"
"2021-07-29","210722_Kerala_GovernmentMedicalCollegeThiruvananthapuram_TestAdj","Prevalence of SARS CoV-2 infection among Health Care Workers of a hybrid tertiary COVID 19 hospital in Kerala","2021-07-22","Local","India; Kerala; Thiruvananthapuram","2021-01-08","2021-01-19","Health care workers and caregivers","Adults (18-64 years)",940.0,0.212,"","","Stratified probability","IgG","Moderate","Preprint","S J Jessy","Government Medical College Thiruvananthapuram","10.1101/2021.07.19.21260792","Unverified","","NR",0.9,1.0,"","IN","IN-KL"
"2021-07-31","210706_Canada_StatisticsCanada_Overall","Study reveals children and youth had highest rates of SARS-CoV-2 infection in Canada before third wave","2021-07-06","National","Canada","2020-11-15","2021-04-15","Household and community samples","Multiple groups",11124.0,0.036,0.026,0.042,"Stratified probability","Not reported","Moderate","News and Media","Statistics Canada","Statistics Canada","https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310081801","Verified","","NR","","","","CA",""
"2021-07-31","210716_England_PublicHealthEngland","Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England","2021-07-16","National","United Kingdom of Great Britain and Northern Ireland; NR; Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham.","2021-03-23","2021-04-21","Students and Daycares","Multiple groups",1800.0,0.209,"","","Convenience","IgG","Moderate","Preprint","Shamez Ladhani","Public Health England","10.1101/2021.07.14.21260496","Unverified","","NR","","","","GB",""
"2021-08-01","210527_NewYorkCity_HospitalForSpecialSurgery_overall","Coronavirus Disease 2019 Exposure in Surgeons and Anesthesiologists at a New York City Specialty Hospital; A Cross-Sectional Study of Symptoms and SARS-CoV-2 Antibody Status","2021-05-27","Local","United States of America; New York; New York City","2020-05-06","2020-06-05","Health care workers and caregivers","Adults (18-64 years)",143.0,0.098,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ellen Soffin","Hospital for Special Surgery","http://dx.doi.org/10.1097/JOM.0000000000002182","Verified","","NR","","","","US","US-NY"
"2021-08-01","210722_Belgium_UniversityOfNamur_overall","Antibody titres decline 3-month post-vaccination with BNT162b2","2021-07-22","National","Belgium","2021-01-16","2021-02-15","Health care workers and caregivers","Multiple groups",200.0,0.29,"","","Unclear","Total Antibody","High","Journal Article (Peer-Reviewed)","Julien Favresse","University of Namur","http://dx.doi.org/10.1080/22221751.2021.1953403","Verified","","NR","","","","BE",""
"2021-08-02","201029_Madrid_HospitalUniversitarioPríncipedeAsturias","Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hospital workers in a severely affected institution in Madrid, Spain: A surveillance cross-sectional study","2020-10-29","Local","Spain; NR; Madrid","2020-05-01","2020-05-30","Health care workers and caregivers","Adults (18-64 years)",2424.0,0.224,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Felipe Perez Garcia","Hospital Universitario Príncipe de Asturias","http://dx.doi.org/10.1017/ice.2020.1303","Verified","","NR",0.88,1.0,"","ES",""
"2021-08-02","210522_Adana_AdanaDr.TurgutNoyanTeachingandResearchHospital","Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic","2021-05-22","Local","Turkey; Mediterranean Region; Adana","2020-05-18","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",572.0,0.037,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Hatice Hale GUMUS","Adana Dr. Turgut Noyan Teaching and Research Hospital","http://mikrobiyolbul.org/managete/fu_folder/2021-03/357-373%20Hatice%20Hale%20Gumus.pdf","Unverified","","NR","","","","TR",""
"2021-08-02","210629_SaoPaulo_UniversidadeFederaldeSãoPaulo_Overall","Lower seroprevalence for SARS-CoV-2-specific antibodies among kidney transplant recipients compared to the general population in the city of Sao Paulo, Brazil.","2021-07-29","Local","Brazil","2020-09-01","2020-09-25","Patients seeking care for non-COVID-19 reasons","Multiple groups",416.0,0.082,"","","Convenience","IgG","High","Preprint","Marina P Cristelli","Universidade Federal de São Paulo","https://dx.doi.org/10.1111/tid.13706","Unverified","","NR","","","","BR",""
"2021-08-02","210720_Jeddah_KingAbdulazizUniversity_Overall","Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia","2021-07-20","Local","Saudi Arabia","2020-06-29","2020-08-10","Health care workers and caregivers","Adults (18-64 years)",693.0,0.322,0.288,0.358,"Convenience","Neutralizing ; IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Rowa Alhabbab","King Abdulaziz University","10.3390/v13071413","Verified","","NR","","","","SA",""
"2021-08-02","210721_FortCollins_ColoradoStateUniversity","Association Between COVID-19 Exposure and Self-reported Compliance With Public Health Guidelines Among Essential Employees at an Institution of Higher Education in the US.","2021-07-21","Local","United States of America; Colorado; Fort Collins","2020-07-13","2020-09-02","Essential non-healthcare workers","Adults (18-64 years)",508.0,0.004,0.001,0.014,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Tracy Nelson","Colorado State University","https://dx.doi.org/10.1001/jamanetworkopen.2021.16543","Unverified","","NR","","","","US","US-CO"
"2021-08-02","210723_France_InstitutPasteur_overall_Luminex+Neut","Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.","2021-07-23","National","France","2020-02-15","2020-08-15","Residual sera","Multiple groups",2399.0,0.053,"","","Convenience","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Tom Woudenberg","Institut Pasteur","https://dx.doi.org/10.1016/j.ebiom.2021.103495","Verified","","NR","","","","FR",""
"2021-08-02","210727_Modena_UniversityofModenaandReggioEmilia_Overall","Frequency of anti-sars-cov-2 antibodies in various occupational sectors in an industrialized area of northern italy from may to october 2020","2021-07-27","Regional","Italy; Modena","2020-05-18","2020-10-05","Essential non-healthcare workers","Adults (18-64 years)",246608.0,0.005,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Alberto Modenese","University of Modena and Reggio Emilia","http://dx.doi.org/10.3390/ijerph18157948","Unverified","","NR","","","","IT","IT-45"
"2021-08-02","210728_Amsterdam_AmsterdamUniversityMedicalCenters_COVIDCare3","Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers.","2021-07-28","Local","Netherlands","2020-03-23","2020-06-25","Health care workers and caregivers","Adults (18-64 years)",439.0,0.132,0.099,0.164,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Jonne Sikkens","Amsterdam University Medical Centers","https://dx.doi.org/10.1001/jamanetworkopen.2021.18554","Verified","","NR",0.852,0.993,"","NL",""
"2021-08-02","210728_Amsterdam_AmsterdamUniversityMedicalCenters_NoPatientCare1","Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers.","2021-07-28","Local","Netherlands","2020-03-23","2020-06-25","Health care workers and caregivers","Adults (18-64 years)",198.0,0.036,0.009,0.061,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Jonne Sikkens","Amsterdam University Medical Centers","https://dx.doi.org/10.1001/jamanetworkopen.2021.18554","Verified","","NR",0.852,0.993,"","NL",""
"2021-08-02","210728_Amsterdam_AmsterdamUniversityMedicalCenters_NonCOVIDCare2","Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care Workers.","2021-07-28","Local","Netherlands","2020-06-25","2020-06-25","Health care workers and caregivers","Adults (18-64 years)",164.0,0.067,0.028,0.105,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Jonne Sikkens","Amsterdam University Medical Centers","https://dx.doi.org/10.1001/jamanetworkopen.2021.18554","Verified","","NR",0.852,0.993,"","NL",""
"2021-08-02","210728_Grisons_KantonsspitalGraubunden_followup_HCW","Healthcare Institutions’ Recommendation Regarding the Use of FFP-2 Masks and SARS-Cov-2 Seropositivity Among Healthcare Workers – A Multicenter Longitudinal Cohort Study","2021-07-28","Regional","Switzerland; Grisons","2021-01-04","2021-02-19","Health care workers and caregivers","Multiple groups",2315.0,0.162,"","","Convenience","Not reported","High","Preprint","Katarzyna Szajek","Kantonsspital Graubunden","https://www.researchsquare.com/article/rs-722792/v1","Verified","","NR",1.0,0.998,"","CH","CH-GR"
"2021-08-03","210715_Cairo_Ain-ShamsUniversity_TestAdj","SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital","2021-07-15","Local","Egypt; Cairo Governate; Cairo","2020-05-05","2020-10-31","Residual sera","Multiple groups",2927.0,0.298,0.282,0.315,"Sequential","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Samia Girgis","Ain-Shams University","http://dx.doi.org/10.1371/journal.pone.0254581","Unverified","","NR",1.0,0.998,"","EG",""
"2021-08-03","210715_Israel_ShaareZedekMedicalCenter_Primary","SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric population","2021-07-15","Local","Israel","2020-10-18","2021-01-12","Residual sera","Children and Youth (0-17 years)",1138.0,0.1,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Adin Breuer","Shaare Zedek Medical Center","http://dx.doi.org/10.1111/apa.16031","Verified","","NR","","","","IL",""
"2021-08-03","210715_USA_GeorgeWashingtonUniversity_Overall","Association of varying clinical manifestations and positive anti-SARS-CoV-2 IgG antibodies: a cross-sectional observational study.","2021-07-15","Regional","United States of America; California, Connecticut, Michigan, New Jersey, New York","2020-05-14","2020-05-30","Household and community samples","Multiple groups",6665.0,0.3,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Jonathan Silverberg","George Washington University","https://dx.doi.org/10.1016/j.jaip.2021.06.046","Verified","","NR","","","","US",""
"2021-08-03","210719_AnambraState_StateMinistryOfHealth_testadj","Population seroprevalence of SARS-CoV-2 antibodies in Anambra state, South-East, Nigeria","2021-07-19","Regional","Nigeria; Anambra State","2020-12-08","2020-12-15","Household and community samples","Multiple groups",3142.0,0.161,"","","Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","OgoChukwu Vincent Okpala","Anambra State Ministry of Health","https://www.sciencedirect.com/science/article/pii/S1201971221005968","Verified","","NR",0.98,0.99,"","NG","NG-AN"
"2021-08-03","210722_Lyon_UniversitéClaudeBernardLyon1_overall","Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.","2021-07-22","Local","France","2020-05-10","2020-06-28","Health care workers and caregivers","Adults (18-64 years)",190.0,0.037,"","","Convenience","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Antonin Bal","Université Claude Bernard Lyon 1","https://dx.doi.org/10.1038/s41598-021-93828-y","Verified","","NR","","","","FR",""
"2021-08-03","210726_Chapecó_CommunityUniversityOfChapecóRegion_Primary","Seroprevalence of SARS-CoV-2 infection in a municipality in southern Brazil","2021-07-26","Local","Brazil; Santa Catarina; Chapecó","2020-06-15","2020-08-15","Household and community samples","Multiple groups",2179.0,0.006,"","","Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Maria Silva","Community University of Chapecó Region","https://rsdjournal.org/index.php/rsd/article/view/17996/16175","Verified","","NR",0.86,0.99,"","BR","BR-SC"
"2021-08-03","210726_Dagahaley_MédecinsSansFrontières_FamilyMembers","Seroprevalence of SARS-CoV-2 Antibodies and Retrospective Mortality in a Refugee Camp, Dagahaley, Kenya","2021-07-26","Local","Kenya; NR; Dagahaley camp, Daadab Refugee Complex","2021-03-01","2021-04-14","Multiple populations","Multiple groups",587.0,0.092,"","","Convenience","IgG; IgM","Moderate","Preprint","Etienne Gignoux","Médicins Sans Frontières","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538","Unverified","","NR",0.958,0.981,"","KE",""
"2021-08-03","210726_Dagahaley_MédecinsSansFrontières_Patients_Overall","Seroprevalence of SARS-CoV-2 Antibodies and Retrospective Mortality in a Refugee Camp, Dagahaley, Kenya","2021-07-26","Local","Kenya; NR; Dagahaley camp, Daadab Refugee Complex","2021-03-01","2021-04-14","Multiple populations","Multiple groups",619.0,0.069,"","","Sequential","IgG; IgM","Moderate","Preprint","Etienne Gignoux","Médicins Sans Frontières","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538","Unverified","","NR",0.958,0.981,"","KE",""
"2021-08-03","210726_Zurich_UniversityofZurich_Adults_Overall","Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.","2021-07-26","Local","Switzerland; Zurich; Zurich","2020-06-16","2020-07-09","Household and community samples","Adults (18-64 years)",857.0,0.036,0.017,0.054,"Simplified probability","IgG; IgA","Low","Journal Article (Peer-Reviewed)","Agne Ulyte","University of Zurich","https://dx.doi.org/10.1136/bmjopen-2020-047483","Verified","","NR",0.983,0.984,"","CH","CH-ZH"
"2021-08-03","210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_HCW_Unadj","The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.","2021-07-27","Local","Romania","2020-05-17","2020-12-01","Health care workers and caregivers","Adults (18-64 years)",30.0,0.233,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Corina Manolea","Carol Davila University of Medicine and Pharmacy","https://dx.doi.org/10.1093/hropen/hoab028","Unverified","","NR","","","","RO",""
"2021-08-03","210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_Patients_Unadj","The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.","2021-07-27","Local","Romania","2020-05-17","2020-12-01","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",516.0,0.068,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Corina Manolea","Carol Davila University of Medicine and Pharmacy","https://dx.doi.org/10.1093/hropen/hoab028","Unverified","","NR","","","","RO",""
"2021-08-03","210727_UK_UniversityHospitalSouthampton_Primary","Immunocompromised Children and Young People Are at No Increased Risk of Severe COVID-19","2021-07-27","National","United Kingdom of Great Britain and Northern Ireland","2021-02-15","2021-03-15","Residual sera","Children and Youth (0-17 years)",478.0,0.098,"","","Simplified probability","IgG","High","Preprint","H Chappell","University Hospital Southampton","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893560","Verified","","NR","","","","GB",""
"2021-08-04","201214_UnitedKingdom_UniversityOfSouthamptonSchoolOfMedicine","Investigations, actions and learning from an outbreak of SARS-CoV-2 infection among healthcare workers in the United Kingdom.","2020-12-14","National","United Kingdom of Great Britain and Northern Ireland","2020-05-13","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",135.0,0.13,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Kordo Saeed","University of Southampton School of Medicine","https://dx.doi.org/10.1177/1757177420976798","Unverified","","NR","","","","GB",""
"2021-08-04","210702_Ahmedabad_AMC-MET-MedicalCollege_Primary","Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city.","2021-07-02","Local","India; Gujarat; Ahmedabad","2020-08-15","2020-08-31","Household and community samples","Multiple groups",10310.0,0.232,0.224,0.241,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Om Prakash","AMC MET Medical College","https://dx.doi.org/10.4103/jfmpc.jfmpc_2062_20","Verified","","NR","","","","IN","IN-GJ"
"2021-08-04","210702_Jaipur_AllIndiaInstituteOfMedicalSciences_2","COVID-19 seropositivity among non-medical frontline office staff from two cities in Rajasthan, India.","2021-07-02","Local","India; Rajasthan; Jaipur","2020-08-04","2020-08-04","Essential non-healthcare workers","Adults (18-64 years)",41.0,0.136,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Vidhi Jain","All India Institute Of Medical Sciences","https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20","Unverified","","NR","","","","IN","IN-RJ"
"2021-08-04","210702_Jodhpur_AllIndiaInstituteOfMedicalSciences_1","COVID-19 seropositivity among non-medical frontline office staff from two cities in Rajasthan, India.","2021-07-02","Local","India; Rajasthan; Jodhpur","2020-07-28","2020-07-28","Essential non-healthcare workers","Adults (18-64 years)",22.0,0.024,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Vidhi Jain","All India Institute Of Medical Sciences","https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20","Unverified","","NR","","","","IN","IN-RJ"
"2021-08-04","210706_London_LondonSchoolofHygiene&TropicalMedicine","SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study","2021-07-06","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-10-19","2020-12-07","Household and community samples","Multiple groups",1242.0,0.643,0.616,0.67,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Katherine Gaskell","London School of Hygiene & Tropical Medicine","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291041/","Verified","","NR",0.962,0.974,"","GB","GB-ENG"
"2021-08-04","210718_England_ImperialCollegeLondon_Round6","Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study","2021-07-18","National","United Kingdom of Great Britain and Northern Ireland","2021-05-12","2021-05-25","Household and community samples","Multiple groups",207337.0,0.611,0.609,0.614,"Stratified probability","IgG","Low","Preprint","Helen Ward","Imperial College London","https://www.medrxiv.org/content/10.1101/2021.07.14.21260497v1","Unverified","","NR",0.844,0.986,"","GB",""
"2021-08-04","210720_Bangkok_ChulalongkornUniversity","Potential applications of the rapid COVID-19 antibody test kit screening in comparison to the RT-PCR in patients and personnel at the Department of Obstetrics and Gynecology","2021-07-20","Local","Thailand","2020-08-15","2021-01-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",210.0,0.01,"","","Unclear","IgG; IgM","High","Preprint","Amarin Narkwichean","Chulalongkorn University","https://www.medrxiv.org/content/10.1101/2021.07.16.21259725v1.full-text","Unverified","","NR",0.887,0.906,"","TH",""
"2021-08-04","210720_Sitakunda_JohnsHopkinsBloombergSchoolofPublicHealth_Adj","SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021","2021-07-20","Local","Bangladesh; NR; Chattogram","2021-03-27","2021-04-13","Household and community samples","Multiple groups",664.0,0.631,0.562,0.698,"Stratified probability","Total Antibody","Low","Preprint","Taufiqur Rahman Bhuiyan","Johns Hopkins Bloomberg School of Public Health","https://www.medrxiv.org/content/10.1101/2021.07.16.21260611v1.full-text","Unverified","","NR",0.873,0.991,"","BD",""
"2021-08-04","210727_Tokyo_MusashinoRed CrossHospital_Baseline","The dynamics of quantitative SARS-CoV-2 anti-spike IgG response to BNT162b2 vaccination.","2021-07-27","Local","Japan","2021-03-15","2021-05-15","Essential non-healthcare workers","Multiple groups",59.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Shun Kaneko","Musashino Red Cross Hospital","https://dx.doi.org/10.1002/jmv.27231","Unverified","","NR",1.0,0.996,"","JP",""
"2021-08-04","210728_NewYorkCity_WeillCornellMedicine_overall","SARS-CoV-2 Antibody Response in Patients Undergoing Kidney Transplantation","2021-07-28","Local","United States of America; New York ; New York City","2020-05-28","2020-12-12","Patients seeking care for non-COVID-19 reasons","Multiple groups",72.0,0.319,"","","Sequential","IgG","High","Preprint","Michelle Lubetzky","Weill Cornell Medicine","https://www.medrxiv.org/content/10.1101/2021.07.25.21261066v1.full-text","Verified","","NR","","","","US","US-NY"
"2021-08-05","210326_Vaud_UniversityofLausanne_CloseContactsOutsideHousehold2_Overall_ClusterAdj","Prevalence of SARS-CoV-2 in Household Members and Other Close Contacts of COVID-19 Cases: A Serologic Study in Canton of Vaud, Switzerland.","2021-03-26","Regional","Switzerland; Vaud","2020-05-04","2020-06-27","Contacts of COVID patients","Multiple groups",69.0,0.19,0.1,0.332,"Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Julien Dupraz","University of Lausanne","https://dx.doi.org/10.1093/ofid/ofab149","Verified","","Lausanne University Hospital, Switzerland",0.967,0.992,"","CH","CH-VD"
"2021-08-05","210326_Vaud_UniversityofLausanne_Household1_Overall_ClusterAdj","Prevalence of SARS-CoV-2 in Household Members and Other Close Contacts of COVID-19 Cases: A Serologic Study in Canton of Vaud, Switzerland.","2021-03-26","Regional","Switzerland; Vaud","2020-05-04","2020-06-27","Contacts of COVID patients","Multiple groups",302.0,0.572,0.495,0.643,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Julien Dupraz","University of Lausanne","https://dx.doi.org/10.1093/ofid/ofab149","Verified","","Lausanne University Hospital, Switzerland",0.967,0.992,"","CH","CH-VD"
"2021-08-05","210407_Slovenia_UniversityofLjubljana_SecondRound_Nov","Seroprevalence of SARS-CoV-2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned","2021-04-07","National","Slovenia","2020-10-17","2020-11-10","Household and community samples","Multiple groups",1211.0,0.043,0.032,0.055,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Mario Poljak","University of Ljubljana","https://dx.doi.org/10.1016/j.cmi.2021.03.009","Verified","Slovenia","NR","","","","SI",""
"2021-08-10","210614_Gothenburg_TheSwedishPublicHealthAgency_Primary","Förekomsten av antikroppar mot SARS-CoV-2 bland äldre i Göteborg 1-16 mars 2021","2021-06-14","Local","Sweden","2021-03-01","2021-03-16","Blood donors","Seniors (65+ years)",724.0,0.069,0.053,0.09,"Self-referral","IgG","High","Institutional Report","Swedish Public Health Agency","The Public Health Agency of Sweden, University of Gothenburg, Sahlgrenska University Hospital and Region Västra Götaland","https://www.folkhalsomyndigheten.se/contentassets/eee8b4f90ef24a18b2a65865341710e1/forekomsten-antikroppar-sars-cov-2-aldre-goteborg.pdf","Unverified","","NR","","","","SE",""
"2021-08-10","210706_Italy_FondazioneIRCCSPoliclinicoSanMatteo_Primary","Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study","2021-07-06","Regional","Italy; Pavia, Lecco, Piacenza","2020-04-29","2020-05-29","Health care workers and caregivers","Adults (18-64 years)",9610.0,0.152,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Francesca Rovida","Fondazione IRCCS Policlinico San Matteo","http://dx.doi.org/10.1016/j.ijid.2021.07.003","Verified","","NR","","","","IT",""
"2021-08-10","210729_Mariana+OuroPreto_FederalUniversityOfOuro","COVID-Inconfidentes - SARS-CoV-2 seroprevalence in two Brazilian urban areas during the pandemic first wave: study protocol and initial results","2021-07-29","Local","Brazil; Minas Gerais; Mariana, OuroPreto","2020-10-15","2020-12-15","Household and community samples","Multiple groups",1762.0,0.055,"","","Convenience","IgG; IgM","High","Preprint","Adriana Lucia Meireles","Federal University of Ouro","https://preprints.scielo.org/index.php/scielo/preprint/view/2720","Unverified","","NR",0.864,0.996,"","BR","BR-MG"
"2021-08-10","210731_Caracas_UniversidadCentraldeVenezuela","IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals might need just one vaccine dose.","2021-07-31","Local","Venezuela (Bolivarian Republic of)","2021-02-01","2021-02-06","Health care workers and caregivers","Multiple groups",86.0,0.314,"","","Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Franklin Claro","Universidad Central de Venezuela","https://dx.doi.org/10.1016/j.ijid.2021.07.070","Verified","","NR","","","","VE",""
"2021-08-10","210801_Riyadh_KingSaudUniversity_Primary","Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia.","2021-08-01","Local","Saudi Arabia","2020-11-22","2020-12-17","Blood donors","Adults (18-64 years)",515.0,0.122,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Mohammed F. Alosaimi","King Saud University","https://dx.doi.org/10.15537/smj.2021.42.8.20210238","Verified","","NR",1.0,0.996,"","SA",""
"2021-08-10","210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Adults","Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021.","2021-08-04","Local","United States of America; Missouri; St Louis","2020-07-25","2020-07-31","Residual sera","Multiple groups",506.0,0.045,0.021,0.069,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Brittany K. Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.00450-21","Verified","","NR",0.982,0.987,"","US","US-MO"
"2021-08-10","210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Children","Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021.","2021-08-04","Local","United States of America; Missouri; St Louis","2020-07-22","2020-08-16","Residual sera","Children and Youth (0-17 years)",546.0,0.052,0.028,0.077,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Brittany K. Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.00450-21","Verified","","NR",0.982,0.987,"","US","US-MO"
"2021-08-10","210805_Bloomington_IndianaUniversity","High-risk alcohol consumption may increase the risk of SARS-CoV-2 seroconversion: a prospective seroepidemiologic cohort study among American college students","2021-08-05","Local","United States of America; Indiana; Bloomington","2020-09-28","2020-11-23","Students and Daycares","Adults (18-64 years)",808.0,0.05,"","","Simplified probability","IgG; IgM","High","Preprint","Sina Kianersi","Indiana University","10.1101/2021.08.03.21261444","Verified","","NR",0.64,1.0,"","US","US-IN"
"2021-08-10","210805_Varmland_CentreforClinicalResearchandEducation_primary","Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.","2021-08-05","Regional","Sweden; Varmland","2020-06-20","2020-10-12","Health care workers and caregivers","Multiple groups",4955.0,0.057,"","","Entire sample","IgG","High","Journal Article (Peer-Reviewed)","Lukas Frans Ocias","Centre for Clinical Research and Education of Varmland","https://dx.doi.org/10.1080/23744235.2021.1959949","Unverified","","NR",0.97,0.995,"","SE","SE-S"
"2021-08-11","210721_Pune_ArmedForcesMedicalCollege","Estimating the proportion and IgG antibody response to SARS-CoV-2 in individuals joining a central educational institute from different parts of India by Enzyme-linked immunosorbent assay (ELISA) based serology.","2021-07-27","Local","India; Maharashtra; Pune","2020-06-16","2020-08-16","Non-essential workers and unemployed persons","Adults (18-64 years)",413.0,0.075,0.053,0.104,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Sourav Sen","Armed Forces Medical College","https://dx.doi.org/10.1016/j.mjafi.2021.02.008","Unverified","","NR",0.98,0.99,"","IN","IN-MH"
"2021-08-11","210802_Calgary_UniversityofCalgary","Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study.","2021-08-02","Local","Canada; Alberta; Calgary","2020-10-15","2021-04-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",279.0,0.011,0.002,0.031,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Gilaad Kaplan","University of Calgary","https://dx.doi.org/10.1136/gutjnl-2021-325238","Verified","","NR",0.95,0.99,"","CA","CA-AB"
"2021-08-11","210803_Mainz_UniversityMedicalCentreOfMainz_Adj","An Epidemiological Cohort Study of SARS-CoV-2 and COVID-19 in German Healthcare Workers ‚Äì Interim Analysis after Six Months of Follow-up","2021-08-03","Local","Germany; Rhineland-Palatinate; Mainz","2020-08-15","2020-10-15","Health care workers and caregivers","Adults (18-64 years)",3664.0,0.019,0.014,0.025,"Convenience","IgG; IgM","High","Preprint","Stephan Gehring","University Medical Centre of Mainz","https://www.researchsquare.com/article/rs-688656/v1","Unverified","","NR","","","","DE","DE-RP"
"2021-08-11","210805_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round2_PopTestAdj","COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020 - April, 2021","2021-08-05","Local","Russian Federation; Northwestern Region; Saint Petersburg","2020-07-20","2020-08-08","Household and community samples","Multiple groups",474.0,0.133,0.099,0.166,"Simplified probability","Total Antibody","Low","Preprint","Anton Barchuk","Smorodinova Research Institute of Influenza","https://www.medrxiv.org/content/10.1101/2021.07.31.21261428v2","Verified","","NR",0.92,1.0,"","RU",""
"2021-08-11","210805_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round3_PopTestAdj","COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020 - April, 2021","2021-08-05","Local","Russian Federation; Northwestern Region; Saint Petersburg","2020-10-12","2020-12-06","Household and community samples","Multiple groups",1322.0,0.229,0.203,0.255,"Simplified probability","Total Antibody","Low","Preprint","Anton Barchuk","Smorodinova Research Institute of Influenza","https://www.medrxiv.org/content/10.1101/2021.07.31.21261428v2","Verified","","NR",0.92,1.0,"","RU",""
"2021-08-12","210701_Kerala_ JubileeMissionMedicalCollegeandResearchInstitute_primary","Serosurveillance of SARS-CoV-2 among the healthcare workers of a tertiary care teaching institution during the post lockdown phase in Central Kerala, India","2021-07-01","Local","India","2020-12-20","2020-12-30","Health care workers and caregivers","Adults (18-64 years)",423.0,0.088,0.062,0.119,"Stratified non-probability","IgG","High","Journal Article (Peer-Reviewed)","Aboobacker Mohamed Rafi","Jubilee Mission Medical College and Research Institute","https://www.jcdr.net/articles/PDF/15154/48703_CE[Ra1]_F(SL)_PF1(AG_OM)_PFA(KM_AnK)%20PB(AG_AnK)_PN(KM).pdf","Unverified","","NR",0.9,1.0,"","IN",""
"2021-08-12","210726_India_ArmedForcesMedicalCollege","Seropositivity of severe acute respiratory syndrome coronavirus 2 infection among healthcare workers of the Armed Forces medical services, India: A multicentric study.","2021-07-26","National","India","2020-08-21","2020-11-20","Health care workers and caregivers","Adults (18-64 years)",3253.0,0.197,0.185,0.217,"Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Subhadeep Ghosh","Armed Forces Medical College","https://dx.doi.org/10.1016/j.mjafi.2021.03.020","Unverified","","NR",0.924,0.979,"","IN",""
"2021-08-13","210501_Ahmedabad_MunicipalMedicalCollege_ContactCases","Reassessing the population based Seroprevalence for IgG antibodies against SARS COV2 in Ahmedabad","2021-05-01","Local","India","2020-10-15","2020-10-31","Contacts of COVID patients","Multiple groups",2038.0,0.26,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Om Prakash","Municipal Medical College","https://www.nepjol.info/index.php/AJMS/article/view/35099","Verified","India","Zydus Diagnostics",0.924,0.979,"","IN",""
"2021-08-13","210501_Ahmedabad_MunicipalMedicalCollege_HCW","Reassessing the population based Seroprevalence for IgG antibodies against SARS COV2 in Ahmedabad","2021-05-01","Local","India","2020-10-15","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",1737.0,0.208,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Om Prakash","Municipal Medical College","https://www.nepjol.info/index.php/AJMS/article/view/35099","Verified","India","Zydus Diagnostics",0.924,0.979,"","IN",""
"2021-08-13","210801_Aracuja_FederalUniversityofSergipe_Overall_IgG","Estimated SARS-CoV-2 infection and seroprevalence in firefighters from a Northeastern Brazilian state: A cross-sectional study","2021-08-01","Local","Brazil; Sergipe; Aracuja","2021-01-01","2021-01-31","Essential non-healthcare workers","Adults (18-64 years)",123.0,0.26,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Lysandro Borges","Federal University of Sergipe","http://dx.doi.org/10.3390/ijerph18158148","Verified","","NR",0.958,0.97,"","BR","BR-SE"
"2021-08-15","210708_Philadelphia_UniversityofPennsylvania","Health care worker sero-monitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration","2021-07-08","Local","United States of America; Pennsylvania; Philadelphia","2020-04-13","2020-05-20","Health care workers and caregivers","Adults (18-64 years)",2043.0,0.02,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Sigrid Gouma","University of Pennsylvania","http://dx.doi.org/10.1172/jci.insight.150449","Unverified","","NR","","","","US","US-PA"
"2021-08-15","210801_Phoenix_DignityHealthResearchInstitute","32 Decay of Anti-SARS-CoV-2 Nucleocapsid IgG in Seropositive Health Care Workers Over Time","2021-08-01","Local","United States of America; Arizona; Phoenix","2020-06-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",1358.0,0.214,"","","Convenience","IgG","High","Presentation or Conference","B. Tiffany","Dignity Health Research Institute","http://dx.doi.org/10.1016/j.annemergmed.2021.07.033","Unverified","","NR","","","","US","US-AZ"
"2021-08-16","210810_Bern_UniversityofBern_primary","A multidimensional cross-sectional analysis of COVID-19 seroprevalence among a police officer cohort: The PoliCOV-19 study","2021-08-10","Local","Switzerland","2021-02-09","2021-03-09","Essential non-healthcare workers","Adults (18-64 years)",978.0,0.129,"","","Convenience","IgG; IgM; IgA","High","Preprint","Parham Sendi","University of Bern","10.1101/2021.08.09.21261789","Verified","","NR","","","","CH",""
"2021-08-16","210810_CzechRepublic_MasarykUniversity_overallAdj","Dynamics of Seroconversion of Anti-Sars-Cov-2 Igg Antibodies in the Czech Unvaccinated Population: Nationwide Prospective Seroconversion (Proseco) Study","2021-08-10","National","Czechia","2020-10-01","2021-03-31","Multiple general populations","Multiple groups",30054.0,0.464,0.458,0.47,"Convenience","IgG","Moderate","Preprint","Pavel PIler","Masaryk University","10.2139/ssrn.3902465","Verified","","NR","","","","CZ",""
"2021-08-16","210810_Odisha_IndianCouncilofMedicalResearch_primary","Antibodies Against SARS-CoV-2 among High-Risk Groups: Findings from Serosurveys in 6 Urban Areas of Odisha, India","2021-08-10","Regional","India; Odisha","2020-07-15","2020-11-15","Multiple populations","Multiple groups",5434.0,0.349,0.336,0.362,"Convenience","IgG","High","Preprint","Srikanta Kanungo","Indian Council of Medical Research","https://www.researchsquare.com/article/rs-664559/v1","Verified","","NR","","","","IN","IN-OR"
"2021-08-16","210811_Munich_LudwigMaximiliansUniversitatMunich_overall","In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers.","2021-08-11","Local","Germany","2020-05-27","2020-08-12","Health care workers and caregivers","Adults (18-64 years)",7554.0,0.022,0.019,0.026,"Convenience","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Paul Wratil","Ludwig Maximilians UNiversitat Munich (LMU Munich)","https://dx.doi.org/10.1007/s15010-021-01672-z","Unverified","Germany","NR","","","","DE",""
"2021-08-16","210811_UnitedStates_NationalInstitutesOfHealth_Primary","SARS-CoV-2 Seroprevalence and Drug Use in Trauma Patients from Six Sites in the United States","2021-08-11","National","United States of America","2020-04-15","2020-10-15","Residual sera","Multiple groups",2542.0,0.079,0.069,0.09,"Convenience","IgG; IgM","High","Preprint","Tran B Ngo","National Institutes of Health","https://www.medrxiv.org/content/10.1101/2021.08.10.21261849v1","Verified","","NR",1.0,1.0,"","US",""
"2021-08-17","210709_Dubai_DubaiHealthAuthority_Overall","Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors","2021-07-09","Local","United Arab Emirates; NR; Dubai","2020-08-15","2020-12-15","Blood donors","Adults (18-64 years)",1418.0,0.135,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","May Raouf","Dubai Health Authority","http://dx.doi.org/10.1159/000517456","Unverified","","NR",0.968,0.996,"","AE",""
"2021-08-17","210726_Corsica_UniversitédeCorse_Overall_PopTestAdj","Impact of the Second Epidemic Wave of SARS-CoV-2: Increased Exposure of Young People.","2021-07-26","Regional","France; Corsica","2020-11-06","2021-02-12","Residual sera","Multiple groups",4505.0,0.087,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Lisandru Capai","Université de Corse","https://dx.doi.org/10.3389/fpubh.2021.715192","Verified","","NR",0.903,0.998,"","FR","FR-COR"
"2021-08-17","210726_Florence_MeyerChildren'sUniversityHospital","Surveillance on Healthcare Workers During the First Wave of SARS-CoV-2 Pandemic in Italy: The Experience of a Tertiary Care Pediatric Hospital.","2021-07-26","Local","Italy; Tuscany; ; Florence","2020-04-02","2020-05-06","Health care workers and caregivers","Adults (18-64 years)",1502.0,0.028,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Valentina Guarnieri","Meyer Children's University Hospital","https://dx.doi.org/10.3389/fpubh.2021.644702","Unverified","","NR","","","","IT","IT-52"
"2021-08-17","210727_California_EmoryUniversity_primary","SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California.","2021-07-27","Regional","United States of America; California","2020-08-15","2020-12-15","Household and community samples","Multiple groups",983.0,0.045,0.028,0.074,"Simplified probability","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Katherine Lamba","Emory University","https://dx.doi.org/10.1093/ofid/ofab379","Verified","","NR",0.922,0.996,"","US","US-CA"
"2021-08-17","210727_FrenchAlps_AnnecyGenevoisHospital","Effect of professional and extra-professional exposure on seroprevalence of SARS-CoV-2 infection among healthcare workers of the French alps: A multicentric cross-sectional study","2021-07-27","Regional","France; French Alps Region; NR","2020-06-27","2020-09-30","Health care workers and caregivers","Adults (18-64 years)",3454.0,0.05,0.043,0.058,"Convenience","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Virginie Vitrat","Annecy Genevois Hospital","http://dx.doi.org/10.3390/vaccines9080824","Verified","","NR","","","","FR",""
"2021-08-17","210729_SãoPaulo_HospitalIsraelitaAlbertEinstein_Adj","A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of São Paulo, Brazil","2021-07-29","Local","Brazil; São Paulo State; ; São Paulo","2020-09-15","2020-12-15","Household and community samples","Multiple groups",272.0,0.452,0.394,0.51,"Simplified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Joao Luiz Miraglia","Hospital Israelita Albert Einstein","https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255412","Verified","","NR","","","","BR","BR-SP"
"2021-08-17","210730_USA_AmericanRedCross_overall","Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines.","2021-07-30","National","United States of America","2020-06-15","2020-11-30","Blood donors","Multiple groups",1531221.0,0.042,"","","Sequential","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Roger Dodd","American Red Cross","https://dx.doi.org/10.1016/j.tmrv.2021.07.001","Verified","","NR",1.0,1.0,"","US",""
"2021-08-17","210803_Brasilia_UniversidadedeBrasilia_OverallCLIA","SARS-CoV-2 Seroprevalence and Accuracy Diagnostic Evaluation During a Covid-19 Outbreak in a Major Penitentiary Complex in Brazil, June-July 2020: A Population-Based Study","2021-08-03","Local","Brazil; Federal District; Brasilia","2020-06-17","2020-07-22","Persons who are incarcerated","Adults (18-64 years)",455.0,0.811,0.744,0.878,"Simplified probability","IgG; IgM","Moderate","Preprint","Fernando Gouvea-Reis","Universidade de Brasília","https://doi.org/10.2139/ssrn.3898505","Verified","","NR","","","","BR","BR-DF"
"2021-08-17","210806_Columbus_OhioStateUniversityCollegeofMedicine","Decline in Sars-CoV-2 antibodies over 6 month follow up in Obstetrical Healthcare workers.","2021-08-06","Local","United States of America; Ohio; Columbus","2020-09-18","2020-09-25","Health care workers and caregivers","Adults (18-64 years)",126.0,0.214,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Miranda Kiefer","Ohio State University College of Medicine","https://dx.doi.org/10.1111/aji.13490","Unverified","","NR","","","","US","US-OH"
"2021-08-17","210806_Rishikesh_AllIndiaInstituteofMedicalSciences","Seroprevalence of Antibodies against SARS COV- 2 among Health Care Workers at Tertiary Care Hospital, Uttarakhand: A Retrospective study","2021-08-06","Local","India; Uttarakhand; Rishikesh","2020-07-15","2020-08-14","Health care workers and caregivers","Adults (18-64 years)",704.0,0.02,"","","Convenience","IgM; IgG","High","Preprint","Amit Saini","All India Institute of Medical Sciences","https://www.researchsquare.com/article/rs-783686/v1","Unverified","","NR","","","","IN","IN-UL"
"2021-08-17","210807_SanDiego&Tijuana_UniversityofCalifornia","Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region","2021-08-07","Local","United States of America; California; San-Diego","2020-10-20","2021-06-16","Multiple populations","Adults (18-64 years)",386.0,0.363,0.315,0.411,"Convenience","IgG; IgM","High","Preprint","Steffanie Strathdee","University of California","https://www.medrxiv.org/content/10.1101/2021.08.05.21261671v1.full-text","Verified","","NR","","","","US","US-CA"
"2021-08-17","210807_Texas_UniversityofTexas","Estimation of Total Immunity to SARS-CoV-2 in Texas","2021-08-07","Regional","United States of America; Texas; NR","2020-10-01","2021-07-04","Multiple populations","Multiple groups",14899.0,0.353,0.337,0.369,"Convenience","Not reported","High","Preprint","Stacia Desantis","University of Texas","https://www.medrxiv.org/content/10.1101/2021.08.05.21261610v1.full-text","Verified","","NR",0.995,0.998,"","US","US-TX"
"2021-08-17","210808_Birmingham_UniversityHospitalsBirmingham_primary","Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection.","2021-08-02","Local","United Kingdom of Great Britain and Northern Ireland","2020-03-15","2020-07-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",990.0,0.259,"","","Convenience","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Gemma D. Banham","University Hospitals Birmingham","https://dx.doi.org/10.1681/ASN.2021020188","Verified","","NR","","","","GB",""
"2021-08-17","210809_Chicago_NorthwesternUniversity","Serologic Status and SARS CoV-2 Infection over 6-Months of Follow-Up in Healthcare Workers in Chicago: A Cohort Study.","2021-08-09","Local","United States of America; Illinois; Chicago","2020-11-09","2021-01-08","Health care workers and caregivers","Adults (18-64 years)",4947.0,0.084,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","John Wilkins","Northwestern University","https://dx.doi.org/10.1017/ice.2021.367","Unverified","United States of America","NR",1.0,0.996,"","US","US-IL"
"2021-08-17","210810_Antwerp_UniversityOfAntwerp","SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital.","2021-08-10","Local","Belgium; Antwerp Province; Antwerp","2020-06-09","2020-06-29","Health care workers and caregivers","Multiple groups",5233.0,0.076,0.069,0.083,"Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Reinout Naesens","University Of Antwerp","https://dx.doi.org/10.1017/S0950268821001497","Unverified","","NR",0.95,0.99,"","BE",""
"2021-08-18","210528_Spain_InstitutodeInvestigacionesBiomédicasdeMálaga_Overall","Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients (p): SOLID study","2021-05-28","National","Spain","2020-04-21","2020-06-03","Patients seeking care for non-COVID-19 reasons","Multiple groups",1500.0,0.085,0.072,0.101,"Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Mariano Provencio","Instituto de Investigaciones Biomédicas de Málaga (IBIMA)","https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.8531","Verified","","NR","","","","ES",""
"2021-08-18","210609_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report June 9, 2021 Report #8: March 2021 Survey Tracking seroprevalence in the vaccine era","2021-06-09","National","Canada","2021-02-27","2021-03-13","Blood donors","Multiple groups",16873.0,0.098,0.094,0.103,"Sequential","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified","","Roche",0.988,0.996,"","CA",""
"2021-08-18","210630_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report June 30, 2021 Report #9: April 2021 Survey Tracking seroprevalence in the vaccine era","2021-06-30","National","Canada","2021-04-13","2021-04-30","Blood donors","Multiple groups",16931.0,0.269,0.262,0.276,"Sequential","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified","","Roche",0.988,0.996,"","CA",""
"2021-08-18","210727_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report July 27, 2021 Report #10: May 2021 Survey Tracking seroprevalence in the vaccine era","2021-07-27","National","Canada","2021-05-08","2021-06-04","Blood donors","Multiple groups",17001.0,0.639,0.632,0.646,"Sequential","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified","","Roche",0.988,0.996,"","CA",""
"2021-08-18","210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Primary","Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021.","2021-08-04","Local","United States of America; Missouri; St Louis","2020-07-22","2020-08-16","Residual sera","Multiple groups",1052.0,0.059,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Brittany K. Smith","Washington University School of Medicine","https://dx.doi.org/10.1128/mSphere.00450-21","Verified","","NR",0.982,0.987,"","US","US-MO"
"2021-08-18","210808_North-WesternItaly_UniversitàDelPiemonteOrientale","Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy.","2021-08-08","Regional","Italy","2020-04-28","2020-08-07","Essential non-healthcare workers","Multiple groups",23568.0,0.05,0.047,0.052,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Chiara Airoldi","Università del Piemonte Orientale","https://dx.doi.org/10.1093/annweh/wxab062","Unverified","","NR",0.933,1.0,"","IT",""
"2021-08-18","210811_Karnataka_IndianInstituteofPublicHealth_Overall_PopTestAdj","Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India","2021-08-11","Regional","India; Karnataka","2021-01-25","2021-02-18","Multiple populations","Multiple groups",41228.0,0.156,0.149,0.163,"Stratified probability","IgG","Moderate","Preprint","Rajagopal Padma","Indian Institute of Public Health","https://www.medrxiv.org/content/10.1101/2021.08.10.21261842v1","Unverified","","Zydus-Cadila",0.924,0.979,"","IN","IN-KA"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave1_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2020-04-02","2020-05-06","Residual sera","Children and Youth (0-17 years)",316.0,0.086,0.051,0.121,"Sequential","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified","","NR",0.946,1.0,"","US","US-AR"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave2_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2020-06-06","2020-08-10","Residual sera","Children and Youth (0-17 years)",300.0,0.098,0.061,0.136,"Sequential","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified","","NR",0.946,1.0,"","US","US-AR"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave3_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2020-09-08","2020-10-17","Residual sera","Children and Youth (0-17 years)",594.0,0.169,0.133,0.206,"Sequential","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified","","NR",0.946,1.0,"","US","US-AR"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave4_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2020-11-07","2020-12-17","Residual sera","Children and Youth (0-17 years)",600.0,0.125,0.096,0.155,"Sequential","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified","","NR",0.946,1.0,"","US","US-AR"
"2021-08-18","210815_Arkansas_UniversityofArkansasforMedicalSciences_Wave5_Overall_Adj","Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic","2021-08-15","Regional","United States of America; Arkansas; Little Rock, Springdale, Ft. Smith, Pine Bluff","2021-04-05","2021-04-28","Residual sera","Children and Youth (0-17 years)",590.0,0.242,0.201,0.282,"Sequential","IgG; IgM","Moderate","Preprint","Karl William Boehme","University of Arkansas for Medical Sciences","https://www.medrxiv.org/content/10.1101/2021.08.04.21261592v3","Verified","","NR",0.946,1.0,"","US","US-AR"
"2021-08-23","210813_Denmark_CopenhagenUniversityHospital_Primary","Testing Denmark: A Danish nationwide surveillance study of COVID-19","2021-08-13","National","Denmark","2020-10-02","2020-10-11","Household and community samples","Multiple groups",318552.0,0.008,"","","Simplified probability","IgG; IgM","Moderate","Preprint","Kamille Fogh","Copenhagen University Hospital","https://www.medrxiv.org/content/10.1101/2021.08.10.21261777v1","Verified","","NR",0.933,0.982,"","DK",""
"2021-08-24","210519_Lombardy_ASSTGaetanoPini-CTOInstitute","Seroprevalence of anti-SARS-CoV-2 antibodies in rheumatic patients treated with biological and targeted therapy living in lombardy, Italy (mainstream project)","2021-05-19","Regional","Italy; Lombardy","2020-05-04","2020-06-16","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",300.0,0.186,0.146,0.234,"Unclear","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Ennio Giulio Favalli","The ASST Gaetano Pini-CTO; Institute","http://dx.doi.org/10.1136/annrheumdis-2021-eular.594","Verified","Argentina","NR","","","","IT","IT-25"
"2021-08-24","210612_Kenya_KEMRI-WellcomeTrustResearchProgramme_PrimaryTestAdj","Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence among Truck Drivers and Assistants in Kenya","2021-06-12","Regional","Kenya; Western Province, Coast Province ; Magarini, Busia, Malaba","2020-09-30","2020-10-23","Essential non-healthcare workers","Adults (18-64 years)",830.0,0.423,0.384,0.463,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Eunice Kagucia","KEMRI-Wellcome Trust Research Programme","http://dx.doi.org/10.1093/ofid/ofab314","Verified","","NR",0.93,0.99,"","KE",""
"2021-08-24","210801_Europe_UniversityHospitalsPitiéSalpêtrière_Primary","SARS-CoV-2 outbreak in autoimmune diseases: The euro-covimid study","2021-08-01","National","France","2020-06-07","2020-12-08","Patients seeking care for non-COVID-19 reasons","Multiple groups",3028.0,0.055,"","","Unclear","Not reported","High","Presentation or Conference","D Saadoun","University Hospitals Pitié Salpêtrière","http://dx.doi.org/10.1136/annrheumdis-2021-eular.3368","Unverified","","NR","","","","FR",""
"2021-08-24","210802_Riyadh_KingSaudUniversity_Primary","Risk factors and predictors that influence SARS-Cov-2 IgG positivity","2021-08-02","Local","Saudi Arabia; Riyadh Province; Riyadh","2020-11-22","2020-12-17","Blood donors","Multiple groups",515.0,0.122,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Mohammed Alosaimi","King Saud University","http://dx.doi.org/10.15537/SMJ.2021.42.8.20210238","Verified","","NR",1.0,0.996,"","SA","SA-01"
"2021-08-24","210813_Brazil_FederalUniversityofOuroPreto_Town1","Logistics workers are a key factor for SARS-CoV-2 spread in Brazilian small towns: case-control study.","2021-08-13","Local","Brazil; Minas Gerais; Nepomuceno","2020-05-30","2020-05-31","Household and community samples","Multiple groups",400.0,0.005,0.001,0.018,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Breno Bernardes-Souza","Federal University of Ouro Preto","https://dx.doi.org/10.2196/30406","Verified","","NR",0.95,1.0,"","BR","BR-MG"
"2021-08-24","210813_Brazil_FederalUniversityofOuroPreto_Town2","Logistics workers are a key factor for SARS-CoV-2 spread in Brazilian small towns: case-control study.","2021-08-13","Local","Brazil; Minas Gerais; Carmópolis","2020-06-27","2020-06-28","Household and community samples","Multiple groups",400.0,0.018,0.008,0.036,"Stratified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Breno Bernardes-Souza","Federal University of Ouro Preto","https://dx.doi.org/10.2196/30406","Verified","","NR",0.95,1.0,"","BR","BR-MG"
"2021-08-24","210813_Geneva_GenevaUniversityHospital_Primary","Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland","2021-08-13","Local","Switzerland","2021-06-01","2021-07-07","Household and community samples","Multiple groups",3355.0,0.299,0.28,0.319,"Stratified probability","Total Antibody","Low","Preprint","Silvia Stringhini","Geneva University Hospital","https://www.medrxiv.org/content/10.1101/2021.08.12.21261929v1","Verified","","NR","","","","CH",""
"2021-08-24","210816_Pakistan_ChughtaiInstituteofPathology_Primary","Seroprevalence of COVID-19 IgG antibodies among healthcare workers of Pakistan: a cross-sectional study assessing exposure to COVID-19 and identification of high-risk subgroups.","2021-08-16","National","Pakistan","2021-07-01","2021-07-20","Health care workers and caregivers","Adults (18-64 years)",15000.0,0.33,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Hijab Batool","Chughtai Institute of Pathology","https://dx.doi.org/10.1136/bmjopen-2020-046276","Unverified","","NR",0.996,0.967,"","PK",""
"2021-08-24","210817_Senegal_UniversityGastonBerger_Primary","Prevalence of SARS-CoV-2 Antibodies in Hemodialysis Patients in Senegal: A Multicenter Cross-Sectional Study","2021-08-17","National","Senegal","2020-06-15","2020-09-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",303.0,0.212,0.167,0.261,"Simplified probability","IgM; IgG","Moderate","Preprint","Sidy Mohamed Seck","University Gaston Berger","https://www.researchsquare.com/article/rs-660094/v1","Unverified","","NR","","","","SN",""
"2021-08-24","210818_Jordan_KingHusseinCancerCenter_Primary","A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity?","2021-08-18","National","Jordan","2021-06-01","2021-06-30","Blood donors","Adults (18-64 years)",536.0,0.744,"","","Sequential","Total Antibody","High","Preprint","Maher Sughayer","King Hussein Cancer Center","https://www.medrxiv.org/content/10.1101/2021.08.15.21261584v1.full-text","Verified","","NR",0.988,1.0,"","JO",""
"2021-08-25","200821_UniversityOfCalifornia_SanFrancisco","Community transmission of severe acute respiratory syndrome coronavirus 2 disproportionately affects the latinx population during shelter-in-place in san francisco","2020-08-21","Local","United States of America; California; San Francisco","2020-04-25","2020-04-28","Household and community samples","Multiple groups",3861.0,0.031,0.025,0.039,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gabriel Chamie","University of California, San Francisco","http://dx.doi.org/10.1093/cid/ciaa1234","Unverified","","NR","","","","US","US-CA"
"2021-08-25","201105_Detroit_OaklandUniversity_TestAdjustment","Coronavirus disease 2019 (covid-19) seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking","2020-11-05","Local","United States of America; Michigan; Detroit","2020-04-13","2020-05-28","Health care workers and caregivers","Adults (18-64 years)",20614.0,0.081,0.068,0.089,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Matthew Sims","Oakland University","http://dx.doi.org/10.1093/cid/ciaa1684","Verified","","NR",0.981,0.993,"","US","US-MI"
"2021-08-25","210805_Estonia_TartuUniversityHospital_Saaremaa_overall_testadj","Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study).","2021-09-07","Local","Estonia","2020-05-08","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",954.0,0.067,0.05,0.084,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Piia Jogi","University of Tartu","https://dx.doi.org/10.1016/j.vaccine.2021.07.093","Verified","","NR","","","","EE",""
"2021-08-25","210805_Estonia_TartuUniversityHospital_Tallinn_overall_testadj","Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study).","2021-09-07","Local","Estonia","2020-05-08","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",1006.0,0.015,0.006,0.024,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Piia Jogi","University of Tartu","https://dx.doi.org/10.1016/j.vaccine.2021.07.093","Verified","","NR","","","","EE",""
"2021-08-25","210806_Barcelona_InstitutdeRecercaSantJoandeDéu","COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era.","2021-08-06","Local","Spain; Catalonia; Barcelona","2020-06-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",65.0,0.107,0.07,0.13,"Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Angela Deya-Martinez","Institut de Recerca Sant Joan de Déu","https://dx.doi.org/10.1016/j.clim.2021.108821","Unverified","","NR","","","","ES","ES-CT"
"2021-08-25","210813_NewJersey_RutgersUniversity","Determinants and dynamics of SARS-CoV-2 infection in a diverse population: 6-month evaluation of a prospective cohort study.","2021-08-13","Local","United States of America; New Jersey; Newark, New Brunswick, Piscataway","2020-03-24","2020-09-22","Health care workers and caregivers","Adults (18-64 years)",831.0,0.1,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Daniel Horton","Rutgers University","https://dx.doi.org/10.1093/infdis/jiab411","Unverified","","NR",0.943,0.997,"","US","US-NJ"
"2021-08-25","210817_Seville_HospitalUniversitarioVirgendeValme_HIV","Incidence of and factors associated with SARS-CoV-2 infection among people living with HIV in Southern Spain after one year of pandemic.","2021-08-17","Local","Spain; Andalusia; Seville","2020-02-09","2021-03-04","Patients seeking care for non-COVID-19 reasons","Multiple groups",707.0,0.075,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Marta Fernandez-Fuertes","Hospital Universitario Virgen de Valme","https://dx.doi.org/10.1111/tbed.14293","Unverified","","NR",0.995,0.998,"","ES","ES-AN"
"2021-08-28","210811_Ischgl_MedicalUniversityOfInnsbruck","Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl","2021-08-01","Local","Austria; Tyrol; Ischgl","2020-11-02","2020-11-08","Household and community samples","Adults (18-64 years)",801.0,0.454,0.42,0.49,"Convenience","IgG; IgA","Moderate","Journal Article (Peer-Reviewed)","Wegene Borena","Medical University Of Innsbruck","https://dx.doi.org/10.1016/j.ebiom.2021.103534","Verified","","NR","","","","AT","AT-7"
"2021-08-29","210810_SaoPaulo_UniversidadedeSaoPaulo_Primary","Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of Sao Paulo, Brazil.","2021-08-10","Regional","Brazil","2020-05-04","2020-05-12","Multiple general populations","Multiple groups",463.0,0.06,0.039,0.083,"Stratified non-probability","IgG; IgM; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Beatriz Tess","Universidade de Sao Paulo","https://dx.doi.org/10.1016/j.bjid.2021.101604","Verified","","NR","","","","BR",""
"2021-08-29","210812_MexicoCity_InstitutoNacionaldeRehabilitacion_Overall","Serological prevalence of SARS-CoV-2 infection and associated factors in healthcare workers in a ""non-COVID"" hospital in Mexico City","2021-08-12","Local","Mexico","2020-08-10","2020-09-09","Health care workers and caregivers","Multiple groups",299.0,0.13,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Esteban Cruz-Arenas","Nacional de Rehabilitacion hospital","http://dx.doi.org/10.1371/journal.pone.0255916","Unverified","","NR",0.946,0.998,"","MX",""
"2021-08-29","210818_Mongomery_WestVirginiaUniversity","Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospital.","2021-08-18","Local","United States of America; West Virginia; Montgomery","2020-09-10","2020-09-10","Hospital visitors","Multiple groups",150.0,0.1,"","","Convenience","IgG","High","Preprint","Alexander Horspool","West Virginia University","https://dx.doi.org/10.1101/2021.08.16.21262128","Unverified","","NR","","","","US","US-WV"
"2021-08-30","210729_NorthernVirginia_InovaHeartandVascularInstitute_Community4_Primary","Seropositivity of COVID-19 among asymptomatic healthcare workers: A multi-site prospective cohort study from Northern Virginia, United States.","2021-07-29","Regional","United States of America; Virginia","2020-06-01","2020-08-14","Household and community samples","Multiple groups",949.0,0.045,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Abdulla Damluji","Inova Heart and Vascular Institute","https://dx.doi.org/10.1016/j.lana.2021.100030","Unverified","","NR","","","","US","US-VA"
"2021-08-30","210729_NorthernVirginia_InovaHeartandVascularInstitute_HCWOctoberNovember3_Primary","Seropositivity of COVID-19 among asymptomatic healthcare workers: A multi-site prospective cohort study from Northern Virginia, United States.","2021-07-29","Regional","United States of America; Virginia","2020-04-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",1323.0,0.048,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Abdulla Damluji","Inova Heart and Vascular Institute","https://dx.doi.org/10.1016/j.lana.2021.100030","Unverified","","NR","","","","US","US-VA"
"2021-08-30","210815_ Czechia_GENNETImmunologyLaboratory_Primary","COVID-19-free workplace: Measuring the level of antibodies against coronavirus as a basis for testing strategy in companies.","2021-08-15","Local","Czechia","2020-03-28","2021-03-28","Health care workers and caregivers","Adults (18-64 years)",182.0,0.357,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Zuzana Kratka","GENNET Immunology Laboratory","https://www.prolekare.cz/casopisy/casopis-lekaru-ceskych/2021-4-5/download?hl=cs","Unverified","","NR","","","","CZ",""
"2021-08-30","210816_Iran_HighInstituteForResearchEducationInTransfusionMedicine_Primary","Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors.","2021-08-21","National","Iran (Islamic Republic of)","2020-05-18","2020-05-27","Blood donors","Multiple groups",1339.0,0.121,0.103,0.138,"Stratified non-probability","IgM; IgG","Moderate","Preprint","Ali Arabkhazaeli","High Institute for Research and Education in Transfusion Medicine","https://dx.doi.org/10.1016/j.tracli.2021.08.008","Verified","","NR",0.85,1.0,"","IR",""
"2021-08-30","210816_Kuwait_MinistryofHealth_primary","Factors associated with SARS-CoV-2 infection amongst healthcare workers in a COVID-19 designated hospital","2021-08-16","National","Kuwait","2020-08-15","2020-10-15","Health care workers and caregivers","Multiple groups",847.0,0.205,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","SarahAl Youha","Ministry of Health","http://dx.doi.org/10.1016/j.jiph.2021.08.012","Unverified","","NR","","","","KW",""
"2021-08-30","210819_NewYork_ColumbiaUniversityIrvingMedicalCenter_Overall","Household level SARS-CoV-2 sero-epidemiology in a high prevalence group of adults and children-implications for community infection control.","2021-08-19","Local","United States of America; New York","2021-01-03","2021-01-21","Household and community samples","Multiple groups",474.0,0.679,"","","Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Alan Werzberger","Columbia University Irving Medical Center","https://dx.doi.org/10.1016/j.ajic.2021.08.015","Verified","","NR","","","","US","US-NY"
"2021-08-30","210820_Maryland_UniversityofMaryland","COVID-19 symptoms, patient contacts, PCR-positivity and seropositivity among healthcare personnel in a Maryland healthcare system.","2021-08-20","Local","United States of America; Maryland","2020-06-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",778.0,0.026,"","","Self-referral","Not reported","High","Journal Article (Peer-Reviewed)","Lyndsay O'Hara","University of Maryland","https://dx.doi.org/10.1017/ice.2021.373","Unverified","","NR","","","","US","US-MD"
"2021-08-30","210825_RhodeIsland_LindsleyFKimballResearchInstitute_CLIA_OverallAdj","Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats.","2021-08-25","Regional","United States of America; Rhode Island","2020-04-27","2020-05-11","Blood donors","Multiple groups",1996.0,0.006,0.002,0.011,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Daniel Nesbitt","Lindsley F Kimball Research Institute","https://dx.doi.org/10.1186/s12879-021-06438-4","Verified","","NR","","","","US","US-RI"
"2021-08-31","210728_HavlickuvBrod_CharlesUniversity_Overall","What is the immunity of high school students to coronavirus?.","2021-07-28","Local","Czechia; Vysočina; Havlíčkův Brod","2021-06-08","2021-06-21","Students and Daycares","Children and Youth (0-17 years)",196.0,0.459,0.388,0.532,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Vaclav Fejt","Charles University (Univerzity Karlovy)","https://www.prolekare.cz/en/journals/journal-of-czech-physicians/2021-4-5/what-is-the-immunity-of-high-school-students-to-coronavirus-127893","Unverified","","NR",0.981,0.996,"","CZ","CZ-VY"
"2021-08-31","210806_China_FudanUniversity_OcularSurfaceDisease_Overall","Association of Ocular Surface Diseases With SARS-CoV-2 Infection in Six Districts of China: An Observational Cohort Study.","2021-08-06","National","China","2020-05-15","2021-03-15","Representative patient population","Multiple groups",1755.0,0.023,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shengjie Li","Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care","https://dx.doi.org/10.3389/fimmu.2021.695428","Unverified","","NR","","","","CN",""
"2021-08-31","210812_Amiens_UniversitéPicardieJules-Verne_LTC","[Covid-19 serology in nursing home and long-term care: prevalence of seroconversion in the Amiens-Picardie University Hospital].","2021-08-12","Local","France; Hauts-de-France  ; Amiens","2020-06-15","2020-06-16","Assisted living and long-term care facilities","Seniors (65+ years)",114.0,0.456,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Julien Moyet","Université Picardie Jules-Verne","https://www.jle.com/10.1684/pnv.2021.0952","Unverified","","NR","","","","FR","FR-HDF"
"2021-08-31","210812_Amiens_UniversitéPicardieJules-Verne_NH","[Covid-19 serology in nursing home and long-term care: prevalence of seroconversion in the Amiens-Picardie University Hospital].","2021-08-12","Local","France; Hauts-de-France  ; Amiens","2020-06-15","2020-06-16","Assisted living and long-term care facilities","Seniors (65+ years)",107.0,0.887,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Julien Moyet","Université Picardie Jules-Verne","https://www.jle.com/10.1684/pnv.2021.0952","Unverified","","NR","","","","FR","FR-HDF"
"2021-08-31","210813_Madurai_UniversityOfCaliforniaBerkeley_Primary","SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study","2021-08-13","Local","India; Tami Nadu; Madurai","2020-10-19","2020-11-05","Household and community samples","Multiple groups",1140.0,0.402,0.359,0.447,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Ramanan Laxminarayan","University of California Berkeley","https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00393-5/fulltext","Verified","","NR",0.93,0.929,"","IN",""
"2021-08-31","210819_England_UniversityofBirmingham_Overall","Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.","2021-08-19","National","United Kingdom of Great Britain and Northern Ireland; England","2020-12-11","2020-12-18","Assisted living and long-term care facilities","Adults (18-64 years)",124.0,0.24,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gokhan Tut","University of Birmingham","https://dx.doi.org/10.1016/S2666-7568(21)00168-9","Unverified","","NR","","","","GB","GB-ENG"
"2021-08-31","210819_RussianFederation_StPetersburgPasteurInstitute_Overall","Sars-cov-2 seroprevalence structure of the russian population during the covid-19 pandemic","2021-08-19","National","Russian Federation","2020-06-15","2020-12-31","Household and community samples","Multiple groups",74158.0,0.192,0.189,0.195,"Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Anna Popova","Saint Petersburg Pasteur Institute","http://dx.doi.org/10.3390/v13081648","Unverified","","NR","","","","RU",""
"2021-08-31","210820_Hamburg_UniversitätHamburg_primary","Low SARS-CoV-2 seroprevalence but high perception of risk among healthcare workers at children's hospital before second pandemic wave in Germany.","2021-08-20","Local","Germany","2020-08-19","2020-09-18","Health care workers and caregivers","Multiple groups",619.0,0.003,0.0,0.012,"Stratified non-probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Marietta Neumann","Universität Hamburg","https://dx.doi.org/10.1007/s12519-021-00447-8","Verified","","NR",0.946,0.998,"","DE",""
"2021-08-31","210820_Poland_CentralClinicalHospitaloftheMinistryoftheInteriorandAdministration","Social distancing during covid-19 pandemic among inflammatory bowel disease patients","2021-08-20","National","Poland; Masovian Voivodeship, Greater Poland Voivodeship, Łódź Voivodeship; Warsaw, Poznań, Łódź","2020-05-01","2020-09-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",473.0,0.093,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Michal Lodyga","Central Clinical Hospital of the Ministry of the Interior and Administration","http://dx.doi.org/10.3390/jcm10163689","Unverified","","NR",0.88,0.99,"","PL",""
"2021-08-31","210822_Denmark_StatensSerumInstitut_August_testadj","Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.","2021-08-22","National","Denmark","2020-08-15","2020-09-30","Household and community samples","Multiple groups",11478.0,0.02,0.017,0.024,"Simplified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Espenhain","Statens Serum Institut","https://dx.doi.org/10.1007/s10654-021-00796-8","Verified","","NR",0.967,0.995,"","DK",""
"2021-08-31","210822_Denmark_StatensSerumInstitut_December_testadj","Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.","2021-08-22","National","Denmark","2020-12-01","2020-12-31","Household and community samples","Multiple groups",4044.0,0.043,0.034,0.051,"Simplified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Espenhain","Statens Serum Institut","https://dx.doi.org/10.1007/s10654-021-00796-8","Verified","","NR",0.967,0.995,"","DK",""
"2021-08-31","210822_Denmark_StatensSerumInstitut_May_testadj","Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.","2021-08-22","National","Denmark","2020-05-05","2020-05-15","Household and community samples","Multiple groups",2512.0,0.015,0.009,0.021,"Simplified probability","Total Antibody","Low","Journal Article (Peer-Reviewed)","Laura Espenhain","Statens Serum Institut","https://dx.doi.org/10.1007/s10654-021-00796-8","Verified","","NR",0.967,0.995,"","DK",""
"2021-08-31","210822_Denmark_StatensSerumInstitut_October_testadj","Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.","2021-08-22","National","Denmark","2020-10-01","2020-11-30","Household and community samples","Multiple groups",9654.0,0.024,0.019,0.028,"Simplified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Espenhain","Statens Serum Institut","https://dx.doi.org/10.1007/s10654-021-00796-8","Verified","","NR",0.967,0.995,"","DK",""
"2021-08-31","210823_Madrid_HospitalUniversitarioPuertadeHierroMajadahonda_HCW","SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.","2021-08-23","Local","Spain; Communidad de Madrid; Madrid","2020-04-24","2020-05-08","Health care workers and caregivers","Adults (18-64 years)",4324.0,0.166,0.155,0.177,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Mireia Cantero","Hospital Universitario Puerta de Hierro Majadahonda","https://dx.doi.org/10.1080/23744235.2021.1963468","Unverified","","NR","","","","ES",""
"2021-08-31","210825_OrangeCounty_UniversityofCaliforniaIrvine","SARS-CoV-2 antibody seroprevalence among firefighters in Orange County, California.","2021-08-25","Local","United States of America; California; NR","2020-10-05","2020-10-23","Essential non-healthcare workers","Adults (18-64 years)",923.0,0.054,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Veronica Vieira","University of California Irvine","https://dx.doi.org/10.1136/oemed-2021-107461","Unverified","","NR",0.996,1.0,"","US","US-CA"
"2021-08-31","210827_Birjand_BirjandUniversityOfMedicalSciences","The high level of adherence of personal protective equipment in health care workers efficiently protects them from COVID-19 infection.","2021-08-27","Local","Iran (Islamic Republic of); South Khorasan Province; Birjand","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",137.0,0.051,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Malihe Zangoue","Birjand University Of MedicalSciences","https://dx.doi.org/10.3233/WOR-210634","Verified","","NR",0.941,0.983,"","IR","IR-29"
"2021-09-01","210806_China_FudanUniversity_NoOcularDisease_Overall","Association of Ocular Surface Diseases With SARS-CoV-2 Infection in Six Districts of China: An Observational Cohort Study.","2021-08-06","National","China","2020-05-15","2021-03-15","Residual sera","Multiple groups",5852.0,0.009,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Shengjie Li","Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care","https://dx.doi.org/10.3389/fimmu.2021.695428","Unverified","","NR","","","","CN",""
"2021-09-01","210806_China_FudanUniversity_NoOcularSurfaceDisease_Overall","Association of Ocular Surface Diseases With SARS-CoV-2 Infection in Six Districts of China: An Observational Cohort Study.","2021-08-06","National","China","2020-05-15","2021-03-15","Representative patient population","Multiple groups",12550.0,0.007,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shengjie Li","Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care","https://dx.doi.org/10.3389/fimmu.2021.695428","Unverified","","NR","","","","CN",""
"2021-09-01","210811_England_OfficeForNationalStatistics_Round6_StaffPrimary","COVID-19 Schools Infection Survey, England: Round 6, June 2021","2021-08-11","National","United Kingdom of Great Britain and Northern Ireland; England","2021-06-14","2021-07-06","Essential non-healthcare workers","Adults (18-64 years)",832.0,0.252,0.197,0.312,"Stratified probability","Not reported","Moderate","Institutional Report","Office for National Statistics","Office for National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021","Unverified","","NR",0.972,0.998,"","GB","GB-ENG"
"2021-09-01","210811_England_OfficeForNationalStatistics_Round6_StaffSecondary","COVID-19 Schools Infection Survey, England: Round 6, June 2021","2021-08-11","National","United Kingdom of Great Britain and Northern Ireland; England","2021-06-14","2021-07-06","Essential non-healthcare workers","Adults (18-64 years)",1574.0,0.234,0.207,0.262,"Stratified probability","Not reported","Moderate","Institutional Report","Office for National Statistics","Office for National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021","Unverified","","NR",0.972,0.998,"","GB","GB-ENG"
"2021-09-01","210819_CityofGuadalupe_UniversidadAutónomadeNuevoLeón_Overall","Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.","2021-08-19","Local","Mexico; Nuevo Leon; Guadalupe","2020-07-09","2020-07-23","Multiple populations","Multiple groups",3268.0,0.059,0.051,0.068,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Cristina Diaz‑Salazar","Universidad Autonoma de Nuevo Leon","https://dx.doi.org/10.1186/s12879-021-06550-5","Verified","","NR",0.995,0.998,"","MX","MX-NLE"
"2021-09-03","210429_Houston_HoustonHealthDepartment_MultipleTest_Primary","Population-Based Estimates of SARS-CoV-2 Seroprevalence in Houston, TX as of September 2020","2021-04-29","Local","United States of America; Texas; Houston","2020-09-01","2020-09-19","Household and community samples","Multiple groups",685.0,0.115,"","","Stratified probability","IgG; IgM; IgA","Low","Journal Article (Peer-Reviewed)","Elaine Symanski","Houston Health Department","https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab203/6258999","Verified","United States of America","NR","","","","US","US-TX"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_1_June_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","Canada; Alberta","2020-06-01","2020-06-05","Residual sera","Multiple groups",8442.0,0.009,0.009,0.009,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified","","NR","","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_2_July_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","Canada; Alberta","2020-07-06","2020-07-10","Residual sera","Multiple groups",13175.0,0.009,0.009,0.009,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified","","NR","","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_3_August_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","Canada; Alberta","2020-08-04","2020-08-11","Residual sera","Multiple groups",12284.0,0.012,0.012,0.012,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified","","NR","","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_4_September_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","Canada; Alberta","2020-09-07","2020-09-11","Residual sera","Multiple groups",12006.0,0.01,0.01,0.01,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified","","NR","","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_5_October_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","Canada; Alberta","2020-09-07","2020-09-11","Residual sera","Multiple groups",13490.0,0.012,0.012,0.012,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified","","NR","","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_6_November_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","Canada; Alberta","2020-09-07","2020-09-11","Residual sera","Multiple groups",11471.0,0.016,0.016,0.016,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified","","NR","","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_7_December_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","Canada; Alberta","2020-12-07","2020-12-10","Residual sera","Multiple groups",12076.0,0.025,0.025,0.025,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified","","NR","","","","CA","CA-AB"
"2021-09-03","210818_Alberta_AlbertaPrecisionLaboratories_8_January_Overall_PopAdj","Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.","2021-08-18","Regional","Canada; Alberta","2021-01-11","2021-01-14","Residual sera","Multiple groups",11094.0,0.046,0.046,0.046,"Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Carmen Charlton","Alberta Precision Laboratories","https://dx.doi.org/10.1128/Spectrum.00291-21","Verified","","NR","","","","CA","CA-AB"
"2021-09-04","210518_Odisha_ICMR-RegionalMedicalResearchCentre_BAM_GenderAdj","Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India.","2021-05-18","Local","India; Odisha; Berhampur","2020-08-01","2020-08-31","Household and community samples","Multiple groups",1375.0,0.311,0.287,0.337,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Jaya Singh Kshatri","ICMR-Regional Medical Research Centre","https://dx.doi.org/10.1038/s41598-021-89877-y","Verified","India","NR","","","","IN","IN-OR"
"2021-09-04","210518_Odisha_ICMR-RegionalMedicalResearchCentre_BBS_GenderAdj","Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India.","2021-05-18","Local","India; Odisha; Bhubaneswar","2020-08-01","2020-08-31","Household and community samples","Multiple groups",1319.0,0.052,0.041,0.066,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Jaya Singh Kshatri","ICMR-Regional Medical Research Centre","https://dx.doi.org/10.1038/s41598-021-89877-y","Verified","India","NR","","","","IN","IN-OR"
"2021-09-04","210518_Odisha_ICMR-RegionalMedicalResearchCentre_RKL_GenderADj","Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India.","2021-05-18","Local","India; Odisha; Rourkela","2020-08-01","2020-08-31","Household and community samples","Multiple groups",1452.0,0.246,0.224,0.269,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Jaya Singh Kshatri","ICMR-Regional Medical Research Centre","https://dx.doi.org/10.1038/s41598-021-89877-y","Verified","India","NR","","","","IN","IN-OR"
"2021-09-06","210829_Delhi_CouncilOfScientificAndIndustrialResearch_overall","27% reinfected during 4th wave in Delhi, says study","2021-08-29","Local","India","2021-05-15","2021-06-15","Multiple populations","Multiple groups",846.0,0.87,"","","Convenience","Not reported","Unclear","News and Media","Anonna Dutt","Council Of Scientific And Industrial Research (CSIR)","https://www.hindustantimes.com/india-news/covid-crisis-one-in-four-patients-in-delhi-were-reinfected-during-the-second-wave-says-preprint-study-101630175376759-amp.html","Unverified","","NR","","","","IN",""
"2021-09-07","210502_Qatar_CornellUniversity_Primary","SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar.","2021-05-02","National","Qatar","2020-07-26","2020-09-09","Essential non-healthcare workers","Multiple groups",2641.0,0.553,0.533,0.573,"Stratified probability","Not reported","Low","Journal Article (Peer-Reviewed)","Mohamed Al-Thani","Cornell University","https://academic.oup.com/ofid/article/8/8/ofab221/6261968","Unverified","","NR","","","","QA",""
"2021-09-07","210826_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Primary","SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.","2021-08-26","Local","Germany","2020-11-02","2020-11-16","Household and community samples","Multiple groups",576.0,0.014,0.006,0.027,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Stefanie Theuring","Universitätsmedizin Berlin","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184","Verified","","NR","","","","DE",""
"2021-09-07","210826_Berlin_UniversitätsmedizinBerlin_PrimaryStudent_Primary","SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.","2021-08-26","Local","Germany","2020-11-02","2020-11-16","Students and Daycares","Children and Youth (0-17 years)",174.0,0.011,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Stefanie Theuring","Universitätsmedizin Berlin","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184","Verified","","NR","","","","DE",""
"2021-09-07","210826_Berlin_UniversitätsmedizinBerlin_SecondaryStudent_Primary","SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.","2021-08-26","Local","Germany","2020-11-02","2020-11-16","Students and Daycares","Children and Youth (0-17 years)",173.0,0.029,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Stefanie Theuring","Universitätsmedizin Berlin","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184","Verified","","NR","","","","DE",""
"2021-09-07","210826_Berlin_UniversitätsmedizinBerlin_Staff_Primary","SARS-CoV-2 infection and transmission in school settings during the second COVID-19 wave: a cross-sectional study, Berlin, Germany, November 2020.","2021-08-26","Local","Germany","2020-11-02","2020-11-16","Essential non-healthcare workers","Adults (18-64 years)",141.0,0.014,0.002,0.05,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Stefanie Theuring","Universitätsmedizin Berlin","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184","Verified","","NR","","","","DE",""
"2021-09-07","210826_Borriana_PublicHealthCenterOfCastellon_PrimaryIgG","Mass gathering events and COVID-19 transmission in Borriana (Spain): A retrospective cohort study","2021-08-26","Local","Spain; Castellon; Borriana","2020-06-23","2020-06-27","Household and community samples","Multiple groups",997.0,0.51,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Salvador Domenech Montoliu","Public Health Center of Castellon","http://dx.doi.org/10.1371/journal.pone.0256747","Verified","","NR","","","","ES",""
"2021-09-07","210827_Linkoping_LinkopingUniversity_Overall","SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic","2021-08-27","Local","Sweden; Ostergotland; Linkoping","2020-03-15","2021-01-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",100.0,0.36,"","","Sequential","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Johanna Sjowall","Linkoping University","https://www.frontiersin.org/articles/10.3389/fimmu.2021.724047/full","Unverified","","NR","","","","SE","SE-E"
"2021-09-07","210830_Nepal_MinistryofHealthandPopulation_Overall","Over two-thirds population has Covid-19 antibodies, seroprevalence study shows","2021-08-30","National","Nepal","2021-07-05","2021-08-14","Household and community samples","Multiple groups",13161.0,0.686,"","","Simplified probability","Not reported","Unclear","News and Media","Shuvam Dhungana","Ministry of Health and Population","https://kathmandupost.com/health/2021/08/30/over-two-thirds-population-has-covid-19-antibodies-seroprevalence-study-shows","Verified","","NR","","","","NP",""
"2021-09-07","210831_Italy_UniversityofVerona_Overall","The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.","2021-08-31","National","Italy; Veneto, Friuli-Venezia Giulia, and Lazio","2020-05-18","2020-11-03","Patients seeking care for non-COVID-19 reasons","Multiple groups",564.0,0.02,0.011,0.035,"Sequential","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Massimiliano Bonifacio","University of Verona","https://dx.doi.org/10.1002/cam4.4179","Unverified","","NR","",1.0,"","IT",""
"2021-09-07","210901_Dusseldorf_HeinrichHeineUniversityDusseldorf","High rate of clinically unrecognized SARS-CoV-2 infections in pediatric palliative care patients.","2021-09-01","Local","Germany; North Rhine-Westphalia; Dusseldorf","2020-12-17","2021-02-19","Patients seeking care for non-COVID-19 reasons","Multiple groups",39.0,0.256,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Benedikt Botticher","Heinrich Heine University","https://dx.doi.org/10.1007/s00431-021-04242-5","Verified","","NR","","","","DE","DE-NW"
"2021-09-07","210901_Utah_UniversityofUtah_genpop_popadj_testadj","Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA.","2021-09-01","Regional","United States of America; Utah","2020-05-04","2020-06-30","Household and community samples","Multiple groups",8108.0,0.008,0.001,0.016,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Matthew Samore","University of Utah","https://wwwnc.cdc.gov/eid/article/27/11/20-4435_article","Verified","","NR",0.864,0.996,"","US","US-UT"
"2021-09-08","210221_UnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust","Adalimumab and infliximab impair SARS-CoV-2 antibody responses: results from a therapeutic drug monitoring study in 11422 biologic-treated patients.","2021-09-02","National","United Kingdom of Great Britain and Northern Ireland","2020-01-29","2020-09-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",13509.0,0.031,"","","Sequential","IgG; IgM; IgA","Moderate","Journal Article (Peer-Reviewed)","Neil Chanchlani","Royal Devon And Exeter NHS Foundation Trust","https://dx.doi.org/10.1093/ecco-jcc/jjab153","Unverified","","NR",0.995,0.998,"","GB",""
"2021-09-08","210616_Austria_UniversityHospitalOfSalzburg_Overall","Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors.","2021-06-16","National","Austria","2020-06-05","2020-12-04","Blood donors","Multiple groups",20228.0,0.025,"","","Convenience","Total Antibody","Low","Journal Article (Peer-Reviewed)","Lisa Weidner","University Hospital of Salzburg","https://dx.doi.org/10.1007/s15010-021-01639-0","Verified","","NR",1.0,0.998,"","AT",""
"2021-09-08","210617_Campinas_UniversityOfCampinas","Low SARS-CoV-2 seroprevalence in a cohort of Brazilian sickle cell disease patients: Possible effects of emphasis on social isolation for a population initially considered to be at very high risk","2021-06-17","Regional","Brazil; Sao Paulo; Campinas","2020-08-15","2021-01-15","Representative patient population","Multiple groups",135.0,0.11,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Luiza Francisco Trafane","University of Campinas","https://onlinelibrary.wiley.com/doi/10.1002/jha2.254","Verified","","NR","","","","BR","BR-SP"
"2021-09-08","210719_Vo_UniversityOfPadova_Overall_Adj","SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo'.","2021-07-19","Local","Italy; Padova; Vo","2020-05-01","2020-05-31","Household and community samples","Multiple groups",2602.0,0.035,0.028,0.043,"Entire sample","IgG","Low","Journal Article (Peer-Reviewed)","Ilaria Dorigatti","University of Padova","https://dx.doi.org/10.1038/s41467-021-24622-7","Verified","","NR","","","","IT","IT-34"
"2021-09-08","210821_Aden_HadhramoutUniversity_Overall","SARS-CoV-2 Seroprevalence in Aden, Yemen a Population-Based Study","2021-08-27","Local","Yemen","2020-11-15","2020-12-15","Household and community samples","Multiple groups",2001.0,0.274,0.256,0.293,"Stratified probability","IgG; IgM","Moderate","Preprint","Abdulla Salem Bin Gouth","Hadhramout University","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3909778","Verified","","NR","","","","YE",""
"2021-09-08","210825_London_NHSFoundationTrust_Overall","SARS-CoV-2 antibody seroprevalence among people living with HIV","2021-08-25","Local","United Kingdom of Great Britain and Northern Ireland","2020-08-01","2020-10-16","Patients seeking care for non-COVID-19 reasons","Multiple groups",1621.0,0.092,"","","Sequential","Not reported","Unclear","Presentation or Conference","Venkateshwaran Sivaraj","Guy's and St Thomas' NHS Foundation Trust","https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.13131","Unverified","","NR","","","","GB",""
"2021-09-08","210830_Conneticut_YaleUniversity","Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel.","2021-08-30","Regional","United States of America; Connecticut","2021-04-15","2020-06-15","Essential non-healthcare workers","Adults (18-64 years)",988.0,0.104,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Joseph Zell","Yale University","https://dx.doi.org/10.1371/journal.pone.0251114","Unverified","","NR",0.995,0.998,"","US","US-CT"
"2021-09-09","210629_RioGrandedoSul_UniversidadeFederaldePelotas_Primary","Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Including 35611 Participants.","2021-06-29","Regional","Brazil; Rio Grande do Sul","2020-04-11","2020-09-06","Household and community samples","Multiple groups",35611.0,0.006,"","","Stratified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Pedro C. Hallal","Universidade Federal de Pelotas","https://dx.doi.org/10.2105/AJPH.2021.306351","Verified","","NR",0.848,1.0,"","BR","BR-RS"
"2021-09-09","210820_ Weißenkirchen_DanubePrivateUniversity","Longitudinal monitoring of SARS-CoV-2-specific immune responses","2021-08-20","Local","Austria; Lower Austria; Weißenkirchen in der Wachau","2021-02-13","2021-02-13","Household and community samples","Multiple groups",552.0,0.25,"","","Convenience","IgG","High","Preprint","Heike Rebholz","Danube Private University","https://doi.org/10.1101/2021.08.14.21262042","Verified","","NR","","","","AT","AT-3"
"2021-09-09","210902_Kenya_KEMRI-WellcomeTrustResearchProgramme_OverallPopAndTestAdjusted","Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.","2021-09-02","National","Kenya","2021-01-03","2021-03-15","Blood donors","Multiple groups",3018.0,0.485,0.452,0.521,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Sophie Uyoga","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1001/jama.2021.15265","Verified","","NR",0.927,0.99,"","KE",""
"2021-09-10","210901_Kentucky_UniversityofKentucky_Primary","Prevalence of SARS-CoV-2 IgG antibodies in health care workers at a tertiary care academic medical center - An assessment of occupational infection risk.","2021-09-01","Local","United States of America; Kentucky; Lexington","2020-06-22","2020-06-26","Health care workers and caregivers","Adults (18-64 years)",322.0,0.016,0.007,0.037,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Derek Forster","University of Kentucky","https://dx.doi.org/10.1016/j.ajic.2021.04.005","Unverified","","NR",1.0,0.996,"","US","US-KY"
"2021-09-11","200925_Stockholm_TheStockholmRegion","25 september: Lägesrapport om arbetet med det nya coronaviruset","2020-09-25","Local","Sweden","2020-06-15","2020-09-20","Household and community samples","Multiple groups",483345.0,0.152,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/09/25-september-lagesrapport-om-arbetet-med-det-nya-coronaviruset/","Verified","","NR","","","","SE",""
"2021-09-11","200929_Stockholm_TheStockholmRegion","29 september: Lägesrapport om covid-19","2020-09-29","Local","Sweden","2020-09-21","2020-09-27","Household and community samples","Multiple groups",9648.0,0.143,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/09/29-september-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-09-12","210731_Greece_NationalandKapodistrianUniversityofAthens_Primary","Low seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece.","2021-07-31","National","Greece","2020-06-01","2020-07-09","Health care workers and caregivers","Adults (18-64 years)",57418.0,0.007,"","","Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Petros Galanis","National and Kapodistrian University of Athens","https://dx.doi.org/10.1016/j.puhe.2021.07.029","Unverified","","NR",1.0,0.996,"","GR",""
"2021-09-13","201006_Stockholm_TheStockholmRegion","6 oktober: Lägesrapport om covid-19","2020-10-06","Local","Sweden","2020-09-28","2020-10-04","Household and community samples","Multiple groups",11670.0,0.154,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/6-oktober-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-09-13","210529_Yokohama_YokohamaDai-ichiHospital","Assessment of sars-cov-2 antibodies in patients on hemodialysis","2021-05-29","Local","Japan","2020-08-01","2020-12-14","Patients seeking care for non-COVID-19 reasons","Multiple groups",55.0,0.036,"","","Sequential","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Takayasu Taira","Yokohama Dai-ichi Hospital","http://dx.doi.org/10.1093/ndt/gfab098.0019","Unverified","","NR","","","","JP",""
"2021-09-13","210701_India_IndianCouncilOfMedicalResearch_GenPop_TestPopAdj","SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021","2021-07-01","National","India","2020-12-18","2021-01-06","Household and community samples","Multiple groups",28598.0,0.241,0.23,0.253,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Manoj V Murhekar","Indian Council of Medical Research","http://dx.doi.org/10.1016/j.ijid.2021.05.040","Verified","India","NR","","","","IN",""
"2021-09-13","210701_India_IndianCouncilOfMedicalResearch_HCWs_TestPopAdj","SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021","2021-07-01","National","India","2020-12-18","2021-01-06","Health care workers and caregivers","Multiple groups",7385.0,0.256,0.235,0.278,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Manoj V Murhekar","Indian Council of Medical Research","http://dx.doi.org/10.1016/j.ijid.2021.05.040","Verified","India","NR",1.0,0.999,"","IN",""
"2021-09-13","210821_Stockholm_KarolinskaUniversityHospital_Overall","Differences in risk for SARS-CoV-2 infection among healthcare workers","2021-08-21","Local","Sweden; Sodermanland and Uppland; Stockholm","2020-04-23","2020-06-24","Health care workers and caregivers","Adults (18-64 years)",12928.0,0.115,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Klara Miriam Elfstrom","Karolinska University Hospital","https://dx.doi.org/10.1016/j.pmedr.2021.101518","Verified","Sweden","N/A - in house",0.994,0.991,"","SE","SE-AB"
"2021-09-13","210827_Italy_AOUCittàdellaSaluteedellaScienzadiTorino","SCREENING FOR SARS-CoV-2 NEUTRALIZING ANTIBODIES IN CIRRHOTIC PATIENTS WAITING FOR LIVER TRANSPLANTATION: IMPACT ON DONOR POOL EXPANSION","2021-08-27","Local","Italy; Piedmont; Turin","2020-11-25","2021-02-12","Patients seeking care for non-COVID-19 reasons","Multiple groups",98.0,0.224,"","","Convenience","IgG","Moderate","Presentation or Conference","Margherita Saracco","AOU Citta della Salute e della Scienza di Torino","https://onlinelibrary.wiley.com/doi/10.1111/tri.13944","Unverified","","NR","","","","IT","IT-21"
"2021-09-13","210901_Riyadh_KingSaudbinAbdulazizUniversity","Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.","2021-09-01","Local","Saudi Arabia; Riyadh Province; Riyadh City","2020-07-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",420.0,0.148,0.115,0.185,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Fayhan Alroqi","King Saudbin Abdulaziz University for Health Sciences","https://dx.doi.org/10.1016/j.jiph.2021.08.029","Unverified","","NR",0.944,0.996,"","SA","SA-01"
"2021-09-13","210901_WesternKenya_WalterReedArmyInstituteofResearch_overall","SARS-CoV-2 antibody prevalence in people with and without HIV in rural western Kenya, January to March 2020.","2021-09-01","Regional","Kenya; Western Region; Kisumu, Kericho","2020-01-01","2020-03-19","Residual sera","Adults (18-64 years)",582.0,0.033,"","","Convenience","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Trevor Crowell","Walter Reed Army Institute of Research","https://dx.doi.org/10.1097/QAD.0000000000003054","Verified","","NR","","","","KE",""
"2021-09-13","210903_SouthAfrica_UniversityoftheWitwatersrand_Rural_Date5_Overall_Adj","SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.","2021-09-03","Local","South Africa; Mpumalanga Province; Bushbuckridge Municipality","2021-03-22","2021-04-11","Household and community samples","Multiple groups",587.0,0.26,0.22,0.29,"Simplified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Jackie Kleynhans","University of the Witwatersrand","https://dx.doi.org/10.3201/eid2712.211465","Verified","","NR",0.995,0.998,"","ZA","ZA-MP"
"2021-09-13","210903_SouthAfrica_UniversityoftheWitwatersrand_Urban_Date5_Overall_Adj","SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.","2021-09-03","Local","South Africa; North West Province; Matlosana Municipality","2021-03-22","2021-04-11","Household and community samples","Multiple groups",510.0,0.41,0.37,0.45,"Simplified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Jackie Kleynhans","University of the Witwatersrand","https://dx.doi.org/10.3201/eid2712.211465","Verified","","NR",0.995,0.998,"","ZA","ZA-NW"
"2021-09-13","210909_SouthWales_CwmTafMorgannwgUniversityHealthBoard_Overall","SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study","2021-09-09","Regional","United Kingdom of Great Britain and Northern Ireland; Wales","2020-09-15","2020-10-27","Non-essential workers and unemployed persons","Multiple groups",991.0,0.07,"","","Convenience","IgG; IgM","High","Preprint","Alice Puchades","Cwm Taf Morgannwg University Health Board","https://www.researchsquare.com/article/rs-850315/v1","Unverified","","NR",0.96,0.955,"","GB","GB-WLS"
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_HCW_primary","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","Belgium","2020-05-06","2020-05-10","Health care workers and caregivers","Multiple groups",785.0,0.084,"","","Convenience","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","NR","","","","BE",""
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_blooddonors_14-16april","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","Belgium","2020-04-14","2020-04-16","Blood donors","Multiple groups",900.0,0.048,"","","Convenience","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","NR","","","","BE",""
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_blooddonors_27-29April","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","Belgium","2020-04-27","2020-04-29","Blood donors","Multiple groups",900.0,0.047,"","","Convenience","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","NR","","","","BE",""
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_blooddonors_march_primary","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","Belgium","2020-03-30","2020-03-30","Blood donors","Multiple groups",584.0,0.013,"","","Convenience","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","NR","","","","BE",""
"2021-09-14","200529_Belgium_BelgianInstituteofHealth_blooddonors_may_primary","COVID-19 – WEKELIJKS EPIDEMIOLOGISCH BULLETIN VAN 29 MEI 2020","2020-05-29","National","Belgium","2020-05-11","2020-05-13","Blood donors","Multiple groups",900.0,0.047,"","","Convenience","Not reported","High","Institutional Report","Belgian Institute of Health","Belgian Institute of Health","https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf","Unverified","","NR","","","","BE",""
"2021-09-14","210529_NewYorkCity_RenalResearchInstitute_Primary","Prevalence and persistence of covid-19 antibodies in New York City hemodialysis clinic","2021-05-29","Local","United States of America; New York; New York City","2020-06-10","2020-07-13","Patients seeking care for non-COVID-19 reasons","Multiple groups",429.0,0.303,"","","Convenience","IgG","Unclear","Presentation or Conference","Ohnmar Thwin","Renal Research Institute","http://dx.doi.org/10.1093/ndt/gfab100.002","Unverified","","NR",1.0,0.98,"","US","US-NY"
"2021-09-14","210719_Sweden_SwedishPublicHealthAgency_Outpatients_Week21-22_Primary","Påvisning av antikroppar mot SARS-CoV-2 i blodprov från öppenvården","2021-07-19","National","Sweden","2021-05-24","2021-06-04","Residual sera","Multiple groups",3949.0,0.522,0.504,0.54,"Stratified non-probability","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Swedish Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-mot-sars-cov-2-blodprov-oppenvarden.pdf","Verified","","NR",0.989,0.994,"","SE",""
"2021-09-14","210726_Dresden_TechnischeUniversitatDresden_200715-201115_Adults","Prevalence and Transmission of Severe Acute Respiratory Syndrome Coronavirus Type 2 in Childcare Facilities: A Longitudinal Study","2021-07-26","Local","Germany; Saxony; Dresden","2020-07-15","2020-11-15","Multiple populations","Multiple groups",350.0,0.006,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Luise Haag","Technische Universitat Dresden","http://dx.doi.org/10.1016/j.jpeds.2021.07.054","Unverified","","NR","","","","DE","DE-SN"
"2021-09-14","210726_Dresden_TechnischeUniversitatDresden_201116-210131_Adults","Prevalence and Transmission of Severe Acute Respiratory Syndrome Coronavirus Type 2 in Childcare Facilities: A Longitudinal Study","2021-07-26","Local","Germany; Saxony; Dresden","2020-07-16","2021-01-31","Multiple populations","Multiple groups",424.0,0.113,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Luise Haag","Technische Universitat Dresden\","http://dx.doi.org/10.1016/j.jpeds.2021.07.054","Unverified","","NR","","","","DE","DE-SN"
"2021-09-14","210802_Delhi_ DirectorateGeneralHealthServices_Aug1_PopTestAdj","The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study.","2021-08-02","Regional","India; NCT Delhi","2020-08-01","2020-08-07","Household and community samples","Multiple groups",14779.0,0.284,0.276,0.291,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Nandini Sharma","Government of National Capital Territory of Delhi","https://dx.doi.org/10.1093/trstmh/trab109","Verified","India","NR",0.921,0.977,"","IN","IN-DL"
"2021-09-14","210802_Delhi_ DirectorateGeneralHealthServices_Oct3_PopTestAdj","The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study.","2021-08-02","Regional","India; NCT Delhi","2020-10-15","2020-10-21","Household and community samples","Multiple groups",14905.0,0.247,0.24,0.254,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Nandini Sharma","Government of National Capital Territory of Delhi","https://dx.doi.org/10.1093/trstmh/trab109","Verified","India","NR",0.991,0.993,"","IN","IN-DL"
"2021-09-14","210802_Delhi_ DirectorateGeneralHealthServices_Sept2_PopTestAdj","The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study.","2021-08-02","Regional","India; NCT Delhi","2020-09-01","2020-09-07","Household and community samples","Multiple groups",16953.0,0.241,0.234,0.247,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Nandini Sharma","Government of National Capital Territory of Delhi","https://dx.doi.org/10.1093/trstmh/trab109","Verified","India","NR",0.991,0.993,"","IN","IN-DL"
"2021-09-14","210902_Manaus_InstitutoNacionaldePesquisasdaAmazônia_overall","Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus.","2021-09-02","Local","Brazil; Amazonas; Manaus","2020-10-10","2020-11-14","Household and community samples","Multiple groups",280.0,0.646,0.59,0.703,"Sequential","IgA; IgG","Moderate","Journal Article (Peer-Reviewed)","Gemilson Soares Pontes","Instituto Nacional de Pesquisas da Amazônia","https://www.nature.com/articles/s41598-021-96843-1","Verified","","NR","","","","BR","BR-AM"
"2021-09-14","210902_Milan_UniversityofMilan_January2021","Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan?","2021-09-02","Local","Italy; Lombardy; Milan","2021-01-01","2021-01-31","Students and Daycares","Children and Youth (0-17 years)",1109.0,0.125,0.106,0.146,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Lucia Barcellini","University of Milan","http://dx.doi.org/10.1371/journal.pone.0257046","Unverified","","NR",0.96,1.0,"","IT","IT-25"
"2021-09-14","210902_Milan_UniversityofMilan_September2020","Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan?","2021-09-02","Local","Italy; Lombardy; Milan","2020-09-01","2020-09-30","Students and Daycares","Children and Youth (0-17 years)",1109.0,0.028,0.019,0.039,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Lucia Barcellini","University of Milan","http://dx.doi.org/10.1371/journal.pone.0257046","Unverified","","NR",0.96,1.0,"","IT","IT-25"
"2021-09-14","210906_Strasbourg_CHUdeStrasbourg_Overall","High SARS-CoV-2 seroconversion rate among geriatric staff from Strasbourg University Hospitals.","2021-09-06","Local","France; Grand Est; Strasbourg","2020-06-22","2020-11-01","Health care workers and caregivers","Adults (18-64 years)",5694.0,0.085,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Baptiste Panaget","Centres Hospitaliers et Universitaires de Strasbourg","https://dx.doi.org/10.1017/ice.2021.402","Unverified","","NR",0.93,0.99,"","FR","FR-GES"
"2021-09-15","210706_Geneva_JohnsHopkinsBloombergSchoolofPublicHealth_RocheS1_Baseline_Overall","Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance","2021-07-06","Local","Switzerland","2020-04-15","2020-07-15","Multiple populations","Multiple groups",187.0,0.123,"","","Simplified probability","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Javier Perez Saez","Johns Hopkins Bloomberg School of Public Health","https://doi.org/10.1016/j.cmi.2021.06.040","Unverified","","NR","","","","CH",""
"2021-09-15","210706_Geneva_JohnsHopkinsBloombergSchoolofPublicHealth_RocheS1_FollowUp_Overall","Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance","2021-07-06","Local","Switzerland","2020-11-01","2020-11-30","Multiple populations","Multiple groups",187.0,0.273,"","","Simplified probability","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Javier Perez Saez","Johns Hopkins Bloomberg School of Public Health","https://doi.org/10.1016/j.cmi.2021.06.040","Unverified","","NR","","","","CH",""
"2021-09-15","210728_Stockholm_TheSwedishPublicHealthAgency","Undersökning av immunologiskt svar mot SARS-CoV-2 hos barn, unga och skolpersonal","2021-07-28","Local","Sweden; Södermanland, Uppland; Stockholm","2020-11-15","2020-12-15","Essential non-healthcare workers","Adults (18-64 years)",49.0,0.367,"","","Unclear","Not reported","High","Institutional Report","Swedish Public Health Agency","The Swedish Public Health Agency","https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/u/undersokning-av-immunologiskt-svar-mot-sars-cov-2-hos-barn-unga-och-skolpersonal/","Unverified","","NR","","","","SE","SE-AB"
"2021-09-15","210801_India_SevenHillsDedicatedCovidHospital","Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Health Care Workers.","2021-08-01","Local","India; Maharashtra; Mumbai","2020-12-15","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",1005.0,0.123,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Chavhan Santosh","Seven Hills Dedicated Covid Hospital","https://europepmc.org/article/med/34472805","Unverified","","NR","","","","IN","IN-MH"
"2021-09-15","210812_NorthCarolina_UniversityOfNorthCarolina","Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color","2021-08-12","Regional","United States of America; North Carolina","2020-04-15","2020-10-15","Household and community samples","Multiple groups",103.0,0.28,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Carla Cerami","University of North Carolina","http://dx.doi.org/10.1093/cid/ciab701","Verified","","NR","","","","US","US-NC"
"2021-09-15","210820_Solothurn_UniversityofBern_Primary","Seroprevalence of SARS-CoV-2 in healthcare workers from outpatient facilities and retirement or nursing homes in a Swiss canton.","2021-08-20","Regional","Switzerland; Canton of Solothurn","2020-06-01","2020-07-01","Health care workers and caregivers","Adults (18-64 years)",357.0,0.034,0.017,0.058,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Kathrin Zurcher","University of Bern","https://dx.doi.org/10.4414/SMW.2021.w30021","Unverified","","NR","","","","CH","CH-SO"
"2021-09-15","210827_Flanders_UniversityofAntwerp_December","Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium.","2021-08-27","Regional","Belgium; Flanders","2020-12-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",698.0,0.134,0.108,0.164,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Joachim Marien","University of Antwerp","https://dx.doi.org/10.1093/fampra/cmab094","Unverified","","NR","",0.99,"","BE","BE-VLG"
"2021-09-16","210830_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report August 30, 2021 Report #11: June 2021 Survey Tracking seroprevalence in the vaccine era","2021-08-30","National","Canada","2021-06-14","2021-06-29","Blood donors","Multiple groups",16884.0,0.908,0.903,0.912,"Sequential","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified","","NR",0.988,0.996,"","CA",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W16","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-04-12","2020-04-18","Household and community samples","Adults (18-64 years)",362.0,0.003,0.0,0.016,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W17","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-04-19","2020-04-25","Household and community samples","Adults (18-64 years)",674.0,0.003,0.001,0.011,"Simplified probability","IgG; Neutralizing","Moderate","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W18","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-04-26","2020-05-02","Household and community samples","Adults (18-64 years)",426.0,0.005,0.001,0.017,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W19","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-05-03","2020-05-09","Household and community samples","Adults (18-64 years)",514.0,0.0,0.0,0.007,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W20","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-05-10","2020-05-16","Household and community samples","Adults (18-64 years)",401.0,0.002,0.0,0.014,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W21","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-05-17","2020-05-23","Household and community samples","Adults (18-64 years)",210.0,0.005,0.001,0.026,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W22","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-05-24","2020-05-30","Household and community samples","Adults (18-64 years)",178.0,0.0,0.0,0.021,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W23","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-05-31","2020-06-06","Household and community samples","Adults (18-64 years)",214.0,0.005,0.001,0.026,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W24","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-06-07","2020-06-13","Household and community samples","Adults (18-64 years)",174.0,0.0,0.0,0.022,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W25","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-06-14","2020-06-20","Household and community samples","Adults (18-64 years)",78.0,0.0,0.0,0.047,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W26","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-06-21","2020-06-27","Household and community samples","Adults (18-64 years)",32.0,0.0,0.0,0.107,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W27","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-06-28","2020-07-04","Household and community samples","Adults (18-64 years)",85.0,0.0,0.0,0.043,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W28","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-07-05","2020-07-11","Household and community samples","Adults (18-64 years)",51.0,0.0,0.0,0.07,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W29","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-07-12","2020-07-18","Household and community samples","Adults (18-64 years)",7.0,0.0,0.0,0.354,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W30","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-07-19","2020-07-25","Household and community samples","Adults (18-64 years)",9.0,0.111,0.02,0.435,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W31","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-07-26","2020-08-01","Household and community samples","Adults (18-64 years)",75.0,0.013,0.002,0.072,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W32","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-08-02","2020-08-08","Household and community samples","Adults (18-64 years)",49.0,0.02,0.004,0.107,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W33","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-08-09","2020-08-15","Household and community samples","Adults (18-64 years)",64.0,0.0,0.0,0.057,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W34","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-08-16","2020-08-22","Household and community samples","Adults (18-64 years)",63.0,0.0,0.0,0.058,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W35","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-08-23","2020-08-29","Household and community samples","Adults (18-64 years)",48.0,0.021,0.004,0.109,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W36","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-08-30","2020-09-05","Household and community samples","Adults (18-64 years)",63.0,0.0,0.0,0.058,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W37","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-09-06","2020-09-12","Household and community samples","Adults (18-64 years)",54.0,0.0,0.0,0.066,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W38","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-09-13","2020-09-19","Household and community samples","Adults (18-64 years)",48.0,0.021,0.004,0.109,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W39","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-09-20","2020-09-26","Household and community samples","Adults (18-64 years)",56.0,0.018,0.003,0.094,"Simplified probability","IgG; Neutralizing","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR","","","","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W40","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-09-27","2020-10-03","Household and community samples","Adults (18-64 years)",60.0,0.017,0.003,0.089,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W41","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-10-04","2020-10-10","Household and community samples","Adults (18-64 years)",51.0,0.0,0.0,0.07,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W42","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-10-11","2020-10-17","Household and community samples","Adults (18-64 years)",59.0,0.017,0.003,0.09,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W43","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-10-18","2020-10-24","Household and community samples","Adults (18-64 years)",55.0,0.0,0.0,0.065,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W44","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-10-25","2020-10-31","Household and community samples","Adults (18-64 years)",56.0,0.018,0.003,0.094,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W45","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-11-01","2020-11-07","Household and community samples","Adults (18-64 years)",55.0,0.054,0.019,0.148,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W46","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-11-08","2020-11-14","Household and community samples","Adults (18-64 years)",52.0,0.019,0.003,0.101,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W47","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-11-15","2020-11-21","Household and community samples","Adults (18-64 years)",64.0,0.031,0.009,0.107,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W48","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-11-22","2020-11-28","Household and community samples","Adults (18-64 years)",85.0,0.035,0.012,0.099,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W49","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-11-29","2020-12-05","Household and community samples","Adults (18-64 years)",80.0,0.025,0.007,0.087,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W50","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-12-06","2020-12-12","Household and community samples","Adults (18-64 years)",106.0,0.009,0.002,0.052,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W51","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-12-13","2020-12-19","Household and community samples","Adults (18-64 years)",115.0,0.009,0.002,0.048,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W52","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-12-20","2020-12-26","Household and community samples","Adults (18-64 years)",65.0,0.0,0.0,0.056,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2020-W53","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2020-12-27","2021-01-02","Household and community samples","Adults (18-64 years)",26.0,0.0,0.0,0.129,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W01","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-01-03","2021-01-09","Household and community samples","Adults (18-64 years)",12.0,0.0,0.0,0.242,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W02","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-01-10","2021-01-16","Household and community samples","Adults (18-64 years)",6.0,0.0,0.0,0.39,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W03","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-01-17","2021-01-23","Household and community samples","Adults (18-64 years)",5.0,0.0,0.0,0.435,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W04","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-01-24","2021-01-30","Household and community samples","Adults (18-64 years)",30.0,0.0,0.0,0.114,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W05","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-01-31","2021-02-06","Household and community samples","Adults (18-64 years)",110.0,0.027,0.009,0.077,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W06","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-02-07","2021-02-13","Household and community samples","Adults (18-64 years)",111.0,0.054,0.025,0.113,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W07","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-02-14","2021-02-20","Household and community samples","Adults (18-64 years)",69.0,0.072,0.031,0.159,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W08","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-02-21","2021-02-27","Household and community samples","Adults (18-64 years)",123.0,0.065,0.033,0.123,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W09","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-02-28","2021-03-06","Household and community samples","Adults (18-64 years)",132.0,0.023,0.008,0.065,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W10","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-03-07","2021-03-13","Household and community samples","Adults (18-64 years)",64.0,0.031,0.009,0.107,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W11","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-03-14","2021-03-20","Household and community samples","Adults (18-64 years)",104.0,0.067,0.033,0.132,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W12","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-03-21","2021-03-27","Household and community samples","Adults (18-64 years)",73.0,0.106,0.067,0.202,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W13","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-03-28","2021-04-03","Household and community samples","Adults (18-64 years)",60.0,0.083,0.036,0.181,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W14","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-04-04","2021-04-10","Household and community samples","Adults (18-64 years)",59.0,0.068,0.027,0.162,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W15","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-04-11","2021-04-17","Household and community samples","Adults (18-64 years)",29.0,0.138,0.055,0.306,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W16","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-04-18","2021-04-24","Household and community samples","Adults (18-64 years)",102.0,0.186,0.123,0.273,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W17","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-04-25","2021-05-01","Household and community samples","Adults (18-64 years)",109.0,0.229,0.16,0.317,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W18","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-05-02","2021-05-08","Household and community samples","Adults (18-64 years)",74.0,0.284,0.194,0.395,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W19","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-05-09","2021-05-15","Household and community samples","Adults (18-64 years)",52.0,0.269,0.168,0.404,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W20","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-05-16","2021-05-22","Household and community samples","Adults (18-64 years)",86.0,0.442,0.342,0.547,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W21","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-05-23","2021-05-29","Household and community samples","Adults (18-64 years)",93.0,0.495,0.395,0.594,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W22","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-05-30","2021-06-05","Household and community samples","Adults (18-64 years)",39.0,0.487,0.339,0.638,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W23","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-06-06","2021-06-12","Household and community samples","Adults (18-64 years)",68.0,0.603,0.484,0.711,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W24","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-06-13","2021-06-19","Household and community samples","Adults (18-64 years)",47.0,0.574,0.433,0.705,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W25","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-06-20","2021-06-26","Household and community samples","Adults (18-64 years)",44.0,0.727,0.582,0.807,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W26","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-06-27","2021-07-03","Household and community samples","Adults (18-64 years)",48.0,0.688,0.547,0.8,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W27","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-07-04","2021-07-10","Household and community samples","Adults (18-64 years)",12.0,0.583,0.32,0.807,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-20","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W28","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-07-11","2021-07-17","Household and community samples","Adults (18-64 years)",2.0,1.0,0.342,1.0,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-09-21","210815_Ethiopia_FederalMinistryofHealth_Overall_Adjusted","Seroprevalence and risk factors for SARS-CoV-2 Infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020","2021-08-15","National","Ethiopia","2020-06-24","2020-07-08","Household and community samples","Multiple groups",16932.0,0.035,0.032,0.038,"Simplified probability","IgG","Low","Journal Article (Peer-Reviewed)","Enyew Birru Tadesse","Federal Ministry of Health","http://dx.doi.org/10.1016/j.ijid.2021.08.028","Verified","","NR",0.545,1.0,"","ET",""
"2021-09-21","210818_NewYork_SunRiverHealth","Covid-19 Sero-Prevalence and Risk Factors in a Sample of Community Health Center Employees in New York State","2021-08-18","Regional","United States of America; New York","2020-07-15","2020-09-15","Health care workers and caregivers","Multiple groups",325.0,0.154,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Anne Kauffman Nolon","Sun River Health","http://dx.doi.org/10.1097/JOM.0000000000002357","Unverified","","NR","","","","US","US-NY"
"2021-09-21","210819_Managua_UniversityOfMichiganAnnArbor_Primary_PopAdj","Clinical spectrum of SARS-CoV-2 infection and protection from symptomatic re-infection","2021-08-19","Local","Nicaragua","2020-10-15","2020-11-15","Household and community samples","Multiple groups",1995.0,0.575,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Hannah E. Maier","University of Michigan, Ann Arbor","http://dx.doi.org/10.1093/cid/ciab717","Verified","","NR","","","","NI",""
"2021-09-21","210827_Belgium_UniversityofLiegeHospital_Overall","Systematic screening for SARS-CoV-2 S1/S2 antibodies helps to better assess the real incidence of COVID-19 in kidney transplant recipients","2021-08-27","National","Belgium","2020-03-01","2020-09-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",525.0,0.027,"","","Unclear","IgG","Unclear","Presentation or Conference","Louis Firket","University of Liege Hospital","http://dx.doi.org/10.1111/tri.13944","Unverified","","NR","","","","BE",""
"2021-09-21","210827_Modena_UniversityofModenaandReggioEmilia_Overall","Seroprevalence of anti-SARS-CoV-2 antibodies in the Northern Italy population before the COVID-19 second wave.","2021-08-27","Local","Italy; Province of Modena; Modena","2020-06-01","2020-09-25","Multiple populations","Multiple groups",7561.0,0.047,0.042,0.052,"Self-referral","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Nausicaa Berselli","University of Modena and Reggio Emilia","https://dx.doi.org/10.13075/ijomeh.1896.01826","Unverified","","NR","","","","IT","IT-45"
"2021-09-21","210910_Kazakhstan_KaragandaMedicalUniversity","Seroprevalence of anti-SARS-CoV-2 IgG and IgA antibodies before the launch of COVID-19 vaccination in Kazakhstan","2021-09-10","Local","Kazakhstan; Karaganda; Karaganda","2021-04-01","2021-05-31","Non-essential workers and unemployed persons","Adults (18-64 years)",98.0,0.347,"","","Convenience","IgA; IgG","High","Preprint","Irina Kadyrova","Karaganda Medical University","https://www.medrxiv.org/content/10.1101/2021.09.03.21262885v1.full-text","Unverified","","NR","","","","KZ","KZ-KAR"
"2021-09-21","210913_Belém_UniversidadeFederaldoPará","Migration in times of pandemic: SARS-CoV-2 infection among the Warao indigenous refugees in Belem, Para, Amazonia, Brazil.","2021-09-13","Local","Brazil; Pará State; Belém","2020-09-15","2021-01-15","Household and community samples","Multiple groups",101.0,0.832,"","","Entire sample","IgG","Moderate","Journal Article (Peer-Reviewed)","Hilton Pereira da Silva","Universidade Federal do Pará","https://dx.doi.org/10.1186/s12889-021-11696-7","Unverified","","NR","","","","BR","BR-PA"
"2021-09-21","210913_Delhi_MaulanaAzadMedicalCollege_PopTestAdj","Second wave of the Covid-19 pandemic in Delhi, India: high seroprevalence not a deterrent?","2021-09-13","Regional","India; Delhi","2021-01-11","2021-01-22","Household and community samples","Multiple groups",27436.0,0.561,0.555,0.568,"Stratified probability","IgG","Low","Preprint","Nandini Sharma","Maulana Azad Medical College","10.1101/2021.09.09.21263331","Verified","","NR",0.9,1.0,"","IN","IN-DL"
"2021-09-21","210913_Syria_ArabInternationalUniversity_Overall","Seropositivity of anti-SARS-CoV-2 IgG antibodies among asymptomatic and pauci-symptomatic students and staff at the Arab International University, Syria: a snapshot after a year of pandemic","2021-09-13","Local","Syrian Arab Republic; Daraa Governorate; Ghabaghib","2021-02-17","2021-03-31","Household and community samples","Multiple groups",94.0,0.638,"","","Convenience","IgG","High","Preprint","Wafika Zarzour","Arab International University","https://www.researchsquare.com/article/rs-885678/v1","Verified","","NR","","","","SY","SY-DR"
"2021-09-21","210914_Estonia_UniversityofTartu_overall","Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination.","2021-09-14","National","Estonia","2021-02-08","2021-03-25","Residual sera","Multiple groups",2517.0,0.201,0.185,0.217,"Stratified non-probability","IgG","High","Journal Article (Peer-Reviewed)","Hiie Soeorg","University of Tartu","https://dx.doi.org/10.1080/23744235.2021.1974540","Verified","","NR","","","","EE",""
"2021-09-21","210914_Louisville_UniversityofLouisville_July2020","Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky.","2021-09-14","Local","United States of America; Kentucky; Louisville","2020-07-06","2020-07-20","Health care workers and caregivers","Adults (18-64 years)",915.0,0.023,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Krystal Hamorsky","University of Louisville","https://dx.doi.org/10.1038/s41598-021-97423-z","Unverified","","NR","","","","US","US-KY"
"2021-09-21","210915_Monterey_UniversityofCalifornia_Primary","Risk Factors Associated With SARS-CoV-2 Infection Among Farmworkers in Monterey County, California.","2021-09-15","Regional","United States of America; California","2020-07-16","2020-11-30","Essential non-healthcare workers","Adults (18-64 years)",1058.0,0.19,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Ana M. Mora","Universityof California,Berkeley","https://dx.doi.org/10.1001/jamanetworkopen.2021.24116","Unverified","","NR","","","","US","US-CA"
"2021-09-21","211001_Antananarivo_InstitutPasteurdeMadagascar_6March2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","Madagascar","2021-03-01","2021-03-31","Blood donors","Adults (18-64 years)",497.0,0.499,0.455,0.543,"Sequential","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Verified","","NR",1.0,0.944,"","MG",""
"2021-09-21","211001_Antananarivo_InstitutPasteurdeMadagascar_8May2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","Madagascar","2021-05-01","2021-05-26","Blood donors","Adults (18-64 years)",500.0,0.648,0.561,0.726,"Sequential","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Verified","","NR",1.0,0.944,"","MG",""
"2021-09-22","210616_Texas_UniversityofTexasatHouston_Overall","Estimated Prevalence of SARS-CoV-2 Antibodies in the Texas Pediatric Population, 2021","2021-06-16","Regional","United States of America; Texas","2021-01-01","2021-06-01","Household and community samples","Children and Youth (0-17 years)",503.0,0.387,0.345,0.431,"Convenience","IgM; IgA; IgG","Moderate","Preprint","Sarah Messiah","University of Texas at Houston","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3868061","Verified","","NR",0.995,0.998,"","US","US-TX"
"2021-09-22","210915_Netherlands_UniversityofAmsterdam_Wantai_Overall","Saliva SARS-CoV-2 Antibody Prevalence in Children.","2021-09-15","Local","Netherlands; North Holland; Amsterdam","2020-04-12","2020-10-02","Residual sera","Children and Youth (0-17 years)",487.0,0.033,0.019,0.053,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Maya Keuning","University of Amsterdam","https://dx.doi.org/10.1128/Spectrum.00731-21","Verified","","NR",0.967,0.975,"","NL","NL-NH"
"2021-09-22","211001_Antananarivo_InstitutPasteurdeMadagascar_3December2020","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","Madagascar","2020-12-01","2020-12-31","Blood donors","Adults (18-64 years)",177.0,0.22,0.166,0.287,"Sequential","IgG","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Verified","","NR","","","","MG",""
"2021-09-22","211001_Antananarivo_InstitutPasteurdeMadagascar_4January2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","Madagascar","2021-01-01","2021-01-31","Blood donors","Adults (18-64 years)",389.0,0.447,0.399,0.497,"Sequential","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Verified","","NR",1.0,0.944,"","MG",""
"2021-09-22","211001_Antananarivo_InstitutPasteurdeMadagascar_5February2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","Madagascar","2021-02-01","2021-02-28","Blood donors","Adults (18-64 years)",319.0,0.505,0.45,0.559,"Sequential","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Unverified","","NR",1.0,0.944,"","MG",""
"2021-09-22","211001_Antananarivo_InstitutPasteurdeMadagascar_7April2021_AntiRBD","Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors","2021-09-14","Local","Madagascar","2021-04-01","2021-04-30","Blood donors","Adults (18-64 years)",493.0,0.584,0.54,0.627,"Sequential","Total Antibody","High","Presentation or Conference","Solohery Razafimahatratra","Institut Pasteur de Madagascar","http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2","Unverified","","NR",1.0,0.944,"","MG",""
"2021-09-23","210909_Chile_UniversidaddeChile","Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.","2021-09-09","National","Chile","2021-03-12","2021-07-02","Household and community samples","Multiple groups",54261.0,0.528,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Denis Saure","Universidad de Chile","https://dx.doi.org/10.1016/S1473-3099(21)00479-5","Unverified","","NR","","","","CL",""
"2021-09-23","210910_SouthWales_PublicHealthWales","The protective effect of previous COVID-19 infection in a high-prevalence hospital setting.","2021-09-10","Regional","United Kingdom of Great Britain and Northern Ireland; Wales","2020-06-02","2020-07-07","Health care workers and caregivers","Adults (18-64 years)",276.0,0.388,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Favian Narrainen","Public Health Wales Microbiology","https://dx.doi.org/10.7861/clinmed.2021-0225","Unverified","","NR","","","","GB","GB-WLS"
"2021-09-24","210413_Verona_UniversityofVerona","SARS-CoV-2 infection: A potential trigger of inflammatory neurological disorders","2021-04-13","Local","Italy","2020-03-01","2020-08-31","Residual sera","Multiple groups",332.0,0.078,"","","Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Cecilia Zivelonghi","University of Verona","https://n.neurology.org/content/96/15_Supplement/4295","Unverified","","NR","","","","IT",""
"2021-09-24","210729_SouthernUSA_WalterReedArmyInstituteOfResearch_Timepoint3","Serological and RT-PCR Surveillance for COVID-19 in an Asymptomatic US Army Trainee Population.","2021-07-29","Local","United States of America; Southern United States; NR","2020-11-18","2021-01-03","Essential non-healthcare workers","Adults (18-64 years)",1211.0,0.095,0.079,0.112,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Shilpa Hakre","Walter Reed Army Institute of Research","https://dx.doi.org/10.1093/ofid/ofab407","Unverified","","NR","","","","US",""
"2021-09-24","210826_Dublin_MaterMisericordiaeUniversityHospital","Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic.","2021-08-26","Local","Ireland","2020-06-24","2020-07-06","Multiple populations","Multiple groups",157.0,0.064,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Brendan O'Kelly","Mater Misericordiae University Hospital","https://dx.doi.org/10.3389/fmed.2021.642318","Unverified","","NR","","","","IE",""
"2021-09-24","210903_Maharashtra_ICMR-NationalInstituteOfImmunohematology","Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection.","2021-09-03","Regional","India; Maharashtra; Dombivli","2020-07-21","2020-08-03","Health care workers and caregivers","Adults (18-64 years)",500.0,0.11,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Reetika Malik Yadav","ICMR-National Institute of Immunohematology","https://dx.doi.org/10.2991/jegh.k.210518.001","Unverified","","NR","","","","IN","IN-MH"
"2021-09-24","210918_Chandigarh_GovernmentMedicalCollegeandHospital_overall","Sero survey: 80% of Chandigarh’s adults have Covid antibodies","2021-09-18","Local","India; Punjab; Chandigarh","2021-07-01","2021-07-31","Household and community samples","Adults (18-64 years)",1200.0,0.802,"","","Simplified probability","Not reported","Unclear","News and Media","Hindustan Times Correspondent","Government Medical College and Hospital","https://www.hindustantimes.com/cities/chandigarh-news/sero-survey-80-of-chandigarh-s-adults-have-covid-antibodies-101631914347989.html","Verified","","NR","","","","IN","IN-PB"
"2021-09-27","201013_Stockholm_TheStockholmRegion","13 oktober: Lägesrapport om covid-19","2020-10-13","Local","Sweden","2020-10-05","2020-10-11","Household and community samples","Multiple groups",11065.0,0.152,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/13-oktober-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-09-27","201020_Stockholm_TheStockholmRegion","20 oktober: Lägesrapport om covid-19","2020-10-20","Local","Sweden","2020-10-12","2020-10-18","Household and community samples","Multiple groups",10297.0,0.154,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/20-oktober-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-09-27","201027_Stockholm_TheStockholmRegion","27 oktober: Lägesrapport om covid-19","2020-10-27","Local","Sweden","2020-10-19","2020-10-25","Household and community samples","Multiple groups",8941.0,0.206,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/27-oktober-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-09-27","210908_Italy_UniversityofFlorence_Players","Soccer in the time of COVID-19: One year report from an Italian top league club, March 2020 - February 2021","2021-09-08","Local","Italy","2020-05-14","2020-05-15","Non-essential workers and unemployed persons","Adults (18-64 years)",27.0,0.67,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Michele Spinicci","University of Florence","http://dx.doi.org/10.1017/S0950268821002065","Unverified","","NR","","","","IT",""
"2021-09-27","210908_Italy_UniversityofFlorence_Staff","Soccer in the time of COVID-19: One year report from an Italian top league club, March 2020 - February 2021","2021-09-08","Local","Italy","2020-05-14","2020-05-15","Non-essential workers and unemployed persons","Adults (18-64 years)",26.0,0.65,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Michele Spinicci","University of Florence","http://dx.doi.org/10.1017/S0950268821002065","Unverified","","NR","","","","IT",""
"2021-09-27","210920_Dublin_UniversityCollegeDublin_overall","Immunological assessment of SARS-CoV-2 infection in pregnancy from diagnosis to delivery: A multicentre prospective study.","2021-09-20","Local","United Kingdom of Great Britain and Northern Ireland; Ireland; Dublin","2020-05-04","2020-05-15","Pregnant or parturient women","Adults (18-64 years)",598.0,0.017,0.008,0.031,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Kate Glennon","University College Dublin","https://dx.doi.org/10.1371/journal.pone.0253090","Verified","","NR","","","","GB",""
"2021-09-27","211103_Stockholm_TheStockholmRegion","3 november: Lägesrapport om covid-19","2020-11-03","Local","Sweden","2020-10-26","2020-11-01","Household and community samples","Multiple groups",9580.0,0.217,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/3-november-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-09-28","210826_FaroeIslands_UniversityoftheFaroeIslands_TestAdjusted","Seroprevalence of SARS-CoV-2-Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020","2021-08-26","National","Faroe Islands","2020-05-01","2020-09-15","Contacts of COVID patients","Multiple groups",584.0,0.053,0.035,0.075,"Entire sample","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Maria Petersen","University of the Faroe Islands","https://wwwnc.cdc.gov/eid/article/27/11/20-4948_article","Unverified","","NR",0.967,0.995,"","FO",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_1-6","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Children and Youth (0-17 years)",55.0,0.109,0.041,0.169,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_14-17","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Children and Youth (0-17 years)",182.0,0.176,0.123,0.239,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_18-29","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Adults (18-64 years)",399.0,0.055,0.035,0.082,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_30-39","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Adults (18-64 years)",388.0,0.049,0.03,0.08,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_40-49","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Adults (18-64 years)",391.0,0.097,0.07,0.131,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_50-59","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Adults (18-64 years)",409.0,0.076,0.052,0.106,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_60-69","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Multiple groups",376.0,0.08,0.054,0.112,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_7-13","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Children and Youth (0-17 years)",151.0,0.086,0.047,0.143,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_70+","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Seniors (65+ years)",377.0,0.148,0.114,0.188,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_Overall","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Multiple groups",2728.0,0.091,0.08,0.102,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210831_Novosibirsk_StPetersburgPasteurInstitute_Phase2-Stage3_Overall","Herd immunity to SARS-CoV-2 in the Novosibirsk Region population amid the COVID-19 pandemic","2021-08-31","Local","Russian Federation","2020-06-28","2020-07-15","Household and community samples","Multiple groups",1651.0,0.31,0.288,0.333,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Anna Popova","St Petersburg Pasteur Institute","https://dx.doi.org/10.36233/0507-4088-54","Unverified","","NR","","","","RU",""
"2021-09-28","210901_Petropolis_SociedadeFrancoBrasileiradeOncologia_baseline","1603P SARS-CoV-2 seroconversion among oncology healthcare workers in Brazil","2021-09-01","Local","Brazil","2020-04-09","2020-04-29","Health care workers and caregivers","Adults (18-64 years)",60.0,0.05,"","","Convenience","IgG; IgM","High","Presentation or Conference","Carla Ismael","Sociedade Franco Brasileira de Oncologia (SFBO)","http://dx.doi.org/10.1016/j.annonc.2021.08.1596","Unverified","","NR","","","","BR",""
"2021-09-28","210901_Petropolis_SociedadeFrancoBrasileiradeOncologia_followup","1603P SARS-CoV-2 seroconversion among oncology healthcare workers in Brazil","2021-09-01","Local","Brazil","2020-11-05","2020-12-28","Health care workers and caregivers","Adults (18-64 years)",60.0,0.1,"","","Convenience","IgG","High","Presentation or Conference","Carla Ismael","Sociedade Franco Brasileira de Oncologia (SFBO)","http://dx.doi.org/10.1016/j.annonc.2021.08.1596","Unverified","","NR","","","","BR",""
"2021-09-28","210914_Denmark_OdenseUniversityTestAdj","SARS-CoV-2 seroprevalence among 7,950 health-care workers in the Region of Southern Denmark. (THEIJID-D-21-01420R1).","2021-09-14","Regional","Denmark; Region of Southern Denmark","2020-05-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",7950.0,0.014,0.01,0.018,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Sebastian von Huth","Odense University","https://dx.doi.org/10.1016/j.ijid.2021.09.023","Unverified","","NR",0.78,0.993,"","DK","DK-83"
"2021-09-28","210915_Wuhan_HubeiProvincialHospital_AgeSexAdj","Seroprevalence of IgM and IgG Antibodies against SARS-CoV-2 in Asymptomatic People in Wuhan: Data from a General Hospital Near South China Seafood Wholesale Market during March to April in 2020.","2021-09-15","Local","China; Hubei; Wuhan","2020-03-25","2020-04-28","Multiple populations","Multiple groups",18712.0,0.032,0.029,0.034,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","LING Rui Jie","Hubei Provincial Hospital","https://dx.doi.org/10.3967/bes2021.103","Verified","","NR","","","","CN","CN-42"
"2021-09-28","210916_Augsburg_UniversityHospitalofAugsburg_HCW","Evaluation of the ESGE recommendations for COVID-19 pre-endoscopy risk-stratification in a high-volume center in Germany.","2021-09-16","Local","Germany; Bavaria; Augsburg","2020-12-24","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",43.0,0.023,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Stephan Zellmer","University Hospital of Augsburg","https://dx.doi.org/10.1055/a-1526-1169","Unverified","","NR","","","","DE","DE-BY"
"2021-09-28","210916_MexicoCity_UniversidadNacionalAutónomaDeMéxico_Primary","SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study.","2021-09-16","Local","Mexico","2020-09-21","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",169.0,0.207,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Fatima Sofía Magana-Guerrero","Universidad Nacional Autónoma De México","https://dx.doi.org/10.1080/09286586.2021.1974493","Unverified","","NR","","","","MX",""
"2021-09-28","210917_Mitu_UniversidaddeCordoba_Overall","High Infection to SARS-CoV-2 in an Indigen Community of the Colombian Amazon Region","2021-09-17","Local","Colombia; Department of Vaupes; Mitu","2020-12-01","2020-12-31","Household and community samples","Multiple groups",590.0,0.576,"","","Unclear","IgG; IgM; IgA","Unclear","Preprint","Hector Serrano-Coll","Universidad de Cordoba","https://www.preprints.org/manuscript/202109.0307/v1","Verified","","NR","","","","CO","CO-VAU"
"2021-09-28","210920_Genoa_UniversitàdegliStudidiGenova_overall","Incidence and Immunomic Features of Apyretic COVID-19 in Patients Affected by Solid Tumors: A Prospective Cohort Study","2021-09-20","Local","Italy; Liguria; Genoa","2020-04-14","2020-08-23","Patients seeking care for non-COVID-19 reasons","Multiple groups",446.0,0.031,"","","Convenience","IgG; IgM","High","Preprint","Francesco Ravera","Università degli Studi di Genova","https://www.researchsquare.com/article/rs-864803/v1","Unverified","","NR","","","","IT","IT-42"
"2021-09-28","210921_Andorra_HospitalNostraSenyoradeMeritxell_November","1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study)","2021-09-21","Local","Andorra","2020-11-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",156.0,0.064,"","","Convenience","Not reported","High","Presentation or Conference","C Royo-Cebrecos","Hospital Nostra Senyora de Meritxell","http://dx.doi.org/10.1016/j.annonc.2021.08.1594","Unverified","","NR","","","","AD",""
"2021-09-28","210922_Flanders_GhentUniversity_residents","Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.","2021-09-22","Regional","Belgium; Flanders; Wingene, Liedekerke, Assenede, Wetteren","2020-08-01","2020-08-31","Assisted living and long-term care facilities","Seniors (65+ years)",199.0,0.302,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Eline Meyers","Ghent University","https://dx.doi.org/10.1128/Spectrum.00178-21","Unverified","","NR","","","","BE","BE-VLG"
"2021-09-28","210922_Flanders_GhentUniversity_staff","Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.","2021-09-22","Regional","Belgium; Flanders; Wingene, Liedekerke, Assenede, Wetteren","2020-08-01","2020-08-31","Assisted living and long-term care facilities","Adults (18-64 years)",241.0,0.286,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Eline Meyers","Ghent University","https://dx.doi.org/10.1128/Spectrum.00178-21","Unverified","","NR","","","","BE","BE-VLG"
"2021-09-29","210610_Vietnam_TheUniversityOfSydney_GenPop1_Female","Sero-prevalence of sars-cov-2 antibodies in high-risk populations in vietnam","2021-06-11","National","Viet Nam; Hanoi Capital, Quang Nam Province, Da Nang Province; Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang","2020-09-04","2020-11-23","Household and community samples","Multiple groups",1410.0,0.005,"","","Unclear","IgG","Moderate","Journal Article (Peer-Reviewed)","Tasnim Hasan","The University of Sydney","http://dx.doi.org/10.3390/ijerph18126353","Verified","","NR",0.968,0.998,"","VN",""
"2021-09-29","210610_Vietnam_TheUniversityOfSydney_GenPop1_Male","Sero-prevalence of sars-cov-2 antibodies in high-risk populations in vietnam","2021-06-11","National","Viet Nam; Hanoi Capital, Quang Nam Province, Da Nang Province; Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang","2020-09-04","2020-11-23","Household and community samples","Multiple groups",1624.0,0.004,"","","Unclear","IgG","Moderate","Journal Article (Peer-Reviewed)","Tasnim Hasan","The University of Sydney","http://dx.doi.org/10.3390/ijerph18126353","Verified","","NR",0.968,0.998,"","VN",""
"2021-09-29","210731_Wisconsin_CentersforDiseaseControlandPrevention_1September","Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti-SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September-November 2020.","2021-07-31","Regional","United States of America; Wisconsin","2020-09-01","2020-09-04","Students and Daycares","Adults (18-64 years)",517.0,0.041,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Hannah Segaloff","Centers for Disease Control and Prevention","https://dx.doi.org/10.1093/ofid/ofab405","Unverified","","NR","","","","US","US-WI"
"2021-09-29","210731_Wisconsin_CentersforDiseaseControlandPrevention_2November","Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti-SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September-November 2020.","2021-07-31","Regional","United States of America; Wisconsin","2020-11-09","2020-11-13","Students and Daycares","Adults (18-64 years)",413.0,0.186,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Hannah Segaloff","Centers for Disease Control and Prevention","https://dx.doi.org/10.1093/ofid/ofab405","Unverified","","NR","","","","US","US-WI"
"2021-09-29","210901_Switzerland_KantonsspitalStGallen","Anti-S1 antibodies after vaccination with anti SARS-CoV-2 mRNA vaccines in patients with rheumatoid arthritis differ in magnitude and kinetics from healthy controls: Results from a prospective, observational controlled study","2021-09-01","Local","Switzerland; St. Gallen; St. Gallen","2021-01-10","2021-03-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",77.0,0.052,"","","Unclear","Not reported","High","Journal Article (Peer-Reviewed)","Andrea Rubbert-Roth","Kantonsspital St. Gallen","https://smw.ch/article/doi/SMW.2021.w30056","Unverified","","NR","","","","CH",""
"2021-09-29","210903_Grisons_CantonalHospitalGrisons","Seroconversion for SARS-COV-2 in health care workers after the first and the second wave of COVID-19 in the canton of Grisons in Switzerland","2021-09-03","Regional","Switzerland; Canton of Grisons","2020-06-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",5109.0,0.093,"","","Convenience","Not reported","High","Presentation or Conference","Katarzyna Szajek","Cantonal Hospital Grisons","https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf","Unverified","","NR","","","","CH",""
"2021-09-29","210917_Gussago_FondazionePoliambulanzaHospital","Antibody response after bnt162b2 vaccination in healthcare workers previously exposed and not exposed to sars-cov-2","2021-09-17","Local","Italy; Brescia; Gussago","2021-01-01","2021-04-01","Health care workers and caregivers","Adults (18-64 years)",337.0,0.38,"","","Unclear","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Marcello Salvaggio","Fondazione Poliambulanza Hospital","http://dx.doi.org/10.3390/jcm10184204","Unverified","","NR","","","","IT","IT-25"
"2021-09-29","210921_USA_CityUniversityofNewYork_Overall","Cohort profile: a national, community-based prospective cohort study of SARS-CoV-2 pandemic outcomes in the USA-the CHASING COVID Cohort study.","2021-09-21","National","United States of America","2020-05-15","2020-08-15","Household and community samples","Multiple groups",4459.0,0.068,0.061,0.076,"Convenience","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","McKaylee Robertson","City University of New York","https://dx.doi.org/10.1136/bmjopen-2021-048778","Verified","","NR",1.0,1.0,"","US",""
"2021-10-04","201110_Stockholm_TheStockholmRegion","10 november: Lägesrapport om covid-19","2020-11-10","Local","Sweden","2020-11-02","2020-11-08","Household and community samples","Multiple groups",11500.0,0.259,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/10-november-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-04","201117_Stockholm_TheStockholmRegion","17 november: Lägesrapport om covid-19","2020-11-17","Local","Sweden","2020-11-09","2020-11-15","Household and community samples","Multiple groups",13273.0,0.278,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/17-november-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-04","201124_Stockholm_TheStockholmRegion","24 november: Lägesrapport om covid-19","2020-11-24","Local","Sweden","2020-11-16","2020-11-22","Household and community samples","Multiple groups",15474.0,0.314,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/24-november-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-04","201201_Stockholm_TheStockholmRegion","1 december: Lägesrapport om covid-19","2020-12-01","Local","Sweden","2020-11-23","2020-11-29","Household and community samples","Multiple groups",16389.0,0.336,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/1-december-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-04","201208_Stockholm_TheStockholmRegion","8 december: Lägesrapport om covid-19","2020-12-08","Local","Sweden","2020-11-30","2020-12-06","Household and community samples","Multiple groups",16943.0,0.367,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/8-december-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-04","210926_RiodeJaneiro_OswaldoCruzFoundation_Primary","P-87 HIGH PREVALENCE OF SARS-COV-2 ANTIBODIES IN PREGNANT WOMEN INFECTED WITH VIRAL HEPATITIS IN BRAZIL","2021-09-26","Local","Brazil; Rio de Janeiro; Rio de Janeiro","2020-01-07","2021-01-11","Pregnant or parturient women","Adults (18-64 years)",31.0,0.194,"","","Unclear","Total Antibody","High","Journal Article (Peer-Reviewed)","Alanna Calheiros Santos","Oswaldo Cruz Foundation","http://dx.doi.org/10.1016/j.aohep.2021.100450","Verified","","NR","","","","BR","BR-RJ"
"2021-10-05","210902_USA_VitalantResearchInstitute_202007_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2020-07-01","2020-07-31","Blood donors","Multiple groups",116513.0,0.037,0.034,0.04,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","NR","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202008_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2020-08-01","2020-08-31","Blood donors","Multiple groups",123200.0,0.048,0.046,0.051,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202009_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2020-09-01","2020-09-30","Blood donors","Multiple groups",131052.0,0.05,0.048,0.053,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202010_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2020-10-01","2020-10-31","Blood donors","Multiple groups",131731.0,0.059,0.057,0.062,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202011_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2020-11-01","2020-11-30","Blood donors","Multiple groups",134061.0,0.082,0.079,0.085,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202012_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2020-12-01","2020-12-31","Blood donors","Multiple groups",135026.0,0.119,0.115,0.122,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202101_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2021-01-01","2021-01-31","Blood donors","Multiple groups",134632.0,0.205,0.202,0.209,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202102_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2021-02-01","2021-02-28","Blood donors","Multiple groups",133288.0,0.335,0.331,0.339,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202103_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2021-03-01","2021-03-31","Blood donors","Multiple groups",134557.0,0.492,0.487,0.496,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202104_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2021-04-01","2021-04-30","Blood donors","Multiple groups",134510.0,0.714,0.711,0.718,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210902_USA_VitalantResearchInstitute_202105_Overall_PopAdj","Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021","2021-09-02","National","United States of America","2021-05-01","2021-05-31","Blood donors","Multiple groups",134949.0,0.833,0.829,0.837,"Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jefferson Jones","Vitalant Research Institute","https://jamanetwork.com/journals/jama/fullarticle/2784013","Verified","","","","","","US",""
"2021-10-05","210909_Milan_FondazioneIRCCSCa’GrandaOspedaleMaggiorePoliclinico","Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area.","2021-09-09","Local","Italy","2020-04-20","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",109.0,0.184,"","","Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Luca Elli","Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico","https://dx.doi.org/10.1016/j.dld.2021.08.027","Unverified","","NR","","","","IT",""
"2021-10-05","210913_UnitedStates_AirForceResearchLaboratory","COVID-19 Seroprevalence and Active Infection in an Asymptomatic Population.","2021-09-13","Local","United States of America; Ohio","2020-07-23","2020-10-23","Household and community samples","Multiple groups",582.0,0.031,"","","Convenience","IgM; IgG; IgA","High","Journal Article (Peer-Reviewed)","Amy Breedon","Air Force Research Laboratory, Wright-Patterson Air Force Base","https://dx.doi.org/10.3389/fmed.2021.749732","Verified","","NR","","","","US","US-OH"
"2021-10-05","210919_India_TataMainHospital_Jul2021_Primary","Results of Serosurveillance and Forecasting the Third Wave of COVID-19 in an Industrial District in India.","2021-09-19","Local","India; Jharkhand","2021-07-01","2021-07-31","Multiple populations","Multiple groups",4575.0,0.75,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Deb Sanjay Nag","Tata Main Hospital","https://dx.doi.org/10.7759/cureus.18097","Verified","","NR",1.0,1.0,"","IN","IN-JH"
"2021-10-05","210920_Egypt_AssiutUniversity_Overall","Sero-prevalence of anti-SARS-CoV-2 antibodies among healthcare workers: A multicenter study from Egypt.","2021-09-20","National","Egypt; Ash Sharqiyah, Asyut; Zagazig, Assiut","2020-10-15","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",82.0,0.463,"","","Unclear","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Rehab El-Sokkary","Assiut University","https://dx.doi.org/10.1016/j.jiph.2021.09.011","Unverified","","NR","","","","EG",""
"2021-10-05","210920_Peru_UniversidadAndinadelCusco_OverallPopAdj","SARS-CoV-2 seroprevalence in a high-altitude setting in Peru: Adult population-based cross-sectional study","2021-09-20","Regional","Peru; Cusco Region","2020-09-12","2020-09-27","Household and community samples","Multiple groups",1924.0,0.331,0.301,0.364,"Simplified probability","Total Antibody","Low","Journal Article (Peer-Reviewed)","Charles Huamani","Universidad Andina del Cusco","http://dx.doi.org/10.7717/peerj.12149","Verified","","NR",0.967,0.986,"","PE","PE-CUS"
"2021-10-05","210922_EspiritoSanto_LaboratoriodeEpidemiologia_Overall","COVID-19 in children, adolescents and young adults: a cross-sectional study in Espirito Santo, Brazil, 2020.","2021-09-22","Regional","Brazil; Espirito Santo; Colatina, Linhares, São Mateus, Afonso Cláudio, Nova Venécia, Cachoeiro de Itapemirim, Alegre, Vila Velha, Cariacica, Serra, Vitória","2020-05-10","2020-06-21","Household and community samples","Children and Youth (0-17 years)",1693.0,0.061,"","","Stratified probability","IgM; IgG","High","Journal Article (Peer-Reviewed)","Ethel Leonor Noia Maciel","Laboratorio de Epidemiologia","https://dx.doi.org/10.1590/S1679-49742021000400001","Verified","","NR",0.864,0.996,"","BR","BR-ES"
"2021-10-05","210922_Madinah_TaibahUniversity_children1_primary","Assessment of SARS-CoV-2 anti-spike IgG antibody in women and children in Madinah, Saudi Arabia: A single-center study","2021-09-22","Local","Saudi Arabia","2021-01-15","2021-04-15","Residual sera","Children and Youth (0-17 years)",332.0,0.587,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Waleed Mahallawi","Taibah University","http://dx.doi.org/10.3390/ijerph18199971","Verified","","NR",0.987,0.984,"","SA",""
"2021-10-05","210922_Madinah_TaibahUniversity_women2","Assessment of SARS-CoV-2 anti-spike IgG antibody in women and children in Madinah, Saudi Arabia: A single-center study","2021-09-22","Local","Saudi Arabia","2021-01-15","2021-04-15","Residual sera","Adults (18-64 years)",247.0,0.502,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Waleed Mahallawi","Taibah University","http://dx.doi.org/10.3390/ijerph18199971","Verified","","NR",0.987,0.984,"","SA",""
"2021-10-05","210922_PimpriChinchwad_DrDYPatilVidyapeeth_Overall","Severe acute respiratory syndrome-coronavirus-2 seroprevalence study in Pimpri-Chinchwad, Maharashtra, India coinciding with falling trend - Do the results suggest imminent herd immunity?.","2021-09-22","Local","India; Maharashtra; Pimpri-Chinchwad","2020-10-07","2020-10-17","Household and community samples","Multiple groups",5000.0,0.34,0.313,0.368,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Amitav Banerjee","Dr. D. Y. Patil Medical College, Hospital and Research Centre","https://www.ijph.in/article.asp?issn=0019-557X;year=2021;volume=65;issue=3;spage=256;epage=260;aulast=Banerjee","Verified","","NR",0.927,0.999,"","IN","IN-MH"
"2021-10-05","210923_Kashmir_GovernmentMedicalCollegeSrinagar_PopAndTestAdjusted","Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020.","2021-09-23","Regional","India; Kashmir","2020-10-17","2020-11-04","Household and community samples","Multiple groups",6230.0,0.367,0.343,0.392,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Muhammad Khan","Government Medical College Srinagar","https://dx.doi.org/10.1136/bmjopen-2021-053791","Verified","","NR",1.0,0.996,"","IN","IN-JK"
"2021-10-05","210929_Islamabad_NationalInstituteofHealth_Overall","Prevalence of SARS-CoV-2: An age-stratified, population-based, seroepidemiological survey in Islamabad, Pakistan","2021-09-29","Local","Pakistan; Islamabad Capital Territory; Islamabad","2020-06-01","2020-06-30","Household and community samples","Multiple groups",6333.0,0.163,"","","Stratified probability","IgG; IgM","Moderate","Preprint","Mirza Amir Baig","National Institute of Health","https://www.medrxiv.org/content/10.1101/2021.09.27.21264003v1.article-info","Verified","","NR","","","","PK","PK-IS"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2020-05_to_2020-06_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","Iran (Islamic Republic of); Tehran; Tehran","2020-05-01","2020-06-30","Household and community samples","Multiple groups",573.0,0.098,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","NR",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2020-07_to_2020-08_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","Iran (Islamic Republic of); Tehran; Tehran","2020-07-01","2020-08-31","Household and community samples","Multiple groups",1221.0,0.204,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","NR",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2020-09_to_2020-10_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","Iran (Islamic Republic of); Tehran; Tehran","2020-09-01","2020-10-31","Household and community samples","Multiple groups",1387.0,0.337,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","NR",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2020-11_to_2020-12_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","Iran (Islamic Republic of); Tehran; Tehran","2020-11-01","2020-12-31","Household and community samples","Multiple groups",1074.0,0.458,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","NR",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2021-01_to_2021-02_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","Iran (Islamic Republic of); Tehran; Tehran","2021-01-01","2021-02-28","Household and community samples","Multiple groups",294.0,0.36,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","NR",0.941,0.983,"","IR","IR-07"
"2021-10-05","210930_Tehran_TehranUniversityofMedicalSciences_2021-03_to_2021-04_Overall","SARS-CoV-2 Seroprevalence in People Referred to Private Medical Laboratories in Different Districts of Tehran, Iran from May 2020 to April 2021.","2021-09-30","Local","Iran (Islamic Republic of); Tehran; Tehran","2021-03-01","2021-04-30","Household and community samples","Multiple groups",367.0,0.251,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Zahra Heydarifard","Tehran University of Medical Sciences","https://dx.doi.org/10.1007/s12250-021-00446-z","Verified","","NR",0.941,0.983,"","IR","IR-07"
"2021-10-06","210920_France_ToulouseUniversityHospital","Antibody titers and protection against a SARS-CoV-2 infection.","2021-09-21","National","France","2020-06-10","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",8758.0,0.032,"","","Unclear","Total Antibody","Unclear","Journal Article (Peer-Reviewed)","Chloe Dimeglio","Tolouse University Hospital","https://dx.doi.org/10.1016/j.jinf.2021.09.013","Verified","","NR","","","","FR",""
"2021-10-06","210924_BneiBrak_MayaneiHayeshuaMedicalCenter_primary","Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy.","2021-09-24","Local","Israel; Tel Aviv District; Bnei Brak","2021-02-28","2021-03-08","Pregnant or parturient women","Adults (18-64 years)",21.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Lior Kashani-Ligumsky","Mayanei Hayeshua Medical Center","https://dx.doi.org/10.1038/s41372-021-01216-1","Unverified","","NR","","","","IL","IL-TA"
"2021-10-06","210927_AbuDhabi_SEHAAbuDhabiHealthServicesCompany","An Analysis Of Antibody Responses And Clinical Sequalae Of The Sinopharm HB02 COVID19 Vaccine In Dialysis Patients In The UAE.","2021-09-27","Local","United Arab Emirates","2021-01-25","2021-03-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",446.0,0.17,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Stephen Holt","SEHA Abu Dhabi Health Services Company","https://dx.doi.org/10.1111/nep.13980","Unverified","","NR","","","","AE",""
"2021-10-06","210928_HyogoPrefecture_KobeUniversity_Primary_NAntigens","Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021","2021-09-28","Local","Japan","2021-07-19","2021-08-06","Residual sera","Multiple groups",1000.0,0.021,"","","Convenience","Not reported","Moderate","Preprint","Zhenxiao Ren","Kobe Univesity","https://www.medrxiv.org/content/10.1101/2021.09.26.21264129v1.full-text","Verified","","NR","","","","JP",""
"2021-10-06","210928_HyogoPrefecture_KobeUniversity_Primary_SAntigens","Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021","2021-09-28","Local","Japan","2021-07-19","2021-08-06","Residual sera","Multiple groups",1000.0,0.387,"","","Convenience","IgG","Moderate","Preprint","Zhenxiao Ren","Kobe Univesity","https://www.medrxiv.org/content/10.1101/2021.09.26.21264129v1.full-text","Verified","","NR","","","","JP",""
"2021-10-06","210929_Atahualpa_StonyBrookUniversity_April2021_primary","Body Composition in Community-Dwelling Older Adults Before and After SARS-CoV-2 Infection: A Longitudinal Prospective Study in a Rural Village Struck by the Pandemic.","2021-09-29","Local","Ecuador","2021-04-01","2021-04-30","Household and community samples","Multiple groups",277.0,0.632,"","","Unclear","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oscar Del Brutto","Stony Brook University","https://dx.doi.org/10.1177/21501327211047781","Verified","","NR","","","","EC",""
"2021-10-06","210929_CasolaDiNapoli_UniversityOfSalerno_Overall","Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: a cohort study.","2021-09-29","Local","Italy; Naples; City of Napoli","2020-06-25","2020-07-12","Household and community samples","Multiple groups",2738.0,0.014,"","","Self-referral","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Carmine Coppola","University of Salerno","https://dx.doi.org/10.1111/jvh.13623","Verified","","NR","","","","IT","IT-72"
"2021-10-07","210901_China_SouthernMedicalUniversity_GuangdongHCW4","Erratum: The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients (Kidney International Reports (2021) 6(9) (2525), (S2468024921013450), (10.1016/j.ekir.2021.07.021))","2021-09-01","Regional","China; Guangdong; Guangzhou, Foshan","2020-03-01","2020-03-15","Health care workers and caregivers","Adults (18-64 years)",260.0,0.012,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","Southern Medical University","http://dx.doi.org/10.1016/j.ekir.2021.07.022","Unverified","","NR",0.83,1.0,"","CN","CN-44"
"2021-10-07","210901_China_SouthernMedicalUniversity_GuangdongPatients2","Erratum: The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients (Kidney International Reports (2021) 6(9) (2525), (S2468024921013450), (10.1016/j.ekir.2021.07.021))","2021-09-01","Regional","China; Guangdong; Guangzhou and Foshan","2020-03-01","2020-03-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",563.0,0.028,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","Southern Medical University","http://dx.doi.org/10.1016/j.ekir.2021.07.022","Unverified","","NR",0.83,1.0,"","CN","CN-44"
"2021-10-07","210901_China_SouthernMedicalUniversity_HubeiHCW3","Erratum: The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients (Kidney International Reports (2021) 6(9) (2525), (S2468024921013450), (10.1016/j.ekir.2021.07.021))","2021-09-01","Regional","China; Hubei province; Honghu and Jingzhou","2020-03-01","2020-03-15","Health care workers and caregivers","Adults (18-64 years)",2945.0,0.012,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Xin Xu","Southern Medical University","http://dx.doi.org/10.1016/j.ekir.2021.07.022","Unverified","","NR",0.83,1.0,"","CN","CN-42"
"2021-10-07","210901_China_SouthernMedicalUniversity_HubeiPatients1","Erratum: The Cumulative Rate of SARS-CoV-2 Infection in Chinese Hemodialysis Patients (Kidney International Reports (2021) 6(9) (2525), (S2468024921013450), (10.1016/j.ekir.2021.07.021))","2021-09-01","Regional","China; Hubei province; Honghu and Jingzhou","2020-03-01","2020-03-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",978.0,0.036,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Xin Xu","Southern Medical University","http://dx.doi.org/10.1016/j.ekir.2021.07.022","Unverified","","NR",0.83,1.0,"","CN","CN-42"
"2021-10-07","210924_Michigan_UniversityOfMichigan_AfterDec14_Overall","Understanding the patterns of serological testing for covid-19 pre-and post-vaccination rollout in michigan","2021-09-24","Local","United States of America; Michigan","2020-12-14","2021-05-03","Household and community samples","Multiple groups",2024.0,0.362,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Zhangchen Zhao","University of Michigan","http://dx.doi.org/10.3390/jcm10194341","Verified","","NR","","","","US","US-MI"
"2021-10-07","210924_Michigan_UniversityOfMichigan_BeforeDec14_Overall","Understanding the patterns of serological testing for covid-19 pre-and post-vaccination rollout in michigan","2021-09-24","Local","United States of America; Michigan","2020-04-27","2020-12-13","Household and community samples","Multiple groups",8026.0,0.092,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Zhangchen Zhao","University of Michigan","http://dx.doi.org/10.3390/jcm10194341","Verified","","NR","","","","US","US-MI"
"2021-10-12","210902_Nairobi_WashingtonStateUniversity_TestAdjPopAdj","High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya","2021-09-02","Local","Kenya","2020-11-02","2020-11-23","Household and community samples","Multiple groups",1164.0,0.347,0.318,0.376,"Simplified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","Isaac Ngere","Washington State University","https://dx.doi.org/10.1016/j.ijid.2021.08.062","Verified","","NR",0.944,1.0,"","KE",""
"2021-10-12","210905_Razarbag_BRACUniversity_GroupII_Overall","Assessment of a rapid pan-antibody dot test for detection of antibodies against SARS-CoV-2","2021-09-05","Local","Bangladesh; Dhaka District; Dhaka","2020-05-15","2020-06-15","Residual sera","Multiple groups",100.0,0.2,"","","Stratified non-probability","IgG","High","Journal Article (Peer-Reviewed)","Md Ahsanul Haq","BRAC University","http://dx.doi.org/10.3329/BJMS.V20I5.55407","Verified","","NR","",0.96,"","BD",""
"2021-10-12","210925_Hamburg_UniversityMedicalCenterHamburg-Eppendorf","Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.","2021-09-25","Local","Germany","2021-05-11","2021-05-31","Health care workers and caregivers","Adults (18-64 years)",872.0,0.927,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Thomas Theo Brehm","the University Medical Center Hamburg-Eppendorf","https://dx.doi.org/10.1016/j.ijheh.2021.113851","Unverified","","NR",0.998,1.0,"","DE",""
"2021-10-12","210927_Hanoi_NationalCenterforGlobalHealthandMedicine_primary","Evaluation of SARS-CoV-2 Antibodies and the Impact of COVID-19 on the HIV Care Continuum, Economic Security, Risky Health Behaviors, and Mental Health Among HIV-Infected Individuals in Vietnam.","2021-09-27","Local","Viet Nam","2020-06-01","2020-07-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",1243.0,0.002,"","","Unclear","IgG","Moderate","Journal Article (Peer-Reviewed)","Shoko Matsumoto","National Center for Global Health and Medicine","https://dx.doi.org/10.1007/s10461-021-03464-w","Unverified","","NR","","","","VN",""
"2021-10-12","210929_England_PublicHealthEngland_Overall","Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England.","2021-09-29","National","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2020-07-23","Students and Daycares","Multiple groups",2179.0,0.14,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Georgina Ireland","Public Health England","https://dx.doi.org/10.1016/j.eclinm.2021.101150","Unverified","","NR","","","","GB","GB-ENG"
"2021-10-12","211001_UnitedStates_OchsnerHealth","Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients.","2021-10-01","Local","United States of America; Louisiana; New Orleans","2020-03-01","2020-05-01","Multiple populations","Adults (18-64 years)",13343.0,0.08,0.075,0.084,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Edmond Kabagambe","Ochsner Health","https://dx.doi.org/10.1016/j.amjms.2021.09.006","Unverified","","NR",1.0,0.996,"","US","US-LA"
"2021-10-12","211002_UnitedStates_CohenChildrensMedicalCenter","Seroprevalence and Clinical Outcomes of SARS-CoV-2 in Paediatric Patients with Rheumatic Disease.","2021-10-02","Local","United States of America; New York; New York City","2020-05-01","2020-11-30","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",262.0,0.13,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Heather Walters","Cohen Children’s Medical Center,","https://dx.doi.org/10.1093/rheumatology/keab730","Unverified","","NR","","","","US","US-NY"
"2021-10-12","211004_Lombardy_UniversityOfPavia","SARS-CoV-2 Serology In Patients On Biological Therapy or Apremilast For Psoriasis: A Study of 93 Patients in the Italian Red Zone.","2021-10-04","Regional","Italy; Lombardy","2020-06-15","2021-05-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",93.0,0.13,"","","Unclear","IgG","Unclear","Journal Article (Peer-Reviewed)","Syed M A Ahmed","University Of Pavia","https://dx.doi.org/10.1111/jdv.17721","Unverified","","NR","","","","IT","IT-25"
"2021-10-12","211005_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall","Impact of SARS-CoV-2 on Progression of Glycemic and Cardiometabolic Variables and Changes in Insulin Indices: A Longitudinal Study.","2021-10-05","Local","India; Delhi; New Delhi","2020-01-01","2021-02-26","Household and community samples","Adults (18-64 years)",352.0,0.452,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Alpesh Goyal","All India Institute of Medical Sciences","https://dx.doi.org/10.1007/s13300-021-01158-z","Unverified","","NR",0.974,0.985,"","IN","IN-DL"
"2021-10-12","211006_Israel_IsraelInstituteforBiologicalResearch","A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.","2021-10-06","National","Israel","2020-04-24","2020-04-24","Household and community samples","Multiple groups",146.0,0.0,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Morly Fisher","Israel Institute for Biological Research","https://dx.doi.org/10.1128/Spectrum.00870-21","Verified","","NR",0.982,1.0,"","IL",""
"2021-10-13","210901_Potheri_SRMInstituteofScienceandTechnology_Group1_Overall","COVID-19 seroprevalence study in asymptomatic healthcare workers, at a tertiary healthcare centre, India","2021-09-01","Local","India; Tamil Nadu; Potheri","2021-01-15","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",82.0,0.098,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Bhuvanamha Ramamurthy","SRM Institute of Science and Technology","https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2021&volume=15&issue=9&page=EC29&issn=0973-709x&id=15422","Unverified","","NR","","","","IN","IN-TN"
"2021-10-13","210901_Potheri_SRMInstituteofScienceandTechnology_Group2_Overall","COVID-19 seroprevalence study in asymptomatic healthcare workers, at a tertiary healthcare centre, India","2021-09-01","Local","India; Tamil Nadu; Potheri","2021-01-15","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",46.0,0.13,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Bhuvanamha Ramamurthy","SRM Institute of Science and Technology","https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2021&volume=15&issue=9&page=EC29&issn=0973-709x&id=15422","Unverified","","NR","","","","IN","IN-TN"
"2021-10-13","210927_Karachi_AgaKhanUniversityandHospital_primary","Increasing IgG antibodies to SARS-CoV-2 in asymptomatic blood donors through the second COVID-19 wave in Karachi associated with exposure and immunity in the population","2021-09-27","Local","Pakistan","2020-12-15","2021-02-14","Blood donors","Multiple groups",558.0,0.534,"","","Convenience","IgG","High","Preprint","Muhammad Hasan","The Aga Khan University and Hospital","https://www.researchsquare.com/article/rs-941908/v1","Verified","","NR","","","","PK",""
"2021-10-13","211001_Colombia_MedicalMissionInstitute_Overall","Direct and indirect proof of sars-cov-2 infections in indigenous wiwa communities in north-eastern colombia-a cross-sectional assessment providing preliminary surveillance data","2021-10-01","Regional","Colombia; Department of Cesar, Department of La Guajira; San Juan, Sabana de Higuieron, Piñoncito, Ahuyamal, Surimena, Tezhumake, Valledupar, La Junta, Atanquez, Los Corazones, Patillal, Siminke and Vereda Platanal.","2021-03-28","2021-04-26","Household and community samples","Multiple groups",452.0,0.25,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Gustavo Concha","Medical Mission Institute","http://dx.doi.org/10.3390/vaccines9101120","Unverified","","NR","",1.0,"","CO",""
"2021-10-13","211001_Estonia_UniversityOfTartu_Stage20_Overall","The study on the prevalence of the coronavirus in Estonia","2021-12-13","National","Estonia","2021-09-15","2021-09-27","Household and community samples","Multiple groups",2302.0,0.767,0.749,0.784,"Stratified probability","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire","Unverified","","NR","","","","EE",""
"2021-10-13","211003_MinneapolisStPaul_UniversityofMinnesota_OverallTestAdjusted","SARS-CoV-2 Seroprevalence among Healthcare Workers","2021-10-03","Local","United States of America; Minnesota ; Minneapolis, Saint Paul","2020-12-18","2021-02-15","Health care workers and caregivers","Multiple groups",423.0,0.183,"","","Convenience","IgG","Moderate","Preprint","Talia Wiggen","University of Minnesota","https://www.medrxiv.org/content/10.1101/2021.10.02.21264468v1","Unverified","","NR",0.97,1.0,"","US","US-MN"
"2021-10-13","211006_Yaoundé_HopitalCentraldeYaounde_PopTestAdj_Overall","SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon.","2021-10-06","Local","Cameroon; Centre; Yaoundé","2020-10-14","2020-11-26","Household and community samples","Multiple groups",971.0,0.292,0.238,0.349,"Simplified probability","IgG","Low","Journal Article (Peer-Reviewed)","Kene Nwosu","Hopital Central de Yaounde","https://dx.doi.org/10.1038/s41467-021-25946-0","Verified","","NR",0.915,0.935,"","CM","CM-CE"
"2021-10-13","211007_Palestine_PalestinianNationalInstituteofPublicHealth_Gaza_Overall","Sero Prevalence of COVID-19 in Palestine in 2020","2021-10-07","Regional","occupied Palestinian territory - including east Jerusalem; Gaza; N/A","2020-12-01","2020-12-31","Household and community samples","Multiple groups",2904.0,0.4,"","","Stratified probability","IgG","Moderate","Preprint","I Rayan","Palestinian National Institute of Public Health","https://www.medrxiv.org/content/10.1101/2021.10.04.21263131v1","Verified","","NR",0.988,1.0,"","PS","PS-GZZ"
"2021-10-13","211007_Palestine_PalestinianNationalInstituteofPublicHealth_WestBank_Overall","Sero Prevalence of COVID-19 in Palestine in 2020","2021-10-07","Regional","occupied Palestinian territory - including east Jerusalem; West Bank; N/A","2020-12-01","2020-12-31","Household and community samples","Multiple groups",4356.0,0.38,"","","Stratified probability","IgG","Moderate","Preprint","I Rayan","Palestinian National Institute of Public Health","https://www.medrxiv.org/content/10.1101/2021.10.04.21263131v1","Verified","","NR",0.988,1.0,"","PS","PS-WBK"
"2021-10-14","201215_Stockholm_TheStockholmRegion","15 december: Lägesrapport om covid-19","2020-12-15","Local","Sweden","2020-12-07","2020-12-13","Household and community samples","Multiple groups",20466.0,0.39,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/15-december-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-14","201222_Stockholm_TheStockholmRegion","22 december: Lägesrapport om covid-19","2020-12-22","Local","Sweden","2020-12-14","2020-12-20","Household and community samples","Multiple groups",23466.0,0.381,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/22-december-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-14","201229_Stockholm_TheStockholmRegion","29 december: Lägesrapport om covid-19","2020-12-29","Local","Sweden","2020-12-21","2020-12-27","Household and community samples","Multiple groups",17624.0,0.378,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/29-december-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-14","210106_UnitedKingdom_OxfordUniversity","The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers","2021-01-06","National","United Kingdom of Great Britain and Northern Ireland","2020-04-23","2020-10-20","Health care workers and caregivers","Multiple groups",3217.0,0.16,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Sheila F Lumley","Oxford University","https://academic.oup.com/cid/article/73/3/e699/6064824","Unverified","","NR","","","","GB",""
"2021-10-14","210930_Oman_MinistryOfHealth_Cycle1_PrimaryEstimate","SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.","2021-09-30","National","Oman","2020-07-12","2020-07-23","Household and community samples","Multiple groups",4210.0,0.055,0.048,0.062,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Seif Al-Abri","Ministry of Health (Oman)","https://dx.doi.org/10.1016/j.ijid.2021.09.062","Verified","","NR","","","","OM",""
"2021-10-14","210930_Oman_MinistryOfHealth_Cycle2_PrimaryEstimate","SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.","2021-09-30","National","Oman","2020-08-16","2020-08-27","Household and community samples","Multiple groups",4403.0,0.097,0.085,0.11,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Seif Al-Abri","Ministry of Health (Oman)","https://dx.doi.org/10.1016/j.ijid.2021.09.062","Verified","","NR","","","","OM",""
"2021-10-14","210930_Oman_MinistryOfHealth_Cycle3_PrimaryEstimate","SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.","2021-09-30","National","Oman","2020-09-13","2020-09-24","Household and community samples","Multiple groups",4780.0,0.164,0.145,0.184,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Seif Al-Abri","Ministry of Health (Oman)","https://dx.doi.org/10.1016/j.ijid.2021.09.062","Verified","","NR","","","","OM",""
"2021-10-14","210930_Oman_MinistryOfHealth_Cycle4_PrimaryEstimate","SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys.","2021-09-30","National","Oman","2020-11-08","2020-11-19","Household and community samples","Multiple groups",4064.0,0.22,0.196,0.246,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Seif Al-Abri","Ministry of Health (Oman)","https://dx.doi.org/10.1016/j.ijid.2021.09.062","Verified","","NR","","","","OM",""
"2021-10-14","210930_Qatar_HamadMedicalCorporation_Primary","Prevalence and risk factors for SARS-CoV-2 infection and seroprevalence among clinical and non-clinical staff in a national healthcare system","2021-09-30","National","Qatar","2020-03-01","2020-10-31","Multiple populations","Multiple groups",12126.0,0.177,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Moza Alishaq","Hamad Medical Corporation","http://dx.doi.org/10.1371/journal.pone.0257845","Unverified","","NR","","","","QA",""
"2021-10-14","211002_NewYork_NorthShoreUniversityHospital_1stTrimester","Persistence of infection-induced SARS-CoV-2 seropositivity throughout gestation.","2021-10-02","Local","United States of America; New York","2020-05-15","2020-06-15","Pregnant or parturient women","Adults (18-64 years)",149.0,0.121,"","","Entire sample","IgG","High","Preprint","Cara Staszewski","North Shore University Hospital","https://dx.doi.org/10.1016/j.ajog.2021.09.037","Unverified","","NR","","","","US","US-NY"
"2021-10-14","211005_Munich_LMUMunich_TestAdjusted","SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort","2021-10-05","Local","Germany; Bavaria; Munich","2020-05-14","2020-09-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",509.0,0.013,0.005,0.024,"Convenience","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Katharina Eisenhut","LMU Munich","https://dx.doi.org/10.1007/s00415-021-10818-w","Unverified","","NR","","","","DE","DE-BY"
"2021-10-14","211006_Italy_IRCCSOrthopedicInstituteGaleazzi_IOG-CSS","Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign.","2021-10-06","National","Italy; Lombardy, Apulia; Milan, San Giovanni Rotondo","2021-01-04","2021-02-12","Health care workers and caregivers","Multiple groups",950.0,0.184,"","","Unclear","IgG","Moderate","Journal Article (Peer-Reviewed)","Davide Ferrari","IRCCS Orthopedic Institute Galeazzi","https://dx.doi.org/10.1515/cclm-2021-0364","Unverified","","NR",1.0,0.999,"","IT",""
"2021-10-14","211006_Italy_IRCCSOrthopedicInstituteGaleazzi_OSR","Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign.","2021-10-06","Local","Italy; Lombardy; Milan","2021-01-04","2021-02-12","Health care workers and caregivers","Multiple groups",3340.0,0.091,"","","Unclear","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Davide Ferrari","IRCCS Orthopedic Institute Galeazzi","https://dx.doi.org/10.1515/cclm-2021-0364","Unverified","","NR","","","","IT","IT-25"
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W29","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-07-18","2021-07-24","Household and community samples","Adults (18-64 years)",2.0,1.0,0.342,1.0,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W30","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-07-25","2021-07-31","Household and community samples","Adults (18-64 years)",11.0,0.818,0.523,0.949,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W31","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-08-01","2021-08-07","Household and community samples","Adults (18-64 years)",42.0,0.929,0.81,0.975,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W32","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-08-08","2021-08-14","Household and community samples","Adults (18-64 years)",25.0,0.84,0.654,0.936,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W33","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-08-15","2021-08-21","Household and community samples","Adults (18-64 years)",7.0,0.857,0.487,0.974,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W34","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-08-22","2021-08-28","Household and community samples","Adults (18-64 years)",8.0,0.75,0.409,0.928,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-10-14","211007_Finland_FinnishInstituteforHealthandWelfare_2021-W35","THL serological population study of the coronavirus epidemic","2021-10-07","National","Finland","2021-08-29","2021-09-04","Household and community samples","Adults (18-64 years)",1.0,0.0,0.0,0.794,"Simplified probability","IgG","High","Institutional Report","Finnish institute for health and welfare","Finnish Institute for Health and Welfare","https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html","Verified","","NR",1.0,1.0,"","FI",""
"2021-10-18","210105_Stockholm_TheStockholmRegion","5 januari: Lägesrapport om covid-19","2021-01-05","Local","Sweden","2020-12-28","2021-01-03","Household and community samples","Multiple groups",15061.0,0.424,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/5-januari-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-18","210112_Stockholm_TheStockholmRegion","12 januari: Lägesrapport om covid-19","2021-01-12","Local","Sweden","2021-01-04","2021-01-10","Household and community samples","Multiple groups",10378.0,0.428,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/12-januari-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-18","210119_Stockholm_TheStockholmRegion","19 januari: Lägesrapport om covid-19","2021-01-19","Local","Sweden","2021-01-11","2021-01-17","Household and community samples","Multiple groups",18544.0,0.453,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/19-januari-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-18","210126_Stockholm_TheStockholmRegion","26 januari: Lägesrapport om covid-19","2021-01-26","Local","Sweden","2021-01-18","2021-01-24","Household and community samples","Multiple groups",15498.0,0.444,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/26-januari-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-18","210202_Stockholm_TheStockholmRegion","2 februari: Lägesrapport om covid-19","2021-02-02","Local","Sweden","2021-01-25","2021-01-31","Household and community samples","Multiple groups",11749.0,0.457,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/2-februari-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-10-18","211012_NortheastPortugal_FernandoPessoaUniversity_Overall","Pre-vaccination immune response to COVID-19 in a population in Northeast Portugal.","2021-10-12","National","Portugal","2020-04-15","2021-02-15","Household and community samples","Multiple groups",358.0,0.304,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Mary Duro","Fernando Pessoa University","https://dx.doi.org/10.1007/s11845-021-02799-6","Verified","","NR","","","","PT",""
"2021-10-19","210917_Lakewood_JointBaseLewisMcChord_Overall","COVID-19 Antibody Prevalence From July to September 2020: One Army Infantry Brigade's Experience","2021-09-17","Local","United States of America; Washington; Lakewood","2020-06-15","2020-09-15","Essential non-healthcare workers","Adults (18-64 years)",264.0,0.004,"","","Unclear","Not reported","High","Journal Article (Peer-Reviewed)","Alex Koo","Joint Base Lewis McChord","https://pubmed.ncbi.nlm.nih.gov/34529807/","Unverified","","NR","","","","US","US-WA"
"2021-10-19","211001_NewYorkCity_NorthShoreUniversityHospital_Overall","THE CLINICAL IMPACT OF COVID-19 ON CYSTIC FIBROSIS PATIENTS IN NEW YORK","2021-10-01","Local","United States of America; New York; New York City","2020-03-01","2020-08-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",812.0,0.023,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Janice Wang","North Shore University Hospital","http://dx.doi.org/10.1016/j.chest.2021.07.1326","Unverified","","NR","","","","US","US-NY"
"2021-10-19","211006_Babahoyo_WayneStateUniversity","Seroprevalence of SARS-CoV-2 immunoglobulins in pregnant women and neonatal cord blood from a highly impacted region.","2021-10-06","Local","Ecuador; Los Ríos; Babahoyo","2020-09-03","2021-01-31","Pregnant or parturient women","Multiple groups",100.0,0.32,"","","Unclear","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Hector Zambrano","Wayne State University","https://dx.doi.org/10.1016/j.placenta.2021.10.001","Unverified","","NR","","","","EC","EC-R"
"2021-10-19","211008_NorthBrabant_RegionalPublicHealthServiceofWestBrabant_Overall","SARS-CoV-2 antibodies in employees working in non-medical contact-intensive professions in the Netherlands: baseline data from the prospective COco-study.","2021-10-08","Regional","Netherlands; North Brabant","2020-06-01","2020-07-14","Non-essential workers and unemployed persons","Multiple groups",497.0,0.113,"","","Convenience","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Dymphie Mioch","Regional Public Health Service of West-Brabant","https://dx.doi.org/10.1016/j.pmedr.2021.101594","Unverified","","NR",0.96,0.99,"","NL","NL-NB"
"2021-10-19","211008_Palestine_An-NajahNationalUniversity_Overall","Prevalence of SARS-CoV-2 antibodies in the Palestinian population: A primary health center-based cross-sectional study.","2021-10-08","Regional","occupied Palestinian territory - including east Jerusalem; West Bank","2020-11-01","2020-12-31","Residual sera","Multiple groups",1269.0,0.24,0.217,0.265,"Simplified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Beesan Maraqa","An-Najah National University","https://dx.doi.org/10.1371/journal.pone.0258255","Verified","","NR","","","","PS","PS-WBK"
"2021-10-19","211009_UnitedStates_AmericanRedCross_Overall_S1","Patterns of antibody response to SARS-CoV-2 among 1.6 million blood donors: Impact of vaccination, United States December 2020 - June 2021.","2021-10-09","National","United States of America","2020-06-15","2021-06-25","Blood donors","Multiple groups",1567446.0,0.601,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Roger Dodd","American Red Cross","https://dx.doi.org/10.1093/infdis/jiab514","Verified","","NR","","","","US",""
"2021-10-19","211011_Kerala_KeralaGovernment_Primary","82% adults in state have Covid-19 antibodies, says latest serosurvey in Kerala","2021-10-11","Regional","India; Kerala","2021-07-04","2021-08-07","Household and community samples","Multiple groups",13000.0,0.826,"","","Unclear","Not reported","Unclear","News and Media","Hindustan Times","Kerala Government","https://www.hindustantimes.com/india-news/82-adults-in-state-have-covid-19-antibodies-says-latest-serosurvey-in-kerala-101633964468707.html","Verified","","NR","","","","IN","IN-KL"
"2021-10-19","211011_NewYork_ChildrensHospitalAtMontefiore","COVID-19 infection in pediatric solid organ transplant patients.","2021-10-11","Local","United States of America; New York; New York","2020-04-15","2020-12-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",108.0,0.111,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Neha Bansal","Childrens Hospital at Montefiore","https://dx.doi.org/10.1111/petr.14156","Unverified","","NR","",1.0,"","US","US-NY"
"2021-10-19","211011_NorthRhineWestphalia_UniversityofDuisburgEssen_Overall","Discrepancy between frequent occurrence of COVID-19-like symptoms and low seroconversion rates among healthcare workers.","2021-10-11","Regional","Germany; North Rhine-Westphalia","2020-06-01","2020-07-31","Health care workers and caregivers","Multiple groups",861.0,0.008,"","","Unclear","IgG","Moderate","Journal Article (Peer-Reviewed)","Dorothea Dehnen","University of Duisburg-Essen","https://dx.doi.org/10.1002/jmv.27385","Unverified","","NR","","","","DE","DE-NW"
"2021-10-19","211011_SaitamaCity_JichiMedicalUniversity_cohort_HCW_primary","Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.","2021-10-11","Local","Japan; Saitama Prefecture; Saitama City","2020-05-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",116.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Hiroshi Hori","Jichi Medical University","https://dx.doi.org/10.1371/journal.pone.0257513","Unverified","","NR",1.0,0.998,"","JP","JP-11"
"2021-10-19","211011_SaitamaCity_JichiMedicalUniversity_crosssectional_HCW","Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.","2021-10-11","Local","Japan; Saitama Prefecture; Saitama City","2020-07-05","2020-07-19","Health care workers and caregivers","Adults (18-64 years)",607.0,0.002,0.0,0.011,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Hiroshi Hori","Jichi Medical University","https://dx.doi.org/10.1371/journal.pone.0257513","Unverified","","NR","","","","JP","JP-11"
"2021-10-19","211012_Colorado_UniversityofColorado_Followup_TestAdjusted","Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders.","2021-10-12","Regional","United States of America; Colorado","2020-05-15","2021-03-15","Essential non-healthcare workers","Adults (18-64 years)",783.0,0.2,"","","Convenience","IgG; IgA","Moderate","Journal Article (Peer-Reviewed)","Brian Montague","University of Colorado","https://dx.doi.org/10.1093/infdis/jiab524","Unverified","","NR","","","","US","US-CO"
"2021-10-19","211012_Ontario_TheHospitalforSickChildren_Primary","SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study.","2021-10-12","Regional","Canada; Ontario","2020-04-01","2020-11-13","Health care workers and caregivers","Adults (18-64 years)",1062.0,0.054,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Michelle Science","The Hospital for Sick Children","https://dx.doi.org/10.9778/cmajo.20210044","Unverified","","NR",0.9,0.98,"","CA","CA-ON"
"2021-10-20","210824_Ireland_UniversityofLimerick_HCW_TestAdjusted","SARS-CoV-2 infection in general practice in Ireland: a seroprevalence study","2021-08-24","Regional","Ireland; Midwest Region","2020-06-15","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",171.0,0.111,0.042,0.186,"Stratified non-probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Michael O'Callaghan","University of Limerick","http://dx.doi.org/10.3399/BJGPO.2021.0038","Verified","","NR",0.71,0.98,"","IE",""
"2021-10-20","210824_Ireland_UniversityofLimerick_Patients_TestAdjusted","SARS-CoV-2 infection in general practice in Ireland: a seroprevalence study","2021-08-24","Regional","Ireland; Midwest Region","2020-06-15","2020-07-10","Residual sera","Multiple groups",796.0,0.126,0.075,0.166,"Stratified non-probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Michael O'Callaghan","University of Limerick","http://dx.doi.org/10.3399/BJGPO.2021.0038","Verified","","NR",0.71,0.98,"","IE",""
"2021-10-20","210917_DenmarkCapitalRegion_UniversityofCopenhagen_Round3_Overall","Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers","2021-09-17","Regional","Denmark; Capital Region of Denmark","2020-09-30","2020-10-07","Health care workers and caregivers","Adults (18-64 years)",27457.0,0.074,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kasper Iversen","University of Copenhagen","http://dx.doi.org/10.1016/j.cmi.2021.09.005","Unverified","","NR",0.967,0.995,"","DK","DK-84"
"2021-10-20","210929_PointAPitre_UniversityHospitalofGuadeloupe","Seroprevalence of SARS-CoV-2 IgG antibodies among workers in the University Hospital of Guadeloupe.","2021-09-29","Local","Guadeloupe; Pointe-à-Pitre; Pointe-à-Pitre","2020-07-01","2020-10-28","Health care workers and caregivers","Adults (18-64 years)",892.0,0.05,0.036,0.065,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Vincenzo Palmeri","University Hospital of Guadeloupe","https://pubmed.ncbi.nlm.nih.gov/34625780/","Unverified","","NR","","","","GP",""
"2021-10-20","211001_Charleston_WestVirginiaUniversity_CEW","COVID-19: ESSENTIAL WORKERS AND THE RISKS WE FACE","2021-10-01","Local","United States of America; West Virginia; Charleston","2020-09-15","2020-12-15","Essential non-healthcare workers","Adults (18-64 years)",623.0,0.058,"","","Unclear","IgG","Unclear","Presentation or Conference","Syed Mahmood","West Virginia University","https://www.sciencedirect.com/science/article/pii/S0012369221020201","Unverified","","NR","","","","US","US-WV"
"2021-10-20","211001_Charleston_WestVirginiaUniversity_HCW","COVID-19: ESSENTIAL WORKERS AND THE RISKS WE FACE","2021-10-01","Local","United States of America; West Virginia; Charleston","2020-09-15","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",458.0,0.1,"","","Unclear","IgG","Unclear","Presentation or Conference","Syed Mahmood","West Virginia University","https://www.sciencedirect.com/science/article/pii/S0012369221020201","Unverified","","NR","","","","US","US-WV"
"2021-10-20","211011_SanSiro_ASSTFatebenefratelliSacco_primary","Differences in the prevalence of sars-cov-2 infection and access to care between italians and non-italians in a social-housing neighbourhood of milan, italy","2021-10-11","Local","Italy; Lombardy; Milan","2020-12-23","2021-02-19","Household and community samples","Multiple groups",2044.0,0.112,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Gabriele Pagani","ASST Fatebenefratelli Sacco","http://dx.doi.org/10.3390/ijerph182010621","Unverified","","NR","","","","IT","IT-25"
"2021-10-20","211012_Germany_UniversitätWürzburg_Overall","[Seroprevalence of COVID-19 and Psychosocial Effects in the General Population: Results of the STAAB-COVID-One Program].","2021-10-12","Local","Germany; Bavaria; Würzburg","2020-06-01","2020-10-31","Household and community samples","Multiple groups",3034.0,0.011,0.007,0.015,"Stratified non-probability","IgA; IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Felizitas Eichner","Universität Würzburg","https://dx.doi.org/10.1055/a-1630-7601","Verified","","NR","","","","DE","DE-BY"
"2021-10-20","211013_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report October 13, 2021 Report #12: July 2021 Survey Tracking Seroprevalence in the Vaccine Era","2021-10-13","National","Canada","2021-07-14","2021-07-23","Blood donors","Multiple groups",8457.0,0.947,0.942,0.952,"Sequential","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Verified","","",0.988,0.996,"","CA",""
"2021-10-20","211014_Milan_UniversitàdegliStudidiMilano_Primary","Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donors.","2021-10-14","Local","Italy","2020-07-01","2021-02-23","Blood donors","Multiple groups",10680.0,0.059,"","","Sequential","IgG; IgM","High","Journal Article (Peer-Reviewed)","Luca Valenti","Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano","https://dx.doi.org/10.1111/trf.16693","Verified","","NR","","","","IT",""
"2021-10-22","210801_SouthBronx_MountSinai_primary","Longitudinal analysis of severe acute respiratory syndrome coronavirus 2 seroprevalence using multiple serology platforms","2021-08-01","Local","United States of America; New York; New York City","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",501.0,0.284,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Juan Manuel Carreno","Icahn School of Medicine at Mount Sinai","https://www.cell.com/iscience/fulltext/S2589-0042(21)00905-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2589004221009056%3Fshowall%3Dtrue","Unverified","","NR",0.95,1.0,"","US","US-NY"
"2021-10-24","201223_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 23 Dec 2020","2020-12-23","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-10-26","2020-11-29","Blood donors","Multiple groups",2499.0,0.063,0.046,0.089,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-december-2020/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-10-24","201223_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 23 Dec 2020","2020-12-23","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-10-26","2020-11-29","Residual sera","Multiple groups",3638.0,0.068,0.057,0.077,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-december-2020/","Verified","","NR",0.875,0.986,"","GB","GB-SCT"
"2021-10-24","210602_Croatia_UniversityofZagreb","Seroprevalence of SARS-CoV-2 in Croatian solid-organ transplant recipients.","2021-06-02","Local","Croatia","2020-09-07","2020-11-27","Patients seeking care for non-COVID-19 reasons","Multiple groups",512.0,0.201,0.164,0.263,"Entire sample","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Mrzljak","University of Zagreb","https://dx.doi.org/10.11613/BM.2021.030901","Unverified","","NR","","","","HR",""
"2021-10-24","211014_Marseille_AixMarseilleUniversity","COVID-19 outbreak among French firefighters, Marseille, France, 2020.","2021-10-14","Local","France","2020-04-02","2020-04-06","Essential non-healthcare workers","Adults (18-64 years)",85.0,0.259,"","","Entire sample","Neutralizing","High","Journal Article (Peer-Reviewed)","Guillaume Durand","Aix Marseille University","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.41.2001676","Unverified","","NR","","","","FR",""
"2021-10-25","210827_Bhubaneswar_AllIndiaInstituteOfMedicalSciences_Primary","Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in a teaching hospital in Eastern India.","2021-08-27","Local","India; Odisha; Bhubaneswar","2020-08-01","2020-08-08","Health care workers and caregivers","Adults (18-64 years)",821.0,0.039,0.026,0.051,"Simplified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Mishra Baijayantimala","All India Institute of Medical Sciences (AIIMS)","https://dx.doi.org/10.4103/jfmpc.jfmpc_2486_20","Unverified","","NR",0.991,0.951,"","IN","IN-OR"
"2021-10-25","211013_Odisha_GovernmentofIndia_Primary","Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection.","2021-10-13","Regional","India; Odisha","2021-01-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",134.0,0.41,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Debaprasad Parai","Government of India","https://dx.doi.org/10.1016/j.tmaid.2021.102170","Unverified","","NR","","","","IN","IN-OR"
"2021-10-25","211015_Jerusalem_ShaareZedekMedicalCenter","COVID-19 in children and young adults with kidney disease: risk factors, clinical features and serological response.","2021-10-15","Local","Israel; Jerusalem District; Jerusalem","2020-12-01","2021-02-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",249.0,0.181,"","","Entire sample","IgG","Low","Journal Article (Peer-Reviewed)","Jenny Weinbrand-Goichberg","Shaare Zedek Medical Centre (SZMC)","https://dx.doi.org/10.1007/s40620-021-01171-2","Unverified","","NR","","","","IL","IL-JM"
"2021-10-25","211018_UnitedKingdom_QueenMaryUniversityofLondon_Overall","Determinants of Pre-Vaccination Antibody Responses to SARS-CoV-2: A Population-Based Longitudinal Study (COVIDENCE UK)","2021-10-18","National","United Kingdom of Great Britain and Northern Ireland","2020-11-06","2021-04-18","Household and community samples","Multiple groups",11130.0,0.152,"","","Convenience","Total Antibody","Moderate","Preprint","Mohammad Talaei","Queen Mary University of London","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3944582","Verified","","NR",0.986,0.983,"","GB",""
"2021-10-26","210127_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 Jan 2021","2021-01-27","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-11-30","2021-01-03","Blood donors","Multiple groups",2499.0,0.059,0.044,0.071,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210127_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 Jan 2021","2021-01-27","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-11-30","2021-01-03","Residual sera","Multiple groups",3485.0,0.096,0.084,0.108,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/","Verified","","NR",0.875,0.986,"","GB","GB-SCT"
"2021-10-26","210303_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 03 March 2021","2021-03-03","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-01-04","2021-02-07","Blood donors","Multiple groups",2497.0,0.152,0.134,0.176,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210303_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 03 March 2021","2021-03-03","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-01-04","2021-02-07","Residual sera","Multiple groups",3606.0,0.125,0.112,0.138,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/","Verified","","NR",0.875,0.986,"","GB","GB-SCT"
"2021-10-26","210407_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 07 April 2021","2021-04-07","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-02-08","2021-03-14","Blood donors","Multiple groups",2492.0,0.252,0.225,0.279,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210407_Scotland_PublicHealthScotland_PregnantWomen3_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 07 April 2021","2021-04-07","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-02-08","2021-03-14","Pregnant or parturient women","Adults (18-64 years)",3355.0,0.096,0.085,0.107,"Sequential","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/","Verified","","NR",0.923,1.0,"","GB","GB-SCT"
"2021-10-26","210407_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 07 April 2021","2021-04-07","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-02-08","2021-03-14","Residual sera","Multiple groups",3436.0,0.237,0.221,0.255,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/","Verified","","NR",0.875,0.986,"","GB","GB-SCT"
"2021-10-26","210512_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 12 May 2021","2021-05-12","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-03-15","2021-04-18","Blood donors","Multiple groups",2493.0,0.466,0.44,0.489,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210512_Scotland_PublicHealthScotland_PregnantWomen3_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 12 May 2021","2021-05-12","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-03-15","2021-04-18","Pregnant or parturient women","Adults (18-64 years)",3326.0,0.125,0.112,0.138,"Sequential","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/","Verified","","NR",0.923,1.0,"","GB","GB-SCT"
"2021-10-26","210512_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 12 May 2021","2021-05-12","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-04-12","2021-04-18","Residual sera","Multiple groups",708.0,0.438,0.402,0.474,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/","Verified","","NR",0.973,0.996,"","GB","GB-SCT"
"2021-10-26","210616_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 16 Jun 2021","2021-06-16","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-04-19","2021-05-23","Blood donors","Multiple groups",2494.0,0.663,0.638,0.684,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210616_Scotland_PublicHealthScotland_PregnantWomen3_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 16 Jun 2021","2021-06-16","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-04-19","2021-05-23","Pregnant or parturient women","Adults (18-64 years)",3333.0,0.108,0.097,0.12,"Sequential","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/","Verified","","NR",0.923,1.0,"","GB","GB-SCT"
"2021-10-26","210616_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 16 Jun 2021","2021-06-16","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-04-19","2021-05-23","Residual sera","Multiple groups",3589.0,0.486,0.47,0.503,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/","Verified","","NR",0.973,0.996,"","GB","GB-SCT"
"2021-10-26","210825_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 August 2021","2021-08-25","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-06-28","2021-08-01","Blood donors","Multiple groups",2493.0,0.995,0.984,1.0,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-10-26","210825_Scotland_PublicHealthScotland_PregnantWomen3_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 August 2021","2021-08-25","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-06-28","2021-08-01","Pregnant or parturient women","Adults (18-64 years)",2990.0,0.138,0.124,0.152,"Sequential","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/","Verified","","NR",0.923,1.0,"","GB","GB-SCT"
"2021-10-26","210825_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 August 2021","2021-08-25","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-06-28","2021-08-01","Residual sera","Multiple groups",3427.0,0.729,0.714,0.744,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/","Verified","","NR",0.973,0.996,"","GB","GB-SCT"
"2021-10-26","211001_Italy_UniversityofUrbino","Prevalence of sars-cov-2 infection in the workplace: results of a year of investigation in the marche nord companies","2021-10-01","Regional","Italy; Marche","2020-05-15","2021-04-15","Non-essential workers and unemployed persons","Adults (18-64 years)",10000.0,0.052,"","","Convenience","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Chiara Orlandi","University of Urbino","http://dx.doi.org/10.23750/abm.v92iS6.12238","Unverified","","NR","","","","IT","IT-57"
"2021-10-26","211013_Cuttack_SriramChandraBhanjaMedicalCollegeandHospital_Primary","SARS COV-2- IgG antibodies in blood donors in pandemic - a game changer for policy makers.","2021-10-13","Local","India; Odisha; ; Cuttack","2020-11-01","2021-01-31","Blood donors","Adults (18-64 years)",1032.0,0.359,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Smita Mahapatra","Sriram Chandra Bhanja Medical College and Hospital","https://dx.doi.org/10.1016/j.tracli.2021.10.004","Verified","","NR","","","","IN","IN-OR"
"2021-10-26","211018_WRNMMC_UniformedServicesUniversity","Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers","2021-10-18","Local","United States of America; Maryland; Bethesda","2021-02-01","2021-08-15","Health care workers and caregivers","Adults (18-64 years)",17.0,0.235,"","","Convenience","IgG","High","Preprint","Eric Laing","Uniformed Services University","https://www.medrxiv.org/content/10.1101/2021.10.16.21265087v1","Unverified","","NR",0.94,1.0,"","US","US-MD"
"2021-10-26","211020_Avon_UniversityOfBristol_G0_Overall","The Avon Longitudinal Study of Parents and Children - A resource for COVID-19 research: Antibody testing results, April ‚Äì June 2021","2021-10-20","Local","United Kingdom of Great Britain and Northern Ireland","2021-04-08","2021-06-28","Household and community samples","Adults (18-64 years)",2555.0,0.964,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Daniel Major-Smith","University of Bristol","https://wellcomeopenresearch.org/articles/6-283","Verified","","NR",0.988,1.0,"","GB",""
"2021-10-26","211020_Avon_UniversityOfBristol_G1_Overall","The Avon Longitudinal Study of Parents and Children - A resource for COVID-19 research: Antibody testing results, April ‚Äì June 2021","2021-10-20","Local","United Kingdom of Great Britain and Northern Ireland","2021-04-08","2021-06-28","Household and community samples","Adults (18-64 years)",1686.0,0.42,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Daniel Major-Smith","University of Bristol","https://wellcomeopenresearch.org/articles/6-283","Verified","","NR",0.988,1.0,"","GB",""
"2021-10-27","210930_Konya_NecmettinErbakanUniversityMeramFacultyofMedicine_Primary","COVID-19 seroprevalance in a university hospital health workers","2021-09-30","Local","Turkey","2020-06-01","2020-11-30","Health care workers and caregivers","Adults (18-64 years)",741.0,0.17,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Gokce Kader Arslan","Necmettin Erbakan University Meram Faculty of Medicine","http://dx.doi.org/10.5578/FLORA.20219706","Unverified","","NR","","","","TR",""
"2021-10-27","211012_Essen_EssenUniversityHospital_overall","[SARS-CoV-2 IgG seroprevalence in personnel of the extraclinical fight against the COVID-19 pandemic].","2021-10-12","Local","Germany","2020-05-28","2020-05-29","Essential non-healthcare workers","Adults (18-64 years)",729.0,0.008,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Bastian Brune","Essen University Hospital","https://dx.doi.org/10.1007/s10049-021-00948-z","Unverified","","NR","",0.958,"","DE",""
"2021-10-27","211018_UniversityofPorto_UniversityofPorto_Overall_TestAdj","The SARS-CoV-2 infection among students in the University of Porto: a cross-sectional study","2021-10-18","Local","Portugal; Norte; Porto","2020-09-24","2020-12-15","Students and Daycares","Multiple groups",6512.0,0.079,0.049,0.111,"Convenience","IgM; IgG","Moderate","Preprint","Paula Meireles","University of Porto","https://www.medrxiv.org/content/10.1101/2021.10.14.21264978v1","Unverified","","NR","","","","PT",""
"2021-10-28","211018_Porto_UniversidadedoPorto","Incidence of SARS-CoV-2 infection in a cohort of workers from the University of Porto","2021-10-18","Local","Portugal; Porto District; Porto","2020-11-27","2021-01-29","Non-essential workers and unemployed persons","Multiple groups",1891.0,0.107,"","","Self-referral","IgG; IgM","Moderate","Preprint","Joana Costa","Universidade do Porto","10.1101/2021.10.14.21264980","Unverified","","NR",0.945,0.957,"","PT","PT-13"
"2021-10-29","210127_Scotland_PublicHealthScotland_PregnantWomen3_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 Jan 2021","2021-01-27","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2020-11-30","2021-01-03","Pregnant or parturient women","Adults (18-64 years)",3052.0,0.058,0.05,0.068,"Sequential","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/","Verified","","NR",0.923,1.0,"","GB","GB-SCT"
"2021-10-29","210303_Scotland_PublicHealthScotland_PregnantWomen3_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 03 March 2021","2021-03-03","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-01-04","2021-02-07","Pregnant or parturient women","Adults (18-64 years)",3478.0,0.075,0.066,0.085,"Sequential","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/","Verified","","NR",0.923,1.0,"","GB","GB-SCT"
"2021-10-31","211013_SarajevoCanton_PublicHealthInstitute_Overall","Study of SARS-CoV-2 Seroprevalence in Canton Sarajevo","2021-10-13","Local","Bosnia and Herzegovina","2021-01-05","2021-03-20","Multiple populations","Multiple groups",3650.0,0.273,"","","Convenience","IgG","Moderate","Institutional Report","Anes Joguncic","Public Health Institute","","Unverified","Bosnia and Herzegovina","NR","","","","BA",""
"2021-11-01","211101_Thrace_UniversityGeneralHospitalOfAlexandroupolis_Primary","Prevalence of anti-SARS-CoV-2 IgG antibodies in a group of patients, a control group, and healthcare workers of thrace area in Greece, by the use of two distinct methods","2021-11-01","Regional","Greece; Thrace","2020-06-15","2020-07-15","Health care workers and caregivers","Adults (18-64 years)",1036.0,0.006,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Theocharis Konstantinidis","University General Hospital of Alexandroupolis","http://dx.doi.org/10.18683/germs.2021.1274","Unverified","","NR","","","","GR",""
"2021-11-02","210906_NashikCity_GovernmentMedicalCollege_NonSlums_Overall","Seroprevalence of COVID-19 in a City in India: A Community-based Cross-Sectional Study","2021-09-06","Local","India; Maharashtra ; Nashik","2021-01-09","2021-01-11","Household and community samples","Multiple groups",1629.0,0.381,0.358,0.405,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Bapusaheb Nagargoje","Government Medical College","https://www.jrmds.in/articles/seroprevalence-of-covid19-in-a-city-in-india-a-communitybased-crosssectional-study-83821.html","Verified","","NR","","","","IN","IN-MH"
"2021-11-02","210906_NashikCity_GovernmentMedicalCollege_Slums_Overall","Seroprevalence of COVID-19 in a City in India: A Community-based Cross-Sectional Study","2021-09-06","Local","India; Maharashtra ; Nashik","2021-01-09","2021-01-11","Household and community samples","Multiple groups",726.0,0.427,0.391,0.464,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Bapusaheb Nagargoje","Government Medical College","https://www.jrmds.in/articles/seroprevalence-of-covid19-in-a-city-in-india-a-communitybased-crosssectional-study-83821.html","Verified","","NR","","","","IN","IN-MH"
"2021-11-02","210915_Oman_ArmedForcesHospital_HCW_overall","Prevalence and persistence of SARS-CoV2 antibodies among healthcare workers in Oman.","2021-09-15","Local","Oman","2020-12-09","2020-12-24","Health care workers and caregivers","Adults (18-64 years)",1111.0,0.336,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Khalid Al-Naamani","Armed Forces Hospital","https://dx.doi.org/10.1016/j.jiph.2021.09.006","Unverified","","NR",0.988,1.0,"","OM",""
"2021-11-02","211001_Verona_IRCCSSacroCuoreDonCalabriaHospital_HCW_overall","A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.","2021-10-01","Local","Italy; Verona; Negrar di Valpolicella","2021-01-01","2021-01-31","Health care workers and caregivers","Adults (18-64 years)",2209.0,0.13,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Mirko Di Ruscio","IRCCS Sacro Cuore Don Calabria Hospital","https://dx.doi.org/10.3390/medicina57101048","Unverified","","NR","","","","IT","IT-34"
"2021-11-02","211001_Verona_IRCCSSacroCuoreDonCalabriaHospital_IBDpatients","A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.","2021-10-01","Local","Italy; Verona; Negrar di Valpolicella","2020-12-07","2021-01-31","Patients seeking care for non-COVID-19 reasons","Adults (18-64 years)",386.0,0.104,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Mirko Di Ruscio","IRCCS Sacro Cuore Don Calabria Hospital","https://dx.doi.org/10.3390/medicina57101048","Unverified","","NR","","","","IT","IT-34"
"2021-11-02","211004_Bavaria_UniversityofRegensburg_ELISA-ELECSYS-Neutralization","Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children","2021-10-04","Regional","Germany; Bavaria; Tirschenreuth, Regensburg city and county, and Oberbayern/ alpine region","2020-05-22","2020-07-22","Multiple general populations","Children and Youth (0-17 years)",2832.0,0.048,"","","Simplified probability","IgG; IgM; IgA; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Otto Laub","University of Regensburg","http://dx.doi.org/10.3389/fped.2021.678937","Verified","","NR","","","","DE","DE-BY"
"2021-11-02","211021_OrangeCounty_Children’sHospitalofOrangeCounty_Overall","SARS-CoV-2 Serology Testing in an Asymptomatic, At-Risk Population: Methods, Results, Pitfalls.","2021-10-21","Local","United States of America; California; NA","2020-05-14","2020-07-13","Health care workers and caregivers","Adults (18-64 years)",282.0,0.003,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Theodore Heyming","Children’s Hospital of Orange County","https://dx.doi.org/10.3390/idr13040082","Unverified","","NR","","","","US","US-CA"
"2021-11-02","211022_AlcaladeHenares_HospitalUniversitarioPríncipedeAsturias_primary","[SARS-CoV-2 seroprevalence among workers in a hospital in Madrid.].","2021-10-22","Local","Spain; Madrid; Alcala de Henares","2020-05-01","2020-07-31","Health care workers and caregivers","Adults (18-64 years)",1339.0,0.226,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Felipe Perez Garcia","Hospital Universitario Príncipede Asturias","https://pubmed.ncbi.nlm.nih.gov/34675168/","Unverified","","NR","","","","ES","ES-MD"
"2021-11-02","211022_Guilan_GuilanUniversityofMedical Sciences","High Seroprevalence of SARS-CoV-2 (COVID-19)-Specific Antibodies among Healthcare Workers: A Cross-Sectional Study in Guilan, Iran.","2021-10-22","Local","Iran (Islamic Republic of); Guilan; Rasht","2020-04-15","2020-05-15","Health care workers and caregivers","Multiple groups",503.0,0.39,0.348,0.433,"Simplified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Heydar Balou","Guilan University of Medical Sciences","https://dx.doi.org/10.1155/2021/9081491","Unverified","","NR",0.941,"","","IR","IR-19"
"2021-11-02","211025_Baden-Württemberg_HeidelbergUniversityHospital_overall","Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May-August 2020.","2021-10-25","Regional","Germany; Baden-Württemberg; Alb-Donau, Breisgau-Hochschwarzwald, Heidelberg/Rhein-Neckar, Karlsruhe, Mannheim, Neckar-Odenwald, Reutlingen, and Tübingen","2020-05-11","2020-08-01","Contacts of COVID patients","Multiple groups",1220.0,0.328,"","","Convenience","IgG; IgM; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Maximilian Stich","Heidelberg University Hospital","https://wwwnc.cdc.gov/eid/article/27/12/21-0978_article","Unverified","","NR","","","","DE","DE-BW"
"2021-11-02","211025_Ynysmaerdy _CardiffUniversity","A cluster of children with facial nerve palsy in a high prevalence area for COVID-19.","2021-10-25","Local","United Kingdom of Great Britain and Northern Ireland; South Wales;  Ynysmaerdy","2020-06-15","2020-10-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",5.0,0.0,"","","Entire sample","Not reported","High","Journal Article (Peer-Reviewed)","David Barron","Cardiff University","https://dx.doi.org/10.1186/s12887-021-02831-9","Verified","","NR","","","","GB",""
"2021-11-02","211026_Iran_NeyshaburUniversityofMedicalSciences_Overall","Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after one year of the COVID-19 Pandemic.","2021-10-26","National","Iran (Islamic Republic of); Razavi Khorasan Province, Mazandaran Province; Neyshabur, Sabzevar, Babol","2021-04-01","2021-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",270.0,0.293,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Seyed Alireza Javadinia","Neyshabur University of Medical Sciences","https://dx.doi.org/10.1080/07357907.2021.1995742","Unverified","","NR",0.941,0.983,"","IR",""
"2021-11-03","210721_Scotland_PublicHealthScotland_BloodDonors2_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 21 July 2021","2021-07-21","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-05-24","2021-06-27","Blood donors","Multiple groups",2494.0,0.818,0.798,0.84,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-11-03","210721_Scotland_PublicHealthScotland_PregnantWomen3_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 21 July 2021","2021-07-21","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-05-24","2021-06-27","Pregnant or parturient women","Adults (18-64 years)",3052.0,0.121,0.108,0.135,"Sequential","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/","Verified","","NR",0.923,1.0,"","GB","GB-SCT"
"2021-11-03","210721_Scotland_PublicHealthScotland_ResidualSera1_overall_adj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 21 July 2021","2021-07-21","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-05-24","2021-06-27","Residual sera","Multiple groups",3554.0,0.614,0.597,0.629,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/","Verified","","NR",0.973,0.996,"","GB","GB-SCT"
"2021-11-03","210804_Italy_UniversityofCampania_Primary","Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic.","2021-08-04","Regional","Italy; Campania (Southern Italy)","2020-04-21","2020-06-10","Blood donors","Multiple groups",1808.0,0.008,"","","Sequential","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Federica Calo","University of Campania","https://dx.doi.org/10.2450/2021.0196-21","Verified","","NR",0.945,1.0,"","IT",""
"2021-11-03","211019_Paris_HopitalEuropeenGeorgesPompidou_Primary","No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris.","2021-10-19","Local","France","2020-03-05","2020-12-04","Health care workers and caregivers","Adults (18-64 years)",3186.0,0.121,0.11,0.133,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Maxime Wack","Hopital Europeen Georges Pompidou","https://dx.doi.org/10.1016/j.jcv.2021.104999","Unverified","","NR","","","","FR",""
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase1","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2020-06-29","2020-07-02","Household and community samples","Multiple groups",2481.0,0.097,0.079,0.118,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase10","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2021-02-02","2021-02-04","Household and community samples","Multiple groups",1742.0,0.16,0.131,0.193,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase11","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2021-02-16","2021-02-18","Household and community samples","Multiple groups",1780.0,0.25,0.217,0.287,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR","","","","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase2","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2020-07-13","2020-07-16","Household and community samples","Multiple groups",2323.0,0.111,0.096,0.129,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase3","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2020-07-28","2020-07-30","Household and community samples","Multiple groups",2529.0,0.109,0.092,0.129,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase4","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2020-08-11","2020-08-13","Household and community samples","Multiple groups",2447.0,0.11,0.09,0.133,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase5","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2020-08-25","2020-08-27","Household and community samples","Multiple groups",2225.0,0.139,0.118,0.162,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase6","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2020-09-08","2020-09-10","Household and community samples","Multiple groups",2125.0,0.119,0.1,0.141,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase7","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2020-09-22","2020-09-24","Household and community samples","Multiple groups",2012.0,0.136,0.116,0.158,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase8","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2021-01-05","2021-01-07","Household and community samples","Multiple groups",1908.0,0.141,0.117,0.168,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase9","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2021-01-19","2021-01-21","Household and community samples","Multiple groups",1795.0,0.139,0.117,0.164,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Pilot","Prevalence evolution of SARS-CoV-2 infection in the city of Sao Paulo, 2020-2021.","2021-10-22","Regional","Brazil; Greater São Paulo","2020-06-10","2020-06-17","Household and community samples","Multiple groups",2645.0,0.095,0.079,0.114,"Stratified probability","IgM; IgG","Low","Journal Article (Peer-Reviewed)","José Albuquerque","Secretaria Municipal de Saude de Sao Paulo","https://dx.doi.org/10.11606/s1518-8787.2021055003970","Unverified","","NR",0.848,0.99,"","BR","BR-SP"
"2021-11-03","211023_Sweden_KarolinskaInstitutet_Overall","SARS-CoV-2 specific B- and T-cell immunity in a population-based study of young Swedish adults.","2021-10-23","National","Sweden","2020-10-06","2021-06-23","Household and community samples","Adults (18-64 years)",977.0,0.284,"","","Convenience","IgA; IgM; IgG","High","Journal Article (Peer-Reviewed)","Sophia Bjorkander","Karolinska Institutet","https://www.sciencedirect.com/science/article/pii/S0091674921016262","Unverified","","NR","","","","SE",""
"2021-11-03","211025_Estonia_UniversityOfTartu_Stage21_Overall","The study on the prevalence of the coronavirus in Estonia","2021-12-13","National","Estonia","2021-10-13","2021-10-25","Household and community samples","Multiple groups",2312.0,0.764,0.743,0.784,"Stratified probability","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire","Unverified","","NR","","","","EE",""
"2021-11-03","211026_Betim_EscoladeSaúdePúblicadeBetim_Survey1","Seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the SARS-CoV-2 pandemic in Betim, Brazil","2021-10-26","Local","Brazil; Minas Gerais; Betim","2020-06-03","2020-06-05","Household and community samples","Multiple groups",1079.0,0.003,"","","Stratified probability","IgG; IgM","Moderate","Preprint","Ana Silva","Escola de Saúde Pública de Betim","https://www.medrxiv.org/content/10.1101/2021.10.21.21265140v1.full-text","Verified","","NR",0.864,0.996,"","BR","BR-MG"
"2021-11-03","211026_Betim_EscoladeSaúdePúblicadeBetim_Survey2","Seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the SARS-CoV-2 pandemic in Betim, Brazil","2021-10-26","Local","Brazil; Minas Gerais; Betim","2020-06-23","2020-06-25","Household and community samples","Multiple groups",1080.0,0.007,"","","Stratified probability","IgG; IgM","Moderate","Preprint","Ana Silva","Escola de Saúde Pública de Betim","https://www.medrxiv.org/content/10.1101/2021.10.21.21265140v1.full-text","Verified","","NR",0.864,0.996,"","BR","BR-MG"
"2021-11-03","211026_Betim_EscoladeSaúdePúblicadeBetim_Survey3","Seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the SARS-CoV-2 pandemic in Betim, Brazil","2021-10-26","Local","Brazil; Minas Gerais; Betim","2020-07-13","2020-07-15","Household and community samples","Multiple groups",1080.0,0.026,"","","Stratified probability","IgG; IgM","Moderate","Preprint","Ana Silva","Escola de Saúde Pública de Betim","https://www.medrxiv.org/content/10.1101/2021.10.21.21265140v1.full-text","Verified","","NR",0.864,0.996,"","BR","BR-MG"
"2021-11-03","211026_France_UniversitéParisSaclay_May(Round1)_Primary","Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort â€“ EPICOV","2021-10-26","National","France","2020-05-01","2020-05-31","Household and community samples","Multiple groups",12114.0,0.045,0.04,0.051,"Simplified probability","IgG","Low","Preprint","Josiane Warszawski","Université Paris-Saclay","https://www.medrxiv.org/content/10.1101/2021.10.25.21265456v1.full-text","Verified","","NR",0.944,"","","FR",""
"2021-11-03","211026_France_UniversitéParisSaclay_November(Round2)_Primary","Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort â€“ EPICOV","2021-10-26","National","France","2020-11-01","2020-11-30","Household and community samples","Multiple groups",63524.0,0.062,0.059,0.066,"Simplified probability","IgG","Low","Preprint","Josiane Warszawski","Université Paris-Saclay","https://www.medrxiv.org/content/10.1101/2021.10.25.21265456v1.full-text","Verified","","NR",0.944,"","","FR",""
"2021-11-03","211026_Tyrol_TirolKlinikenGmbH_Abbott_Primary","Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020.","2021-10-26","Regional","Austria; Tyrol","2020-06-08","2020-09-04","Blood donors","Multiple groups",5345.0,0.031,0.026,0.036,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Anita Siller","Tirol Kliniken GmbH","https://dx.doi.org/10.1007/s00508-021-01963-3","Unverified","","NR",1.0,0.996,"","AT","AT-7"
"2021-11-04","2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week21-22","Påvisning av antikroppar mot SARS-CoV-2 hos blodgivare","2021-10-28","National","Sweden","2021-05-24","2021-06-04","Blood donors","Multiple groups",3009.0,0.519,0.495,0.544,"Self-referral","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf","Unverified","","NR","","","","SE",""
"2021-11-04","2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week38-39","Påvisning av antikroppar mot SARS-CoV-2 hos blodgivare","2021-10-28","National","Sweden","2021-09-20","2021-10-03","Blood donors","Multiple groups",402.0,0.968,0.945,0.985,"Self-referral","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf","Unverified","","NR","","","","SE",""
"2021-11-04","2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week9-10","Påvisning av antikroppar mot SARS-CoV-2 hos blodgivare","2021-10-28","National","Sweden","2021-03-01","2021-03-12","Blood donors","Multiple groups",3067.0,0.224,0.203,0.245,"Self-referral","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Sweden Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf","Unverified","","NR","","","","SE",""
"2021-11-04","2101028_Sweden_SwedishPublicHealthAgency_Outpatients_Week38-39_Primary","Påvisning av antikroppar mot SARS-CoV-2 i blodprov från öppenvården","2021-10-28","National","Sweden","2021-09-20","2021-10-03","Residual sera","Multiple groups",2959.0,0.756,0.738,0.773,"Convenience","Not reported","Moderate","Institutional Report","Swedish Public Health Agency","Swedish Public Health Agency","https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-mot-sars-cov-2-blodprov-oppenvarden.pdf","Verified","","NR",0.989,0.994,"","SE",""
"2021-11-04","210826_Nairobi_KenyaMedicalResearchInstitute_Overall_PopAdjusted","Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi","2021-08-26","Local","Kenya","2020-11-27","2020-12-05","Household and community samples","Multiple groups",511.0,0.433,0.374,0.495,"Stratified probability","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Patrick Munywoki","Kenya Medical Research Institute","https://f1000research.com/articles/10-853","Unverified","","NR",0.944,1.0,"","KE",""
"2021-11-04","210927_Turkey_HacettepeUniversity_Primary","SARS-CoV-2 seropositivity among pediatric health care personnel just after the first peak of pandemic: A nationwide surveillance","2021-09-27","National","Turkey; Middle Anatolia region; Marmara region; Aegean region; East Anatolia region; South-east Anatolian region; Black Sea region; Mediterranean region","2020-05-25","2020-06-10","Health care workers and caregivers","Adults (18-64 years)",4927.0,0.061,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Pembe Derin Oygar","Hacettepe University","http://dx.doi.org/10.1016/j.ijid.2021.09.054","Unverified","","NR","","","","TR",""
"2021-11-04","211018_Venlo_VieCuriMedicalCentre_Overall","SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: A cross-sectional study","2021-10-18","Local","Netherlands; Limburg; Venlo","2020-06-22","2020-07-03","Health care workers and caregivers","Multiple groups",2507.0,0.211,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Maud Bouwman","VieCuri Medical Centre","http://dx.doi.org/10.1136/bmjopen-2021-051573","Unverified","","NR",0.975,0.996,"","NL","NL-LI"
"2021-11-04","211020_NewDelhi_ SirGangaRamHospital_Overall","A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.","2021-10-20","Local","India","2020-09-18","2020-09-24","Health care workers and caregivers","Multiple groups",1033.0,0.258,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Chand Wattal","Sir Ganga Ram Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.09.011","Unverified","","NR","","","","IN",""
"2021-11-04","211021_Spain_AlcalaUniversity_Students_Overall","High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcala, Spain: Contributing Factors.","2021-10-21","Regional","Spain; Community of Madrid, Community of Castilla-La Mancha; Madrid, Guadalajara","2020-06-08","2020-06-16","Students and Daycares","Adults (18-64 years)",507.0,0.172,"","","Stratified probability","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Ramon Perez-Tanoira","Alcala University","https://dx.doi.org/10.2147/IJGM.S332803","Unverified","","NR","","","","ES",""
"2021-11-04","211022_Switzerland_CantonalHospitalStGallen","Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection â€“ results of a prospective multicenter cohort","2021-10-22","National","Switzerland","2021-01-15","2021-02-15","Health care workers and caregivers","Multiple groups",3334.0,0.203,"","","Convenience","Total Antibody","Moderate","Preprint","Carol Strahm","Cantonal Hospital St Gallen","https://www.medrxiv.org/content/10.1101/2021.10.19.21265187v1.full-text","Unverified","","NR",0.88,0.99,"","CH",""
"2021-11-04","211023_Peru_GermanCentreforInfectionResearch_CLIAandNeutralization","High SARS-CoV-2 seroprevalence in rural Peru, 2021; a cross-sectional population-based study","2021-10-23","Regional","Peru; San Martin","2021-03-01","2021-03-31","Household and community samples","Multiple groups",563.0,0.59,0.55,0.63,"Simplified probability","IgG; Neutralizing","Moderate","Preprint","Andres Moreira-Soto","German Centre for Infection Research","https://www.medrxiv.org/content/10.1101/2021.10.19.21265219v1.full-text","Verified","","NR","","","","PE","PE-SAM"
"2021-11-04","211025_Germany_RuhrUniversityBochum_Overall","Seroconversion rate and socioeconomic and ethnic risk factors for SARS-CoV-2 infection in children in a population-based cohort","2021-10-25","Regional","Germany; Western Germany","2020-06-15","2021-02-15","Residual sera","Children and Youth (0-17 years)",2124.0,0.027,"","","Sequential","IgG; IgM","Moderate","Preprint","Folke Brinkmann","Ruhr University Bochum","https://www.medrxiv.org/content/10.1101/2021.10.21.21265322v1.full-text","Verified","","NR","","","","DE",""
"2021-11-04","211026_NewYorkCity_MountSinaiHealthSystem_Phase2_Overall_Spike","Longitudinal humoral antibody response to SARS-CoV-2 infection among healthcare workers in a New York City hospital.","2021-10-26","Local","United States of America; New York; New York","2020-08-15","2020-09-15","Health care workers and caregivers","Adults (18-64 years)",176.0,0.386,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Vidya Menon","Mount Sinai Health System","https://dx.doi.org/10.1136/bmjopen-2021-051045","Unverified","","NR",0.94,1.0,"","US","US-NY"
"2021-11-04","211101_Ethiopia_UniversityofMunich_AddisAbaba_AddisKetema","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","Ethiopia","2021-04-08","2021-04-10","Household and community samples","Multiple groups",176.0,0.727,0.659,0.791,"Convenience","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Unverified","","NR",1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_AddisAbaba_Yeka","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","Ethiopia","2021-04-01","2021-04-03","Household and community samples","Multiple groups",188.0,0.548,0.477,0.619,"Convenience","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Unverified","","NR",1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_HCW_AddisAbaba","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","Ethiopia","2021-01-19","2021-03-12","Health care workers and caregivers","Adults (18-64 years)",121.0,0.537,0.448,0.625,"Unclear","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Unverified","","NR",1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_HCW_Jimma","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","Ethiopia","2021-01-05","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",372.0,0.561,0.511,0.611,"Unclear","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Unverified","","NR",1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_JimmaRural","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","Ethiopia","2021-02-04","2021-03-16","Household and community samples","Multiple groups",100.0,0.31,0.223,0.403,"Convenience","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Unverified","","NR",1.0,0.998,"","ET",""
"2021-11-04","211101_Ethiopia_UniversityofMunich_JimmaUrban","Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities.","2021-11-01","Local","Ethiopia","2021-02-02","2021-03-15","Household and community samples","Multiple groups",166.0,0.452,0.377,0.527,"Convenience","Not reported","Moderate","Journal Article (Peer-Reviewed)","Esayas Gudina","University of Munich","https://dx.doi.org/10.1016/S2214-109X(21)00386-7","Unverified","","NR",1.0,0.998,"","ET",""
"2021-11-05","211014_Delhi_InstituteofLiverandBiliarySciences_Primary","SARS-Coronavirus-2 seroprevalence in asymptomatic healthy blood donors: Indicator of community spread.","2021-10-14","Local","India","2020-09-24","2020-10-31","Blood donors","Adults (18-64 years)",1066.0,0.276,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Pratibha Kale","Institute of Liver and Biliary Sciences","https://dx.doi.org/10.1016/j.transci.2021.103293","Verified","","NR","","","","IN",""
"2021-11-05","211022_Belgium_UniversitéLibreDeBruxelles","SARS-CoV-2 seroprevalence in children and their family members, July-October 2020, Brussels.","2021-10-22","National","Belgium","2020-07-01","2020-10-31","Students and Daycares","Children and Youth (0-17 years)",112.0,0.125,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Lorraine Dethioux","Université Libre de Bruxelles","https://dx.doi.org/10.1007/s00431-021-04284-9","Unverified","","NR","","","","BE",""
"2021-11-05","211101_Manaus_UniversidadeFederaldoAmazona_Primary","High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.","2021-11-01","Local","Brazil; Amazonas; Manaus","2020-08-20","2020-11-20","Household and community samples","Multiple groups",1631.0,0.131,0.115,0.148,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Pritesh Lalwani","Universidade Federal do Amazonas","https://dx.doi.org/10.1016/S2214-109X(21)00355-7","Verified","","NR",0.943,0.97,"","BR","BR-AM"
"2021-11-08","201027_Vermont_UniversityOfVermont_Staff_Primary","SARS CoV-2 seroprevalence in a US school district during COVID-19.","2021-10-27","Local","United States of America; Vermont","2020-12-02","2020-12-19","Students and Daycares","Adults (18-64 years)",336.0,0.046,0.025,0.077,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Sean S M Bullis","University of Vermont","https://dx.doi.org/10.1136/bmjpo-2021-001259","Unverified","","NR",0.95,0.99,"","US","US-VT"
"2021-11-08","201027_Vermont_UniversityOfVermont_Student_Primary","SARS CoV-2 seroprevalence in a US school district during COVID-19.","2021-10-27","Local","United States of America; Vermont","2020-12-02","2020-12-19","Students and Daycares","Children and Youth (0-17 years)",196.0,0.049,0.02,0.093,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Sean S M Bullis","University of Vermont","https://dx.doi.org/10.1136/bmjpo-2021-001259","Unverified","","NR",0.95,0.99,"","US","US-VT"
"2021-11-08","211021_Spain_AlcalaUniversity_AdminStaff_Overall","High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcala, Spain: Contributing Factors.","2021-10-21","Regional","Spain; Community of Madrid, Community of Castilla-La Mancha; Madrid, Guadalajara","2020-06-08","2020-06-16","Essential non-healthcare workers","Multiple groups",66.0,0.136,"","","Stratified probability","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Ramon Perez-Tanoira","Alcala University","https://dx.doi.org/10.2147/IJGM.S332803","Unverified","","NR","","","","ES",""
"2021-11-08","211021_Spain_AlcalaUniversity_TeachingStaff_Overall","High Seroprevalence Against SARS-CoV-2 Among Faculty of Medicine and Health Sciences Personnel and Students of the University of Alcala, Spain: Contributing Factors.","2021-10-21","Regional","Spain; Community of Madrid, Community of Castilla-La Mancha; Madrid, Guadalajara","2020-06-08","2020-06-16","Essential non-healthcare workers","Multiple groups",132.0,0.258,"","","Stratified probability","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Ramon Perez-Tanoira","Alcala University","https://dx.doi.org/10.2147/IJGM.S332803","Unverified","","NR","","","","ES",""
"2021-11-08","211103_NewYorkCity_NewYorkCityHealthandHospitals_Overall","Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York.","2021-11-03","Local","United States of America; New York ; New York","2020-04-30","2020-06-30","Health care workers and caregivers","Multiple groups",727.0,0.294,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Alexander Bryan","New York City Health and hospitals","https://dx.doi.org/10.1136/bmjopen-2021-053158","Unverified","","NR","","","","US","US-NY"
"2021-11-09","210917_Senegal_InstitutPasteurdeDakar_Overall_PopandTestAdj","Seroprevalence of Anti-SARS-CoV-2 Antibodies in Senegal: A National Population-Based Cross-Sectional Survey, between October and November 2020","2021-09-17","National","Senegal","2020-10-25","2020-11-26","Household and community samples","Multiple groups",1422.0,0.284,0.261,0.308,"Stratified probability","Total Antibody","Low","Preprint","Cheikh Talla","Institut Pasteur de Dakar","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3925475","Verified","","NR","","","","SN",""
"2021-11-09","211002_Madrid_HospitalLaPaz_Overall","Serum prevalence of SARS-COv2 antibodies in patients with inflammatory bowel disease before vaccination","2021-10-02","Local","Spain; Community of Madrid; Madrid","2021-02-26","2021-03-26","Patients seeking care for non-COVID-19 reasons","Multiple groups",338.0,0.186,"","","Convenience","IgG","High","Presentation or Conference","M. Hernandez Perez","Hospital La Paz","http://dx.doi.org/10.1002/ueg2.12144","Unverified","","NR","","","","ES","ES-MD"
"2021-11-09","211015_JordanUniversityOfScienceAndTechnology_Primary","Prevalence of COVID-19 among blood donors: The Jordan University of Science and Technology experience.","2021-10-15","Local","Jordan","2020-09-15","2021-01-15","Blood donors","Adults (18-64 years)",1000.0,0.145,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Ziad Elnasser","Jordan University of Science and Technology","https://dx.doi.org/10.1097/MD.0000000000027537","Verified","","NR","","","","JO",""
"2021-11-09","211019_Qatar_PrimaryHealthCareCorporation_Timepoint1","Antibody Response to SARS-CoV-2: A Cohort Study in Qatar's Primary Care Settings","2021-10-19","National","Qatar","2020-07-01","2020-07-31","Household and community samples","Multiple groups",943.0,0.12,"","","Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","Mohamed Syed","Primary Health Care Corporation (PHCC)","https://journals.sagepub.com/doi/full/10.1177/21501327211050569","Verified","","NR","","","","QA",""
"2021-11-09","211019_Qatar_PrimaryHealthCareCorporation_Timepoint2","Antibody Response to SARS-CoV-2: A Cohort Study in Qatar's Primary Care Settings","2021-10-19","National","Qatar","2020-10-01","2020-10-31","Household and community samples","Multiple groups",943.0,0.172,"","","Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","Mohamed Syed","Primary Health Care Corporation (PHCC)","https://journals.sagepub.com/doi/full/10.1177/21501327211050569","Verified","","NR","","","","QA",""
"2021-11-09","211023_Harare_BiomedicalResearchandTrainingInstituteHarare_February2021_Overall","Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe.","2021-10-23","Local","Zimbabwe; Harare; Harare","2021-02-10","2021-04-17","Household and community samples","Multiple groups",1530.0,0.53,0.496,0.564,"Simplified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Arun Fryatt","Biomedical Research and Training Institute","https://dx.doi.org/10.1016/j.eclinm.2021.101172","Verified","","NR",0.992,0.986,"","ZW","ZW-HA"
"2021-11-09","211023_Harare_BiomedicalResearchandTrainingInstituteHarare_November2020_Overall","Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe.","2021-10-23","Local","Zimbabwe; Harare; Harare","2020-11-20","2020-12-20","Household and community samples","Multiple groups",620.0,0.19,0.151,0.235,"Simplified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Arun Fryatt","Biomedical Research and Training Institute","https://dx.doi.org/10.1016/j.eclinm.2021.101172","Verified","","NR",0.992,0.986,"","ZW","ZW-HA"
"2021-11-09","211027_Amazon_UniversidaddeCórdoba_Primary","High prevalence of SARS-CoV-2 in an indigenous community of the Colombian amazon region","2021-10-27","Local","Colombia; Columbian Amazon; Mitú","2020-12-01","2020-12-31","Household and community samples","Multiple groups",589.0,0.576,"","","Unclear","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Hector Serrano-Coll","Universidad de Córdoba","http://dx.doi.org/10.3390/tropicalmed6040191","Unverified","","NR",0.901,0.992,"","CO",""
"2021-11-09","211028_UniversityHospitalofTrieste_University of Trieste","Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers' serum for COVID-19 screening.","2021-10-28","Local","Italy; Northeast Italy; Trieste","2020-05-15","2020-09-15","Health care workers and caregivers","Adults (18-64 years)",389.0,0.347,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Francesca Filon","University of Trieste","https://dx.doi.org/10.23749/mdl.v112i5.11798","Unverified","","NR","","","","IT",""
"2021-11-09","211029_Delhi_MaulanaAzadMedicalCollege","Covid antibodies found in 97% of Delhi residents","2021-10-29","Local","India","2020-09-24","2021-10-09","Household and community samples","Multiple groups",28000.0,0.97,"","","Stratified probability","Not reported","Moderate","News and Media","The Times of India","Maulana Azad Medical College","https://timesofindia.indiatimes.com/city/delhi/covid-antibodies-found-in-97-of-delhi-residents/articleshow/87350053.cms","Unverified","","NR","","","","IN",""
"2021-11-09","211030_Massachusetts_UniversityofMassachusetts","Trends in SARS-CoV-2 seroprevalence in Massachusetts estimated from newborn screening specimens","2021-10-30","Regional","United States of America; Massachusetts","2019-11-15","2020-12-15","Perinatal","Children and Youth (0-17 years)",72117.0,0.018,"","","Convenience","IgG","Unclear","Preprint","Kevin Ma","University of Massachusetts","https://www.medrxiv.org/content/10.1101/2021.10.29.21265678v1.full-text","Unverified","","NR","","","","US","US-MA"
"2021-11-09","211101_Riyadh_PrinceSultanMilitaryMedicalCity_Primary","SARS-CoV-2 seroprevalence among healthcare workers from a tertiary care center in Riyadh, Saudi Arabia.","2021-11-01","Local","Saudi Arabia","2020-07-15","2020-08-15","Health care workers and caregivers","Adults (18-64 years)",188.0,0.032,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Abeer M. Albaadani","Prince Sultan Military Medical City","https://dx.doi.org/10.15537/smj.2021.42.11.20210391","Unverified","","NR","","","","SA",""
"2021-11-10","210804_Cambridge_RoyalPapworthHospitalNHSTrust_HCW","Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19.","2021-08-04","Local","United Kingdom of Great Britain and Northern Ireland; England; Cambridge","2020-04-20","2020-06-10","Health care workers and caregivers","Adults (18-64 years)",498.0,0.14,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Helen Baxendale","Cambridge University Hospitals NHS Foundation Trust","https://dx.doi.org/10.2478/jccm-2021-0018","Unverified","","NR",0.97,1.0,"","GB","GB-ENG"
"2021-11-10","210811_England_OfficeForNationalStatistics_Round6_StudentsPrimary3_PopAdj_TestAdj","COVID-19 Schools Infection Survey, England: Round 6, June 2021","2021-08-11","National","United Kingdom of Great Britain and Northern Ireland; England","2021-06-14","2021-07-06","Students and Daycares","Children and Youth (0-17 years)",3798.0,0.112,0.089,0.139,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office for National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021","Unverified","","NR",0.8,0.99,"","GB","GB-ENG"
"2021-11-10","210811_England_OfficeForNationalStatistics_Round6_StudentsSecondary4_TestAdj_PopAdj","COVID-19 Schools Infection Survey, England: Round 6, June 2021","2021-08-11","National","United Kingdom of Great Britain and Northern Ireland; England","2021-06-14","2021-07-06","Students and Daycares","Children and Youth (0-17 years)",6927.0,0.13,0.116,0.144,"Stratified probability","IgG","Moderate","Institutional Report","Office for National Statistics","Office for National Statistics","https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021","Unverified","","NR",0.8,0.99,"","GB","GB-ENG"
"2021-11-10","210930_UnitedKingdom_QueensUniversityBelfast_Round2_overall","Seroprevalence and kinetics of SARS-CoV-2 antibodies in children in the UK: A prospective multicentre cohort study","2021-09-30","National","United Kingdom of Great Britain and Northern Ireland; England, Northern Ireland, Wales, Scotland; London, Belfast, Cardiff, Glasgow, Manchester","2020-06-16","2020-06-30","Family of essential workers","Children and Youth (0-17 years)",849.0,0.077,0.06,0.096,"Unclear","Not reported","High","Journal Article (Peer-Reviewed)","Cathal Roarty","Queens University Belfast","http://dx.doi.org/10.1136/archdischild-2021-rcpch.65","Unverified","","NR","","","","GB",""
"2021-11-10","211021_France_UNIVIsanté","[Seroprevalence, risk factors and clinical presentation after the first wave of COVID-19 in nursing homes of the UNIVI group: The SEROCOVID study].","2021-10-21","National","France","2020-08-31","2020-10-16","Assisted living and long-term care facilities","Seniors (65+ years)",1141.0,0.144,0.124,0.164,"Unclear","IgG","High","Journal Article (Peer-Reviewed)","Marc Harboun","UNIVI santé","https://dx.doi.org/10.1016/j.revmed.2021.10.330","Unverified","","NR","","","","FR",""
"2021-11-10","211029_Jatni_ICMRRegionalMedicalResearchCentre","Investigating immunological interaction between lymphatic filariasis and COVID-19 infection: a preliminary evidence.","2021-10-29","Local","India; Odisha; Jatni","2021-01-15","2021-02-15","Household and community samples","Multiple groups",174.0,0.425,"","","Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Abhinav Sinha","ICMR-Regional Medical Research Centre","https://dx.doi.org/10.1080/21645515.2021.1989925","Unverified","","NR",0.98,0.98,"","IN","IN-OR"
"2021-11-10","211029_Thailand_ChulalongkornUniversity_overall_popadj","COVID-19 seroprevalence among hospital staff and preprocedural patients in Thai community hospitals: a cross-sectional study.","2021-10-29","National","Thailand; Northern Region, Northeastern Region, Central Region, Eastern Region, Southern Region","2020-04-06","2020-06-26","Multiple populations","Adults (18-64 years)",857.0,0.063,"","","Convenience","IgM; IgG","High","Journal Article (Peer-Reviewed)","Tanawin Nopsopon","Chulalongkorn University","https://dx.doi.org/10.1136/bmjopen-2020-046676","Unverified","","NR",0.941,0.98,"","TH",""
"2021-11-10","211030_Aichi_NationalCenterforGeriatricsandGerontology_Primary","Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan.","2021-10-30","Regional","Japan; Aichi Prefecture","2021-06-01","2021-06-30","Health care workers and caregivers","Adults (18-64 years)",556.0,0.937,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Akihiko Nishikimi","National Center for Geriatrics and Gerontology","https://dx.doi.org/10.1016/j.jinf.2021.10.021","Unverified","","NR","","","","JP","JP-23"
"2021-11-10","211030_UnitedKingdom_QueensUniversityBelfast","Symptoms of SARS-CoV-2 infection in the UK paediatric population","2021-09-30","Regional","United Kingdom of Great Britain and Northern Ireland; Northern Ireland, Scotland, Wales, England; Belfast, Glasgow, Cardiff, Manchester,; London","2020-04-16","2020-07-03","Household and community samples","Children and Youth (0-17 years)",992.0,0.068,"","","Unclear","IgG; Not reported","Unclear","Presentation or Conference","Claire McGinn","Queens University Belfast","http://dx.doi.org/10.1136/archdischild-2021-rcpch.135","Unverified","","NR","","","","GB",""
"2021-11-10","211102_Guatemala_UnidadNacionaldeOftalmología_HCW","SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.","2021-11-02","Local","Guatemala","2020-11-25","2020-11-25","Health care workers and caregivers","Adults (18-64 years)",94.0,0.18,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Pamela Davila Siliezar","Unidad Nacional de Oftalmología","https://dx.doi.org/10.1080/07853890.2021.1993325","Unverified","","NR",1.0,0.998,"","GT",""
"2021-11-10","211102_Luanda_UniversidadeAgostinhoNeto_Primary","Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola.","2021-11-02","Local","Angola; NR; Luanda","2019-12-15","2020-09-15","Blood donors","Adults (18-64 years)",343.0,0.047,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Cruz Sebastiao","Instituto Nacional de Investigação em Saúde","https://dx.doi.org/10.1186/s12879-021-06814-0","Verified","","NR","","","","AO",""
"2021-11-10","211103_Catalonia_BarcelonaInstituteForGlobalHealth_adults_popadj","Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain.","2021-11-03","Regional","Spain; Catalonia","2020-06-30","2020-11-15","Household and community samples","Multiple groups",4740.0,0.153,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Marianna Karachaliou","Barcelona Institute For Global Health","https://dx.doi.org/10.1038/s41598-021-00807-4","Verified","","NR",0.958,1.0,"","ES","ES-CT"
"2021-11-10","211103_Madrid_LaPazUniversityHospitalInstituteforHealthResearch_Overall_Testadj","SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown.","2021-11-03","Local","Spain; Community of Madrid; Madrid","2020-04-15","2020-06-15","Multiple populations","Multiple groups",449.0,0.337,0.293,0.382,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Patricia Torres Martinez","La Paz University Hospital Institute for Health Research","https://dx.doi.org/10.1038/s41598-021-00990-4","Unverified","","NR",1.0,0.98,"","ES","ES-MD"
"2021-11-10","211103_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 3 Nov 2021","2021-11-03","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-09-06","2021-10-10","Blood donors","Multiple groups",2494.0,0.997,0.993,1.0,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-11-10","211103_Scotland_PublicHealthScotland_PregnantWomen3_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 3 Nov 2021","2021-11-03","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-09-06","2021-10-10","Pregnant or parturient women","Adults (18-64 years)",3023.0,0.197,0.18,0.213,"Sequential","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/","Verified","","NR",0.923,1.0,"","GB","GB-SCT"
"2021-11-10","211103_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 3 Nov 2021","2021-11-03","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-09-06","2021-10-10","Residual sera","Multiple groups",3132.0,0.776,0.759,0.793,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/","Verified","","NR",0.973,0.996,"","GB","GB-SCT"
"2021-11-10","211104_Bronx_MontefioreMedicalCenter","Prevalence and dynamics of SARS-CoV-2 nucleocapsid IGG in kidney transplant recipients","2021-11-04","Local","United States of America; New York; New York","2021-05-03","2021-05-05","Patients seeking care for non-COVID-19 reasons","Multiple groups",1164.0,0.171,"","","Unclear","IgG","Unclear","Presentation or Conference","Yorg Azzi","Montefiore Medical Center","http://dx.doi.org/10.1681/asn.2020030362","Unverified","","NR","","","","US","US-NY"
"2021-11-10","211104_Ireland_St.James’sHospital_Primary","Prevalence of Antibodies to SARS-CoV-2 following natural infection and vaccination in Irish Hospital Healthcare Workers; changing epidemiology as the pandemic progresses","2021-11-04","National","Ireland","2021-04-19","2021-04-28","Health care workers and caregivers","Multiple groups",5085.0,0.18,0.17,0.19,"Self-referral","Total Antibody","Moderate","Preprint","Niamh Allen","St. James's Hospital","https://www.medrxiv.org/content/10.1101/2021.11.04.21265921v1.full-text","Unverified","","NR","","","","IE",""
"2021-11-11","210523_Qatar_CornellUniversity_Overall_PopTestAdj","SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals","2021-05-23","National","Qatar","2020-05-12","2020-09-09","Residual sera","Multiple groups",112941.0,0.148,"","","Sequential","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Peter Coyle","Cornell University","http://dx.doi.org/10.1016/j.isci.2021.102646","Unverified","","NR",0.89,0.998,"","QA",""
"2021-11-11","210604_NewYorkCity_LiveOnNY","Covid studies in 208 patients with consent for donation","2021-06-04","Local","United States of America; New York; New York City","2020-03-16","2020-12-02","Patients seeking care for non-COVID-19 reasons","Multiple groups",208.0,0.034,"","","Unclear","Not reported","Unclear","Presentation or Conference","Amy Friedman","LiveOnNY","https://atcmeetingabstracts.com/abstract/covid-studies-in-208-patients-with-consent-for-donation/","Unverified","","NR","","","","US","US-NY"
"2021-11-11","210605_Bronx_MontefioreMedicalCenter","Prevalence and dynamics of SARS-CoV-2 IGG in kidney transplant recipients","2021-06-05","Local","United States of America; New York; New York","2020-05-03","2020-11-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",1042.0,0.157,"","","Unclear","IgG","Unclear","Presentation or Conference","Yorg Azzi","Montefiore Medical Center","https://atcmeetingabstracts.com/abstract/prevalence-and-dynamics-of-sars-cov-2-igg-in-kidney-transplant-recipients/","Unverified","","NR","","","","US","US-NY"
"2021-11-11","211026_UttarPrasesh_GovernmentofUttarPradesh_primary","Understanding the Prevalence and Geographic Heterogeneity of SARS-CoV-2 Infection: Findings of the First Serosurvey in Uttar Pradesh, India.","2021-10-26","Regional","India; Uttar Pradesh","2020-09-04","2020-09-10","Household and community samples","Multiple groups",16012.0,0.222,0.215,0.229,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Vasanthakumar Namasivayam","Government of Uttar Pradesh","https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546397/","Verified","","NR",0.924,0.979,"","IN","IN-UP"
"2021-11-11","211029_Ecuador_UniversidadEspirituSanto","Factors Associated With a Persistent Seronegative Status 1 Year After a SARS-CoV-2 Massive Infection Outbreak in Community Dwellers Living in Rural Ecuador: A Prospective Population-based Study.","2021-10-29","Local","Ecuador; Santa Elena Province; Atahualpa","2020-05-01","2021-04-30","Household and community samples","Adults (18-64 years)",673.0,0.637,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oscar Del Brutto","Universidad Espíritu Santo","https://dx.doi.org/10.1177/21501327211054989","Verified","","NR",0.975,1.0,"","EC","EC-SE"
"2021-11-11","211029_Vitória_UniversidadeFederalDoEspíritoSanto_AGNSN","Living conditions, seroprevalence and symptoms of COVID-19 in slums in the Metropolitan Region of Vitoria (Espirito Santo).","2021-10-29","Regional","Brazil; Espírito Santo; Vitória","2020-06-22","2020-06-26","Persons living in slums","Multiple groups",733.0,0.102,0.08,0.125,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Ethel Leonor Noia Maciel","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210048","Unverified","","NR",0.864,0.976,"","BR","BR-ES"
"2021-11-11","211029_Vitória_UniversidadeFederalDoEspíritoSanto_AGSN","Living conditions, seroprevalence and symptoms of COVID-19 in slums in the Metropolitan Region of Vitoria (Espirito Santo).","2021-10-29","Regional","Brazil; Espírito Santo; Vitória","2020-06-22","2020-06-26","Household and community samples","Multiple groups",714.0,0.121,0.096,0.145,"Stratified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ethel Leonor Noia Maciel","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210048","Unverified","","NR",0.864,0.976,"","BR","BR-ES"
"2021-11-11","211101_Germany_RuhrUniversityBochum","Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center.","2021-11-01","Local","Germany","2020-08-15","2021-02-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",110.0,0.091,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Oliver Overheu","Ruhr-University Bochum","https://dx.doi.org/10.1159/000520572","Unverified","","NR",0.995,"","","DE",""
"2021-11-12","211103_Catalonia_BarcelonaInstituteForGlobalHealth_adolescents_unadj","Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain.","2021-11-03","Regional","Spain; Catalonia","2020-06-30","2020-11-15","Household and community samples","Children and Youth (0-17 years)",260.0,0.115,"","","Convenience","IgG; IgA; IgM","High","Journal Article (Peer-Reviewed)","Marianna Karachaliou","Barcelona Institute For Global Health","https://dx.doi.org/10.1038/s41598-021-00807-4","Verified","","NR",0.958,1.0,"","ES","ES-CT"
"2021-11-15","211030_Turkey_BiruniUniversity_AirCrew","COVID-19 seroconversion in the aircrew from Turkey.","2021-10-30","Local","Turkey; Istanbul; Istanbul","2020-12-01","2021-01-13","Essential non-healthcare workers","Adults (18-64 years)",313.0,0.46,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Mehmet Islamoglu","Biruni University","https://dx.doi.org/10.1016/j.tmaid.2021.102190","Unverified","","NR","","","","TR","TR-34"
"2021-11-15","211030_Turkey_BiruniUniversity_HCW","COVID-19 seroconversion in the aircrew from Turkey.","2021-10-30","Local","Turkey; Istanbul; Istanbul","2020-12-01","2021-01-13","Health care workers and caregivers","Adults (18-64 years)",451.0,0.41,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Mehmet Islamoglu","Biruni University","https://dx.doi.org/10.1016/j.tmaid.2021.102190","Unverified","","NR","","","","TR","TR-34"
"2021-11-15","211030_Turkey_BiruniUniversity_Other","COVID-19 seroconversion in the aircrew from Turkey.","2021-10-30","Local","Turkey; Istanbul; Istanbul","2020-12-01","2021-01-13","Residual sera","Adults (18-64 years)",4258.0,0.353,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Mehmet Islamoglu","Biruni University","https://dx.doi.org/10.1016/j.tmaid.2021.102190","Unverified","","NR","","","","TR","TR-34"
"2021-11-15","211108_Virginia_InovaHealthSystem","A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States.","2021-11-08","Regional","United States of America; Virginia","2020-07-31","2020-10-13","Multiple general populations","Children and Youth (0-17 years)",1038.0,0.085,0.069,0.103,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Rebecca Levorson","Inova Health System","https://dx.doi.org/10.1371/journal.pone.0259823","Unverified","","NR","","","","US","US-VA"
"2021-11-15","211109_Quebec_McGillUniversity_EDM","Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study","2021-11-09","Local","Canada; Québec; Montréal","2021-01-19","2021-07-20","Persons who are incarcerated","Adults (18-64 years)",600.0,0.273,"","","Unclear","IgG","Moderate","Preprint","Nadine Kronfli","McGill University","10.2139/ssrn.3959665","Unverified","","NR",0.998,0.995,"","CA","CA-QC"
"2021-11-15","211109_Quebec_McGillUniversity_EDRDP","Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study","2021-11-09","Local","Canada; Québec; Montréal","2021-02-03","2021-03-24","Persons who are incarcerated","Adults (18-64 years)",300.0,0.147,"","","Unclear","IgG","Moderate","Preprint","Nadine Kronfli","McGill University","10.2139/ssrn.3959665","Unverified","","NR",0.998,0.995,"","CA","CA-QC"
"2021-11-15","211109_Quebec_McGillUniversity_EDSJ","Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study","2021-11-09","Local","Canada; Québec; Saint-Jérôme","2021-03-30","2021-09-15","Persons who are incarcerated","Adults (18-64 years)",200.0,0.19,"","","Unclear","IgG","Moderate","Preprint","Nadine Kronfli","McGill University","10.2139/ssrn.3959665","Unverified","","NR",0.998,0.995,"","CA","CA-QC"
"2021-11-16","211019_Daegu_KyungpookNationalUniversity_Overall","Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.","2021-10-19","Local","Republic of Korea","2021-01-18","2021-02-26","Health care workers and caregivers","Multiple groups",2935.0,0.004,"","","Convenience","IgG; IgM; IgA; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Yu Kim","Kyungpook National University","https://dx.doi.org/10.3346/jkms.2021.36.e294","Unverified","","NR","","","","KR",""
"2021-11-16","211109_Denver_CentersforDiseaseControlandPrevention_CommunitySurvey_Overall","Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.","2021-11-09","Regional","United States of America; Colorado; Denver","2020-07-22","2020-08-08","Household and community samples","Multiple groups",381.0,0.08,0.039,0.157,"Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kiersten Kugeler","Centers for Disease Control and Prevention","https://dx.doi.org/10.1177/00333549211055137","Verified","","NR",0.932,0.99,"","US","US-CO"
"2021-11-17","210908_SanFrancisco_UniversityofCalifornia_overall","Seroprevalence of SARS-CoV-2 Among Firefighters/Paramedics in San Francisco, CA.","2021-09-08","Local","United States of America; California; San Francisco","2020-06-15","2020-07-02","Essential non-healthcare workers","Adults (18-64 years)",1231.0,0.002,0.0,0.007,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Megan Grant","University of California","https://dx.doi.org/10.1097/JOM.0000000000002383","Unverified","","NR","","","","US","US-CA"
"2021-11-17","211019_Geneva_GenevaUniversityHospitals_Overall_Adjusted","Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study","2021-10-19","Regional","Switzerland; Canton of Geneva","2020-04-06","2020-06-30","Household and community samples","Multiple groups",8344.0,0.078,0.068,0.089,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Aude Richard","Geneva University Hospitals","10.1177/14034948211048050","Unverified","","NR",0.93,1.0,"","CH","CH-GE"
"2021-11-17","211019_SãoPaulo_FederalUniversityofParaná_homeless_overall","High SARS-CoV-2 seroprevalence in persons experiencing homelessness and shelter workers from a day-shelter in Sao Paulo, Brazil","2021-10-19","Local","Brazil; São Paulo State; São Paulo","2020-08-25","2020-08-27","Persons experiencing homelessness","Multiple groups",203.0,0.547,0.478,0.615,"Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Anahi Chechia do Couto","Federal University of Paraná","https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009754","Unverified","","NR","","","","BR","BR-SP"
"2021-11-17","211019_SãoPaulo_FederalUniversityofParaná_workers_overall","High SARS-CoV-2 seroprevalence in persons experiencing homelessness and shelter workers from a day-shelter in Sao Paulo, Brazil","2021-10-19","Local","Brazil; São Paulo State; São Paulo","2020-08-25","2020-08-27","Essential non-healthcare workers","Multiple groups",87.0,0.494,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Anahi Chechia do Couto","Federal University of Paraná","https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009754","Unverified","","NR","","","","BR","BR-SP"
"2021-11-17","211021_EssexCounty_RutgersUniversity_Overall","Prevalence and Correlates of SARS CoV-2 Among a Community-Based Sample Recruited Using Randomized Venue-Based Sampling. Essex County, NJ, 2020.","2021-11-08","Local","United States of America; New Jersey","2020-09-15","2020-12-22","Household and community samples","Multiple groups",924.0,0.09,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Henry Raymond","Rutgers University","https://dx.doi.org/10.1007/s40615-021-01175-5","Verified","","NR","","","","US","US-NJ"
"2021-11-17","211029_OsakaCity_OsakaCityGeneralHospital_Overall","Recent Outpatient Services in General Internal Medicine: 6.4% of Symptomatic Patients Were Post-Acute COVID-19.","2021-10-29","Local","Japan; Osaka Prefecture; Osaka City","2020-11-01","2021-03-31","Residual sera","Multiple groups",94.0,0.064,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Yusuke Hanioka","Osaka City General Hospital","https://dx.doi.org/10.2147/IJGM.S330525","Unverified","","NR",0.995,0.998,"","JP","JP-27"
"2021-11-17","211105_Colombia_InstitutoNacionaldeSalud_TestAdj","Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities.","2021-11-05","National","Colombia","2020-09-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",3296.0,0.35,0.33,0.37,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Jeadran Nevardo Malagon-Rojas","Instituto Nacional de Salud","https://dx.doi.org/10.1136/oemed-2021-107487","Unverified","","NR",0.86,0.99,"","CO",""
"2021-11-17","211105_SouthAfrica_NationalHealthLaboratoryService_Overall_Overall","Seroprevalence of SARS-CoV-2 after the Second Wave in South Africa in HIV-Infected and Uninfected Persons: A Cross-Sectional Household Survey, November 2020 â€“ April 2021","2021-11-05","National","South Africa; KwaZulu-Natal, North West Province, Western Cape; Pietermaritzburg, Klerksdorp, Mitchell's Plain","2020-11-15","2021-04-15","Household and community samples","Multiple groups",7577.0,0.452,0.437,0.467,"Simplified probability","Total Antibody","Moderate","Preprint","Nicole Wolter","National Health Laboratory Service","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3957112","Unverified","","NR","","","","ZA",""
"2021-11-17","211108_Colombo_UniversityofSriJayewardenepura","Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020.","2021-11-08","Local","Sri Lanka","2020-04-15","2020-05-19","Contacts of COVID patients","Multiple groups",2633.0,0.034,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Chandima Jeewandara","University of Sri Jayewardenepura","https://dx.doi.org/10.1371/journal.pone.0257548","Unverified","","NR","",1.0,"","LK",""
"2021-11-17","211108_France_UniversitedeParis_Overall","Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.","2021-11-08","National","France","2020-05-15","2020-11-15","Household and community samples","Adults (18-64 years)",26823.0,0.041,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Joane Matta","Universite de Paris","https://dx.doi.org/10.1001/jamainternmed.2021.6454","Verified","","NR",0.87,0.975,"","FR",""
"2021-11-17","211109_EasternCape_WalterSisuluUniversity_HCW_overall","Cumulative incidence of SARS-CoV-2 and associated risk factors among healthcare workers in the Eastern Cape, South Africa","2021-11-09","Regional","South Africa; Eastern Cape; Buffalo City, Amathole, Chris Hani, Joe Gqabi","2020-11-04","2020-12-18","Health care workers and caregivers","Multiple groups",1295.0,0.377,"","","Stratified non-probability","IgG","Moderate","Preprint","David Stead","Walter Sisulu University","https://www.medrxiv.org/content/10.1101/2021.11.08.21265966v1.full-text","Unverified","","NR",1.0,0.999,"","ZA","ZA-EC"
"2021-11-18","210101_Kerala_GovernmentofKerala","ICMR - Serological Surveillance Report - Round 3","2021-01-01","Regional","India; Kerala","2020-12-20","2020-12-30","Household and community samples","Multiple groups",1246.0,0.116,0.099,0.135,"Unclear","IgG","Unclear","Institutional Report","Government of Kerala","Government of Kerala Department of Health & Family Welfare","https://health.kerala.gov.in/pdf/Technical-paper-COVID-19-Sero-Surveillance-Round-3-ICMR.pdf","Unverified","","NR","","","","IN","IN-KL"
"2021-11-18","210601_Kerala_GovernmentofKerala","ICMR - Serological Surveillance Report - Round 4","2021-06-01","National","India","2021-05-01","2021-05-31","Household and community samples","Multiple groups",28975.0,0.676,"","","Unclear","IgG","Unclear","Institutional Report","Government of Kerala","Government of Kerala Department of Health & Family Welfare","https://health.kerala.gov.in/pdf/Technical_paper_COVID_19_Sero_Surveillance_Round_4_ICMR.pdf","Unverified","","NR","","","","IN",""
"2021-11-18","211104_OrangeCounty_UniversityofCaliforniaIrvine_1_SantaAna_Multiplex","Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination.","2021-11-04","Local","United States of America; California; Santa Ana","2020-12-01","2020-12-30","Household and community samples","Multiple groups",3347.0,0.26,"","","Stratified probability","IgG","High","Journal Article (Peer-Reviewed)","Rafael Assis","University of California Irvine","https://dx.doi.org/10.1038/s41541-021-00396-3","Unverified","","NR","","","","US","US-CA"
"2021-11-18","211104_OrangeCounty_UniversityofCaliforniaIrvine_2_HCW_May_Multiplex","Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination.","2021-11-04","Local","United States of America; California; Inrvine","2020-05-01","2020-05-31","Health care workers and caregivers","Adults (18-64 years)",1060.0,0.04,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Rafael Assis","University of California Irvine","https://dx.doi.org/10.1038/s41541-021-00396-3","Unverified","","NR","","","","US","US-CA"
"2021-11-18","211104_OrangeCounty_UniversityofCaliforniaIrvine_3_HCW_December_Multiplex","Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination.","2021-11-04","Local","United States of America; California; Irvine","2020-12-01","2020-12-30","Health care workers and caregivers","Adults (18-64 years)",313.0,0.11,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Rafael Assis","University of California Irvine","https://dx.doi.org/10.1038/s41541-021-00396-3","Unverified","","NR","","","","US","US-CA"
"2021-11-18","211109_Norway_NorwegianInstituteofPublicHealth_Time1_PopTestAdj","Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.","2021-11-09","National","Norway","2020-04-19","2020-05-16","Residual sera","Multiple groups",900.0,0.01,0.001,0.024,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Gro Tunheim","Norwegian Institute of Public Health","https://dx.doi.org/10.1111/irv.12932","Unverified","","NR",0.86,1.0,"","NO",""
"2021-11-18","211109_Norway_NorwegianInstituteofPublicHealth_Time2_PopTestAdj","Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.","2021-11-09","National","Norway","2020-07-19","2020-09-12","Residual sera","Multiple groups",1812.0,0.006,0.002,0.012,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Gro Tunheim","Norwegian Institute of Public Health","https://dx.doi.org/10.1111/irv.12932","Unverified","","NR",0.86,0.999,"","NO",""
"2021-11-18","211109_Norway_NorwegianInstituteofPublicHealth_Time3_PopTestAdj","Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.","2021-11-09","National","Norway","2020-12-27","2021-02-13","Residual sera","Multiple groups",1912.0,0.032,0.023,0.042,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Gro Tunheim","Norwegian Institute of Public Health","https://dx.doi.org/10.1111/irv.12932","Unverified","","NR",0.96,0.998,"","NO",""
"2021-11-18","211109_Norway_NorwegianInstituteofPublicHealth_Time4_Primary","Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.","2021-11-09","National","Norway","2019-08-01","2019-08-31","Residual sera","Multiple groups",216.0,0.0,"","","Convenience","IgG","Unclear","Journal Article (Peer-Reviewed)","Gro Tunheim","Norwegian Institute of Public Health","https://dx.doi.org/10.1111/irv.12932","Unverified","","NR","","","","NO",""
"2021-11-18","211109_Poland_SlaskiUniwersytetMedyczny_Primary","[Infection Fatality Rate (IFR) during the course of COVID-19 pandemic in Upper Silesia Metropolitan Area (Poland) in 2020].","2021-11-09","Local","Poland","2020-10-15","2020-11-15","Household and community samples","Multiple groups",1167.0,0.114,0.095,0.132,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Jan E. Zejda","Slaski Uniwersytet Medyczny","https://dx.doi.org/10.13075/mp.5893.01179","Unverified","","NR",0.88,0.99,"","PL",""
"2021-11-18","211110_FaroeIslands_TheFaroeseHospitalSystem_TestAdj","Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020.","2021-11-10","National","Faroe Islands","2020-11-21","2020-11-30","Household and community samples","Multiple groups",960.0,0.004,0.001,0.01,"Simplified probability","Total Antibody","Low","Journal Article (Peer-Reviewed)","Maria Skaalum Petersen","The Faroese Hospital System","https://dx.doi.org/10.3201/eid2801.210917","Verified","","NR",0.944,1.0,"","FO",""
"2021-11-18","211110_Malaysia_UniversityofMalaya_PopAdjusted","Changing predominant SARS-CoV-2 lineages drive successive COVID-19 waves in Malaysia, February 2020 to March 2021.","2021-11-10","Regional","Malaysia; Selangor; Kuala Lumpur","2020-12-15","2021-04-15","Residual sera","Multiple groups",653.0,0.03,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","I-Ching Sam","University of Malaya","https://dx.doi.org/10.1002/jmv.27441","Unverified","","NR",0.967,0.995,"","MY","MY-10"
"2021-11-18","211111_Australia_NSWWestmeadHospital_Primary","The utility of SARS-CoV-2-specific serology in COVID-19 diagnosis.","2021-11-11","National","Australia; Australia (Western Australia, South Australia, Tasmania, Victoria; and the Australian Capital Territory) and countries (New Zealand)","2020-01-24","2020-07-31","Multiple populations","Multiple groups",10595.0,0.098,"","","Sequential","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Tasnim Hasan","New South Wales Westmead Hospital","https://dx.doi.org/10.1111/1753-6405.13155","Verified","","NR",0.913,0.989,"","AU",""
"2021-11-19","210930_Kerala_GovernmentOfKerala_Antenatal_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","India; Kerala","2021-08-15","2021-09-15","Pregnant or parturient women","Adults (18-64 years)",2274.0,0.654,0.634,0.674,"Convenience","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Unverified","","NR","","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_Children_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","India; Kerala","2021-09-01","2021-09-30","Household and community samples","Children and Youth (0-17 years)",1459.0,0.402,"","","Stratified probability","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Unverified","","NR","","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_Coastal_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","India; Kerala","2021-09-01","2021-09-30","Household and community samples","Multiple groups",1476.0,0.877,0.86,0.893,"Stratified probability","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Unverified","","NR","","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_GenPop_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","India; Kerala","2021-09-01","2021-09-30","Household and community samples","Multiple groups",4429.0,0.826,0.815,0.837,"Stratified probability","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Unverified","","NR","","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_Slum_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","India; Kerala","2021-09-01","2021-09-30","Household and community samples","Multiple groups",1706.0,0.853,0.836,0.87,"Stratified probability","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Unverified","","NR","","","","IN","IN-KL"
"2021-11-19","210930_Kerala_GovernmentOfKerala_Tribal_Primary","Kerala COVID-19 (SARS CoV2 IgG) Seroprevalence Study September 2021","2021-09-30","Regional","India; Kerala","2021-09-01","2021-09-30","Household and community samples","Multiple groups",1521.0,0.782,"","","Stratified probability","IgG","Moderate","Institutional Report","Government of Kerala","Government of Kerala Department of Health","https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf","Unverified","","NR","","","","IN","IN-KL"
"2021-11-19","211109_Denver_CentersforDiseaseControlandPrevention_ClinicalResidualSera_Overall","Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.","2021-11-09","Regional","United States of America; Colorado","2020-07-22","2020-08-08","Residual sera","Multiple groups",1598.0,0.068,0.05,0.092,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kiersten Kugeler","Centers for Disease Control and Prevention","https://dx.doi.org/10.1177/00333549211055137","Verified","","NR",0.932,0.99,"","US","US-CO"
"2021-11-21","211112_Denmark_AarhusUniversity_2020Weeks41to44_TestAdjusted","Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark.","2021-11-12","National","Denmark","2020-10-05","2020-11-01","Blood donors","Adults (18-64 years)",22690.0,0.021,0.012,0.025,"Entire sample","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kathrine Kaspersen","Aarhus University","https://dx.doi.org/10.1093/infdis/jiab566","Verified","","NR",0.967,0.995,"","DK",""
"2021-11-21","211112_Denmark_AarhusUniversity_2021Weeks5to8_Unadjusted","Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark.","2021-11-12","National","Denmark","2021-02-01","2021-02-28","Blood donors","Adults (18-64 years)",20398.0,0.074,"","","Entire sample","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Kathrine Kaspersen","Aarhus University","https://dx.doi.org/10.1093/infdis/jiab566","Verified","","NR",0.967,0.995,"","DK",""
"2021-11-22","210209_Stockholm_TheStockholmRegion","9 februari: Lägesrapport om covid-19","2021-02-09","Local","Sweden","2021-02-01","2021-02-07","Household and community samples","Multiple groups",11175.0,0.447,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/9-februari-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-11-22","210216_Stockholm_TheStockholmRegion","16 februari: Lägesrapport om covid-19","2021-02-16","Local","Sweden","2021-02-08","2021-02-14","Household and community samples","Multiple groups",8108.0,0.425,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/16-februari-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-11-22","210223_Stockholm_TheStockholmRegion","23 februari: Lägesrapport om covid-19","2021-02-23","Local","Sweden","2021-02-15","2021-02-21","Household and community samples","Multiple groups",9024.0,0.424,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/23-februari-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-11-22","210302_Stockholm_TheStockholmRegion","2 mars: Lägesrapport om covid-19","2021-03-02","Local","Sweden","2021-02-22","2021-02-28","Household and community samples","Multiple groups",12605.0,0.409,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/2-mars-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-11-22","210309_Stockholm_TheStockholmRegion","9 mars: Lägesrapport om covid-19","2021-03-09","Local","Sweden","2021-03-01","2021-03-07","Household and community samples","Multiple groups",9237.0,0.395,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/9-mars-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-11-22","210316_Stockholm_TheStockholmRegion","16 mars: Lägesrapport om covid-19","2021-03-16","Local","Sweden","2021-03-08","2021-03-14","Household and community samples","Multiple groups",9769.0,0.398,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/16-mars-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-11-22","210323_Stockholm_TheStockholmRegion","23 mars: Lägesrapport om covid-19","2021-03-23","Local","Sweden","2021-03-15","2021-03-21","Household and community samples","Multiple groups",9040.0,0.404,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/23-mars-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-11-22","210330_Stockholm_TheStockholmRegion","30 mars: Lägesrapport om covid-19","2021-03-30","Local","Sweden","2021-03-22","2021-03-28","Household and community samples","Multiple groups",10146.0,0.409,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/30-mars-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-11-22","210406_Stockholm_TheStockholmRegion","6 april: Lägesrapport om covid-19","2021-04-06","Local","Sweden","2021-03-29","2021-04-04","Household and community samples","Multiple groups",10419.0,0.427,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/6-april-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-11-22","211028_Italy_FondazioneIRCCS_STest","Kidney transplant rejection rate in screened patients for anti-SARS-CoV-2 antibodies, during COVID-19 pandemic in Northern Italy.","2021-10-28","Local","Italy","2020-06-15","2020-12-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",201.0,0.144,"","","Sequential","IgG","High","Journal Article (Peer-Reviewed)","Anna Lia Asti","IRCCS San Matteo Hospital","https://pubmed.ncbi.nlm.nih.gov/34783351/","Unverified","","NR","","","","IT",""
"2021-11-22","211109_Strasbourg_StrasbourgUniversityHospitals_V0","COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.","2021-11-09","Local","France","2020-04-06","2020-05-07","Health care workers and caregivers","Multiple groups",1497.0,0.344,"","","Stratified probability","IgG; IgM","High","Preprint","A Velay","Strasbourg University Hospitals","https://dx.doi.org/10.1016/j.idnow.2021.11.002","Unverified","","NR","","","","FR",""
"2021-11-22","211113_Tokyo_TokyoMetropolitanInstituteofMedicalScience_Overall","Serologic survey of IgG against SARS-CoV-2 among hospital visitors without a history of SARS-CoV-2 infection in Tokyo, 2020-2021.","2021-11-13","Local","Japan","2020-09-01","2021-03-31","Residual sera","Multiple groups",23234.0,0.018,0.017,0.02,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Takahiro Sanada","Tokyo Metropolitan Institute of Medical Science","https://dx.doi.org/10.2188/jea.JE20210324","Unverified","","NR","",1.0,"","JP",""
"2021-11-22","211115_HongKong_TheChineseUniversityofHongKong_Overall_PopAdjusted","Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.","2021-11-15","National","""China, Hong Kong SAR""; NR; NR","2020-04-21","2021-04-18","Household and community samples","Multiple groups",4198.0,0.002,0.001,0.003,"Convenience","IgG; Not reported","Moderate","Journal Article (Peer-Reviewed)","Siaw Boon","The Chinese University of Hong Kong","https://dx.doi.org/10.1001/jamanetworkopen.2021.32923","Unverified","","NR","","","","CN",""
"2021-11-23","200515_Boston_BostonPublicHealthCommission","Results released for antibody and COVID-19 testing of Boston residents","2020-05-18","Local","United States of America; Massachusetts; Boston","","2020-05-15","Household and community samples","","","","","","","","High","News and Media","City of Boston","Boston Public Health Commission","https://www.boston.gov/news/results-released-antibody-and-covid-19-testing-boston-residents","Unverified","United States of America","NR","","","","US","US-MA"
"2021-11-23","211112_FrenchGuiana_InstitutPasteurinFrenchGuiana_Overall_PopAdjusted","Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020.","2021-11-12","National","French Guiana; Cayenne, Saint-Laurent-du-Maroni; Cayenne, Matoury, Mana, Apatou, Saint-Laurent-du-Maroni, Awala-Yalimapo, Iracoubo, Sinnamary, Kourou, Macouria, Cayenne, Rémire-Montjoly, Saint-Georges, Maripasoula, Papaïchton, Grand-Santi","2020-07-15","2020-07-23","Residual sera","Multiple groups",480.0,0.154,0.093,0.244,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Claude Flamand","Institut Pasteur in French Guiana","https://dx.doi.org/10.1371/journal.pntd.0009945","Unverified","","NR","",0.979,"","GF",""
"2021-11-23","211115_TamilNadu_GovernmentofTamilNadu_Round1_Primary","Seroprevalence in Tamil Nadu through India‚Äôs two COVID waves: Evidence on antibody decline following infection and vaccination","2021-11-15","Regional","India; Tamil Nadu","2020-10-19","2020-11-30","Household and community samples","Multiple groups",26135.0,0.316,0.303,0.327,"Stratified probability","IgG","Moderate","Preprint","T S Selvavinayagam","Government of Tamil Nadu","https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text","Unverified","","NR","","","","IN","IN-TN"
"2021-11-23","211115_TamilNadu_GovernmentofTamilNadu_Round2_Primary","Seroprevalence in Tamil Nadu through India‚Äôs two COVID waves: Evidence on antibody decline following infection and vaccination","2021-11-15","Regional","India; Tamil Nadu","2021-04-07","2021-04-30","Household and community samples","Multiple groups",21992.0,0.229,0.218,0.239,"Stratified probability","IgG","Moderate","Preprint","T S Selvavinayagam","Government of Tamil Nadu","https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text","Unverified","","NR","","","","IN","IN-TN"
"2021-11-23","211115_TamilNadu_GovernmentofTamilNadu_Round3_Primary","Seroprevalence in Tamil Nadu through India‚Äôs two COVID waves: Evidence on antibody decline following infection and vaccination","2021-11-15","Regional","India; Tamil Nadu","2021-06-28","2021-07-07","Household and community samples","Multiple groups",26592.0,0.671,0.659,0.683,"Stratified probability","IgG","Moderate","Preprint","T S Selvavinayagam","Government of Tamil Nadu","https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text","Unverified","","NR","","","","IN","IN-TN"
"2021-11-23","211116_RioGrandedoSul_UniversidadeFederaldoRioGrandedoSul_August_Overall","Prospective study on COVID-19 seroprevalence and behavioural patterns in military personnel from the Southern Brazil.","2021-11-16","Regional","Brazil; Rio Grande do Sul","2020-08-01","2020-08-31","Essential non-healthcare workers","Multiple groups",46.0,0.023,0.003,0.147,"Stratified non-probability","Not reported","High","Preprint","Sergio Renato da Rosa Decker","Universidade Federal do Rio Grande do Sul","https://dx.doi.org/10.1080/23744235.2021.1995039","Unverified","","NR","","","","BR","BR-RS"
"2021-11-23","211116_RioGrandedoSul_UniversidadeFederaldoRioGrandedoSul_July_Overall","Prospective study on COVID-19 seroprevalence and behavioural patterns in military personnel from the Southern Brazil.","2021-11-16","Regional","Brazil; Rio Grande do Sul","2020-07-01","2020-07-31","Essential non-healthcare workers","Multiple groups",48.0,0.061,0.019,0.177,"Stratified non-probability","Not reported","High","Preprint","Sergio Renato da Rosa Decker","Universidade Federal do Rio Grande do Sul","https://dx.doi.org/10.1080/23744235.2021.1995039","Unverified","","NR","","","","BR","BR-RS"
"2021-11-24","210527_Krakow_JagiellonianUniversityMedicalCollege_Primary","SARS-CoV-2 infection and seroconversion in pediatric patients on biological therapy for Crohn's disease: single tertiary center experience","2021-05-27","Local","Poland","2020-03-04","2021-03-03","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",62.0,0.306,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ruth Sladek","Jagiellonian University Medical College","https://academic.oup.com/ecco-jcc/article/15/Supplement_1/S372/6286668","Unverified","","NR","","","","PL",""
"2021-11-24","210930_Novara_UniversityofPiemonteOrientale_nonpregnant_overall","COVID-19 seroprevalence in a group of pregnant women compared to a group of non-pregnant women","2021-09-30","Local","Italy; Novara; ; Novara City","2020-04-27","2020-07-01","Household and community samples","Adults (18-64 years)",588.0,0.128,"","","Unclear","Not reported","High","Journal Article (Peer-Reviewed)","Viviana Piccirllo","University of Piemonte Orientale","http://dx.doi.org/10.1080/14767058.2021.1962370","Unverified","","NR","","","","IT",""
"2021-11-24","210930_Novara_UniversityofPiemonteOrientale_pregnant_overall","COVID-19 seroprevalence in a group of pregnant women compared to a group of non-pregnant women","2021-09-30","Local","Italy; Novara; Novara City","2020-04-27","2020-07-01","Pregnant or parturient women","Adults (18-64 years)",344.0,0.026,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Viviana Piccirllo","University of Piemonte Orientale","http://dx.doi.org/10.1080/14767058.2021.1962370","Unverified","","NR","","","","IT",""
"2021-11-24","211110_Bangalore_BangaloreBaptistHospital_Phase1_HCW_overall","Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.","2021-11-10","Local","India; Karnataka; Bangalore","2020-05-15","2020-06-15","Health care workers and caregivers","Adults (18-64 years)",210.0,0.0,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Sindhulina Chandrasingh","Bangalore Baptist Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.10.006","Unverified","","NR",0.972,0.998,"","IN","IN-KA"
"2021-11-24","211110_Bangalore_BangaloreBaptistHospital_Phase2_HCW_overall","Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.","2021-11-10","Local","India; Karnataka; Bangalore","2020-09-15","2020-11-15","Health care workers and caregivers","Adults (18-64 years)",206.0,0.092,0.086,0.094,"Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Sindhulina Chandrasingh","Bangalore Baptist Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.10.006","Unverified","","NR",0.972,0.998,"","IN","IN-KA"
"2021-11-24","211110_Karnataka_BangaloreBaptistHospital_Phase1_BloodDonors_overall","Are hospitals epicentres of COVID19 transmission? Findings of serial serosurveys among healthcare workers from a tertiary hospital in South India.","2021-11-10","Regional","India; Karnataka","2020-05-15","2020-06-15","Blood donors","Multiple groups",211.0,0.0,"","","Unclear","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Sindhulina Chandrasingh","Bangalore Baptist Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.10.006","Unverified","","NR",0.972,0.998,"","IN","IN-KA"
"2021-11-24","211111_Rennes_RennesUniversityHospital_Primary","Risk factors for SARS-CoV-2 infection among health care workers","2021-11-11","Local","France","2020-05-29","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",3234.0,0.038,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Christophe Paris","Rennes University Hospital","https://dx.doi.org/10.1016/j.ajic.2021.11.001","Unverified","","NR","","","","FR",""
"2021-11-24","211116_Italy_BambinoGesuChildrensHospital","SARS-COV2 Seroprevalence in a Cohort of Perinatally HIV Infected Children and Young Adults From May to December 2020 in Italy","2021-11-16","Local","Italy","2020-05-01","2021-01-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",85.0,0.058,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Chiara Casamento Tumeo","Bambino Gesù Children’s Hospital","https://www.researchsquare.com/article/rs-1061389/v1","Unverified","","NR","","","","IT",""
"2021-11-24","211117_Catalonia_BarcelonaInstituteforGlobalHealth_Overall","Ambient Air Pollution in Relation to SARS-CoV-2 Infection, Antibody Response, and COVID-19 Disease: A Cohort Study in Catalonia, Spain (COVICAT Study).","2021-11-17","Regional","Spain; Catalonia","2020-05-15","2020-11-30","Household and community samples","Adults (18-64 years)",4103.0,0.181,"","","Convenience","IgM; IgA; IgG","Moderate","Journal Article (Peer-Reviewed)","Manolis Kogevinas","Barcelona Institute for Global Health","https://dx.doi.org/10.1289/EHP9726","Unverified","","NR",0.958,1.0,"","ES","ES-CT"
"2021-11-24","211118_Belgium_CliniqueNotreDamedeGrace","SARS-CoV-2 seroprevalence in high-risk health care workers in a Belgian general hospital: evolution from the first wave to the second.","2021-11-18","Local","Belgium","2021-01-18","2021-02-08","Health care workers and caregivers","Adults (18-64 years)",189.0,0.418,"","","Convenience","IgG; Total Antibody","High","Journal Article (Peer-Reviewed)","Loris Wauthier","Clinique Notre-Dame de Grâce","https://dx.doi.org/10.1080/17843286.2021.2004349","Unverified","","NR","","","","BE",""
"2021-11-25","211031_Texas_UniversityOfTexas_Children2_Primary","Texas Coronavirus Antibody Response Survey October 2021","2021-10-31","Regional","United States of America; Texas","","2021-10-04","Household and community samples","Children and Youth (0-17 years)",3889.0,0.365,0.35,0.381,"Self-referral","Total Antibody","Moderate","Institutional Report","The University of Texas Health Science Center at Houston","University of Texas Health Science Center","https://sph.uth.edu/projects/texascares/docs/TexasCARES%20-%20October%20Report.pdf","Unverified","","NR","","","","US","US-TX"
"2021-11-25","211111_Belgium_Sciensano_Residents","The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.","2021-11-11","National","Belgium; Flanders, Wallonia, Brussels","2020-10-01","2020-12-08","Assisted living and long-term care facilities","Seniors (65+ years)",259.0,0.293,"","","Convenience","Not reported; IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Goossens","Sciensano","https://dx.doi.org/10.1186/s13690-021-00715-z","Unverified","","NR","","","","BE",""
"2021-11-25","211111_Belgium_Sciensano_Staff","The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.","2021-11-11","National","Belgium; Flanders, Wallonia, Brussels","2020-10-01","2020-12-08","Assisted living and long-term care facilities","Adults (18-64 years)",509.0,0.208,"","","Convenience","Not reported; IgG; IgM","High","Journal Article (Peer-Reviewed)","Maria Goossens","Sciensano","https://dx.doi.org/10.1186/s13690-021-00715-z","Unverified","","NR","","","","BE",""
"2021-11-25","211111_Qatar_HamadMedicalCorporation_SchoolEnd","SARS-CoV-2 PCR and antibody positivity among school staff at the beginning and end of the first school term.","2021-11-11","Local","Qatar","2020-12-16","2020-12-22","Essential non-healthcare workers","Adults (18-64 years)",331.0,0.317,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Moza Alishaq","Hamad Medical Corporation","https://dx.doi.org/10.1186/s12889-021-12134-4","Unverified","","NR",0.995,0.998,"","QA",""
"2021-11-25","211111_UZBrussel_UZBrussel_Phase2","Fear for CoViD-19 and reluctance to work among health care workers during the epidemic, a prospective monocentric cohort study.","2021-11-11","Local","Belgium","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",2336.0,0.079,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Marco Moretti","University Hospital Brussels","https://dx.doi.org/10.1016/j.ajic.2021.10.042","Unverified","","NR","","","","BE",""
"2021-11-25","211112_London_UniversityOfOxford","Tracking the Incidence and Risk Factors for Sars-Cov-2 Infection in North West London by Detection of Antibody in Historical Maternal Booking Serum Samples","2021-11-12","Local","United Kingdom of Great Britain and Northern Ireland","2019-10-15","2020-09-15","Pregnant or parturient women","Adults (18-64 years)",11256.0,0.17,"","","Sequential","Not reported","Moderate","Preprint","Edward Mullins","University of Oxford","https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3954923","Unverified","","NR",0.989,0.996,"","GB",""
"2021-11-25","211115_Foggia_UniversityHospital“Ospedali Riuniti”Foggia_general_primary","Increased SARS-CoV-2 seroprevalence in healthy blood donors after the second pandemic wave in South-Eastern Italy: evidence for asymptomatic young donors as potential virus spreaders.","2021-11-16","Local","Italy","2020-05-15","2021-03-15","Blood donors","Multiple groups",8183.0,0.063,"","","Convenience","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Francescopaolo Antonucci","University Hospital “Ospedali Riuniti” Foggia","https://dx.doi.org/10.1080/23744235.2021.2003856","Unverified","","NR","","","","IT",""
"2021-11-25","211931_Texas_UniversityOfTexas_Adults1_Primary","Texas Coronavirus Antibody Response Survey October 2021","2021-10-31","Regional","United States of America; Texas","","2021-10-04","Household and community samples","Multiple groups",83977.0,0.231,0.229,0.234,"Self-referral","Total Antibody","Moderate","Institutional Report","The University of Texas Health Science Center at Houston","University of Texas Health Science Center","https://sph.uth.edu/projects/texascares/docs/TexasCARES%20-%20October%20Report.pdf","Unverified","","NR","","","","US","US-TX"
"2021-11-29","211120_Italy_UniversitàCattolicadelSacroCuore_Primary","Seroprevalence of sars-cov-2 in a large cohort of italian police officers","2021-11-21","National","Italy","2020-04-15","2020-07-15","Essential non-healthcare workers","Multiple groups",10535.0,0.048,0.044,0.053,"Self-referral","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Sergio Garbarino","Università Cattolica del Sacro Cuore","http://dx.doi.org/10.3390/ijerph182212201","Unverified","","NR","",1.0,"","IT",""
"2021-11-30","210430_StLouis_WashingtonUniversityinStLouis_Overall","Limited Diagnostic Utility of SARS-CoV2 Serologic Testing in Symptomatic PCR Negative Patients","2021-04-30","Local","United States of America; Missouri; St. Louis","2020-08-29","2020-09-19","Residual sera","Multiple groups",393.0,0.036,"","","Convenience","IgG","High","Preprint","Kwaku D Tawiah","Washington University in St. Louis","10.1093/jalm/jfab021","Unverified","","NR","","","","US","US-MO"
"2021-11-30","210528_Lille_OscarLambretComprehensiveCancerCenter","Very low seroprevalence of sars-cov-2 among health care personnel (HCP) in a French northern comprehensive cancer center at the end of first national containment","2021-05-28","Local","France; Hauts-de-France; Lille","2020-05-04","2020-06-26","Health care workers and caregivers","Adults (18-64 years)",392.0,0.018,0.007,0.036,"Convenience","Not reported","High","Presentation or Conference","Philippe Doutrelant","Oscar Lambret Comprehensive Cancer Center","https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.e13604","Unverified","","NR","","","","FR","FR-HDF"
"2021-11-30","210721_France_UniversitedeParis_PREVENIR_Primary","SARS CoV-2 seroprevalence among HIV-negative participants using tenofovir/emtricitabine-based PrEP in 2020-a sub-study of PREVENIR-ANRS and SAPRIS-Sero","2021-07-21","National","France","2020-05-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",844.0,0.103,"","","Unclear","IgG","High","Presentation or Conference","C Delaugerre","Université de Paris","https://onlinelibrary.wiley.com/doi/full/10.1002/jia2.25755","Unverified","","NR","","","","FR",""
"2021-11-30","210721_France_UniversitedeParis_SAPRIS-Sero_Primary","SARS CoV-2 seroprevalence among HIV-negative participants using tenofovir/emtricitabine-based PrEP in 2020-a sub-study of PREVENIR-ANRS and SAPRIS-Sero","2021-07-21","National","France","2020-05-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",844.0,0.092,"","","Unclear","IgG","High","Presentation or Conference","C Delaugerre","Université de Paris","https://onlinelibrary.wiley.com/doi/full/10.1002/jia2.25755","Unverified","","NR","","","","FR",""
"2021-11-30","210914_Chennai_NationalInstituteofEpidemiology_Overall_PopandTestAdjusted","Monitoring the trend of SARS-CoV-2 seroprevalence in Chennai, India, July and October 2020","2021-09-14","Local","India; Tamil Nadu; Chennai","2020-10-08","2020-10-15","Household and community samples","Multiple groups",6366.0,0.301,0.247,0.361,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Muthusamy Santhosh Kumar","National Institute of Epidemiology","https://doi.org/10.1093/trstmh/trab136","Unverified","","NR",1.0,0.996,"","IN","IN-TN"
"2021-11-30","211001_Israel_MaccabiHealthcareServices_Overall_TestAdjusted","COVID-19 seropositive rates between the Waves, Israel","2021-10-01","National","Israel","2020-06-28","2020-07-27","Residual sera","Multiple groups",15459.0,0.019,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Anat Ekka Zohar","Maccabi Healthcare Services","https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2021&month=10&page=611","Unverified","","NR","","","","IL",""
"2021-11-30","211027_SicilianRegion_UniversityOfCatania_Primary","How to Prevent SARS-CoV-2 Transmission in the Agri-Food Industry during the First Pandemic Wave: Effects on Seroprevalence","2021-10-27","Local","Italy; Sicilian","2020-04-01","2020-06-30","Non-essential workers and unemployed persons","Multiple groups",328.0,0.0,"","","Entire sample","IgG; IgM","High","Journal Article (Peer-Reviewed)","Ermanno Vitale","University of Catania","https://www.mdpi.com/2076-3417/11/21/10051/htm","Unverified","","NR","","","","IT",""
"2021-11-30","211118_Delhi_RajivGandhiSuperSpecialityHospital","Evaluation of SARS-CoV-2 antibody responses in healthcare workers at a tertiary care COVID 19 dedicated hospital in Delhi.","2021-11-18","Local","India","2020-10-01","2020-10-31","Health care workers and caregivers","Adults (18-64 years)",305.0,0.22,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","B.L. Sherwal","Rajiv Gandhi Super Speciality Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.11.006","Unverified","","NR","","","","IN",""
"2021-11-30","211119_Malawi_Malawi-Liverpool-WellcomeTrustClinicalResearchProgramme_Primary","SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021.","2021-11-19","National","Malawi","2020-01-15","2021-07-15","Blood donors","Multiple groups",5085.0,0.276,"","","Simplified probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Jonathan Mandolo","Malawi-Liverpool-Wellcome Trust Clinical Research Programme","https://dx.doi.org/10.1186/s12916-021-02187-y","Unverified","","NR","","","","MW",""
"2021-11-30","211119_RiodeJaneiro_FundaçãoOswaldoCruz_Primary","Anti-SARS-CoV-2 antibodies seroprevalence among patients submitted to treatment for tuberculosis in Rio de Janeiro, Brazil: a cross-sectional study","2021-11-19","Local","Brazil","2020-09-01","2021-02-28","Patients seeking care for non-COVID-19 reasons","Multiple groups",83.0,0.265,0.17,0.36,"Convenience","IgG; IgM","High","Preprint","Karen Gomes","Fundação Oswaldo Cruz","10.1101/2021.11.17.21266274","Unverified","","NR","","","","BR",""
"2021-11-30","211120_ChapelHill_UniversityofNorthCarolinaatChapelHill_3Months_Primary","A prospective study of asymptomatic SARS-CoV-2 infection among individuals involved in academic research under limited operations during the COVID-19 pandemic","2021-11-20","Local","United States of America; North Carolina; Chapel Hill","2020-07-15","2020-12-15","Multiple populations","Adults (18-64 years)",751.0,0.101,0.074,0.127,"Convenience","IgG","Moderate","Preprint","Audrey Pettifor","University of North Carolina at Chapel Hill","https://www.medrxiv.org/content/10.1101/2021.11.17.21266367v1.full-text","Unverified","","NR",0.98,1.0,"","US","US-NC"
"2021-11-30","211121_Bengui_UniversityofBangui","Very high relative seroprevalence of anti-SARS-CoV-2 antibodies among communities in Bangui, Central African Republic","2021-11-21","Local","Central African Republic","2021-07-12","2021-08-20","Household and community samples","Multiple groups",799.0,0.741,"","","Simplified probability","Total Antibody","Low","Preprint","Alexandre Manirakiza","University of Bangui","https://www.medrxiv.org/content/10.1101/2021.11.18.21266496v1.full-text","Unverified","","NR","",0.994,"","CF",""
"2021-11-30","211123_SaudiArabia_JohnsHopkinsAramcoHealthcare","Seroprevalence of Antibodies against SARS-CoV-2 Infection among Healthcare Workers at a Tertiary Hospital in Saudi Arabia","2021-11-23","Local","Saudi Arabia; Eastern Province; Dhahran","2020-06-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",682.0,0.127,"","","Convenience","IgG","Moderate","Preprint","Hayat Mushcab","Johns Hopkins Aramco Healthcare","10.21203/rs.3.rs-1102731/v1","Unverified","","NR",1.0,1.0,"","SA","SA-04"
"2021-11-30","211124_Germany_RobertKochInstitute_Primary","Germany's low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study","2021-11-24","National","Germany","2020-10-15","2020-11-15","Household and community samples","Multiple groups",14781.0,0.013,0.009,0.017,"Stratified probability","IgG","Low","Preprint","Hannelore Neuhauser","Robert Koch Institute","10.1101/2021.11.22.21266711","Unverified","","NR",0.811,0.997,"","DE",""
"2021-11-30","211124_Texas_TheUniversityofTexasHealthScienceCenter_Primary","Durability of SARS-CoV-2 Antibodies from Natural Infection in Children and Adolescents","2021-11-24","Regional","United States of America; Texas","2020-10-15","2021-07-15","Household and community samples","Multiple groups",159.0,0.434,"","","Convenience","Total Antibody","High","Preprint","Sarah Messiah","The University of Texas Health Science Center","10.1101/2021.11.21.21266484","Unverified","","NR",0.97,0.97,"","US","US-TX"
"2021-12-01","210413_Stockholm_TheStockholmRegion","13 april: Lägesrapport om covid-19","2021-04-13","Local","Sweden","2021-04-05","2021-04-11","Household and community samples","Multiple groups",2084.0,0.509,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/13-april-lagesrapport-om-covid-19/","Verified","","NR","","","","SE",""
"2021-12-01","210420_Stockholm_TheStockholmRegion","20 april: Lägesrapport om covid-19","2021-04-20","Local","Sweden","2021-04-12","2021-04-18","Household and community samples","Multiple groups",868.0,0.576,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/mall-lagesrapport-med-tabell/","Verified","","NR","","","","SE",""
"2021-12-01","210427_Stockholm_TheStockholmRegion","27 april: Lägesrapport om covid-19","2021-04-27","Local","Sweden","2021-04-19","2021-04-25","Household and community samples","Multiple groups",953.0,0.615,"","","Unclear","Not reported","Unclear","Institutional Report","The Stockholm Region","The Stockholm Region","https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/27-april-Lagesrapport-om-ovid-19/","Verified","","NR","","","","SE",""
"2021-12-01","211105_Mexico_InstitutoNacionaldeSaludPublica_Adolescent_Primary","Seroprevalence of SARS-CoV-2 in Mexican children and adolescents in primary and secondary education age","2021-11-05","National","Mexico","2020-08-15","2020-11-15","Household and community samples","Children and Youth (0-17 years)",944.0,0.187,0.149,0.225,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Francisco Canto-Osorio","Instituto Nacional de Salud Públic","https://saludpublica.mx/index.php/spm/article/view/12847","Unverified","","NR",0.92,0.995,"","MX",""
"2021-12-01","211105_Mexico_InstitutoNacionaldeSaludPublica_Children_Primary","Seroprevalence of SARS-CoV-2 in Mexican children and adolescents in primary and secondary education age","2021-11-05","National","Mexico","2020-08-15","2020-11-15","Household and community samples","Children and Youth (0-17 years)",858.0,0.267,0.221,0.313,"Stratified probability","IgG","Low","Journal Article (Peer-Reviewed)","Francisco Canto-Osorio","Instituto Nacional de Salud Públic","https://saludpublica.mx/index.php/spm/article/view/12847","Unverified","","NR",0.92,0.995,"","MX",""
"2021-12-01","211109_Nayarit_AutonomousUniversityofNayarit_overall","Anti-SARS CoV-2 IgG levels in children from Nayarit, Mexico, as a biomarker of community immunity. Case study of 17 months after the COVID-19 pandemic","2021-11-09","Local","Mexico; Nayarit; Ciudad de Tepic","2021-06-28","2021-06-28","Household and community samples","Children and Youth (0-17 years)",134.0,0.17,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Gladys Alejandra Toledo-Ibarra","Autonomous University of Nayarit","https://saludpublica.mx/index.php/spm/article/view/13128/12175","Unverified","","NR","","","","MX","MX-NAY"
"2021-12-01","211110_PalmBeachCounty_FloridaDepartmentofHealth_overall","SARS-CoV-2 Seroprevalence in Florida Department of Health in Palm Beach County Obstetric Clinics: A Cross-Sectional Study during the First Pandemic Surge.","2021-11-10","Local","United States of America; Florida; Lantana, West Palm Beach, Delray Beach, Belle Glade","2020-06-29","2020-08-05","Pregnant or parturient women","Adults (18-64 years)",618.0,0.264,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Charles Gonik","Wayne State University School of Medicine","https://dx.doi.org/10.1055/s-0041-1739353","Unverified","","NR",1.0,0.996,"","US","US-FL"
"2021-12-01","211116_SouthAndaman_AndamanandNicobarIslandsInstituteofMedicalSciences_Overall","A seroprevalence study of Covid 19 antibody after 1st wave of the pandemic in South Andaman district, India.","2021-11-16","Local","India; Andaman and Nicobar Islands","2020-12-15","2021-02-15","Household and community samples","Multiple groups",2400.0,0.393,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Deepak Kumar","Andaman and Nicobar Islands Institute of Medical Sciences","https://dx.doi.org/10.1016/j.cegh.2021.100901","Unverified","","NR",0.95,0.993,"","IN","IN-AN"
"2021-12-01","211117_Norway_OsloUniversityHospital_KidneyTransplantRecipient","Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway.","2021-11-17","National","Norway","2020-06-15","2020-10-31","Representative patient population","Multiple groups",815.0,0.0,"","","Convenience","IgG","High","Preprint","Kjersti B. Blom","Oslo University Hospital","https://dx.doi.org/10.1016/j.xkme.2021.09.006","Unverified","","NR","","","","NO",""
"2021-12-01","211119_Kashmir_GovernmentMedicalCollegeSrinagarJammuKashmir_Primary","The burden of SARS-CoV-2 among healthcare workers across 16 hospitals of Kashmir, India-A seroepidemiological study.","2021-11-19","Regional","India; Kashmir","2021-01-14","2021-01-17","Health care workers and caregivers","Adults (18-64 years)",2003.0,0.268,0.248,0.288,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Inaamul Haq","Government Medical College Srinagar, Jammu and Kashmir","https://dx.doi.org/10.1371/journal.pone.0259893","Unverified","","NR",1.0,0.99,"","IN","IN-JK"
"2021-12-01","211122_Germany_SaarlandUniversity_PEP/PrEP_Primary","IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.","2021-11-22","Regional","Germany; South-west Germany","2020-04-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",50.0,0.06,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Dominic Kaddu-Mulindwa","Saarland University","https://dx.doi.org/10.1111/hiv.13207","Unverified","","NR","","","","DE",""
"2021-12-01","211122_Germany_SaarlandUniversity_PLWH_Primary","IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.","2021-11-22","Regional","Germany; South-west Germany","2020-04-01","2020-06-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",594.0,0.019,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Dominic Kaddu-Mulindwa","Saarland University","https://dx.doi.org/10.1111/hiv.13207","Unverified","","NR","","","","DE",""
"2021-12-01","211122_Montreal_UniversityOfMontreal","Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.","2021-11-23","Local","Canada; Quebec; Montreal","2020-10-22","2021-03-22","Students and Daycares","Children and Youth (0-17 years)",1632.0,0.058,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Kate Zinszer","University of Montreal","https://dx.doi.org/10.1001/jamanetworkopen.2021.35975","Unverified","","NR",0.95,1.0,"","CA","CA-QC"
"2021-12-01","211122_OrangeCounty_UniversityofCalifornia_Primary","Infection prevention strategies are highly protective in COVID-19 units while main risks to healthcare professionals come from coworkers and the community.","2021-11-22","Local","United States of America; California","2020-05-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",654.0,0.133,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Shruti Gohil","University of California","https://dx.doi.org/10.1186/s13756-021-01031-5","Unverified","","NR","","","","US","US-CA"
"2021-12-01","211122_SanJuandeLurigancho_InstitutodeInvestigacionNutricional_overall","SARS-CoV-2 Infections in Households in a Peri-Urban Community of Lima, Peru: A Prospective Cohort Study","2021-11-22","Local","Peru","2020-12-09","2021-03-19","Household and community samples","Multiple groups",132.0,0.098,0.054,0.162,"Sequential","IgG","High","Preprint","Claudio Lanata","Vanderbilt University and Vanderbilt University Medical Center","10.2139/ssrn.3961370","Unverified","","NR","","","","PE",""
"2021-12-01","211123_Athens_UniversityofAthens_June_Overall","A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021.","2021-11-23","Local","Greece; Attica; Athens","2021-06-01","2021-06-22","Residual sera","Multiple groups",764.0,0.557,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Helena Maltezou","University of Athens","https://dx.doi.org/10.1002/jmv.27465","Unverified","","NR","","","","GR","GR-I"
"2021-12-01","211123_Athens_UniversityofAthens_March_Overall","A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021.","2021-11-23","Local","Greece; Attica; Athens","2021-03-01","2021-03-22","Residual sera","Multiple groups",901.0,0.116,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Helena Maltezou","University of Athens","https://dx.doi.org/10.1002/jmv.27465","Unverified","","NR","","","","GR","GR-I"
"2021-12-01","211123_Perpignan_PerpignanHospitalCenter_Overall","Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.","2021-11-23","Local","France; Occitanie; Perpignan","2020-06-29","2020-07-17","Household and community samples","Multiple groups",700.0,0.354,0.302,0.41,"Stratified probability","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Adeline Beaumont","Perpignan Hospital Center","https://dx.doi.org/10.1136/bmjopen-2021-053201","Unverified","","NR",0.995,0.998,"","FR","FR-OCC"
"2021-12-02","211102_Sweden_UniversityofGothenburg_BloodDonorsTP5_N+S","Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses.","2021-11-02","Local","Sweden","2021-01-12","2021-01-29","Blood donors","Multiple groups",253.0,0.119,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Emelie Marklund","University of Gothenburg","https://dx.doi.org/10.3389/fimmu.2021.750448","Verified","","NR","","","","SE",""
"2021-12-02","211102_Sweden_UniversityofGothenburg_HCWsTP5_N+S","Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses.","2021-11-02","Local","Sweden","2021-01-12","2021-01-29","Health care workers and caregivers","Multiple groups",280.0,0.293,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Emelie Marklund","University of Gothenburg","https://dx.doi.org/10.3389/fimmu.2021.750448","Verified","","NR","","","","SE",""
"2021-12-02","211112_Zurich_UniversityofZurich_T3","Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona.","2021-11-12","Regional","Switzerland; Zurich","2021-03-15","2021-04-16","Students and Daycares","Children and Youth (0-17 years)",1965.0,0.155,"","","Stratified probability","IgA; IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Agne Ulyte","University of Zurich","https://dx.doi.org/10.4414/smw.2021.w30092","Unverified","","NR",0.982,0.994,"","CH","CH-ZH"
"2021-12-02","211116_Bratislava_SlovakAcademyOfSciences","Seroprevalence of SARS-CoV-2 IgG antibodies in the staff of the Slovak Academy of Sciences in response to COVID-19 and/or vaccination: situation in August 2021.","2021-11-16","Local","Slovakia","2021-07-01","2021-08-15","Non-essential workers and unemployed persons","Multiple groups",1928.0,0.841,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Ivana Kajanova","Slovak Academy Of Sciences","https://dx.doi.org/10.4149/av_2021_407","Unverified","","NR",0.944,0.996,"","SK",""
"2021-12-02","211121_NewYorkCity_ IcahnSchoolofMedicine","SARS-CoV-2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort.","2021-11-21","Local","United States of America; New York; New York City","2020-04-20","2020-09-22","Pregnant or parturient women","Adults (18-64 years)",696.0,0.151,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Nina Molenaar","Icahn School of Medicine","https://dx.doi.org/10.1111/ppe.12812","Unverified","","NR",0.95,1.0,"","US","US-NY"
"2021-12-02","211122_RioGrandedoSul_UniversidadeFederaldePelotas_Round10_Overall","Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil.","2021-11-22","Regional","Brazil; Rio Grande do Sul","2021-04-09","2021-04-11","Household and community samples","Multiple groups",4499.0,0.182,0.169,0.195,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Aluisio Barros","Universidade Federal de Pelotas","https://www.scielosp.org/article/rsp/2021.v55/78/","Unverified","","NR",0.95,0.986,"","BR","BR-RS"
"2021-12-02","211122_RioGrandedoSul_UniversidadeFederaldePelotas_Round9_Overall","Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil.","2021-11-22","Regional","Brazil; Rio Grande do Sul","2021-02-05","2021-02-07","Household and community samples","Multiple groups",4501.0,0.1,0.091,0.11,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Aluisio Barros","Universidade Federal de Pelotas","https://www.scielosp.org/article/rsp/2021.v55/78/","Unverified","","NR",0.95,0.986,"","BR","BR-RS"
"2021-12-02","211124_EastHararghe_UniversityofLondon_Overall","Seroprevalence of anti-SARS-CoV-2 antibodies in women attending antenatal care in eastern Ethiopia: a facility-based surveillance.","2021-11-24","Regional","Ethiopia; Oromia, Harari; Haramaya, Harar","2020-04-01","2021-03-31","Pregnant or parturient women","Adults (18-64 years)",1447.0,0.057,0.046,0.07,"Simplified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Nega Assefa","The London School of Hygiene & Tropical Medicine","https://dx.doi.org/10.1136/bmjopen-2021-055834","Verified","","NR",1.0,0.988,"","ET",""
"2021-12-03","211125_France_UnitédesVirusÉmergents_Overall_PopAdjusted","Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France.","2021-11-25","National","France; Haut de France, Normandi, Ile de France, Bretagne, Grand Est, Bourgogne France Comte, Centre val de Loire, Auvergne Rhome Alpes, Pays de Loire, Occitanie, Nouvelle Aquitaine, Provence-Alpes-Côte d'Azur","2020-05-04","2020-09-30","Household and community samples","Multiple groups",82126.0,0.051,0.049,0.054,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Fabrice Carrat","Unité des Virus Émergents","https://dx.doi.org/10.1007/s15010-021-01731-5","Unverified","","NR",0.87,0.975,"","FR",""
"2021-12-06","211126_Jazan_JazanUniversity_Primary","Community-based seroprevalence of sars-cov-2 antibodies following the first wave of the covid-19 pandemic in jazan province, saudi arabia","2021-11-26","Regional","Saudi Arabia; Jazan province","2020-08-25","2020-12-30","Household and community samples","Multiple groups",594.0,0.258,0.212,0.3,"Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Abdulaziz Alhazmi","Jazan University","http://dx.doi.org/10.3390/ijerph182312451","Unverified","","NR","","","","SA","SA-09"
"2021-12-06","211130_France_SorbonneParisNordUniversity_Primary","Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Sante cohort.","2021-11-30","National","France","2020-05-15","2020-10-15","Blood donors","Multiple groups",7766.0,0.04,"","","Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Melanie Deschasaux-Tanguy","Sorbonne Paris Nord University","https://dx.doi.org/10.1186/s12916-021-02168-1","Unverified","","NR","","","","FR",""
"2021-12-06","211201_Veneto_MonastierDiTrevisoHospital_Primary","Epidemiological study in a small rural area of Veneto (Italian region) during Sars-Cov-2 Pandemia.","2021-12-01","Local","Italy; Veneto","2020-05-04","2020-07-15","Household and community samples","Multiple groups",922.0,0.021,"","","Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Marco Bassanello","Monastier di Treviso Hospital","https://dx.doi.org/10.1038/s41598-021-02654-9","Unverified","","NR","","","","IT","IT-34"
"2021-12-06","211202_Philadelphia_UniversityofPennsylvania_Overall","Evolution of SARS-CoV-2 Seroprevalence Among Employees of a United States Academic Children's Hospital During the COVID-19 Pandemic.","2021-12-02","Local","United States of America; Pennsylvania; Philadelphia","2020-04-20","2020-11-04","Health care workers and caregivers","Multiple groups",1740.0,0.053,"","","Convenience","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Brian T Fisher","University of Pennsylvania","https://dx.doi.org/10.1017/ice.2021.487","Unverified","","NR",1.0,0.989,"","US","US-PA"
"2021-12-07","211029_Maharashtra_ArmedForcesMedicalCollege_Primary","Impact of Safety Measures in Endoscopic Procedures in Health Care Professionals during Corona Virus Pandemic","2021-10-29","Regional","India; Maharashtra","2020-08-01","2020-08-31","Health care workers and caregivers","Adults (18-64 years)",117.0,0.325,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Harish Kumur","Armed Forces Medical College","https://www.journaljpri.com/index.php/JPRI/article/view/33074","Unverified","","NR","","","","IN","IN-MH"
"2021-12-07","211105_Gauteng_NationalHealthLaboratoryService_OverallFullAdjust","Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August- October 2020","2021-11-05","Regional","South Africa; Gauteng","2020-08-01","2020-10-31","Residual sera","Multiple groups",6477.0,0.278,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Jaya George","National Health Laboratory Service","https://doi.org/10.7196/SAMJ.2021.v111i11.15669","Unverified","","NR",0.93,0.99,"","ZA","ZA-GT"
"2021-12-07","211112_Ruhr_RuhrUniversityBochum_Primary","Longitudinal Rise in Seroprevalence of SARS-CoV-2 Infections in Children in Western Germany-A Blind Spot in Epidemiology?.","2021-11-12","Regional","Germany; Ruhr; Bochum, Gütersloh, Herne","2020-06-15","2021-02-15","Residual sera","Children and Youth (0-17 years)",2145.0,0.026,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Folke Brinkmann","Ruhr University Bochum","https://dx.doi.org/10.3390/idr13040088","Verified","","NR","","","","DE",""
"2021-12-07","211123_Mongolia_MongolianNationalUniversityofMedicalSciences_Primary","SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey.","2021-11-23","National","Mongolia","2020-10-13","2020-12-04","Household and community samples","Multiple groups",5000.0,0.014,0.011,0.016,"Stratified probability","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Battogtokh Chimeddorj","Mongolian National University of Medical Sciences","https://dx.doi.org/10.1016/j.lanwpc.2021.100317","Unverified","","NR","","","","MN",""
"2021-12-07","211128_Prishtina_MunicipalityofPrishtina_Primary","Seroprevalence of anti-SARS-CoV-2 antibodies among municipal staff in the municipality of Prishtina","2021-11-28","Local","Kosovo","2020-10-01","2020-11-30","Non-essential workers and unemployed persons","Adults (18-64 years)",418.0,0.211,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Bujar Gashi","Municipality of Prishtina","http://dx.doi.org/10.3390/ijerph182312545","Unverified","","NR","","","","XK",""
"2021-12-08","210501_Ithaca_CornellUniversity_Primary_AntiRBD","Development of a quantitative COVID-19 Multiplex Assay and its use for serological surveillance in a low SARS-CoV-2 incidence community","2021-05-01","Local","United States of America; New York; Ithaca","2020-06-01","2020-06-15","Household and community samples","Multiple groups",332.0,0.051,"","","Unclear","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Cassandra Guarino","Cornell University","https://www.jimmunol.org/content/206/1_Supplement/114.11?ct=&utm_source=TrendMD&utm_medium=cpc&utm_campaign=J_Immunol_TrendMD_1","Unverified","","NR","","","","US","US-NY"
"2021-12-08","211111_Brazil_UniversidadedeSantaCruzdoSul_Primary","[Social distancing as protection factor against COVID-19 in a non-metropolitan area in the State of Rio Grande do Sul, BrazilLas medidas de distanciamiento social como factor de proteccion contra la COVID-19 en el interior de Rio Grande do Sul, Brasil].","2021-11-11","Regional","Brazil; Vale do Rio Pardo","2020-08-01","2020-10-17","Household and community samples","Multiple groups",4252.0,0.029,"","","Stratified probability","IgG; IgM","Low","Journal Article (Peer-Reviewed)","Ana Schneider","Universidade de Santa Cruz do Sul","https://dx.doi.org/10.26633/RPSP.2021.145","Unverified","","NR",0.968,0.976,"","BR",""
"2021-12-08","211118_Guangdong_GuangzhouMedicalUniversity_OverallPopAdjust","Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020.","2021-11-18","Regional","China; Guangdong; Chaozhou,Heyuan,Jiangmen,Jieyang,Maoming,Meizhou,Qingyuan,Shantou,Shanwei,Shaoguan,Yangjiang,Yunfu,Zhanjiang,Zhaoqing,Dongguan,Foshan,Guangzhou,Huizhou,Shenzhen,Zhongshan,Zhuhai","2020-03-11","2020-06-24","Residual sera","Multiple groups",14629.0,0.002,0.001,0.002,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Cheng Xiao","Guangzhou Medical University","https://www.mdpi.com/2076-0817/10/11/1505/htm","Unverified","","NR",0.896,0.992,"","CN","CN-44"
"2021-12-09","211105_Sergipe_FederalUniversityofSergipe_Phase1_Overall","Does In-Person Visiting Affect the Number of COVID-19 Cases in Prisons?.","2021-11-05","Regional","Brazil; Sergipe","2020-08-31","2020-09-09","Persons who are incarcerated","Multiple groups",778.0,0.32,"","","Simplified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Lysandro Pinto Borges","Federal University of Sergipe","https://dx.doi.org/10.3390/life11111184","Unverified","","NR",0.97,0.99,"","BR","BR-SE"
"2021-12-09","211105_Sergipe_FederalUniversityofSergipe_Phase2","Does In-Person Visiting Affect the Number of COVID-19 Cases in Prisons?.","2021-11-05","Regional","Brazil; Sergipe","2020-10-05","2020-10-09","Persons who are incarcerated","Multiple groups",453.0,0.196,"","","Simplified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Lysandro Pinto Borges","Federal University of Sergipe","https://dx.doi.org/10.3390/life11111184","Unverified","","NR",0.97,0.99,"","BR","BR-SE"
"2021-12-09","211128_SanFrancisco_UniversityofCalifornia_Round3","Development and Implementation of Dried Blood Spot-based COVID-19 Serological Assays for Epidemiologic Studies","2021-11-28","Regional","United States of America; California","2021-02-15","2021-04-15","Household and community samples","Multiple groups",4641.0,0.313,"","","Convenience","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Marcus Wong","University of California","https://www.medrxiv.org/content/10.1101/2021.11.25.21266786v1.full-text","Unverified","","NR","","","","US","US-CA"
"2021-12-09","211128_SanFrancisco_UniversityofCalifornia_Round3_S+N","Development and Implementation of Dried Blood Spot-based COVID-19 Serological Assays for Epidemiologic Studies","2021-11-28","Regional","United States of America; California","2021-02-15","2021-04-15","Household and community samples","Multiple groups",4641.0,0.018,"","","Convenience","Total Antibody; IgG","Moderate","Journal Article (Peer-Reviewed)","Marcus Wong","University of California","https://www.medrxiv.org/content/10.1101/2021.11.25.21266786v1.full-text","Unverified","","NR","","","","US","US-CA"
"2021-12-09","211201_Wuhan_ZhongnanHospitalUniversityOfWuhan_IgG","Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients.","2021-12-01","Local","China; Hubei; Wuhan","2020-03-01","2020-06-30","Multiple populations","Multiple groups",21398.0,0.046,0.043,0.049,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Yufeng Shang","University of Wuhan Zhongnan Hospital","https://dx.doi.org/10.1002/jmv.27483","Unverified","","NR","","","","CN","CN-42"
"2021-12-13","211115_Ireland_RoyalCollegeofSurgeonsinIreland","Babies born in the 1st 2020 lockdown: Early data from the CORAL study","2021-11-15","National","Ireland","2020-03-15","2020-05-15","Perinatal","Children and Youth (0-17 years)",200.0,0.015,"","","Unclear","Not reported","Unclear","Journal Article (Peer-Reviewed)","Marguerite Lawler","Royal College of Surgeons in Ireland","http://dx.doi.org/10.1111/all.15095","Unverified","","NR","","","","IE",""
"2021-12-13","211125_Ireland_IrishBloodTransfusionService_Primary","Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection.","2021-11-25","National","Ireland","2020-02-15","2020-09-15","Blood donors","Multiple groups",8509.0,0.024,0.021,0.028,"Simplified probability","IgG; IgM; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Dearbhla Butler","Irish Blood Transfusion Service","https://dx.doi.org/10.1016/j.jcv.2021.105045","Unverified","","NR","","","","IE",""
"2021-12-13","211207_MayoClinicRochester_MayoClinic","Autoimmune encephalitis after SARS-CoV-2 infection","2021-12-07","Local","United States of America; Minnesota; Rochester","2019-10-15","2020-12-15","Residual sera","Multiple groups",556.0,0.032,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Cristina Sanchez","Mayo Clinic","http://dx.doi.org/10.1212/WNL.0000000000012931","Unverified","","NR","","","","US","US-MN"
"2021-12-13","211208_SaudiArabia_JohnsHopkinsAramcoHealthcare_Primary","High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia.","2021-12-08","National","Saudi Arabia","2020-08-01","2020-08-31","Household and community samples","Multiple groups",5629.0,0.502,0.488,0.515,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Sami Almudarra","Saudi Ministry of Health","https://dx.doi.org/10.1007/s15010-021-01726-2","Unverified","","NR","","","","SA",""
"2021-12-14","211021_Armenia_EcoSenseDiagnosticCenter","Serological investigation of covid 19 antibodies in Armenia","2021-10-21","National","Armenia","2020-03-15","2020-12-15","Household and community samples","Multiple groups",837.0,0.253,"","","Self-referral","IgG","High","Presentation or Conference","I Nazaryan","EcoSense Diagnostic Center","http://dx.doi.org/10.1515/cclm-2021-5027","Unverified","","NR","","","","AM",""
"2021-12-14","211022_Canada_UniversityofAlberta","COVID-19 infection and mental wellness in a Canadian cohort study of healthcare workers","2021-10-22","National","Canada; British Columbia, Alberta, Ontario, and Quebec","2020-03-19","2020-09-22","Health care workers and caregivers","Adults (18-64 years)",5135.0,0.002,"","","Unclear","Not reported","Unclear","Presentation or Conference","Nicola Cherry","University of Alberta","http://dx.doi.org/10.1136/OEM-2021-EPI.34","Unverified","","NR","","","","CA",""
"2021-12-14","211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVneg_MarApr2021","People with HIV and suppressed viremia on ART are not at increased risk for acquiring SARS-CoV- 2 infection","2021-10-27","Local","Netherlands","2021-03-01","2021-04-30","Residual sera","Multiple groups",288.0,0.122,"","","Convenience","Total Antibody","High","Presentation or Conference","M.L. Verburgh","Amsterdam University Medical Centers","http://dx.doi.org/10.1111/hiv.13183","Unverified","","NR","","","","NL",""
"2021-12-14","211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVneg_SepOct2020","People with HIV and suppressed viremia on ART are not at increased risk for acquiring SARS-CoV- 2 infection","2021-10-27","Local","Netherlands","2020-09-01","2020-10-31","Residual sera","Multiple groups",312.0,0.067,"","","Convenience","Total Antibody","High","Presentation or Conference","M.L. Verburgh","Amsterdam University Medical Centers","http://dx.doi.org/10.1111/hiv.13183","Unverified","","NR","","","","NL",""
"2021-12-14","211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVpos_MarApr2021","People with HIV and suppressed viremia on ART are not at increased risk for acquiring SARS-CoV- 2 infection","2021-10-27","Local","Netherlands","2021-03-01","2021-04-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",202.0,0.129,"","","Convenience","Total Antibody","High","Presentation or Conference","M.L. Verburgh","Amsterdam University Medical Centers","http://dx.doi.org/10.1111/hiv.13183","Unverified","","NR","","","","NL",""
"2021-12-14","211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVpos_SepOct2020","People with HIV and suppressed viremia on ART are not at increased risk for acquiring SARS-CoV- 2 infection","2021-10-27","Local","Netherlands","2020-09-01","2020-10-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",236.0,0.055,"","","Convenience","Total Antibody","High","Presentation or Conference","M.L. Verburgh","Amsterdam University Medical Centers","http://dx.doi.org/10.1111/hiv.13183","Unverified","","NR","","","","NL",""
"2021-12-14","211029_Cairo_AinShamsUniversity","Seropositive coronavirus disease 2019 detection among apparently healthy voluntary blood donors: a preliminary step to catch asymptomatic cases as a potential viral spread route","2021-10-29","Local","Egypt","2020-09-06","2020-10-31","Blood donors","Adults (18-64 years)",100.0,0.38,"","","Simplified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Sahar Abdelmaksoud","Ain-Shams University","https://www.ehj.eg.net/article.asp?issn=1110-1067;year=2021;volume=46;issue=2;spage=65;epage=69;aulast=Abdelmaksoud","Verified","","NR","","","","EG",""
"2021-12-14","211110_Modena_UniversityofModenaandReggioEmilia","eP034 Usefulness of serological antibodies assays to better evaluate the prevalence of SARS-CoV-2 infection in youths with type 1 diabetes","2021-11-10","Local","Italy","2021-01-15","2021-06-15","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",85.0,0.153,"","","Unclear","IgG","Unclear","Presentation or Conference","B Predieri","University of Modena and Reggio Emilia","http://dx.doi.org/10.1111/pedi.13269","Unverified","","NR","","","","IT",""
"2021-12-14","211112_Colombo_UniversityofSriJayewardenepura_Overall","Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka","2021-11-12","Local","Sri Lanka; Western Province; Colombo","2021-01-15","2021-01-31","Household and community samples","Multiple groups",2547.0,0.245,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Chandima Jeewandara","University of Sri Jayewardenepura","https://www.frontiersin.org/articles/10.3389/fpubh.2021.724398/full","Unverified","","NR",0.98,1.0,"","LK","LK-1"
"2021-12-14","211201_GreaterLondon_PublicHealthEngland_Residents","Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.","2021-12-01","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-11","2020-07-26","Assisted living and long-term care facilities","Seniors (65+ years)",459.0,0.577,"","","Convenience","IgG; Not reported","High","Journal Article (Peer-Reviewed)","Anna Jeffery-Smith","Public Health England","https://dx.doi.org/10.1016/S2666-7568(21)00253-1","Unverified","","NR","","","","GB","GB-ENG"
"2021-12-14","211201_GreaterLondon_PublicHealthEngland_Staff","Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.","2021-12-01","Local","United Kingdom of Great Britain and Northern Ireland; England; London","2020-05-11","2020-07-26","Assisted living and long-term care facilities","Adults (18-64 years)",712.0,0.496,"","","Convenience","IgG; Not reported","High","Journal Article (Peer-Reviewed)","Anna Jeffery-Smith","Public Health England","https://dx.doi.org/10.1016/S2666-7568(21)00253-1","Unverified","","NR","","","","GB","GB-ENG"
"2021-12-14","211202_Israel_Tel-AvivUniversity","Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.","2021-12-02","Local","Israel; Tel Aviv District; Ramat Gan","2020-04-04","2020-07-13","Health care workers and caregivers","Adults (18-64 years)",428.0,0.007,0.002,0.02,"Self-referral","IgG","High","Journal Article (Peer-Reviewed)","Yaniv Lustig","Tel-Aviv University","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001690","Unverified","","NR",0.818,0.98,"","IL","IL-TA"
"2021-12-14","211202_Tehran_ImamHosseinHospital","Routine COVID-19 testing may not be necessary for most cancer patients.","2021-12-02","Local","Iran (Islamic Republic of); Tehran; Tehran","2020-08-01","2020-10-30","Patients seeking care for non-COVID-19 reasons","Multiple groups",107.0,0.14,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ali Motlagh","Imam Hossein Hospital","https://dx.doi.org/10.1038/s41598-021-02692-3","Unverified","","NR","","","","IR","IR-07"
"2021-12-14","211207_Calgary_CummingSchoolofMedicine","SARS-CoV-2 seroprevalence, seroconversion and neutralizing antibodies in a systemic lupus erythematosus cohort and comparison to controls.","2021-12-07","Local","Canada; Alberta; Calgary","2020-01-01","2021-01-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",173.0,0.035,"","","Convenience","IgG; IgA","High","Journal Article (Peer-Reviewed)","Hanna Mathew","Cumming School of Medicine, University of Calgary","https://dx.doi.org/10.1177/09612033211063793","Unverified","","NR","","","","CA","CA-AB"
"2021-12-15","211025_Piacenza_1AUSLPiacenza","ELBA03 Efficacy and Safety of COVID-19 Vaccine in Cancer Patients","2021-10-25","Local","Italy; Emilia-Romagna; Piacenza","2021-03-20","2021-05-29","Patients seeking care for non-COVID-19 reasons","Multiple groups",293.0,0.072,"","","Convenience","IgG","High","Presentation or Conference","Biasini C","Azienda Unita Sanitaria Locale di Piacenza","http://dx.doi.org/10.1177/03008916211041664","Unverified","","NR","","","","IT","IT-45"
"2021-12-15","211111_Verona_UniversityofVerona","Inflammatory peripheral neuropathies during the covid-19 pandemic: Is there a relation?","2021-11-11","Local","Italy; Veneto; Verona","2020-01-01","2020-12-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",49.0,0.184,"","","Convenience","IgG; IgA","High","Presentation or Conference","M Trentinaglia","University of Verona","http://dx.doi.org/10.1111/jns.12472","Unverified","","NR","","","","IT","IT-34"
"2021-12-15","211202_Ireland_HealthProtectionSurveillanceCentre_Dublin_OverallCrude","The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A seroprevalence study, June to July 2020.","2021-12-02","Local","Ireland","2020-06-22","2020-07-16","Household and community samples","Multiple groups",913.0,0.031,"","","Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Heavey","Health Protection Surveillance Centre","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001741","Unverified","","NR","","","","IE",""
"2021-12-15","211202_Ireland_HealthProtectionSurveillanceCentre_Sligo_OverallCrude","The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A seroprevalence study, June to July 2020.","2021-12-02","Local","Ireland","2020-06-22","2020-07-16","Household and community samples","Multiple groups",820.0,0.006,"","","Simplified probability","IgG; Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Laura Heavey","Health Protection Surveillance Centre","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001741","Unverified","","NR","","","","IE",""
"2021-12-15","211202_Israel_TelAvivUniversity_Overall","Under-diagnosis of SARS-CoV-2 infections among children aged 0-15 years, a nationwide seroprevalence study, Israel, January 2020 to March 2021.","2021-12-02","National","Israel","2020-01-01","2021-03-31","Residual sera","Children and Youth (0-17 years)",2765.0,0.056,0.048,0.066,"Convenience","IgG; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Victoria Indenbaum","Tel Aviv University","https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2101040","Unverified","","NR","","","","IL",""
"2021-12-15","211207_Philadelphia_ThomasJeffersonUniversity","Comprehensive Serological Profile and Specificity of Maternal and Neonatal Cord Blood SARS CoV-2 Antibodies","2021-12-07","Local","United States of America; Pennsylvania; Philadelphia","2020-04-01","2021-02-28","Pregnant or parturient women","Adults (18-64 years)",76.0,0.2,"","","Convenience","IgG; IgM","High","Preprint","Rupsa Boelig","Thomas Jefferson University","https://www.medrxiv.org/content/10.1101/2021.12.06.21267328v1.full-text","Unverified","","NR","","","","US","US-PA"
"2021-12-15","211208_Scotland_PublicHealthScotland_BloodDonors2_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 8 December 2021","2021-12-08","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-10-11","2021-11-14","Blood donors","Multiple groups",2496.0,0.998,0.994,1.0,"Sequential","IgG","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/","Verified","","NR",0.84,1.0,"","GB","GB-SCT"
"2021-12-15","211208_Scotland_PublicHealthScotland_PregnantWomen3_Overall_Anti-S_Unadj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 8 December 2021","2021-12-08","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-10-11","2021-11-14","Pregnant or parturient women","Adults (18-64 years)",2890.0,0.862,"","","Sequential","Total Antibody","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/","Verified","","NR",0.923,1.0,"","GB","GB-SCT"
"2021-12-15","211208_Scotland_PublicHealthScotland_ResidualSera1_Overall_PopAdj_TestAdj","Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 8 December 2021","2021-12-08","National","United Kingdom of Great Britain and Northern Ireland; Scotland","2021-10-11","2021-11-14","Residual sera","Multiple groups",2882.0,0.805,0.786,0.82,"Stratified probability","Not reported","Moderate","Institutional Report","Public Health Scotland","Public Health Scotland","https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/","Verified","Argentina","NR",0.973,0.996,"","GB","GB-SCT"
"2021-12-15","211209_Kyrgyzstan_SaintPetersburgPasteurInstitute_Overall","SARS-CoV-2 Herd Immunity of the Kyrgyz Population in 2021","2021-12-09","National","Kyrgyzstan","2021-06-28","2021-07-03","Household and community samples","Multiple groups",9471.0,0.487,0.477,0.497,"Simplified probability","IgG","Moderate","Preprint","Anna Popova","Saint Petersburg Pasteur Institute","https://www.researchsquare.com/article/rs-1138128/v1","Unverified","","NR","","","","KG",""
"2021-12-15","211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_HCW_Primary","Prevalence of COVID-19 infection in the prison system in Espirito Santo/Brazil: persons deprived of liberty and justice workers.","2021-12-10","Regional","Brazil; Espírito Santo","2020-08-31","2020-09-04","Health care workers and caregivers","Adults (18-64 years)",311.0,0.119,0.081,0.157,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Adriana Ilha da Silva","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210053","Unverified","","NR",0.974,0.993,"","BR","BR-ES"
"2021-12-15","211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_PDL_Primary","Prevalence of COVID-19 infection in the prison system in Espirito Santo/Brazil: persons deprived of liberty and justice workers.","2021-12-10","Regional","Brazil; Espírito Santo","2020-08-31","2020-09-04","Persons who are incarcerated","Adults (18-64 years)",884.0,0.316,0.284,0.348,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Adriana Ilha da Silva","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210053","Unverified","","NR",0.974,0.993,"","BR","BR-ES"
"2021-12-15","211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_PrisonOfficer_Primary","Prevalence of COVID-19 infection in the prison system in Espirito Santo/Brazil: persons deprived of liberty and justice workers.","2021-12-10","Regional","Brazil; Espírito Santo","2020-08-31","2020-09-04","Essential non-healthcare workers","Adults (18-64 years)",675.0,0.221,0.189,0.253,"Stratified probability","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Adriana Ilha da Silva","Universidade Federal do Espírito Santo","https://dx.doi.org/10.1590/1980-549720210053","Unverified","","NR",0.974,0.993,"","BR","BR-ES"
"2021-12-16","211201_Ermont_CliniqueClaudeBernard_Overall","SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers.","2021-12-01","Local","France; Île-de-France; Ermont","2020-09-15","2020-10-15","Residual sera","Multiple groups",299.0,0.197,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Henri Boulanger","Clinique Claude Bernard","https://dx.doi.org/10.1155/2021/4747221","Unverified","","NR","","","","FR","FR-IDF"
"2021-12-16","211205_CaliforniaBayArea_UniversityofCalifornia_Round3_primary","Impact of individual-level characteristics and transmission mitigation behaviors on SARS-CoV-2 infection and seroprevalence in a large Northern California Bay Area cohort","2021-12-05","Regional","United States of America; California","2021-02-11","2021-03-20","Household and community samples","Multiple groups",4608.0,0.276,0.228,0.335,"Convenience","Total Antibody; IgG","Moderate","Preprint","Cameron Adams","University of California, Berkeley","https://www.medrxiv.org/content/10.1101/2021.12.02.21266871v1.full-text","Unverified","","NR","","","","US","US-CA"
"2021-12-21","211211_California_CaliforniaDepartmentofPublicHealth_Adults_Infection","CalScope: Monitoring SARS-CoV-2 Seroprevalence from Vaccination and Prior Infection in Adults and Children in California May 2021‚Äì July 2021","2021-12-11","Regional","United States of America; California","2021-04-26","2021-08-02","Household and community samples","Multiple groups",7483.0,0.27,0.23,0.31,"Stratified probability","Total Antibody","Low","Preprint","Megha L. Mehrotra","California Department of Public Health","https://www.medrxiv.org/content/10.1101/2021.12.09.21267565v1.full-text","Unverified","","NR",1.0,1.0,"","US","US-CA"
"2021-12-21","211211_California_CaliforniaDepartmentofPublicHealth_Children_Infection","CalScope: Monitoring SARS-CoV-2 Seroprevalence from Vaccination and Prior Infection in Adults and Children in California May 2021‚Äì July 2021","2021-12-11","Regional","United States of America; California","2021-04-26","2021-08-02","Household and community samples","Children and Youth (0-17 years)",1375.0,0.3,0.24,0.36,"Stratified probability","Total Antibody","Low","Preprint","Megha L. Mehrotra","California Department of Public Health","https://www.medrxiv.org/content/10.1101/2021.12.09.21267565v1.full-text","Unverified","","NR",1.0,1.0,"","US","US-CA"
"2021-12-23","211027_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report October 27, 2021 Report #13: August 2021 Survey Tracking seroprevalence in the vaccine era","2021-10-27","National","Canada","2021-08-15","2021-08-26","Blood donors","Multiple groups",9109.0,0.961,0.956,0.965,"Sequential","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Unverified","","",0.988,0.996,"","CA",""
"2021-12-23","211130_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report November 30th, 2021 Report #14: September 2021 Survey Tracking seroprevalence in the vaccine era","2021-11-30","National","Canada","2021-09-14","2021-09-24","Blood donors","Multiple groups",9363.0,0.97,0.966,0.974,"Sequential","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Unverified","","",0.988,0.996,"","CA",""
"2021-12-23","211130_England_UKHSA_2020NovDec_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","United Kingdom of Great Britain and Northern Ireland","2020-11-01","2020-12-31","Residual sera","Children and Youth (0-17 years)",711.0,0.148,0.112,0.198,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Unverified","","NR",0.955,1.0,"","GB",""
"2021-12-23","211130_England_UKHSA_2020SepOct_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","United Kingdom of Great Britain and Northern Ireland","2020-09-01","2020-10-31","Residual sera","Children and Youth (0-17 years)",119.0,0.076,0.032,0.182,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Unverified","","NR",0.955,1.0,"","GB",""
"2021-12-23","211130_England_UKHSA_2021JanFeb_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","United Kingdom of Great Britain and Northern Ireland","2021-01-01","2021-02-28","Residual sera","Children and Youth (0-17 years)",970.0,0.233,0.184,0.295,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Unverified","","NR",0.955,1.0,"","GB",""
"2021-12-23","211130_England_UKHSA_2021JulAug_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","United Kingdom of Great Britain and Northern Ireland","2021-07-01","2021-08-31","Residual sera","Children and Youth (0-17 years)",685.0,0.264,0.201,0.353,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Unverified","","NR",0.955,1.0,"","GB",""
"2021-12-23","211130_England_UKHSA_2021MarApr_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","United Kingdom of Great Britain and Northern Ireland","2021-03-01","2021-04-30","Residual sera","Children and Youth (0-17 years)",925.0,0.315,0.253,0.391,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Unverified","","NR",0.955,1.0,"","GB",""
"2021-12-23","211130_England_UKHSA_2021MayJun_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","United Kingdom of Great Britain and Northern Ireland","2021-05-01","2021-06-30","Residual sera","Children and Youth (0-17 years)",1186.0,0.275,0.207,0.372,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Unverified","","NR",0.955,1.0,"","GB",""
"2021-12-23","211130_England_UKHSA_2021SepOct_Overall_AdjustedS","Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.","2021-11-30","National","United Kingdom of Great Britain and Northern Ireland","2021-09-01","2021-10-31","Residual sera","Children and Youth (0-17 years)",600.0,0.461,0.383,0.536,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Clarissa Oeser","UK Health Security Agency (UKHSA, formerly PHE)","https://dx.doi.org/10.1016/j.jinf.2021.11.019","Unverified","","NR",0.955,1.0,"","GB",""
"2021-12-23","211215_Lima_InstitutoNacionalMaternoPerinatal","Clinical and epidemiological characterization in the follow-up of newborns with COVID-19: a descriptive study.","2021-12-15","Local","Peru","2020-06-01","2020-09-30","Pregnant or parturient women","Adults (18-64 years)",4733.0,0.314,"","","Sequential","IgM; IgG","High","Journal Article (Peer-Reviewed)","Carmen Davila-Aliaga","Instituto Nacional Materno Perinatal","https://dx.doi.org/10.5867/medwave.2021.11.002141","Unverified","","NR","","","","PE",""
"2021-12-25","211211_England_UKHealthSecurityAgency_Round1_Total_S","Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England","2021-12-11","Regional","United Kingdom of Great Britain and Northern Ireland; England; Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham","2020-09-22","2020-10-17","Multiple general populations","Multiple groups",1755.0,0.169,"","","Unclear","IgG","High","Preprint","Shamez N. Ladhani","The UK Health Security Agency","https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text","Unverified","","NR","","","","GB","GB-ENG"
"2021-12-25","211211_England_UKHealthSecurityAgency_Round2_Total_S","Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England","2021-12-11","Regional","United Kingdom of Great Britain and Northern Ireland; England; Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham","2020-12-03","2020-12-17","Multiple general populations","Multiple groups",1766.0,0.225,"","","Unclear","IgG","High","Preprint","Shamez N. Ladhani","The UK Health Security Agency","https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text","Unverified","","NR","","","","GB","GB-ENG"
"2021-12-25","211211_England_UKHealthSecurityAgency_Round3_Total_S","Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England","2021-12-11","Regional","United Kingdom of Great Britain and Northern Ireland; England; Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham","2021-03-21","2021-04-21","Multiple general populations","Multiple groups",1803.0,0.481,"","","Unclear","IgG","High","Preprint","Shamez N. Ladhani","The UK Health Security Agency","https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text","Unverified","","NR","","","","GB","GB-ENG"
"2021-12-25","211211_England_UKHealthSecurityAgency_Round4_Total_S","Emergence of the Delta Variant and risk of SARS-CoV-2 infection in secondary school students and staff: prospective surveillance in 18 schools, England","2021-12-11","Regional","United Kingdom of Great Britain and Northern Ireland; England; Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham","2021-05-20","2021-07-14","Multiple general populations","Multiple groups",1294.0,0.692,"","","Unclear","IgG","High","Preprint","Shamez N. Ladhani","The UK Health Security Agency","https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text","Unverified","","NR","","","","GB","GB-ENG"
"2021-12-29","211210_India_ICMR_GenPop_OverallTestAdjust","Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.","2021-12-10","National","India; Andhra Pradesh,Assam,Bihar,Chhattisgarh,Gujarat,Haryana,Himachal Pradesh,Jammu & Kashmir,Jharkhand,Karnataka,Kerala,Madhya Pradesh,Maharashtra,Odisha,Punjab,Rajasthan,Tamil Nadu,Telangana,Uttar Pradesh,Uttarakhand,West Bengal","2021-06-14","2021-07-06","Household and community samples","Multiple groups",28975.0,0.668,0.655,0.68,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Manoj Murhekar","Indian Council of Medical Research","https://dx.doi.org/10.1371/journal.pmed.1003877","Unverified","","NR",0.8,0.99,"","IN",""
"2021-12-29","211210_India_ICMR_HCW_OverallTestAdjust","Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.","2021-12-10","National","India; Andhra Pradesh,Assam,Bihar,Chhattisgarh,Gujarat,Haryana,Himachal Pradesh,Jammu & Kashmir,Jharkhand,Karnataka,Kerala,Madhya Pradesh,Maharashtra,Odisha,Punjab,Rajasthan,Tamil Nadu,Telangana,Uttar Pradesh,Uttarakhand,West Bengal","2021-06-14","2021-07-06","Health care workers and caregivers","Multiple groups",7252.0,0.874,0.856,0.891,"Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Manoj Murhekar","Indian Council of Medical Research","https://dx.doi.org/10.1371/journal.pmed.1003877","Unverified","","NR",0.8,0.99,"","IN",""
"2022-01-01","211020_Leon_NationalAutonomousUniversityofNicaraguaatLeon_FebMar2021_TestAdj","Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in Leon, Nicaragua","2021-10-20","Local","Nicaragua","2021-02-15","2021-03-15","Household and community samples","Multiple groups",1243.0,0.347,0.312,0.382,"Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Fredman Gonzalez","The National Autonomous University of Nicaragua at León","10.1017/s0950268821002144","Unverified","","NR",0.952,0.967,"","NI",""
"2022-01-01","211213_Quebec_InstitutNationaldeSantePubliqueduQuebec","SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.","2021-12-13","Regional","Canada; Quebec","2020-07-06","2020-09-24","Health care workers and caregivers","Adults (18-64 years)",2056.0,0.117,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Nicholas Brousseau","Institut National de Sante Publique du Quebec","https://dx.doi.org/10.1503/cmaj.202783","Unverified","","NR",0.82,1.0,"","CA","CA-QC"
"2022-01-02","211108_Istanbul_UmraniyeTrainingandResearchHospital","Clinical course of COVID-19 in children with rheumatic disease under biologic therapy","2021-11-08","Local","Turkey","2020-04-01","2020-12-01","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",436.0,0.005,"","","Convenience","Not reported","Unclear","Presentation or Conference","Ferhat Demir","Umraniye Training and Research; Hospital","https://dx.doi.org/10.1186/s12969-021-00632-z","Unverified","","NR","","","","TR",""
"2022-01-02","211210_Rome_UniversityofRomeTorVergata","Factors associated with pre-vaccination sars-cov-2 infection risk among hospital nurses facing covid-19 outbreak","2021-12-10","Local","Italy","2020-03-01","2020-12-31","Health care workers and caregivers","Adults (18-64 years)",918.0,0.021,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Luca Coppeta","University of Rome Tor Vergata","https://dx.doi.org/10.3390/ijerph182413053","Unverified","","NR",0.986,0.995,"","IT",""
"2022-01-03","211210_California_SutterHealth_Overall","COVID-19 in pregnancy by race and ethnicity: Implications for development of a vaccination strategy.","2021-12-10","Regional","United States of America; California","2020-10-01","2020-12-31","Pregnant or parturient women","Adults (18-64 years)",4500.0,0.081,"","","Convenience","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Alice Pressman","Sutter Health","https://dx.doi.org/10.1177/17455065211063300","Unverified","","NR",1.0,0.998,"","US","US-CA"
"2022-01-04","211107_India_ESICMedicalCollegeAndHospital_OverallCrude","Screening of Asymptomatic Healthcare Workers for SARS-COV-2 for Occult Infections: A Cross-Sectional Study.","2021-11-07","Local","India; Telangana; Hyderabad","2020-10-15","2021-01-15","Health care workers and caregivers","Multiple groups",190.0,0.253,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Lakshmi Tadi","ESIC Medical College & Hospital","https://dx.doi.org/10.7759/cureus.19341","Unverified","","NR","","","","IN","IN-TG"
"2022-01-04","211127_Bydgoszcz_NicolausCopernicusUniversity_OverallIgG","The differences in the level of anti-sars-cov-2 antibodies after mrna vaccine between convalescent and non-previously infected people disappear after the second dose-study in healthcare workers group in Poland","2021-11-27","Local","Poland; Kuyavian-Pomeranian; Bydgoszcz","2020-07-15","2020-12-15","Health care workers and caregivers","Adults (18-64 years)",120.0,0.0,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Joanna Kwiecinska-Pirog","Nicolaus Copernicus University","https://dx.doi.org/10.3390/vaccines9121402","Unverified","","NR","","","","PL",""
"2022-01-04","211205_Tokyo_UniversityofTokyo_iFlashIgG","Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers.","2021-12-05","Local","Japan","2020-06-11","2020-12-22","Multiple populations","Adults (18-64 years)",10039.0,0.002,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Akihisa Mitani","University of Tokyo","https://dx.doi.org/10.1016/j.jiac.2021.11.020","Unverified","","NR","","","","JP",""
"2022-01-04","211213_MexicoCity_INCMNSZ_FollowUp","SARS-CoV-2 Infection Rate in Patients With Cancer and Health Care Workers in a Chemoradiotherapy Unit During the Pandemic: A Prospective Cohort in Mexico.","2021-12-13","Local","Mexico","2020-08-15","2020-09-30","Multiple populations","Multiple groups",97.0,0.072,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Monica Meneses-Medina","The National Institute of Medical Sciences and Nutrition Salvador Zubirán","https://dx.doi.org/10.1200/GO.21.00207","Unverified","","NR","","","","MX",""
"2022-01-06","211101_Kazan_ScientificResearchInstitutesofRospotrebnadzor_HCW","Study of features of humoral immune response to the new coronavirus infection covid-19 among healthcare workers","2021-11-01","Local","Russian Federation; Tatarstan; Kazan","2020-06-30","2020-07-27","Health care workers and caregivers","Adults (18-64 years)",60.0,0.467,"","","Simplified probability","IgG; IgM","High","Journal Article (Peer-Reviewed)","Irina Dmitrievna Reshetnikova","Scientific Research Institutes of Rospotrebnadzor","https://dx.doi.org/10.15789/2220-7619-SOT-1587","Unverified","","NR","","","","RU","RU-TA"
"2022-01-06","211101_Kazan_ScientificResearchInstitutesofRospotrebnadzor_nonHCW","Study of features of humoral immune response to the new coronavirus infection covid-19 among healthcare workers","2021-11-01","Local","Russian Federation; Tatarstan; Kazan","2020-06-30","2020-07-27","Essential non-healthcare workers","Adults (18-64 years)",61.0,0.213,"","","Simplified probability","IgG; IgM","Unclear","Journal Article (Peer-Reviewed)","Irina Dmitrievna Reshetnikova","Scientific Research Institutes of Rospotrebnadzor","https://dx.doi.org/10.15789/2220-7619-SOT-1587","Unverified","","NR","","","","RU","RU-TA"
"2022-01-08","200720_Guangzhou_NanfangHospital_Primary","Personnel protection strategy for healthcare workers in Wuhan during the COVID-19 epidemic","2020-07-20","Local","China; Hubei; Wuhan","2020-03-20","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",943.0,0.0,"","","Entire sample","IgG; IgM","High","Journal Article (Peer-Reviewed)","Fan Fan Hou","Nanfang Hospital","https://dx.doi.org/10.1093/PCMEDI/PBAA024","Unverified","","NR",0.873,0.995,"","CN","CN-42"
"2022-01-08","200720_Wuhan_NanfangHospital_Primary","Personnel protection strategy for healthcare workers in Wuhan during the COVID-19 epidemic","2020-07-20","Local","China; Hubei; Wuhan","2020-03-20","2020-04-15","Health care workers and caregivers","Adults (18-64 years)",7586.0,0.032,"","","Entire sample","IgG; IgM","","Journal Article (Peer-Reviewed)","Fan Fan Hou","Nanfang Hospital","https://dx.doi.org/10.1093/PCMEDI/PBAA024","Unverified","","NR",0.873,0.995,"","CN","CN-42"
"2022-01-08","211205_Jaipur_MahatmaGandhiMedicalCollege&Hospital_Overall","Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study.","2021-12-05","Local","India; Rajasthan; Jaipur","2020-12-15","2021-01-15","Blood donors","Adults (18-64 years)",534.0,0.429,"","","Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Ram Jaiswal","Mahatma Gandhi Medical College & Hospital","https://dx.doi.org/10.1016/j.transci.2021.103338","Unverified","","NR",0.9,1.0,"","IN","IN-RJ"
"2022-01-08","211227_Vellore_ChristianMedicalCollege_Jan2021_PopAdj","Community seroprevalence and risk factors for SARS CoV-2 infection in different subpopulations in Vellore, India and its implications for future prevention.","2021-12-27","Local","India","2021-01-01","2021-01-31","Household and community samples","Multiple groups",1228.0,0.285,0.223,0.337,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Divya Dayanand","Christian Medical College","https://dx.doi.org/10.1016/j.ijid.2021.12.356","Unverified","","NR","",0.976,"","IN",""
"2022-01-08","211227_Vellore_ChristianMedicalCollege_July2021_PopAdj","Community seroprevalence and risk factors for SARS CoV-2 infection in different subpopulations in Vellore, India and its implications for future prevention.","2021-12-27","Local","India","2021-07-01","2021-07-31","Household and community samples","Multiple groups",1205.0,0.716,0.628,0.805,"Stratified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Divya Dayanand","Christian Medical College","https://dx.doi.org/10.1016/j.ijid.2021.12.356","Unverified","","NR","",0.976,"","IN",""
"2022-01-08","211228_Deskati_UniversityofThessaly_Overall","Defining antibody seroprevalence and duration of humoral responses to sars-cov-2 infection and/or vaccination in a greek community","2021-12-28","Local","Greece; West Macedonia; Deskati","2021-06-06","2021-06-06","Household and community samples","Multiple groups",69.0,0.797,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ourania Kotsiou","University of Thessaly","https://dx.doi.org/10.3390/ijerph19010407","Unverified","","NR",0.999,1.0,"","GR","GR-C"
"2022-01-08","211228_Limburg_SouthLimburgPublicHealthService_Primary","Exposure Factors Associated With SARS-CoV-2 Seroprevalence During the First Eight Months of the COVID-19 Pandemic in the Netherlands: A Cross-sectional Study","2021-12-28","Regional","Netherlands; Limburg","2020-10-28","2020-12-23","Household and community samples","Multiple groups",10001.0,0.195,0.187,0.203,"Convenience","Total Antibody","High","Preprint","Demi Pagen","South Limburg Public Health Service","https://assets.researchsquare.com/files/rs-1159143/v1/ad6e3392-8480-4bf2-9e9a-37c27020976e.pdf?c=1640718437","Unverified","","NR",0.954,0.996,"","NL","NL-LI"
"2022-01-08","211228_MâncioLima_UniversityofSãoPaulo_AprtoMay2021","Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021.","2021-12-28","Regional","Brazil; Acre; Mâncio Lima","2021-04-15","2021-05-15","Household and community samples","Multiple groups",729.0,0.287,0.267,0.389,"Unclear","IgG","High","Journal Article (Peer-Reviewed)","Vanessa Nicolete","University of São Paulo","https://dx.doi.org/10.3201/eid2803.211993","Unverified","","NR",0.9,1.0,"","BR","BR-AC"
"2022-01-08","211228_MâncioLima_UniversityofSãoPaulo_OcttoNov2020","Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021.","2021-12-28","Regional","Brazil; Acre; Mâncio Lima","2020-10-15","2020-11-15","Household and community samples","Multiple groups",1215.0,0.335,0.332,0.448,"Unclear","IgG","Moderate","Journal Article (Peer-Reviewed)","Vanessa Nicolete","University of São Paulo","https://dx.doi.org/10.3201/eid2803.211993","Unverified","","NR",0.9,1.0,"","BR","BR-AC"
"2022-01-08","220101_England_UCLInstituteOfHealthInformatics_Primary","Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.","2022-01-01","Regional","United Kingdom of Great Britain and Northern Ireland; England","2020-06-01","2021-04-30","Multiple general populations","Multiple groups",4722.0,0.288,"","","Self-referral","IgG","Moderate","Journal Article (Peer-Reviewed)","Maria Krutikov","UCL Institute of Health Informatics","https://dx.doi.org/10.1016/S2666-7568(21)00282-8","Unverified","","NR","","","","GB","GB-ENG"
"2022-01-09","210921_Mumbai_UniversityofPittsburghMedicalCenter_Patients_Overall","From infection to immunity - Impact of COVID-19 across nine hemodialysis centres in Mumbai","2021-09-21","Local","India; Maharashtra; Mumbai","2020-03-24","2020-05-17","Residual sera","Multiple groups",110.0,0.373,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Viswanath Billa","University of Pittsburgh Medical Center","https://dx.doi.org/10.4103/ijn.IJN_361_20","Unverified","","NR","","","","IN","IN-MH"
"2022-01-09","210921_Mumbai_UniversityofPittsburghMedicalCenter_Staff_Overall","From infection to immunity - Impact of COVID-19 across nine hemodialysis centres in Mumbai","2021-09-21","Local","India; Maharashtra; Mumbai","2020-03-24","2020-05-17","Health care workers and caregivers","Multiple groups",85.0,0.435,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Viswanath Billa","University of Pittsburgh Medical Center","https://dx.doi.org/10.4103/ijn.IJN_361_20","Unverified","","NR","","","","IN","IN-MH"
"2022-01-09","211207_Milan_SanGiuseppeHospital_Total1stWave","Prevalence of SARS-CoV-2 amongst ophthalmologists throughout the first and second waves of the pandemic.","2021-12-17","Local","Italy","2020-03-15","2020-05-15","Health care workers and caregivers","Adults (18-64 years)",25.0,0.04,"","","Self-referral","IgG; IgM","High","Journal Article (Peer-Reviewed)","Matteo Sacchi","San Giuseppe Hospital","https://dx.doi.org/10.1097/MD.0000000000028192","Unverified","","NR","","","","IT",""
"2022-01-09","211220_Amsterdam_AmsterdamInfectionandImmunityInstitute_Overall","Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV.","2021-12-20","Local","Netherlands; North Holland; Amsterdam","2020-09-15","2021-04-15","Household and community samples","Multiple groups",563.0,0.108,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Myrthe Verburgh","Amsterdam Infection and Immunity Institute","https://dx.doi.org/10.1093/infdis/jiab616","Unverified","","NR",1.0,0.982,"","NL","NL-NH"
"2022-01-09","211223_TanjungPriok_CenterforIndonesia’sStrategicDevelopmentInitiatives_Primary","Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia.","2021-12-23","Local","Indonesia","2020-11-23","2021-02-19","Household and community samples","Adults (18-64 years)",3196.0,0.285,0.254,0.318,"Simplified probability","Not reported","Moderate","Journal Article (Peer-Reviewed)","Olivia Herlinda","World Health Organization, Geneva, Switzerland","https://dx.doi.org/10.1371/journal.pone.0261931","Unverified","","NR","",0.998,"","ID",""
"2022-01-09","211227_Kaduna_UniversityofGlasgow_KadunaCity_Primary","SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant","2021-12-27","Local","Nigeria; Kaduna","2021-10-11","2021-11-05","Residual sera","Multiple groups",400.0,0.425,"","","Convenience","IgG; IgM","High","Preprint","Gloria Chechet","University of Glasgow","10.1101/2021.12.21.21268166","Unverified","","NR","","","","NG","NG-KD"
"2022-01-09","211227_Kaduna_UniversityofGlasgow_Kofar-Gayan_Primary","SARS-CoV-2 seroprevalence in Kaduna State, Nigeria during October/November 2021, following three waves of infection and immediately prior to detection of the Omicron variant","2021-12-27","Local","Nigeria; Kaduna","2021-10-12","2021-11-08","Residual sera","Multiple groups",402.0,0.535,"","","Convenience","IgG; IgM","High","Preprint","Gloria Chechet","University of Glasgow","10.1101/2021.12.21.21268166","Unverified","","NR","","","","NG","NG-KD"
"2022-01-09","211227_Kenya_KEMRI-WellcomeTrustResearchProgramme_BloodDonors_Aug2021_WANTAI","Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations","2021-12-27","National","Kenya","2021-08-01","2021-08-31","Blood donors","Adults (18-64 years)",176.0,0.83,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","James Nyagwange","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1016/j.jcv.2021.105061","Verified","","NR",0.953,0.979,"","KE",""
"2022-01-09","211228_Ticino_Ufficiodelmedicocantonale_Phase4_OverallAdjusted","Seroprevalence of the SARS-CoV-2 virus in the population of the southern Switzerland (Canton Ticino) - cohort study, results at 12 months.","2021-12-28","Regional","Switzerland; Ticino","2021-05-03","2021-06-13","Household and community samples","Multiple groups",722.0,0.223,0.192,0.257,"Stratified probability","IgM; IgG","Moderate","Journal Article (Peer-Reviewed)","Ottavio Beretta","Ufficio del medico cantonale","https://smw.ch/article/doi/smw.2021.w30116","Unverified","","NR",0.951,0.989,"","CH","CH-TI"
"2022-01-09","220104_Wuhan_ZhongnanHospitalOfWuhanUniversity_IgG","Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown.","2022-01-04","Local","China; Hubei; Wuhan","2020-03-21","2020-05-21","Residual sera","Multiple groups",3062.0,0.075,"","","Convenience","IgG","Moderate","Journal Article (Peer-Reviewed)","Yueting Tang","Zhongnan Hospital of Wuhan University","https://dx.doi.org/10.1186/s12879-021-07010-w","Unverified","","NR",0.89,0.98,"","CN","CN-42"
"2022-01-09","220105_Bern_InselspitalUniversityHospital_ELISA_S1","Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study.","2022-01-05","Local","Switzerland","2020-04-15","2020-11-15","Multiple populations","Multiple groups",3658.0,0.063,"","","Sequential","IgG","Moderate","Journal Article (Peer-Reviewed)","Michael P Horn","Inselspital University Hospital","https://dx.doi.org/10.1111/all.15206","Unverified","","NR",0.862,0.982,"","CH",""
"2022-01-10","211102_Seattle_UniversityOfWashington_Baseline","25 Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children and adolescents with cystic fibrosis","2021-11-02","Local","United States of America; Washington; Seattle","2020-07-20","2021-02-28","Patients seeking care for non-COVID-19 reasons","Children and Youth (0-17 years)",125.0,0.04,"","","Convenience","IgG","High","Presentation or Conference","Georgene Hergenroeder","University of Washington","https://dx.doi.org/10.1016/S1569-1993%2821%2901450-8","Unverified","","NR","","","","US","US-WA"
"2022-01-10","211201_NorthernFrance_CentreHospitalierdeTourcoing","History of COVID-19 Symptoms and Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Northern France after the First Wave of the Pandemic.","2021-12-01","Local","France; Northern France; Tourcoing","2020-04-01","2020-08-01","Patients seeking care for non-COVID-19 reasons","Multiple groups",600.0,0.027,"","","Convenience","IgG; IgM","High","Journal Article (Peer-Reviewed)","Agnes Meybeck","Centre Hospitalier de Tourcoing","https://dx.doi.org/10.3390/microorganisms9122491","Unverified","","NR","","","","FR",""
"2022-01-10","211212_Italy_UniversitàdegliStudidiMilano_Overall","SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy.","2021-12-12","Regional","Italy; Northern Italy","2021-03-15","2021-06-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",434.0,0.148,0.115,0.184,"Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","Gianfranco Alicandro","Università degli Studi di Milano","https://dx.doi.org/10.1016/j.jcf.2021.12.011","Unverified","","NR",0.988,1.0,"","IT",""
"2022-01-10","211213_Estonia_UniversityOfTartu_Stage22_Overall","The study on the prevalence of the coronavirus in Estonia","2021-12-13","National","Estonia","2021-12-01","2021-12-13","Household and community samples","Multiple groups",2290.0,0.815,0.781,0.848,"Stratified probability","IgG","Moderate","Institutional Report","University of Tartu","Univeristy of Tartu","https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire","Unverified","","NR","","","","EE",""
"2022-01-10","211213_Sindh_ShaheedMohtarmaBenazirBhuttoMedicalUniversity_Primary","Seroprevalence of Anti-SARS-CoV-2 Antibodies in COVID-19 Patients in Hyderabad, Sindh","2021-12-13","Regional","Pakistan; Sindh; Hyderabad","2020-08-01","2020-11-30","Residual sera","Adults (18-64 years)",1229.0,0.168,"","","Convenience","Not reported","High","Journal Article (Peer-Reviewed)","Shahzad Rasheed Qureshi","Liaquat University of Medical and Health; Sciences","http://libraryaplos.com/xmlui/handle/123456789/8719","Unverified","","NR","","","","PK","PK-SD"
"2022-01-10","211221_GautengProvince_UniversityoftheWitwatersrand_PrimaryEstimate","South African Population Immunity and Severe Covid-19 with Omicron Variant","2021-12-21","Regional","South Africa; Gauteng Province","2021-10-22","2021-12-09","Household and community samples","Multiple groups",7010.0,0.731,0.72,0.741,"Stratified probability","IgG","Moderate","Preprint","Shabir Madhi","University of the Witwatersrand","10.1101/2021.12.20.21268096","Unverified","","NR","","","","ZA","ZA-GT"
"2022-01-10","211223_Lima_UniversidadPeruanaCayetanoHeredia","SARS-CoV-2 antibody status at time of delivery and the risk of preeclampsia","2022-01-01","Local","Peru; Lima; Lima","2020-08-01","2020-09-30","Pregnant or parturient women","Adults (18-64 years)",440.0,0.375,"","","Convenience","IgG; IgM","High","Presentation or Conference","Arianna Portmann-Baracco","Universidad Peruana Cayetano Heredia","https://dx.doi.org/10.1016/j.ajog.2021.11.1178","Unverified","","NR","","","","PE","PE-LIM"
"2022-01-10","211231_NewDelhi_HIMSR&HAHCHospital_Overall","Asymptomatic SARS-COV-2 carriage and sero-positivity in high risk contacts of COVID-19 cases","2021-12-31","Local","India","2020-09-15","2021-02-15","Contacts of COVID patients","Adults (18-64 years)",407.0,0.289,0.246,0.336,"Unclear","Total Antibody","High","Journal Article (Peer-Reviewed)","Ayan Kumar Das","HIMSR & HAHC Hospital","https://dx.doi.org/10.1016/j.ijmmb.2021.12.012","Unverified","","NR","","","","IN",""
"2022-01-10","220101_Philadelphia_ChildrensHospitalofPhiladelphia","36 Assessment of SARS-CoV-2 serostatus and hypertensive disorders of pregnancy","2022-01-01","Local","United States of America; Pennsylvania; Philadelphia","2020-04-15","2020-12-15","Pregnant or parturient women","Adults (18-64 years)",6192.0,0.092,"","","Convenience","IgG; IgM","Moderate","Presentation or Conference","Jourdan Triebwasser","Children’s Hospital of Philadelphia","https://dx.doi.org/10.1016/j.ajog.2021.11.092","Unverified","","NR","","","","US","US-PA"
"2022-01-10","220104_Wuerzburg_UniversityHospitalWuerzburg_ChildcareWorkers_AfterStudy","Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial","2022-01-04","Local","Germany; Bavaria; Wuerzburg","2021-03-01","2021-03-15","Essential non-healthcare workers","Multiple groups",109.0,0.046,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Johannes Forster","University Hospital Wuerzburg","https://dx.doi.org/10.1001/jamanetworkopen.2021.42057","Unverified","","NR","","","","DE","DE-BY"
"2022-01-10","220104_Wuerzburg_UniversityHospitalWuerzburg_ChildcareWorkers_BeforeStudy","Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial","2022-01-04","Local","Germany; Bavaria; Wuerzburg","2020-10-01","2020-10-15","Essential non-healthcare workers","Multiple groups",139.0,0.007,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Johannes Forster","University Hospital Wuerzburg","https://dx.doi.org/10.1001/jamanetworkopen.2021.42057","Unverified","","NR","","","","DE","DE-BY"
"2022-01-10","220104_Wuerzburg_UniversityHospitalWuerzburg_Children_AfterStudy","Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial","2022-01-04","Local","Germany; Bavaria; Wuerzburg","2021-03-01","2021-03-15","Students and Daycares","Multiple groups",338.0,0.024,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Johannes Forster","University Hospital Wuerzburg","https://dx.doi.org/10.1001/jamanetworkopen.2021.42057","Unverified","","NR","","","","DE","DE-BY"
"2022-01-10","220104_Wuerzburg_UniversityHospitalWuerzburg_Children_BeforeStudy","Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial","2022-01-04","Local","Germany; Bavaria; Wuerzburg","2020-10-01","2020-10-15","Students and Daycares","Multiple groups",381.0,0.003,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Johannes Forster","University Hospital Wuerzburg","https://dx.doi.org/10.1001/jamanetworkopen.2021.42057","Unverified","","NR","","","","DE","DE-BY"
"2022-01-11","211006_UnitedStates_UniversityofMinnesota_EarlyTreatment","Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials","2021-10-06","National","United States of America","2020-03-17","2020-05-20","Multiple populations","Multiple groups",123.0,0.29,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Sarah Lofgren","University of Minnesota","https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true","Unverified","","NR","","","","US",""
"2022-01-11","211006_UnitedStates_UniversityofMinnesota_PostexposureProphylaxis","Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials","2021-10-06","National","United States of America","2020-03-17","2020-05-20","Multiple populations","Multiple groups",266.0,0.11,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Sarah Lofgren","University of Minnesota","https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true","Unverified","","NR","","","","US",""
"2022-01-11","211006_UnitedStates_UniversityofMinnesota_Pre-exposureProphylaxis","Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials","2021-10-06","National","United States of America","2020-04-06","2020-07-13","Multiple populations","Multiple groups",542.0,0.04,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Sarah Lofgren","University of Minnesota","https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true","Unverified","","NR","","","","US",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_HungarianIntProgram","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Students and Daycares","Adults (18-64 years)",682.0,0.016,0.007,0.026,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified","","NR","","","","HU",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_HungarianProgram","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Students and Daycares","Adults (18-64 years)",956.0,0.006,0.0,0.011,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified","","NR","","","","HU",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_IntStudents","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Students and Daycares","Adults (18-64 years)",1832.0,0.021,0.014,0.027,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified","","NR","","","","HU",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_OtherHCW","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Health care workers and caregivers","Adults (18-64 years)",2926.0,0.018,0.014,0.023,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified","","NR","","","","HU",""
"2022-01-11","211215_Budapest_SemmelweisUniversity_Physicians","Acute SARS-CoV-2 infection and seropositivity among healthcare workers and medical students in summer 2020, Hungary.","2021-12-15","Local","Hungary; Central Hungary; Budapest","2020-07-01","2020-08-01","Health care workers and caregivers","Adults (18-64 years)",1552.0,0.015,0.009,0.022,"Convenience","IgG","High","Journal Article (Peer-Reviewed)","Annamaria Kosztin","Semmelweis University","https://dx.doi.org/10.13075/ijomeh.1896.01804","Unverified","","NR","","","","HU",""
"2022-01-11","211229_Lucknow_KingGeorgeMedicalUniversity_HCWs","SARS-CoV-2 IgG Surveillance in Asymptomatic Blood Donors and Health Workers.","2021-12-29","Local","India; Uttar Pradesh; Lucknow","2020-06-01","2020-06-30","Health care workers and caregivers","Adults (18-64 years)",560.0,0.023,0.011,0.036,"Simplified probability","IgG","High","Journal Article (Peer-Reviewed)","Tulika Chandra","King George Medical University","https://dx.doi.org/10.1155/2021/2404170","Unverified","","NR","","","","IN","IN-UP"
"2022-01-11","211229_UttarPradesh_KingGeorgeMedicalUniversity_blooddonors_Overall","SARS-CoV-2 IgG Surveillance in Asymptomatic Blood Donors and Health Workers.","2021-12-29","Regional","India; Uttar Pradesh; Lucknow","2020-06-01","2020-06-30","Blood donors","Adults (18-64 years)",2163.0,0.019,0.014,0.025,"Sequential","IgG","High","Journal Article (Peer-Reviewed)","Tulika Chandra","King George Medical University","https://dx.doi.org/10.1155/2021/2404170","Unverified","","NR","","","","IN","IN-UP"
"2022-01-12","211119_IwateMedicalUniversity_IwateMedicalUniversity","Investigation of antibody level by the presence or absence of side effects after the new coronavirus vaccine","2021-11-19","Local","Japan; Tohoku; Morioke","2021-03-15","2021-05-31","Health care workers and caregivers","Adults (18-64 years)",10.0,0.0,"","","Unclear","Not reported","High","Presentation or Conference","Hiromi Nagashima","Iwate Medical University","https://onlinelibrary.wiley.com/doi/full/10.1111/resp.14150_356","Unverified","","NR","","","","JP",""
"2022-01-12","211206_CochinHospital_ParisDescartesUniversity_Overall_Nonly","Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases","2021-12-06","Local","France; Île-de-France; Paris","2020-06-01","2020-08-31","Patients seeking care for non-COVID-19 reasons","Multiple groups",283.0,0.028,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Clothilde Gros","Paris Descartes Université","https://dx.doi.org/10.1016/j.jbspin.2021.105312","Unverified","","NR","","","","FR","FR-IDF"
"2022-01-12","211214_Amsterdam_UniversityofAmsterdam_Visit1","Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study.","2021-12-14","Local","Netherlands; North Holland; Amsterdam","2020-06-24","2020-10-09","Household and community samples","Multiple groups",2497.0,0.09,"","","Convenience","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Liza Coyer","University of Amsterdam","https://dx.doi.org/10.1016/j.lanepe.2021.100284","Unverified","","NR","","","","NL","NL-NH"
"2022-01-12","211214_Amsterdam_UniversityofAmsterdam_Visit2","Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological study.","2021-12-14","Local","Netherlands; North Holland; Amsterdam","2020-11-23","2021-06-04","Household and community samples","Multiple groups",2075.0,0.236,"","","Convenience","IgA; IgG; IgM","High","Journal Article (Peer-Reviewed)","Liza Coyer","University of Amsterdam","https://dx.doi.org/10.1016/j.lanepe.2021.100284","Unverified","","NR","","","","NL","NL-NH"
"2022-01-12","211214_NewDelhi_AllIndiaInstituteofMedicalSciences_overall","SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls.","2021-12-14","Local","India; National Capital Territory of Delhi; New Delhi","2020-10-01","2021-02-27","Multiple populations","Multiple groups",643.0,0.504,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Alpesh Goyal","All India Institute of Medical Sciences","https://dx.doi.org/10.1016/j.eprac.2021.12.009","Unverified","","NR","","","","IN","IN-DL"
"2022-01-12","211217_Lilongwe_UniversitatsmedizinBerlin","SARS-CoV-2 prevalence and immunity: a hospital-based study from Malawi.","2021-12-17","Local","Malawi; Central Region; Lilongwe","2020-08-24","2020-09-03","Multiple populations","Multiple groups",914.0,0.08,"","","Convenience","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","C Meinus","University of Malawi","https://dx.doi.org/10.1016/j.ijid.2021.12.336","Unverified","","NR","","","","MW","MW-C"
"2022-01-12","211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_GenPop3_Overall","Impact of cytokine inhibitor therapy on the prevalence, seroconversion rate and longevity of the humoral immune response against SARS-CoV-2 in an unvaccinated cohort.","2021-12-23","Local","Germany; Bavaria; Erlangen","2020-12-15","2021-03-15","Household and community samples","Multiple groups",1184.0,0.071,0.057,0.087,"Unclear","IgG","High","Journal Article (Peer-Reviewed)","David Simon","Friedrich-Alexander University (FAU) Erlangen-Nuremberg","https://dx.doi.org/10.1002/art.42035","Unverified","","NR","","","","DE","DE-BY"
"2022-01-12","211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_HCW2_Overall","Impact of cytokine inhibitor therapy on the prevalence, seroconversion rate and longevity of the humoral immune response against SARS-CoV-2 in an unvaccinated cohort.","2021-12-23","Local","Germany; Bavaria; Erlangen","2020-12-15","2021-03-15","Health care workers and caregivers","Multiple groups",455.0,0.112,0.085,0.145,"Unclear","IgG","High","Journal Article (Peer-Reviewed)","David Simon","Friedrich-Alexander University (FAU) Erlangen-Nuremberg","https://dx.doi.org/10.1002/art.42035","Unverified","","NR","","","","DE","DE-BY"
"2022-01-12","211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_Patients1_Overall","Impact of cytokine inhibitor therapy on the prevalence, seroconversion rate and longevity of the humoral immune response against SARS-CoV-2 in an unvaccinated cohort.","2021-12-23","Local","Germany; Bavaria; Erlangen","2020-12-15","2021-03-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",2869.0,0.042,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","David Simon","Friedrich-Alexander University (FAU) Erlangen-Nuremberg","https://dx.doi.org/10.1002/art.42035","Unverified","","NR","","","","DE","DE-BY"
"2022-01-12","211226_Chile_UniversidaddeChile_Overall","A cross sectional study found differential risks for COVID-19 seropositivity amongst health care professionals in Chile.","2021-12-26","National","Chile","2020-09-11","2020-10-24","Health care workers and caregivers","Multiple groups",85529.0,0.072,"","","Convenience","IgG; IgM","Moderate","Journal Article (Peer-Reviewed)","Marcela Zuniga","Universidad de Chile","https://dx.doi.org/10.1016/j.jclinepi.2021.12.026","Unverified","","NR",0.958,1.0,"","CL",""
"2022-01-12","211226_Male'_MaldivesNationalUniversity_overall","A sero-epidemiological study after two waves of the COVID-19 epidemic.","2021-12-26","Local","Maldives","2020-10-15","2020-11-16","Household and community samples","Multiple groups",1940.0,0.134,"","","Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Raheema Abdul-Raheem","Hulhumale’ Hospital","https://apjai-journal.org/wp-content/uploads/2022/01/AP-040721-1177.pdf","Unverified","","NR",0.9,1.0,"","MV",""
"2022-01-12","211227_Chicago_NorthwesternUniversity","COVID-19 vaccine intentions and uptake in a tertiary care healthcare system: A longitudinal study.","2021-12-27","Local","United States of America; Illinois; Chicago","2020-05-26","2020-07-10","Health care workers and caregivers","Adults (18-64 years)",4180.0,0.043,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Charlesnika Evans","Northwestern University Feinberg School of Medicine","https://dx.doi.org/10.1017/ice.2021.523","Unverified","","NR","","","","US","US-IL"
"2022-01-12","211229_Delhi_MaulanaAzadMedicalCollege_Overall_PopTestAdj","SARS-CoV-2 seroprevalence in Delhi, India: September October 2021: a population based seroepidemiological study","2021-12-29","Regional","India; Delhi; Delhi","2021-09-24","2021-10-14","Household and community samples","Multiple groups",27811.0,0.975,0.97,0.98,"Stratified probability","IgG","Low","Preprint","Pragya Sharma","Maulana Azad Medical College","https://www.medrxiv.org/content/10.1101/2021.12.28.21268451v1","Unverified","","NR",0.9,1.0,"","IN","IN-DL"
"2022-01-12","220103_Regensburg_UniversityHospitalRegensburg","[Low incidence of SARS-CoV-2 infections in healthcare workers at a tertiary care hospital: Results of a prospective serological cohort study of the first and second COVID-19 pandemic wave]","2022-01-03","Local","Germany; Bavaria; Regensburg","2020-03-15","2021-02-15","Health care workers and caregivers","Adults (18-64 years)",205.0,0.051,"","","Convenience","IgG; IgM; IgA","High","Journal Article (Peer-Reviewed)","Julian Hupf","University Hospital Regensburg","https://dx.doi.org/10.1007/s00063-021-00890-5","Unverified","","NR","","","","DE","DE-BY"
"2022-01-13","122221_MaricopaCounty_ArizonaStateUniversity_popadj","Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona.","2021-12-22","Local","United States of America; Arizona","2020-09-12","2020-10-01","Household and community samples","Multiple groups",260.0,0.14,0.072,0.24,"Stratified probability","Total Antibody","Moderate","Journal Article (Peer-Reviewed)","Megan Jehn","Arizona State University","https://dx.doi.org/10.2105/AJPH.2021.306568","Unverified","","NR",0.998,0.995,"","US","US-AZ"
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_ComorbidityNo","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",947.0,0.289,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_ComorbidityYes","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",159.0,0.27,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationBachelor","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",422.0,0.299,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationCompletedSecondary","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",258.0,0.298,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationMastersOrHigher","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",300.0,0.273,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationPrimary","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",53.0,0.264,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationSomeSecondary","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",73.0,0.247,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Female","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",278.0,0.313,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Male","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",823.0,0.278,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Married","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",883.0,0.282,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationGovernmentEmployee","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",682.0,0.286,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationPrivateSectorEmployee","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",184.0,0.293,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationShopOwner","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",168.0,0.262,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationTaxiDriver","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",72.0,0.333,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Overall","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",1106.0,0.287,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionHamedan","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Local","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Hamedan","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",338.0,0.26,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionKermanshah","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Local","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Kermanshah","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",362.0,0.273,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionSanandaj","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Local","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Sanandaj","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",406.0,0.32,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Single","Seroepidemiology of COVID-19 in high-risk occupational groups in west of Iran, November 2020","2021-10-07","Regional","Iran (Islamic Republic of); Three provinces of Kurdistan, Kermanshah, and Hamedan.; Three cities of Sanandaj, Kermanshah, and Hamedan.","2020-11-05","2020-11-15","Essential non-healthcare workers","Multiple groups",219.0,0.301,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Ghobad Moradi","Kurdistan University of Medical Sciences","http://jmums.mazums.ac.ir/article-1-16926-en.html","Unverified","","NR","","","","IR",""
"2022-01-13","211031_Belarus_StPetersburgPasteurInstitute_Overall","HERD IMMUNITY to SARS-CoV-2 among the POPULATION of the REPUBLIC of BELARUS AMID the COVID-19 PANDEMIC","2021-10-31","National","Belarus","2021-05-14","2021-05-19","Household and community samples","Multiple groups",12926.0,0.384,0.376,0.455,"Simplified probability","IgG","Moderate","Journal Article (Peer-Reviewed)","Anna Popova","St. Petersburg Pasteur Institute","https://dx.doi.org/10.15789/2220-7619-HIT-1798","Unverified","","NR","","","","BY",""
"2022-01-13","211113_Hannover_HannoverMedicalSchool_Overall_Roche+Neut","Children and Adolescents' Behavioral Patterns in Response to Escalating COVID-19 Restriction Reveal Sex and Age Differences.","2021-11-23","Local","Germany; Lower Saxony; Hannover","2020-06-15","2021-06-15","Students and Daycares","Children and Youth (0-17 years)",667.0,0.016,"","","Convenience","Total Antibody; Neutralizing","Moderate","Journal Article (Peer-Reviewed)","Mira Paulsen","Hannover Medical School","https://dx.doi.org/10.1016/j.jadohealth.2021.11.021","Unverified","","NR","","","","DE","DE-NI"
"2022-01-13","211227_Ghent_GhentUniversityHospital_AntiN","Comparison of the positivity rate of anti-spike and anti-nucleocapsid SARS-CoV-2 IgG in asymptomatic pregnant women.","2021-12-27","Local","Belgium; East Flanders; Ghent","2020-01-15","2020-11-15","Pregnant or parturient women","Adults (18-64 years)",265.0,0.0,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Laura Heireman","Ghent University Hospital","https://dx.doi.org/10.1080/01443615.2021.1997960","Unverified","","NR","","","","BE",""
"2022-01-13","211227_Ghent_GhentUniversityHospital_AntiS","Comparison of the positivity rate of anti-spike and anti-nucleocapsid SARS-CoV-2 IgG in asymptomatic pregnant women.","2021-12-27","Local","Belgium; East Flanders; Ghent","2020-01-15","2020-11-15","Pregnant or parturient women","Adults (18-64 years)",265.0,0.015,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Laura Heireman","Ghent University Hospital","https://dx.doi.org/10.1080/01443615.2021.1997960","Unverified","","NR","","","","BE",""
"2022-01-13","211227_Ghent_GhentUniversityHospital_Overall","Comparison of the positivity rate of anti-spike and anti-nucleocapsid SARS-CoV-2 IgG in asymptomatic pregnant women.","2021-12-27","Local","Belgium; East Flanders; Ghent","2020-01-15","2020-11-15","Pregnant or parturient women","Adults (18-64 years)",265.0,0.015,"","","Unclear","IgG","High","Journal Article (Peer-Reviewed)","Laura Heireman","Ghent University Hospital","https://dx.doi.org/10.1080/01443615.2021.1997960","Unverified","","NR","","","","BE",""
"2022-01-13","211228_Kanagawa_ ShonanFujisawaTokushukaiHospital_AbbottIgG-S","Antibody Responses to the BNT162b2 mRNA Vaccine in Healthcare Workers in a General Hospital in Japan: A Comparison of Two Assays for Anti-spike Protein Immunoglobulin G.","2021-12-28","Local","Japan; NR; Kanagawa","2021-04-15","2021-05-15","Health care workers and caregivers","Adults (18-64 years)",100.0,0.05,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Makoto Hibino","Shonan Fujisawa Tokushukai Hospital","https://dx.doi.org/10.2169/internalmedicine.8704-21","Unverified","","NR",1.0,1.0,"","JP",""
"2022-01-13","211231_RibeiraoPreto_ButantanInstitute_Primary","SARS-CoV-2 SEROLOGICAL CROSS-REACTIVITY TESTING IN BRAZILIAN BLOOD DONORS, OCTOBER-DECEMBER, 2019.","2021-12-31","Local","Brazil; Sao Paulo; Ribeirao Preto","2019-10-01","2019-12-31","Blood donors","Multiple groups",546.0,0.0,"","","Unclear","IgG; Neutralizing","High","Journal Article (Peer-Reviewed)","Victoria Simionatto Zucherato","Butantan Institute","https://dx.doi.org/10.1016/j.jinf.2021.12.041","Unverified","","NR","","","","BR","BR-SP"
"2022-01-14","211218_Italy_SanRaffaeleUniversity_Overall","COVID-19 in Solid Organ Transplant Recipient: Exploring Cumulative Incidence, Seroprevalence and Risk Factors for Disease Severity.","2021-12-18","Local","Italy; Milan; Milan","2020-02-15","2021-04-15","Patients seeking care for non-COVID-19 reasons","Multiple groups",291.0,0.103,"","","Convenience","IgG","High","Journal Article (Peer-Reviewed)","Rossana Caldara","Vita-Salute San Raffaele University","https://dx.doi.org/10.3390/biology10121349","Unverified","","NR",0.97,1.0,"","IT",""
"2022-01-14","211227_Kenya_KEMRI-WellcomeTrustResearchProgramme_BloodDonors_May2020_Wantai","Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations","2021-12-27","National","Kenya","2020-05-01","2020-05-31","Blood donors","Adults (18-64 years)",176.0,0.023,"","","Convenience","Total Antibody","High","Journal Article (Peer-Reviewed)","James Nyagwange","KEMRI-Wellcome Trust Research Programme","https://dx.doi.org/10.1016/j.jcv.2021.105061","Verified","","NR",0.953,0.979,"","KE",""
"2022-01-14","220103_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj","COVID-19 Seroprevalence Report January 3rd, 2022 Report #15: October 2021 Survey Tracking seroprevalence in the vaccine era","2022-01-03","National","Canada","2021-10-14","2021-10-23","Blood donors","Multiple groups",9627.0,0.98,0.976,0.984,"Sequential","Total Antibody","Moderate","Institutional Report","Canadian Blood Services","Canadian Blood Services","N/A","Unverified","","",0.988,0.996,"","CA",""
